pathway_name,pathway_source,num_overlapping_genes,overlapping_genes,num_all_pathway_genes,P_genes,Q_genes,num_overlapping_metabolites,overlapping_metabolites,num_all_pathway_metabolites,P_metabolites,Q_metabolites,P_joint,Q_joint
Metabolism,Reactome,860,RPL22;RPL23A;EPHX1;ACP6;RIDA;RPL24;GLYAT;RPL26;RPL27;RPL30;AADAC;RPL28;PLBD1;RPL32;GLRX5;GPHN;RPL34;RPL38;MAN2C1;MAN2B1;MANBA;ACACA;MAOA;MAOB;ACADM;ACADS;ACADSB;ACADVL;ACAT1;ACAT2;APOE;RPS3;MARS1;RPS4X;MAT2A;RPS5;ESD;ACOX1;CHDH;ACP5;NAT1;RPS8;RPS9;ETFA;RPS11;ETFDH;RPS13;RPS14;RPS15;RPS15A;AS3MT;CYGB;GCLM;L2HGDH;RPS16;PTGR2;RPS19;ISCA2;RPS21;RPS23;RPS24;RPS25;AKR1A1;RPS27;ACOT4;GMPR2;MDH1;ACY1;RRM1;ADA;CYP39A1;ME1;AUH;RXRA;NT5C;ACOX2;ACOX3;FABP4;FABP1;FABP7;ADH5;PIK3R4;ADH6;ADK;AFMID;ACSL4;PAOX;FAH;BPNT1;ESYT2;FASN;CEPT1;ACSM3;FBP1;SARS1;ADSL;PEMT;ACAD11;MGST2;MGST3;ST3GAL4;GSTA5;FDFT1;RPL36A;GM2A;AGL;CSAD;FDX1;DLAT;FDXR;FECH;OSBPL1A;AGXT;AHCY;ACACB;LYPLA1;SCP2;ACADL;PYGL;AK2;AK4;ACAA2;SLC25A11;RPL22L1;ALB;ECI2;ALDH1A1;CPOX;ALDH1B1;EPHX2;ALDH9A1;ALDH3A2;ALDOA;DHRS7B;ALDOB;DHTKD1;AKR1B1;BBOX1;ALDH6A1;ATP5PD;SLC25A17;PPP1CC;MOCS1;SDHA;SDHB;SDHC;SDHD;OPLAH;SEC13;MCAT;MPST;PTGES2;AMPD2;AMT;ISYNA1;ASRGL1;STAB2;ACLY;RAE1;HACD3;RPS6;ACAD9;COQ5;NT5C3A;CPT1A;GNB1;IYD;GNB2;AOX1;ABCD1;LARS1;VNN1;SHMT1;SHMT2;GPAM;APOA1;APOA2;APOA4;SRR;SCLY;IDH3G;APOC2;APOC3;PLEKHA6;FXN;MTHFS;ACSF2;DNPH1;NUBPL;APRT;RPS10;ECSIT;PAICS;AKT1S1;DEGS1;SLC2A2;KMO;PDXK;ARF1;NUP35;NMRAL1;SACM1L;AKR7A2;ARG1;TPK1;SLC23A1;RPIA;ATP5MG;TKFC;HSD3B7;GLRX;SEPHS2;VAC14;NDUFAF4;PIPOX;SLC10A1;ARSB;STS;MT-ATP8;MT-CO1;MT-CO2;MT-CO3;MTAP;GSTK1;PTGR1;SLC16A1;SLC25A12;NUDT9;ASAH1;SLC25A1;ASL;FLAD1;MT-ND1;ASNS;MT-ND3;EBP;ASPA;PPA2;ASS1;AKR7A3;NT5C2;CNDP2;GOT2;AGK;ABCB11;MPC1;UQCRQ;ALDH4A1;SLC27A2;COASY;MOCOS;GNS;PLPP3;KDSR;DMAC2L;PTGES3;SLC37A4;ATP5F1A;GAA;ALDH7A1;MVK;ACSL5;ATP5F1B;SORD;MTHFD1;ATP5F1D;ATP5PB;ATP5ME;ATP5PF;CMPK1;PECR;UPB1;GALK1;ATP5PO;GLS2;GALT;GAMT;HMOX2;GAPDH;SPR;ACOT13;NADK2;CDS2;STARD10;BAAT;SRD5A1;NAGLU;AKR1D1;SRM;GBA;GBE1;LHPP;GC;GCDH;RBKS;BCKDHA;BCKDHB;GCH1;GCK;GCKR;NDUFA2;ALDH1L1;TIMMDC1;NDUFA5;RANBP2;NDUFA6;NDUFA7;NDUFA8;GNMT;SUCLG2;NDUFAB1;SUCLA2;NDUFB2;NDUFB3;NDUFB4;NDUFB5;NDUFB6;NDUFB7;NDUFB8;NDUFB10;NDUFC1;BDH1;NDUFS1;NDUFS2;NAGS;NDUFS3;NDUFV1;NDUFS4;NDUFS8;NDUFV2;IQGAP1;BHMT;NUP205;SULT1E1;RPL10A;APOM;GPD1L;BLVRA;BLVRB;HOGA1;NUP133;ADHFE1;DUOX1;SULT1B1;HEXA;BPGM;BPHL;NDUFA12;GLB1;SULT1A1;GNG12;SULT1C2;SUOX;GCLC;BSG;GLDC;ALDH1L2;BTD;SGPL1;GLO1;GLS;NUP210;GLUD1;UGT2A1;CPNE3;GLUL;FAAH;CALM1;CPNE1;ACSF3;GNA11;GNAI2;ACOT2;GNAQ;GNAS;NME1;NME2;NME3;GPT2;NQO2;COX15;NNMT;TALDO1;KYNU;NUP160;SDS;TAT;GOT1;SLC27A5;CA3;CA5A;PNP;CKB;GPD1;GPD2;GPI;LIAS;WASL;SLC25A20;CAD;GLYATL1;NUDT16;MLX;GART;MAT2B;HYKK;NT5E;HEXB;ESYT1;GPT;GPX1;GPX4;NUP98;AMDHD1;GLYATL2;OAT;PFKL;ACAD10;RPL14;TDO2;CAV1;NFS1;SERPINA6;ABHD14B;OGDH;HIBADH;CBR1;CBS;KYAT1;RBP4;GSR;GSS;GSTA1;GSTA2;GSTA3;GSTA4;GSTM1;MMAA;GSTM2;GSTM4;CBR4;GSTP1;GSTT1;GSTT2;GSTZ1;OSBP;OTC;ADO;NUDT5;GCAT;MDH2;GUK1;NAPRT;MMUT;TKT;GYG1;INMT;ETHE1;QPRT;GYS2;ISCU;CD38;PAH;TM7SF2;DGAT1;MGST1;HAAO;KYAT3;ST3GAL6;COX7A2L;MSMO1;HSD17B10;HAGH;HADHA;CARNMT1;RPL35;HADH;HAL;ACMSD;PNPLA7;MMAB;PC;PCBD1;PCCA;PCCB;NNT;SLC22A1;ENTPD8;PCK2;CHP1;TPI1;VAPB;VAPA;CMBL;TPMT;TPR;HGD;PCYT1A;SDSL;CDO1;PHYKPL;AIP;DDAH1;HK1;PIK3R1;HK3;AIMP1;PDHA1;FH;PDHB;PDK1;PDK2;SLCO2B1;PDK4;ENPP1;AMACR;COX5A;SLC25A10;GLYCTK;ELOVL5;ACOT7;HMBS;CDIPT;PFAS;MGLL;CA14;HMGCL;CYC1;HMGCS1;HMGCS2;PAPSS2;HMOX1;HAO1;TST;CHKB;PON3;UQCR10;PGAM1;SQOR;TTPA;PLA2G15;TTR;FMO1;ENOPH1;PGM1;NADSYN1;TXNRD1;RPL23;CKM;PHKB;SLC25A32;PHKG2;ACOT8;PHYH;VKORC1;CTPS2;MT-ND5;UBE2I;GRHPR;GGCT;HPD;IMPA2;PI4KA;HPRT1;ACAD8;VKORC1L1;HSD17B13;UGDH;BHMT2;UGP2;PKLR;PKM;PGLS;UGT2B10;UGT2B15;FADS2;OSBPL8;PIP4P1;UMPS;PITPNB;PISD;PLCB3;UQCRB;MLYCD;UQCRC1;UQCRC2;HSD11B1;ABCC2;UROD;HSD17B2;HSD17B4;TXN2;GSTO1;ALAD;STARD5;NAXE;MTARC1;VDAC1;HSP90AB1;CERS2;DMGDH;INPP1;NDUFB11;SUMF2;MPC2;PGD;UQCRFS1;COMT;NMNAT1;MBOAT7;UQCRH;COX4I1;IARS1;COX5B;TECR;CYB5B;COX6A1;PGP;ACBD5;COX6C;PON1;PON2;COX7C;POR;XDH;PM20D1;ATP5MF;ETNPPL;SAMHD1;PPA1;IDH1;IDH2;IDH3A;IDH3B;CPS1;IDI1;PPAT;CPT2;CTSA;D2HGDH;CRAT;NDUFA11;PPOX;PPP1CA;PPP1CB;NMNAT3;ACOT12;UGT1A3;AGXT2;IDO2;PPP2CB;PPP2R1A;GDA;CRYM;CROT;CS;PPP2R5D;NUP155;PPT1;PRELP;LYRM4;CSNK2A1;CSNK2A2;CSNK2B;AASS;PRKAA2;AGMO;PRKACA;PRKACB;HELZ2;PRKAR1A;PRKAR2A;PRKCA;HACL1;PNPLA8;HSP90AA1;CTH;NUP93;SELENOI;ACO2;FITM2;NAXD;ADPGK;CYB5A;UROC1;GDPD1;CYP1A2;MAT1A;MCCC2;RPS3A;PYGB;RPLP0;SPHK2;NDUFA3;NDUFS7;GUSB;FTCD;PSAP;NUP58;IMPDH2;CYP2E1;RARS1;EEFSEC;CYP4B1;CYP7A1;CYP8B1;COQ3;ACSS2;ACY3;CYP27A1;ACSM1;AGPAT3;NDUFA9;BDH2;DAO;SUCLG1;DARS1;DBI;MCCC1;PSPH;DBT;ECI1;DCN;RETSAT;DDC;AKR1C1;PTGS1;ENTPD5;LCLAT1;ITPA;ITPR2;MRI1;IVD;DECR1;HSD17B7;SLC26A1;FMO3;NDUFC2;CHPT1;HIBCH;PTS;DGUOK;DHCR7;DHCR24;DHFR;COQ9;DHODH;CYB5R3;NQO1;PXMP2;NADK;DIO1;LPGAT1;PCYT2;DLD;ACSM5;DLST;KHK;XYLB;BGN;SARDH;QARS1;QDPR;RAB4A;RAB5A;PYCR3;HSD17B8;DNM2;PLD4;ACSS3;KPNB1;NUDT19;NDUFA4;GMPS;DPEP1;RAN;DPYD;DPYS;HADHB;RAP1A;NDUFV3;EPM2A;GNPDA1;AIMP2;NDUFAF2;EEF1E1;AGPAT2;ASPG;PTPMT1;RRM2B;RBP1;COQ6;GCSH;ATIC;RPS17;RPSA;MCEE;TYMP;LDHA;ECHS1;PPCS;CERT1;LDHB;ETFB;PDHX;RPS27L;PNPO;DERA;PGM2;CRYL1;RAB14;SEPSECS;NAMPT;FADS1;MECR;NDUFAF1;BCO2;RDH11;PCK1;SHPK;EHHADH;APOB;MARCKS;TMLHE;LPCAT3;SLC25A13;SLC25A15;UGT2A3;IMPA1;COQ7;ACSL1;LRP1;HSD17B12;PRODH2;LSS;LTA4H;ADI1;LUM;PIP4K2C;AADAT;FAHD1;HSD17B11;ENO1;RPE;RPL3;HAO2;RPL4;RPL5;RPL18;RPL6;RPL7A;RPL8;RPL9;RPL11;RPL12;RPL13;RPL17;HPGDS;RPL18A;RPL19,1952 (1954),1.6e-174,7.51e-171,101,HMDB0006842;HMDB0035312;HMDB0033934;HMDB0000172;HMDB0006271;HMDB0000472;HMDB0000036;HMDB0004878;HMDB0004842;HMDB0001416;HMDB0001388;HMDB0006841;HMDB0006528;HMDB0000077;HMDB0000189;HMDB0006894;HMDB0012455;HMDB0001231;HMDB0000687;HMDB0002183;HMDB0000244;HMDB0062206;HMDB0000043;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0062259;HMDB0001090;HMDB0000054;HMDB0001920;HMDB0001186;HMDB0003134;HMDB0000145;HMDB0002995;HMDB0014813;HMDB0240251;HMDB0001976;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0003550;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0002719;HMDB0006281;HMDB0062420;HMDB0000032;HMDB0002104;HMDB0000840;HMDB0001178;HMDB0060136;HMDB0001170;HMDB0001547;HMDB0001325;HMDB0000279;HMDB0000015;HMDB0001016;HMDB0000290;HMDB0003944;HMDB0000637;HMDB0000951;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0006763;HMDB0004067;HMDB0012130;HMDB0000195;HMDB0001342;HMDB0001276;HMDB0006734;HMDB0001229;HMDB0003349#HMDB0000528;HMDB0030020;HMDB0004949;HMDB0006344;HMDB0060050;HMDB0006543;HMDB0001052;HMDB0000876;HMDB0000304;HMDB0006454;HMDB0001934;HMDB0000123;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0062321;HMDB0006519;HMDB0001286;HMDB0001188;HMDB0000067;HMDB0010213;HMDB0041905;HMDB0001043;HMDB0004080;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314;HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0000234;HMDB0003208;HMDB0001251;HMDB0000138;HMDB0013195;HMDB0000653;HMDB0062325;HMDB0001457;HMDB0001993,863 (1411),0.144,1,9.29e-173,3.18e-169
Metabolism of amino acids and derivatives,Reactome,209,RPL22;RPL23A;RIDA;RPL24;HGD;RPL26;RPL27;CDO1;RPL28;PHYKPL;RPL32;RPL34;RPL38;RPL36A;RPLP0;INMT;EEFSEC;HAO1;ACADSB;AUH;ACAT1;AIMP1;PDHA1;PDHB;RPS3;MARS1;MAT1A;RPS5;RPS6;CHDH;RPS19;RPS8;RPS9;RPS10;RPS11;NMRAL1;RPS14;RPS15;RPS15A;SDSL;PIPOX;RPL30;DAO;GCDH;BCKDHA;BCKDHB;RPS21;RPS23;RPS24;RPS25;MCCC2;RPS27;FTCD;MCCC1;PSPH;GCSH;TST;GNMT;NDUFAB1;SQOR;DDC;AHCY;ENOPH1;PAH;NAGS;BHMT;TXNRD1;GLUL;AFMID;CKM;PAOX;FAH;PRODH2;DUOX1;SARS1;HIBCH;GRHPR;SUOX;HPD;GLDC;GLS2;HOGA1;SRM;CSAD;GLS;KMO;GLUD1;AGXT;BHMT2;NQO1;PXMP2;DIO1;GAMT;DLAT;DLD;DLST;RPL22L1;PAPSS2;SARDH;ALDH9A1;GPT2;QARS1;TXN2;NNMT;DHTKD1;BBOX1;ALDH6A1;KYNU;PYCR3;SDS;TAT;CTH;GOT1;GOT2;RPL10A;MPST;DMGDH;LIAS;RPS3A;RPL35;AMT;MRI1;ASRGL1;RPS4X;AIMP2;DBT;RPL23;HYKK;ASPG;CKB;IARS1;EEF1E1;IYD;GPT;LARS1;AMDHD1;SHMT1;OAT;RPSA;SRR;SCLY;RPL14;TDO2;QDPR;CPS1;ECHS1;OGDH;HIBADH;CBS;AKT1S1;PDHX;KYAT1;RPS17;GSR;RPS27L;IVD;RPS13;ARG1;AGXT2;GSTZ1;IDO2;SEPHS2;OTC;SEPSECS;CRYM;ACAD8;MTAP;SLC25A12;ADO;RARS1;GCAT;AASS;TMLHE;ETHE1;ASL;SLC25A13;SLC25A15;RPS16;ASNS;ASPA;SLC25A10;ASS1;RPL9;HAAO;KYAT3;ALDH4A1;HSD17B10;CARNMT1;ADI1;HAL;DARS1;ACMSD;AADAT;PCBD1;UROC1;RPL3;RPL4;RPL5;RPL6;RPL7A;RPL8;ALDH7A1;RPL11;RPL12;RPL13;RPL17;RPL18;RPL18A;RPL19,339 (339),1.81e-69,4.23e-66,17,HMDB0001229;HMDB0001186;HMDB0033934;HMDB0006454;HMDB0002104;HMDB0000472;HMDB0004067;HMDB0000279;HMDB0000123;HMDB0000172;HMDB0012130;HMDB0240251;HMDB0001052;HMDB0001325;HMDB0000043;HMDB0001276;HMDB0000687,222 (286),0.956,1,2.76e-67,4.71e-64
The citric acid (TCA) cycle and respiratory electron transport,Reactome,116,ATP5F1D;ATP5PB;CYC1;ATP5ME;ATP5PF;NDUFS7;NDUFA4;ATP5PO;PDHA1;PDHB;PDK1;PDK2;PDK4;ACO2;ECSIT;ETFA;ETFB;ETFDH;L2HGDH;NDUFAB1;NDUFA2;NDUFA3;TIMMDC1;NDUFA5;NDUFA6;NDUFA7;NDUFA8;MDH2;NDUFA9;SUCLG2;SUCLG1;SUCLA2;NDUFB2;NDUFB3;NDUFB4;NDUFB5;NDUFB6;NDUFB7;NDUFB8;ME1;NDUFB10;NDUFC1;NDUFC2;NDUFS1;NDUFS2;NDUFS3;NDUFV1;NDUFS4;NDUFS8;NDUFV2;NDUFV3;ADHFE1;NDUFA12;COX5A;BSG;GLO1;DLAT;DLD;DLST;UQCRB;UQCRC1;UQCRC2;UQCRFS1;UQCRH;FH;D2HGDH;ATP5PD;SDHA;SDHB;SDHC;SDHD;NDUFB11;MPC2;NDUFAF2;COX4I1;ACAD9;COX5B;COX6A1;COX6C;COX7C;PM20D1;ATP5MF;IDH2;IDH3A;IDH3B;IDH3G;NUBPL;UQCR10;LDHA;OGDH;LDHB;PDHX;NDUFA11;ATP5MG;GSTZ1;NDUFAF4;CS;MT-ATP8;NDUFAF1;MT-CO1;MT-CO2;MT-CO3;SLC16A1;MT-ND1;MT-ND3;MT-ND5;MPC1;COX7A2L;UQCRQ;HAGH;FAHD1;DMAC2L;NNT;ATP5F1A;ATP5F1B;VDAC1,162 (162),7.8e-49,1.22e-45,0,,46 (59),1,1,8.71e-47,9.93e-44
Metabolism of proteins,Reactome,606,RPL22;RPL23A;RPL24;RPL26;RPL27;RPL30;STAM2;AARS1;RPL32;RPL34;MAN1A1;MAN2A1;RPL36A;RPLP0;MRPL12;RPN1;RPN2;BET1;RPS3;MARS1;RPS4X;RPS5;RPS6;SMC1A;MRPL37;RPS8;RPS9;RPS10;RPS11;RPS13;RPS14;RPS15;RPS15A;EIF3C;RPS16;RPS17;RPS19;RPS21;RPS23;RPL28;ACTL6A;RPS27;F2;TFG;F9;RXRA;RAB8A;TUBA1B;PARP1;TUBB4B;FARSA;MGAT1;SAFB;RPL38;ACTR1A;OTULIN;MIA2;AARS2;MAVS;EEF1E1;CCT2;UCHL5;VARS1;AGT;ATXN3;FGA;COMMD10;RPL22L1;ALB;FGG;GNA11;TGOLN2;LMAN2;COG5;PFDN6;MRRF;EIF3M;SEC23A;VCPIP1;MPI;PPA1;CUL4B;CUL4A;CUL3;CUL2;CUL1;AMFR;COG2;RPS3A;MIA3;SCFD1;MRPL17;CCDC22;NUDT14;USP9X;ANK1;FN1;NOP56;ANPEP;MCFD2;SPCS1;MRPS18B;PARK7;RNF135;OTUB1;COMMD5;LARS1;ARFGEF2;APCS;APEH;CCT7;APOA1;ST6GAL1;APOB;CARS2;ST3GAL4;COPS3;SEC31A;COPS6;APOE;TARS2;RAB14;SKIV2L;SKP1;USP15;RAB6B;AP3M1;PABPC1;ETFB;RAB18;ARCN1;YARS1;ARF1;NUP35;ARF4;ARF5;MSRA;RHOA;MSRB2;ARFGAP2;NOP58;IARS2;ARSB;STS;BABAM1;RUVBL1;RAB13;DPH5;CCT5;GOLGA2;YKT6;COMMD9;ASGR1;ASGR2;RABGGTA;ARFGAP1;NUP155;PPA2;COMMD7;MRPS23;NUP133;PTRH2;CCT8;MRPS34;DYNC1LI2;SERPINC1;EIF3A;EIF3B;TRAPPC3;EIF3D;EIF3F;EIF3G;EIF3H;EIF3I;EIF3J;SYVN1;RAB21;USO1;STAG2;SEC24C;RPS24;RPS25;UAP1;SNX3;CAND1;GBF1;GALNT2;CUL5;SEC24A;SPTA1;SPTAN1;SPTB;SPTBN1;SPTBN2;RAB11A;MRPL43;MRPS27;GBA;SRP9;SRP14;SRP19;SRP68;SRP72;SRPRA;MRPS36;SSR1;SSR3;CMAS;DPM1;GFPT1;GGCX;STAT3;NUP205;COMMD6;RPL10A;NEDD8;MRPS30;RAB10;GANAB;STX5;PSME4;GLB1;GNG12;COPS8;VNN1;RARS1;RAB30;NAE1;NUP210;EIF2B4;EIF2B3;EIF2B2;EIF2B5;EIF2S2;KDELR1;HNRNPK;EIF3K;SEC61B;ANKRD28;OS9;C3;TMED2;C4A;GNAQ;CKAP4;TMED10;GNB1;GNB2;MRPL49;MAT2B;COPS5;NUP160;TARS1;TBCA;TBCD;FUCA1;NPM1;ELOC;ELOB;RAB35;DCAF11;RAB31;CALM1;TCP1;ADRM1;NSF;CALR;CALU;WDR61;CANX;TUBA1C;GPS1;NUCB1;CAPZA1;USP24;NUP98;NAT8;ACTB;UBA3;UBE2M;RPL14;NCSTN;NR3C1;TF;PDIA3;GGA1;COMMD3;CAPZA2;GSPT1;CAPZB;USP14;MGAT2;USP10;USP8;HARS2;DCUN1D1;OXA1L;TMED7;SMC3;P4HB;NANS;SARS1;MRPS25;SEC11A;HGS;SEC23IP;H2AX;ST3GAL6;MRPL3;RPL35;HARS1;RNF139;CDH2;SERPIND1;TOP1;TOP2B;RAD21;PCMT1;PCNA;HDAC2;NPL;PIGN;TPR;RAB11B;HSP90B1;HIF1A;UBE2K;DDX58;CCT3;AIMP1;CTSC;COPE;PSME3;DPM3;PEX13;PEX14;PFDN1;PFDN2;PFDN4;PFDN5;GFUS;COPS2;TUBA4A;HNRNPC;TUFM;PGM3;RAB38;TBCB;RPL23;SPCS3;SERPINA1;UBA1;UBE2D3;UBE2G1;UBE2G2;UBE2H;UBE2I;UBE2L3;UBE2N;UBE2V2;STX17;RAB43;UCHL3;ALG5;UFD1;MRPS21;FBXO7;COPZ1;FKBP8;PLG;YARS2;GMPPB;GMPPA;SEC61A1;HSPA5;COG4;HSPA8;MTRF1L;VCP;VDAC1;VDAC2;PML;PMM2;ENGASE;PREB;SUMF2;PSMF1;WARS1;EIF4H;COPB1;RAB8B;IARS1;ERO1A;GOSR1;UGGT1;GNPNAT1;CP;BRCC3;SEC22B;IDE;GOSR2;CTSA;BABAM2;PDIA6;PSMB5;ALG2;DAD1;IGF1;IGFALS;NARS1;MRPL14;PPP6C;NAPG;NAPA;CSNK1D;CSNK2A1;CSNK2A2;CSNK2B;MRPS26;PSMC5;DYNLL2;MRPS11;EIF5B;MRPS5;TMED9;CTBP1;PRKCSH;NUP93;DARS1;VDAC3;GFM1;CTSD;CTSH;SEC13;DNAJC3;MRPL9;MRPL1;CTSZ;RAB33B;PSMD11;SEL1L;TRIM25;TRAM1;DCAF8;MLEC;NGLY1;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;SPCS2;PSMB6;PSMB7;PSMB8;PSMB9;PSMB10;PSMC1;PSMC2;PSMC3;PSMC4;MRPL19;PSMC6;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;TUBB2B;PSMD12;PSMD13;PSME1;PSME2;NUP58;DCTN1;DDB1;MRPS22;DDOST;XRN2;DDX5;COPS7A;PSMD6;DAP3;TOMM70;SEC24D;SARS2;FBXO6;FBXO4;MOGS;MRPL16;CD59;ITIH2;ARFGAP3;ERO1B;SEC16A;RAE1;USP7;PEX2;PEX5;RAB7A;STT3A;COPA;DERL1;KIFC3;QARS1;RAB1A;RAB2A;PARS2;RAB4A;RAB5A;RAB5B;RAB6A;UBE2Z;DYNC1H1;KNG1;RABGGTB;DYNC1I2;RAB5C;USP47;RAB1B;RBX1;PTCD3;RAD23A;RAD23B;DCTN2;SEC16B;DPP4;TTLL12;RANBP2;RANGAP1;ABRAXAS2;AIMP2;GNE;APOA5;LONP2;MRPL47;COG7;ETF1;KTN1;FN3KRP;DERL2;RCN1;UBA2;SAE1;FARSB;LAMB2;ALG11;MRPS16;RPSA;RELA;UBXN1;LGALS1;TSFM;RPS27L;EEF1A1;CCT6A;MRPL4;ENPEP;EEF1B2;USP5;EEF1G;EEF2;LMAN1;LMO7;TRIM28;MRPS2;EIF2S1;EIF2B1;COMMD2;EIF4A1;EIF4A2;SAR1B;EIF4E;EIF4G1;EIF5A;COPS4;UBA6;DYNC1LI1;SERPINA10;COPG2;CCT4;DCTN3;APOA2;RPL17;PSMD14;RPL3;RPL4;RPL5;RPL6;RPL7A;RPL8;RPL9;RPL11;RPL12;RPL13;PPP6R3;RPL18;RPL18A;RPL19,1934 (1935),8.82e-47,1.03e-43,16,HMDB0001547;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0033934;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0030020;HMDB0011669;HMDB0000123;HMDB0000172;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0000195;HMDB0001445;HMDB0000290;HMDB0060579;HMDB0001090;HMDB0000687;HMDB0000304,131 (288),0.327,1,3.12e-45,2.67e-42
Translation,Reactome,168,RPL22;RPL23A;RPL24;RPL26;RPL27;RPL30;RPL28;AARS1;RPL32;RPL34;RPL38;EIF2B1;RPL36A;RPLP0;MRPL12;AIMP1;RPN1;RPN2;RPS3;RPS3A;RPS4X;RPS5;RPS6;MRPL37;RPS19;RPS8;RPS9;RPS10;SPCS2;RPS13;RPS14;RPS15;RPS15A;MRPS27;NARS1;SRP9;SRP14;SRP19;MRPL19;RPS17;SRP72;SRPRA;DARS1;RPS21;RPS23;RPS24;RPS25;RPS27;SSR1;SSR3;MRPS36;AIMP2;MRPS21;MRPS22;DDOST;TUFM;RPL10A;MRPS30;RPL23;DAP3;SPCS3;FARSA;SARS2;SARS1;AARS2;MRPL16;EEF1A1;WARS1;MRPS34;EIF2B4;EIF2B3;EIF2B2;EIF2B5;EIF2S2;YARS1;EIF3K;SEC61B;RPL22L1;CARS2;MRPL49;SEC61A1;MRRF;EIF3M;TARS1;MTRF1L;PTCD3;MRPL3;MARS1;RPL35;RARS1;EIF4H;EIF3H;MRPL47;SPCS1;MRPS18B;IARS1;EEF1E1;LARS1;APEH;FARSB;MRPS16;RPSA;QARS1;RPL14;PPA1;TARS2;EIF4A1;ETF1;PABPC1;RPS11;PARS2;TSFM;GSPT1;RPS27L;YARS2;MRPL4;MRPL17;SRP68;MRPL43;EEF1B2;HARS2;RPL5;EEF1G;EEF2;IARS2;EIF4A2;OXA1L;VARS1;MRPL14;RPL6;MRPS2;EIF2S1;TRAM1;MRPS25;MRPS26;SEC11A;RPS16;EIF4E;PPA2;EIF4G1;MRPS23;MRPS11;EIF5B;MRPS5;EIF3A;EIF3B;EIF3C;EIF3D;EIF3F;EIF3G;HARS1;EIF3I;EIF3J;GFM1;RPL3;RPL4;MRPL9;MRPL1;RPL7A;RPL8;RPL9;RPL11;RPL12;RPL13;RPL17;RPL18;RPL18A;RPL19,307 (307),9.14e-46,8.56e-43,3,HMDB0000123;HMDB0000172;HMDB0000687,29 (80),0.616,1,5.93e-44,4.05e-41
Vesicle-mediated transport,Reactome,249,SNF8;GBF1;EPS15;STAM2;HSP90B1;GAPVD1;GAK;EPN1;MCFD2;MAN2A1;GALNT2;MYO1C;MYO6;EPS15L1;FCHO2;USE1;RAB30;VPS4A;SEC24A;CTSC;SPTA1;SPTAN1;SPTB;SPTBN1;HSPH1;RALA;AGPAT3;PACSIN3;PPP6R3;NAPG;NAPA;GABARAP;AP3B1;TPD52;PAFAH1B1;TSG101;RAB11B;UBQLN1;ARFGAP1;GNS;WASL;CLTA;COPS2;TFG;DCTN1;GDI1;TRIP11;CHMP2A;PICALM;PAFAH1B3;COPG2;GDI2;RAB8A;FTH1;COPS7A;SNAP29;RAB38;YWHAG;RAB10;HSPA8;ARPC4;SERPINA1;LRP1;AP2M1;BNIP1;MAN1A1;CHMP3;STX4;STX5;MIA2;TXNDC5;AP2A1;AP2A2;AP1B1;AP2B1;AP1G1;COPS8;GOSR2;ARFGAP3;RAB43;SURF4;RAB3GAP2;CD163;PRKAB1;CLTB;CLTC;HPX;KDELR1;ANKRD28;GOLIM4;RAB7A;AP1M1;COPA;TMED2;LMAN2;ALB;KIF5B;SCFD1;YWHAQ;TMED10;ARF4;COG5;VAMP2;COPS6;RAB1A;STX17;ACBD3;COPS5;RAB5A;RAB5B;RAB6A;ARF5;RAB13;GOLGA2;DYNC1H1;SEC23A;DYNC1I2;RAB5C;DYNC1LI2;HSP90AA1;DNM2;SEC13;BET1;COL1A2;AMBP;COL4A2;KIF13B;CCZ1B;SEC16B;COG2;RAB35;MIA3;RAB31;STAB2;UBQLN2;CHMP6;HYOU1;ANK1;CALM1;COPZ1;COPB1;NSF;CALR;DCTN2;COG7;COG4;YWHAZ;RAB8B;VPS4B;CHMP5;GOSR1;ARPC1A;COPE;CAPZA1;CAPZA2;CAPZB;GRB2;TMED7;CTTN;VTA1;APOA1;SPTBN2;SEC22B;VPS36;COPS3;GPS1;SEC31A;VPS25;SEC24D;APOE;TRAPPC8;SNX9;RAB14;KLC4;CHMP4B;GJB1;RAB6B;YWHAB;TF;YWHAE;ARPC5;YWHAH;ARPC3;ACTR3;ACTR2;ARCN1;RAB11A;ARF1;NECAP1;TGOLN2;ARPC2;ARF6;PREB;RAB4A;AP1S1;TFRC;ACTR1A;NBAS;AP2S1;ARFGAP2;ARL1;RAB3GAP1;RAB18;NECAP2;YKT6;SEC16A;LMAN1;TOR1A;SEC24C;PPP6C;EGFR;USO1;TRAPPC12;TJP1;CSNK1D;TBC1D17;SCARB1;SCARB2;SAR1B;PAFAH1B2;HGS;PRKAA2;SEC23IP;DYNLL2;COPS4;PRKAG1;DNM3;CD59;DYNC1LI1;TMED9;RAB1B;CLINT1;TRAPPC3;VPS28;ZW10;VAMP8;RAB21;GGA1;M6PR;APOB;COL1A1;HP;CTSZ;SNX2;PACSIN2;DCTN3;SNX5;RAB33B;KIF1C,617 (617),4.95e-37,3.31e-34,4,HMDB0000067;HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,31 (66),0.43,1,1.82e-35,1.03e-32
Parkinson disease - Homo sapiens (human),KEGG,136,CYC1;ATP5PB;ATP5F1D;ATP5PF;NDUFA2;NDUFS7;ATP5PO;MAOA;MAOB;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMC1;PSMC2;PSMC3;PSMC4;PSMC5;PSMC6;PSMD1;PSMD2;PSMD3;PSMD4;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;NDUFA3;NDUFA4;NDUFA5;NDUFA6;NDUFA7;NDUFA8;NDUFA9;NDUFAB1;NDUFB2;NDUFB3;NDUFB4;NDUFB5;NDUFB6;NDUFB7;NDUFB8;NDUFB10;NDUFC1;NDUFC2;NDUFS1;NDUFS2;NDUFS3;NDUFV1;NDUFS4;NDUFS8;NDUFV2;NDUFV3;ITPR2;PSMD6;TUBA1B;TUBA4A;UBA1;UBE2G1;UBE2G2;COX5A;UBE2L3;MFN2;GNAI2;GNAI3;KIF5B;UQCRC1;UQCRC2;GNAS;UQCRH;TXN2;ATP5PD;HSPA5;SDHA;SDHB;SDHC;SDHD;VDAC2;VDAC3;UQCRB;UQCR10;UBE2J1;NDUFB11;CAMK2A;UQCRFS1;CALM1;SLC25A4;SLC25A5;HTRA2;ADRM1;COX4I1;CAMK2D;PARK7;TUBA1C;COX6A1;COX6C;CASP3;COX7C;TUBB4B;KLC4;MFN1;NDUFA11;PPIF;TRAP1;MT-ATP8;BAX;MT-CO1;MT-CO2;MT-CO3;EIF2S1;MCU;MT-ND1;MT-ND3;NDUFA12;MT-ND5;PRKACA;PRKACB;COX7A2L;UQCRQ;MAPK9;PSMD14;COX5B;ATP5F1A;ATP5F1B;VDAC1;TUBB2B,249 (249),4.78e-37,3.31e-34,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,19 (21),0.885,1,3.59e-35,1.75e-32
Protein localization,Reactome,105,CYC1;VAPA;TIMM17B;PECR;CHCHD10;ACOT4;EPHX2;DNAJC19;USP9X;AMACR;ACO2;ACOX1;BAAT;PIPOX;PEX1;PEX6;PEX7;PEX13;PEX14;HMGCL;HMOX1;HAO1;TYSND1;BCS1L;NDUFB8;CMC2;GFER;ACOX2;ACOX3;PAOX;LDHD;TOMM70;CHCHD3;PHYH;COA6;DHRS4;STX5;TOMM22;PMPCA;PEX5;VAMP2;AGXT;ABCD3;PXMP2;PEX2;SCP2;SEC61B;TOMM40;SAMM50;ECI2;HSD17B4;ALDH3A2;TIMM44;BAG6;SLC25A17;PMPCB;VDAC1;SLC27A2;ACOT2;HSPD1;NUDT19;MPV17;ABCD1;ACOT8;SLC25A4;LONP2;SGTA;PEX3;ACBD5;CAT;FIS1;PAM16;IDE;IDH1;FXN;IDH3G;ECH1;OTC;CRAT;MLYCD;CS;GRPEL1;TIMM10B;CROT;TIMM10;TIMM9;TIMM8B;MTX2;SLC25A12;ATAD1;TIMM21;UBE2D3;GSTK1;HSPA9;EHHADH;SLC25A13;GET3;DAO;TIMM50;HACL1;MTX1;HAO2;ATP5F1A;CYB5A;ATP5F1B,165 (165),5.83e-37,3.41e-34,0,,4 (4),1,1,4.92e-35,2.1e-32
Amyotrophic lateral sclerosis - Homo sapiens (human),KEGG,170,ATP5F1D;ATP5PB;VAPB;ATXN2L;ATP5PF;PSMD13;NDUFS7;CHCHD10;ATP5PO;NUP58;SIGMAR1;TPR;PSMA1;PSMA2;PSMA4;MATR3;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;ACTB;PSMB5;PSMB6;PSMB7;PFN1;PSMC1;BAX;PSMC3;ACTG1;PSMC4;GABARAP;PSMC6;PSMD1;PSMD2;PSMD3;NCBP1;PSMD7;PSMD8;CYC1;TUBB2B;PSMD12;NDUFA2;NDUFA3;NDUFA4;NDUFA5;NDUFA6;NDUFA7;NDUFA8;KLC4;NDUFA9;NDUFAB1;NDUFB2;NDUFB3;NDUFB4;NDUFB5;NDUFB6;NDUFB7;NDUFB8;DCTN1;NDUFB10;HNRNPA2B1;NDUFC2;NDUFS1;NDUFS2;RAC1;NDUFS3;NDUFV1;NDUFS4;NDUFS8;NDUFV2;RAB8A;NDUFV3;BID;PIK3R4;PSMD6;TUBA1B;TUBB4B;NDUFA12;COX5A;ATXN2;SQSTM1;NUP210;SRSF7;PSMC2;TOMM40;HNRNPA1;KIF5B;UQCRC1;UQCRC2;UQCRFS1;UQCRH;RAB1A;ATP5PD;HSPA5;NUP160;SDHA;SDHB;VCP;SDHD;HNRNPA3;SEC13;UQCRB;NDUFB11;RANBP2;UBQLN2;UBQLN1;SRSF3;HDAC6;RAE1;DERL1;ADRM1;DCTN2;COX4I1;COX5B;TUBA1C;ANXA11;COX6A1;GPX1;PSMA5;NUP98;COX6C;CASP3;ANXA7;COX7C;CAT;ACTR1A;NDUFC1;UQCR10;PSMB4;UBQLN4;NDUFA11;NUP35;NUP205;ACTR1B;RAB5A;TARDBP;MAPK14;PPP3CA;MT-ATP8;NUP155;MT-CO1;MT-CO2;MT-CO3;MTOR;EIF2S1;TUBA4A;MCU;MT-ND1;MT-ND3;MT-ND5;CCS;NUP133;SDHC;ALYREF;COX7A2L;UQCRQ;PSMD4;NUP93;FUS;ATP5F1B;PSMD14;MAP2K3;ATP5F1A;WIPI2;PSMC5;SOD1;DCTN3;VDAC1;PSMD11,364 (364),1.34e-34,6.98e-32,0,,10 (14),1,1,1.06e-32,4.02e-30
Neutrophil degranulation,Reactome,203,HEXB;COMMD9;CAB39;PA2G4;VAPA;ATP6V0C;CPPED1;ATP6V0A1;CAND1;PSAP;MAN2B1;MANBA;IMPDH2;MLEC;GHDC;PFKL;IQGAP2;ACLY;CTSC;SPTAN1;PSMA5;B2M;PSMB1;PSMB7;XRCC5;PSMC2;IST1;SRP14;TCIRG1;PSMD1;PSMD2;PSMD3;PSMD7;LGALS3;PSMD12;PSMD13;HMOX2;ILF2;GSDMD;CREG1;PGAM1;GDI2;TTR;NDUFC2;DDOST;PGM1;ITGB2;IQGAP1;CYB5R3;SNAP29;PSMD6;DIAPH1;S100A9;RAB10;HSPA8;TUBB4B;JUP;PTPN6;CYFIP1;FAF2;TXNDC5;GLB1;MGST1;PTPRJ;PIGR;CCT8;HP;DYNC1LI1;VNN1;AGA;CPNE1;AGL;SURF4;ATP6V1D;COMMD3;MIF;ERP44;VPS35L;CPNE3;HRAS;PKM;GSN;RAB7A;TOLLIP;PYGB;AP1M1;PYGL;C3;ALAD;CKAP4;LAMTOR1;CEACAM1;IDH1;NME2;ALDOA;MVP;RAB5B;RAB6A;GNS;METTL7A;DYNC1H1;RAB5C;VCP;HSP90AA1;SLC27A2;ARG1;PNP;VAT1;HSP90AB1;GM2A;DPP7;MPO;GPI;PTGES2;RAP1A;RAP1B;DNAJC13;RAB31;STBD1;LAMTOR2;ANPEP;COPB1;DSP;S100A8;ANXA2;SCAMP1;PSMA2;CAPN1;UBR4;TOM1;DBNL;S100A11;HGSNAT;NIT2;CAP1;APEH;LAMP1;CAT;CCT2;NPC2;ARL8A;NCSTN;CTSD;RAB14;APRT;AGPAT2;CTSA;SERPINA1;ARPC5;COTL1;DEGS1;ACTR2;VAMP8;PRDX6;PDXK;EEF1A1;DERA;RHOA;GSTP1;RHOG;ACTR1B;ORM1;EEF2;RAB18;MAPK14;ARSB;PDAP1;CD14;PSMC3;PGRMC1;ASAH1;NAPRT;GUSB;GYG1;CSNK2B;PAFAH1B2;FTH1;CD47;CSTB;VCL;CD59;AP2A2;TMEM30A;RAC1;HK3;ROCK1;LTA4H;OSTF1;FUCA1;MAPK1;GRN;CTSB;PSMD14;CTSH;DNAJC3;PGM2;KPNB1;CTSZ;XRCC6;GAA;DGAT1;STOM;PSMD11,486 (487),1.18e-32,5.03e-30,0,,0 (0),1,1,1.18e-32,5.03e-30
Membrane Trafficking,Reactome,231,SNF8;GBF1;ARPC4;EPS15;STAM2;GAPVD1;GAK;EPN1;MAN1A1;MAN2A1;GALNT2;MYO1C;MYO6;EPS15L1;USE1;RAB30;VPS4A;SEC24A;CTSC;SPTA1;SPTAN1;SPTB;SPTBN1;SPTBN2;SEC16B;AGPAT3;PACSIN3;PPP6R3;NAPG;NAPA;GABARAP;AP3B1;TPD52;PAFAH1B1;TSG101;RAB11B;UBQLN1;RAB13;ARFGAP1;GNS;WASL;CLTA;COPS2;TFG;DCTN1;GDI1;GDI2;CHMP2A;PICALM;PAFAH1B3;TRIP11;RAB8A;FTH1;COPS7A;SNAP29;RAB38;YWHAG;RAB10;SEC24D;SERPINA1;AP2M1;AP1S1;AP2S1;CHMP3;STX4;STX5;MIA2;TXNDC5;AP2A1;AP2A2;AP1B1;AP2B1;AP1G1;COPS8;GOSR2;ARFGAP3;RAB43;SURF4;RAB3GAP2;PRKAB1;CLTB;CLTC;SEC16A;KDELR1;ANKRD28;GOLIM4;RAB7A;AP1M1;COPA;TMED2;LMAN2;KIF5B;SCFD1;YWHAQ;TMED10;ARF4;COG5;VAMP2;COPS6;RAB1A;STX17;ACBD3;COPS5;RAB5A;RAB5B;RAB6A;ARF5;HSPA8;GOLGA2;DYNC1H1;SEC23A;DYNC1I2;RAB5C;DYNC1LI2;DNM2;SEC13;BET1;CLINT1;KIF13B;CCZ1B;RALA;COG2;RAB35;MIA3;RAB31;UBQLN2;CHMP6;ANK1;CALM1;COPZ1;COPB1;NSF;MCFD2;DCTN2;COG7;COG4;YWHAZ;RAB8B;VPS4B;CHMP5;GOSR1;ARPC1A;COPE;CAPZA1;CAPZA2;CAPZB;GRB2;TMED7;VAMP8;VTA1;SEC22B;VPS36;COPS3;GPS1;SEC31A;VPS25;FCHO2;TRAPPC8;SNX9;RAB14;KLC4;CHMP4B;GJB1;RAB6B;YWHAB;TF;YWHAE;ARPC5;YWHAH;ARPC3;ACTR3;ACTR2;ARCN1;RAB11A;ARF1;NECAP1;TGOLN2;ARPC2;ARF6;PREB;RAB4A;BNIP1;TFRC;ACTR1A;NBAS;ARFGAP2;ARL1;RAB3GAP1;RAB18;NECAP2;YKT6;LMAN1;TOR1A;SEC24C;PPP6C;EGFR;USO1;TRAPPC12;TJP1;CSNK1D;TBC1D17;SCARB2;SAR1B;PAFAH1B2;HGS;PRKAA2;SEC23IP;DYNLL2;COPS4;PRKAG1;DNM3;CD59;DYNC1LI1;TMED9;RAB1B;COPG2;TRAPPC3;VPS28;ZW10;CTTN;RAB21;GGA1;M6PR;APOB;CTSZ;SNX2;PACSIN2;DCTN3;SNX5;RAB33B;KIF1C,578 (578),1.42e-33,6.64e-31,4,HMDB0000067;HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,20 (31),0.159,1,1.78e-32,6.07e-30
Respiratory electron transport_ ATP synthesis by chemiosmotic coupling_ and heat production by uncoupling proteins.,Reactome,79,NDUFA11;ATP5PB;NDUFA4;ATP5F1D;ATP5MG;ATP5ME;ATP5PF;NDUFB11;MT-ND5;UQCRC1;NDUFS7;NUBPL;NDUFAF4;UQCRC2;ATP5PO;MT-ATP8;SDHD;NDUFAF1;MT-CO1;MT-CO2;MT-CO3;NDUFA5;NDUFAF2;UQCRH;ATP5F1A;COX4I1;ACAD9;COX5B;MT-ND1;MT-ND3;NDUFA12;ETFA;ETFB;ETFDH;NDUFB10;COX7C;COX5A;PM20D1;COX6C;COX7A2L;NDUFB2;UQCRQ;COX6A1;CYC1;UQCRB;NDUFA2;NDUFA3;TIMMDC1;UQCRFS1;ATP5MF;NDUFA6;NDUFA7;NDUFA8;ECSIT;NDUFA9;NDUFAB1;UQCR10;DMAC2L;NDUFB4;NDUFB5;NDUFB6;NDUFB7;NDUFB8;ATP5PD;NDUFC1;NDUFC2;NDUFS1;NDUFS2;NDUFB3;NDUFS3;NDUFV1;NDUFS4;SDHA;SDHB;SDHC;NDUFS8;NDUFV2;ATP5F1B;NDUFV3,113 (113),2.08e-32,8.11e-30,0,,17 (25),1,1,1.54e-30,4.78e-28
Asparagine N-linked glycosylation,Reactome,138,NPL;UAP1;GBF1;MAN2A1;MLEC;RPN1;RPN2;BET1;SEC24A;CTSC;COPE;SPTAN1;SPTB;SPTBN1;SPTBN2;DAD1;PSMC1;NAPG;NAPA;DPM3;GFUS;CMAS;TFG;DCTN1;DPM1;MPI;GFPT1;DDOST;PGM3;STT3A;SEC24D;SERPINA1;MGAT1;MAN1A1;GANAB;STX5;MIA2;GLB1;MOGS;ST3GAL6;ARFGAP3;ALG5;SEC16A;KDELR1;ANKRD28;OS9;COPZ1;TMED2;LMAN2;COPB1;SCFD1;TMED10;COG5;RAB1A;STX17;COG4;GOLGA2;DYNC1H1;SEC23A;DYNC1I2;DYNC1LI2;SEC13;PMM2;RAD23B;SEL1L;CALR;ENGASE;SEC16B;AMFR;COG2;MIA3;NUDT14;ANK1;COPA;DERL1;GNE;NSF;MCFD2;DCTN2;COG7;CANX;GOSR1;SPTA1;CAPZA1;CAPZA2;CAPZB;DERL2;UGGT1;TMED7;GNPNAT1;ALG11;COPG2;ST6GAL1;SEC22B;ST3GAL4;SEC31A;UBXN1;GMPPB;GOSR2;CTSA;GMPPA;PDIA3;ARCN1;ALG2;ARF1;ARF4;ARF5;PREB;ACTR1A;MGAT2;ARFGAP2;YKT6;LMAN1;SEC24C;PPP6C;USO1;PRKCSH;NANS;CSNK1D;ASGR1;ASGR2;SAR1B;ARFGAP1;SEC23IP;DYNLL2;CD59;DYNC1LI1;VCP;TMED9;RAB1B;FUCA1;TRAPPC3;NGLY1;SYVN1;RNF139;CTSZ;DCTN3;PPP6R3,283 (283),1.16e-30,4.17e-28,3,HMDB0000290;HMDB0001090;HMDB0001445,65 (121),0.977,1,7.91e-29,2.25e-26
Metabolism of lipids,Reactome,227,GDPD1;VAPA;ACP6;HEXA;CYP1A2;PCYT1A;HEXB;PLBD1;SPHK2;PECR;GPD2;PIK3R1;PSAP;ACACA;ACACB;ACADL;ACADM;ACADS;ACADVL;ACAT1;ACAT2;PTGR1;CYP4B1;CYP7A1;CYP8B1;ACLY;ACOT13;ACOX1;CPT1A;ACBD5;CDS2;STARD10;BAAT;SRD5A1;AGPAT3;ELOVL5;BDH2;ACOT7;DHCR24;PTGR2;DBI;GC;MGLL;MCAT;HMGCL;HMGCS1;HMGCS2;ECHS1;ACOT4;VAPB;CHKB;NDUFAB1;CYP39A1;PLA2G15;AKR1C1;BDH1;RXRA;NDUFS3;ACOX2;FAAH;FABP4;FABP1;FABP7;PIK3R4;DECR1;GPD1L;ACSL1;PTGES3;ACSL4;CPNE1;ESYT2;FASN;PTGS1;CEPT1;ACSM3;PEMT;ACAD11;CHPT1;MSMO1;LPGAT1;HPGDS;FDFT1;SGPL1;PI4KA;DHCR7;FDX1;CDIPT;FDXR;PIP4P1;HSD17B13;OSBPL1A;CPNE3;OSBPL8;ACOX3;SCP2;FADS2;GM2A;PCYT2;ACSF3;LCLAT1;PITPNB;PISD;CYP2E1;ALB;ABCD1;HSD11B1;CERS2;HSD17B2;HSD17B4;ALDH3A2;LTA4H;PPP1CA;AKR1B1;PPP1CB;RAB4A;RAB5A;SLC25A17;STARD5;HSD17B8;SLC27A5;SLC27A2;PLD4;ACSS3;KPNB1;MCEE;GPD1;NUDT19;DPEP1;ECI2;RAN;SUMF2;SLC25A20;ACOT8;HSD17B7;HADH;PTPMT1;AMACR;ACOT2;HACD3;ESYT1;TECR;AGPAT2;GPX1;GPX4;PON1;PON2;PON3;GPAM;ETNPPL;ACAD10;CYP27A1;PLEKHA6;ACSF2;IDI1;ECI1;RAB14;PHYH;SERPINA6;CTSA;CERT1;CRAT;CBR1;DEGS1;CPT2;PTGES2;AKR1D1;ARF1;MLYCD;DHRS7B;SACM1L;PPP1CC;ACOT12;MMAA;GSTM4;CBR4;GLB1;EPHX2;HSD3B7;OSBP;VAC14;MBOAT7;CROT;FADS1;SLC10A1;ARSB;STS;MECR;GBA;PPT1;PLPP3;EHHADH;ASAH1;SLC25A1;CSNK2A1;LPCAT3;CSNK2A2;CSNK2B;EBP;PRKAA2;AGMO;PRKACA;PRKACB;HELZ2;TM7SF2;DGAT1;AGK;ABCB11;HSD17B12;UBE2I;ACAA2;HACL1;LSS;PNPLA8;HADHA;HADHB;SELENOI;PIP4K2C;PNPLA7;HSD17B11;KDSR;FITM2;PCCA;PCCB;HAO2;MMUT;MVK;ACSL5,645 (646),7.07e-24,1.27e-21,66,HMDB0001170;HMDB0004878;HMDB0033934;HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0000123;HMDB0001547;HMDB0006271;HMDB0000145;HMDB0002995;HMDB0062321;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0001090;HMDB0000036;HMDB0006519;HMDB0001286;HMDB0001188;HMDB0000067;HMDB0010213;HMDB0004842;HMDB0001416;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0001388;HMDB0006841;HMDB0006528;HMDB0001043;HMDB0006894;HMDB0012455;HMDB0002311;HMDB0001231;HMDB0002265;HMDB0003550;HMDB0000876;HMDB0002183;HMDB0000637;HMDB0000951;HMDB0000234;HMDB0006842;HMDB0000077;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0000015;HMDB0062206;HMDB0006763;HMDB0000304;HMDB0003208;HMDB0004080;HMDB0002719;HMDB0001976;HMDB0001251;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0060136;HMDB0000138;HMDB0006734;HMDB0006281;HMDB0002343;HMDB0062420;HMDB0000032;HMDB0062259;HMDB0004949;HMDB0060050;HMDB0002314;HMDB0000054;HMDB0062325;HMDB0003944;HMDB0001457;HMDB0001993,352 (626),8.01e-07,0.000805,3.87e-28,1.02e-25
Prion disease - Homo sapiens (human),KEGG,133,CYC1;ATP5PB;ATP5F1D;ATP5PF;NDUFA2;NDUFS7;ATP5PO;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMC1;PSMC2;PSMC3;PSMC4;PSMC5;PSMC6;PSMD1;PSMD2;PSMD3;PSMD4;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;NDUFA3;NDUFA4;NDUFA5;NDUFA6;NDUFA7;NDUFA8;NDUFA9;NDUFAB1;NDUFB2;NDUFB3;NDUFB4;NDUFB5;NDUFB6;NDUFB7;NDUFB8;NDUFB10;NDUFC1;NDUFC2;NDUFS1;NDUFS2;NDUFS3;NDUFV1;NDUFS4;NDUFS8;NDUFV2;NDUFV3;ITPR2;PSMD6;TUBA1B;TUBB4B;NDUFA12;COX5A;PIK3R1;STIP1;UQCRB;C5;UQCRC1;UQCRC2;UQCRFS1;C8A;UQCRH;C9;ATP5PD;HSPA5;HSPA8;SDHA;SDHB;SDHC;VDAC1;VDAC2;VDAC3;UQCR10;NDUFB11;SLC25A4;SLC25A5;ADRM1;C8B;COX4I1;COX5B;TUBA1C;COX6A1;COX6C;CASP3;COX7C;CAV1;KLC4;NDUFA11;PPIF;MAPK14;PPP3CA;MT-ATP8;BAX;MT-CO1;MT-CO2;MT-CO3;EIF2S1;KIF5B;TUBA4A;CSNK2A1;CSNK2A2;CSNK2B;MCU;MT-ND1;MT-ND3;MT-ND5;PRKACA;PRKACB;RAC1;COX7A2L;UQCRQ;MAPK1;SDHD;MAPK9;PSMD14;ATP5F1A;SOD1;ATP5F1B;TUBB2B,273 (273),1.56e-29,4.86e-27,1,HMDB0001547,5 (5),0.433,1,4.6e-28,1.12e-25
Respiratory electron transport,Reactome,66,TIMMDC1;NDUFA4;CYC1;NDUFB11;UQCRC1;NDUFS7;NDUFAF4;UQCRC2;MT-ND5;NDUFA5;SDHD;NDUFAF1;MT-CO1;MT-CO2;MT-CO3;NUBPL;NDUFAF2;UQCRH;COX4I1;ACAD9;COX5B;MT-ND1;MT-ND3;NDUFA12;ETFA;ETFB;ETFDH;COX6C;COX7C;COX5A;COX7A2L;NDUFA11;UQCRQ;COX6A1;UQCRB;NDUFA2;NDUFA3;UQCR10;UQCRFS1;NDUFA6;NDUFA7;NDUFA8;ECSIT;NDUFA9;NDUFAB1;NDUFB2;NDUFB3;NDUFB4;NDUFB5;NDUFB6;NDUFB7;NDUFB8;NDUFB10;NDUFC1;NDUFC2;NDUFS1;NDUFS2;NDUFS3;NDUFV1;NDUFS4;SDHA;SDHB;SDHC;NDUFS8;NDUFV2;NDUFV3,89 (89),9.18e-30,3.07e-27,0,,13 (17),1,1,6.23e-28,1.42e-25
VEGFA-VEGFR2 Signaling Pathway,Wikipathways,177,TPM3;RPL26;RPL27;EPS15;KATNAL2;MYH9;MYH11;CAV1;ACACA;ACACB;MYO1C;GAPDH;MYO6;ZC3H15;CFL1;RPS6;ACP1;RPS11;RAB11A;NAP1L1;FADD;TMOD3;ACTG1;PSMD4;EWSR1;LRRC59;PSMD11;EIF4E;SSR3;PRKAA1;PFN1;PRKAA2;ATP6V1E1;ITGB1;EIF4G1;PGD;DPM1;CLTC;STAT3;IQGAP1;ITGB3;RPL10A;DECR1;TFAM;TRIP4;PTPN6;PTPN11;AP2S1;FAM120A;SARS1;TXNDC5;AP2A1;TFCP2;PTPRJ;CLIC1;BSG;PIK3R1;TPP1;PRDX6;GLUD1;NUMB;HRAS;FGA;FGB;PXN;SDF2L1;AFDN;SLC25A11;STIP1;ALB;FGG;EEA1;ASCC3;ALDOA;EPN1;DNAJA1;DHX29;RAB4A;RAB5A;PTMA;CNP;VCL;RAC1;HSP90AA1;PNP;ELOC;FLII;FLNB;ANXA1;MAP2K4;EIF3D;RAP1A;RAP1B;ITCH;NAPA;HYOU1;FN1;EIF3H;STAT6;FXR2;CALR;CALU;NCK1;TUBA1C;ICAM1;CAPN2;GPX1;CAPZB;RCN1;GRB2;DNAJB4;ABCF2;CCT7;RELA;PRDX2;IDH2;LDHA;MAP2K3;PLCB3;CDC42BPB;YWHAE;GRSF1;AKT1S1;RBM39;FAF1;CRIP2;CRK;PPM1G;ARF4;PPP1CA;ARF6;SHC1;RHOA;USP10;RPL5;PDIA6;MAPK14;ATP6V0D1;PPP3CA;LMAN1;NCL;SND1;CSK;P4HB;MTOR;TKT;FARSB;HSPB1;CSRP1;HGS;RACK1;PABPC1;EIF4G2;SMARCA2;TBCA;PAK2;PRKCA;ROCK1;TMSB10;ARPC5L;CTNNA1;CGNL1;EIF3F;MAPK1;CTNNB1;CTNND1;FSCN1;MAPK9;EIF2A;MAP2K1;MAP2K2;CDC42;HERPUD1;EPB41;SOD2;UBAP2L;RPL18A,433 (433),3.39e-27,8.35e-25,0,,0 (0),1,1,3.39e-27,8.35e-25
Amino Acid metabolism,Wikipathways,66,ADH5;CBS;MPST;FAH;CS;OTC;PKM;CAD;IDH1;ACLY;RARS1;MAOA;ACADM;HIBCH;AUH;PCK1;PDHA1;GCLM;TAT;PDK4;WARS1;IARS1;ACO2;ASNS;MMUT;FH;ASS1;PC;GLUL;SRM;FTCD;FARSB;DLD;ALDH7A1;SUCLG1;OAT;DLST;GLS;CTH;HMGCS2;TDO2;ALDH1A1;HADH;MCCC1;GLUD1;CPS1;MDH1;MDH2;GPT2;LDHA;OGDH;HIBADH;GOT1;DDC;VARS1;HAL;SDS;PDHX;HMGCL;SDHA;GOT2;GSR;GSS;BHMT;EHHADH;ARG1,91 (91),8.38e-29,2.45e-26,7,HMDB0000725;HMDB0000123;HMDB0000172;HMDB0001052;HMDB0000472;HMDB0003349#HMDB0000528;HMDB0000687,92 (108),0.88,1,4.85e-27,1.04e-24
Oxidative phosphorylation - Homo sapiens (human),KEGG,83,PPA1;CYC1;ATP5PB;ATP5F1D;ATP5MG;ATP5ME;ATP5PF;ATP6V1A;MT-ND5;ATP6V1B2;ATP6V0C;ATP6V1C1;ATP6V1E1;NDUFS7;ATP6V1H;ATP6V0A1;ATP6AP1;ATP6V0D1;ATP5PO;UQCRFS1;NDUFA12;MT-CO1;COX5A;MT-CO3;UQCRH;ATP5F1A;NDUFA11;COX4I1;COX5B;UQCRQ;ATP6V1D;MT-ND1;COX6A1;UQCRC1;SDHA;MT-ND3;COX6C;NDUFB11;ATP5MF;COX7C;MT-CO2;TCIRG1;UQCRC2;COX15;LHPP;ATP6V1G1;COX7A2L;SDHD;MT-ATP8;UQCRB;NDUFA2;NDUFA3;NDUFA4;NDUFA5;PPA2;NDUFA6;NDUFA7;NDUFA8;NDUFA9;UQCR10;NDUFAB1;NDUFB2;NDUFB3;NDUFB4;NDUFB5;NDUFB6;NDUFB7;NDUFB8;NDUFB10;NDUFC1;NDUFC2;NDUFS1;NDUFS2;NDUFS3;NDUFV1;NDUFS4;ATP5PD;SDHB;SDHC;NDUFS8;NDUFV2;ATP5F1B;NDUFV3,133 (133),1.41e-28,3.89e-26,0,,14 (16),1,1,9.2e-27,1.85e-24
Protein processing in endoplasmic reticulum - Homo sapiens (human),KEGG,96,DNAJB12;DNAJB11;HSP90B1;MAN1A1;UBE4B;RPN1;RPN2;SEC24A;DNAJA2;UBE2J1;HSPH1;BAG1;DAD1;BAX;SSR1;SSR3;RRBP1;ERLEC1;DDOST;STT3A;SEC24D;UBXN4;GANAB;UBE2D3;PLAA;UBE2G1;TXNDC5;NSFL1C;MOGS;HYOU1;UFD1;ATXN3;SEC61B;OS9;LMAN2;ERP29;DNAJC1;CKAP4;DNAJB2;DNAJA1;SEC61A1;HSPA5;HSPA8;SEC23B;SEC23A;VCP;HSP90AA1;RBX1;SEC13;HSP90AB1;RAD23B;SEL1L;CUL1;PREB;DNAJB1;AMFR;UBQLN2;UBQLN1;ERO1B;DERL1;CALR;ERO1A;CANX;CAPN1;CAPN2;SYVN1;DERL2;UGGT1;SEC31A;UBXN1;SKP1;SAR1A;PDIA3;UBQLN4;NPLOC4;SIL1;STT3B;PDIA4;PDIA6;LMAN1;SEC24C;P4HB;EIF2S1;TRAM1;FBXO6;SEC62;SAR1B;UBE2G2;PRKCSH;NGLY1;SEC63;MAPK9;EIF2AK2;DNAJC3;HERPUD1;RAD23A,170 (171),5.59e-28,1.45e-25,0,,1 (6),1,1,3.56e-26,6.77e-24
Electron Transport Chain (OXPHOS system in mitochondria),Wikipathways,69,ATP5F1D;ATP5PB;ATP5MG;ATP5ME;ATP5PF;NDUFA2;NDUFA3;NDUFS7;NDUFA4;ATP5PO;MT-ATP8;NDUFA5;NDUFA12;MT-CO1;COX5A;MT-CO3;SLC25A4;SLC25A5;UQCRH;NDUFS3;COX4I1;COX5B;MT-ND1;COX6A1;MT-ND5;COX6C;SCO1;COX7C;MT-CO2;NDUFB10;COX15;COX7A2L;UQCRQ;NDUFS8;UQCRB;MT-ND3;UQCRC1;UQCRC2;UQCRFS1;ATP5MF;NDUFA6;NDUFA7;NDUFA8;DMAC2L;NDUFA9;UQCR10;NDUFAB1;NDUFB2;NDUFB3;NDUFB4;NDUFB5;NDUFB6;NDUFB7;NDUFB8;ATP5PD;NDUFC1;NDUFC2;NDUFS1;NDUFS2;ATP5F1A;NDUFV1;NDUFS4;SDHA;SDHB;SDHC;SDHD;NDUFV2;ATP5F1B;NDUFV3,103 (103),1.06e-26,2.48e-24,0,,10 (12),1,1,6.45e-25,1.16e-22
Selenoamino acid metabolism,Reactome,78,TXNRD1;RPL10A;RPL22;RPL23A;RPL23;EEFSEC;RPL24;RPL26;RPL27;RPL30;RPL28;MARS1;SEPHS2;RPL32;SEPSECS;RPL34;RPL14;RPL38;MAT1A;SARS1;RPLP0;RPS23;RPS5;RPS6;RARS1;AIMP1;RPS13;RPS3;RPS3A;RPL36A;IARS1;INMT;RPL5;RPL35;RPS8;RPS9;RPS10;RPS11;AHCY;LARS1;RPS15;RPS15A;RPS4X;RPS14;RPS16;RPS17;RPS19;GSR;RPS21;RPL22L1;RPS24;RPS25;RPL13;RPS27;PAPSS2;DARS1;GNMT;QARS1;AIMP2;NNMT;RPSA;RPL3;CBS;RPL4;EEF1E1;RPS27L;RPL6;RPL7A;CTH;RPL8;RPL9;RPL11;RPL12;SCLY;RPL17;RPL18;RPL18A;RPL19,128 (128),6.03e-26,1.3e-23,2,HMDB0000123;HMDB0033934,48 (63),0.972,1,3.46e-24,5.89e-22
ER to Golgi Anterograde Transport,Reactome,81,PREB;ARCN1;ACTR1A;SEC16B;COG2;COG7;MIA3;SEC31A;ANK1;DYNC1LI1;GBF1;STX5;YKT6;MIA2;LMAN1;SEC24C;PPP6C;COPZ1;COPB1;CD59;USO1;SERPINA1;NSF;BET1;MCFD2;DCTN2;CSNK1D;ARFGAP3;DYNC1LI2;SEC24A;CTSC;COPE;SPTAN1;SPTB;SPTBN1;SPTBN2;SPTA1;ARFGAP1;ARFGAP2;SEC23IP;CAPZA1;CAPZA2;DYNLL2;CAPZB;KDELR1;NAPG;NAPA;COG5;ANKRD28;TMED9;COPA;COPG2;TMED2;LMAN2;SAR1B;SEC22B;RAB1B;TRAPPC3;SCFD1;SEC24D;TMED10;DCTN3;GOSR2;PPP6R3;RAB1A;STX17;DCTN1;TFG;GOSR1;COG4;GOLGA2;CTSZ;SEC23A;DYNC1I2;TMED7;ARF1;ARF4;SEC16A;SEC13;ARF5;DYNC1H1,136 (136),6.13e-26,1.3e-23,0,,6 (11),1,1,3.62e-24,5.89e-22
Cap-dependent Translation Initiation,Reactome,79,RPL10A;RPL22;RPL23A;EIF3B;RPL24;RPL26;RPL27;RPL30;RPL28;EIF2S1;RPL32;RPS10;RPL34;RPL14;RPS27;RPL38;EIF2B1;RPL36A;RPL23;RPS23;RPL6;EIF4H;RPS5;EIF3A;RPS3;RPS3A;RPS4X;RPL3;RPS6;RPL35;EIF4A1;EIF4A2;EIF4E;EIF2B4;RPS9;EIF2B2;RPS11;EIF2S2;RPS13;RPS14;RPS15;RPS15A;EIF5B;EIF3K;RPS16;RPS17;EIF2B5;RPS19;RPSA;RPS21;RPL22L1;RPS24;RPS25;EIF3C;EIF3D;EIF3F;EIF3G;EIF3H;EIF3I;RPS8;EIF2B3;RPLP0;EIF4G1;PABPC1;RPL4;RPL5;RPS27L;EIF3M;RPL7A;RPL8;RPL9;RPL11;RPL12;RPL13;EIF3J;RPL17;RPL18;RPL18A;RPL19,131 (131),7.79e-26,1.52e-23,0,,5 (8),1,1,4.58e-24,6.81e-22
Eukaryotic Translation Initiation,Reactome,79,RPL10A;RPL22;RPL23A;EIF3B;RPL24;RPL26;RPL27;RPL30;RPL28;EIF2S1;RPL32;RPS10;RPL34;RPL14;RPS27;RPL38;EIF2B1;RPL36A;RPL23;RPS23;RPL6;EIF4H;RPS5;EIF3A;RPS3;RPS3A;RPS4X;RPL3;RPS6;RPL35;EIF4A1;EIF4A2;EIF4E;EIF2B4;RPS9;EIF2B2;RPS11;EIF2S2;RPS13;RPS14;RPS15;RPS15A;EIF5B;EIF3K;RPS16;RPS17;EIF2B5;RPS19;RPSA;RPS21;RPL22L1;RPS24;RPS25;EIF3C;EIF3D;EIF3F;EIF3G;EIF3H;EIF3I;RPS8;EIF2B3;RPLP0;EIF4G1;PABPC1;RPL4;RPL5;RPS27L;EIF3M;RPL7A;RPL8;RPL9;RPL11;RPL12;RPL13;EIF3J;RPL17;RPL18;RPL18A;RPL19,131 (131),7.79e-26,1.52e-23,0,,5 (8),1,1,4.58e-24,6.81e-22
Huntington disease - Homo sapiens (human),KEGG,136,CYC1;ATP5PB;ATP5F1D;ATP5PF;NDUFA2;NDUFS7;ATP5PO;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMC1;PSMC2;PSMC3;KLC4;PSMC4;PSMC5;PSMC6;PSMD1;PSMD2;PSMD3;PSMD4;PSMD7;PSMD8;TUBB2B;PSMD12;PSMD13;NDUFA3;NDUFA4;NDUFA5;NDUFA6;NDUFA7;NDUFA8;NDUFA9;NDUFAB1;NDUFB2;NDUFB3;NDUFB4;DCTN1;NDUFB6;NDUFB7;NDUFB8;NDUFB5;NDUFB10;TUBA4A;NDUFC2;NDUFS1;NDUFS2;NDUFS3;NDUFV1;NDUFS4;NDUFS8;NDUFV2;NDUFV3;PIK3R4;PSMD6;TUBA1B;TUBB4B;AP2M1;AP2S1;NDUFA12;AP2A1;AP2A2;AP2B1;DCTN3;CLTA;CLTB;CLTC;PLCB3;UQCRB;KIF5B;UQCRC1;UQCRC2;UQCRFS1;UQCRH;ATP5PD;SDHA;SDHB;SDHC;SDHD;VDAC2;VDAC3;NDUFB11;GNAQ;SLC25A4;SLC25A5;ADRM1;DCTN2;COX4I1;COX5B;POLR2A;COX6A1;GPX1;COX6C;CASP3;TUBA1C;COX7C;NDUFC1;UQCR10;TFAM;NDUFA11;PPIF;ACTR1B;ACTR1A;TGM2;MT-ATP8;BAX;MT-CO1;MT-CO2;MT-CO3;MTOR;MT-ND1;MT-ND3;MT-ND5;COX5A;COX7A2L;UQCRQ;HDAC2;MAPK9;PSMD14;ATP5F1A;WIPI2;SOD1;SOD2;ATP5F1B;VDAC1;PSMD11,306 (306),3.19e-25,5.98e-23,0,,5 (6),1,1,1.83e-23,2.61e-21
mRNA Splicing - Major Pathway,Reactome,92,PRPF31;SRRM1;MAGOH;DDX5;BCAS2;EIF4A3;SF3A1;HNRNPM;U2AF2;NCBP1;PRPF6;PTBP1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPD;HNRNPF;HNRNPH1;HNRNPK;HNRNPL;HNRNPU;LSM3;DHX9;EFTUD2;DHX15;PRPF40A;U2AF1;SF3A3;DDX46;CHERP;RNPS1;BUD31;SNRNP40;CPSF1;SNU13;PRPF19;LSM4;RBM8A;PPIH;PLRG1;HSPA8;PUF60;FUS;SRSF1;SRSF2;SRSF3;SRSF4;SRSF5;SRSF6;SRSF7;TRA2B;DNAJC8;NUDT21;POLR2A;HNRNPA3;SRRM2;HNRNPUL1;SNRPB2;PRPF8;PHF5A;SF1;SART1;SNRNP200;LSM6;SNW1;SF3B1;SF3B3;SF3B2;PABPN1;SF3B6;CTNNBL1;CCAR1;ELAVL1;ALYREF;USP39;CDC5L;SNRNP70;SNRPA;SNRPA1;SNRPB;PCBP1;PCBP2;SNRPD1;SNRPD2;SNRPD3;LSM8;SNRPF;SNRPG;SF3A2;SF3B5;HNRNPR;CPSF7,177 (177),2.45e-23,3.58e-21,0,,0 (2),1,1,2.45e-23,3.58e-21
SRP-dependent cotranslational protein targeting to membrane,Reactome,72,RPL10A;RPL22;RPL23A;RPL23;RPL24;SPCS1;RPL26;RPL27;RPL30;RPL28;SPCS3;RPL32;RPL34;RPL14;RPL38;TRAM1;RPL36A;RPLP0;RPS23;RPL7A;RPN1;RPN2;RPS3;RPS3A;RPS4X;RPS5;RPS6;RPL35;SEC11A;RPS8;RPS9;RPS10;RPS11;RPS17;RPS13;RPS14;RPS15;RPS15A;SRP9;SRP14;SRP19;RPS16;SRP68;SRP72;SEC61B;SRPRA;RPS19;RPSA;RPS21;RPL22L1;RPS24;RPS25;RPS27L;RPS27;SSR1;SSR3;SEC61A1;RPL3;RPL4;RPL5;SPCS2;RPL6;DDOST;RPL8;RPL9;RPL11;RPL12;RPL13;RPL17;RPL18;RPL18A;RPL19,123 (123),1.43e-22,1.86e-20,0,,0 (2),1,1,1.43e-22,1.86e-20
Diabetic cardiomyopathy - Homo sapiens (human),KEGG,101,CYC1;ATP5PB;ATP5F1D;ATP5PF;NDUFS7;ATP5PO;GAPDH;PDHA1;PDHB;PDK2;PDK4;NDUFB2;NDUFA2;NDUFA3;NDUFA4;NDUFA5;NDUFA6;NDUFA7;NDUFA8;NDUFA9;NDUFAB1;UQCR10;NDUFB3;NDUFB4;NDUFB5;NDUFB6;NDUFB7;NDUFB8;NDUFB10;NDUFC1;NDUFC2;NDUFS1;NDUFS2;GFPT1;NDUFS3;NDUFV1;NDUFS4;NDUFS8;NDUFV2;NDUFV3;PARP1;NDUFA12;COX5A;PIK3R1;AGT;GSR;PLCB3;UQCRB;UQCRC1;UQCRC2;UQCRFS1;UQCRH;ATP5PD;SDHA;SDHB;RAC1;SDHD;VDAC2;VDAC3;COL1A1;COL1A2;NDUFB11;MPC2;COX4I1;SLC25A4;SLC25A5;COX5B;CAMK2A;CAMK2D;COX6A1;COX6C;COX7C;RELA;CPT2;NDUFA11;PPIF;PPP1CA;PPP1CB;PPP1CC;PTPA;MAPK14;MT-ATP8;MT-CO1;MT-CO2;MT-CO3;MTOR;GYS2;MT-ND1;MT-ND3;MT-ND5;PRKCA;SDHC;MPC1;COX7A2L;UQCRQ;MAPK9;CTSD;ATP2A2;ATP5F1A;ATP5F1B;VDAC1,203 (203),1.38e-23,2.3e-21,3,HMDB0000290;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0004949,26 (39),0.54,1,4.03e-22,5.51e-20
Fatty acid metabolism,Reactome,92,EPHX2;CYP1A2;PECR;ACACA;ACADL;ACADM;ACADS;ACADVL;CYP4B1;CYP8B1;ACLY;AMACR;ACOX1;ACBD5;ELOVL5;ACOT7;PTGR2;DBI;ACOT4;CHKB;NDUFAB1;PTGS1;ACOX2;ACOX3;DECR1;ACSL1;ACSL4;PHYH;FASN;ACSM3;ACAD11;HPGDS;FAAH;SCP2;FADS2;ACSF3;ACAA2;ACOT2;ABCD1;HSD17B4;ALDH3A2;SLC25A17;HSD17B8;SLC27A2;MCAT;NUDT19;DPEP1;ECI2;PTGES2;MLYCD;SLC25A20;ACOT8;ACOT13;HACD3;TECR;GPX1;GPX4;PON1;PON2;PON3;MCEE;ACAD10;ACSF2;CPT1A;CPT2;ECHS1;CRAT;CBR1;PTGES3;ECI1;ACOT12;MMAA;CBR4;CROT;FADS1;MECR;PPT1;PTGR1;EHHADH;SLC25A1;PRKAA2;HSD17B12;HACL1;LTA4H;HADHA;HADHB;HADH;PCCA;PCCB;HAO2;MMUT;ACSL5,176 (177),1.44e-23,2.3e-21,18,HMDB0006519;HMDB0002343;HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0062259;HMDB0000123;HMDB0001416;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0001388;HMDB0002995;HMDB0001043;HMDB0004080;HMDB0001976;HMDB0002311;HMDB0002183;HMDB0002265;HMDB0002314;HMDB0003944,182 (257),0.685,1,5.31e-22,6.98e-20
Proteasome - Homo sapiens (human),KEGG,39,PSMD6;PSMF1;PSME4;ADRM1;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;PSMB10;PSMC1;PSMC2;PSMC3;PSMC4;PSMC5;PSMC6;PSMD1;PSMD2;PSMD3;PSMD4;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;PSME1;PSME2;PSMD14;PSME3,46 (46),5.9e-22,7.26e-20,0,,0 (0),1,1,5.9e-22,7.26e-20
Metabolism of RNA,Reactome,210,RPL22;RPL23A;TPR;RPL24;PRPF31;SRRM1;RPL27;RPL30;RPL28;HBS1L;RPL32;MAGOH;RPL38;RPL36A;ZBTB8OS;HNRNPUL1;FBL;RPS3;RPS3A;BCAS2;RPS4X;RPS5;RPS6;SF3A1;RPS8;RPS9;RPS10;RPL26;HNRNPM;RPS13;RPS14;RPS15;RPS15A;RPS16;U2AF2;NCBP1;RPS19;RPS21;PRPF6;RPS24;RPS25;RPS27;NUP58;PTBP1;THOC7;NSUN2;HNRNPA1;SKIV2L;HNRNPA2B1;EIF4G1;HNRNPD;HNRNPF;HNRNPH1;DDX1;HNRNPK;DDX5;HNRNPU;RPL34;LSM3;DHX9;NUP205;EFTUD2;RPL10A;DHX15;RPL23;SNRNP200;ELAC2;U2AF1;SNRNP40;DDX46;HNRNPC;GAR1;CHERP;RNPS1;SUPT5H;CLNS1A;NUP210;RPLP0;EXOSC6;PRKCA;BUD31;NOP56;SF3A3;PRPF19;CPSF1;SNU13;HNRNPL;LSM4;RAE1;DDX6;RBM8A;RPL22L1;NUP35;TP53RK;EIF4A1;PPIH;PLRG1;DDX39B;HSPA8;RPL17;HSPB1;SEC13;TNPO1;PUF60;SF3A2;PHF5A;SF3B1;RAN;RANBP2;NUP93;A1CF;FUS;SRSF1;SRSF2;SRSF3;SRSF4;SRSF5;SRSF6;SRSF7;TRA2B;RTCB;DNAJC8;NUDT21;POLR2A;TPRKB;HNRNPA3;NUP98;TUT7;RPSA;RPL14;UPF1;SNRPB;XPO1;OSGEP;PCBP1;PRPF8;ETF1;SARNP;YWHAB;PABPC1;PRPF40A;PAIP1;RPS11;SF1;THOC5;RPS17;GSPT1;RPS27L;KHSRP;SNRPD3;LSM8;SART1;SNRPF;SNRPG;NOP58;LSM6;TRNT1;MAPK14;SNW1;NUP160;SF3B3;NUP155;SF3B2;UPF2;EIF4A3;PABPN1;TTC37;RTRAF;EIF4A2;SF3B6;EIF4E;ANP32A;NUP133;CTNNBL1;CCAR1;ELAVL1;ALYREF;TNKS1BP1;HSD17B10;RPL13;RPL35;USP39;CDC5L;WDR61;SNRNP70;SNRPA;SNRPA1;SRRM2;SNRPB2;PCBP2;SNRPD1;SNRPD2;RPL3;CNOT1;RPL4;RPL5;RPL18;RPL6;RPL7A;SF3B5;RPL8;RPL9;RPL11;RPL12;RPS23;DDX39A;HNRNPR;CPSF7;RPL18A;RPL19,583 (584),1.44e-23,2.3e-21,2,HMDB0001495;HMDB0033934,35 (77),0.903,1,7.01e-22,8.68e-20
Pathways of neurodegeneration - multiple diseases - Homo sapiens (human),KEGG,181,ATP5F1D;ATP5PB;VAPB;ATXN2L;ATP5PF;PSMD13;NDUFS7;ATP5PO;SIGMAR1;PSMA1;PARK7;PSMA4;PSMA5;PSMA6;SPTBN2;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;FADD;BAX;PSMC3;KLC4;PSMC4;GABARAP;PSMC6;PSMD1;PSMD2;PSMD3;PSMD4;PSMD7;PSMD8;CYC1;TUBB2B;PSMD12;NDUFA2;NDUFA3;NDUFA4;NDUFA5;NDUFA6;NDUFA7;NDUFA8;NDUFA9;NDUFAB1;NDUFB2;NDUFB3;NDUFB4;NDUFB5;NDUFB6;NDUFB7;NDUFB8;DCTN1;NDUFB10;TUBA4A;NDUFC2;NDUFS1;NDUFS2;NDUFS3;NDUFV1;NDUFS4;NDUFS8;NDUFV2;RAB8A;NDUFV3;BID;PIK3R4;PSMD6;TUBA1B;TUBB4B;PSMD14;UBA1;CAMK2D;UBE2G1;NDUFA12;COX5A;UBE2L3;ATXN2;SQSTM1;ATXN3;HRAS;MFN2;PLCB3;TOMM40;UQCRB;KIF5B;GNAQ;UQCRC2;UQCRFS1;UQCRH;RAB1A;ATP5PD;HSPA5;ITPR2;SDHA;SDHB;VCP;SDHD;VDAC2;VDAC3;UBE2J1;NDUFB11;UQCRC1;COX4I1;CALM1;SLC25A4;SLC25A5;HTRA2;ADRM1;DCTN2;CAMK2A;COX5B;PSMA2;TUBA1C;CAPN1;CAPN2;COX6A1;GPX1;COX6C;CASP3;PSMC5;CAT;ACTR1A;PSMA7;RELA;NDUFC1;UQCR10;PPID;ARAF;MFN1;NDUFA11;PPIF;ACTR1B;RAB5A;TARDBP;TRAP1;MAPK14;PSMC1;PPP3CA;MT-ATP8;PSMC2;MT-CO1;MT-CO2;MT-CO3;COX7C;MTOR;CSNK1A1;EIF2S1;RAC1;CSNK2A1;CSNK2A2;CSNK2B;MCU;MT-ND1;MT-ND3;UBE2G2;MT-ND5;CCS;DERL1;PRKCA;SDHC;COX7A2L;UQCRQ;HSD17B10;FUS;MAPK1;CTNNB1;ATP5F1B;MAPK9;MAP2K1;MAP2K2;MAP2K3;ATP2A2;ATP5F1A;WIPI2;SOD1;DCTN3;VDAC1;PSMD11,475 (475),1.48e-23,2.3e-21,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,20 (32),0.898,1,7.11e-22,8.68e-20
L13a-mediated translational silencing of Ceruloplasmin expression,Reactome,73,RPL10A;RPL22;RPL23A;EIF3B;RPL24;RPL26;RPL27;RPL30;RPL28;EIF2S1;RPL32;RPL34;RPL14;RPS27;RPL38;RPL36A;RPL23;RPS23;RPL6;EIF4H;RPS5;EIF3A;RPS3;RPS3A;RPS4X;RPL3;RPS6;RPL35;EIF4A1;EIF4A2;EIF4E;RPS8;RPS9;RPS10;RPS11;EIF2S2;RPS13;RPS14;RPS15;RPS15A;EIF3K;RPS16;RPS17;RPS19;RPSA;RPS21;RPL22L1;RPS24;RPS25;EIF3C;EIF3D;EIF3F;EIF3G;EIF3H;EIF3I;EIF3J;RPLP0;EIF4G1;PABPC1;RPL4;RPL5;RPS27L;EIF3M;RPL7A;RPL8;RPL9;RPL11;RPL12;RPL13;RPL17;RPL18;RPL18A;RPL19,123 (123),2.26e-23,3.41e-21,0,,3 (5),1,1,1.2e-21,1.41e-19
Peroxisome - Homo sapiens (human),KEGG,55,ACSL1;EPHX2;MPV17;PAOX;ABCD1;PHYH;PECR;ACOT8;ACSL5;NUDT19;GSTK1;PEX5;CROT;EHHADH;AMACR;ACOX1;PEX3;BAAT;PRDX1;AGXT;PIPOX;ABCD3;SLC27A2;PXMP2;PEX2;PEX1;SCP2;PEX7;XDH;PEX14;HACL1;CAT;HMGCL;PEX13;ECI2;IDH1;IDH2;HAO1;PEX6;HSD17B4;PEX11A;ECH1;DAO;CRAT;MVK;HAO2;PRDX5;SLC25A17;ACOX2;ACOX3;SOD1;SOD2;MLYCD;ACSL4;DHRS4,82 (82),1.38e-21,1.61e-19,0,,0 (0),1,1,1.38e-21,1.61e-19
mRNA Splicing,Reactome,92,PRPF31;SRRM1;MAGOH;DDX5;BCAS2;EIF4A3;SF3A1;HNRNPM;U2AF2;NCBP1;PRPF6;PTBP1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPD;HNRNPF;HNRNPH1;HNRNPK;HNRNPL;HNRNPU;LSM3;DHX9;EFTUD2;DHX15;PRPF40A;U2AF1;SF3A3;DDX46;CHERP;RNPS1;BUD31;SNRNP40;CPSF1;SNU13;PRPF19;LSM4;RBM8A;PPIH;PLRG1;HSPA8;PUF60;FUS;SRSF1;SRSF2;SRSF3;SRSF4;SRSF5;SRSF6;SRSF7;TRA2B;DNAJC8;NUDT21;POLR2A;HNRNPA3;SRRM2;HNRNPUL1;SNRPB2;PRPF8;PHF5A;SF1;SART1;SNRNP200;LSM6;SNW1;SF3B1;SF3B3;SF3B2;PABPN1;SF3B6;CTNNBL1;CCAR1;ELAVL1;ALYREF;USP39;CDC5L;SNRNP70;SNRPA;SNRPA1;SNRPB;PCBP1;PCBP2;SNRPD1;SNRPD2;SNRPD3;LSM8;SNRPF;SNRPG;SF3A2;SF3B5;HNRNPR;CPSF7,185 (185),1.41e-21,1.61e-19,0,,0 (3),1,1,1.41e-21,1.61e-19
GTP hydrolysis and joining of the 60S ribosomal subunit,Reactome,73,RPL10A;RPL22;RPL23A;EIF3B;RPL24;RPL26;RPL27;RPL30;RPL28;EIF2S1;RPL32;RPL34;RPL14;RPS27;RPL38;RPL36A;RPL23;RPS23;RPL6;EIF4H;EIF3A;RPS3;RPS3A;RPS4X;RPS5;RPS6;RPL35;EIF4A1;EIF4A2;EIF4E;RPS8;RPS9;RPS10;RPS11;EIF2S2;RPS13;RPS14;RPS15;RPS15A;EIF5B;EIF3K;RPS16;RPS17;RPS19;RPSA;RPS21;RPL22L1;RPS24;RPS25;EIF3C;EIF3D;EIF3F;EIF3G;EIF3H;EIF3I;EIF3J;RPLP0;EIF4G1;RPL3;RPL4;RPL5;RPS27L;EIF3M;RPL7A;RPL8;RPL9;RPL11;RPL12;RPL13;RPL17;RPL18;RPL18A;RPL19,124 (124),4.48e-23,6.36e-21,0,,3 (6),1,1,2.35e-21,2.68e-19
Transport to the Golgi and subsequent modification,Reactome,88,GBF1;MAN2A1;BET1;SEC24A;CTSC;SPTA1;SPTAN1;SPTB;SPTBN1;SPTBN2;NAPG;NAPA;TFG;DCTN1;SEC24D;SERPINA1;MGAT1;MGAT2;STX5;MIA2;ARFGAP3;ARCN1;SEC16A;KDELR1;ANKRD28;COPA;TMED2;LMAN2;SCFD1;TMED10;COG5;RAB1A;STX17;COG4;GOLGA2;DYNC1H1;SEC23A;DYNC1I2;DYNC1LI2;SEC13;SEC16B;COG2;MIA3;ANK1;COPZ1;COPB1;NSF;MCFD2;DCTN2;COG7;GOSR1;COPE;CAPZA1;CAPZA2;CAPZB;TMED7;COPG2;ST6GAL1;SEC22B;ST3GAL4;SEC31A;GOSR2;MAN1A1;ARF1;ARF4;ARF5;PREB;ACTR1A;ARFGAP2;YKT6;LMAN1;SEC24C;PPP6C;USO1;CSNK1D;SAR1B;ARFGAP1;SEC23IP;DYNLL2;CD59;DYNC1LI1;TMED9;RAB1B;FUCA1;TRAPPC3;CTSZ;DCTN3;PPP6R3,167 (167),6.47e-23,8.9e-21,1,HMDB0000290,15 (37),0.819,1,2.77e-21,3.05e-19
Warburg Effect,SMPDB,39,GPI;RPIA;CS;GLS2;PFKL;GAPDH;SLC16A1;PDHA1;PDHB;TKT;ACO1;ACO2;GLUD1;PKLR;PKM;PGLS;DLAT;DLD;MPC1;DLST;IDH1;IDH3A;IDH3B;IDH3G;MDH1;FH;SUCLG2;SUCLG1;PC;ALDOB;ENO1;TALDO1;PGD;OGDH;SLC2A2;SDHA;SDHB;SDHC;SDHD,45 (45),1.1e-22,1.47e-20,1,HMDB0033934,52 (58),0.997,1,5.64e-21,6.03e-19
Processing of Capped Intron-Containing Pre-mRNA,Reactome,111,TPR;PRPF31;SRRM1;MAGOH;DDX5;BCAS2;EIF4A3;SF3A1;HNRNPM;U2AF2;NCBP1;PRPF6;NUP58;PTBP1;HNRNPA1;HNRNPA2B1;HNRNPC;HNRNPD;HNRNPF;HNRNPH1;HNRNPK;HNRNPL;HNRNPU;LSM3;DHX9;NUP205;EFTUD2;DHX15;PRPF40A;U2AF1;SF3A3;DDX46;CHERP;RNPS1;NUP210;BUD31;RAE1;SNRNP40;CPSF1;SNU13;PRPF19;LSM4;RBM8A;NUP160;PPIH;PLRG1;DDX39B;SF3B2;SEC13;PUF60;RANBP2;THOC7;FUS;SRSF1;SRSF2;SRSF3;SRSF4;SRSF5;SRSF6;SRSF7;TRA2B;DNAJC8;NUDT21;POLR2A;HNRNPA3;NUP98;DDX39A;HNRNPUL1;SNRPB2;PRPF8;SARNP;PHF5A;SF1;THOC5;NUP35;SART1;SNRNP200;SNRPB;LSM6;SNW1;SF3B1;SF3B3;NUP155;HSPA8;PABPN1;SF3B6;EIF4E;NUP133;CTNNBL1;CCAR1;ELAVL1;ALYREF;NUP93;USP39;CDC5L;SNRNP70;SNRPA;SNRPA1;SRRM2;PCBP1;PCBP2;SNRPD1;SNRPD2;SNRPD3;LSM8;SNRPF;SNRPG;SF3A2;SF3B5;HNRNPR;CPSF7,241 (241),2.59e-22,3.27e-20,0,,3 (7),1,1,1.31e-20,1.36e-18
Alzheimer disease - Homo sapiens (human),KEGG,148,ATP5F1D;ATP5PB;CYC1;ATP5PF;PSMD13;NDUFS7;ATP5PO;GAPDH;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;FADD;PSMC2;PSMC3;PSMC4;RTN3;PSMC6;PSMD1;PSMD2;PSMD3;PSMD4;NDUFB2;PSMD8;TUBB2B;PSMD12;NDUFA2;NDUFA3;NDUFA4;NDUFA5;NDUFA6;NDUFA7;NDUFA8;NDUFA9;NDUFAB1;UQCR10;NDUFB3;NDUFB4;NDUFB5;NDUFB6;NDUFB7;NDUFB8;NDUFB10;TUBA4A;NDUFC2;NDUFS1;NDUFS2;NDUFS3;NDUFV1;NDUFS4;NDUFS8;NDUFV2;NDUFV3;BID;PIK3R4;PSMD6;TUBA1B;TUBB4B;PSMD14;NDUFA12;COX5A;PIK3R1;NAE1;HRAS;PLCB3;UQCRB;KIF5B;UQCRC1;UQCRC2;UQCRFS1;UQCRH;ATP5PD;ITPR2;SDHA;SDHB;SDHC;VDAC1;VDAC2;VDAC3;NDUFB11;GNAQ;CALM1;SLC25A4;SLC25A5;ADRM1;COX4I1;COX5B;TUBA1C;CAPN1;CAPN2;COX6A1;COX6C;CASP3;RTN4;COX7C;RELA;IDE;NCSTN;APOE;NDUFC1;KLC4;PPID;ARAF;NDUFA11;PPIF;PSMC1;PPP3CA;MT-ATP8;MT-CO1;MT-CO2;MT-CO3;MTOR;CSNK1A1;EIF2S1;CSNK2A1;CSNK2A2;CSNK2B;MCU;MT-ND1;MT-ND3;MT-ND5;LRP1;COX7A2L;UQCRQ;HSD17B10;MAPK1;CTNNB1;SDHD;MAPK9;MAP2K1;MAP2K2;PSMD7;ATP2A2;EIF2AK2;ATP5F1A;WIPI2;PSMC5;ATP5F1B;PSMD11,369 (369),6.4e-22,7.69e-20,0,,9 (16),1,1,3.19e-20,3.21e-18
Formation of a pool of free 40S subunits,Reactome,65,RPL10A;RPL22;RPL23A;EIF3B;RPL24;RPL26;RPL27;RPL30;RPL28;RPL32;RPL34;RPL14;RPS27;RPL38;RPL36A;RPL23;RPS23;RPL6;EIF3A;RPS3;RPS3A;RPS4X;RPS5;RPS6;RPL35;RPS8;RPS9;RPS10;RPS11;RPS13;RPS14;RPS15;RPS15A;EIF3K;RPS16;RPS17;RPS19;RPSA;RPS21;RPL22L1;RPS24;RPS25;EIF3C;EIF3D;EIF3F;EIF3G;EIF3H;EIF3I;EIF3J;RPLP0;RPL3;RPL4;RPL5;RPS27L;EIF3M;RPL7A;RPL8;RPL9;RPL11;RPL12;RPL13;RPL17;RPL18;RPL18A;RPL19,113 (113),6.07e-20,6.04e-18,0,,0 (0),1,1,6.07e-20,6.04e-18
Valine_ leucine and isoleucine degradation - Homo sapiens (human),KEGG,39,IVD;HADHA;AGXT2;ABAT;ACAD8;ACADM;ACADS;ACADSB;AUH;ACAT1;ACAT2;EHHADH;AOX1;ACSF3;DLD;ACAA2;BCKDHB;HIBCH;HSD17B10;MCEE;HMGCS2;MCCC2;HADHB;HADH;MCCC1;ALDH1B1;DBT;ALDH9A1;ALDH3A2;ECHS1;BCKDHA;PCCB;ALDH6A1;PCCA;HIBADH;MMUT;HMGCL;ALDH7A1;HMGCS1,48 (48),1.24e-20,1.38e-18,3,HMDB0001052;HMDB0000172;HMDB0000687,34 (42),0.724,1,4.22e-19,4.13e-17
Glyoxylate and dicarboxylate metabolism - Homo sapiens (human),KEGG,29,AFMID;AMT;CS;GRHPR;ACAT1;ACAT2;GLDC;ACO1;HOGA1;ACO2;ACSS2;PGP;AGXT;GLYCTK;GLUL;SHMT1;SHMT2;DLD;CAT;MCEE;HAO1;GCSH;MDH1;MDH2;HYI;PCCA;PCCB;HAO2;MMUT,30 (30),2.14e-20,2.33e-18,3,HMDB0000123;HMDB0033934;HMDB0001166,46 (62),0.886,1,8.82e-19,8.37e-17
Cytoplasmic Ribosomal Proteins,Wikipathways,54,RPL10A;RPL22;RPL23A;RPL23;RPL24;RPL26;RPL27;RPL30;RPL28;RPL32;RPL34;RPL14;RPS27;RPL38;RPL36A;RPLP0;RPS3;RPS3A;RPS4X;RPS5;RPS6;RPS6KA1;MRPL19;RPS8;RPS9;RPS10;RPS11;RPS13;RPS14;RPS15;RPS15A;RPS16;RPS17;RPS19;RPSA;RPS21;RPS23;RPS24;RPS25;RPL35;RPL3;RPL4;RPL5;RPL6;RPL7A;RPL8;RPL9;RPL11;RPL12;RPL13;RPL17;RPL18;RPL18A;RPL19,88 (88),1.44e-18,1.23e-16,0,,0 (0),1,1,1.44e-18,1.23e-16
Peroxisomal protein import,Reactome,46,NUDT19;EPHX2;MPV17;PAOX;MLYCD;PHYH;PECR;DHRS4;PEX2;UBE2D3;GSTK1;SCP2;LONP2;EHHADH;USP9X;AMACR;ACOX1;BAAT;TYSND1;PEX13;PIPOX;PEX1;PEX5;PEX7;DAO;PEX14;HACL1;CAT;HMGCL;ACOT2;ECI2;IDE;IDH1;ACOT4;HAO1;PEX6;HSD17B4;ECH1;CRAT;HAO2;AGXT;ACOX2;ACOX3;SLC27A2;CROT;ACOT8,64 (64),3.37e-20,3.59e-18,0,,1 (1),1,1,1.54e-18,1.43e-16
Pyruvate metabolism and Citric Acid (TCA) cycle,Reactome,41,GSTZ1;ADHFE1;MPC2;CS;SLC16A1;PDHA1;BSG;PDK1;PDK2;PDK4;ACO2;GLO1;MDH2;FAHD1;L2HGDH;DLAT;DLD;MPC1;DLST;VDAC1;SUCLA2;HAGH;IDH2;IDH3A;IDH3B;IDH3G;FH;SUCLG2;SUCLG1;LDHA;D2HGDH;ME1;LDHB;NNT;OGDH;PDHX;SDHA;SDHB;SDHC;SDHD;PDHB,53 (53),3.74e-20,3.89e-18,0,,38 (44),1,1,1.71e-18,1.54e-16
Citrate cycle,INOH,30,FAH;CS;ACAT1;ACAT2;ACLY;ACO1;ACO2;ASL;MDH2;PKLR;PKM;DLD;DLST;SUCLA2;IDH3A;IDH3B;IDH3G;MDH1;FH;SUCLG2;SUCLG1;PC;OGDH;ENO1;PCK1;PCK2;SDHA;SDHB;SDHC;SDHD,32 (32),5.43e-20,5.52e-18,0,,35 (35),1,1,2.46e-18,2.16e-16
Thermogenesis - Homo sapiens (human),KEGG,102,CYC1;ATP5PB;ATP5F1D;ATP5ME;ATP5PF;NDUFS7;ATP5PO;RPS6;RPS6KA1;ACTB;ACTG1;MGLL;ACTL6A;NDUFA2;NDUFA3;NDUFA4;NDUFA5;NDUFA6;NDUFA7;NDUFA8;NDUFA9;NDUFAB1;NDUFB2;NDUFB3;NDUFB4;NDUFB5;NDUFB6;NDUFB7;NDUFB8;NDUFB10;NDUFC1;NDUFC2;NDUFS1;NDUFS2;NDUFS3;NDUFV1;NDUFS4;NDUFS8;NDUFV2;NDUFV3;ACSL1;ACSL4;COA6;PRKAG1;NDUFA12;COX5A;PRKAB1;HRAS;UQCRB;UQCRC1;UQCRC2;GNAS;UQCRH;ATP5PD;SDHA;SDHB;SDHC;SDHD;NDUFB11;SLC25A20;UQCRFS1;COA3;NDUFAF2;COX4I1;COX5B;COX6A1;COX6C;GRB2;COX7C;COX15;ATP5MF;COX18;CPT1A;CPT2;UQCR10;AKT1S1;NDUFA11;RHEB;ATP5MG;NDUFAF4;MAPK14;MT-ATP8;NDUFAF1;MT-CO1;MT-CO2;MT-CO3;MTOR;MT-ND1;MT-ND3;PRKAA1;PRKAA2;MT-ND5;PRKACA;PRKACB;SMARCA2;SMARCC2;COX7A2L;UQCRQ;MAP2K3;ATP5F1A;ACSL5;ATP5F1B,232 (232),8.58e-19,7.73e-17,4,HMDB0001934;HMDB0004080;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,19 (23),0.139,1,5.3e-18,4.53e-16
Spliceosome - Homo sapiens (human),KEGG,75,PHF5A;DHX15;SRSF2;SART1;ACIN1;SF3A2;SNRNP200;PRPF31;U2AF1;SF3B1;SNRNP40;MAGOH;RBM25;DDX46;SRSF1;DDX39B;SRSF3;SRSF4;SRSF5;SRSF6;SRSF7;SF3B2;TRA2B;RBMXL1;USP39;PUF60;BCAS2;EIF4A3;SNRPF;SNRPA1;SF3A1;SF3B6;HNRNPA3;SF3B5;HNRNPM;BUD31;SF3A3;CTNNBL1;SNRNP70;SNU13;U2AF2;PRPF19;LSM4;ALYREF;NCBP1;SNRPA;TCERG1;PRPF6;PLRG1;LSM6;FUS;CDC5L;SNW1;SNRPB2;PPIH;PRPF8;CHERP;SNRPB;PCBP1;SNRPD1;SNRPD2;HNRNPA1;LSM8;PRPF40A;SNRPG;SF3B3;HNRNPC;HSPA8;RBM8A;HNRNPK;DDX5;HNRNPU;LSM3;SNRPD3;EFTUD2,151 (151),8.53e-18,6.66e-16,0,,0 (0),1,1,8.53e-18,6.66e-16
COPI-mediated anterograde transport,Reactome,53,ACTR1A;ARFGAP2;GBF1;STX5;YKT6;ANK1;COPZ1;COPB1;CD59;USO1;NSF;BET1;NAPA;DCTN2;COG7;ARFGAP3;SPTA1;SPTAN1;SPTB;GOSR1;SPTBN2;COPE;ARFGAP1;CAPZA1;CAPZA2;DYNLL2;CAPZB;KDELR1;SPTBN1;NAPG;DYNC1LI1;COG2;ARF1;TMED9;COPA;COPG2;TMED2;RAB1B;TMED10;ARF4;COG5;RAB1A;DCTN1;GOSR2;COG4;GOLGA2;DYNC1H1;ARCN1;DYNC1I2;TMED7;DYNC1LI2;DCTN3;ARF5,83 (83),2.22e-19,2.17e-17,0,,4 (5),1,1,9.76e-18,8.14e-16
mRNA Processing,Wikipathways,69,PHF5A;DHX15;HNRNPAB;HNRNPD;SRRM1;U2AF1;SF3A3;SMC1A;SNRPG;XRN2;SFPQ;SRSF1;SRSF2;SRSF3;SRSF4;SRSF5;SRSF6;SRSF7;RBM39;CELF1;SF3B1;RNPS1;PABPN1;NUDT21;CLK2;SUPT5H;SF3A1;POLR2A;SNRPF;HNRNPM;HNRNPH1;SNRPD3;SNRNP40;CPSF1;SNU13;U2AF2;HNRNPL;PRMT1;TRA2B;NCBP1;SNRPA;PRPF6;FUS;TMED10;PTBP1;SNRNP70;PRPF8;SNRPA1;SNRPB;SNRPB2;PCBP2;SNRPD1;DHX9;HNRNPA1;HNRNPC;PRPF40A;HNRNPA2B1;SF3B3;SF3A2;SF3B2;SF3B5;DDX1;HNRNPK;SNRPD2;PPM1G;HNRNPU;HNRNPR;DNAJC8;EFTUD2,127 (127),3.26e-19,3.11e-17,0,,2 (2),1,1,1.42e-17,1.16e-15
Nonsense-Mediated Decay (NMD),Reactome,65,RPL10A;RPL22;RPL23A;RPL23;RPL24;RPL26;RPL27;RPL30;RPL28;UPF1;RPL32;RPL34;RPL14;RPL38;EIF4A3;RPL36A;RPLP0;RPS23;UPF2;RPS5;RNPS1;RPS3;RPS3A;RPS4X;RPL3;RPS6;RPL35;RPS8;RPS9;RPS10;RPS11;RPS13;RPS14;RPS15;RPS15A;RPS16;RPS17;RPL11;NCBP1;RPS19;RPSA;RPS21;RPL22L1;RPS24;RPS25;RPL13;RPS27;MAGOH;ETF1;PABPC1;RPL4;RPL5;EIF4G1;RPL6;RPL7A;RBM8A;RPL8;RPL9;GSPT1;RPL12;RPS27L;RPL17;RPL18;RPL18A;RPL19,117 (117),7.44e-19,6.82e-17,0,,3 (5),1,1,3.18e-17,2.47e-15
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),Reactome,65,RPL10A;RPL22;RPL23A;RPL23;RPL24;RPL26;RPL27;RPL30;RPL28;UPF1;RPL32;RPL34;RPL14;RPL38;EIF4A3;RPL36A;RPLP0;RPS23;UPF2;RPS5;RNPS1;RPS3;RPS3A;RPS4X;RPL3;RPS6;RPL35;RPS8;RPS9;RPS10;RPS11;RPS13;RPS14;RPS15;RPS15A;RPS16;RPS17;RPL11;NCBP1;RPS19;RPSA;RPS21;RPL22L1;RPS24;RPS25;RPL13;RPS27;MAGOH;ETF1;PABPC1;RPL4;RPL5;EIF4G1;RPL6;RPL7A;RBM8A;RPL8;RPL9;GSPT1;RPL12;RPS27L;RPL17;RPL18;RPL18A;RPL19,117 (117),7.44e-19,6.82e-17,0,,3 (5),1,1,3.18e-17,2.47e-15
Citrate cycle (TCA cycle) - Homo sapiens (human),KEGG,28,CS;PDHA1;PDHB;ACLY;ACO1;ACO2;MDH2;DLAT;DLD;DLST;SUCLA2;IDH1;IDH2;IDH3A;IDH3B;IDH3G;MDH1;FH;SUCLG2;SUCLG1;PC;OGDH;PCK1;PCK2;SDHA;SDHB;SDHC;SDHD,30 (30),1.36e-18,1.18e-16,1,HMDB0003974,17 (20),0.856,1,4.93e-17,3.75e-15
The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria ,SMPDB,28,CS;GLS2;PDHA1;PDHB;ACO1;ACO2;GLUD1;MDH2;L2HGDH;DLAT;DLD;MPC1;DLST;IDH1;IDH2;IDH3A;IDH3B;IDH3G;FH;SUCLG2;SUCLG1;PC;D2HGDH;OGDH;SDHA;SDHB;SDHC;SDHD,30 (30),1.36e-18,1.18e-16,1,HMDB0033934,39 (41),0.988,1,5.68e-17,4.22e-15
Oxidative phosphorylation,Wikipathways,43,ATP5F1D;ATP5PB;ATP5MG;ATP5ME;ATP5PF;NDUFS7;ATP6AP1;ATP5PO;ATP5F1A;MT-ND1;MT-ND3;MT-ND5;NDUFB10;ATP5MF;NDUFS8;NDUFA2;NDUFA3;NDUFA4;NDUFA5;NDUFA6;NDUFA7;NDUFA8;NDUFA9;NDUFAB1;NDUFB2;DMAC2L;NDUFB4;NDUFB5;NDUFB6;NDUFB7;NDUFB8;ATP5PD;NDUFC1;NDUFC2;NDUFS1;NDUFS2;NDUFS3;NDUFV1;NDUFS4;NDUFA11;NDUFV2;ATP5F1B;NDUFV3,61 (61),1.91e-18,1.6e-16,0,,5 (5),1,1,7.99e-17,5.81e-15
Cellular response to starvation,Reactome,74,RPL10A;RPL22;RPL23A;RPL23;RRAGC;RPL24;RPL26;ATP6V1A;RPL30;RPL28;EIF2S1;ATP6V1C1;ATP6V1E1;RPL34;RPL14;RPL38;ATP6V0D1;LAMTOR2;RPL36A;RPLP0;RPS23;LAMTOR4;MTOR;RPS3;RPS3A;RPS4X;RPS5;RPS6;RPL35;ATP6V1D;ASNS;RPS8;RPS9;RPS10;RPS11;EIF2S2;RPS13;RPS14;RPS15;RPS15A;RPL27;TCIRG1;RPS16;RPS17;ATP6V1G1;RPS19;RPSA;RPS21;RPL22L1;ATP6V1B2;RPS25;RPS27L;RPS27;ATP6V0C;LAMTOR1;RPL17;ATP6V1H;RPL32;GCN1;RPL3;RPL4;RPL5;RHEB;RPL6;RPL7A;RPL8;RPL9;RPL11;RPL12;RPL13;RPL19;RPL18;RPL18A;RPS24,145 (145),1.96e-18,1.61e-16,0,,6 (8),1,1,8.18e-17,5.83e-15
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),Reactome,60,RPL10A;RPL22;RPL23A;RPL23;RPL24;RPL26;RPL27;RPL30;RPL28;UPF1;RPL32;RPL34;RPL14;RPL38;RPL36A;RPLP0;RPS23;RPS5;RPS3;RPS3A;RPS4X;RPL3;RPS6;RPL35;RPS8;RPS9;RPS10;RPS11;RPS13;RPS14;RPS15;RPS15A;RPS16;RPS17;RPL11;NCBP1;RPS19;RPSA;RPS21;RPL22L1;RPS24;RPS25;RPL13;RPS27;ETF1;PABPC1;RPL4;RPL5;EIF4G1;RPL6;RPL7A;RPL8;RPL9;GSPT1;RPL12;RPS27L;RPL17;RPL18;RPL18A;RPL19,105 (105),2.55e-18,2.06e-16,0,,1 (3),1,1,1.06e-16,7.39e-15
The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria,SMPDB,27,CS;GLS2;PDHA1;PDHB;ACO1;ACO2;GLUD1;MDH2;L2HGDH;DLAT;DLD;MPC1;DLST;IDH1;IDH2;IDH3A;IDH3B;IDH3G;FH;SUCLG2;SUCLG1;PC;OGDH;SDHA;SDHB;SDHC;SDHD,29 (29),6.8e-18,5.4e-16,1,HMDB0033934,39 (41),0.988,1,2.73e-16,1.86e-14
superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle,HumanCyc,36,GPI;CS;HK1;HK3;IDH3A;GAPDH;PDHA1;PDHB;BPGM;ACO1;ACO2;OGDH;FH;PKLR;PKM;DLAT;DLD;SUCLG1;DLST;GCK;PFKL;IDH3B;IDH3G;MDH1;MDH2;SUCLG2;ALDOA;SUCLA2;ALDOB;ENO1;PGAM1;SDHA;SDHB;SDHC;SDHD;TPI1,47 (48),1.33e-17,1.02e-15,0,,33 (36),1,1,5.31e-16,3.56e-14
Glutaminolysis and Cancer,SMPDB,31,CS;GLS2;SLC16A1;PDHA1;PDHB;MTOR;ACLY;ACO2;MYCBP;GLUD1;FH;GOT2;DLAT;DLD;MPC1;DLST;LDHA;IDH2;IDH3A;IDH3B;IDH3G;MDH2;SUCLG2;SUCLG1;PC;OGDH;ME1;SDHA;SDHB;SDHC;SDHD,37 (37),2.14e-17,1.62e-15,2,HMDB0033934;HMDB0000687,42 (44),0.95,1,8.01e-16,5.27e-14
Selenocysteine synthesis,Reactome,58,RPL10A;RPL22;RPL23A;RPL23;EEFSEC;RPL24;RPL26;RPL27;RPL30;RPL28;SEPHS2;RPL32;SEPSECS;RPL34;RPL14;RPL38;RPS4X;SARS1;RPLP0;RPS23;RPS3;RPS3A;RPL36A;RPS5;RPS6;RPL35;RPS8;RPS9;RPS10;RPS11;RPS13;RPS14;RPS15;RPS15A;RPS16;RPS17;RPS19;RPSA;RPS21;RPL22L1;RPS24;RPS25;RPL13;RPS27;RPL3;RPL4;RPL5;RPL6;RPL7A;RPL8;RPL9;RPL11;RPL12;RPS27L;RPL17;RPL18;RPL18A;RPL19,103 (103),2.41e-17,1.79e-15,0,,13 (20),1,1,9.47e-16,6.11e-14
Non-alcoholic fatty liver disease - Homo sapiens (human),KEGG,71,CYC1;UQCR10;COX6C;NDUFA11;NDUFB11;UQCRC1;NDUFS7;UQCRC2;ITCH;COX4I1;UQCRFS1;NDUFA12;MT-CO1;NDUFS2;MT-CO3;CYP2E1;UQCRH;EIF2S1;PIK3R1;COX5B;UQCRQ;COX5A;COX6A1;PRKAA1;PRKAA2;PRKAB1;PKLR;PRKAG1;CASP3;BAX;COX7C;MLX;SDHC;COX7A2L;SDHD;RELA;UQCRB;NDUFA2;NDUFA3;NDUFA4;NDUFA5;NDUFA6;NDUFA7;NDUFA8;NDUFA9;MAPK9;NDUFAB1;NDUFB2;NDUFB3;NDUFB4;NDUFB5;NDUFB6;NDUFB7;NDUFB8;NDUFB10;NDUFC1;NDUFC2;NDUFS1;RXRA;MT-CO2;NDUFS3;NDUFV1;NDUFS4;SDHA;SDHB;RAC1;NDUFS8;NDUFV2;NDUFV3;BID;CDC42,150 (150),1.64e-15,7.16e-14,0,,0 (2),1,1,1.64e-15,7.16e-14
Proteasome Degradation,Wikipathways,43,PSMD6;UBA1;UBE2D3;H2AX;RPN1;RPN2;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;PSMB10;PSMC1;PSMC2;PSMC3;PSMC4;PSMC5;PSMC6;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;PSME3;PSMD12;PSMD13;PSME1;PSME2;UCHL3;NEDD4;PSMD11,64 (64),3.28e-17,2.4e-15,0,,1 (1),1,1,1.28e-15,8.09e-14
Complex I biogenesis,Reactome,40,NDUFB11;NDUFS7;NDUFAF4;NDUFAF1;NDUFAF2;ACAD9;MT-ND1;MT-ND3;NDUFA12;MT-ND5;NDUFA9;NDUFA11;NDUFA2;NDUFA3;TIMMDC1;NDUFA5;NDUFA6;NDUFA7;NDUFA8;ECSIT;NUBPL;NDUFAB1;NDUFB2;NDUFB3;NDUFB4;NDUFB5;NDUFB6;NDUFB7;NDUFB8;NDUFB10;NDUFC1;NDUFC2;NDUFS1;NDUFS2;NDUFS3;NDUFV1;NDUFS4;NDUFS8;NDUFV2;NDUFV3,57 (57),3.86e-17,2.78e-15,0,,2 (3),1,1,1.5e-15,8.66e-14
3-Methylglutaconic Aciduria Type I,SMPDB,27,IVD;ABAT;BCKDHA;ACAD8;ACADM;ACADS;ACADSB;AUH;ACAT1;AOX1;DLD;ACAA2;BCKDHB;HMGCL;HSD17B10;HIBCH;HMGCS2;MCCC2;MCCC1;DBT;ECHS1;PCCA;HIBADH;ALDH6A1;PCCB;MMUT;MCEE,30 (30),5.58e-17,3.18e-15,4,HMDB0001052;HMDB0006868;HMDB0000172;HMDB0000687,54 (58),0.847,1,1.82e-15,8.66e-14
Valine_ Leucine and Isoleucine Degradation,SMPDB,27,IVD;ABAT;BCKDHA;ACAD8;ACADM;ACADS;ACADSB;AUH;ACAT1;AOX1;DLD;ACAA2;BCKDHB;HMGCL;HSD17B10;HIBCH;HMGCS2;MCCC2;MCCC1;DBT;ECHS1;PCCA;HIBADH;ALDH6A1;PCCB;MMUT;MCEE,30 (30),5.58e-17,3.18e-15,4,HMDB0001052;HMDB0006868;HMDB0000172;HMDB0000687,54 (58),0.847,1,1.82e-15,8.66e-14
2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency,SMPDB,27,IVD;ABAT;BCKDHA;ACAD8;ACADM;ACADS;ACADSB;AUH;ACAT1;AOX1;DLD;ACAA2;BCKDHB;HMGCL;HSD17B10;HIBCH;HMGCS2;MCCC2;MCCC1;DBT;ECHS1;PCCA;HIBADH;ALDH6A1;PCCB;MMUT;MCEE,30 (30),5.58e-17,3.18e-15,4,HMDB0001052;HMDB0006868;HMDB0000172;HMDB0000687,54 (58),0.847,1,1.82e-15,8.66e-14
Isovaleric Aciduria,SMPDB,27,IVD;ABAT;BCKDHA;ACAD8;ACADM;ACADS;ACADSB;AUH;ACAT1;AOX1;DLD;ACAA2;BCKDHB;HMGCL;HSD17B10;HIBCH;HMGCS2;MCCC2;MCCC1;DBT;ECHS1;PCCA;HIBADH;ALDH6A1;PCCB;MMUT;MCEE,30 (30),5.58e-17,3.18e-15,4,HMDB0001052;HMDB0006868;HMDB0000172;HMDB0000687,54 (58),0.847,1,1.82e-15,8.66e-14
3-Methylcrotonyl Coa Carboxylase Deficiency Type I,SMPDB,27,IVD;ABAT;BCKDHA;ACAD8;ACADM;ACADS;ACADSB;AUH;ACAT1;AOX1;DLD;ACAA2;BCKDHB;HMGCL;HSD17B10;HIBCH;HMGCS2;MCCC2;MCCC1;DBT;ECHS1;PCCA;HIBADH;ALDH6A1;PCCB;MMUT;MCEE,30 (30),5.58e-17,3.18e-15,4,HMDB0001052;HMDB0006868;HMDB0000172;HMDB0000687,54 (58),0.847,1,1.82e-15,8.66e-14
Propionic Acidemia,SMPDB,27,IVD;ABAT;BCKDHA;ACAD8;ACADM;ACADS;ACADSB;AUH;ACAT1;AOX1;DLD;ACAA2;BCKDHB;HMGCL;HSD17B10;HIBCH;HMGCS2;MCCC2;MCCC1;DBT;ECHS1;PCCA;HIBADH;ALDH6A1;PCCB;MMUT;MCEE,30 (30),5.58e-17,3.18e-15,4,HMDB0001052;HMDB0006868;HMDB0000172;HMDB0000687,54 (58),0.847,1,1.82e-15,8.66e-14
Maple Syrup Urine Disease,SMPDB,27,IVD;ABAT;BCKDHA;ACAD8;ACADM;ACADS;ACADSB;AUH;ACAT1;AOX1;DLD;ACAA2;BCKDHB;HMGCL;HSD17B10;HIBCH;HMGCS2;MCCC2;MCCC1;DBT;ECHS1;PCCA;HIBADH;ALDH6A1;PCCB;MMUT;MCEE,30 (30),5.58e-17,3.18e-15,4,HMDB0001052;HMDB0006868;HMDB0000172;HMDB0000687,54 (58),0.847,1,1.82e-15,8.66e-14
3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency,SMPDB,27,IVD;ABAT;BCKDHA;ACAD8;ACADM;ACADS;ACADSB;AUH;ACAT1;AOX1;DLD;ACAA2;BCKDHB;HMGCL;HSD17B10;HIBCH;HMGCS2;MCCC2;MCCC1;DBT;ECHS1;PCCA;HIBADH;ALDH6A1;PCCB;MMUT;MCEE,30 (30),5.58e-17,3.18e-15,4,HMDB0001052;HMDB0006868;HMDB0000172;HMDB0000687,54 (58),0.847,1,1.82e-15,8.66e-14
Isobutyryl-coa dehydrogenase deficiency,SMPDB,27,IVD;ABAT;BCKDHA;ACAD8;ACADM;ACADS;ACADSB;AUH;ACAT1;AOX1;DLD;ACAA2;BCKDHB;HMGCL;HSD17B10;HIBCH;HMGCS2;MCCC2;MCCC1;DBT;ECHS1;PCCA;HIBADH;ALDH6A1;PCCB;MMUT;MCEE,30 (30),5.58e-17,3.18e-15,4,HMDB0001052;HMDB0006868;HMDB0000172;HMDB0000687,54 (58),0.847,1,1.82e-15,8.66e-14
3-hydroxyisobutyric aciduria,SMPDB,27,IVD;ABAT;BCKDHA;ACAD8;ACADM;ACADS;ACADSB;AUH;ACAT1;AOX1;DLD;ACAA2;BCKDHB;HMGCL;HSD17B10;HIBCH;HMGCS2;MCCC2;MCCC1;DBT;ECHS1;PCCA;HIBADH;ALDH6A1;PCCB;MMUT;MCEE,30 (30),5.58e-17,3.18e-15,4,HMDB0001052;HMDB0006868;HMDB0000172;HMDB0000687,54 (58),0.847,1,1.82e-15,8.66e-14
3-hydroxyisobutyric acid dehydrogenase deficiency,SMPDB,27,IVD;ABAT;BCKDHA;ACAD8;ACADM;ACADS;ACADSB;AUH;ACAT1;AOX1;DLD;ACAA2;BCKDHB;HMGCL;HSD17B10;HIBCH;HMGCS2;MCCC2;MCCC1;DBT;ECHS1;PCCA;HIBADH;ALDH6A1;PCCB;MMUT;MCEE,30 (30),5.58e-17,3.18e-15,4,HMDB0001052;HMDB0006868;HMDB0000172;HMDB0000687,54 (58),0.847,1,1.82e-15,8.66e-14
Isovaleric acidemia,SMPDB,27,IVD;ABAT;BCKDHA;ACAD8;ACADM;ACADS;ACADSB;AUH;ACAT1;AOX1;DLD;ACAA2;BCKDHB;HMGCL;HSD17B10;HIBCH;HMGCS2;MCCC2;MCCC1;DBT;ECHS1;PCCA;HIBADH;ALDH6A1;PCCB;MMUT;MCEE,30 (30),5.58e-17,3.18e-15,4,HMDB0001052;HMDB0006868;HMDB0000172;HMDB0000687,54 (58),0.847,1,1.82e-15,8.66e-14
Methylmalonate Semialdehyde Dehydrogenase Deficiency,SMPDB,27,IVD;ABAT;BCKDHA;ACAD8;ACADM;ACADS;ACADSB;AUH;ACAT1;AOX1;DLD;ACAA2;BCKDHB;HMGCL;HSD17B10;HIBCH;HMGCS2;MCCC2;MCCC1;DBT;ECHS1;PCCA;HIBADH;ALDH6A1;PCCB;MMUT;MCEE,30 (30),5.58e-17,3.18e-15,4,HMDB0001052;HMDB0006868;HMDB0000172;HMDB0000687,54 (58),0.847,1,1.82e-15,8.66e-14
Methylmalonic Aciduria,SMPDB,27,IVD;ABAT;BCKDHA;ACAD8;ACADM;ACADS;ACADSB;AUH;ACAT1;AOX1;DLD;ACAA2;BCKDHB;HMGCL;HSD17B10;HIBCH;HMGCS2;MCCC2;MCCC1;DBT;ECHS1;PCCA;HIBADH;ALDH6A1;PCCB;MMUT;MCEE,30 (30),5.58e-17,3.18e-15,4,HMDB0001052;HMDB0006868;HMDB0000172;HMDB0000687,54 (58),0.847,1,1.82e-15,8.66e-14
3-Methylglutaconic Aciduria Type IV,SMPDB,27,IVD;ABAT;BCKDHA;ACAD8;ACADM;ACADS;ACADSB;AUH;ACAT1;AOX1;DLD;ACAA2;BCKDHB;HMGCL;HSD17B10;HIBCH;HMGCS2;MCCC2;MCCC1;DBT;ECHS1;PCCA;HIBADH;ALDH6A1;PCCB;MMUT;MCEE,30 (30),5.58e-17,3.18e-15,4,HMDB0001052;HMDB0006868;HMDB0000172;HMDB0000687,54 (58),0.847,1,1.82e-15,8.66e-14
3-Methylglutaconic Aciduria Type III,SMPDB,27,IVD;ABAT;BCKDHA;ACAD8;ACADM;ACADS;ACADSB;AUH;ACAT1;AOX1;DLD;ACAA2;BCKDHB;HMGCL;HSD17B10;HIBCH;HMGCS2;MCCC2;MCCC1;DBT;ECHS1;PCCA;HIBADH;ALDH6A1;PCCB;MMUT;MCEE,30 (30),5.58e-17,3.18e-15,4,HMDB0001052;HMDB0006868;HMDB0000172;HMDB0000687,54 (58),0.847,1,1.82e-15,8.66e-14
Beta-Ketothiolase Deficiency,SMPDB,27,IVD;ABAT;BCKDHA;ACAD8;ACADM;ACADS;ACADSB;AUH;ACAT1;AOX1;DLD;ACAA2;BCKDHB;HMGCL;HSD17B10;HIBCH;HMGCS2;MCCC2;MCCC1;DBT;ECHS1;PCCA;HIBADH;ALDH6A1;PCCB;MMUT;MCEE,30 (30),5.58e-17,3.18e-15,4,HMDB0001052;HMDB0006868;HMDB0000172;HMDB0000687,54 (58),0.847,1,1.82e-15,8.66e-14
Post-translational protein modification,Reactome,389,STAM2;MAN1A1;MAN2A1;RPN1;RPN2;BET1;USP9X;SMC1A;ACTB;ETFB;ACTL6A;F2;TFG;F9;RXRA;RAB8A;TUBA1B;PARP1;TUBB4B;MGAT1;SAFB;MGAT2;OTULIN;MIA2;MAVS;UCHL5;ATXN3;FGA;COMMD10;ALB;FGG;ARF4;LMAN2;COG5;SEC23A;SEC13;MPI;SEL1L;CUL4B;CUL4A;CUL3;CUL2;CUL1;AMFR;COG2;MIA3;CCDC22;NUDT14;ANK1;FN1;RAE1;COPZ1;MCFD2;DCTN2;PARK7;RNF135;OTUB1;COMMD5;COPG2;APOA1;ST6GAL1;APOB;ST3GAL4;COPS3;SEC31A;APOE;RAB14;SKP1;STX17;RAB6B;ARCN1;ARF1;NUP35;TGOLN2;ARF5;RHOA;ARFGAP2;NOP58;RAB18;DPH5;STS;BABAM1;RUVBL1;RAB13;ARSB;USO1;YKT6;COMMD9;ASGR1;ASGR2;RABGGTA;ARFGAP1;COMMD7;NUP133;PTRH2;DYNC1LI2;SERPINC1;FUCA1;TRAPPC3;NGLY1;WDR61;SYVN1;RAB21;STAG2;UAP1;SNX3;CAND1;GBF1;GALNT2;SEC24A;SPTA1;SPTAN1;SPTB;SPTBN1;SPTBN2;RAB11A;NAPG;NAPA;CMAS;DPM1;GFPT1;GGCX;NUP205;COMMD6;TTLL12;ABRAXAS2;RAB10;GANAB;STX5;PSME4;GLB1;COPS8;VNN1;RAB30;NAE1;NUP210;KDELR1;HNRNPK;ANKRD28;OS9;C3;TMED2;C4A;SCFD1;CKAP4;TMED10;COPS6;COPS5;NUP160;GOLGA2;NPM1;ELOC;ELOB;RAB35;DCAF11;RAB31;CALM1;MAT2B;ADRM1;NSF;CALR;CALU;CANX;TUBA1C;GPS1;NUCB1;CAPZA1;USP24;NUP98;UBA3;UBE2M;NR3C1;TF;PDIA3;COMMD3;CAPZA2;CAPZB;USP14;USP10;USP8;DCUN1D1;UBA2;SMC3;P4HB;NANS;HGS;SEC23IP;CD59;ST3GAL6;RNF139;CDH2;SERPIND1;TOP1;TOP2B;PCNA;DCTN3;NPL;PIGN;TPR;RAB11B;HSP90B1;HIF1A;UBE2K;DDX58;CTSC;COPE;DPM3;PEX13;PEX14;GFUS;COPS2;HNRNPC;PGM3;RAB38;SERPINA1;UBA1;UBE2D3;UBE2G1;UBE2G2;UBE2H;UBE2I;UBE2L3;UBE2N;UBE2V2;RAB43;UCHL3;ALG5;UFD1;FBXO7;FKBP8;GMPPB;GMPPA;COG4;HSPA8;VCP;VDAC1;VDAC2;PML;PMM2;ENGASE;PREB;SUMF2;PSMF1;COPA;COPB1;RAB8B;GOSR1;UGGT1;GNPNAT1;CP;BRCC3;SEC22B;IDE;GOSR2;CTSA;BABAM2;EEF2;ALG2;PSMB10;NUP155;SEC24C;PPP6C;CSNK1D;DYNLL2;TMED9;CTBP1;PRKCSH;NUP93;VDAC3;VCPIP1;DNAJC3;CTSZ;RAB33B;PSMD11;TRIM25;DCAF8;MLEC;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;DAD1;PSMC1;PSMC2;PSMC3;PSMC4;PSMC5;PSMC6;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;TUBB2B;PSMD12;PSMD13;PSME1;PSME2;NUP58;DCTN1;DDB1;DDOST;STT3A;COPS7A;PSMD6;TOMM70;SEC24D;FBXO6;FBXO4;MOGS;ITIH2;ARFGAP3;SEC16A;USP7;PEX2;PEX5;RAB7A;DDX5;DERL1;RAB1A;USP15;RAB4A;RAB5A;RAB5B;RAB6A;UBE2Z;DYNC1H1;KNG1;RABGGTB;DYNC1I2;RAB5C;USP47;SERPINA10;RBX1;RAD21;RAD23A;RAD23B;SEC16B;NEDD8;RANBP2;RANGAP1;GNE;APOA5;COG7;KTN1;FN3KRP;DERL2;RCN1;TMED7;SAE1;LAMB2;ALG11;RELA;UBXN1;LGALS1;EEF1A1;CUL5;ACTR1A;USP5;PDIA6;LMAN1;LMO7;TRIM28;RAB2A;COMMD2;SAR1B;EIF5A;COPS4;UBA6;DYNC1LI1;RAB1B;PSME3;HDAC2;APOA2;PSMD14;PPP6R3,1425 (1425),1.05e-16,5.67e-15,10,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0030020;HMDB0011669;HMDB0000123;HMDB0001547;HMDB0001090;HMDB0001445;HMDB0000290;HMDB0000304,96 (182),0.591,1,2.39e-15,1.12e-13
Metabolic reprogramming in colon cancer,Wikipathways,33,GPI;FASN;RPIA;HK3;IDH3A;GAPDH;PDHA1;FH;PDHB;TKT;ACLY;ACO2;GLS;GLUD1;PPAT;PKM;SDHB;SHMT2;DLST;PFKL;IDH2;PSPH;GART;MDH2;SUCLG2;LDHA;ALDOB;PGAM1;TALDO1;PGD;ENO1;PAICS;GOT2,42 (42),7.85e-17,4.38e-15,2,HMDB0000123;HMDB0033934,29 (35),0.835,1,2.51e-15,1.16e-13
Saturated fatty acids beta-oxidation,EHMN,24,DBI;PECR;SLC25A20;ACOT8;MECR;ACADL;ACADM;ACADS;ACADSB;ACAT1;EHHADH;ACOX1;BAAT;GCDH;ACAA2;HSD17B10;HADHA;HADHB;HADH;ACOT4;HSD17B4;ECHS1;ACOX2;ACOX3,25 (25),7.8e-17,4.38e-15,2,HMDB0062259;HMDB0003944,43 (43),0.954,1,2.84e-15,1.29e-13
Eukaryotic Translation Elongation,Reactome,58,RPL10A;RPL22;RPL23A;RPL23;RPL24;RPL26;RPL27;RPL30;EEF1B2;RPL28;EEF1G;EEF2;RPL34;RPL14;RPL38;RPL36A;RPLP0;RPS23;RPS3;RPS3A;RPS4X;RPS5;RPS6;RPL35;RPS8;RPS9;RPS10;RPS11;RPS13;RPS14;RPS15;RPS15A;RPS16;RPS17;RPS19;RPSA;RPS21;RPL22L1;RPS24;RPS25;RPL13;RPS27;EEF1A1;RPL32;RPL3;RPL4;RPL5;RPL6;RPL7A;RPL8;RPL9;RPL11;RPL12;RPS27L;RPL17;RPL18;RPL18A;RPL19,105 (105),8.15e-17,4.49e-15,0,,3 (26),1,1,3.1e-15,1.4e-13
Propanoate metabolism - Homo sapiens (human),KEGG,29,ABAT;ACACA;ACACB;ACADS;ACAT1;ACAT2;EHHADH;ACOX1;HIBCH;DLD;BCKDHA;BCKDHB;LDHA;MCEE;HADHA;DBT;ACSS2;SUCLG2;SUCLG1;SUCLA2;ECHS1;PCCA;PCCB;ALDH6A1;MMUT;ACOX3;LDHB;MLYCD;ACSS3,34 (34),8.96e-17,4.88e-15,2,HMDB0000863;HMDB0000820,38 (48),0.927,1,3.16e-15,1.4e-13
IL-1 JNK,INOH,40,PSMD6;MAP2K4;UBE2N;UBE2V1;PSMC4;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;PSMB10;PSMC1;PSMC2;PSMC3;TOLLIP;PSMC5;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;MAPK9;MAP2K1;MAP2K2;MAP2K3,62 (62),3.49e-15,1.46e-13,0,,0 (0),1,1,3.49e-15,1.46e-13
Peptide chain elongation,Reactome,56,RPL10A;RPL22;RPL23A;RPL23;RPL24;RPL26;RPL27;RPL30;RPL28;RPL32;EEF2;RPL34;RPL14;RPL38;RPL36A;RPLP0;RPS23;RPS3;RPS3A;RPS4X;RPS5;RPS6;RPL35;RPS8;RPS9;RPS10;RPS11;RPS13;RPS14;RPS15;RPS15A;RPS16;RPS17;RPS19;RPSA;RPS21;RPL22L1;RPS24;RPS25;RPL13;RPS27;EEF1A1;RPL3;RPL4;RPL5;RPL6;RPL7A;RPL8;RPL9;RPL11;RPL12;RPS27L;RPL17;RPL18;RPL18A;RPL19,100 (100),1.21e-16,6.41e-15,0,,3 (26),1,1,4.54e-15,1.99e-13
Eukaryotic Translation Termination,Reactome,57,RPL10A;RPL22;RPL23A;RPL23;RPL24;RPL26;RPL27;RPL30;RPL28;RPL32;RPL34;RPL14;RPL38;RPL36A;RPLP0;RPS23;RPS3;RPS3A;RPS4X;RPS5;RPS6;RPL35;RPS8;RPS9;RPS10;RPS11;RPS13;RPS14;RPS15;RPS15A;APEH;RPS16;RPS17;RPL11;RPS19;RPSA;RPS21;RPL22L1;RPS24;RPS25;RPL13;RPS27;ETF1;RPL3;RPL4;RPL5;RPL6;RPL7A;RPL8;RPL9;GSPT1;RPL12;RPS27L;RPL17;RPL18;RPL18A;RPL19,103 (103),1.34e-16,7.07e-15,0,,6 (11),1,1,5.04e-15,2.18e-13
The oncogenic action of 2-hydroxyglutarate,SMPDB,25,CS;GLS2;PDHA1;PDHB;ACO1;ACO2;FH;DLAT;DLD;MPC1;DLST;IDH1;IDH2;IDH3A;IDH3B;IDH3G;MDH2;SUCLG2;SUCLG1;PC;OGDH;SDHA;SDHB;SDHC;SDHD,27 (27),1.68e-16,8.74e-15,1,HMDB0033934,38 (40),0.987,1,6.19e-15,2.65e-13
Metabolism of vitamins and cofactors,Reactome,82,MMAA;TPK1;GPHN;APOM;NAPRT;SLC25A32;NADSYN1;APOA4;APOC2;FASN;BTD;NAMPT;MTHFS;VKORC1;VNN1;ACACA;ACACB;CALM1;NMNAT1;BCO2;RDH11;SPR;MTHFD1;NT5E;ALDH1L2;PTS;CYP8B1;ENPP1;COQ5;QPRT;FLAD1;NADK2;DHFR;CD38;COQ9;RBP1;AOX1;NAXD;RBP4;CYB5R3;LRP1;NADK;ACP5;SHMT1;SHMT2;VKORC1L1;APOA1;APOA2;HSP90AA1;APOB;GCH1;MCCC2;ALDH1L1;IDH1;MCCC1;COASY;APOE;COQ3;NFS1;NNMT;MMAB;PC;RETSAT;PPCS;GSTO1;PCCA;PCCB;COQ6;TTPA;SLC23A1;TTR;AKR1C1;NAXE;MOCS1;MMUT;COQ7;PDXK;CYB5A;MOCOS;PNPO;NMNAT3;APOC3,180 (180),1.81e-16,9.3e-15,9,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0003134;HMDB0000244;HMDB0000067;HMDB0000123;HMDB0001416;HMDB0001016;HMDB0030020;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,136 (188),0.966,1,6.51e-15,2.75e-13
Urea cycle and metabolism of arginine_ proline_ glutamate_ aspartate and asparagine,EHMN,57,GLUL;PAOX;GSTZ1;SLC6A13;RANBP2;OTC;ABAT;SLC25A20;SLC38A3;GLS2;NUP155;MAOA;MGST1;MGST2;MGST3;GSTK1;GCLC;P4HB;AGA;SLC38A4;SLC25A15;ACY3;GLS;NUP210;GLUD1;ACY1;SLC25A10;GPX4;NUP98;NUP133;AGMAT;MAOB;L2HGDH;DAO;ANPEP;OAT;ALDH4A1;NUP93;NUP58;ALDH1B1;CPS1;ALDH9A1;ALDH3A2;GCLM;PARS2;CRAT;GPX1;ALDH5A1;AKT1S1;NAGS;NUP160;ALDH7A1;GOT2;GSR;NUP35;SFXN3;NUP205,105 (105),4.35e-16,2.19e-14,11,HMDB0002064;HMDB0060460;HMDB0001186;HMDB0033934;HMDB0002104;HMDB0000725;HMDB0002172;HMDB0000123;HMDB0001276;HMDB0002189;HMDB0000489,93 (125),0.413,1,6.7e-15,2.79e-13
Biological oxidations,Reactome,92,CMBL;EPHX1;CYP1A2;GLYAT;AADAC;TPMT;MAOA;MAOB;CYP2E1;CYP4B1;CYP7A1;CYP8B1;MAT1A;MAT2A;ESD;ACY3;CYP27A1;ACSM1;AS3MT;AKR1A1;ABHD14B;ACSS2;ACY1;CYP39A1;SLC26A1;PTGS1;AHCY;SULT1E1;ADH5;ADH6;GLYATL1;PAOX;BPNT1;SULT1B1;BPHL;MGST1;MGST2;MGST3;GCLC;HPGDS;GSTA5;FDX1;FDXR;UGT2A1;UGDH;CYB5R3;UGP2;UGT2B10;UGT2B15;ACSM5;ALDH1A1;ALDH1B1;NQO2;NNMT;GSTO1;MTARC1;OPLAH;HSP90AB1;DPEP1;NAT1;FMO1;FMO3;COMT;MAT2B;CYB5B;GLYATL2;POR;AIP;PAPSS2;GSS;GSTA1;GSTA2;GSTA3;GSTA4;AKR7A2;GSTM1;GSTM2;UGT1A3;GSTM4;GSTP1;GSTT1;GSTT2;GSTZ1;GSTK1;UGT2A3;AKR7A3;CNDP2;SULT1A1;SULT1C2;PTGES3;GGCT;GCLM,219 (219),1.48e-15,6.58e-14,30,HMDB0001186;HMDB0033934;HMDB0001934;HMDB0000123;HMDB0001547;HMDB0000145;HMDB0002995;HMDB0000015;HMDB0001251;HMDB0000067;HMDB0014813;HMDB0041905;HMDB0000077;HMDB0000290;HMDB0000876;HMDB0003550;HMDB0000234;HMDB0001043;HMDB0006763;HMDB0003208;HMDB0001276;HMDB0013195;HMDB0006344;HMDB0000653;HMDB0000840;HMDB0006543;HMDB0000054;HMDB0060136;HMDB0001920;HMDB0001993,231 (320),0.147,1,8.04e-15,3.31e-13
IL-1 p38,INOH,41,PSMD6;MAP2K4;MAPK14;UBE2N;UBE2V1;PSMC4;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;PSMB10;PSMC1;PSMC2;PSMC3;TOLLIP;PSMC5;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;MAPK9;MAP2K1;MAP2K2;MAP2K3,66 (66),1.09e-14,4.35e-13,0,,0 (0),1,1,1.09e-14,4.35e-13
Nonalcoholic fatty liver disease,Wikipathways,71,CYC1;UQCR10;COX6C;NDUFB7;NDUFA11;NDUFB11;NDUFB4;NDUFA3;NDUFS7;NDUFA4;ITCH;PIK3R1;NDUFA5;NDUFA12;MT-CO1;COX5A;MT-CO3;CYP2E1;UQCRH;EIF2S1;COX4I1;COX5B;COX6A1;PRKAA1;PRKAA2;PRKAB1;MLX;PKLR;PRKAG1;CASP3;BAX;COX7C;MT-CO2;RAC1;COX7A2L;NDUFS8;RELA;UQCRB;NDUFA2;UQCRC1;UQCRC2;UQCRFS1;NDUFA6;NDUFA7;NDUFA8;NDUFA9;MAPK9;NDUFAB1;NDUFB2;NDUFB3;CDC42;UQCRQ;NDUFB6;RXRA;NDUFB8;NDUFB5;NDUFB10;NDUFC1;NDUFC2;NDUFS1;NDUFS2;NDUFS3;NDUFV1;NDUFS4;SDHA;SDHB;SDHC;SDHD;NDUFV2;NDUFV3;BID,155 (155),1.36e-14,5.34e-13,0,,0 (4),1,1,1.36e-14,5.34e-13
TLR JNK,INOH,41,PSMD6;MAP2K4;CD14;UBE2N;UBE2V1;PSMC4;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;PSMB10;PSMC1;PSMC2;PSMC3;TOLLIP;PSMC5;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;MAPK9;MAP2K1;MAP2K2;MAP2K3,62 (62),4.25e-16,2.16e-14,0,,1 (1),1,1,1.55e-14,6.3e-13
Metabolism of steroids,Reactome,50,DHCR24;RAN;HSD3B7;OSBP;FASN;ACOT8;HSD17B7;SLC10A1;ACACB;UBE2I;MSMO1;ACAT2;CYP7A1;CYP8B1;FDFT1;AMACR;DHCR7;FDX1;FDXR;CYP27A1;BAAT;SRD5A1;OSBPL1A;AKR1D1;TM7SF2;SLC27A5;SCP2;ABCB11;HSD17B12;SERPINA6;GPAM;LSS;HMGCS1;HSD11B1;EBP;IDI1;HSD17B4;HSD17B11;CYP39A1;AKR1B1;RXRA;AKR1C1;KPNB1;HSD17B2;ACOX2;MVK;SLC27A2;GC;STARD5;ALB,124 (124),2.21e-08,3.61e-07,33,HMDB0006842;HMDB0001170;HMDB0000123;HMDB0001547;HMDB0006271;HMDB0000145;HMDB0000036;HMDB0000015;HMDB0001286;HMDB0001188;HMDB0000067;HMDB0006841;HMDB0000077;HMDB0006894;HMDB0012455;HMDB0001231;HMDB0000876;HMDB0003550;HMDB0000637;HMDB0000951;HMDB0000234;HMDB0062206;HMDB0006763;HMDB0002719;HMDB0001251;HMDB0000138;HMDB0006281;HMDB0062420;HMDB0000032;HMDB0001090;HMDB0060136;HMDB0001457;HMDB0001993,113 (142),2.33e-08,3.12e-05,1.86e-14,7.48e-13
Pyruvate dehydrogenase deficiency (E3),SMPDB,21,SUCLG2;SUCLG1;PC;OGDH;PDHA1;DLAT;PDHB;SDHC;MPC1;IDH3G;ACO2;MDH2;SDHA;SDHB;CS;SDHD;IDH3A;IDH3B;DLD;DLST;FH,21 (21),5.78e-16,2.71e-14,0,,31 (33),1,1,2.09e-14,7.75e-13
Pyruvate dehydrogenase deficiency (E2),SMPDB,21,SUCLG2;SUCLG1;PC;OGDH;PDHA1;DLAT;PDHB;SDHC;MPC1;IDH3G;ACO2;MDH2;SDHA;SDHB;CS;SDHD;IDH3A;IDH3B;DLD;DLST;FH,21 (21),5.78e-16,2.71e-14,0,,31 (33),1,1,2.09e-14,7.75e-13
2-ketoglutarate dehydrogenase complex deficiency,SMPDB,21,SUCLG2;SUCLG1;PC;OGDH;PDHA1;DLAT;PDHB;SDHC;MPC1;IDH3G;ACO2;MDH2;SDHA;SDHB;CS;SDHD;IDH3A;IDH3B;DLD;DLST;FH,21 (21),5.78e-16,2.71e-14,0,,31 (33),1,1,2.09e-14,7.75e-13
Mitochondrial complex II deficiency,SMPDB,21,SUCLG2;SUCLG1;PC;OGDH;PDHA1;DLAT;PDHB;SDHC;MPC1;IDH3G;ACO2;MDH2;SDHA;SDHB;CS;SDHD;IDH3A;IDH3B;DLD;DLST;FH,21 (21),5.78e-16,2.71e-14,0,,31 (33),1,1,2.09e-14,7.75e-13
Fumarase deficiency,SMPDB,21,SUCLG2;SUCLG1;PC;OGDH;PDHA1;DLAT;PDHB;SDHC;MPC1;IDH3G;ACO2;MDH2;SDHA;SDHB;CS;SDHD;IDH3A;IDH3B;DLD;DLST;FH,21 (21),5.78e-16,2.71e-14,0,,31 (33),1,1,2.09e-14,7.75e-13
Congenital lactic acidosis,SMPDB,21,SUCLG2;SUCLG1;PC;OGDH;PDHA1;DLAT;PDHB;SDHC;MPC1;IDH3G;ACO2;MDH2;SDHA;SDHB;CS;SDHD;IDH3A;IDH3B;DLD;DLST;FH,21 (21),5.78e-16,2.71e-14,0,,31 (33),1,1,2.09e-14,7.75e-13
Citric Acid Cycle,SMPDB,21,SUCLG2;SUCLG1;PC;OGDH;PDHA1;DLAT;PDHB;SDHC;MPC1;IDH3G;ACO2;MDH2;SDHA;SDHB;CS;SDHD;IDH3A;IDH3B;DLD;DLST;FH,21 (21),5.78e-16,2.71e-14,0,,31 (33),1,1,2.09e-14,7.75e-13
Tryptophan metabolism - Homo sapiens (human),KEGG,32,AFMID;CYP1A2;IDO2;MAOA;MAOB;ALDH1B1;ACAT1;ACAT2;EHHADH;INMT;AOX1;HAAO;ALDH8A1;DLD;KYAT3;DLST;HADHA;TDO2;HADH;GCDH;ACMSD;AADAT;ALDH9A1;ALDH3A2;CAT;ECHS1;DHTKD1;DDC;KYNU;KYAT1;KMO;ALDH7A1,42 (42),1.14e-15,5.22e-14,5,HMDB0062259;HMDB0004095;HMDB0004369;HMDB0004259;HMDB0000472,59 (83),0.775,1,3.15e-14,1.16e-12
Innate Immune System,Reactome,303,VAPA;CFH;CRK;CFHR1;CAB39;LGMN;ATP6V1A;HEXB;AAMP;ATP6V0C;ATP6V1C1;CPPED1;ATP6V1E1;ATP6V0A1;CAND1;IGHG1;TRIM25;AGA;PSAP;HK3;MANBA;ERP44;MLEC;DDX58;NCKAP1;IQGAP2;BRK1;ACLY;CFL1;CTSC;SPTAN1;PSMA5;B2M;PSMB1;ACTB;GSDMD;PSMB7;XRCC5;FADD;PSMC2;PSMC3;SRP14;TCIRG1;PSMD1;PSMD2;PSMD3;PSMD7;NCK1;ATP6V1B2;PSMD12;PSMD13;SKP1;ACTG1;PFKL;HSP90B1;ILF2;F2;CREG1;PGAM1;ITGB2;TTR;NDUFC2;DDOST;PGM1;CFB;GRB2;PGRMC1;STAT6;FTH1;DHX9;ITPR2;SNAP29;PIK3R4;PSMD6;DIAPH1;S100A9;RAB10;TOMM70;AP2A2;TUBB4B;JUP;PTPN6;ASAH1;FGA;COTL1;CYFIP1;UBE2D3;FAF2;SUGT1;TXNDC5;GLB1;MGST1;MAVS;PTPRJ;PIGR;CD59;UBE2N;UBE2V1;HP;DYNC1LI1;VNN1;MAP2K4;PIK3R1;GM2A;AGL;CCT8;SURF4;ATP6V1D;COMMD3;MIF;IMPDH2;VPS35L;CPNE3;HRAS;PKM;FGB;LGALS3;SERPING1;RAB7A;TOLLIP;PYGB;AP1M1;PYGL;GHDC;C3;C4A;ALAD;S100A11;C5;BAIAP2;PRKACA;CKAP4;C8A;C8B;CEACAM1;IDH1;C9;ALDOA;PDXK;MVP;C4BPA;RAB6A;GNS;HSPA8;DYNC1H1;RAB5C;CAP1;HSP90AA1;SLC27A2;PLD4;ARG1;PNP;VAT1;HSP90AB1;FUCA1;DPP7;MPO;ATG5;GPI;CUL1;IQGAP1;PTGES2;WASL;RAP1A;CYB5R3;RAP1B;DNAJC13;ABI1;RAB31;VTN;ITCH;STBD1;LAMTOR2;FGG;CALM1;ANPEP;COPB1;DSP;LAMTOR1;S100A8;ANXA2;CTSB;SCAMP1;PSMA2;DUSP3;CAPN1;ARPC1A;RNF135;NME2;DBNL;CAPZA1;CAPZA2;SHC1;DNAJC3;HGSNAT;CPNE1;NIT2;GDI2;APEH;PPP2CB;NLRX1;LAMP1;METTL7A;ATP6V1G1;CAT;CCT2;UBR4;APOB;ARL8A;NCSTN;HMOX2;CTSD;RAB14;APRT;CFI;TOM1;CTSA;PCBP2;SERPINA1;ARPC5;ARPC4;ARPC3;ARPC1B;DEGS1;ACTR2;VAMP8;PRDX6;GSN;CYFIP2;EEF1A1;ARPC2;DERA;KPNB1;RHOA;GSTP1;RHOG;ACTR1B;PGM2;ORM1;PPP2R1A;RAB5B;PPP2R5D;EEF2;RAB18;ATP6V1H;TKFC;MAPK14;ATP6V0D1;ARSB;PPP3CA;PDAP1;CD14;ISG15;IST1;MAP2K3;COMMD9;NAPRT;GUSB;RAC1;GYG1;CSNK2B;PAFAH1B2;ATOX1;PRKACB;GRN;CD47;PIN1;CSTB;VCL;PAK2;CNPY3;AGPAT2;TMEM30A;VCP;RPS6KA1;ROCK1;CD81;LTA4H;LRRFIP1;OSTF1;PRKCSH;FUS;MAPK1;CTNNB1;MAPK9;LYN;MAP2K1;PSMD14;CDC42;NPC2;CTSH;CTSL;CLU;MAN2B1;RELA;ACTR3;CTSZ;XRCC6;GAA;DGAT1;STOM;PA2G4;PSMD11,1064 (1065),1.24e-15,5.62e-14,5,HMDB0000067;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0029931;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,57 (119),0.748,1,3.29e-14,1.2e-12
TLR p38,INOH,41,PSMD6;MAP2K4;MAPK14;CD14;UBE2N;UBE2V1;PSMC4;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;PSMB10;PSMC1;PSMC2;PSMC3;TOLLIP;PSMC5;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;MAP2K1;MAP2K2;MAP2K3,63 (63),9.97e-16,4.62e-14,0,,1 (1),1,1,3.54e-14,1.27e-12
Valine_ leucine and isoleucine degradation,EHMN,35,IVD;DBI;ABAT;IARS2;ACADL;ACADM;HIBCH;ACADSB;AUH;SLC16A1;EHHADH;SLC38A4;SLC43A1;ALDH9A1;DLD;BCKDHA;BCKDHB;ACADS;HSD17B10;HADHA;MCCC2;HADHB;HADH;MCCC1;ALDH1B1;HSD17B4;ECHS1;PCCA;PCCB;ALDH6A1;VARS1;HIBADH;HMGCL;ALDH7A1;ACAA2,49 (49),1.52e-15,6.72e-14,5,HMDB0006868;HMDB0001052;HMDB0000172;HMDB0000687;HMDB0033934,52 (62),0.671,1,3.62e-14,1.29e-12
Translation Factors,Wikipathways,34,EEF1B2;PAIP1;EEF1G;EEF2;EIF4H;EIF2S1;EIF2B1;EIF4A1;EIF4A2;EIF4E;EIF2B4;EIF2B3;EIF2B2;EIF4G1;EIF2S2;EIF5A;EIF5B;EIF3A;EIF3B;EIF3C;EIF3D;EIF3F;EIF3G;EIF3H;EIF3I;EIF3J;EIF1;ETF1;PABPC1;EIF6;CLUH;EIF2B5;EEF1A1;EIF2AK2,50 (50),3.99e-14,1.46e-12,0,,0 (0),1,1,3.99e-14,1.46e-12
Glyoxylate metabolism and glycine degradation,Reactome,27,AGXT2;LIAS;PRODH2;AMT;GRHPR;PDHA1;PDHB;GLDC;GCSH;HOGA1;AGXT;PXMP2;DLAT;DAO;DLST;BCKDHA;BCKDHB;ALDH4A1;HAO1;DBT;GNMT;NDUFAB1;DHTKD1;OGDH;DLD;PDHX;GOT2,32 (32),1.86e-15,8.05e-14,3,HMDB0240251;HMDB0000123;HMDB0033934,32 (42),0.684,1,4.48e-14,1.58e-12
Translation initiation complex formation,Reactome,42,EIF3B;EIF2S1;EIF3D;EIF4H;RPS3;RPS3A;RPS4X;RPS5;RPS6;EIF4A1;EIF4A2;EIF4E;RPS8;RPS9;RPS10;RPS11;EIF2S2;RPS13;RPS14;RPS15;RPS15A;EIF3K;RPS16;RPS17;RPS19;RPSA;RPS21;RPS23;EIF3A;RPS25;EIF3C;RPS27;EIF3F;EIF3G;EIF3H;EIF3I;EIF3J;PABPC1;EIF4G1;EIF3M;RPS27L;RPS24,66 (66),1.47e-15,6.58e-14,0,,1 (3),1,1,5.17e-14,1.8e-12
Cellular responses to stress,Reactome,180,RPL22;RPL23A;TPR;RPL24;RPL26;RPL27;RPL30;ATP6V1B2;ATP6V0C;ATP6V1C1;RPL32;HIF1A;RPL34;RPL38;RPL36A;RPLP0;RPS3;RPS3A;RPS4X;RPS5;RPS6;RPS6KA1;DNAJA2;DNAJB1;HSPH1;RPS8;RPS9;RPS10;BAG1;RPS13;RPS14;RPS15;RPS15A;ATP6V1A;TCIRG1;RPS16;RPS17;RPS19;RPS21;RPS23;RPS24;RPS25;RPS27;NDUFA4;NUP58;HMOX2;HM13;DNAJC7;ATP6V1E1;RPL28;RXRA;STAT3;FABP1;RRAGC;NUP35;NUP205;HSPA13;RPL10A;BLVRA;BLVRB;UBE2D3;NUP93;COX5A;DNAJA4;ATP6V1D;PRDX3;NUP210;EIF2S2;STIP1;RPL22L1;ALB;RPS27L;LAMTOR1;PRDX5;TXN2;DNAJA1;GCN1;HSPA4;HSPA5;NUP160;HSPA8;HSPA9;HSPB1;HMOX1;CCS;VCP;HSP90AA1;RBX1;SEC13;HSP90AB1;TXNRD1;CUL3;CUL2;CUL1;ELOC;ELOB;RANBP2;MAP2K4;ATM;COX4I1;LAMTOR2;HDAC6;RPL23;RAE1;COX5B;RBBP4;HIKESHI;CAMK2A;CAMK2D;COX6A1;BAG3;GPX1;NUDT2;NUP98;COX6C;COX7C;ATP6V1G1;APOA1;RPSA;RELA;AKT1S1;RPL14;AQP8;PRDX2;XPO1;TXNRD2;NR3C1;SKP1;SERPINH1;YWHAE;ERO1A;RPS11;PRDX6;GSR;RHEB;RAD50;GSTP1;ATP6V1H;MAPK14;ATP6V0D1;NUP155;MT-CO1;FKBP4;MT-CO3;LAMTOR4;FKBP5;P4HB;MTOR;APOB;EIF2S1;ASNS;PRDX1;HELZ2;NUP133;H2AX;MT-CO2;RPL11;CCAR2;COX7A2L;SOD2;RPL35;MAPK1;CAT;MAPK9;MAP2K3;PTGES3;RPL3;RPL4;RPL5;RPL6;RPL7A;RPL8;RPL9;SOD1;RPL12;RPL13;RPL17;RPL18;RPL18A;RPL19,553 (554),3.15e-15,1.34e-13,6,HMDB0000234;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0000067;HMDB0001388;HMDB0000054;HMDB0001043,55 (74),0.548,1,6.03e-14,2.08e-12
Response of EIF2AK4 (GCN2) to amino acid deficiency,Reactome,58,RPL10A;RPL22;RPL23A;RPL23;RPL24;RPL26;RPL27;RPL30;RPL28;RPS3A;RPL32;RPL34;RPL14;RPL38;RPL36A;RPLP0;RPS23;RPS3;EIF2S1;RPS4X;RPS5;RPS6;RPL35;ASNS;RPS8;RPS9;RPS10;RPS11;EIF2S2;RPS13;RPS14;RPS15;RPS15A;RPS16;RPS17;RPS19;RPSA;RPS21;RPL22L1;RPS24;RPS25;RPL13;RPS27;GCN1;RPL3;RPL4;RPL5;RPL6;RPL7A;RPL8;RPL9;RPL11;RPL12;RPS27L;RPL17;RPL18;RPL18A;RPL19,111 (111),2.41e-15,1.03e-13,0,,2 (4),1,1,8.35e-14,2.85e-12
EGFR1,NetPath,151,MTA2;WBP2;ANXA4;RPL30;STAM2;AHCYL1;MYH9;EPPK1;RPLP0;MYO6;ZPR1;CFL1;RPS6KA1;ACP1;GSN;ACTB;SRI;SPART;EPS15;ACTN4;NCK1;ACTN1;LPP;PFN1;WASL;TFG;PGAM1;ITGB1;HNRNPA1;STAT2;STAT3;DDX6;STAT5B;IQGAP1;MPRIP;NEDD4;CDV3;S100A10;S100A11;JUP;PTPN6;PTPN11;AP2S1;STX4;AP2A1;AP2B1;PKP2;ACTR2;PIK3R1;AHNAK;PITPNA;CLTA;CLTC;HRAS;PKM;PXN;TJP2;TOLLIP;PYGB;CRKL;STIP1;ALB;TAGLN2;BAIAP2;PLEC;ALDOA;EPN1;MVP;RAB5A;HGS;CAVIN2;VCL;RAC1;VIM;HSPE1;RALB;FLNB;FLOT2;KRT8;RAP1A;SFPQ;ABI1;ITCH;PDCD6IP;CALD1;CALM1;DSG2;DSP;ATP1A1;ANXA1;ANXA2;ESYT1;SH3BGRL;TOM1;SHC1;GRB2;CTTN;GRB14;RELA;LYN;CAV1;PLEKHA6;LDHA;MAP2K3;RPS10;CDH1;YWHAZ;ACTR3;ARAF;CRK;SNRPD2;RPS27L;ARF4;EEF1A1;TFRC;RHOA;LSR;MAPK14;MT-CO2;PDLIM1;CSK;MTOR;PEBP1;TKT;MAP4K5;PKP3;TLN1;PRKAA1;PRKAA2;EIF4G1;SMU1;CSTB;PRKAR1A;CD59;KHDRBS1;PRKCA;CTBP1;EGFR;MAPK1;CTNND1;MAPK9;FLOT1;MAP2K1;MAP2K2;CDC42;ENO1;CDH2;TNS1;ATXN2;SNX5;HNRNPR,454 (455),8.34e-14,2.98e-12,0,,0 (0),1,1,8.34e-14,2.98e-12
Activation of the mRNA upon binding of the cap-binding complex and eIFs_ and subsequent binding to 43S,Reactome,42,EIF3B;EIF2S1;RPS27;EIF4H;RPS3;RPS3A;RPS4X;RPS5;RPS6;EIF4A1;EIF4A2;EIF4E;RPS8;RPS9;RPS10;EIF4G1;EIF2S2;RPS13;RPS14;RPS15;RPS15A;EIF3K;RPS16;RPS17;RPS19;RPSA;RPS21;RPS23;EIF3A;RPS25;EIF3C;EIF3D;EIF3F;EIF3G;EIF3H;EIF3I;EIF3J;PABPC1;RPS11;EIF3M;RPS27L;RPS24,67 (67),3.22e-15,1.36e-13,0,,1 (4),1,1,1.11e-13,3.75e-12
TNF,INOH,40,PSMD6;MAP2K4;CASP3;ITCH;PSMC2;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;PSMB10;PSMC1;BAX;PSMC3;PSMC4;PSMC5;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;FADD;MAPK9;RELA;BID,67 (67),1.53e-13,5.36e-12,0,,0 (0),1,1,1.53e-13,5.36e-12
Mitochondrial protein import,Reactome,41,CYC1;TIMM17B;HSPD1;LDHD;CS;TOMM70;CHCHD3;OTC;TIMM10B;CHCHD10;TIMM10;TIMM9;TIMM8B;MTX2;SLC25A12;TOMM22;TIMM21;SLC25A4;PMPCB;DNAJC19;ACO2;SLC25A13;TIMM50;GRPEL1;PAM16;PMPCA;TOMM40;SAMM50;FXN;IDH3G;MTX1;TIMM44;COA6;BCS1L;NDUFB8;CMC2;GFER;HSPA9;ATP5F1A;VDAC1;ATP5F1B,65 (65),5.03e-15,2.08e-13,0,,4 (4),1,1,1.71e-13,5.72e-12
Glycine_ serine and threonine metabolism - Homo sapiens (human),KEGG,30,DMGDH;SDSL;AMT;BPGM;MAOA;MAOB;GRHPR;AGXT2;GCAT;GLDC;GCSH;CHDH;AGXT;GLYCTK;PIPOX;SHMT1;GAMT;SHMT2;DLD;SRR;CTH;PSPH;SARDH;GNMT;DAO;PGAM1;CBS;SDS;ALDH7A1;BHMT,40 (40),1.88e-14,7.29e-13,6,HMDB0033934;HMDB0006454;HMDB0000043;HMDB0000123;HMDB0001149;HMDB0012249,42 (50),0.292,1,1.86e-13,6.18e-12
Cellular responses to external stimuli,Reactome,182,RPL22;RPL23A;TPR;RPL24;RPL26;RPL27;RPL30;ATP6V1B2;ATP6V0C;ATP6V1C1;RPL32;HIF1A;RPL34;RPL38;RPL36A;RPLP0;RPS3;RPS3A;RPS4X;RPS5;RPS6;RPS6KA1;DNAJA2;DNAJB1;HSPH1;RPS8;RPS9;RPS10;BAG1;RPS13;RPS14;RPS15;RPS15A;ATP6V1A;TCIRG1;RPS16;RPS17;RPS19;RPS21;RPS23;RPS24;RPS25;RPS27;NDUFA4;NUP58;HMOX2;HM13;DNAJC7;ATP6V1E1;RPL28;RXRA;STAT3;FABP1;RRAGC;NUP35;NUP205;HSPA13;RPL10A;BLVRA;BLVRB;UBE2D3;NUP93;COX5A;DNAJA4;ATP6V1D;PRDX3;NUP210;EIF2S2;STIP1;RPL22L1;ALB;RPS27L;LAMTOR1;PRDX5;TXN2;DNAJA1;GCN1;HSPA4;HSPA5;NUP160;HSPA8;HSPA9;HSPB1;HMOX1;CCS;VCP;HSP90AA1;RBX1;SEC13;HSP90AB1;TXNRD1;CUL3;CUL2;CUL1;ELOC;ELOB;RANBP2;MAP2K4;ATM;COX4I1;LAMTOR2;HDAC6;RPL23;RAE1;COX5B;RBBP4;HIKESHI;CAMK2A;CAMK2D;COX6A1;BAG3;GPX1;NUDT2;NUP98;COX6C;COX7C;ATP6V1G1;APOA1;RPSA;RELA;AKT1S1;RPL14;AQP8;PRDX2;XPO1;TXNRD2;NR3C1;SKP1;SERPINH1;YWHAE;ERO1A;RPS11;PRDX6;GSR;RHEB;RAD50;MT2A;GSTP1;ATP6V1H;MAPK14;ATP6V0D1;NUP155;MT-CO1;FKBP4;MT-CO3;LAMTOR4;FKBP5;P4HB;MTOR;APOB;EIF2S1;ASNS;CSRP1;PRDX1;HELZ2;NUP133;H2AX;MT-CO2;RPL11;CCAR2;COX7A2L;SOD2;RPL35;MAPK1;CAT;MAPK9;MAP2K3;PTGES3;RPL3;RPL4;RPL5;RPL6;RPL7A;RPL8;RPL9;SOD1;RPL12;RPL13;RPL17;RPL18;RPL18A;RPL19,568 (569),1.18e-14,4.67e-13,6,HMDB0000234;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0000067;HMDB0001388;HMDB0000054;HMDB0001043,57 (76),0.584,1,2.31e-13,7.6e-12
The oncogenic action of Succinate,SMPDB,26,HIF1A;CS;PDHA1;PDHB;ACO1;ACO2;FH;SLC25A10;DLAT;DLD;MPC1;DLST;IDH1;IDH2;IDH3A;IDH3B;IDH3G;MDH2;SUCLG2;SUCLG1;PC;OGDH;SDHA;SDHB;SDHC;SDHD,31 (31),8.39e-15,3.41e-13,1,HMDB0000725,38 (41),0.987,1,2.77e-13,8.93e-12
The oncogenic action of Fumarate,SMPDB,26,HIF1A;CS;PDHA1;PDHB;ACO1;ACO2;FH;SLC25A10;DLAT;DLD;MPC1;DLST;IDH1;IDH2;IDH3A;IDH3B;IDH3G;MDH2;SUCLG2;SUCLG1;PC;OGDH;SDHA;SDHB;SDHC;SDHD,31 (31),8.39e-15,3.41e-13,1,HMDB0000725,38 (42),0.987,1,2.77e-13,8.93e-12
Ribosomal scanning and start codon recognition,Reactome,41,EIF3B;EIF2S1;EIF3D;EIF4H;RPS3;RPS3A;RPS4X;RPS5;RPS6;EIF4A1;EIF4A2;EIF4E;RPS8;RPS9;RPS10;RPS11;EIF2S2;RPS13;RPS14;RPS15;RPS15A;EIF3K;RPS16;RPS17;RPS19;RPSA;RPS21;RPS23;EIF3A;RPS25;EIF3C;RPS27;EIF3F;EIF3G;EIF3H;EIF3I;EIF3J;EIF4G1;EIF3M;RPS27L;RPS24,66 (66),1.09e-14,4.35e-13,0,,4 (7),1,1,3.6e-13,1.15e-11
TCA cycle,HumanCyc,19,SUCLG2;SUCLG1;SUCLA2;OGDH;DLD;SDHC;FH;DLST;ACO1;ACO2;SDHA;SDHB;CS;SDHD;IDH3A;IDH3B;IDH3G;MDH1;MDH2,19 (19),1.64e-14,6.41e-13,0,,23 (23),1,1,5.38e-13,1.7e-11
proteasome complex,BioCarta,22,UBA1;RPN1;RPN2;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMD3;PSMD4;PSMD11;PSMD12;PSMD14;UBE3A,24 (24),2.01e-14,7.73e-13,0,,2 (2),1,1,6.55e-13,2.06e-11
Pyruvate metabolism - Homo sapiens (human),KEGG,33,ADH5;ADH6;LDHD;ACACA;ACACB;GRHPR;ACAT1;ACAT2;PDHA1;PDHB;GLO1;ACSS2;ALDH9A1;PKLR;PKM;DLAT;DLD;LDHA;HAGH;AKR1A1;ALDH1B1;MDH1;MDH2;ALDH3A2;ACYP1;PC;ME1;LDHB;FH;PCK1;PCK2;ALDH7A1;ACOT12,47 (47),2.22e-14,8.44e-13,0,,26 (32),1,1,7.19e-13,2.24e-11
Glucose metabolism,Reactome,50,GPI;TPR;PPP2CB;PPP2R1A;RANBP2;GNPDA1;PPP2R5D;HK1;FBP1;SLC25A12;HK3;NUP155;RAE1;GAPDH;BPGM;SLC25A1;SLC25A13;NUP210;PGP;SLC25A10;PRKACA;PRKACB;NUP98;PKLR;NUP133;PKM;SLC25A11;GCK;GCKR;NUP93;NUP58;PFKL;MDH1;MDH2;ALDOA;PC;ALDOB;PGAM1;ENO1;SLC37A4;NUP160;ADPGK;PCK1;PCK2;GOT1;GOT2;NUP35;SEC13;NUP205;TPI1,92 (93),2.62e-14,9.88e-13,0,,32 (39),1,1,8.45e-13,2.6e-11
IL-1 NFkB,INOH,38,PSMD6;CUL1;UBE2N;UBE2V1;PSMC4;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;PSMB10;PSMC1;PSMC2;PSMC3;TOLLIP;PSMC5;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;SKP1;RELA,64 (64),7.94e-13,2.64e-11,0,,0 (0),1,1,7.94e-13,2.64e-11
Valine Leucine Isoleucine degradation,INOH,26,IVD;HMGCS2;HADHB;ACAD11;ACADM;ACADS;AUH;EHHADH;ACAA2;HMGCL;HSD17B10;HMGCS1;HADHA;MCCC2;ALDH1A1;HADH;MCCC1;ALDH1B1;ALDH9A1;ALDH3A2;ECHS1;PCCA;PCCB;ALDH6A1;HIBADH;ALDH7A1,32 (32),3.67e-14,1.36e-12,3,HMDB0001052;HMDB0000172;HMDB0000687,36 (40),0.759,1,8.97e-13,2.74e-11
Mitochondrial Fatty Acid Beta-Oxidation,Reactome,28,MMAA;DECR1;HADHA;ACSM3;MECR;ACAD11;ACADM;ACADS;ACADVL;ACOT13;ACOT7;ACADL;ACAA2;ACOT2;ACAD10;MCAT;DBI;HADHB;HADH;ACSF2;ECI1;NDUFAB1;ECHS1;PCCA;PCCB;MMUT;ACOT12;MCEE,36 (37),2.87e-14,1.08e-12,2,HMDB0062259;HMDB0003944,53 (66),0.983,1,9.09e-13,2.75e-11
Phase II - Conjugation of compounds,Reactome,56,GSTM1;GSTM2;UGT1A3;GSTM4;GSTP1;GSTT1;NAT1;GSTZ1;AKR1A1;BPNT1;SULT1B1;TPMT;COMT;MGST1;MGST2;SULT1C2;GSTK1;GLYATL1;MAT2B;GCLC;GCLM;GSTA5;MAT1A;MAT2A;CYP1A2;ESD;CNDP2;UGT2A3;ACSM1;UGDH;AHCY;UGP2;GLYATL2;AS3MT;UGT2B10;UGT2B15;SULT1A1;ACSM5;MGST3;GLYAT;GSS;ABHD14B;PAPSS2;NNMT;GSTO1;SLC26A1;UGT2A1;GSTT2;GGCT;OPLAH;GSTA1;GSTA2;GSTA3;GSTA4;HPGDS;SULT1E1,111 (111),5.23e-14,1.9e-12,12,HMDB0000067;HMDB0006344;HMDB0001934;HMDB0000123;HMDB0014813;HMDB0000145;HMDB0000653;HMDB0000840;HMDB0006543;HMDB0000054;HMDB0000077;HMDB0000290,115 (149),0.588,1,9.88e-13,2.96e-11
TCA cycle,EHMN,25,CS;ACO1;SLC25A1;ACO2;MDH2;DLD;DLST;SLC25A11;IDH1;IDH2;IDH3A;IDH3B;IDH3G;MDH1;FH;SUCLG2;SUCLG1;SUCLA2;OGDH;PCK1;PCK2;SDHA;SDHB;SDHC;SDHD,30 (30),3.76e-14,1.39e-12,2,HMDB0003974;HMDB0000189,36 (36),0.912,1,1.1e-12,3.27e-11
Endocytosis - Homo sapiens (human),KEGG,98,SNF8;EPS15;STAM2;SNX3;CAV1;GBF1;VPS4A;RAB11A;IST1;SPART;TSG101;RAB11B;HGS;CHMP2A;RAB8A;EHD4;EHD3;NEDD4;RAB10;EPS15L1;AP2M1;AP2S1;DNM3;AP2A1;AP2A2;AP2B1;SNX6;WASHC5;ARFGAP3;WASHC2C;ARF5;EHD1;CLTA;CLTB;CLTC;HRAS;WASHC1;RAB7A;KIF5B;EEA1;EPN1;RAB4A;RAB5A;RAB5B;ARPC2;HSPA8;RAB5C;DNM2;PML;SMAP1;RAB35;WASL;RAB31;ITCH;CHMP6;WASHC4;PDCD6IP;VPS26B;VPS4B;CHMP5;ARPC1A;CAPZA1;CAPZA2;CAPZB;ARFGEF2;ARFGEF1;WASHC3;VTA1;VPS36;VPS26A;VPS25;CHMP4B;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;ARF1;ARF4;TFRC;ARF6;RHOA;ARFGAP2;USP8;SH3GLB1;EGFR;VPS29;VPS35;ARFGAP1;CHMP3;ARPC5L;VPS28;CDC42;SNX1;SNX2;SNX5;RAB11FIP3,252 (252),6.38e-14,2.3e-12,0,,3 (6),1,1,2e-12,5.91e-11
Ribosome - Homo sapiens (human),KEGG,68,RPL10A;MRPL4;RPL22;RPL23A;RPL23;RPL24;MRPS2;RPL26;RPL27;RPL30;RPL28;RPL5;RPL32;RPL12;MRPL17;RPL34;RPL38;RPL36A;RPLP0;MRPL14;RPL6;MRPL16;MRPL12;RPL19;RPS3;RPS3A;RPS4X;RPS5;RPS6;RPL35;MRPL19;RPL8;RPS8;RPS9;RPS10;RPS11;RPS13;RPS14;RPS15;RPS15A;MRPS11;RPS16;RPS17;MRPS16;RPS19;RPSA;RPS21;RPS23;RPS24;RPS25;RPS27L;RPS27;MRPS21;RPL3;RPL4;MRPL9;MRPL1;RPL7A;RPL13;MRPS5;RPL9;RPL11;MRPL3;RPL22L1;RPL17;RPL18;RPL18A;RPL14,158 (158),1.91e-12,6.12e-11,0,,0 (0),1,1,1.91e-12,6.12e-11
Bacterial invasion of epithelial cells - Homo sapiens (human),KEGG,42,RHOA;CRK;RHOG;WASL;ILK;FN1;PIK3R1;SEPTIN9;CD2AP;ARPC1A;CLTA;ACTB;CLTC;SHC1;DNM3;PXN;ACTG1;SEPTIN11;RAC1;ARPC5L;CTNNA1;CTNNA2;CAV1;CTNNB1;ITGA5;CTTN;CDC42;CDH1;ITGB1;CLTB;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;HCLS1;VCL;CRKL;DNM2;ARPC2;SEPTIN2,77 (77),2.6e-12,8.12e-11,0,,0 (0),1,1,2.6e-12,8.12e-11
superpathway of purine nucleotide salvage,HumanCyc,37,ATP5F1D;ATP5PB;ADK;GMPS;ATP5MG;ATP5ME;ATP6V1A;ATP6V1B2;ATP6V0C;ATP6V1C1;ATP6V1E1;ATP6V1H;ATP6V0A1;ATP6V0D1;MT-ATP8;ADSL;IMPDH2;GUK1;HPRT1;RRM2B;ATP6V1D;NME3;AK2;AK4;ATP6V1G1;ATP5MF;NME1;NME2;RRM1;APRT;ADA;DMAC2L;ATP5PD;ATP5F1A;AK3;ATP5F1B;PNP,59 (59),1.42e-13,4.98e-12,1,HMDB0000195,30 (30),0.967,1,4.19e-12,1.23e-10
purine nucleotides <i>de novo</i> biosynthesis,HumanCyc,37,ATP5F1D;ATP5PB;GMPS;ATP5MG;ATP5ME;ATP6V1A;ATP6V1B2;ATP6V0C;ATP6V1C1;ATP6V1E1;ATP6V1H;ATP6V0A1;ATP6V0D1;MT-ATP8;ADSL;IMPDH2;GUK1;RRM2B;ATP6V1D;GART;NME2;NME3;AK2;AK4;PFAS;ATP5MF;ATP6V1G1;ATIC;NME1;PPAT;RRM1;DMAC2L;ATP5PD;PAICS;ATP5F1A;AK3;ATP5F1B,59 (59),1.42e-13,4.98e-12,1,HMDB0000123,37 (37),0.985,1,4.27e-12,1.24e-10
Glutathione metabolism - Homo sapiens (human),KEGG,36,GSTM1;GSTM2;GSTM4;GSTP1;GSTT1;GSTT2;NAT8;MGST1;MGST2;MGST3;GSTK1;GGCT;GCLM;GSTA5;RRM2B;TXNDC12;GPX1;GPX4;SRM;ANPEP;GSS;IDH1;IDH2;RRM1;GSTO1;PGD;GSTA4;LAP3;PRDX6;GCLC;GSR;OPLAH;GSTA1;GSTA2;GSTA3;HPGDS,57 (57),2.21e-13,7.66e-12,1,HMDB0000123,21 (38),0.909,1,6.07e-12,1.74e-10
Metabolism of nucleotides,Reactome,52,TXNRD1;GMPS;NT5E;ADK;AGXT2;DPYD;DPYS;UPB1;CAD;CMPK1;CTPS2;NUDT5;ADSL;IMPDH2;DGUOK;ENTPD8;GUK1;HPRT1;RRM2B;NUDT16;GLRX;GART;PPAT;ENTPD5;NME2;RRM1;NT5C2;AK2;XDH;UMPS;AK4;PFAS;LHPP;AMPD2;GSR;SAMHD1;ATIC;NT5C3A;GDA;GMPR2;NME1;NUDT9;NME3;APRT;TYMP;DHODH;ADA;PAICS;NT5C;DNPH1;ITPA;PNP,102 (102),2.43e-13,8.37e-12,6,HMDB0000123;HMDB0000195;HMDB0001178;HMDB0000189;HMDB0001342;HMDB0003349#HMDB0000528,125 (154),0.995,1,7.27e-12,2.07e-10
COPII-mediated vesicle transport,Reactome,40,PREB;SEC16B;SEC24D;SERPINA1;STX5;YKT6;LMAN1;SEC24C;PPP6C;NAPG;USO1;NSF;BET1;MCFD2;SCFD1;CSNK1D;SEC24A;CTSC;SAR1B;SEC23IP;SEC16A;CD59;NAPA;ANKRD28;TMED2;LMAN2;SEC22B;RAB1B;TRAPPC3;SEC31A;TMED10;RAB1A;GOSR2;STX17;TFG;GOLGA2;CTSZ;SEC23A;PPP6R3;SEC13,68 (68),3.05e-13,1.04e-11,0,,6 (11),1,1,9.09e-12,2.57e-10
TCA Cycle (aka Krebs or citric acid cycle),Wikipathways,17,SUCLG2;SUCLG1;IDH3A;OGDH;DLD;SDHC;DLST;ACO2;SDHA;SDHB;CS;SDHD;IDH2;MDH2;IDH3B;IDH3G;FH,17 (17),4.67e-13,1.58e-11,0,,24 (24),1,1,1.37e-11,3.85e-10
Citric acid cycle (TCA cycle),Reactome,20,SUCLG2;SUCLG1;SUCLA2;OGDH;IDH3G;DLD;CS;FH;DLST;ACO2;SDHA;SDHB;SDHC;SDHD;IDH2;IDH3A;IDH3B;NNT;FAHD1;MDH2,22 (22),4.81e-13,1.62e-11,0,,28 (31),1,1,1.41e-11,3.92e-10
Golgi-to-ER retrograde transport,Reactome,55,KIF13B;ACTR1A;NBAS;ARFGAP2;RAB3GAP1;RAB18;BNIP1;GBF1;GALNT2;COPZ1;COPB1;TMED7;NSF;USE1;DYNC1LI1;DCTN2;ARFGAP3;DCTN3;SURF4;RAB3GAP2;PAFAH1B1;PAFAH1B2;ARFGAP1;CAPZA1;AGPAT3;DYNLL2;CAPZB;KDELR1;NAPG;NAPA;ARF1;TMED9;COPA;COPG2;TMED2;SEC22B;RAB1B;KIF5B;TMED10;PAFAH1B3;ZW10;KLC4;RAB1A;DCTN1;RAB6B;RAB6A;KIF1C;DYNC1H1;DYNC1I2;ARCN1;CAPZA2;DYNC1LI2;ARF4;ARF5;COPE,116 (116),2.28e-12,7.28e-11,2,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,9 (11),0.25,1,1.67e-11,4.6e-10
TLR NFkB,INOH,40,PSMD6;CUL1;CD14;UBE2N;UBE2V1;PSMC4;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;PSMB10;PSMC1;PSMC2;PSMC3;TOLLIP;PSMC5;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;ECSIT;SKP1;RELA,69 (69),5.94e-13,1.99e-11,0,,1 (1),1,1,1.73e-11,4.74e-10
Steroid biosynthesis - Homo sapiens (human),KEGG,10,MSMO1;TM7SF2;HSD17B7;FDFT1;LSS;SOAT2;LIPA;DHCR7;DHCR24;EBP,20 (20),0.00162,0.00824,20,HMDB0001170;HMDB0001251;HMDB0000032;HMDB0001188;HMDB0006842;HMDB0000067;HMDB0000937;HMDB0006851;HMDB0006271;HMDB0006846;HMDB0006841;HMDB0002719;HMDB0001242;HMDB0006927#HMDB0001181;HMDB0002374;HMDB0036591;HMDB0001286;HMDB0006845;HMDB0000876;HMDB0003550,40 (58),4.03e-10,1.62e-06,1.9e-11,5.17e-10
tRNA Aminoacylation,Reactome,29,HARS2;AARS1;FARSA;IARS2;SARS2;WARS1;AARS2;AIMP1;MARS1;RARS1;IARS1;EEF1E1;PPA2;YARS1;LARS1;NARS1;FARSB;DARS1;QARS1;PPA1;HARS1;TARS2;CARS2;AIMP2;VARS1;TARS1;PARS2;SARS1;YARS2,42 (42),1.67e-12,5.4e-11,3,HMDB0000123;HMDB0000172;HMDB0000687,22 (65),0.425,1,2.06e-11,5.55e-10
Metabolism of carbohydrates,Reactome,104,HEXA;HEXB;TPR;GUSB;GALK1;HK1;MAN2C1;HK3;MANBA;GALT;SLC25A1;GAPDH;NAGLU;GLYCTK;GBE1;RBKS;GCK;GCKR;AKR1A1;NUP58;PFKL;MDH1;MDH2;DCN;PGAM1;PGD;SLC26A1;PGM1;BGN;NUP205;PHKB;PHKG2;FBP1;BPGM;GLB1;ST3GAL6;MAN2B1;SHPK;AGL;NUP210;UGP2;PKLR;PKM;PGLS;PYGB;PYGL;SLC25A11;KHK;XYLB;ALDH1A1;PGP;ALDOA;ALDOB;AKR1B1;TALDO1;NUP160;GOT1;GOT2;SEC13;GPI;RANBP2;EPM2A;GNPDA1;STAB2;RAE1;CALM1;NUP98;CRYL1;ST3GAL4;PAPSS2;NUP35;DERA;PPP2CB;PPP2R1A;RPIA;TKFC;PPP2R5D;ARSB;SLC25A12;NUP155;PRELP;TKT;GYG1;SLC25A13;GYS2;SLC25A10;PRKACA;PRKACB;NUP133;NUP93;LUM;GNS;PC;ENO1;RPE;PGM2;SLC37A4;ADPGK;PCK1;PCK2;GAA;SORD;CHP1;TPI1,284 (285),9.76e-13,3.22e-11,3,HMDB0000290;HMDB0035312;HMDB0000304,90 (157),0.998,1,2.79e-11,7.46e-10
Formation of the ternary complex_ and subsequently_ the 43S complex,Reactome,36,EIF3B;EIF2S1;EIF3D;RPS3;RPS3A;RPS4X;RPS5;RPS6;RPS8;RPS9;RPS10;RPS11;EIF2S2;RPS13;RPS14;RPS15;RPS15A;EIF3K;RPS16;RPS17;RPS19;RPSA;RPS21;RPS23;EIF3A;RPS25;EIF3C;RPS27;EIF3F;EIF3G;EIF3H;EIF3I;EIF3J;EIF3M;RPS27L;RPS24,59 (59),1e-12,3.28e-11,0,,1 (2),1,1,2.87e-11,7.6e-10
Cholesterol metabolism - Homo sapiens (human),KEGG,26,NPC1;VAPB;VAPA;LIPA;LIPC;CYP7A1;SCARB1;CYP27A1;LRP1;ABCB11;LRPAP1;APOA1;APOA2;APOA4;APOB;APOC2;APOC3;LCAT;APOE;APOH;NCEH1;NPC2;SOAT2;VDAC1;VDAC2;VDAC3,50 (50),1.4e-07,2.05e-06,6,HMDB0000036;HMDB0000637;HMDB0000951;HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0000138,7 (10),9.25e-06,0.00745,3.67e-11,9.65e-10
bile acid biosynthesis_ neutral pathway,HumanCyc,14,SCP2;POR;CYP7A1;HSD3B7;AMACR;ACAA2;ACOX2;SLC27A5;SLC27A2;CYP27A1;BAAT;CYP8B1;AKR1D1;HSD17B4,15 (15),8.72e-10,1.82e-08,11,HMDB0000036;HMDB0000637;HMDB0000951;HMDB0000067;HMDB0000123;HMDB0000138;HMDB0006894;HMDB0012455;HMDB0001231;HMDB0001457;HMDB0001993,38 (44),0.00151,0.129,3.72e-11,9.72e-10
superpathway of methionine degradation,HumanCyc,18,AHCYL1;MCEE;SUOX;MAT2B;PCCA;PCCB;DLD;CBS;CDO1;BCKDHB;MAT1A;MAT2A;BCKDHA;MMUT;CTH;GOT1;DBT;AHCY,19 (19),1.37e-12,4.45e-11,1,HMDB0000043,34 (36),0.979,1,3.8e-11,9.84e-10
Glycine Serine metabolism,INOH,28,DMGDH;CDO1;SARS1;MAOA;MAOB;PTGR1;AGXT2;TARS1;GCAT;GLDC;HSD17B12;DLD;PEMT;PIPOX;SHMT1;GAMT;SHMT2;DAO;PISD;CTH;PSPH;GNMT;CBS;AGXT;SDS;GOT1;GOT2;BHMT,40 (40),2.4e-12,7.58e-11,5,HMDB0001149;HMDB0000123;HMDB0033934;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0000043,53 (68),0.687,1,4.63e-11,1.19e-09
DroToll-like,INOH,36,PSMD6;CASP3;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;PSMB10;PSMC1;PSMC2;PSMC3;CASP6;PSMC4;PSMC5;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;NCSTN;F2,65 (65),5.26e-11,1.37e-09,0,,0 (1),1,1,5.26e-11,1.37e-09
TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc),Wikipathways,16,SUCLG2;PC;OGDH;PDHA1;DLAT;DLD;ACLY;ACO1;PCK1;SDHA;CS;DLST;IDH1;IDH3A;MDH1;FH,16 (16),2.49e-12,7.81e-11,1,HMDB0003974,16 (19),0.838,1,5.81e-11,1.48e-09
2-Hydroxyglutric Aciduria (D And L Form),SMPDB,20,GLUL;GMPS;QARS1;GOT2;GNPNAT1;GCLM;ALDH5A1;GLS2;GCLC;GFPT1;ABAT;ALDH4A1;CAD;NADSYN1;GSR;GSS;GLUD1;GPT;CPS1;PPAT,23 (23),3.03e-12,9.03e-11,3,HMDB0000123;HMDB0001178;HMDB0033934,47 (49),0.895,1,7.48e-11,1.83e-09
Homocarnosinosis,SMPDB,20,GLUL;GMPS;QARS1;GOT2;GNPNAT1;GCLM;ALDH5A1;GLS2;GCLC;GFPT1;ABAT;ALDH4A1;CAD;NADSYN1;GSR;GSS;GLUD1;GPT;CPS1;PPAT,23 (23),3.03e-12,9.03e-11,3,HMDB0000123;HMDB0001178;HMDB0033934,47 (49),0.895,1,7.48e-11,1.83e-09
Hyperinsulinism-Hyperammonemia Syndrome,SMPDB,20,GLUL;GMPS;QARS1;GOT2;GNPNAT1;GCLM;ALDH5A1;GLS2;GCLC;GFPT1;ABAT;ALDH4A1;CAD;NADSYN1;GSR;GSS;GLUD1;GPT;CPS1;PPAT,23 (23),3.03e-12,9.03e-11,3,HMDB0000123;HMDB0001178;HMDB0033934,47 (49),0.895,1,7.48e-11,1.83e-09
Succinic semialdehyde dehydrogenase deficiency,SMPDB,20,GLUL;GMPS;QARS1;GOT2;GNPNAT1;GCLM;ALDH5A1;GLS2;GCLC;GFPT1;ABAT;ALDH4A1;CAD;NADSYN1;GSR;GSS;GLUD1;GPT;CPS1;PPAT,23 (23),3.03e-12,9.03e-11,3,HMDB0000123;HMDB0001178;HMDB0033934,47 (49),0.895,1,7.48e-11,1.83e-09
4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency,SMPDB,20,GLUL;GMPS;QARS1;GOT2;GNPNAT1;GCLM;ALDH5A1;GLS2;GCLC;GFPT1;ABAT;ALDH4A1;CAD;NADSYN1;GSR;GSS;GLUD1;GPT;CPS1;PPAT,23 (23),3.03e-12,9.03e-11,3,HMDB0000123;HMDB0001178;HMDB0033934,47 (49),0.895,1,7.48e-11,1.83e-09
Glutamate Metabolism,SMPDB,20,GLUL;GMPS;QARS1;GOT2;GNPNAT1;GCLM;ALDH5A1;GLS2;GCLC;GFPT1;ABAT;ALDH4A1;CAD;NADSYN1;GSR;GSS;GLUD1;GPT;CPS1;PPAT,23 (23),3.03e-12,9.03e-11,3,HMDB0000123;HMDB0001178;HMDB0033934,47 (49),0.895,1,7.48e-11,1.83e-09
Cysteine and methionine metabolism - Homo sapiens (human),KEGG,32,BHMT;MPST;AGXT2;SDSL;CDO1;AHCYL1;MRI1;MTAP;MAT2B;GCLC;GCLM;MAT1A;MAT2A;MDH2;BHMT2;SRM;KYAT3;CTH;ADI1;MDH1;TST;LDHA;LDHB;CBS;ENOPH1;SDS;TAT;KYAT1;GOT1;GOT2;GSS;AHCY,50 (50),2.83e-12,8.78e-11,1,HMDB0012249,50 (63),0.997,1,7.79e-11,1.89e-09
Sulfur amino acid metabolism,Reactome,22,MPST;CDO1;MRI1;ADO;MTAP;SUOX;MAT1A;ETHE1;CSAD;SLC25A10;BHMT2;CTH;ADI1;TST;TXN2;SQOR;CBS;AHCY;ENOPH1;GOT1;GOT2;BHMT,27 (27),3.26e-12,9.66e-11,2,HMDB0033934;HMDB0000043,49 (67),0.974,1,8.73e-11,2.1e-09
Fatty acid degradation - Homo sapiens (human),KEGG,29,ADH5;ADH6;ACSL1;ACSL4;ACADL;ACADM;ACADS;ACADSB;ACADVL;ACAT1;ACAT2;EHHADH;ACOX1;ECI1;GCDH;ACAA2;HADHA;ECI2;HADHB;HADH;ALDH1B1;CPT1A;ALDH9A1;ALDH3A2;ECHS1;CPT2;ALDH7A1;ACOX3;ACSL5,43 (43),4.21e-12,1.23e-10,3,HMDB0062259;HMDB0001166;HMDB0003944,40 (50),0.82,1,9.46e-11,2.26e-09
Hedgehog,INOH,38,PSMD6;CUL1;PSMC2;PRKAR2A;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PRKACA;PRKACB;PSMB8;PSMB9;PSMB10;PSMC1;PRKAR1A;PSMC3;PSMC4;PSMC5;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;SKP1;PSMB6;PSMB7,72 (72),1.06e-10,2.52e-09,0,,0 (0),1,1,1.06e-10,2.52e-09
PDGFR-beta signaling pathway,PID,58,YWHAE;SLC9A3R2;RAB5A;ARHGDIA;PPP2R1A;ARPC4;WASL;RAP1A;RHOA;RAP1B;PTPN11;ABI1;ARPC5;SLC9A3R1;BAIAP2;EIF2AK2;PTPRJ;BRK1;STAT3;MAP2K4;PIK3R1;PIN1;SHC1;HRAS;LRP1;GRB2;CTTN;CSK;PRKCA;RAC1;AFDN;ARPC3;ACTN4;NCK1;NCKAP1;STAT5B;MAPK1;YWHAQ;TAGLN;YES1;MAPK9;LYN;MAP2K1;MAP2K2;YWHAB;ITGB3;RAB4A;YWHAG;YWHAH;YWHAZ;ARPC1B;ACTR3;ACTR2;CRK;CYFIP2;DNM2;IQGAP1;ARPC2,127 (127),4.14e-12,1.22e-10,0,,6 (6),1,1,1.13e-10,2.67e-09
Fatty acid beta-oxidation,Wikipathways,25,DECR1;ACSL1;ACSL4;SLC25A20;LIPC;GPD2;ACADL;ACADM;ACADS;ACADVL;ACAT1;CPT1A;ECI1;DLD;GCDH;HADHA;HADHB;HADH;ACSS2;CHKB;ECHS1;CRAT;CPT2;ACSL5;TPI1,34 (34),6.27e-12,1.81e-10,3,HMDB0062259;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0003944,32 (34),0.684,1,1.17e-10,2.75e-09
Pyruvate metabolism,INOH,25,LDHD;ACACA;ACACB;ACAT1;ACAT2;PDHA1;PDHB;GLO1;PKLR;PKM;DLAT;DLD;HMGCL;HAGH;ALDH1A1;ALDH1B1;ACSS2;ALDH9A1;ALDH3A2;ACYP1;LDHA;ME1;LDHB;ALDH7A1;MLYCD,34 (34),6.27e-12,1.81e-10,0,,30 (31),1,1,1.68e-10,3.94e-09
Cytosolic tRNA aminoacylation,Reactome,20,LARS1;IARS1;QARS1;RARS1;NARS1;EEF1E1;FARSB;TARS1;AIMP1;MARS1;HARS1;VARS1;AARS1;FARSA;WARS1;YARS1;SARS1;PPA1;DARS1;AIMP2,24 (24),1.49e-11,4.04e-10,3,HMDB0000123;HMDB0000172;HMDB0000687,22 (65),0.425,1,1.7e-10,3.95e-09
Lysine degradation,INOH,19,ALDH3A2;ECHS1;ACAT1;SHMT1;ACAT2;SHMT2;ACLY;EHHADH;AASS;GCDH;TMLHE;ALDH7A1;HADHA;CS;ALDH1A1;ALDH1B1;BBOX1;AADAT;ALDH9A1,22 (22),1.41e-11,3.83e-10,4,HMDB0062259;HMDB0001325;HMDB0000123;HMDB0000279,33 (36),0.479,1,1.8e-10,4.16e-09
Intra-Golgi and retrograde Golgi-to-ER traffic,Reactome,74,STX5;KIF13B;ACTR1A;NBAS;COG2;COG7;ARL1;RAB3GAP1;RAB18;BNIP1;GBF1;MAN1A1;YKT6;COG4;MAN2A1;GALNT2;ARFGAP1;COPZ1;COPB1;COPE;TMED7;NSF;USE1;DYNC1LI1;DCTN2;RAB43;ARFGAP3;DCTN3;RAB30;SURF4;RAB3GAP2;GOSR1;PAFAH1B1;PAFAH1B2;PAFAH1B3;CAPZA1;AGPAT3;DYNLL2;CAPZB;KDELR1;GOLIM4;NAPG;NAPA;COG5;DYNC1LI2;TMED9;COPA;COPG2;TMED2;SEC22B;RAB1B;KIF5B;TMED10;ARF4;ZW10;KLC4;GOSR2;RAB1A;DCTN1;RAB6B;TRIP11;M6PR;RAB6A;KIF1C;ARFGAP2;DYNC1I2;ARCN1;CAPZA2;ARF1;TGOLN2;RAB33B;ARF5;SNAP29;DYNC1H1,186 (186),2.12e-11,5.67e-10,2,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,11 (13),0.334,1,1.89e-10,4.33e-09
Peroxisomal lipid metabolism,Reactome,23,NUDT19;SLC27A2;PHYH;PECR;CROT;EHHADH;AMACR;ACOX1;ACBD5;ABCD1;SCP2;HACL1;ECI2;ACOT4;HSD17B4;ALDH3A2;CRAT;HAO2;SLC25A17;ACOX2;ACOX3;MLYCD;ACOT8,30 (30),1.04e-11,2.98e-10,1,HMDB0001416,38 (61),0.987,1,2.69e-10,6.13e-09
Omega-6 fatty acid metabolism,EHMN,22,DECR1;ACSL1;HADHA;ACSL4;FADS1;EHHADH;ACOX1;FADS2;ACAA2;HSD17B10;DBI;ECI2;HADHB;HADH;HSD17B4;ECI1;ECH1;ECHS1;ACOX2;ACOX3;ACSL5;SLC27A2,28 (28),1.25e-11,3.57e-10,1,HMDB0001043,20 (23),0.898,1,2.94e-10,6.66e-09
Glutathione conjugation,Reactome,26,GSTM1;GSTM2;GSTM4;GSTP1;GSTT1;GSTT2;GSTZ1;OPLAH;MGST1;MGST2;MGST3;GSTK1;GCLC;GCLM;GSTA5;ESD;CNDP2;HPGDS;AKR1A1;GSTO1;GGCT;GSS;GSTA1;GSTA2;GSTA3;GSTA4,37 (37),1.28e-11,3.64e-10,1,HMDB0000123,25 (31),0.942,1,3.16e-10,7.12e-09
Pyruvate Dehydrogenase Complex Deficiency,SMPDB,19,ACYP1;PKLR;PC;GRHPR;ACAT1;AKR1B1;PDHA1;LDHD;DLD;ME1;ACOT12;PCK1;GLO1;HAGH;DLAT;ACSS2;PDHB;MDH1;ACACA,22 (22),1.41e-11,3.83e-10,0,,43 (46),1,1,3.65e-10,7.9e-09
Primary hyperoxaluria II_ PH2,SMPDB,19,ACYP1;PKLR;PC;GRHPR;ACAT1;AKR1B1;PDHA1;LDHD;DLD;ME1;ACOT12;PCK1;GLO1;HAGH;DLAT;ACSS2;PDHB;MDH1;ACACA,22 (22),1.41e-11,3.83e-10,0,,43 (46),1,1,3.65e-10,7.9e-09
Pyruvate kinase deficiency,SMPDB,19,ACYP1;PKLR;PC;GRHPR;ACAT1;AKR1B1;PDHA1;LDHD;DLD;ME1;ACOT12;PCK1;GLO1;HAGH;DLAT;ACSS2;PDHB;MDH1;ACACA,22 (22),1.41e-11,3.83e-10,0,,43 (46),1,1,3.65e-10,7.9e-09
Leigh Syndrome,SMPDB,19,ACYP1;PKLR;PC;GRHPR;ACAT1;AKR1B1;PDHA1;LDHD;DLD;ME1;ACOT12;PCK1;GLO1;HAGH;DLAT;ACSS2;PDHB;MDH1;ACACA,22 (22),1.41e-11,3.83e-10,0,,43 (46),1,1,3.65e-10,7.9e-09
Pyruvate Metabolism,SMPDB,19,ACYP1;PKLR;PC;GRHPR;ACAT1;AKR1B1;PDHA1;LDHD;DLD;ME1;ACOT12;PCK1;GLO1;HAGH;DLAT;ACSS2;PDHB;MDH1;ACACA,22 (22),1.41e-11,3.83e-10,0,,43 (46),1,1,3.65e-10,7.9e-09
Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency),SMPDB,19,ACYP1;PKLR;PC;GRHPR;ACAT1;AKR1B1;PDHA1;LDHD;DLD;ME1;ACOT12;PCK1;GLO1;HAGH;DLAT;ACSS2;PDHB;MDH1;ACACA,22 (22),1.41e-11,3.83e-10,0,,43 (46),1,1,3.65e-10,7.9e-09
Primary bile acid biosynthesis - Homo sapiens (human),KEGG,13,SCP2;CYP39A1;HSD17B4;CYP7A1;HSD3B7;AMACR;ACOX2;SLC27A5;CYP27A1;BAAT;CYP8B1;AKR1D1;ACOT8,17 (17),4.15e-07,5.63e-06,14,HMDB0000036;HMDB0000637;HMDB0000951;HMDB0000067;HMDB0000123;HMDB0006281;HMDB0006888;HMDB0001993;HMDB0006894;HMDB0012455;HMDB0060136;HMDB0001231;HMDB0001457;HMDB0000138,40 (47),3.4e-05,0.0149,3.67e-10,7.9e-09
Metabolism of water-soluble vitamins and cofactors,Reactome,52,MMAA;TPK1;GPHN;NAPRT;SLC25A32;NAMPT;FASN;BTD;NADSYN1;ACACA;ACACB;NMNAT1;MTHFD1;NT5E;ALDH1L2;CYP8B1;ENPP1;QPRT;FLAD1;NADK2;DHFR;CD38;NAXD;AOX1;CYB5R3;VNN1;NADK;ACP5;SHMT1;SHMT2;MCCC2;ALDH1L1;MCCC1;COASY;MTHFS;NFS1;NNMT;MMAB;PC;PPCS;GSTO1;PCCA;PCCB;SLC23A1;NAXE;MOCS1;MMUT;PDXK;CYB5A;MOCOS;PNPO;NMNAT3,111 (111),1.61e-11,4.33e-10,5,HMDB0001416;HMDB0000123;HMDB0003134;HMDB0001016;HMDB0000244,91 (125),0.974,1,4.06e-10,8.67e-09
Ciliary landscape,Wikipathways,78,VAPB;RABEP2;CNOT1;VIM;COX6C;GLB1;RALB;ARHGDIA;COPS4;LRPPRC;VPS4A;MYL6;UBE2H;CALM1;IQGAP2;HTRA2;AIMP1;COPS8;NEK7;CBS;YAP1;ARFGAP3;CAMK2A;APMAP;RAB2A;PAFAH1B1;PGRMC2;AGPAT2;SSNA1;PSMC6;HDAC2;DYNLL2;RBM14;NDUFA9;NUP133;EIF5B;AFG3L2;DYNC1LI1;PSMC4;DYNLRB1;RAC1;LSM4;UQCC1;DYNLT3;TNKS1BP1;PSMD7;PSMD8;COPS3;PSMD12;PSMD13;DCAF11;COPS6;NDUFA5;CTNNB1;IQGAP1;TIPRL;SNRPB2;RAB14;EXOC5;RAB21;CTSA;COPS2;NUDC;GDI1;COPS5;GID8;DNPEP;DYNC1H1;EHD3;DYNC1I2;DDX5;STOM;ECHS1;RAB8A;EXOC4;COPS7A;SNAP29;EFTUD2,213 (213),6.81e-10,1.46e-08,0,,0 (0),1,1,6.81e-10,1.46e-08
Salmonella infection - Homo sapiens (human),KEGG,91,HSP90B1;NCKAP1;BRK1;MYO6;RPS3;VPS33A;ACTB;FADD;BAX;ACTG1;FYCO1;TUBB2B;PFN1;WASL;DCTN1;TUBA4A;TUBA1B;S100A10;TUBB4B;CYFIP1;MYL9;AHNAK;HRAS;RAB7A;DYNLRB1;ARF1;KIF5B;GAPDH;TXN2;SNX9;ACBD3;RAB5A;RAB5B;DYNC1H1;DYNC1I2;RAB5C;DYNC1LI2;HSP90AA1;DNM2;KPNA1;HSP90AB1;KPNA3;KPNA4;RALA;FLNA;FLNB;MAP2K4;RHOA;ABI1;DCTN2;ANXA2;TUBA1C;ARPC1A;CASP3;DYNLT3;RELA;ARL8A;KLC4;SKP1;CDC42;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;CYFIP2;ARPC2;ARF6;MYL12A;RHOG;ACTR1B;ACTR1A;EXOC5;MAPK14;CSE1L;CD14;GSDMD;DYNLL2;DYNC1LI1;RAC1;ARPC5L;MAPK1;CTNNB1;MAPK9;MAP2K1;MAP2K2;MAP2K3;M6PR;DCTN3;EXOC4,249 (249),2.94e-11,7.82e-10,0,,2 (5),1,1,7.43e-10,1.58e-08
Mitochondrial LC-Fatty Acid Beta-Oxidation,Wikipathways,16,ECI1;ACADL;ACADM;ACADS;ACSL1;ACADVL;SCP2;EHHADH;PECR;SLC25A20;CPT1A;HADHA;CPT2;HADH;ACSF2;ACSL4,17 (17),3.48e-11,9.2e-10,0,,2 (6),1,1,8.73e-10,1.84e-08
Response to elevated platelet cytosolic Ca2+,Reactome,59,ITGA2B;ORM1;ACTN1;FLNA;TUBA4A;SERPINA1;SERPINA4;IGF1;SCCPDH;STX4;PSAP;STXBP2;STXBP3;FN1;CALM1;CLU;TEX264;PLG;CALU;OLA1;CFL1;KNG1;ANXA5;TLN1;RARRES2;FGA;FGB;SERPING1;SOD1;HRG;PRKCA;CAP1;PF4;FAM3C;ITIH3;ACTN4;NHLRC2;CHID1;TAGLN2;FGG;APOA1;WDR1;VTI1B;APOH;PFN1;SERPINF2;ALDOA;ECM1;TTN;TF;HSPA5;F13A1;CYRIB;ITIH4;VCL;LGALS3BP;FERMT3;ITGB3;ALB,136 (136),3.73e-11,9.8e-10,0,,10 (11),1,1,9.32e-10,1.96e-08
Glutamate Glutamine metabolism,INOH,21,GLUL;ALDH3A2;GPT2;QARS1;CAD;GCLC;GCLM;ALDH5A1;CPS1;GPT;GSR;ABAT;ALDH4A1;ALDH7A1;GLS;ALDH1A1;GSS;GLUD1;ALDH1B1;GLS2;ALDH9A1,27 (27),5.25e-11,1.37e-09,2,HMDB0000123;HMDB0033934,28 (34),0.82,1,1.07e-09,2.23e-08
One-carbon metabolism and related pathways,Wikipathways,30,DMGDH;PCYT1A;CDO1;AHCYL1;CEPT1;PEMT;CHPT1;AGXT2;GCLC;GCLM;MAT1A;MAT2A;CSAD;CHDH;BAAT;GPX1;GPX4;GNMT;SHMT1;SHMT2;PCYT2;BHMT2;SOD2;CTH;SARDH;CHKB;SOD1;GSR;GSS;BHMT,52 (52),5.53e-10,1.23e-08,7,HMDB0000036;HMDB0000951;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0000123;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0006485;HMDB0000043,37 (42),0.094,1,1.28e-09,2.66e-08
Alanine Aspartate Asparagine metabolism,INOH,20,PKLR;GPT2;PC;NARS1;AGXT2;CAD;ASL;DARS1;AARS1;AGXT;ABAT;PKM;GOT1;GOT2;ASNS;ASS1;GPT;ASPA;ADSL;UPB1,25 (25),6.13e-11,1.58e-09,2,HMDB0000123;HMDB0033934,39 (45),0.933,1,1.41e-09,2.9e-08
Propanoate metabolism,INOH,20,ALDH3A2;ACAD11;ACADM;LDHA;ECHS1;PCCA;PCCB;LDHB;ACAA2;MCEE;HADHB;MMUT;ALDH7A1;HADHA;ALDH6A1;ALDH1A1;ALDH1B1;EHHADH;ACSS2;ALDH9A1,25 (25),6.13e-11,1.58e-09,0,,24 (26),1,1,1.5e-09,3.07e-08
Drug metabolism - other enzymes - Homo sapiens (human),KEGG,41,GSTM1;GMPS;GSTM2;UGT1A3;TPMT;GSTP1;MPO;GSTT1;NAT1;DPYD;DPYS;UPB1;GSTM4;IMPDH2;MGST1;MGST2;CYP2E1;GSTA5;GUSB;HPRT1;RRM2B;UGT2A3;UGT2A1;NME3;UGT2B10;UGT2B15;XDH;UMPS;MGST3;CMPK1;NME1;NME2;RRM1;TYMP;GSTO1;GSTT2;ITPA;GSTA1;GSTA2;GSTA3;GSTA4,80 (80),6.6e-11,1.68e-09,2,HMDB0060428;HMDB0060411,39 (52),0.933,1,1.51e-09,3.07e-08
Mono-unsaturated fatty acid beta-oxidation,EHMN,18,ACADL;ACADM;ACADSB;ACOX3;ACSL4;EHHADH;SLC27A2;DBI;ACAA2;HADH;ACOX1;HSD17B10;HADHA;ACSL5;HADHB;ACSL1;HSD17B4;ECHS1,21 (21),6.48e-11,1.66e-09,0,,12 (12),1,1,1.59e-09,3.12e-08
Di-unsaturated fatty acid beta-oxidation,EHMN,19,ECI1;ACADL;DECR1;ACSL1;ACOX3;ACSL4;EHHADH;ACSL5;DBI;ACAA2;HADH;ACOX1;HSD17B10;HADHA;ECI2;HADHB;SLC27A2;ECHS1;HSD17B4,23 (23),6.64e-11,1.68e-09,0,,19 (19),1,1,1.62e-09,3.12e-08
Medium chain acyl-coa dehydrogenase deficiency (MCAD),SMPDB,14,CPT2;ACADL;ACADM;ACADS;ECHS1;ACADVL;ACAT1;GCDH;ACAA2;HADHA;HADHB;ACSL1;CPT1A;ACADSB,14 (14),7.05e-11,1.69e-09,2,HMDB0001166;HMDB0003944,43 (43),0.954,1,1.64e-09,3.12e-08
Very-long-chain acyl coa dehydrogenase deficiency (VLCAD),SMPDB,14,CPT2;ACADL;ACADM;ACADS;ECHS1;ACADVL;ACAT1;GCDH;ACAA2;HADHA;HADHB;ACSL1;CPT1A;ACADSB,14 (14),7.05e-11,1.69e-09,2,HMDB0001166;HMDB0003944,43 (43),0.954,1,1.64e-09,3.12e-08
Ethylmalonic Encephalopathy,SMPDB,14,CPT2;ACADL;ACADM;ACADS;ECHS1;ACADVL;ACAT1;GCDH;ACAA2;HADHA;HADHB;ACSL1;CPT1A;ACADSB,14 (14),7.05e-11,1.69e-09,2,HMDB0001166;HMDB0003944,43 (43),0.954,1,1.64e-09,3.12e-08
Long chain acyl-CoA dehydrogenase deficiency (LCAD),SMPDB,14,CPT2;ACADL;ACADM;ACADS;ECHS1;ACADVL;ACAT1;GCDH;ACAA2;HADHA;HADHB;ACSL1;CPT1A;ACADSB,14 (14),7.05e-11,1.69e-09,2,HMDB0001166;HMDB0003944,43 (43),0.954,1,1.64e-09,3.12e-08
Trifunctional protein deficiency,SMPDB,14,CPT2;ACADL;ACADM;ACADS;ECHS1;ACADVL;ACAT1;GCDH;ACAA2;HADHA;HADHB;ACSL1;CPT1A;ACADSB,14 (14),7.05e-11,1.69e-09,2,HMDB0001166;HMDB0003944,43 (43),0.954,1,1.64e-09,3.12e-08
Carnitine palmitoyl transferase deficiency (II),SMPDB,14,CPT2;ACADL;ACADM;ACADS;ECHS1;ACADVL;ACAT1;GCDH;ACAA2;HADHA;HADHB;ACSL1;CPT1A;ACADSB,14 (14),7.05e-11,1.69e-09,2,HMDB0001166;HMDB0003944,43 (43),0.954,1,1.64e-09,3.12e-08
Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency),SMPDB,14,CPT2;ACADL;ACADM;ACADS;ECHS1;ACADVL;ACAT1;GCDH;ACAA2;HADHA;HADHB;ACSL1;CPT1A;ACADSB,14 (14),7.05e-11,1.69e-09,2,HMDB0001166;HMDB0003944,43 (43),0.954,1,1.64e-09,3.12e-08
Fatty acid Metabolism,SMPDB,14,CPT2;ACADL;ACADM;ACADS;ECHS1;ACADVL;ACAT1;GCDH;ACAA2;HADHA;HADHB;ACSL1;CPT1A;ACADSB,14 (14),7.05e-11,1.69e-09,2,HMDB0001166;HMDB0003944,43 (43),0.954,1,1.64e-09,3.12e-08
Glutaric Aciduria Type I,SMPDB,14,CPT2;ACADL;ACADM;ACADS;ECHS1;ACADVL;ACAT1;GCDH;ACAA2;HADHA;HADHB;ACSL1;CPT1A;ACADSB,14 (14),7.05e-11,1.69e-09,2,HMDB0001166;HMDB0003944,43 (43),0.954,1,1.64e-09,3.12e-08
Carnitine palmitoyl transferase deficiency (I),SMPDB,14,CPT2;ACADL;ACADM;ACADS;ECHS1;ACADVL;ACAT1;GCDH;ACAA2;HADHA;HADHB;ACSL1;CPT1A;ACADSB,14 (14),7.05e-11,1.69e-09,2,HMDB0001166;HMDB0003944,43 (43),0.954,1,1.64e-09,3.12e-08
Glycolysis and Gluconeogenesis,EHMN,36,GPI;RANBP2;ADHFE1;CS;HK1;ME1;NUP155;ALDH1B1;SLC16A1;PDHA1;PDHB;PCK2;SLC25A1;NUP210;SLC25A10;NUP98;NUP133;PKM;DLAT;DLD;AKR1A1;NUP93;NUP58;PFKL;ALDH9A1;PC;ALDOB;PGAM1;ENO1;NUP160;PCK1;PDHX;ALDH7A1;NUP35;NUP205;ACOT12,66 (67),9.48e-11,2.26e-09,0,,48 (52),1,1,2.28e-09,4.31e-08
Mercaptopurine Action Pathway,SMPDB,29,GMPS;TPMT;GDA;SLC29A1;ADK;NUDT5;ADSL;ATAD1;GUCY1B1;GUK1;HPRT1;DGUOK;GART;AOX1;ENTPD5;NUDT2;NT5C2;XDH;PFAS;ATIC;PPAT;RRM1;APRT;ADA;PAICS;ENTPD8;RAC1;ITPA;PNP,47 (47),1.11e-10,2.6e-09,5,HMDB0000123;HMDB0000195;HMDB0001178;HMDB0033934;HMDB0000189,78 (84),0.934,1,2.49e-09,4.66e-08
Thioguanine Action Pathway,SMPDB,29,GMPS;TPMT;GDA;SLC29A1;ADK;NUDT5;ADSL;ATAD1;GUCY1B1;GUK1;HPRT1;DGUOK;GART;AOX1;ENTPD5;NUDT2;NT5C2;XDH;PFAS;ATIC;PPAT;RRM1;APRT;ADA;PAICS;ENTPD8;RAC1;ITPA;PNP,47 (47),1.11e-10,2.6e-09,5,HMDB0000123;HMDB0000195;HMDB0001178;HMDB0033934;HMDB0000189,79 (85),0.938,1,2.5e-09,4.66e-08
Azathioprine Action Pathway,SMPDB,29,GMPS;TPMT;GDA;SLC29A1;ADK;NUDT5;ADSL;ATAD1;GUCY1B1;GUK1;HPRT1;DGUOK;GART;AOX1;ENTPD5;NUDT2;NT5C2;XDH;PFAS;ATIC;PPAT;RRM1;APRT;ADA;PAICS;ENTPD8;RAC1;ITPA;PNP,47 (47),1.11e-10,2.6e-09,5,HMDB0000123;HMDB0000195;HMDB0001178;HMDB0033934;HMDB0000189,80 (86),0.942,1,2.51e-09,4.66e-08
Host Interactions of HIV factors,Reactome,43,CUL5;ARF1;NPM1;TPR;ELOC;ELOB;RAN;RANBP1;RANBP2;AP2M1;AP1S1;AP2S1;NUP160;NUP58;NUP155;PSIP1;AP2A2;AP1B1;AP2B1;SLC25A5;B2M;NUP210;NUP98;RAE1;NUP133;PAK2;AP1M1;RCC1;SLC25A4;NUP93;AP1G1;XPO1;SKP1;ATP6V1H;KPNA1;BANF1;RAC1;AP2A1;NUP35;RBX1;SEC13;KPNB1;NUP205,89 (89),2.65e-10,6.06e-09,1,HMDB0033934,5 (9),0.433,1,2.75e-09,5.08e-08
Leukotriene metabolism,EHMN,47,ACSL1;ACSL4;DPEP1;GSTZ1;ECI2;RANBP2;ADHFE1;NUP93;ACOT8;ACOT4;NUP155;MGST1;MGST2;MGST3;GSTK1;EHHADH;CYP4B1;CYP1A2;ACOX1;NUP210;BAAT;ALDH9A1;ACOX2;NUP98;NUP133;ACOT7;ACAA2;CYP2E1;HSD17B10;ACOT2;HADHA;SLC27A2;HADHB;HADH;NUP58;ALDH1B1;HSD17B4;ALDH3A2;ECHS1;CBR1;NUP160;ALDH7A1;ACOX3;ACSL5;NUP35;NUP205;DHRS4,102 (102),3.05e-10,6.87e-09,3,HMDB0002995;HMDB0000123;HMDB0001043,25 (27),0.512,1,3.69e-09,6.78e-08
Glycolysis and Gluconeogenesis,Wikipathways,28,GPI;MPC2;HK1;FBP1;HK3;GAPDH;PDHA1;PKLR;PKM;DLAT;DLD;MPC1;PC;GCK;PFKL;MDH1;MDH2;ALDOA;LDHA;ALDOB;PGAM1;LDHB;ENO1;PCK1;SLC2A2;GOT1;GOT2;TPI1,45 (45),1.75e-10,4.08e-09,0,,14 (18),1,1,4.12e-09,7.52e-08
Platelet degranulation ,Reactome,56,ITGA2B;ORM1;ACTN1;FLNA;TUBA4A;SERPINA1;SERPINA4;IGF1;SCCPDH;PSAP;STXBP2;RARRES2;CALM1;CLU;TEX264;PLG;CALU;OLA1;CFL1;KNG1;ANXA5;TLN1;FN1;FGA;FGB;SERPING1;SOD1;HRG;LGALS3BP;PF4;FAM3C;ITIH3;ACTN4;NHLRC2;CHID1;TAGLN2;FGG;APOA1;WDR1;VTI1B;APOH;PFN1;SERPINF2;ALDOA;ECM1;TTN;TF;HSPA5;F13A1;CYRIB;ITIH4;VCL;CAP1;FERMT3;ITGB3;ALB,131 (131),2.32e-10,5.39e-09,0,,9 (9),1,1,5.39e-09,9.8e-08
Propanoate metabolism,EHMN,16,ACADL;ACADM;HIBCH;ACADSB;HADHA;PCCA;ALDH6A1;EHHADH;MMUT;ALDH7A1;DBI;MLYCD;HADHB;ECHS1;ALDH1B1;MCEE,18 (18),2.58e-10,5.95e-09,0,,29 (33),1,1,5.95e-09,1.08e-07
Lysosome - Homo sapiens (human),KEGG,55,NPC1;HEXA;HEXB;ATP6V1H;LGMN;ATP6V0C;CTSF;LIPA;AP1S1;ATP6V0A1;ATP6AP1;ATP6V0D1;AP3D1;PSAP;MAN2B1;MANBA;GLB1;AP1B1;ARSB;AP1G1;ASAH1;GUSB;AGA;TPP1;GM2A;CTSC;ACP2;ACP5;CLTA;NAGA;NAGLU;HGSNAT;GBA;TCIRG1;AP1M1;LAMP1;PPT1;CLTC;SCARB2;FUCA1;CTSB;AP3B1;CTSA;CTSD;NPC2;GGA1;CLTB;M6PR;PLA2G15;GNS;CTSH;CTSZ;GAA;AP3M1;CTSL,128 (128),2.65e-10,6.06e-09,0,,3 (4),1,1,6.12e-09,1.1e-07
Fatty Acid Biosynthesis,Wikipathways,18,ACACB;ECHDC3;ECH1;ECHS1;ACSL4;ACAA2;ACSL1;ACLY;PECR;FASN;PC;MECR;DECR1;ACSL5;ECHDC2;HADH;ACSS2;ACACA,22 (22),2.93e-10,6.66e-09,0,,4 (14),1,1,6.73e-09,1.2e-07
UCH proteinases,Reactome,47,NEDD8;PSMD6;PSMF1;ACTL6A;PSME4;RUVBL1;UCHL5;PSMA2;PSMA1;UCHL3;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;ACTB;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;PSMB10;PSMC1;PSMC2;PSMC3;PSMC4;PSMC5;PSMC6;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;PSME1;PSME2;PSMD14;USP15;PSMB4;ADRM1;PSME3,102 (102),3.05e-10,6.87e-09,0,,1 (3),1,1,6.99e-09,1.25e-07
Synthesis of bile acids and bile salts,Reactome,18,CYP39A1;SCP2;ABCB11;CYP7A1;CYP8B1;OSBP;AMACR;AKR1C1;ACOX2;SLC27A5;CYP27A1;SLC27A2;BAAT;HSD17B4;OSBPL1A;HSD3B7;AKR1D1;ACOT8,30 (30),7.3e-07,9.04e-06,15,HMDB0000036;HMDB0000637;HMDB0006281;HMDB0062420;HMDB0062206;HMDB0000123;HMDB0000951;HMDB0000067;HMDB0000138;HMDB0006894;HMDB0012455;HMDB0060136;HMDB0001231;HMDB0001457;HMDB0001993,55 (75),0.000438,0.0518,7.31e-09,1.3e-07
Bile Acid Biosynthesis,SMPDB,13,CYP39A1;SCP2;CYP7A1;HSD3B7;AMACR;LIPA;ACOX2;SLC27A5;CYP27A1;BAAT;CYP8B1;AKR1D1;HSD17B4,17 (17),4.15e-07,5.63e-06,15,HMDB0000036;HMDB0000637;HMDB0000951;HMDB0001231;HMDB0000896;HMDB0000067;HMDB0000123;HMDB0006281;HMDB0006888;HMDB0000631;HMDB0006894;HMDB0012455;HMDB0000138;HMDB0001457;HMDB0001993,58 (64),0.000812,0.076,7.69e-09,1.31e-07
27-Hydroxylase Deficiency,SMPDB,13,CYP39A1;SCP2;CYP7A1;HSD3B7;AMACR;LIPA;ACOX2;SLC27A5;CYP27A1;BAAT;CYP8B1;AKR1D1;HSD17B4,17 (17),4.15e-07,5.63e-06,15,HMDB0000036;HMDB0000637;HMDB0000951;HMDB0001231;HMDB0000896;HMDB0000067;HMDB0000123;HMDB0006281;HMDB0006888;HMDB0000631;HMDB0006894;HMDB0012455;HMDB0000138;HMDB0001457;HMDB0001993,58 (64),0.000812,0.076,7.69e-09,1.31e-07
Congenital Bile Acid Synthesis Defect Type II,SMPDB,13,CYP39A1;SCP2;CYP7A1;HSD3B7;AMACR;LIPA;ACOX2;SLC27A5;CYP27A1;BAAT;CYP8B1;AKR1D1;HSD17B4,17 (17),4.15e-07,5.63e-06,15,HMDB0000036;HMDB0000637;HMDB0000951;HMDB0001231;HMDB0000896;HMDB0000067;HMDB0000123;HMDB0006281;HMDB0006888;HMDB0000631;HMDB0006894;HMDB0012455;HMDB0000138;HMDB0001457;HMDB0001993,58 (64),0.000812,0.076,7.69e-09,1.31e-07
Cerebrotendinous Xanthomatosis (CTX),SMPDB,13,CYP39A1;SCP2;CYP7A1;HSD3B7;AMACR;LIPA;ACOX2;SLC27A5;CYP27A1;BAAT;CYP8B1;AKR1D1;HSD17B4,17 (17),4.15e-07,5.63e-06,15,HMDB0000036;HMDB0000637;HMDB0000951;HMDB0001231;HMDB0000896;HMDB0000067;HMDB0000123;HMDB0006281;HMDB0006888;HMDB0000631;HMDB0006894;HMDB0012455;HMDB0000138;HMDB0001457;HMDB0001993,58 (64),0.000812,0.076,7.69e-09,1.31e-07
Zellweger Syndrome,SMPDB,13,CYP39A1;SCP2;CYP7A1;HSD3B7;AMACR;LIPA;ACOX2;SLC27A5;CYP27A1;BAAT;CYP8B1;AKR1D1;HSD17B4,17 (17),4.15e-07,5.63e-06,15,HMDB0000036;HMDB0000637;HMDB0000951;HMDB0001231;HMDB0000896;HMDB0000067;HMDB0000123;HMDB0006281;HMDB0006888;HMDB0000631;HMDB0006894;HMDB0012455;HMDB0000138;HMDB0001457;HMDB0001993,58 (64),0.000812,0.076,7.69e-09,1.31e-07
Familial Hypercholanemia (FHCA),SMPDB,13,CYP39A1;SCP2;CYP7A1;HSD3B7;AMACR;LIPA;ACOX2;SLC27A5;CYP27A1;BAAT;CYP8B1;AKR1D1;HSD17B4,17 (17),4.15e-07,5.63e-06,15,HMDB0000036;HMDB0000637;HMDB0000951;HMDB0001231;HMDB0000896;HMDB0000067;HMDB0000123;HMDB0006281;HMDB0006888;HMDB0000631;HMDB0006894;HMDB0012455;HMDB0000138;HMDB0001457;HMDB0001993,58 (64),0.000812,0.076,7.69e-09,1.31e-07
Congenital Bile Acid Synthesis Defect Type III,SMPDB,13,CYP39A1;SCP2;CYP7A1;HSD3B7;AMACR;LIPA;ACOX2;SLC27A5;CYP27A1;BAAT;CYP8B1;AKR1D1;HSD17B4,17 (17),4.15e-07,5.63e-06,15,HMDB0000036;HMDB0000637;HMDB0000951;HMDB0001231;HMDB0000896;HMDB0000067;HMDB0000123;HMDB0006281;HMDB0006888;HMDB0000631;HMDB0006894;HMDB0012455;HMDB0000138;HMDB0001457;HMDB0001993,58 (64),0.000812,0.076,7.69e-09,1.31e-07
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,Reactome,15,SCP2;ABCB11;HSD17B4;CYP7A1;HSD3B7;AKR1C1;AMACR;ACOX2;SLC27A5;SLC27A2;CYP27A1;BAAT;CYP8B1;AKR1D1;ACOT8,20 (20),7.81e-08,1.21e-06,11,HMDB0000036;HMDB0000637;HMDB0000951;HMDB0000067;HMDB0000123;HMDB0000138;HMDB0006894;HMDB0012455;HMDB0001231;HMDB0001457;HMDB0001993,43 (49),0.00441,0.291,7.85e-09,1.33e-07
Clathrin-mediated endocytosis,Reactome,58,ARPC4;RAB5A;EPS15;STAM2;PICALM;WASL;EPS15L1;GAPVD1;GAK;AP2M1;AP2S1;UBQLN2;UBQLN1;M6PR;GRB2;AP2A1;ACTR3;NECAP2;EGFR;COPS8;SCARB2;ARPC1A;GPS1;HGS;CLTA;CLTB;CLTC;COPS4;PACSIN3;DNM3;TOR1A;CTTN;APOB;AP2B1;COPS3;NECAP1;COPS6;EPN1;FCHO2;COPS7A;VAMP8;AP2A2;SNX9;COPS2;VAMP2;TF;COPS5;ARPC5;RAB5B;ARPC3;ARPC2;HSPA8;ACTR2;PACSIN2;RAB5C;DNM2;TGOLN2;TFRC,142 (142),9.42e-10,1.95e-08,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,12 (17),0.374,1,8.03e-09,1.36e-07
Notch,INOH,37,PSMD6;CUL1;ITCH;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;PSMB10;PSMC1;PSMC2;PSMC3;PSMC4;PSMC5;NUMB;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;NCSTN;SKP1,78 (78),8.76e-09,1.5e-07,0,,0 (0),1,1,8.76e-09,1.5e-07
Bile acid biosynthesis,EHMN,27,ADHFE1;ACOT8;SLC10A1;EHHADH;CYP7A1;CYP8B1;SLC38A4;ACOX1;CYP27A1;BAAT;SRD5A1;AKR1D1;ACOX2;ACOT7;ACOX3;SCP2;ABCB11;ACOT2;DBI;ACOT4;ALDH1B1;ALDH9A1;ALDH3A2;SOAT2;ALDH7A1;SLC27A5;SLC27A2,53 (53),1.4e-07,2.05e-06,12,HMDB0000036;HMDB0000951;HMDB0000896;HMDB0000067;HMDB0000123;HMDB0006886;HMDB0000138;HMDB0006894;HMDB0012455;HMDB0001231;HMDB0001457;HMDB0001993,47 (55),0.00303,0.214,9.58e-09,1.61e-07
RHOBTB GTPase Cycle,Reactome,24,CUL3;VIM;TXNL1;SRRM1;CCT6A;CDC37;DDX39B;TRA2B;MYO6;GPS1;ACTB;COPS4;TMOD3;ACTG1;ROCK1;CCT7;CCT2;ACTN1;COPS2;HNRNPC;HSP90AA1;TWF1;CPSF7;HSP90AB1,36 (36),4.43e-10,9.93e-09,0,,1 (1),1,1,9.99e-09,1.67e-07
Signaling by Rho GTPases,Reactome,194,VAPB;TPM3;TPM4;SRRM1;STAM2;MYH9;SLK;MYH11;STIP1;EMC3;ATP6AP1;MYL6;MYLK;FARP1;HMOX2;IQGAP2;BRK1;MYO6;USP9X;CFL1;SPTAN1;SPTBN1;ACTB;CKAP5;ACTC1;ACTG1;FAM91A1;NCK1;TMPO;ACTN1;RPS27;NDUFA5;FLOT2;DBT;PFN1;WASL;ARHGDIA;COPS2;ITGB1;PICALM;HNRNPC;RCC2;NDUFS3;IQGAP1;TWF1;FARP2;CKB;PIK3R4;DIAPH1;TXNL1;YWHAG;COPS4;ARPC4;JUP;TAOK3;YWHAZ;CYFIP1;STX5;NDEL1;MYL9;NSFL1C;PAK2;ARFGAP3;PIK3R1;DDRGK1;PIN1;PGRMC2;S100A9;CLTC;GOPC;ABCD3;C1QBP;OSBPL11;TJP2;RAB7A;HINT2;SWAP70;KIF5B;SCFD1;BAIAP2;YWHAQ;LAMTOR1;ALDH3A2;FERMT2;DDX39B;DOCK8;DYNC1H1;DYNC1I2;PKN3;VCP;HSP90AA1;SEC13;HSP90AB1;CUL3;VIM;HSPE1;FLNA;RANBP2;RRAS2;RANGAP1;ABI1;ANKFY1;STBD1;CKAP4;RHOD;CALM1;TRA2B;DSG2;DSP;S100A8;ESYT1;TUBA1B;KTN1;ARPC1A;GPS1;ACBD5;CAPZB;GRB2;NCKAP1;SHMT2;PPP2CB;ARHGAP17;EFHD2;CCT7;CCT2;PPP1CC;CAV1;XPO1;KLC4;NUDC;YWHAB;CDC42BPB;YWHAE;ARPC5;YWHAH;ARPC3;ARPC1B;ACTR3;ACTR2;LETM1;CYFIP2;ARHGEF10L;PPP1CB;ARPC2;NUP98;RHOA;CDC37;WDR91;MAPRE1;ARHGAP1;CSK;CCT6A;ARHGDIB;PPP2R1A;MAPK14;PPP2R5A;PPP2R5D;PPP2R5E;NUP160;YKT6;LMAN1;ARHGEF12;LMNB1;DST;TMOD3;MYH14;TFRC;RAC1;GNA13;FAF2;PAFAH1B1;HGS;DYNLL2;NUP133;H2AX;DYNC1LI1;STEAP3;PRKCA;DYNC1LI2;ROCK1;CTNNA1;MAPK1;CTNNB1;ZW10;BUB3;CTTN;FLOT1;RHOG;CDC42;CDH1;TOR1AIP1;ARFGAP2;STOM;CPSF7,688 (689),6.39e-10,1.41e-08,2,HMDB0000234;HMDB0001043,24 (29),0.746,1,1.07e-08,1.74e-07
Arginine Proline metabolism,INOH,31,CKB;CKM;OTC;ABAT;GOT1;RARS1;MAOA;MAOB;GCLC;GCLM;ASL;GLUD1;FH;ASS1;ALDH7A1;GLUL;SRM;SDHB;GAMT;OAT;ALDH4A1;ALDH1A1;ALDH1B1;ALDH9A1;ALDH3A2;PYCR3;SDHA;GOT2;SDHC;SDHD;ARG1,55 (55),6.36e-10,1.4e-08,5,HMDB0000725;HMDB0002064;HMDB0000123;HMDB0033934;HMDB0002104,58 (68),0.762,1,1.09e-08,1.74e-07
RNA transport - Homo sapiens (human),KEGG,71,NUP93;TPR;UPF2;SRRM1;FXR1;DDX19A;RAN;RANBP2;UPF1;THOC7;MAGOH;CYFIP1;DDX39B;XPO1;NUP155;RAE1;UBE2I;STRAP;KPNB1;EIF3G;NUP133;RNPS1;EIF2S1;EIF4A3;EIF4A1;EIF4A2;CLNS1A;NUP210;EIF2B4;EIF2B3;EIF2B2;EIF2B5;EIF2S2;NUP98;FUS;TARDBP;EIF2B1;EIF3C;PNN;EIF5B;CYFIP2;ALYREF;NCBP1;RBM8A;EIF3A;EIF3B;PABPC4;EIF3D;EIF3F;NUP58;EIF3H;EIF3I;EIF3J;EIF1;ACIN1;RANGAP1;EIF4G1;PABPC1;PAIP1;NUP160;ELAC2;EIF4E;THOC5;TRNT1;EIF4G2;FXR2;NUP35;EEF1A1;SEC13;NUP205;EIF4E2,186 (186),4.85e-10,1.08e-08,0,,2 (3),1,1,1.09e-08,1.74e-07
Glycine and Serine Metabolism,SMPDB,20,MAOA;GAMT;PSPH;SHMT1;DMGDH;SDS;GCAT;DLD;GLDC;CTH;AGXT;SARS1;SHMT2;SRR;AMT;CBS;GNMT;BHMT;SARDH;GLYCTK,27 (27),6.92e-10,1.46e-08,5,HMDB0000043;HMDB0000123;HMDB0033934;HMDB0006454;HMDB0001149,54 (55),0.704,1,1.09e-08,1.74e-07
3-Phosphoglycerate dehydrogenase deficiency,SMPDB,20,MAOA;GAMT;PSPH;SHMT1;DMGDH;SDS;GCAT;DLD;GLDC;CTH;AGXT;SARS1;SHMT2;SRR;AMT;CBS;GNMT;BHMT;SARDH;GLYCTK,27 (27),6.92e-10,1.46e-08,5,HMDB0000043;HMDB0000123;HMDB0033934;HMDB0006454;HMDB0001149,54 (55),0.704,1,1.09e-08,1.74e-07
Non Ketotic Hyperglycinemia,SMPDB,20,MAOA;GAMT;PSPH;SHMT1;DMGDH;SDS;GCAT;DLD;GLDC;CTH;AGXT;SARS1;SHMT2;SRR;AMT;CBS;GNMT;BHMT;SARDH;GLYCTK,27 (27),6.92e-10,1.46e-08,5,HMDB0000043;HMDB0000123;HMDB0033934;HMDB0006454;HMDB0001149,54 (55),0.704,1,1.09e-08,1.74e-07
Dimethylglycine Dehydrogenase Deficiency,SMPDB,20,MAOA;GAMT;PSPH;SHMT1;DMGDH;SDS;GCAT;DLD;GLDC;CTH;AGXT;SARS1;SHMT2;SRR;AMT;CBS;GNMT;BHMT;SARDH;GLYCTK,27 (27),6.92e-10,1.46e-08,5,HMDB0000043;HMDB0000123;HMDB0033934;HMDB0006454;HMDB0001149,54 (55),0.704,1,1.09e-08,1.74e-07
Hyperglycinemia_ non-ketotic,SMPDB,20,MAOA;GAMT;PSPH;SHMT1;DMGDH;SDS;GCAT;DLD;GLDC;CTH;AGXT;SARS1;SHMT2;SRR;AMT;CBS;GNMT;BHMT;SARDH;GLYCTK,27 (27),6.92e-10,1.46e-08,5,HMDB0000043;HMDB0000123;HMDB0033934;HMDB0006454;HMDB0001149,54 (55),0.704,1,1.09e-08,1.74e-07
Dimethylglycine Dehydrogenase Deficiency,SMPDB,20,MAOA;GAMT;PSPH;SHMT1;DMGDH;SDS;GCAT;DLD;GLDC;CTH;AGXT;SARS1;SHMT2;SRR;AMT;CBS;GNMT;BHMT;SARDH;GLYCTK,27 (27),6.92e-10,1.46e-08,5,HMDB0000043;HMDB0000123;HMDB0033934;HMDB0006454;HMDB0001149,54 (55),0.704,1,1.09e-08,1.74e-07
Sarcosinemia,SMPDB,20,MAOA;GAMT;PSPH;SHMT1;DMGDH;SDS;GCAT;DLD;GLDC;CTH;AGXT;SARS1;SHMT2;SRR;AMT;CBS;GNMT;BHMT;SARDH;GLYCTK,27 (27),6.92e-10,1.46e-08,5,HMDB0000043;HMDB0000123;HMDB0033934;HMDB0006454;HMDB0001149,54 (55),0.704,1,1.09e-08,1.74e-07
Dihydropyrimidine Dehydrogenase Deficiency (DHPD),SMPDB,20,MAOA;GAMT;PSPH;SHMT1;DMGDH;SDS;GCAT;DLD;GLDC;CTH;AGXT;SARS1;SHMT2;SRR;AMT;CBS;GNMT;BHMT;SARDH;GLYCTK,27 (27),6.92e-10,1.46e-08,5,HMDB0000043;HMDB0000123;HMDB0033934;HMDB0006454;HMDB0001149,54 (55),0.704,1,1.09e-08,1.74e-07
Signaling by Rho GTPases_ Miro GTPases and RHOBTB3,Reactome,197,VAPB;TPM3;TPM4;SRRM1;STAM2;MYH9;SLK;MYH11;EMC3;ATP6AP1;MYL6;MYLK;FARP1;SWAP70;IQGAP2;BRK1;MYO6;USP9X;CFL1;SPTAN1;SPTBN1;ACTB;CKAP5;ACTC1;ACTG1;FAM91A1;NCK1;TMPO;ACTN1;RPS27;NDUFA5;HMOX2;DBT;PFN1;WASL;ARHGDIA;COPS2;ITGB1;PICALM;HNRNPC;RCC2;NDUFS3;IQGAP1;TWF1;FARP2;RANBP2;PIK3R4;RAP1GDS1;DIAPH1;TXNL1;YWHAG;COPS4;ARPC4;JUP;TAOK3;YWHAZ;CYFIP1;STX5;NDEL1;MYL9;NSFL1C;PAK2;RAB7A;ARFGAP3;PIK3R1;DDRGK1;PIN1;PGRMC2;S100A9;CLTC;GOPC;ABCD3;C1QBP;OSBPL11;TJP2;MFN2;HINT2;STIP1;KIF5B;SCFD1;BAIAP2;YWHAQ;LAMTOR1;ALDH3A2;FERMT2;DDX39B;DOCK8;DYNC1H1;DYNC1I2;PKN3;VCP;HSP90AA1;SEC13;HSP90AB1;CKB;CUL3;VIM;HSPE1;FLNA;FLOT2;RRAS2;RANGAP1;ABI1;ANKFY1;STBD1;CKAP4;RHOD;CALM1;TRA2B;DSG2;DSP;S100A8;ESYT1;TUBA1B;KTN1;ARPC1A;GPS1;ACBD5;CAPZB;GRB2;NCKAP1;SHMT2;PPP2CB;ARHGAP17;EFHD2;CCT7;CCT2;PPP1CC;CAV1;XPO1;KLC4;NUDC;YWHAB;CDC42BPB;YWHAE;ARPC5;YWHAH;ARPC3;ARPC1B;ACTR3;ACTR2;LETM1;MFN1;CYFIP2;ARHGEF10L;PPP1CB;ARPC2;NUP98;RHOA;CDC37;WDR91;MAPRE1;ARHGAP1;CSK;CCT6A;ARHGDIB;PPP2R1A;MAPK14;PPP2R5A;PPP2R5D;PPP2R5E;NUP160;YKT6;LMAN1;ARHGEF12;LMNB1;DST;TMOD3;MYH14;TFRC;RAC1;GNA13;FAF2;PAFAH1B1;HGS;DYNLL2;NUP133;H2AX;DYNC1LI1;STEAP3;PRKCA;DYNC1LI2;ROCK1;CTNNA1;MAPK1;CTNNB1;ZW10;BUB3;CTTN;FLOT1;RHOG;CDC42;CDH1;TOR1AIP1;ARFGAP2;STOM;CPSF7,704 (705),9.35e-10,1.94e-08,2,HMDB0000234;HMDB0001043,24 (29),0.746,1,1.54e-08,2.44e-07
Glycolysis / Gluconeogenesis - Homo sapiens (human),KEGG,35,ADH5;BPGM;ADH6;GPI;HK1;FBP1;HK3;PFKL;GAPDH;PDHA1;PDHB;GALM;PKLR;PKM;DLAT;DLD;GCK;AKR1A1;ALDH1B1;ACSS2;ALDH9A1;ALDH3A2;ALDOA;LDHA;ALDOB;ENO1;LDHB;PGAM1;PGM2;ADPGK;PCK1;PCK2;PGM1;ALDH7A1;TPI1,67 (67),8.33e-10,1.75e-08,0,,25 (31),1,1,1.82e-08,2.87e-07
Purine Nucleoside Phosphorylase Deficiency,SMPDB,24,GMPS;GDA;NUDT5;ADSL;ATAD1;GUCY1B1;GUK1;HPRT1;DGUOK;GART;ENTPD5;NUDT2;NT5C2;XDH;PFAS;ATIC;PPAT;RRM1;APRT;ADA;PAICS;ENTPD8;ITPA;PNP,37 (37),1.04e-09,2.01e-08,5,HMDB0000123;HMDB0000195;HMDB0001178;HMDB0033934;HMDB0000189,70 (73),0.886,1,2e-08,2.96e-07
Xanthine Dehydrogenase Deficiency (Xanthinuria),SMPDB,24,GMPS;GDA;NUDT5;ADSL;ATAD1;GUCY1B1;GUK1;HPRT1;DGUOK;GART;ENTPD5;NUDT2;NT5C2;XDH;PFAS;ATIC;PPAT;RRM1;APRT;ADA;PAICS;ENTPD8;ITPA;PNP,37 (37),1.04e-09,2.01e-08,5,HMDB0000123;HMDB0000195;HMDB0001178;HMDB0033934;HMDB0000189,70 (73),0.886,1,2e-08,2.96e-07
Adenylosuccinate Lyase Deficiency,SMPDB,24,GMPS;GDA;NUDT5;ADSL;ATAD1;GUCY1B1;GUK1;HPRT1;DGUOK;GART;ENTPD5;NUDT2;NT5C2;XDH;PFAS;ATIC;PPAT;RRM1;APRT;ADA;PAICS;ENTPD8;ITPA;PNP,37 (37),1.04e-09,2.01e-08,5,HMDB0000123;HMDB0000195;HMDB0001178;HMDB0033934;HMDB0000189,70 (73),0.886,1,2e-08,2.96e-07
AICA-Ribosiduria,SMPDB,24,GMPS;GDA;NUDT5;ADSL;ATAD1;GUCY1B1;GUK1;HPRT1;DGUOK;GART;ENTPD5;NUDT2;NT5C2;XDH;PFAS;ATIC;PPAT;RRM1;APRT;ADA;PAICS;ENTPD8;ITPA;PNP,37 (37),1.04e-09,2.01e-08,5,HMDB0000123;HMDB0000195;HMDB0001178;HMDB0033934;HMDB0000189,70 (73),0.886,1,2e-08,2.96e-07
Adenine phosphoribosyltransferase deficiency (APRT),SMPDB,24,GMPS;GDA;NUDT5;ADSL;ATAD1;GUCY1B1;GUK1;HPRT1;DGUOK;GART;ENTPD5;NUDT2;NT5C2;XDH;PFAS;ATIC;PPAT;RRM1;APRT;ADA;PAICS;ENTPD8;ITPA;PNP,37 (37),1.04e-09,2.01e-08,5,HMDB0000123;HMDB0000195;HMDB0001178;HMDB0033934;HMDB0000189,70 (73),0.886,1,2e-08,2.96e-07
Mitochondrial DNA depletion syndrome,SMPDB,24,GMPS;GDA;NUDT5;ADSL;ATAD1;GUCY1B1;GUK1;HPRT1;DGUOK;GART;ENTPD5;NUDT2;NT5C2;XDH;PFAS;ATIC;PPAT;RRM1;APRT;ADA;PAICS;ENTPD8;ITPA;PNP,37 (37),1.04e-09,2.01e-08,5,HMDB0000123;HMDB0000195;HMDB0001178;HMDB0033934;HMDB0000189,70 (73),0.886,1,2e-08,2.96e-07
Myoadenylate deaminase deficiency,SMPDB,24,GMPS;GDA;NUDT5;ADSL;ATAD1;GUCY1B1;GUK1;HPRT1;DGUOK;GART;ENTPD5;NUDT2;NT5C2;XDH;PFAS;ATIC;PPAT;RRM1;APRT;ADA;PAICS;ENTPD8;ITPA;PNP,37 (37),1.04e-09,2.01e-08,5,HMDB0000123;HMDB0000195;HMDB0001178;HMDB0033934;HMDB0000189,70 (73),0.886,1,2e-08,2.96e-07
Purine Metabolism,SMPDB,24,GMPS;GDA;NUDT5;ADSL;ATAD1;GUCY1B1;GUK1;HPRT1;DGUOK;GART;ENTPD5;NUDT2;NT5C2;XDH;PFAS;ATIC;PPAT;RRM1;APRT;ADA;PAICS;ENTPD8;ITPA;PNP,37 (37),1.04e-09,2.01e-08,5,HMDB0000123;HMDB0000195;HMDB0001178;HMDB0033934;HMDB0000189,70 (73),0.886,1,2e-08,2.96e-07
Molybdenum Cofactor Deficiency,SMPDB,24,GMPS;GDA;NUDT5;ADSL;ATAD1;GUCY1B1;GUK1;HPRT1;DGUOK;GART;ENTPD5;NUDT2;NT5C2;XDH;PFAS;ATIC;PPAT;RRM1;APRT;ADA;PAICS;ENTPD8;ITPA;PNP,37 (37),1.04e-09,2.01e-08,5,HMDB0000123;HMDB0000195;HMDB0001178;HMDB0033934;HMDB0000189,70 (73),0.886,1,2e-08,2.96e-07
Adenosine Deaminase Deficiency,SMPDB,24,GMPS;GDA;NUDT5;ADSL;ATAD1;GUCY1B1;GUK1;HPRT1;DGUOK;GART;ENTPD5;NUDT2;NT5C2;XDH;PFAS;ATIC;PPAT;RRM1;APRT;ADA;PAICS;ENTPD8;ITPA;PNP,37 (37),1.04e-09,2.01e-08,5,HMDB0000123;HMDB0000195;HMDB0001178;HMDB0033934;HMDB0000189,70 (73),0.886,1,2e-08,2.96e-07
Gout or Kelley-Seegmiller Syndrome,SMPDB,24,GMPS;GDA;NUDT5;ADSL;ATAD1;GUCY1B1;GUK1;HPRT1;DGUOK;GART;ENTPD5;NUDT2;NT5C2;XDH;PFAS;ATIC;PPAT;RRM1;APRT;ADA;PAICS;ENTPD8;ITPA;PNP,37 (37),1.04e-09,2.01e-08,5,HMDB0000123;HMDB0000195;HMDB0001178;HMDB0033934;HMDB0000189,70 (73),0.886,1,2e-08,2.96e-07
Lesch-Nyhan Syndrome (LNS),SMPDB,24,GMPS;GDA;NUDT5;ADSL;ATAD1;GUCY1B1;GUK1;HPRT1;DGUOK;GART;ENTPD5;NUDT2;NT5C2;XDH;PFAS;ATIC;PPAT;RRM1;APRT;ADA;PAICS;ENTPD8;ITPA;PNP,37 (37),1.04e-09,2.01e-08,5,HMDB0000123;HMDB0000195;HMDB0001178;HMDB0033934;HMDB0000189,70 (73),0.886,1,2e-08,2.96e-07
Xanthinuria type I,SMPDB,24,GMPS;GDA;NUDT5;ADSL;ATAD1;GUCY1B1;GUK1;HPRT1;DGUOK;GART;ENTPD5;NUDT2;NT5C2;XDH;PFAS;ATIC;PPAT;RRM1;APRT;ADA;PAICS;ENTPD8;ITPA;PNP,37 (37),1.04e-09,2.01e-08,5,HMDB0000123;HMDB0000195;HMDB0001178;HMDB0033934;HMDB0000189,70 (73),0.886,1,2e-08,2.96e-07
Xanthinuria type II,SMPDB,24,GMPS;GDA;NUDT5;ADSL;ATAD1;GUCY1B1;GUK1;HPRT1;DGUOK;GART;ENTPD5;NUDT2;NT5C2;XDH;PFAS;ATIC;PPAT;RRM1;APRT;ADA;PAICS;ENTPD8;ITPA;PNP,37 (37),1.04e-09,2.01e-08,5,HMDB0000123;HMDB0000195;HMDB0001178;HMDB0033934;HMDB0000189,70 (73),0.886,1,2e-08,2.96e-07
COPI-independent Golgi-to-ER retrograde traffic,Reactome,22,ACTR1A;RAB3GAP1;RAB18;GALNT2;DCTN2;RAB3GAP2;PAFAH1B1;PAFAH1B2;PAFAH1B3;AGPAT3;CAPZA1;CAPZA2;DYNLL2;CAPZB;DYNC1LI1;DCTN1;RAB6B;RAB6A;DYNC1H1;DYNC1I2;DYNC1LI2;DCTN3,34 (34),5.58e-09,9.79e-08,2,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,7 (9),0.168,1,2.04e-08,3.01e-07
Alanine_ aspartate and glutamate metabolism - Homo sapiens (human),KEGG,24,CAD;AGXT2;ABAT;ASRGL1;GLS2;ADSL;ASL;GLS;GLUD1;GPT;AGXT;GLUL;ASNS;ALDH4A1;CPS1;PPAT;GPT2;ASPA;ALDH5A1;ASS1;GFPT1;GOT1;GOT2;NIT2,37 (37),1.04e-09,2.01e-08,1,HMDB0033934,25 (28),0.942,1,2.12e-08,3.11e-07
Butanoate metabolism,INOH,15,ACADS;ECHS1;HADHA;ACAT1;ACAT2;DLAT;EHHADH;BDH1;HMGCL;HSD17B10;HMGCS1;HMGCS2;HADH;ACSM1;ACSS2,17 (17),1.22e-09,2.37e-08,1,HMDB0062259,21 (23),0.909,1,2.4e-08,3.51e-07
tRNA charging,HumanCyc,24,HARS2;AARS1;FARSA;IARS2;SARS2;WARS1;AARS2;MARS1;RARS1;IARS1;YARS1;LARS1;NARS1;FARSB;DARS1;CARS2;HARS1;TARS2;QARS1;VARS1;TARS1;PARS2;SARS1;YARS2,38 (38),2.31e-09,4.34e-08,3,HMDB0000123;HMDB0000172;HMDB0000687,24 (24),0.484,1,2.41e-08,3.51e-07
Cholesterol Biosynthesis with Skeletal Dysplasias,Wikipathways,3,EBP;DHCR7;DHCR24,7 (7),0.129,0.326,10,HMDB0001170;HMDB0002027;HMDB0001251;HMDB0000032;HMDB0006842;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0001286,12 (14),9.45e-09,1.9e-05,2.63e-08,3.81e-07
Platelet activation_ signaling and aggregation,Reactome,90,AAMP;PSAP;CFL1;ABHD6;PF4;MGLL;ACTN4;NHLRC2;ACTN1;ITGA2B;OLA1;PFN1;F2;TTN;ITGB3;TUBA4A;F13A1;ITIH3;ITIH4;ITPR2;PTPN6;SERPINA4;PTPN11;STX4;STXBP2;STXBP3;GNG12;CLU;TEX264;PIK3R1;FN1;FGA;FGB;SERPING1;HRG;FAM3C;GNAI2;GNAI3;TAGLN2;GNAQ;FGG;GNA11;PLG;GNB1;GNB2;SERPINF2;ALDOA;HSPA5;KNG1;VCL;CAP1;VTI1B;ALB;FLNA;RAP1A;RAP1B;RARRES2;CALM1;WDR1;CALU;ANXA5;SHC1;GRB2;APOA1;APOH;ECM1;SERPINA1;TF;YWHAZ;CYRIB;CRK;LGALS3BP;RHOA;RHOG;ORM1;IGF1;MAPK14;SCCPDH;CSK;GNA13;TLN1;PRKCA;RAC1;CHID1;MAPK1;FERMT3;LYN;CDC42;ABHD12;SOD1,263 (263),1.91e-09,3.67e-08,2,HMDB0001043;HMDB0003208,22 (28),0.701,1,2.86e-08,4.13e-07
y branching of actin filaments,BioCarta,14,PIR;WASL;NCKAP1;CDC42;ACTR2;ARPC4;ARPC3;ARPC1B;ACTR3;ARPC1A;NCK1;RAC1;PSMA7;ARPC2,17 (17),2.69e-08,4.39e-07,0,,0 (0),1,1,2.69e-08,4.39e-07
Ammonia Recycling,SMPDB,12,GLUL;GLUD1;DLD;GLDC;GLS2;SDS;AMT;ASRGL1;ASNS;HAL;CPS1;GCSH,12 (12),2e-09,3.81e-08,2,HMDB0000123;HMDB0033934,29 (29),0.835,1,3.53e-08,5.08e-07
Plasma lipoprotein assembly_ remodeling_ and clearance,Reactome,29,NPC1;LSR;LIPA;AP2M1;LIPC;AP2S1;AP2A1;AP2A2;AP2B1;P4HB;SCARB1;CLTA;CLTC;PRKACA;PRKACB;MTTP;APOA1;NCEH1;NPC2;APOB;ALB;APOC2;APOC3;LCAT;APOE;APOA2;APOA4;SOAT2;HDLBP,60 (60),2.11e-07,3.03e-06,5,HMDB0000067;HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,13 (21),0.00854,0.528,3.81e-08,5.44e-07
Bile acid and bile salt metabolism,Reactome,22,HSD3B7;OSBP;ACOT8;SLC10A1;CYP7A1;CYP8B1;AMACR;CYP27A1;BAAT;OSBPL1A;AKR1D1;SCP2;ABCB11;ALB;HSD17B4;CYP39A1;AKR1C1;RXRA;ACOX2;SLC27A5;SLC27A2;STARD5,43 (43),1.83e-06,2.12e-05,15,HMDB0000036;HMDB0000637;HMDB0006281;HMDB0062420;HMDB0062206;HMDB0000123;HMDB0000951;HMDB0000067;HMDB0000138;HMDB0006894;HMDB0012455;HMDB0060136;HMDB0001231;HMDB0001457;HMDB0001993,59 (79),0.000985,0.0901,3.82e-08,5.44e-07
Dimethyl-branched-chain fatty acid mitochondrial beta-oxidation,EHMN,12,ACADL;ACADM;ECHS1;EHHADH;AMACR;ACAA2;HSD17B10;HADHA;HADHB;HADH;HSD17B4;ACADSB,12 (12),2e-09,3.81e-08,0,,10 (10),1,1,4.2e-08,5.95e-07
MHC class II antigen presentation,Reactome,32,LGMN;SEC24D;CTSF;AP2M1;AP1S1;AP2S1;SEC24C;AP2A2;AP1B1;AP2B1;AP1G1;SEC24A;CTSC;CANX;SAR1B;CLTA;CLTC;AP2A1;DNM3;IFI30;AP1M1;CD74;SEC31A;CTSB;CTSA;CTSD;CTSH;CTSL;SEC23A;ARF1;DNM2;SEC13,60 (60),2.23e-09,4.23e-08,0,,3 (6),1,1,4.66e-08,6.58e-07
Glycolysis,Reactome,36,GPI;TPR;PPP2CB;PPP2R1A;RANBP2;GNPDA1;PPP2R5D;HK1;HK3;NUP155;RAE1;GAPDH;BPGM;NUP210;PRKACA;PRKACB;NUP98;PKLR;NUP133;PKM;GCK;GCKR;NUP93;NUP58;PFKL;PGP;ALDOA;ALDOB;ENO1;PGAM1;NUP160;ADPGK;NUP35;SEC13;NUP205;TPI1,72 (73),2.3e-09,4.34e-08,0,,21 (27),1,1,4.8e-08,6.76e-07
adenosine ribonucleotides <i>de novo</i> biosynthesis,HumanCyc,24,ATP5F1D;ATP5PB;ATP5MG;ATP5ME;ATP6V1A;ATP6V1B2;ATP6V0C;ATP6V1C1;ATP6V1E1;ATP6V1H;ATP6V0A1;ATP6V0D1;MT-ATP8;ADSL;ATP6V1D;AK2;AK4;ATP6V1G1;ATP5MF;DMAC2L;ATP5PD;ATP5F1A;AK3;ATP5F1B,38 (38),2.31e-09,4.34e-08,0,,12 (12),1,1,4.82e-08,6.76e-07
PPAR signaling pathway - Homo sapiens (human),KEGG,36,ACSL1;HMGCS2;ACSL4;ILK;ACADL;ACADM;APOA5;EHHADH;CYP7A1;CYP8B1;SLC27A1;ACOX1;CYP27A1;SLC27A5;SCP2;FADS2;FABP4;APOA1;APOA2;SORBS1;HMGCS1;DBI;APOC3;CPT1A;CPT2;ME1;RXRA;PCK1;PCK2;ACOX2;ACOX3;ACSL5;FABP1;SLC27A2;PLIN2;FABP7,74 (76),5.93e-09,1.04e-07,1,HMDB0002995,5 (5),0.433,1,5.34e-08,7.45e-07
Cellular response to chemical stress,Reactome,44,TXNRD1;CUL3;BLVRB;CUL1;COX6C;NDUFA4;BLVRA;MT-CO1;MT-CO2;MT-CO3;HMOX2;GSTP1;ERO1A;P4HB;COX4I1;COX5B;PRDX3;COX6A1;PRDX1;NUDT2;HELZ2;COX7C;COX5A;COX7A2L;FABP1;ALB;AQP8;PRDX2;HMOX1;TXNRD2;HM13;PRDX5;CAT;SKP1;TXN2;GPX1;RXRA;GSR;PRDX6;CCS;STAT3;SOD1;SOD2;RBX1,99 (99),4.53e-09,8.17e-08,3,HMDB0001388;HMDB0000054;HMDB0001043,33 (41),0.704,1,6.56e-08,9.12e-07
Pathogenic Escherichia coli infection,Wikipathways,29,RHOA;TUBA1B;ARPC4;WASL;ARPC3;CD14;YWHAQ;TUBA1C;ARPC1A;ACTB;ACTG1;PRKCA;ROCK1;ARPC5L;NCK1;NCL;TUBB2B;TUBB4B;CTNNB1;CTTN;CDC42;CDH1;ITGB1;ARPC5;TUBA4A;YWHAZ;ARPC1B;HCLS1;ARPC2,56 (56),3.01e-08,4.85e-07,1,HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,1 (1),0.107,1,6.64e-08,9.19e-07
Parkin-Ubiquitin Proteasomal System pathway,Wikipathways,34,PSMD6;CUL1;TUBA1B;UBE2J1;TUBB4B;UBA1;UBE2G1;UBE2G2;UBE2L3;TUBA4A;TUBA1C;PSMC1;PSMC2;PSMC3;PSMC4;PSMC5;PSMC6;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;TUBB2B;PSMD12;PSMD13;PSMD14;HSPA4;HSPA5;HSPA8;HSPA9;CASK;PSMD11,73 (73),6.17e-08,9.66e-07,0,,0 (0),1,1,6.17e-08,9.66e-07
TP53 Regulates Metabolic Genes,Reactome,37,TXNRD1;GPI;PRDX2;AGO2;LAMTOR2;GLS2;MT-CO1;MT-CO2;MT-CO3;LAMTOR4;MTOR;COX4I1;COX5B;RRM2B;GLS;COX6A1;PRKAA1;PRKAA2;PRKAB1;COX6C;PRKAG1;COX7C;COX5A;COX7A2L;RRAGC;NDUFA4;YWHAQ;LAMTOR1;PRDX5;PRDX1;YWHAE;YWHAG;YWHAH;YWHAZ;YWHAB;GSR;RHEB,76 (76),3.56e-09,6.67e-08,0,,22 (25),1,1,7.29e-08,1e-06
E-cadherin signaling in the nascent adherens junction,PID,23,RHOA;JUP;RAP1A;RAP1B;ABI1;NCKAP1;TJP1;PIK3R1;AP1M1;DLG1;AFDN;CTNNA1;CTNNB1;CTNND1;NME1;CTTN;CDC42;CDH1;RAC1;CRK;CYFIP2;IQGAP1;ARF6,36 (36),3.6e-09,6.72e-08,0,,3 (3),1,1,7.37e-08,1.01e-06
RHOBTB2 GTPase cycle,Reactome,18,TRA2B;CDC37;MYO6;TMOD3;ACTG1;TXNL1;ACTB;SRRM1;CCT6A;CCT7;DDX39B;CCT2;ACTN1;HSP90AA1;CUL3;HNRNPC;TWF1;HSP90AB1,24 (24),3.65e-09,6.78e-08,0,,1 (1),1,1,7.46e-08,1.02e-06
glutathione-mediated detoxification,HumanCyc,17,GSTM1;MGST1;ANPEP;MGST3;GSTM4;GSTP1;MGST2;GSTT1;GSTT2;GSTZ1;GSTA5;GSTK1;GSTA1;GSTA2;GSTA3;GSTA4;GSTM2,22 (22),4.64e-09,8.17e-08,1,HMDB0000123,14 (14),0.797,1,7.55e-08,1.03e-06
Tryptophan metabolism,Wikipathways,25,AFMID;CYP1A2;WARS1;MAOB;CYP2E1;ACAT1;INMT;DHCR24;AOX1;HAAO;PRMT1;GCDH;HSD17B10;TDO2;ALDH1A1;HADH;CAT;ACMSD;AADAT;ALDH9A1;ALDH3A2;ECHS1;OGDH;DDC;KYNU,42 (42),6.27e-09,1.09e-07,3,HMDB0004369;HMDB0004095;HMDB0000472,30 (38),0.64,1,8.15e-08,1.11e-06
Malonyl-coa decarboxylase deficiency,SMPDB,13,ACADM;HIBCH;ECHS1;ACAT1;PCCA;PCCB;ALDH6A1;ABAT;MMUT;MCEE;MLYCD;ACSS3;ACACA,14 (14),4.34e-09,7.93e-08,0,,35 (38),1,1,8.78e-08,1.17e-06
Malonic Aciduria,SMPDB,13,ACADM;HIBCH;ECHS1;ACAT1;PCCA;PCCB;ALDH6A1;ABAT;MMUT;MCEE;MLYCD;ACSS3;ACACA,14 (14),4.34e-09,7.93e-08,0,,35 (38),1,1,8.78e-08,1.17e-06
Propanoate Metabolism,SMPDB,13,ACADM;HIBCH;ECHS1;ACAT1;PCCA;PCCB;ALDH6A1;ABAT;MMUT;MCEE;MLYCD;ACSS3;ACACA,14 (14),4.34e-09,7.93e-08,0,,35 (38),1,1,8.78e-08,1.17e-06
Methylmalonic Aciduria Due to Cobalamin-Related Disorders,SMPDB,13,ACADM;HIBCH;ECHS1;ACAT1;PCCA;PCCB;ALDH6A1;ABAT;MMUT;MCEE;MLYCD;ACSS3;ACACA,14 (14),4.34e-09,7.93e-08,0,,35 (38),1,1,8.78e-08,1.17e-06
Gluconeogenesis,SMPDB,17,ALDOA;PC;GPI;ENO1;SLC25A11;MDH2;PGAM1;MPC1;GAPDH;SLC37A4;BPGM;PCK1;SLC2A2;PGM1;FBP1;GALM;TPI1,22 (22),4.64e-09,8.17e-08,0,,29 (34),1,1,9.37e-08,1.21e-06
Glycogenosis_ Type IA. Von gierke disease,SMPDB,17,ALDOA;PC;GPI;ENO1;SLC25A11;MDH2;PGAM1;MPC1;GAPDH;SLC37A4;BPGM;PCK1;SLC2A2;PGM1;FBP1;GALM;TPI1,22 (22),4.64e-09,8.17e-08,0,,29 (34),1,1,9.37e-08,1.21e-06
Glycogenosis_ Type IC,SMPDB,17,ALDOA;PC;GPI;ENO1;SLC25A11;MDH2;PGAM1;MPC1;GAPDH;SLC37A4;BPGM;PCK1;SLC2A2;PGM1;FBP1;GALM;TPI1,22 (22),4.64e-09,8.17e-08,0,,29 (34),1,1,9.37e-08,1.21e-06
Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease,SMPDB,17,ALDOA;PC;GPI;ENO1;SLC25A11;MDH2;PGAM1;MPC1;GAPDH;SLC37A4;BPGM;PCK1;SLC2A2;PGM1;FBP1;GALM;TPI1,22 (22),4.64e-09,8.17e-08,0,,29 (34),1,1,9.37e-08,1.21e-06
Triosephosphate isomerase,SMPDB,17,ALDOA;PC;GPI;ENO1;SLC25A11;MDH2;PGAM1;MPC1;GAPDH;SLC37A4;BPGM;PCK1;SLC2A2;PGM1;FBP1;GALM;TPI1,22 (22),4.64e-09,8.17e-08,0,,29 (34),1,1,9.37e-08,1.21e-06
Fructose-1_6-diphosphatase deficiency,SMPDB,17,ALDOA;PC;GPI;ENO1;SLC25A11;MDH2;PGAM1;MPC1;GAPDH;SLC37A4;BPGM;PCK1;SLC2A2;PGM1;FBP1;GALM;TPI1,22 (22),4.64e-09,8.17e-08,0,,29 (34),1,1,9.37e-08,1.21e-06
Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1),SMPDB,17,ALDOA;PC;GPI;ENO1;SLC25A11;MDH2;PGAM1;MPC1;GAPDH;SLC37A4;BPGM;PCK1;SLC2A2;PGM1;FBP1;GALM;TPI1,22 (22),4.64e-09,8.17e-08,0,,29 (34),1,1,9.37e-08,1.21e-06
Glycogenosis_ Type IB,SMPDB,17,ALDOA;PC;GPI;ENO1;SLC25A11;MDH2;PGAM1;MPC1;GAPDH;SLC37A4;BPGM;PCK1;SLC2A2;PGM1;FBP1;GALM;TPI1,22 (22),4.64e-09,8.17e-08,0,,29 (34),1,1,9.37e-08,1.21e-06
Spinocerebellar ataxia - Homo sapiens (human),KEGG,56,PIK3R4;PSMD6;ATXN2L;NOP56;SLC25A4;SLC25A5;ATXN2;VDAC3;MTOR;PIK3R1;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;SPTBN2;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;ATXN10;PSMC1;PSMC2;PSMC3;PSMA7;PSMC4;PSMC5;PSMC6;PSMD1;PSMD2;PSMD3;PSMD4;PSMD7;PSMD8;PLCB3;PSMD11;PSMD12;PSMD13;GNAQ;PRKCA;MAPK9;AFG3L2;PSMD14;MCU;ATP2A2;ADRM1;PPIF;OPA1;WIPI2;VDAC1;VDAC2;ATXN3;ITPR2,143 (143),1.12e-08,1.89e-07,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,6 (7),0.494,1,1.11e-07,1.43e-06
Stabilization and expansion of the E-cadherin adherens junction,PID,25,RHOA;CTNNA1;LIMA1;ABI1;IGF1;STX4;NCKAP1;EGFR;MYO6;LPP;NECTIN2;DIAPH1;AFDN;ROCK1;NCK1;ACTN1;KIFC3;CTNNB1;CTNND1;CDH1;ZYX;VCL;CYFIP2;EXOC4;ARF6,42 (42),6.27e-09,1.09e-07,0,,3 (3),1,1,1.25e-07,1.6e-06
PPAR signaling pathway,Wikipathways,34,ACSL1;HMGCS2;ACSL4;ILK;ACADL;ACADM;APOA5;EHHADH;CYP7A1;CYP8B1;SLC27A1;ACOX1;CYP27A1;ACOX3;SCP2;FADS2;FABP4;APOA1;APOA2;SORBS1;DBI;APOC3;CPT1A;CPT2;ME1;RXRA;PCK1;PCK2;ACOX2;SLC27A5;ACSL5;FABP1;SLC27A2;FABP7,68 (68),6.39e-09,1.1e-07,0,,1 (7),1,1,1.27e-07,1.63e-06
Glycolysis Gluconeogenesis,INOH,26,GPI;AGXT2;LDHD;HK1;FBP1;HK3;GLB1;GAPDH;BPGM;GPT;AGXT;UGP2;PKLR;PKM;GPT2;PC;GCK;ENO1;PFKL;ALDOA;LDHA;ALDOB;PGAM1;LDHB;ME1;PGM1,45 (46),7.53e-09,1.3e-07,2,HMDB0035312;HMDB0000123,32 (34),0.873,1,1.3e-07,1.66e-06
Amino sugar and nucleotide sugar metabolism - Homo sapiens (human),KEGG,27,NPL;HEXA;HEXB;GPI;UAP1;GNPDA1;GALK1;HK1;HK3;GALT;GNE;NANS;UGDH;CYB5R3;UGP2;GNPNAT1;GCK;GFUS;CMAS;GMPPB;GMPPA;PGM2;GFPT1;PGM1;PGM3;PMM2;MPI,48 (48),8.63e-09,1.48e-07,4,HMDB0000290;HMDB0012305;HMDB0013112;HMDB0000304,49 (108),0.788,1,1.35e-07,1.71e-06
LDL clearance,Reactome,14,NPC1;AP2A2;AP2B1;AP2A1;LSR;NCEH1;NPC2;APOB;SOAT2;LIPA;AP2M1;AP2S1;CLTA;CLTC,18 (18),9.99e-08,1.53e-06,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,5 (9),0.0922,1,1.8e-07,2.27e-06
Protein export - Homo sapiens (human),KEGG,16,SRP9;SRP14;SEC61B;SRP68;SRP72;SPCS1;HSPA5;SRPRA;SPCS3;SRP19;SEC11A;SEC62;SEC61A1;OXA1L;SPCS2;SEC63,23 (23),1.57e-07,2.28e-06,0,,0 (0),1,1,1.57e-07,2.28e-06
Coronavirus disease - COVID-19 - Homo sapiens (human),KEGG,79,RPL10A;RPL22;RPL23A;RPL23;RPL24;RPL26;RPL27;RPL30;RPL28;RPL32;RPL34;MAPK14;RPL38;PIK3R1;RPL36A;RPLP0;RPL7A;DDX58;EGFR;RPL19;RPL9;RPS3;RPS3A;RPS4X;RPS5;RPS6;RPL35;RPS8;RPS9;RPS10;RPS11;RPS13;RPS14;RPS15;RPS15A;FGA;FGB;MAPK1;RPS16;RPS17;MAVS;C3;RPS19;C4A;RPSA;RELA;RPS21;RPS23;RPS24;RPS25;C5;RPS27;ISG15;FGG;C8A;C8B;C9;PRKCA;MAPK9;F2;EIF2AK2;RPL18;RPL4;RPL5;RPS27L;RPL6;RPL17;F13A1;RPL13;RPL8;STAT2;STAT3;RPL11;RPL12;RPL22L1;CFB;RPL3;RPL18A;RPL14,231 (232),1.9e-08,3.17e-07,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,6 (10),0.494,1,1.83e-07,2.31e-06
Chylomicron assembly,Reactome,9,MTTP;P4HB;APOA1;APOA2;APOA4;APOB;APOC2;APOC3;APOE,9 (9),3e-07,4.23e-06,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,3 (4),0.032,1,1.87e-07,2.35e-06
trans-Golgi Network Vesicle Budding,Reactome,35,GAK;AP1S1;GBF1;STX4;GNS;TXNDC5;AP1B1;AP1G1;HGS;CLTA;CLTB;CLTC;FTH1;NAPA;AP1M1;CLINT1;DNM2;VAMP8;AP3B1;SNX5;SNX9;VAMP2;ACBD3;CHMP2A;PICALM;TFRC;HSPA8;CTSZ;SNX2;RAB5C;ARF1;NECAP1;TGOLN2;TPD52;M6PR,72 (72),9.88e-09,1.68e-07,0,,5 (6),1,1,1.92e-07,2.4e-06
Neddylation,Reactome,81,COPS4;CUL5;CUL4B;CUL4A;CUL3;CUL2;CUL1;ELOC;ELOB;NEDD8;DCAF11;PSMF1;DCUN1D1;CCDC22;PSMB7;UBE2D3;DCAF8;FBXO6;PSMD6;FBXO4;CAND1;COPS3;COPS8;GPS1;COMMD9;PSMA1;PSMA2;COMMD2;UCHL3;PSME4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;COMMD7;PSMB8;FBXO7;PSMB9;PSMB10;PSMC1;PSMC2;PSMC3;PSMC4;PSMC5;PSMC6;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;UBE2M;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;PSME1;PSME2;COPS6;UBA3;COMMD10;SKP1;PSMD14;COPS2;DDB1;COPS5;PSMA4;LMO7;NAE1;HIF1A;COMMD3;RBX1;COMMD5;COPS7A;COMMD6;PSME3,236 (236),1.05e-08,1.78e-07,0,,4 (4),1,1,2.03e-07,2.53e-06
3-oxo-10R-octadecatrienoate beta-oxidation,EHMN,11,DECR1;ECHS1;EHHADH;SLC33A1;ACAA2;ACOX1;HSD17B10;HADHA;HADHB;HADH;HSD17B4,11 (11),1.06e-08,1.79e-07,0,,10 (10),1,1,2.05e-07,2.55e-06
Nicotinate and nicotinamide metabolism - Homo sapiens (human),KEGG,22,NAMPT;SIRT2;NADSYN1;NMNAT1;NT5E;NAPRT;ENPP1;ENPP3;QPRT;NADK2;CD38;AOX1;NT5C2;NADK;NNMT;NNT;SIRT5;NT5C;SIRT3;ASPDH;PNP;NMNAT3,35 (35),1.23e-08,2.07e-07,2,HMDB0001240;HMDB0240264,32 (55),0.873,1,2.09e-07,2.58e-06
Pathways in clear cell renal cell carcinoma,Wikipathways,37,GPI;LDHD;SDSL;FASN;HIF1A;HK1;HK3;DEPTOR;ACACA;ACACB;PSPH;EGFR;GAPDH;MTOR;SQSTM1;ACLY;ENPP3;PKLR;PKM;SHMT1;SHMT2;CAMK1;PFKL;MDH1;ALDOA;LDHA;ALDOB;ME1;LDHB;ENO1;PGM2;AKT1S1;SDS;PGM1;STAT3;RHEB;TPI1,86 (86),2.1e-07,3.01e-06,0,,0 (1),1,1,2.1e-07,3.01e-06
mcalpain and friends in cell motility,BioCarta,20,SHC1;HRAS;EGFR;GRB2;PRKAR2A;ITGB1;PRKAR1A;MAP2K2;CAPN1;CAPN2;PXN;TLN1;RAC1;ITGA1;MAP2K1;MAPK1;CAST;CAPNS1;MYLK;PRKACB,30 (30),1.3e-08,2.18e-07,0,,3 (3),1,1,2.49e-07,3.08e-06
Branched-chain amino acid catabolism,Reactome,16,IVD;HIBCH;ACADSB;AUH;ACAT1;HIBADH;ALDH6A1;DLD;DBT;BCKDHA;BCKDHB;HSD17B10;MCCC2;ECHS1;ACAD8;MCCC1,21 (21),1.92e-08,3.18e-07,3,HMDB0001052;HMDB0000172;HMDB0000687,34 (39),0.724,1,2.65e-07,3.26e-06
Ubiquinone and other terpenoid-quinone biosynthesis - Homo sapiens (human),KEGG,10,NQO1;HPD;TAT;COQ5;COQ7;VKORC1L1;VKORC1;COQ6;COQ3;GGCX,11 (11),5.15e-07,6.82e-06,7,HMDB0004649;HMDB0030020;HMDB0060487;HMDB0012958;HMDB0030554;HMDB0004198;HMDB0060355,29 (71),0.0297,1,2.9e-07,3.56e-06
Simvastatin Action Pathway,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,43 (47),8.52e-05,0.0149,3.13e-07,3.63e-06
Hyper-IgD syndrome,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,43 (46),8.52e-05,0.0149,3.13e-07,3.63e-06
Cholesteryl ester storage disease,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,43 (46),8.52e-05,0.0149,3.13e-07,3.63e-06
Lysosomal Acid Lipase Deficiency (Wolman Disease),SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,43 (46),8.52e-05,0.0149,3.13e-07,3.63e-06
Rosuvastatin Action Pathway,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,43 (47),8.52e-05,0.0149,3.13e-07,3.63e-06
Mevalonic aciduria,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,43 (46),8.52e-05,0.0149,3.13e-07,3.63e-06
Wolman disease,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,43 (46),8.52e-05,0.0149,3.13e-07,3.63e-06
Cerivastatin Action Pathway,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,43 (47),8.52e-05,0.0149,3.13e-07,3.63e-06
Smith-Lemli-Opitz Syndrome (SLOS),SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,43 (46),8.52e-05,0.0149,3.13e-07,3.63e-06
Chondrodysplasia Punctata II_ X Linked Dominant (CDPX2),SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,43 (46),8.52e-05,0.0149,3.13e-07,3.63e-06
CHILD Syndrome,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,43 (46),8.52e-05,0.0149,3.13e-07,3.63e-06
Desmosterolosis,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,43 (46),8.52e-05,0.0149,3.13e-07,3.63e-06
Hypercholesterolemia,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,43 (46),8.52e-05,0.0149,3.13e-07,3.63e-06
Steroid Biosynthesis,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,43 (46),8.52e-05,0.0149,3.13e-07,3.63e-06
Zoledronate Action Pathway,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,43 (47),8.52e-05,0.0149,3.13e-07,3.63e-06
Ibandronate Action Pathway,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,43 (46),8.52e-05,0.0149,3.13e-07,3.63e-06
N-glycan trimming in the ER and Calnexin/Calreticulin cycle,Reactome,21,SEL1L;MOGS;AMFR;ENGASE;RAD23B;DERL2;DERL1;PRKCSH;PDIA3;OS9;CALR;PSMC1;MLEC;CANX;UGGT1;VCP;NGLY1;GANAB;UBXN1;RNF139;SYVN1,33 (33),1.94e-08,3.2e-07,0,,4 (25),1,1,3.63e-07,4.2e-06
Degradation of cysteine and homocysteine,Reactome,12,TXN2;SUOX;SQOR;CDO1;ETHE1;CTH;CSAD;GOT2;MPST;ADO;SLC25A10;TST,13 (13),2.14e-08,3.52e-07,1,HMDB0033934,31 (40),0.971,1,3.89e-07,4.48e-06
L-kynurenine degradation,HumanCyc,12,IDO2;AFMID;DHTKD1;HAAO;KYAT3;KYNU;KYAT1;KMO;GOT2;TDO2;ACMSD;AADAT,13 (13),2.14e-08,3.52e-07,0,,29 (30),1,1,4e-07,4.59e-06
Pravastatin Action Pathway,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,44 (47),0.000113,0.0152,4.09e-07,4.59e-06
Atorvastatin Action Pathway,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,44 (47),0.000113,0.0152,4.09e-07,4.59e-06
Alendronate Action Pathway,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,44 (47),0.000113,0.0152,4.09e-07,4.59e-06
Lovastatin Action Pathway,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,44 (47),0.000113,0.0152,4.09e-07,4.59e-06
Risedronate Action Pathway,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,44 (47),0.000113,0.0152,4.09e-07,4.59e-06
Pamidronate Action Pathway,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,44 (47),0.000113,0.0152,4.09e-07,4.59e-06
Fluvastatin Action Pathway,SMPDB,12,HSD17B7;MSMO1;TM7SF2;DHCR24;ACAT2;FDFT1;LSS;LIPA;HMGCS1;MVK;EBP;IDI1,22 (22),0.000194,0.00128,14,HMDB0006842;HMDB0002027;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090;HMDB0000876,44 (47),0.000113,0.0152,4.09e-07,4.59e-06
superpathway of cholesterol biosynthesis,HumanCyc,14,HSD17B7;MSMO1;TM7SF2;MVK;ACAT1;ACAT2;FDFT1;LSS;DHCR7;DHCR24;EBP;HMGCS2;IDI1;HMGCS1,25 (25),3.81e-05,0.000319,12,HMDB0006842;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001090,40 (62),0.000646,0.0722,4.56e-07,5.09e-06
Signaling events mediated by VEGFR1 and VEGFR2,PID,33,RHOA;VTN;PTPN11;MAPK14;PXN;CALM1;PTPRJ;MAP2K3;PIK3R1;HGS;PRKACA;GRB2;PAK2;PRKCA;ROCK1;NCK1;CTNNA1;CAV1;MAPK1;CTNNB1;MAP2K2;MAP2K1;AKAP1;CDC42;PTPN6;ITGB3;NEDD4;VCL;ARF1;HSP90AA1;DNM2;IQGAP1;HSP90AB1,68 (68),2.74e-08,4.45e-07,0,,8 (8),1,1,5.05e-07,5.62e-06
Folate metabolism,INOH,20,NME3;PKLR;PKM;QDPR;SHMT1;AMT;SPR;MTHFD1;DHFR;PTS;SHMT2;GCH1;NME1;ATIC;ALDH1L1;FTCD;GART;MTHFS;NUDT2;NME2,31 (31),3.02e-08,4.85e-07,2,HMDB0000123;HMDB0033934,43 (46),0.954,1,5.29e-07,5.87e-06
erk and pi-3 kinase are necessary for collagen binding in corneal epithelia,BioCarta,20,PFN1;DIAPH1;VCL;RHOA;MAP2K1;CSK;ITGB1;TNS1;ACTN1;CAPN1;ROCK1;ZYX;ACTN4;GSN;TLN1;ITGA1;MAPK1;PIK3R1;MYLK;PXN,31 (31),3.02e-08,4.85e-07,0,,1 (1),1,1,5.52e-07,6.11e-06
Plasma lipoprotein clearance,Reactome,18,NPC1;AP2A2;AP2B1;CLTC;AP2A1;AP2S1;APOA1;NCEH1;NPC2;APOB;SOAT2;LIPA;AP2M1;LSR;CLTA;APOE;HDLBP;SCARB1,29 (29),3.55e-07,4.94e-06,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,5 (9),0.0922,1,5.96e-07,6.57e-06
Methionine Cysteine metabolism,INOH,17,MAT2A;LDHA;MPST;MAT2B;LDHB;CBS;CDO1;MARS1;MAT1A;AHCYL1;CTH;CSAD;GOT1;GOT2;BAAT;BHMT;AHCY,24 (24),4.14e-08,6.63e-07,3,HMDB0000036;HMDB0033934;HMDB0000043,41 (45),0.833,1,6.26e-07,6.88e-06
Vibrio cholerae infection - Homo sapiens (human),KEGG,26,PDIA4;ATP6V1A;ATP6V1B2;ATP6V0C;ATP6V1C1;ATP6V1E1;ATP6V1H;ATP6V0A1;ATP6AP1;ATP6V0D1;TJP1;ERO1A;ATP6V1D;ACTB;PRKACA;PRKACB;KDELR1;TJP2;ACTG1;TCIRG1;PRKCA;SEC61B;ATP6V1G1;GNAS;SEC61A1;ARF1,50 (50),1.4e-07,2.05e-06,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0033934,9 (9),0.25,1,6.36e-07,6.96e-06
Shigellosis - Homo sapiens (human),KEGG,76,PIK3R4;ATG5;MYL12A;CBX3;CRK;CUL1;ARPC5;U2AF1;WASL;RHOA;ARF1;MAPK14;HK1;UBE2D3;HK3;MYL9;PXN;CD14;ILK;EGFR;UBE2N;UBE2V1;UBE2V2;MTOR;SQSTM1;PIK3R1;SEPTIN9;TLN1;CAPN1;ARPC1A;CAPNS1;ACTB;CAST;MAPK1;DIAPH1;ARPC1B;BAX;ACTG1;SEPTIN11;GABARAP;RAC1;TLN2;ROCK1;C3;CTTN;ACTN4;RELA;PLCB3;ACTN1;ATM;ARPC5L;SEPTIN7;ITGA5;PFN1;MAPK9;SKP1;CDC42;ARPC2;ITGB1;PPID;CAPN2;ARPC4;ARPC3;AKT1S1;ACTR3;ACTR2;HCLS1;WIPI2;VCL;CRKL;VDAC1;RRAGC;RBX1;ITPR2;ARF6;SEPTIN2,246 (246),3.32e-06,3.65e-05,4,HMDB0004878;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000172;HMDB0000687,9 (14),0.0106,0.624,6.37e-07,6.96e-06
Drug metabolism - cytochrome P450 - Homo sapiens (human),KEGG,33,GSTM1;ADH5;GSTM2;UGT1A3;GSTM4;GSTP1;GSTT1;GSTT2;ADH6;FMO1;FMO3;FMO4;FMO5;MAOA;MGST1;MGST2;MGST3;GSTK1;HPGDS;GSTA5;CYP1A2;UGT2A3;AOX1;UGT2A1;UGT2B10;UGT2B15;MAOB;CYP2E1;GSTO1;GSTA1;GSTA2;GSTA3;GSTA4,70 (72),6.68e-08,1.04e-06,9,HMDB0014426;HMDB0060682;HMDB0014813;HMDB0060678;HMDB0060679;HMDB0060656;HMDB0060673;HMDB0060655;HMDB0014477,83 (88),0.54,1,6.55e-07,7.13e-06
7-oxo-C and 7beta-HC pathways,Wikipathways,11,NPC1;SCP2;CYP7A1;AMACR;NPC2;ACOX2;SLC27A5;CYP27A1;SLC27A2;BAAT;HSD11B1,13 (13),5.67e-07,7.16e-06,0,,0 (0),1,1,5.67e-07,7.16e-06
Selenium Micronutrient Network,Wikipathways,38,TXNRD1;MPO;SELENOT;SEPHS2;KYNU;PRDX2;TXNRD2;FLAD1;SCARB1;ICAM1;SELENOO;SELENOF;PRDX1;GPX4;FGA;FGB;DIO1;XDH;PRDX3;APOA1;SOD2;APOB;CTH;ALB;SELENOI;FGG;CAT;PLG;PRDX5;F2;GPX1;CBS;RELA;PTGS1;KMO;SOD1;GSR;PNPO,86 (86),6.11e-08,9.6e-07,9,HMDB0001043;HMDB0000244;HMDB0000067;HMDB0003208;HMDB0001388;HMDB0002995;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0001976;HMDB0002183,91 (107),0.655,1,7.22e-07,7.84e-06
Gluconeogenesis,Reactome,21,SLC25A1;ALDOA;PC;GPI;GAPDH;ENO1;SLC25A10;PGAM1;PCK2;SLC37A4;ALDOB;PCK1;SLC25A11;FBP1;GOT1;GOT2;SLC25A13;TPI1;SLC25A12;MDH1;MDH2,34 (35),4.16e-08,6.65e-07,0,,25 (31),1,1,7.49e-07,8.11e-06
Pathogenic Escherichia coli infection - Homo sapiens (human),KEGG,67,MAPK14;ARF1;ARPC4;TUBA1B;TUBB4B;WASL;PTPN6;MYH9;MYH11;ABI1;CYFIP1;SLC9A3R1;CASP3;RELA;RHOA;ARHGEF12;SEC24C;MYO1C;MYO1D;NCKAP1;BRK1;MYO6;MYH14;TJP1;RPS3;PTPN11;MYO1E;SEC24A;HCLS1;TUBA1C;ARPC1A;ACTB;TMBIM6;MAPK1;FADD;BAX;PAK2;ACTG1;RAC1;ROCK1;MYO1B;ABCF2;ARPC5L;NCK1;NCL;TUBB2B;BAIAP2;SEC24D;TMED10;GAPDH;MAPK9;F2;RAB1A;CDC42;ITGB1;ARPC5;TUBA4A;ARPC3;ARPC1B;ACTR3;ACTR2;GNA13;CTTN;CYFIP2;ARPC2;ARF6;CLDN3,196 (197),2.29e-07,3.26e-06,1,HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,2 (3),0.203,1,8.3e-07,8.94e-06
Pyruvate metabolism,Reactome,19,LDHA;GSTZ1;PDHB;SLC16A1;ME1;PDHA1;DLAT;DLD;PDK1;PDK2;MPC2;PDK4;PDHX;GLO1;HAGH;LDHB;VDAC1;MPC1;BSG,29 (29),4.65e-08,7.4e-07,0,,24 (25),1,1,8.32e-07,8.94e-06
RHO GTPases Activate WASPs and WAVEs,Reactome,22,WASL;ABI1;CYFIP1;MAPK1;NCKAP1;BRK1;ARPC1A;ACTB;GRB2;ACTG1;CYFIP2;NCK1;BAIAP2;CDC42;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;RAC1;ARPC2,37 (37),5.29e-08,8.39e-07,0,,4 (6),1,1,9.39e-07,1.01e-05
TNFalpha,NetPath,75,PDK1;CDC37;ACTL6A;CUL1;YWHAH;RPL4;FLNA;IQGAP2;LRPPRC;PTPN11;ROMO1;MAPK14;ITCH;PSMD6;UBE2D3;HDAC6;GRB2;GLB1;PPP6C;EGFR;ELP1;FBL;GLG1;PIK3R1;PSMC1;CSNK2A1;G3BP2;SMARCC2;KTN1;RACK1;RPS11;SEC16A;FADD;PSMC2;PSMC3;UBE2I;RPL30;PRKCA;PSMD1;PSMD2;PSMD3;GTF2I;KPNA6;PFDN2;SPAG9;COPS3;PSMD12;PSMD13;CAV1;MAPK1;YWHAQ;CASP3;MAPK9;PML;SKP1;RPL6;PSMD7;YWHAB;YWHAE;YWHAG;RELA;YWHAZ;PSMB5;RXRA;FKBP5;HSPB1;RPL8;HSP90AB1;HSP90AA1;FAF1;HDAC2;RPS13;BID;KPNA2;KPNA3,234 (234),8.21e-07,1.01e-05,0,,0 (0),1,1,8.21e-07,1.01e-05
Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids,SMPDB,10,CPT2;ACADL;ACSL1;ACAA2;SLC25A20;HADHA;HADH;HADHB;ECHS1;CPT1A,10 (10),5.64e-08,8.89e-07,1,HMDB0000848,26 (26),0.948,1,9.5e-07,1.01e-05
ErbB1 downstream signaling,PID,44,RAB5A;RALA;PPP2R1A;ARPC4;WASL;PPP2R2A;YWHAZ;ABI1;YWHAG;BAIAP2;PPP5C;CALM1;NCKAP1;EGFR;BRK1;MTOR;PEBP1;MAP2K4;PIK3R1;RPS6;CAPN2;HRAS;GRB2;PRKCA;CYFIP2;MAPK1;YWHAQ;IQGAP1;MAPK9;MAP2K1;MAP2K2;CDC42;YWHAB;YWHAE;ARPC5;YWHAH;ARPC3;ARPC1B;ACTR3;ACTR2;STAT3;RAC1;ARF4;ARPC2,106 (106),5.55e-08,8.77e-07,0,,7 (7),1,1,9.82e-07,1.05e-05
integrin signaling pathway,BioCarta,19,SHC1;HRAS;VCL;RHOA;CSK;ITGB1;TNS1;CRKL;CAPN1;ROCK1;LRPAP1;ZYX;ACTN4;PXN;TLN1;ACTN1;ITGA1;CAV1;GRB2,33 (33),8.72e-07,1.07e-05,0,,0 (0),1,1,8.72e-07,1.07e-05
Glutathione metabolism,Wikipathways,15,GSTM1;GSTM2;GSTT1;GCLC;GCLM;ANPEP;GSTA5;GSTT2;GSS;GSR;OPLAH;GSTA1;GPX1;IDH1;GPX4,20 (20),7.81e-08,1.21e-06,1,HMDB0000123,12 (19),0.745,1,1.03e-06,1.09e-05
Lysine catabolism,Reactome,11,PIPOX;OGDH;HYKK;DLD;AASS;DLST;CRYM;ALDH7A1;GCDH;PHYKPL;AADAT,12 (12),1.05e-07,1.6e-06,3,HMDB0012130;HMDB0033934;HMDB0000279,30 (32),0.64,1,1.18e-06,1.25e-05
Vitamin E metabolism,EHMN,24,RANBP2;HADHB;NUP155;SLC16A1;EHHADH;AMACR;ACOX1;NUP210;BAAT;NUP98;NUP133;ACOT7;ACAA2;HSD17B10;ACOT2;HADHA;NUP93;HADH;NUP58;HSD17B4;ECHS1;NUP160;NUP35;NUP205,43 (43),7.14e-08,1.11e-06,0,,21 (21),1,1,1.25e-06,1.31e-05
Adherens junction - Homo sapiens (human),KEGG,31,RHOA;CTNNA1;WASL;PTPN6;BAIAP2;PTPRJ;EGFR;LMO7;TJP1;CSNK2A1;CSNK2A2;CSNK2B;ACP1;NECTIN2;ACTB;ACTG1;AFDN;ACTN4;SORBS1;ACTN1;CTNNA2;MAPK1;CTNNB1;CTNND1;YES1;CDC42;CDH1;VCL;RAC1;IQGAP1;FARP2,71 (71),1.36e-06,1.63e-05,0,,0 (0),1,1,1.36e-06,1.63e-05
Purine metabolism - Homo sapiens (human),KEGG,50,GMPS;GUK1;ADK;FHIT;AMPD2;NUDT5;ADSL;IMPDH2;GUCY1A1;GUCY1B1;NT5E;ENPP1;ENPP3;HPRT1;DGUOK;NUDT16;RRM2B;GART;NME2;NTPCR;ENTPD5;NUDT2;PKLR;NT5C2;PKM;URAD;XDH;AK2;AK4;PFAS;ITPA;PPAT;ATIC;PAPSS2;NT5C3A;GDA;GMPR2;NME3;NME1;NUDT9;RRM1;APRT;ENTPD8;ADA;PGM2;PAICS;NT5C;PGM1;AK3;PNP,129 (130),9.92e-08,1.53e-06,5,HMDB0000123;HMDB0000195;HMDB0001178;HMDB0033934;HMDB0000189,78 (95),0.934,1,1.59e-06,1.68e-05
Pentose phosphate pathway - Homo sapiens (human),KEGG,19,RBKS;ALDOA;PFKL;PGLS;GPI;RPE;PGD;PGM2;TALDO1;TKT;RGN;ALDOB;PGM1;RPIA;IDNK;H6PD;FBP1;GLYCTK;DERA,30 (30),1.04e-07,1.6e-06,0,,25 (35),1,1,1.78e-06,1.87e-05
Trihydroxycoprostanoyl-CoA beta-oxidation,EHMN,11,ECHS1;HADHA;EHHADH;AMACR;ACOX1;HSD17B10;ACOX2;ACOX3;HADHB;HADH;HSD17B4,12 (12),1.05e-07,1.6e-06,0,,10 (10),1,1,1.8e-06,1.88e-05
Phagosome - Homo sapiens (human),KEGG,53,MPO;RAB5B;TUBA1B;ATP6V1A;ATP6V1B2;ATP6V0C;ATP6V1C1;ATP6V1E1;ATP6V1H;ATP6V0A1;ATP6AP1;ATP6V0D1;DYNC1LI1;CD14;EEA1;CORO1A;FCGR2B;CTSL;CALR;RAB7A;SEC61B;CANX;ATP6V1D;HGS;ACTB;SCARB1;TUBA1C;ACTG1;TCIRG1;RAC1;LAMP1;C3;SEC22B;ATP6V1G1;TUBB2B;TUBB4B;ITGA5;STX7;SEC61A1;ITGB1;ITGB2;ITGB3;TAP2;RAB5A;TUBA4A;M6PR;DYNC1H1;DYNC1I2;RAB5C;DYNC1LI2;STX12;TFRC;MRC1,151 (152),1.64e-06,1.91e-05,0,,0 (1),1,1,1.64e-06,1.91e-05
nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell,Wikipathways,12,EIF1;EIF2S1;EIF3A;EIF3B;EIF3C;EIF3D;EIF3F;EIF3G;EIF3H;EIF3I;EIF3J;EIF2S2,16 (16),1.7e-06,1.98e-05,0,,0 (1),1,1,1.7e-06,1.98e-05
RHO GTPase cycle,Reactome,128,VAPB;TPM3;TPM4;SRRM1;STAM2;SLK;EMC3;ATP6AP1;FARP1;NCKAP1;IQGAP2;BRK1;MYO6;USP9X;SPTAN1;SPTBN1;ACTB;ACTC1;ACTG1;FAM91A1;NCK1;ACTN1;NDUFA5;HMOX2;DBT;WASL;ARHGDIA;COPS2;ITGB1;PICALM;HNRNPC;NDUFS3;IQGAP1;TWF1;FARP2;CKB;DIAPH1;TUBA1B;JUP;TAOK3;CYFIP1;STX5;FAF2;NSFL1C;ARFGAP3;PIK3R1;TMPO;PGRMC2;CLTC;GOPC;ABCD3;C1QBP;OSBPL11;TJP2;RAB7A;HINT2;SWAP70;SCFD1;BAIAP2;LAMTOR1;ALDH3A2;FERMT2;DDX39B;DSP;STIP1;PKN3;VCP;HSP90AA1;HSP90AB1;CUL3;VIM;HSPE1;FLOT2;RRAS2;ABI1;ANKFY1;CDC37;STBD1;CKAP4;RHOD;TRA2B;DSG2;DOCK8;ESYT1;TXNL1;KTN1;GPS1;ACBD5;CAPZB;ARHGEF12;SHMT2;ARFGAP2;ARHGAP17;EFHD2;CCT7;CCT2;CAV1;NUDC;CDC42BPB;LETM1;CYFIP2;ARHGEF10L;TFRC;RHOA;DDRGK1;WDR91;RHOG;ARHGAP1;CCT6A;ARHGDIB;YKT6;LMAN1;LMNB1;DST;TMOD3;GNA13;HGS;COPS4;PAK2;STEAP3;RAC1;ROCK1;CSK;FLOT1;CDC42;TOR1AIP1;STOM;CPSF7,442 (442),1.14e-07,1.72e-06,0,,6 (6),1,1,1.93e-06,2.02e-05
Phytanic acid peroxisomal oxidation,EHMN,13,AMACR;ACSL1;SCP2;ACSL4;EHHADH;HACL1;PHYH;ACOX1;ACOX2;ACOX3;ACSL5;SLC27A2;HSD17B4,16 (16),1.18e-07,1.79e-06,0,,21 (22),1,1,2e-06,2.08e-05
Protein folding,Reactome,41,TBCB;TUBA1B;CCT6A;TUBB4B;XRN2;FBXO6;NOP56;GNG12;CCT3;CCT5;TCP1;LONP2;STAT3;CSNK2A1;CSNK2A2;CSNK2B;TUBA1C;ACTB;FBXO4;ARFGEF2;GBA;CCT8;CCT7;GNA11;CCT2;PFDN1;PFDN2;PFDN4;PFDN5;TUBB2B;GNAQ;KIFC3;CCT4;GNB1;GNB2;SKIV2L;PFDN6;AP3M1;TUBA4A;TBCA;TBCD,98 (98),1.2e-07,1.81e-06,0,,4 (4),1,1,2.04e-06,2.11e-05
Pentose Phosphate Pathway,SMPDB,12,ALDOA;PFKL;PGLS;GPI;RPE;TKT;RBKS;TALDO1;PGM1;RPIA;FBP1;DERA,14 (14),1.24e-07,1.84e-06,0,,26 (29),1,1,2.1e-06,2.15e-05
Glucose-6-phosphate dehydrogenase deficiency,SMPDB,12,ALDOA;PFKL;PGLS;GPI;RPE;TKT;RBKS;TALDO1;PGM1;RPIA;FBP1;DERA,14 (14),1.24e-07,1.84e-06,0,,26 (29),1,1,2.1e-06,2.15e-05
Ribose-5-phosphate isomerase deficiency,SMPDB,12,ALDOA;PFKL;PGLS;GPI;RPE;TKT;RBKS;TALDO1;PGM1;RPIA;FBP1;DERA,14 (14),1.24e-07,1.84e-06,0,,26 (29),1,1,2.1e-06,2.15e-05
Transaldolase deficiency,SMPDB,12,ALDOA;PFKL;PGLS;GPI;RPE;TKT;RBKS;TALDO1;PGM1;RPIA;FBP1;DERA,14 (14),1.24e-07,1.84e-06,0,,26 (29),1,1,2.1e-06,2.15e-05
Butanoate metabolism - Homo sapiens (human),KEGG,18,BDH2;ACADS;ECHS1;HMGCS2;ACAT1;ACAT2;L2HGDH;EHHADH;ALDH5A1;ACSM5;BDH1;ABAT;HMGCL;HMGCS1;HADHA;ACSM3;HADH;ACSM1,28 (28),1.63e-07,2.36e-06,2,HMDB0062259;HMDB0001166,28 (42),0.82,1,2.25e-06,2.3e-05
Retrograde endocannabinoid signaling - Homo sapiens (human),KEGG,51,NDUFB11;GNAQ;NDUFS7;GNAI2;MAPK14;MAPK1;NDUFA12;GNG12;GNB1;MT-ND1;MT-ND3;MT-ND5;ABHD6;PRKACB;PRKCA;MGLL;NDUFA11;PLCB3;GNAI3;NDUFA2;NDUFA3;NDUFA4;NDUFA5;NDUFA6;NDUFA7;NDUFA8;GNB2;NDUFA9;MAPK9;NDUFAB1;NDUFB2;NDUFB3;NDUFB4;NDUFB5;NDUFB6;NDUFB7;NDUFB8;NDUFB10;NDUFC1;NDUFC2;NDUFS1;NDUFS2;NDUFS3;NDUFV1;NDUFS4;PRKACA;FAAH;NDUFS8;NDUFV2;NDUFV3;ITPR2,148 (148),4.71e-06,5.12e-05,5,HMDB0004080;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0001043;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,17 (19),0.0287,1,2.27e-06,2.31e-05
Tryptophan degradation,INOH,31,AFMID;CYP1A2;WARS1;MAOA;MAOB;CYP2E1;ACAT1;ACAT2;UBE3A;EHHADH;CYP4B1;INMT;QPRT;ALDH1B1;AOX1;HAAO;CAT;HSD17B10;HADHA;TDO2;ALDH1A1;HADH;GCDH;ACMSD;ALDH9A1;ALDH3A2;ECHS1;DDC;KYNU;KMO;ALDH7A1,66 (66),1.85e-07,2.66e-06,5,HMDB0062259;HMDB0004369;HMDB0000123;HMDB0033934;HMDB0000472,56 (62),0.734,1,2.28e-06,2.31e-05
Cargo concentration in the ER,Reactome,20,SEC24C;PREB;GOSR2;STX5;LMAN2;CD59;MCFD2;SEC22B;TMED2;MIA3;SERPINA1;SEC24A;CTSC;SEC23A;CTSZ;SAR1B;SEC24D;TMED10;MIA2;LMAN1,33 (33),1.38e-07,2.05e-06,0,,1 (6),1,1,2.32e-06,2.35e-05
Transport of Mature mRNA derived from an Intron-Containing Transcript,Reactome,34,TPR;SRRM1;U2AF1;RANBP2;THOC7;MAGOH;SRSF1;NUP160;SRSF3;SRSF4;SRSF5;SRSF6;SRSF7;SRSF2;RNPS1;EIF4A3;NUP210;NUP155;NUP98;RAE1;NUP133;U2AF2;ALYREF;NCBP1;RBM8A;NUP93;DDX39A;NUP58;SARNP;DDX39B;THOC5;NUP35;SEC13;NUP205,75 (75),1.4e-07,2.05e-06,0,,3 (5),1,1,2.35e-06,2.37e-05
Butanoate metabolism,EHMN,16,BDH2;ACADS;ECHS1;HMGCS2;SLC16A1;EHHADH;DBI;BDH1;ALDH7A1;HADHA;HADHB;ECHDC2;ALDH1B1;SLC25A10;ACSM1;AADAT,23 (23),1.57e-07,2.28e-06,1,HMDB0001166,34 (36),0.979,1,2.56e-06,2.58e-05
Prefoldin mediated transfer of substrate  to CCT/TriC,Reactome,18,CCT3;CCT5;TCP1;CCT8;PFDN6;CCT6A;TUBA4A;CCT7;CCT4;CCT2;PFDN1;PFDN2;PFDN4;PFDN5;TUBB2B;TUBA1C;TUBB4B;ACTB,28 (28),1.63e-07,2.36e-06,0,,1 (1),1,1,2.72e-06,2.72e-05
Immune System,Reactome,424,PIK3AP1;HEXB;AAMP;CPPED1;UBA5;MAN2B1;MANBA;ACLY;RPS6KA1;ACTB;ACTG1;TCIRG1;DTX3L;F2;CYB5R3;PIK3R4;S100A8;S100A9;S100A11;TUBB4B;AP2A1;AP2A2;MAVS;AP2B1;AP1G1;FCGR2B;IFITM3;AGA;SEC61B;AGL;ATP6V1D;MIF;FGA;FGB;IFI30;ARF1;ALAD;BAIAP2;ALDOA;FKBP1A;CTSB;SEC23A;CAP1;SEC13;VAT1;MPO;CUL3;CUL2;CUL1;MRC1;UBE2J1;FLNA;FLNB;PTGES2;MAP2K4;LAMTOR2;ANPEP;ANXA2;ARPC1A;RNF135;C9;DBNL;SHC1;APEH;CCT2;NPC2;APOB;SEC31A;RAB14;APRT;SKP1;DEGS1;PDXK;CYFIP2;ARG1;RHOA;ATP6V1H;RHOG;MAPK14;RAB18;MT2A;ARSB;ASAH1;FTH1;CCT8;CNPY3;TMEM30A;FUCA1;FUS;ATOX1;RBX1;CSK;VAMP8;XRCC6;GAA;DGAT1;MTOR;CAB39;ATP6V1A;ATP6V1B2;ATP6V0C;ATP6V1C1;ATP6V1E1;CTSF;ATP6V0A1;CAND1;ERP44;GHDC;NCKAP1;IQGAP2;BRK1;SEC24A;SPTAN1;B2M;FADD;SRP14;GBP2;NCK1;RNF114;CREG1;CEACAM1;GDI2;NDUFC2;STAT2;STAT3;STAT4;STAT5B;IQGAP1;NEDD4;STIM1;RAB10;CYFIP1;CSTB;STX4;FAF2;SUGT1;GLB1;VNN1;SQSTM1;SURF4;CPNE3;SERPING1;CPNE1;AP1M1;C3;C4A;C4BPA;C5;CKAP4;C8A;C8B;NME2;TAP2;TAPBP;GNS;SLC27A2;PNP;GM2A;GPI;ELOC;ELOB;WASL;DNAJC13;RAB31;STBD1;UBE3C;CALM1;CALR;CAMK2A;CAMK2D;CANX;CAPN1;UBR4;CAPZA1;CAPZA2;HGSNAT;CASP3;GRB2;UBA3;UBE2M;PFKL;ARL8A;NCSTN;PDIA3;COTL1;COMMD3;GSN;CTSL;AP2M1;DNAJC3;GSTP1;ORM1;ATP6V0D1;CD14;P4HB;NAPRT;GUSB;GYG1;PAFAH1B2;GRN;CD47;CD59;MGST1;CD74;AP1B1;CD81;PIGR;CAT;UFL1;CDC42;CDH1;CLU;UBE2V2;LRRFIP1;VAPA;CFH;CFHR1;HSP90B1;UBE2K;HK3;DDX58;CFL1;CTSC;PDAP1;HMOX2;PGAM1;TRIP12;TTR;PGM1;SNAP29;HRAS;UBE4A;SERPINA1;UBA1;AP1S1;AP2S1;UBE2D3;UBE2G1;UBE2G2;UBE2H;PPM1B;UBE2L3;UBE2N;UBE2V1;HP;UBE3A;PIK3R1;PIN1;CLTA;CLTC;FBXO7;PKM;TOLLIP;ARIH1;SEC61A1;HSPA5;ARPC2;HSPA8;VCL;VCP;HSP90AA1;PML;EIF4E2;DPP7;ATG5;VTN;FGG;COPB1;SCAMP1;ICAM1;XDH;ATP6V1G1;SEC22B;SAMHD1;IDH1;XRCC5;CFI;CTSA;YES1;IFI35;YWHAB;HECTD1;YWHAZ;TRIM5;PRDX6;CRK;CRKL;RNF14;PPP2CB;PPP2R1A;PPP2R5A;TKFC;PPP2R5D;PPP2R5E;PPP3CA;COMMD9;SEC24C;METTL7A;ISG15;PSMC3;IGHG1;IGHM;CSNK2B;PRKACA;PRKACB;DNM3;PRKCSH;MAPK1;CTNNB1;MAPK9;MAP2K1;CTSD;MAP2K3;CTSH;EIF2AK2;HERC4;CTSZ;CXADR;ABCE1;LGMN;ILF2;TRIM25;PSAP;IMPDH2;MLEC;EIF4A3;HSP90AB1;PSMA2;PSMA5;PSMB1;PSMB7;PSMB8;PSMC2;IST1;PSMD1;PSMD2;PSMD3;PTPN22;PSMD7;PSMD11;PSMD12;PSMD13;TRIM14;ITGB1;ITGB2;DDOST;PGRMC1;NIT2;DHX9;ITPR2;PSMD6;TOMM70;SEC24D;JUP;PTPN6;PTPN11;FBXO6;TXNDC5;FBXO4;PTPRJ;PAK2;NECTIN2;VPS35L;CFB;DIAPH1;RAB7A;PYGB;PA2G4;PYGL;LAMTOR1;STAT6;MVP;RAB5B;RAB6A;UBE2Z;DYNC1H1;RAB5C;RAC1;DNM2;PLD4;KPNB1;RAP1A;RAP1B;ABI1;ITCH;DSP;DUSP3;NLRX1;TOM1;LAMP1;RELA;AGPAT2;PCBP2;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;LGALS3;EEF1A1;LGALS9;DERA;CUL5;ACTR1B;EEF2;LMO7;SIGIRR;GSDMD;EIF4A1;EIF4A2;SAR1B;EIF4E;EIF4G1;EIF4G2;UBA6;DYNC1LI1;ROCK1;LTA4H;OSTF1;LYN;PSMD14;PGM2;STOM,1827 (1828),3.56e-07,4.95e-06,7,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0000067;HMDB0004949;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0029931,65 (147),0.556,1,3.26e-06,3.26e-05
Threonine and 2-Oxobutanoate Degradation,SMPDB,9,PCCA;PCCB;DLD;MMUT;SDS;BCKDHB;MCEE;BCKDHA;DBT,9 (9),3e-07,4.23e-06,1,HMDB0033934,17 (19),0.856,1,4.15e-06,4.14e-05
Fibroblast growth factor-1,NetPath,31,RAN;STAM2;FLOT2;CDV3;MAPK14;MAPK1;AP1B1;AP2B1;CSNK2A1;SCAMP1;RPS6KA1;CSNK2B;HGS;RAB11A;SHC1;GRB2;MAPK9;LRRC59;CLINT1;XPO1;CTNNB1;LAMTOR1;CTTN;MAP2K1;MAP2K2;CDH1;ITGB3;STAT3;HSP90AA1;TFRC;PRKCSH,74 (74),3.94e-06,4.31e-05,0,,0 (1),1,1,3.94e-06,4.31e-05
Cellular response to heat stress,Reactome,40,TPR;DNAJB1;RANBP2;NUP93;NUP160;HDAC6;NUP155;RAE1;HSPA8;MTOR;HIKESHI;CAMK2A;CAMK2D;HSPH1;NUP210;BAG3;BAG1;NUP98;NUP133;NUP58;CCAR2;ATM;MAPK1;DNAJC7;SERPINH1;PTGES3;YWHAE;HSPA4;HSPA5;AKT1S1;FKBP4;HSPA9;HSPB1;HSP90AB1;VCP;HSP90AA1;NUP35;SEC13;NUP205;HSPA13,97 (97),2.72e-07,3.87e-06,0,,8 (10),1,1,4.38e-06,4.36e-05
Arginine and proline metabolism - Homo sapiens (human),KEGG,24,CKB;CKM;PRODH2;MAOA;GAMT;HOGA1;GOT1;SRM;CNDP2;AGMAT;MAOB;DAO;OAT;L3HYPDH;ALDH4A1;ALDH1B1;ALDH9A1;ALDH3A2;SAT2;PYCR3;LAP3;ALDH7A1;GOT2;ARG1,50 (51),2.74e-06,3.06e-05,10,HMDB0002064;HMDB0012230;HMDB0002104;HMDB0000725;HMDB0060460;HMDB0033460;HMDB0006272;HMDB0059659;HMDB0004225;HMDB0012249,60 (78),0.102,1,4.51e-06,4.47e-05
fatty acid &beta;-oxidation,HumanCyc,14,ECI1;ACADL;ACSL1;SCP2;ACSL4;EHHADH;ECI2;ACAA2;HADH;HSD17B10;ACSL5;HADHB;SLC27A2;ECHS1,19 (19),3.13e-07,4.39e-06,4,HMDB0062259;HMDB0001166;HMDB0000944;HMDB0003944,60 (84),0.9,1,4.53e-06,4.48e-05
fatty acid &beta;-oxidation (peroxisome),HumanCyc,14,ACSL1;SCP2;ACSL4;EHHADH;ACAA2;HADH;ACOX1;HSD17B10;ACOX2;ACSL5;HADHB;SLC27A2;HSD17B4;ECHS1,19 (19),3.13e-07,4.39e-06,4,HMDB0062259;HMDB0001166;HMDB0000944;HMDB0003944,61 (85),0.907,1,4.57e-06,4.5e-05
Transfer of Acetyl Groups into Mitochondria,SMPDB,9,PC;ME1;PDHA1;PDHB;MPC1;ACLY;SLC25A11;CS;MDH1,9 (9),3e-07,4.23e-06,0,,20 (22),1,1,4.8e-06,4.72e-05
role of pi3k subunit p85 in regulation of actin organization and cell migration,BioCarta,12,WASL;RHOA;CDC42;ARPC4;ARPC3;PIK3R1;ACTR3;ACTR2;RAC1;ARPC1A;ARPC1B;ARPC2,17 (17),4.77e-06,5.17e-05,0,,0 (0),1,1,4.77e-06,5.17e-05
Transport of Mature Transcript to Cytoplasm,Reactome,36,TPR;SRRM1;U2AF1;RANBP2;THOC7;MAGOH;SRSF1;NUP160;SRSF3;SRSF4;SRSF5;SRSF6;RAE1;SRSF2;RNPS1;EIF4A3;NUP210;NUP155;NUP98;SRSF7;NUP133;CPSF1;U2AF2;ALYREF;NCBP1;RBM8A;EIF4E;NUP93;DDX39A;NUP58;SARNP;DDX39B;THOC5;NUP35;SEC13;NUP205,84 (84),3.42e-07,4.79e-06,0,,3 (5),1,1,5.44e-06,5.33e-05
Phenylalanine and Tyrosine Metabolism,SMPDB,10,FARSB;HGD;HPD;GSTZ1;FARSA;TAT;YARS1;FAH;PAH;GOT1,11 (11),5.15e-07,6.82e-06,2,HMDB0033934;HMDB0002281,27 (28),0.803,1,6.49e-06,6.28e-05
Phenylketonuria,SMPDB,10,FARSB;HGD;HPD;GSTZ1;FARSA;TAT;YARS1;FAH;PAH;GOT1,11 (11),5.15e-07,6.82e-06,2,HMDB0033934;HMDB0002281,27 (28),0.803,1,6.49e-06,6.28e-05
Tyrosinemia Type 3 (TYRO3),SMPDB,10,FARSB;HGD;HPD;GSTZ1;FARSA;TAT;YARS1;FAH;PAH;GOT1,11 (11),5.15e-07,6.82e-06,2,HMDB0033934;HMDB0002281,27 (28),0.803,1,6.49e-06,6.28e-05
Tyrosinemia Type 2 (or Richner-Hanhart syndrome),SMPDB,10,FARSB;HGD;HPD;GSTZ1;FARSA;TAT;YARS1;FAH;PAH;GOT1,11 (11),5.15e-07,6.82e-06,2,HMDB0033934;HMDB0002281,27 (28),0.803,1,6.49e-06,6.28e-05
cholesterol biosynthesis I,HumanCyc,8,MSMO1;TM7SF2;HSD17B7;FDFT1;LSS;DHCR7;DHCR24;EBP,13 (13),0.000825,0.00467,9,HMDB0006842;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006927#HMDB0001181;HMDB0001251,24 (32),0.000505,0.058,6.53e-06,6.31e-05
Glycine_ serine_ alanine and threonine metabolism,EHMN,34,CKB;DMGDH;LDHD;RANBP2;AMT;SARS2;SLC38A3;NUP155;AARS2;SLC16A1;GCAT;GLDC;SLC38A4;SLC43A1;GLYAT;NUP210;DAO;CHDH;NUP98;NUP133;PIPOX;DLD;GLOD4;NUP93;NUP58;HAO1;SARDH;TARS2;HAO2;NUP160;NAGS;AGXT;NUP35;NUP205,78 (78),4.44e-07,6.01e-06,4,HMDB0000123;HMDB0033934;HMDB0006454;HMDB0000043,73 (88),0.963,1,6.7e-06,6.45e-05
Sterol regulatory element-binding proteins (SREBP) signaling,Wikipathways,30,AMFR;SEC24D;FASN;ACACA;SEC24C;MTOR;FDFT1;ACLY;SEC24A;MDH1;SAR1B;PRKAA1;PRKAA2;PRKAB1;RBP4;SCARB1;PRKAG1;GPAM;LSS;HMGCS1;DBI;SEC31A;IDI1;RNF139;SAR1A;SEC23B;SEC23A;PRKACA;SEC13;KPNB1,68 (68),1.53e-06,1.82e-05,1,HMDB0000067,3 (5),0.289,1,6.92e-06,6.56e-05
Lysine Degradation,SMPDB,11,PIPOX;ECHS1;DHTKD1;ACAT1;DLD;AASS;GCDH;ALDH7A1;HADH;DLST;AADAT,13 (13),5.67e-07,7.16e-06,2,HMDB0001166;HMDB0000279,26 (27),0.786,1,6.96e-06,6.56e-05
Hyperlysinemia I_ Familial,SMPDB,11,PIPOX;ECHS1;DHTKD1;ACAT1;DLD;AASS;GCDH;ALDH7A1;HADH;DLST;AADAT,13 (13),5.67e-07,7.16e-06,2,HMDB0001166;HMDB0000279,26 (27),0.786,1,6.96e-06,6.56e-05
2-aminoadipic 2-oxoadipic aciduria,SMPDB,11,PIPOX;ECHS1;DHTKD1;ACAT1;DLD;AASS;GCDH;ALDH7A1;HADH;DLST;AADAT,13 (13),5.67e-07,7.16e-06,2,HMDB0001166;HMDB0000279,26 (27),0.786,1,6.96e-06,6.56e-05
Pyridoxine dependency with seizures,SMPDB,11,PIPOX;ECHS1;DHTKD1;ACAT1;DLD;AASS;GCDH;ALDH7A1;HADH;DLST;AADAT,13 (13),5.67e-07,7.16e-06,2,HMDB0001166;HMDB0000279,26 (27),0.786,1,6.96e-06,6.56e-05
Saccharopinuria/Hyperlysinemia II,SMPDB,11,PIPOX;ECHS1;DHTKD1;ACAT1;DLD;AASS;GCDH;ALDH7A1;HADH;DLST;AADAT,13 (13),5.67e-07,7.16e-06,2,HMDB0001166;HMDB0000279,26 (27),0.786,1,6.96e-06,6.56e-05
Glutaric Aciduria Type I,SMPDB,11,PIPOX;ECHS1;DHTKD1;ACAT1;DLD;AASS;GCDH;ALDH7A1;HADH;DLST;AADAT,13 (13),5.67e-07,7.16e-06,2,HMDB0001166;HMDB0000279,26 (27),0.786,1,6.96e-06,6.56e-05
Hyperlysinemia II or Saccharopinuria,SMPDB,11,PIPOX;ECHS1;DHTKD1;ACAT1;DLD;AASS;GCDH;ALDH7A1;HADH;DLST;AADAT,13 (13),5.67e-07,7.16e-06,2,HMDB0001166;HMDB0000279,26 (27),0.786,1,6.96e-06,6.56e-05
beta-Alanine metabolism - Homo sapiens (human),KEGG,18,ALDH3A2;ACADS;HIBCH;CNDP2;ACOX3;ALDH6A1;EHHADH;ALDH7A1;DPYD;DPYS;ABAT;ACOX1;UPB1;HADHA;MLYCD;ECHS1;ALDH1B1;ALDH9A1,30 (30),7.3e-07,9.04e-06,3,HMDB0060442;HMDB0001016;HMDB0061880,29 (32),0.616,1,7.02e-06,6.6e-05
mitochondrial fatty acid beta-oxidation of saturated fatty acids,Reactome,10,ACADL;ACADM;ACADS;ECHS1;ACADVL;ACSM3;HADHA;HADHB;HADH;MECR,11 (11),5.15e-07,6.82e-06,2,HMDB0062259;HMDB0003944,42 (42),0.95,1,7.59e-06,7.11e-05
Nucleobase biosynthesis,Reactome,12,GMPS;UMPS;LHPP;PAICS;PFAS;CAD;ATIC;IMPDH2;GART;DHODH;ADSL;PPAT,15 (15),5.13e-07,6.82e-06,2,HMDB0003349#HMDB0000528;HMDB0000123,46 (48),0.966,1,7.69e-06,7.18e-05
valine degradation,HumanCyc,11,HIBCH;ECHS1;HIBADH;ALDH6A1;DLD;ABAT;BCKDHA;BCKDHB;HADHA;ACAD8;DBT,13 (13),5.67e-07,7.16e-06,1,HMDB0001052,19 (20),0.885,1,7.78e-06,7.25e-05
Arginine biosynthesis - Homo sapiens (human),KEGG,15,GLUL;ARG1;GPT2;GOT2;NAGS;ASS1;OTC;ASL;GOT1;CPS1;GLS;GLUD1;GPT;GLS2;ACY1,22 (22),5.84e-07,7.35e-06,1,HMDB0033934,18 (23),0.871,1,7.89e-06,7.33e-05
Tight junction - Homo sapiens (human),KEGG,59,MYL12A;TUBA1B;ARPC5;PPP2CB;PPP2R1A;ARPC4;PPP2R2A;RAP1A;MYH9;MYH11;PCNA;SLC9A3R1;LLGL2;MYL6;MYL9;F11R;RAB13;MYH14;TJP1;RAB8B;TUBA1C;ARPC1A;CGN;PRKAA2;ACTB;RDX;PRKACA;PRKACB;PRKAG1;TJP2;ACTG1;ARHGAP17;DLG1;AFDN;ROCK1;ACTN4;CLDN3;ACTN1;CGNL1;RHOA;PRKAA1;CTTN;MAPK9;CDC42;ARPC5L;ITGB1;PRKAB1;HSPA4;TUBA4A;ARPC3;ARPC1B;ACTR3;ACTR2;HCLS1;TJP3;RAC1;RAB8A;ARPC2;NEDD4,169 (169),5.31e-07,7.03e-06,0,,1 (1),1,1,8.21e-06,7.6e-05
Argininemia,SMPDB,11,SLC25A15;CPS1;OTC;ASL;GOT2;ASS1;GLUD1;GPT;SLC25A12;GLS2;ARG1,13 (13),5.67e-07,7.16e-06,1,HMDB0033934,27 (27),0.954,1,8.35e-06,7.61e-05
Citrullinemia Type I,SMPDB,11,SLC25A15;CPS1;OTC;ASL;GOT2;ASS1;GLUD1;GPT;SLC25A12;GLS2;ARG1,13 (13),5.67e-07,7.16e-06,1,HMDB0033934,27 (27),0.954,1,8.35e-06,7.61e-05
Carbamoyl Phosphate Synthetase Deficiency,SMPDB,11,SLC25A15;CPS1;OTC;ASL;GOT2;ASS1;GLUD1;GPT;SLC25A12;GLS2;ARG1,13 (13),5.67e-07,7.16e-06,1,HMDB0033934,27 (27),0.954,1,8.35e-06,7.61e-05
Argininosuccinic Aciduria,SMPDB,11,SLC25A15;CPS1;OTC;ASL;GOT2;ASS1;GLUD1;GPT;SLC25A12;GLS2;ARG1,13 (13),5.67e-07,7.16e-06,1,HMDB0033934,27 (27),0.954,1,8.35e-06,7.61e-05
Urea Cycle,SMPDB,11,SLC25A15;CPS1;OTC;ASL;GOT2;ASS1;GLUD1;GPT;SLC25A12;GLS2;ARG1,13 (13),5.67e-07,7.16e-06,1,HMDB0033934,27 (27),0.954,1,8.35e-06,7.61e-05
Ornithine Transcarbamylase Deficiency (OTC Deficiency),SMPDB,11,SLC25A15;CPS1;OTC;ASL;GOT2;ASS1;GLUD1;GPT;SLC25A12;GLS2;ARG1,13 (13),5.67e-07,7.16e-06,1,HMDB0033934,27 (27),0.954,1,8.35e-06,7.61e-05
Phenylalanine and tyrosine metabolism,Reactome,11,PCBD1;FAH;PAH;HPD;AKT1S1;TAT;KYAT1;ASRGL1;HGD;QDPR;GSTZ1,13 (13),5.67e-07,7.16e-06,1,HMDB0033934,30 (33),0.967,1,8.46e-06,7.69e-05
Selective autophagy,Reactome,28,ATG5;MFN1;TOMM70;HDAC6;TOMM22;UBE2N;UBE2V1;DYNC1LI1;CSNK2A2;SQSTM1;CSNK2A1;PARK7;CSNK2B;PRKAA2;DYNLL2;PEX5;MFN2;VCP;VDAC1;TOMM40;ATM;PGAM5;HSPA8;DYNC1H1;DYNC1I2;DYNC1LI2;HSP90AA1;PLIN2,59 (59),5.51e-07,7.16e-06,0,,3 (4),1,1,8.49e-06,7.7e-05
Metapathway biotransformation Phase I and II,Wikipathways,60,GSTM1;GSTM2;UGT1A3;EPHX1;EPHX2;GSTP1;CYP1A2;GSTT2;GSTZ1;GLYATL2;GSTA5;SULT1B1;FMO1;FMO3;FMO4;FMO5;COMT;SULT1A1;MGST2;MGST3;GSTK1;CYP4B1;CYP7A1;CYP8B1;GSTO1;INMT;SULT1C3;GLYAT;CYP27A1;BAAT;CYP20A1;UGT2A1;AKR1D1;GPX4;AKR7A3;GLYATL1;NAT8;GSTM4;UGT2B15;MGST1;UGT2A3;CYP2E1;GSTT1;SULT1C2;AKR1A1;NAA50;TPMT;NAT1;NNMT;CYP39A1;AKR1B1;AKR1C1;GSR;GSS;GSTA1;GSTA2;GSTA3;GSTA4;AKR7A2;SULT1E1,186 (186),7.99e-06,7.79e-05,0,,0 (0),1,1,7.99e-06,7.79e-05
Golgi Associated Vesicle Biogenesis,Reactome,27,GAK;AP1S1;TXNDC5;AP1B1;AP1G1;CLTA;VAMP2;CLTC;FTH1;NAPA;AP1M1;CLINT1;NECAP1;VAMP8;AP3B1;SNX5;SNX9;ACBD3;PICALM;HSPA8;SNX2;RAB5C;ARF1;DNM2;TGOLN2;TPD52;TFRC,56 (56),5.88e-07,7.38e-06,0,,5 (5),1,1,9.03e-06,8.17e-05
Oxysterols derived from cholesterol,Wikipathways,11,CYP39A1;SCP2;CYP8B1;AMACR;ACOX2;SLC27A5;CYP27A1;SLC27A2;BAAT;HSD3B7;AKR1D1,15 (15),6.81e-06,7.16e-05,2,HMDB0001457;HMDB0001993,5 (10),0.0922,1,9.59e-06,8.65e-05
Oncogenic MAPK signaling,Reactome,31,ITGA2B;LSR;RAP1A;RAP1B;FXR1;MAPK1;FN1;LMNA;CALM1;SND1;CSK;CAMK2A;CAMK2D;TLN1;HRAS;FGA;FGB;AGK;FGG;AP3B1;MAP2K1;MAP2K2;PPP1CB;ITGB3;ZC3HAV1;ARAF;VCL;YWHAB;IQGAP1;MPRIP;PPP1CC,69 (69),6.33e-07,7.92e-06,0,,8 (17),1,1,9.66e-06,8.7e-05
Fructose Mannose metabolism,INOH,18,GFUS;ALDOA;ALDOB;GMPPA;AKR1B1;PGM2;HK3;MPI;GFPT1;KHK;GPI;GCK;GNPDA1;HK1;FBP1;SORD;PMM2;GMPPB,30 (30),7.3e-07,9.04e-06,1,HMDB0033934,28 (33),0.959,1,1.06e-05,9.53e-05
Aminocaproic Acid Action Pathway,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,2,HMDB0000015;HMDB0001901,5 (5),0.0922,1,1.07e-05,9.55e-05
Chaperonin-mediated protein folding,Reactome,38,TUBA1B;CCT6A;TUBB4B;XRN2;FBXO6;NOP56;GNG12;CCT3;CCT5;TCP1;LONP2;CSNK2A1;CSNK2A2;CSNK2B;TUBA1C;ACTB;FBXO4;ARFGEF2;GBA;CCT8;CCT7;GNA11;CCT2;PFDN1;PFDN2;PFDN4;PFDN5;TUBB2B;GNAQ;KIFC3;CCT4;GNB1;GNB2;SKIV2L;PFDN6;AP3M1;TUBA4A;STAT3,93 (93),7.08e-07,8.84e-06,0,,4 (4),1,1,1.07e-05,9.59e-05
Mitochondrial Electron Transport Chain,SMPDB,14,ATP5F1D;ATP5PB;GPD2;GAPDH;SLC37A4;UQCRC1;ATP5F1A;SLC25A4;SDHA;SDHB;SDHC;SDHD;ATP5F1B;GPD1,20 (20),8.62e-07,1.06e-05,1,HMDB0001060,17 (18),0.856,1,1.12e-05,9.93e-05
Autophagy,Reactome,43,PIK3R4;ATG5;TOMM70;DYNC1LI1;LAMTOR2;HDAC6;TOMM22;LAMTOR4;UBE2N;UBE2V1;MTOR;CSNK2A2;SQSTM1;CSNK2A1;PARK7;CSNK2B;PRKAA1;PRKAA2;PRKAB1;DYNLL2;PRKAG1;PEX5;MFN2;GABARAP;VCP;HSP90AA1;TOMM40;RRAGC;ATM;LAMTOR1;EEF1A1;ATG3;PGAM5;HSPA8;DYNC1H1;DYNC1I2;WIPI2;MFN1;DYNC1LI2;VDAC1;RHEB;PLIN2;HSP90AB1,113 (113),1.37e-06,1.64e-05,1,HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,7 (13),0.549,1,1.13e-05,0.000101
Ardeparin Action Pathway,SMPDB,14,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;SERPINC1;VKORC1;FGG;PLG;COL1A1;GGCX,21 (21),2.13e-06,2.43e-05,1,HMDB0000015,4 (4),0.365,1,1.17e-05,0.000104
Fondaparinux Action Pathway,SMPDB,14,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;SERPINC1;VKORC1;FGG;PLG;COL1A1;GGCX,21 (21),2.13e-06,2.43e-05,1,HMDB0000015,4 (5),0.365,1,1.17e-05,0.000104
Macroautophagy,Reactome,41,PIK3R4;ATG5;TOMM70;DYNC1LI1;LAMTOR2;HDAC6;TOMM22;LAMTOR4;UBE2N;UBE2V1;MTOR;CSNK2A2;SQSTM1;CSNK2A1;PARK7;CSNK2B;PRKAA1;PRKAA2;PRKAB1;DYNLL2;PRKAG1;PEX5;MFN2;GABARAP;VCP;HSP90AA1;TOMM40;RRAGC;ATM;LAMTOR1;ATG3;PGAM5;HSPA8;DYNC1H1;DYNC1I2;WIPI2;MFN1;DYNC1LI2;VDAC1;RHEB;PLIN2,106 (106),1.46e-06,1.74e-05,1,HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,7 (12),0.549,1,1.21e-05,0.000106
Squalene and cholesterol biosynthesis,EHMN,17,NUP98;NUP133;MSMO1;NUP58;FDFT1;NUP160;DHCR7;MVK;NUP210;NUP93;NUP35;EBP;RANBP2;TM7SF2;NUP205;IDI1;NUP155,37 (37),0.000154,0.00107,10,HMDB0006842;HMDB0001251;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0002719;HMDB0001286;HMDB0001090,38 (42),0.00527,0.337,1.22e-05,0.000107
Cristae formation,Reactome,12,ATP5F1D;ATP5PB;DMAC2L;ATP5MG;ATP5ME;ATP5PF;ATP5PD;ATP5MF;ATP5F1A;ATP5F1B;ATP5PO;MT-ATP8,18 (18),1.19e-05,0.000111,0,,0 (0),1,1,1.19e-05,0.000111
er associated degradation (erad) pathway,BioCarta,12,UBE2I;SKP1;CUL1;MOGS;SAE1;UGGT1;MAN1A1;GANAB;RBX1;MAN2C1;MAN2B1;SEC61A1,18 (18),1.19e-05,0.000111,0,,0 (0),1,1,1.19e-05,0.000111
HIV Infection,Reactome,64,CUL5;NPM1;TPR;ELOC;ELOB;RAN;RANBP1;RANBP2;NUP93;TAF3;AP2M1;AP1S1;AP2S1;VPS4A;NUP58;NUP155;PSIP1;AP2A2;AP1B1;AP2B1;SLC25A5;SLC25A4;SUPT5H;NMT1;RAC1;KPNB1;VPS4B;POLR2A;B2M;NUP210;PDCD6IP;SUPT16H;NUP98;RAE1;NUP133;CHMP3;CHMP5;PAK2;AP1M1;VTA1;RCC1;TSG101;TAF15;NCBP1;VPS28;AP1G1;XPO1;SSRP1;NUP160;XRCC5;CHMP4B;SKP1;ATP6V1H;CHMP6;SEC13;CHMP2A;BANF1;XRCC6;ARF1;AP2A1;NUP35;RBX1;KPNA1;NUP205,192 (192),1.15e-06,1.39e-05,1,HMDB0033934,12 (19),0.745,1,1.29e-05,0.000113
Mitochondrial calcium ion transport,Reactome,14,MICU2;PHB2;AFG3L2;AKAP1;PMPCB;MAIP1;LETM1;PMPCA;MCU;VDAC1;VDAC2;VDAC3;PHB;SPG7,20 (20),8.62e-07,1.06e-05,0,,4 (4),1,1,1.29e-05,0.000113
Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,Reactome,19,CCT3;CCT5;TCP1;CCT8;PFDN6;TUBA1B;CCT6A;TUBA4A;CCT7;CCT4;CCT2;PFDN1;PFDN2;PFDN4;PFDN5;TUBB2B;TUBA1C;TUBB4B;ACTB,33 (33),8.72e-07,1.07e-05,0,,4 (4),1,1,1.3e-05,0.000114
PPAR-alpha pathway,Wikipathways,15,CPT2;RXRA;ACADM;SCP2;APOA5;EHHADH;CYP7A1;CYP8B1;APOA1;APOA2;SLC27A1;DBI;FABP1;APOC3;CPT1A,26 (26),1.23e-05,0.000115,0,,0 (1),1,1,1.23e-05,0.000115
Heparin Action Pathway,SMPDB,14,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;SERPINC1;VKORC1;FGG;PLG;COL1A1;GGCX,21 (21),2.13e-06,2.43e-05,1,HMDB0000015,5 (5),0.433,1,1.38e-05,0.00012
Enoxaparin Action Pathway,SMPDB,14,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;SERPINC1;VKORC1;FGG;PLG;COL1A1;GGCX,21 (21),2.13e-06,2.43e-05,1,HMDB0000015,5 (5),0.433,1,1.38e-05,0.00012
Nucleobase catabolism,Reactome,20,NT5C3A;TYMP;AGXT2;ENTPD8;NUDT5;XDH;NT5E;NT5C2;DPYD;DPYS;NT5C;SAMHD1;GDA;UPB1;ITPA;NUDT9;PNP;ENTPD5;NUDT16;DNPH1,36 (36),9.8e-07,1.19e-05,4,HMDB0001342;HMDB0000195;HMDB0001178;HMDB0000189,78 (99),0.975,1,1.42e-05,0.000123
Chylomicron remodeling,Reactome,7,APOA1;APOA2;APOA4;APOB;APOC2;APOC3;APOE,9 (9),0.000213,0.00137,3,HMDB0000067;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,4 (7),0.0045,0.292,1.42e-05,0.000123
RAC1 signaling pathway,PID,26,ARHGDIA;MAP2K4;ABI1;MAPK14;NCKAP1;BRK1;CFL1;STAT3;PAK2;RAC1;CTNNA1;BAIAP2;CTNNB1;MAPK9;MAP2K3;CDH1;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;CRK;CYFIP2;IQGAP1;ARPC2,54 (54),9.82e-07,1.19e-05,0,,3 (3),1,1,1.46e-05,0.000125
Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids,SMPDB,8,ACADL;ACADS;ECHS1;ACAT1;ACAA2;HSD17B10;HADH;ACSS3,8 (8),1.59e-06,1.86e-05,2,HMDB0001166;HMDB0003944,19 (19),0.621,1,1.47e-05,0.000126
Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD),SMPDB,8,ACADL;ACADS;ECHS1;ACAT1;ACAA2;HSD17B10;HADH;ACSS3,8 (8),1.59e-06,1.86e-05,2,HMDB0001166;HMDB0003944,19 (19),0.621,1,1.47e-05,0.000126
Apoptotic cleavage of cellular proteins,Reactome,19,LMNA;LMNB1;FNTA;CASP3;DSG2;TJP2;VIM;DSP;GAS2;TJP1;CDH1;ROCK1;CASP6;SPTAN1;GSN;ACIN1;PLEC;DBNL;CTNNB1,38 (38),1.42e-05,0.000132,0,,0 (0),1,1,1.42e-05,0.000132
Smooth Muscle Contraction,Reactome,21,TPM1;CALM1;TPM3;TPM4;MYLK;PXN;GUCY1A1;SORBS3;GUCY1B1;ANXA1;ANXA2;MYL12A;SORBS1;MYH11;TLN1;ITGA1;VCL;ANXA6;MYL6;MYL9;CALD1,39 (39),1.05e-06,1.28e-05,0,,9 (9),1,1,1.55e-05,0.000133
Integrin-linked kinase signaling,PID,23,CDC37;RHOG;PARP1;LIMS1;ILK;XPO1;MYL9;RUVBL1;NACA;PARVA;CKAP5;PXN;ACTN1;DIAPH1;CTNNB1;CDC42;RUVBL2;TNS1;ZYX;RAC1;HSP90AA1;IQGAP1;LIMS2,45 (45),1.1e-06,1.32e-05,0,,3 (3),1,1,1.61e-05,0.000138
Ferroptosis,Wikipathways,21,ATG5;SAT2;ACSL1;PCBP1;PCBP2;STEAP3;GCLC;TF;ACSL5;CP;TFRC;LPCAT3;FTH1;GSS;VDAC2;HMOX1;VDAC3;SLC39A14;GCLM;ACSL4;GPX4,40 (40),1.82e-06,2.12e-05,2,HMDB0011130;HMDB0001043,19 (29),0.621,1,1.66e-05,0.000141
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met),PID,34,RHOA;EPS15;MAP2K4;RAP1A;RAP1B;PTPN11;DEPTOR;PXN;PTPRJ;MTOR;PIK3R1;EIF4E;HGS;SHC1;HRAS;GRB2;PAK2;NUMB;RAC1;NCK1;CTNNA1;MAPK1;CTNNB1;WASL;MAP2K1;MAP2K2;CDC42;CDH1;RAB5A;AKT1S1;CRK;CRKL;KPNB1;ARF6,81 (81),1.29e-06,1.55e-05,0,,4 (4),1,1,1.88e-05,0.000159
Mitochondrial complex III assembly,Wikipathways,11,LYRM7;CYC1;UQCR10;BCS1L;UQCC1;UQCRQ;UQCRB;UQCRC1;UQCRC2;UQCRFS1;UQCRH,16 (16),1.81e-05,0.000164,0,,0 (2),1,1,1.81e-05,0.000164
eukaryotic protein translation,BioCarta,11,EIF1;EIF5B;EIF3A;EIF6;EIF2S1;EIF4A1;EIF4A2;EIF4E;EIF4G1;EIF4G2;EIF2S2,16 (16),1.81e-05,0.000164,0,,0 (0),1,1,1.81e-05,0.000164
Methionine and cysteine metabolism,EHMN,33,MPST;CDO1;RANBP2;SLC25A12;NUP155;COPA;COPB1;SUOX;MAT2B;MAT2A;COPE;SLC25A13;NUP210;SLC25A10;FTH1;NUP98;NUP133;CP;COPG2;NUP93;NUP58;ACY1;CARS2;CBS;SLC26A1;NUP160;NAGS;TAT;ARCN1;GOT2;NUP35;AHCY;NUP205,78 (78),1.49e-06,1.77e-05,3,HMDB0000123;HMDB0011182;HMDB0033934,65 (80),0.977,1,2.1e-05,0.000178
Nuclear Envelope (NE) Reassembly,Reactome,33,TNPO1;TUBA1B;RAN;PPP2R1A;TUBB4B;PPP2R2A;RANGAP1;SIRT2;NUP160;NUP155;LMNA;UBE2I;KPNB1;VPS4A;TUBA1C;NUP98;NUP133;CHMP3;IST1;LMNB1;TMPO;RCC1;TUBB2B;NUP93;NUP58;CHMP4B;CHMP6;CHMP2A;TUBA4A;BANF1;NUP35;SEC13;NUP205,78 (78),1.49e-06,1.77e-05,0,,9 (12),1,1,2.14e-05,0.000181
NAD Biosynthesis II (from tryptophan),Wikipathways,8,NMNAT1;AFMID;HAAO;TDO2;KYNU;QPRT;KMO;NADSYN1,8 (8),1.59e-06,1.86e-05,0,,24 (24),1,1,2.29e-05,0.000192
2-oxobutanoate degradation,HumanCyc,8,PCCA;PCCB;DLD;BCKDHB;BCKDHA;MMUT;MCEE;DBT,8 (8),1.59e-06,1.86e-05,0,,13 (14),1,1,2.29e-05,0.000192
Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids,SMPDB,8,ACADM;ECHS1;ACAA2;SLC25A20;HADHA;HADHB;HADH;ACSM1,8 (8),1.59e-06,1.86e-05,0,,25 (25),1,1,2.29e-05,0.000192
superpathway of tryptophan utilization,HumanCyc,22,ADH6;AFMID;CYP1A2;IDO2;TDO2;NADSYN1;MAOA;MAOB;NMNAT1;POR;QPRT;UGT2B10;SULT1A1;HAAO;AKR1A1;ACMSD;ALDH3A2;DHTKD1;DDC;KYNU;KMO;NMNAT3,43 (43),1.83e-06,2.12e-05,4,HMDB0004095;HMDB0000472;HMDB0002281;HMDB0004259,59 (70),0.892,1,2.34e-05,0.000196
Vitamin B9 (folate) metabolism,EHMN,16,COPA;COPB1;SLC25A5;SHMT1;SLC25A22;AMT;SLC25A12;MTHFD1;COPG2;SHMT2;SLC25A4;ARCN1;SLC25A13;FTCD;COPE;MTHFS,26 (26),1.9e-06,2.19e-05,2,HMDB0000123;HMDB0033934,31 (35),0.861,1,2.35e-05,0.000196
EPHB-mediated forward signaling,Reactome,19,HRAS;ARPC4;LYN;YES1;CDC42;CFL1;ACTG1;ARPC5;ROCK1;ARPC3;ARPC1B;ACTR3;ACTR2;RHOA;RAC1;ARPC1A;ACTB;ARPC2;WASL,35 (35),2.93e-06,3.26e-05,1,HMDB0000123,8 (10),0.597,1,2.49e-05,0.000207
mRNA Splicing - Minor Pathway,Reactome,23,SNRNP200;SF3B3;SF3B1;SRSF1;SRSF6;SRSF7;SRSF2;POLR2A;SF3B6;SNRNP40;SNU13;NCBP1;PRPF6;PRPF8;SNRPB;SNRPD1;SNRPD2;SNRPD3;SNRPF;SNRPG;SF3B2;SF3B5;EFTUD2,52 (52),2.39e-05,0.000211,0,,0 (2),1,1,2.39e-05,0.000211
Statin inhibition of cholesterol production,Wikipathways,16,LRP1;DGAT1;APOA5;CYP7A1;FDFT1;APOA1;APOA2;APOA4;APOB;MTTP;SCARB1;LIPC;APOC2;APOC3;LCAT;APOE,31 (31),4.11e-05,0.000337,3,HMDB0000067;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,8 (17),0.0454,1,2.65e-05,0.00022
isoleucine degradation,HumanCyc,10,ECHS1;ACAT1;ACAT2;DLD;BCKDHA;BCKDHB;HSD17B10;HADHA;ACADSB;DBT,12 (12),2.56e-06,2.87e-05,1,HMDB0000172,14 (16),0.797,1,2.88e-05,0.000238
Methionine De Novo and Salvage Pathway,Wikipathways,14,MSRA;SRM;MAT2B;MSRB2;ENOPH1;MAT1A;MAT2A;BHMT;TAT;MRI1;ADI1;MTAP;CHDH;AHCY,21 (21),2.13e-06,2.43e-05,2,HMDB0033934;HMDB0000043,47 (48),0.969,1,2.91e-05,0.00024
cholesterol biosynthesis III (via desmosterol),HumanCyc,8,MSMO1;TM7SF2;HSD17B7;FDFT1;LSS;DHCR7;DHCR24;EBP,13 (13),0.000825,0.00467,8,HMDB0006842;HMDB0001286;HMDB0001188;HMDB0000067;HMDB0006271;HMDB0002719;HMDB0006927#HMDB0001181;HMDB0001251,24 (32),0.00251,0.18,2.92e-05,0.00024
Cholesterol biosynthesis,Reactome,12,HSD17B7;MSMO1;TM7SF2;MVK;ACAT2;FDFT1;LSS;DHCR7;DHCR24;EBP;IDI1;HMGCS1,25 (25),0.00089,0.00495,11,HMDB0006842;HMDB0001286;HMDB0000032;HMDB0001188;HMDB0001170;HMDB0000067;HMDB0006271;HMDB0006841;HMDB0002719;HMDB0001251;HMDB0001090,40 (46),0.00238,0.174,2.98e-05,0.000245
Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human),KEGG,32,GSTM1;ADH5;GSTM2;UGT1A3;GSTM4;GSTP1;GSTT1;GSTT2;ADH6;EPHX1;MGST1;MGST2;MGST3;GSTK1;HPGDS;GSTA5;CYP1A2;UGT2A3;UGT2A1;AKR7A3;UGT2B10;UGT2B15;CYP2E1;HSD11B1;GSTO1;CBR1;AKR1C1;GSTA1;GSTA2;GSTA3;GSTA4;AKR7A2,76 (78),2.42e-06,2.75e-05,1,HMDB0001934,95 (121),1,1,3.37e-05,0.000277
Folding of actin by CCT/TriC,Reactome,9,CCT3;CCT5;TCP1;CCT8;CCT6A;CCT7;CCT4;CCT2;ACTB,10 (10),2.49e-06,2.82e-05,0,,3 (3),1,1,3.46e-05,0.000283
NAD <i>de novo</i> biosynthesis,HumanCyc,10,NMNAT1;AFMID;HAAO;IDO2;KYNU;QPRT;KMO;TDO2;NADSYN1;NMNAT3,12 (12),2.56e-06,2.87e-05,0,,23 (24),1,1,3.55e-05,0.000288
how does salmonella hijack a cell,BioCarta,10,ACTR3;CDC42;ARPC4;ARPC3;ARPC1B;WASL;ACTR2;RAC1;ARPC1A;ARPC2,12 (12),2.56e-06,2.87e-05,0,,2 (2),1,1,3.55e-05,0.000288
Oxidation of Branched Chain Fatty Acids,SMPDB,10,CPT2;ACSL1;CRAT;PEX13;PEX14;HACL1;PHYH;SLC25A20;CROT;ABCD1,12 (12),2.56e-06,2.87e-05,0,,23 (25),1,1,3.55e-05,0.000288
Alanine and aspartate metabolism,Wikipathways,10,ASPA;DARS1;AGXT;ABAT;ASL;GOT1;GOT2;GPT;ASS1;PC,12 (12),2.56e-06,2.87e-05,0,,19 (20),1,1,3.55e-05,0.000288
Urokinase Action Pathway,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,1,HMDB0000015,4 (4),0.365,1,3.84e-05,0.000302
Reteplase Action Pathway,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,1,HMDB0000015,4 (4),0.365,1,3.84e-05,0.000302
Streptokinase Action Pathway,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,1,HMDB0000015,4 (4),0.365,1,3.84e-05,0.000302
Tenecteplase Action Pathway,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,1,HMDB0000015,4 (4),0.365,1,3.84e-05,0.000302
Alteplase Action Pathway,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,1,HMDB0000015,4 (4),0.365,1,3.84e-05,0.000302
Anistreplase Action Pathway,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,1,HMDB0000015,4 (4),0.365,1,3.84e-05,0.000302
Aprotinin Action Pathway,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,1,HMDB0000015,4 (4),0.365,1,3.84e-05,0.000302
Acenocoumarol Action Pathway,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,1,HMDB0000015,4 (5),0.365,1,3.84e-05,0.000302
Coagulation ,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,1,HMDB0000015,4 (4),0.365,1,3.84e-05,0.000302
Bivalirudin Action Pathway,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,1,HMDB0000015,4 (4),0.365,1,3.84e-05,0.000302
Phenprocoumon Action Pathway,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,1,HMDB0000015,4 (5),0.365,1,3.84e-05,0.000302
Ximelagatran Action Pathway,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,1,HMDB0000015,4 (5),0.365,1,3.84e-05,0.000302
Lepirudin Action Pathway,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,1,HMDB0000015,4 (4),0.365,1,3.84e-05,0.000302
Ferroptosis - Homo sapiens (human),KEGG,21,ATG5;SAT2;ACSL1;PCBP1;ACSL4;TFRC;STEAP3;GCLC;GCLM;PCBP2;CP;GSS;LPCAT3;FTH1;ACSL5;VDAC2;HMOX1;VDAC3;SLC39A14;TF;GPX4,41 (41),3.07e-06,3.38e-05,1,HMDB0001043,21 (31),0.909,1,3.85e-05,0.000302
Alpha Linolenic Acid and Linoleic Acid Metabolism,SMPDB,3,FADS1;ELOVL5;FADS2,6 (6),0.0854,0.234,9,HMDB0006246;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0003073;HMDB0001388;HMDB0006528;HMDB0001043;HMDB0001976;HMDB0002177;HMDB0002183,18 (18),3.37e-05,0.0149,3.96e-05,0.00031
Detoxification of Reactive Oxygen Species,Reactome,19,TXNRD1;PRDX5;TXN2;GSTP1;ERO1A;GPX1;P4HB;SOD1;PRDX3;CAT;SOD2;PRDX6;CCS;AQP8;GSR;PRDX2;TXNRD2;PRDX1;NUDT2,35 (35),2.93e-06,3.26e-05,0,,20 (24),1,1,4.03e-05,0.000314
Complement and coagulation cascades - Homo sapiens (human),KEGG,32,CFH;CFHR1;SERPINA1;VTN;SERPING1;CLU;C8B;FGA;FGB;CD59;C3;C4A;C4BPA;F2;SERPINC1;C5;FGG;C8A;PLG;C9;SERPINF2;CFI;CR1L;ITGB2;KLKB1;SERPIND1;F9;F11;F12;F13A1;KNG1;CFB,85 (85),3.8e-05,0.000319,0,,0 (1),1,1,3.8e-05,0.000319
VEGFR3 signaling in lymphatic endothelium,PID,14,SHC1;GRB2;ITGB1;PIK3R1;MAP2K4;MAPK14;RPS6KA1;COL1A2;CRK;ITGA1;MAPK1;COL1A1;ITGA5;FN1,25 (25),3.81e-05,0.000319,0,,0 (0),1,1,3.81e-05,0.000319
Interactions of Vpr with host cellular proteins,Reactome,18,PSIP1;NUP98;NUP133;SLC25A4;SLC25A5;TPR;KPNA1;NUP160;BANF1;RAE1;NUP210;NUP93;NUP35;NUP58;RANBP2;SEC13;NUP205;NUP155,37 (37),3.84e-05,0.000321,0,,0 (1),1,1,3.84e-05,0.000321
Influenza Infection,Reactome,22,KPNA4;TPR;RAN;RANBP2;NUP58;NUP155;RAE1;KPNB1;PABPN1;NUP210;NUP98;NUP133;NUP93;XPO1;SEC13;EIF2AK2;NUP160;NUP35;KPNA1;NUP205;KPNA2;KPNA3,44 (44),3.02e-06,3.35e-05,0,,8 (12),1,1,4.14e-05,0.000322
Pentose phosphate cycle,INOH,15,ALDOA;FBP1;PGLS;ALDOB;GPI;TALDO1;PGD;UMPS;TKT;RBKS;PGM1;RPIA;H6PD;PFKL;PPAT,24 (24),3.05e-06,3.37e-05,0,,28 (31),1,1,4.18e-05,0.000324
DNA Damage Recognition in GG-NER,Reactome,15,CUL4B;CUL4A;COPS6;COPS2;COPS8;DDB1;COPS5;COPS4;PARP1;COPS3;GPS1;RBX1;COPS7A;RAD23A;RAD23B,24 (24),3.05e-06,3.37e-05,0,,2 (3),1,1,4.18e-05,0.000324
Tranexamic Acid Action Pathway,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,1,HMDB0000015,5 (5),0.433,1,4.5e-05,0.000345
Phenindione Action Pathway,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,1,HMDB0000015,5 (5),0.433,1,4.5e-05,0.000345
Dicoumarol Action Pathway,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,1,HMDB0000015,5 (5),0.433,1,4.5e-05,0.000345
Warfarin Action Pathway,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,1,HMDB0000015,5 (5),0.433,1,4.5e-05,0.000345
Argatroban Action Pathway,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,1,HMDB0000015,5 (5),0.433,1,4.5e-05,0.000345
Dicumarol Action Pathway,SMPDB,13,F2;FGB;KLKB1;F9;F11;F12;F13A1;FGA;GGCX;VKORC1;FGG;PLG;COL1A1,20 (20),7.63e-06,7.46e-05,1,HMDB0000015,5 (5),0.433,1,4.5e-05,0.000345
RNA Polymerase II Transcription Termination,Reactome,29,SRRM1;U2AF1;SNRPB;THOC7;MAGOH;SRSF1;SRSF2;SRSF3;SRSF4;SRSF5;SRSF6;SRSF7;RNPS1;PABPN1;NUDT21;EIF4A3;CPSF1;U2AF2;ALYREF;NCBP1;RBM8A;SARNP;DDX39A;SNRPD3;SNRPF;SNRPG;DDX39B;THOC5;CPSF7,67 (67),3.66e-06,4.01e-05,0,,1 (6),1,1,4.94e-05,0.000377
Class I peroxisomal membrane protein import,Reactome,12,ATAD1;ABCD3;PXMP2;PEX2;PEX13;PEX14;ALDH3A2;SLC25A17;FIS1;ABCD1;PEX3;ACBD5,20 (20),5.51e-05,0.000426,0,,0 (0),1,1,5.51e-05,0.000426
Cargo recognition for clathrin-mediated endocytosis,Reactome,38,EPS15;STAM2;EPS15L1;AP2M1;AP2S1;UBQLN2;NECAP2;GRB2;AP2A1;AP2A2;AP2B1;EGFR;COPS8;SCARB2;GPS1;HGS;CLTA;VAMP2;CLTC;COPS4;TOR1A;APOB;COPS3;UBQLN1;COPS6;FCHO2;VAMP8;EPN1;COPS2;CLTB;TF;COPS5;PICALM;TFRC;M6PR;NECAP1;TGOLN2;COPS7A,105 (105),2.13e-05,0.000191,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,8 (10),0.209,1,5.92e-05,0.00045
superpathway of choline degradation to L-serine,HumanCyc,7,SHMT1;DMGDH;SHMT2;ALDH7A1;BHMT;SARDH;CHDH,7 (7),8.46e-06,8.17e-05,2,HMDB0000123;HMDB0000043,16 (16),0.525,1,5.92e-05,0.00045
mRNA surveillance pathway - Homo sapiens (human),KEGG,35,SRRM1;TARDBP;DDX19A;PPP2R1A;HBS1L;PPP2R2A;MAGOH;PPP2R5A;PPP2R5D;PPP2R5E;DAZAP1;PNN;RNPS1;PABPN1;NUDT21;CPSF6;EIF4A3;ACIN1;PABPC4;ETF1;CPSF1;PPP2CB;UPF2;NCBP1;ALYREF;RBM8A;UPF1;FUS;PABPC1;CPSF7;DDX39B;GSPT1;PPP1CA;PPP1CB;PPP1CC,98 (98),6.08e-05,0.000463,0,,0 (0),1,1,6.08e-05,0.000463
Tyrosine metabolism,INOH,18,ADH5;MAOB;ADH6;MAOA;FAH;HGD;GSTZ1;DDC;COMT;ADHFE1;TAT;SDHA;SDHB;SDHC;SDHD;ALDH1A3;HPD;FH,33 (33),4.89e-06,5.29e-05,2,HMDB0000318;HMDB0033934,43 (44),0.954,1,6.2e-05,0.00047
Signaling by BRAF and RAF fusions,Reactome,27,LSR;RAP1A;RAP1B;FXR1;ITGA2B;FN1;LMNA;CALM1;SND1;CSK;CAMK2A;CAMK2D;TLN1;MAPK1;FGA;FGB;AGK;FGG;AP3B1;MAP2K1;MAP2K2;ITGB3;ARAF;VCL;IQGAP1;MPRIP;ZC3HAV1,61 (61),4.7e-06,5.12e-05,0,,6 (9),1,1,6.23e-05,0.000472
Selenocompound metabolism - Homo sapiens (human),KEGG,12,TXNRD1;TXNRD2;PAPSS2;INMT;KYAT3;MARS1;SEPHS2;SEPHS1;CTH;SCLY;KYAT1;SEPSECS,17 (17),4.77e-06,5.17e-05,0,,16 (27),1,1,6.33e-05,0.000477
CD4 T cell receptor signaling,INOH,46,PSMD6;PPP3CA;GRB2;CALM1;UBE2N;UBE2V1;PIK3R1;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;HRAS;PSMB9;PSMB10;PSMC1;PSMC2;PSMC3;PSMC4;PSMC5;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;MAPK1;MAPK9;MAP2K1;MAP2K2;RELA;ARAF;RAC1,132 (132),9.67e-06,9.3e-05,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,6 (7),0.494,1,6.33e-05,0.000477
RHO GTPase Effectors,Reactome,91,MYH9;MYH11;MYL6;MYLK;NCKAP1;IQGAP2;BRK1;CFL1;ACTB;CKAP5;ACTG1;NCK1;RPS27;PFN1;ITGB1;RCC2;IQGAP1;PIK3R4;S100A8;S100A9;ARPC5;ARPC4;YWHAZ;CYFIP1;NDEL1;MYL9;H2AX;PIN1;GOPC;DIAPH1;KIF5B;BAIAP2;YWHAQ;NUP160;DYNC1H1;DYNC1I2;PKN3;RAC1;SEC13;FLNA;RANBP2;WASL;RANGAP1;ABI1;RHOD;CALM1;RHOG;KTN1;ARPC1A;NUP98;GRB2;XPO1;KLC4;CDC42;YWHAB;YWHAE;YWHAG;YWHAH;ARPC3;ARPC1B;ACTR3;ACTR2;CYFIP2;PPP1CB;PPP1CC;RHOA;MAPRE1;PPP2CB;ARPC2;PPP2R1A;MAPK14;PPP2R5A;PPP2R5D;PPP2R5E;MYH14;PAFAH1B1;DYNLL2;NUP133;PAK2;DYNC1LI1;PRKCA;DYNC1LI2;ROCK1;CTNNA1;MAPK1;CTNNB1;ZW10;BUB3;CTTN;NUDC;CDH1,313 (314),6.42e-06,6.79e-05,2,HMDB0000234;HMDB0001043,24 (29),0.746,1,6.35e-05,0.000477
HDL remodeling,Reactome,6,APOA1;ALB;APOC2;APOC3;LCAT;APOE,9 (9),0.00223,0.0109,5,HMDB0000067;HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,10 (13),0.00219,0.163,6.47e-05,0.000484
Purine nucleotides nucleosides metabolism,INOH,40,GMPS;GUK1;ADK;RRM1;GDA;NUDT5;ADSL;IMPDH2;GUCY1A1;GUCY1B1;NT5E;HPRT1;GART;NME2;ENTPD5;NUDT2;PKLR;NT5C2;PKM;XDH;AK2;AK4;PFAS;PPAT;GCH1;ATIC;PAPSS2;NT5C3A;AMPD2;GMPR2;NME1;NUDT9;NME3;APRT;TYMP;ADA;PAICS;NT5C;ITPA;PNP,107 (107),5.27e-06,5.62e-05,5,HMDB0001178;HMDB0000195;HMDB0000123;HMDB0033934;HMDB0000189,77 (80),0.929,1,6.48e-05,0.000484
Signaling downstream of RAS mutants,Reactome,21,CALM1;IQGAP1;FGA;ITGA2B;MAP2K2;HRAS;YWHAB;ITGB3;ARAF;VCL;CAMK2A;CAMK2D;RAP1A;RAP1B;MAP2K1;TLN1;FGB;FGG;CSK;MAPK1;FN1,42 (42),5.06e-06,5.4e-05,0,,6 (9),1,1,6.67e-05,0.000494
Signaling by RAS mutants,Reactome,21,CALM1;IQGAP1;FGA;ITGA2B;MAP2K2;HRAS;YWHAB;ITGB3;ARAF;VCL;CAMK2A;CAMK2D;RAP1A;RAP1B;MAP2K1;TLN1;FGB;FGG;CSK;MAPK1;FN1,42 (42),5.06e-06,5.4e-05,0,,6 (9),1,1,6.67e-05,0.000494
Signaling by moderate kinase activity BRAF mutants,Reactome,21,CALM1;IQGAP1;FGA;ITGA2B;MAP2K2;HRAS;YWHAB;ITGB3;ARAF;VCL;CAMK2A;CAMK2D;RAP1A;RAP1B;MAP2K1;TLN1;FGB;FGG;FN1;MAPK1;CSK,42 (42),5.06e-06,5.4e-05,0,,6 (9),1,1,6.67e-05,0.000494
Paradoxical activation of RAF signaling by kinase inactive BRAF,Reactome,21,CALM1;IQGAP1;FGA;ITGA2B;MAP2K2;HRAS;YWHAB;ITGB3;ARAF;VCL;CAMK2A;CAMK2D;RAP1A;RAP1B;MAP2K1;TLN1;FGB;FGG;CSK;MAPK1;FN1,42 (42),5.06e-06,5.4e-05,0,,6 (10),1,1,6.67e-05,0.000494
Signaling by RAF1 mutants,Reactome,21,CALM1;IQGAP1;FGA;ITGA2B;MAP2K2;HRAS;YWHAB;ITGB3;ARAF;VCL;CAMK2A;CAMK2D;RAP1A;RAP1B;MAP2K1;TLN1;FGB;FGG;FN1;MAPK1;CSK,42 (42),5.06e-06,5.4e-05,0,,6 (9),1,1,6.67e-05,0.000494
COPI-dependent Golgi-to-ER retrograde traffic,Reactome,33,KIF13B;NBAS;ARFGAP2;BNIP1;GBF1;COPA;COPB1;NAPG;NSF;USE1;ARFGAP3;COPE;SURF4;ARFGAP1;KDELR1;TMED7;NAPA;TMED9;COPZ1;COPG2;TMED2;SEC22B;RAB1B;KIF5B;TMED10;ZW10;KLC4;RAB1A;KIF1C;ARCN1;ARF1;ARF4;ARF5,82 (82),5.56e-06,5.9e-05,0,,4 (5),1,1,7.28e-05,0.000537
insulin Mam,INOH,33,PPP2R1A;PTPA;PPP2R5A;PPP2R5D;PPP2R5E;MAPK1;GRB2;MTOR;PIK3R1;RPS6;EIF4A1;EIF4A2;EIF4E;PRKAA1;PRKAA2;PRKAB1;EIF4G1;SHC1;HRAS;PRKAG1;GYS2;FKBP8;YWHAQ;MAP2K1;MAP2K2;FKBP1A;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;AKT1S1;RHEB,82 (82),5.56e-06,5.9e-05,0,,6 (7),1,1,7.28e-05,0.000537
Disulfiram Action Pathway,SMPDB,15,MAOA;COMT;CYP2E1;FAH;HGD;GSTZ1;DDC;CAT;HAAO;TAT;GOT1;MIF;ALDH1B1;HPD;ACSS2,25 (25),6.29e-06,6.66e-05,5,HMDB0001229;HMDB0000318;HMDB0033934;HMDB0002281;HMDB0004067,72 (77),0.9,1,7.41e-05,0.000545
FOXA2 and FOXA3 transcription factor networks,PID,20,CHKB;PKLR;ACADM;F2;HNF4A;ACADVL;ALB;TTR;TAT;BDH1;APOA1;ALDOB;PCK1;SLC2A2;HMGCS1;HADH;NR3C1;TFRC;CPT1A;GCK,45 (45),7.39e-05,0.000551,0,,0 (0),1,1,7.39e-05,0.000551
Biosynthesis of unsaturated fatty acids - Homo sapiens (human),KEGG,14,ELOVL5;ACOT7;SCP2;HACD3;HSD17B12;FADS2;ACOX1;TECR;ACOT2;ACOX3;FADS1;ACOT4;BAAT;HSD17B4,27 (27),0.000117,0.000834,8,HMDB0006519;HMDB0000944;HMDB0005060;HMDB0003073;HMDB0001388;HMDB0006528;HMDB0001043;HMDB0002183,39 (74),0.0508,1,7.76e-05,0.000569
Hyperornithinemia with gyrate atrophy (HOGA),SMPDB,13,CKB;GAMT;GOT1;DAO;ALDH4A1;CPS1;OTC;ASL;OAT;SLC25A15;GLUD1;ASS1;ARG1,20 (20),7.63e-06,7.46e-05,4,HMDB0240251;HMDB0000123;HMDB0033934;HMDB0002104,52 (52),0.826,1,8.18e-05,0.000585
Creatine deficiency_ guanidinoacetate methyltransferase deficiency,SMPDB,13,CKB;GAMT;GOT1;DAO;ALDH4A1;CPS1;OTC;ASL;OAT;SLC25A15;GLUD1;ASS1;ARG1,20 (20),7.63e-06,7.46e-05,4,HMDB0240251;HMDB0000123;HMDB0033934;HMDB0002104,52 (52),0.826,1,8.18e-05,0.000585
L-arginine:glycine amidinotransferase deficiency,SMPDB,13,CKB;GAMT;GOT1;DAO;ALDH4A1;CPS1;OTC;ASL;OAT;SLC25A15;GLUD1;ASS1;ARG1,20 (20),7.63e-06,7.46e-05,4,HMDB0240251;HMDB0000123;HMDB0033934;HMDB0002104,52 (52),0.826,1,8.18e-05,0.000585
Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome],SMPDB,13,CKB;GAMT;GOT1;DAO;ALDH4A1;CPS1;OTC;ASL;OAT;SLC25A15;GLUD1;ASS1;ARG1,20 (20),7.63e-06,7.46e-05,4,HMDB0240251;HMDB0000123;HMDB0033934;HMDB0002104,52 (52),0.826,1,8.18e-05,0.000585
Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency),SMPDB,13,CKB;GAMT;GOT1;DAO;ALDH4A1;CPS1;OTC;ASL;OAT;SLC25A15;GLUD1;ASS1;ARG1,20 (20),7.63e-06,7.46e-05,4,HMDB0240251;HMDB0000123;HMDB0033934;HMDB0002104,52 (52),0.826,1,8.18e-05,0.000585
Prolinemia Type II,SMPDB,13,CKB;GAMT;GOT1;DAO;ALDH4A1;CPS1;OTC;ASL;OAT;SLC25A15;GLUD1;ASS1;ARG1,20 (20),7.63e-06,7.46e-05,4,HMDB0240251;HMDB0000123;HMDB0033934;HMDB0002104,52 (52),0.826,1,8.18e-05,0.000585
Prolidase Deficiency (PD),SMPDB,13,CKB;GAMT;GOT1;DAO;ALDH4A1;CPS1;OTC;ASL;OAT;SLC25A15;GLUD1;ASS1;ARG1,20 (20),7.63e-06,7.46e-05,4,HMDB0240251;HMDB0000123;HMDB0033934;HMDB0002104,52 (52),0.826,1,8.18e-05,0.000585
Arginine and Proline Metabolism,SMPDB,13,CKB;GAMT;GOT1;DAO;ALDH4A1;CPS1;OTC;ASL;OAT;SLC25A15;GLUD1;ASS1;ARG1,20 (20),7.63e-06,7.46e-05,4,HMDB0240251;HMDB0000123;HMDB0033934;HMDB0002104,52 (52),0.826,1,8.18e-05,0.000585
Hyperprolinemia Type I,SMPDB,13,CKB;GAMT;GOT1;DAO;ALDH4A1;CPS1;OTC;ASL;OAT;SLC25A15;GLUD1;ASS1;ARG1,20 (20),7.63e-06,7.46e-05,4,HMDB0240251;HMDB0000123;HMDB0033934;HMDB0002104,52 (52),0.826,1,8.18e-05,0.000585
Hyperprolinemia Type II,SMPDB,13,CKB;GAMT;GOT1;DAO;ALDH4A1;CPS1;OTC;ASL;OAT;SLC25A15;GLUD1;ASS1;ARG1,20 (20),7.63e-06,7.46e-05,4,HMDB0240251;HMDB0000123;HMDB0033934;HMDB0002104,52 (52),0.826,1,8.18e-05,0.000585
Ornithine Aminotransferase Deficiency (OAT Deficiency),SMPDB,13,CKB;GAMT;GOT1;DAO;ALDH4A1;CPS1;OTC;ASL;OAT;SLC25A15;GLUD1;ASS1;ARG1,20 (20),7.63e-06,7.46e-05,4,HMDB0240251;HMDB0000123;HMDB0033934;HMDB0002104,52 (52),0.826,1,8.18e-05,0.000585
Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency),SMPDB,13,CKB;GAMT;GOT1;DAO;ALDH4A1;CPS1;OTC;ASL;OAT;SLC25A15;GLUD1;ASS1;ARG1,20 (20),7.63e-06,7.46e-05,4,HMDB0240251;HMDB0000123;HMDB0033934;HMDB0002104,52 (52),0.826,1,8.18e-05,0.000585
Fragile X Syndrome,Wikipathways,43,GPHN;CYFIP1;ABAT;PTPN11;AP2S1;AGO2;PPP3CA;DEPTOR;PRKAR1A;AP2A1;AP2B1;SLC16A1;MTOR;CAMK2A;PDK1;TECR;EIF4A1;EIF4E;CLTA;CLTB;EIF4G1;PRKACA;DUSP3;SHC1;ABCD3;GRB2;PRKCA;CLTC;DNM2;CAMK1;MAPK1;CPT1A;ALDH3A2;EEF1A1;MAP2K1;MAP2K2;ALDH5A1;AKT1S1;ARAF;CYFIP2;RHEB;PPP1CA;AP2M1,119 (119),6.58e-06,6.93e-05,0,,3 (6),1,1,8.5e-05,0.000607
Trans-sulfuration and one-carbon metabolism,Wikipathways,17,MAT2A;BHMT;SHMT1;MAT2B;SHMT2;GCLC;GCLM;CBS;CTH;MAT1A;AHCYL1;AMT;DHFR;GSS;PSPH;MTHFD1;AHCY,31 (31),8.17e-06,7.95e-05,2,HMDB0000123;HMDB0000043,31 (33),0.861,1,9.05e-05,0.000645
sarcosine oncometabolite pathway ,SMPDB,10,GNMT;DMGDH;SHMT1;MAT2B;SHMT2;MAT2A;CHDH;BHMT;SARDH;ALDH7A1,13 (13),9.2e-06,8.86e-05,2,HMDB0000123;HMDB0000043,25 (26),0.767,1,9.08e-05,0.000645
Purine metabolism,EHMN,69,TUFM;ATP5PB;ATP5F1D;MPO;ATP5MG;ATP5ME;ATP5PF;ATP6V1A;NT5C2;ATP6V1B2;RANBP2;ATP6V1E1;SLC29A1;ATP6V0A1;ATP5PO;SLC25A12;MT-ATP8;NUP155;COPA;COPB1;COPE;GUCY1A1;GUCY1B1;NT5E;POLE;NT5C3A;RRM2B;SLC25A13;POLR2A;NUP210;SLC25A10;ENTPD5;NUP98;NUP133;PKM;TCIRG1;PRDX6;XDH;AK2;AK4;COPG2;ATP5MF;KPNA6;DGUOK;PNPT1;DNM2;NUP93;NUP58;ATP1A1;NME1;NME2;ENTPD8;ATP1B1;TYMP;ATP1B3;GFM1;ATP2A2;ATP2B1;ATP5PD;SLC25A17;NUP160;NT5C;ATP5F1A;ARCN1;AK3;NUP35;ATP5F1B;NUP205;XPO7,222 (222),7.36e-06,7.46e-05,4,HMDB0000195;HMDB0000123;HMDB0033934;HMDB0000189,86 (94),0.987,1,9.33e-05,0.000662
Chemical carcinogenesis - Homo sapiens (human),KEGG,33,GSTM1;ADH5;GSTM2;UGT1A3;EPHX1;GSTP1;CYP1A2;NAT1;ADH6;GSTM4;SULT1A1;MGST2;MGST3;GSTK1;HPGDS;GSTA5;GSTT1;UGT2A3;GSTT2;UGT2A1;UGT2B10;UGT2B15;MGST1;KYAT3;CYP2E1;HSD11B1;GSTO1;CBR1;KYAT1;GSTA1;GSTA2;GSTA3;GSTA4,83 (83),7.57e-06,7.46e-05,2,HMDB0031419;HMDB0013195,57 (99),0.988,1,9.58e-05,0.000678
Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD),SMPDB,7,PPT1;ECHS1;ACAA2;HSD17B10;HADHA;HADHB;MECR,7 (7),8.46e-06,8.17e-05,1,HMDB0003944,34 (34),0.979,1,0.000105,0.000742
Fatty Acid Elongation In Mitochondria,SMPDB,7,PPT1;ECHS1;ACAA2;HSD17B10;HADHA;HADHB;MECR,7 (7),8.46e-06,8.17e-05,1,HMDB0003944,34 (34),0.979,1,0.000105,0.000742
Fructose metabolism,Reactome,7,ALDOB;AKR1B1;KHK;TKFC;ALDH1A1;SORD;GLYCTK,7 (7),8.46e-06,8.17e-05,0,,16 (20),1,1,0.000107,0.000755
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,Reactome,12,AP2A1;AP2A2;AP1B1;AP2B1;AP1G1;ATP6V1H;AP1M1;B2M;ARF1;AP2M1;AP1S1;AP2S1,21 (21),0.000107,0.000769,0,,0 (0),1,1,0.000107,0.000769
Translation inhibitors in chronically activated PDGFRA cells,Wikipathways,20,MAPK9;PDK1;MAP2K1;MAP2K2;MAP2K3;PRKCA;MTOR;RPS6;PIK3R1;MAP2K4;CSNK2A1;PDCD4;RPS6KA1;EIF4A1;EIF4A2;MAPK14;EIF4E;MAPK1;EIF4G1;PRKACA,46 (46),0.000108,0.000776,0,,0 (2),1,1,0.000108,0.000776
Oxidative Stress,Wikipathways,16,MAOA;TXNRD1;MAPK14;TXN2;MGST1;GCLC;XDH;NQO1;CAT;GSTT2;GSR;SOD1;SOD2;HMOX1;TXNRD2;GPX1,33 (33),0.000109,0.000782,0,,0 (1),1,1,0.000109,0.000782
CD4 T cell receptor signaling-NFkB cascade,INOH,36,PSMD6;UBE2N;UBE2V1;PIK3R1;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;PSMB10;PSMC1;PSMC2;PSMC3;PSMC4;PSMC5;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;RELA,99 (99),3.08e-05,0.000264,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,3 (4),0.289,1,0.000112,0.000789
Complement system,Wikipathways,34,CFH;RPS19;VTN;C1QBP;FGG;CD59;CALR;CSNK1A1;ICAM1;PRKACA;FGA;FGB;APCS;SERPING1;PRKCA;CFI;C3;APOA1;C4A;C4BPA;GNAI2;ALB;C5;ITGA2B;C8A;PLG;C9;DCN;KLKB1;FKBP2;F13A1;CFB;ITGB3;GNAI3,93 (93),4.46e-05,0.00036,1,HMDB0000693,2 (5),0.203,1,0.000114,0.000801
Platelet activation - Homo sapiens (human),KEGG,42,STIM1;RHOA;GNAS;RAP1A;MYL12A;RAP1B;MAPK14;FGG;MYLK;LYN;GUCY1A1;GUCY1B1;PIK3R1;GNA13;TLN1;ACTB;PRKACA;PRKACB;MAPK1;FGA;FGB;ARHGEF12;ACTG1;TLN2;ROCK1;PLCB3;GNAI3;PPP1CC;GNAQ;ITGA2B;VAMP8;F2;ITGB1;ITGB3;PTGS1;ITPR2;GNAI2;FERMT3;PPP1CA;PPP1CB;COL1A1;COL1A2,124 (124),4.99e-05,0.000393,3,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0001043;HMDB0003208,14 (14),0.184,1,0.000115,0.000807
cholesterol biosynthesis II (via 24_25-dihydrolanosterol),HumanCyc,8,MSMO1;TM7SF2;HSD17B7;FDFT1;LSS;DHCR7;DHCR24;EBP,13 (13),0.000825,0.00467,6,HMDB0001170;HMDB0001251;HMDB0001188;HMDB0000032;HMDB0000067;HMDB0006841,19 (32),0.0117,0.643,0.000121,0.000846
Nicotinate Nicotinamide metabolism,INOH,14,NT5C3A;NMNAT1;NADK;NNMT;NT5C;NT5E;NT5C2;ENPP1;ENPP3;QPRT;NAMPT;NADSYN1;CD38;PNP,23 (23),1.02e-05,9.78e-05,1,HMDB0001178,26 (26),0.948,1,0.000122,0.000848
Mitochondrial biogenesis,Reactome,24,ATP5F1D;ATP5PB;ATP5MG;ATP5ME;ATP5PF;MAPK14;ATP5PO;MT-ATP8;CALM1;SIRT3;GLUD1;PRKAA2;PRKAB1;PRKAG1;ATP5MF;IDH2;ACSS2;DMAC2L;TFAM;ATP5PD;SIRT5;ATP5F1A;SOD2;ATP5F1B,53 (53),9.75e-06,9.35e-05,0,,7 (8),1,1,0.000122,0.00085
RHOBTB1 GTPase cycle,Reactome,14,COPS4;TRA2B;CUL3;MYO6;COPS2;VIM;TXNL1;SRRM1;ROCK1;CCT7;HNRNPC;CCT2;GPS1;CPSF7,23 (23),1.02e-05,9.78e-05,0,,1 (1),1,1,0.000128,0.000887
Glycogen Synthesis and Degradation,Wikipathways,18,UGP2;PGM1;GYG1;CALM1;GBE1;PHKB;PYGB;PYGL;PHKG2;PPP2R1A;PPP2R2A;AGL;PTPA;PPP2R5A;GYS2;PPP2R5D;PPP2R5E;PPP2CB,36 (36),2.39e-05,0.000211,1,HMDB0000757,5 (6),0.433,1,0.000129,0.000896
Binding and Uptake of Ligands by Scavenger Receptors,Reactome,20,ALB;AMBP;COL4A2;HSPH1;HP;CALR;HYOU1;APOA1;HSP90B1;STAB2;APOB;LRP1;CD163;SCARB1;HSP90AA1;FTH1;APOE;COL1A1;COL1A2;HPX,42 (42),2.14e-05,0.000191,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,15 (41),0.49,1,0.000131,0.000904
Vitamin B3 (nicotinate and nicotinamide) metabolism,EHMN,22,NUP133;RANBP2;NUP155;NMNAT1;NT5E;ENPP1;ENPP3;NT5C3A;CD38;NUP210;CYB5R3;NUP98;NT5C2;NADK;NUP93;NUP58;NNT;NUP160;NT5C;NUP35;NMNAT3;NUP205,47 (47),1.18e-05,0.000111,1,HMDB0001178,33 (36),0.977,1,0.000143,0.000986
Formation of ATP by chemiosmotic coupling,Reactome,12,ATP5F1D;ATP5PB;DMAC2L;ATP5MG;ATP5ME;ATP5PF;ATP5PD;ATP5MF;ATP5F1A;ATP5F1B;ATP5PO;MT-ATP8,18 (18),1.19e-05,0.000111,0,,5 (5),1,1,0.000146,0.000998
Fructose intolerance_ hereditary,SMPDB,12,GFUS;ALDOA;FBP1;GMPPB;AKR1B1;TPI1;ALDOB;KHK;HK1;PFKL;SORD;MPI,18 (18),1.19e-05,0.000111,0,,28 (31),1,1,0.000146,0.000998
Fatty acid biosynthesis - Homo sapiens (human),KEGG,12,ACACB;ACSL1;CBR4;ACSL4;ACSF3;FASN;OXSM;MCAT;ACSL5;HSD17B8;MECR;ACACA,18 (18),1.19e-05,0.000111,0,,10 (58),1,1,0.000146,0.000998
Fructose and Mannose Degradation,SMPDB,12,GFUS;ALDOA;FBP1;GMPPB;AKR1B1;TPI1;ALDOB;KHK;HK1;PFKL;SORD;MPI,18 (18),1.19e-05,0.000111,0,,28 (31),1,1,0.000146,0.000998
Fructosuria,SMPDB,12,GFUS;ALDOA;FBP1;GMPPB;AKR1B1;TPI1;ALDOB;KHK;HK1;PFKL;SORD;MPI,18 (18),1.19e-05,0.000111,0,,28 (31),1,1,0.000146,0.000998
tryptophan degradation,HumanCyc,8,AFMID;DHTKD1;HAAO;IDO2;KYNU;KMO;TDO2;ACMSD,9 (9),1.19e-05,0.000112,0,,21 (22),1,1,0.000147,0.001
Beta-oxidation of pristanoyl-CoA,Reactome,8,ACOX2;SCP2;CROT;AMACR;CRAT;ACOT8;ACOX3;HSD17B4,9 (9),1.19e-05,0.000112,0,,17 (21),1,1,0.000147,0.001
Metabolism of porphyrins,Reactome,16,FECH;BLVRA;BLVRB;HMBS;GSTA1;COX15;SLCO2B1;UROD;ALAD;CPOX;ALB;FABP1;HMOX1;HMOX2;ABCC2;PPOX,29 (29),1.36e-05,0.000127,2,HMDB0000054;HMDB0000123,34 (43),0.894,1,0.00015,0.00102
RHOG GTPase cycle,Reactome,30,VAPB;RHOG;ARHGAP1;ARHGDIA;ARHGDIB;CYFIP1;STX5;YKT6;LMAN1;STBD1;IQGAP2;DSG2;NDUFS3;ARFGAP3;PIK3R1;ESYT1;HSPE1;KTN1;PGRMC2;PAK2;RAB7A;SHMT2;TMPO;CAV1;NDUFA5;LAMTOR1;CDC42;ITGB1;LETM1;TFRC,74 (74),1.23e-05,0.000115,0,,4 (4),1,1,0.000152,0.00103
Plasma lipoprotein assembly,Reactome,11,MTTP;P4HB;APOA1;APOA2;APOA4;APOB;APOC2;APOC3;APOE;PRKACA;PRKACB,17 (17),4.24e-05,0.000343,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,10 (11),0.292,1,0.000152,0.00103
Cell-extracellular matrix interactions,Reactome,10,FERMT2;PXN;ITGB1;RSU1;FLNA;LIMS1;ACTN1;ILK;PARVA;LIMS2,16 (16),0.000147,0.00104,0,,0 (1),1,1,0.000147,0.00104
Iron uptake and transport,Reactome,25,NEDD8;CUL1;ATP6V1A;ATP6V1B2;ATP6V0C;ATP6V1C1;ATP6V1E1;ATP6V1H;ATP6V0A1;CAND1;ATP6AP1;ATP6V0D1;ACO1;TCIRG1;ATP6V1D;FTH1;STEAP3;CP;ATP6V1G1;HMOX1;HMOX2;SKP1;TF;TFR2;TFRC,57 (57),1.28e-05,0.000119,0,,18 (23),1,1,0.000157,0.00106
EGF-EGFR signaling pathway,Wikipathways,50,NEDD8;RALA;RALB;EPS15;USP8;STAM2;EPS15L1;RAP1A;PTPN11;ABI1;CAV1;MAPK14;ITCH;PIK3R1;GRB2;AP2A1;MT-CO2;AP2B1;EGFR;CSK;ATXN2;MTOR;PEBP1;CAMK2A;CFL1;RPS6KA1;HGS;SHC1;HRAS;STAT3;PRKCA;PCNA;ROCK1;NCK1;EPN1;MAPK1;AP2S1;MAPK9;MAP2K1;MAP2K2;CDC42;RAB5A;RAC1;NEDD4;CRK;CRKL;STAT5B;IQGAP1;ARF6;AP2M1,162 (162),0.000154,0.00107,0,,0 (0),1,1,0.000154,0.00107
Glycerophospholipid metabolism,EHMN,44,GPD1;GPD2;LIPC;RANBP2;ADHFE1;LIPA;CEPT1;NUP155;GLB1;COPA;COPB1;PLPP3;PLA2G12B;LCAT;SLC38A4;COPE;CDS2;NUP210;AGPAT2;AGPAT3;NUP98;PEMT;NUP133;MTTP;AGK;CHPT1;COPG2;PISD;GPAM;AKR1A1;NUP93;NUP58;ALDH1B1;ALDH9A1;ALDH3A2;ALDOB;AKR1B1;PLA2G15;NUP160;ARCN1;ALDH7A1;DGAT1;NUP35;NUP205,136 (136),0.000114,0.000817,10,HMDB0006790;HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0000067;HMDB0011149;HMDB0000123;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0011148;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,62 (95),0.121,1,0.000168,0.00113
MAP2K and MAPK activation,Reactome,19,HRAS;IQGAP1;FGA;MAP2K1;CSK;YWHAB;ITGB3;VCL;ARAF;RAP1A;RAP1B;TLN1;ITGA2B;FGB;FGG;FN1;LAMTOR2;MAPK1;MAP2K2,38 (38),1.42e-05,0.000132,0,,6 (15),1,1,0.000173,0.00116
Interactions of Rev with host cellular proteins,Reactome,19,RAE1;NUP98;NUP133;NPM1;RANBP2;TPR;RAN;RANBP1;NUP205;RCC1;XPO1;NUP210;NUP93;NUP35;NUP58;NUP160;SEC13;KPNB1;NUP155,38 (38),1.42e-05,0.000132,0,,3 (4),1,1,0.000173,0.00116
insulin,INOH,31,PPP2R1A;PTPA;PPP2R5A;PPP2R5D;PPP2R5E;MTOR;PIK3R1;RPS6;EIF4A1;EIF4A2;GYS2;EIF4E;PRKAA1;PRKAA2;PRKAB1;EIF4G1;SHC1;HRAS;PRKAG1;GRB2;MAPK1;YWHAQ;MAP2K1;MAP2K2;FKBP1A;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;RHEB,78 (78),1.43e-05,0.000132,0,,4 (5),1,1,0.000174,0.00116
CDC42 signaling events,PID,29,ARHGDIA;MAP2K4;MAPK14;CDC42;MAPK1;MTOR;PIK3R1;CFL1;HRAS;PAK2;DLG1;CTNNA1;BAIAP2;CTNNB1;MAPK9;YES1;MAP2K3;CDH1;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;RAC1;IQGAP1;ARPC2;WASL;SEPTIN2,71 (71),1.44e-05,0.000133,0,,6 (6),1,1,0.000175,0.00117
Vpr-mediated nuclear import of PICs,Reactome,16,PSIP1;NUP98;NUP133;TPR;KPNA1;NUP160;BANF1;RAE1;NUP210;NUP93;NUP35;NUP58;RANBP2;SEC13;NUP205;NUP155,34 (34),0.00017,0.00117,0,,0 (1),1,1,0.00017,0.00117
Lysosome Vesicle Biogenesis,Reactome,18,VAMP8;AP1B1;AP1M1;AP1G1;CLTB;M6PR;CHMP2A;GNS;HSPA8;CTSZ;AP1S1;ARF1;DNM2;HGS;CLTA;VAMP2;CLTC;TXNDC5,35 (35),1.45e-05,0.000133,0,,5 (6),1,1,0.000176,0.00118
Omega-3 fatty acid metabolism,EHMN,11,ACSL1;ACSL4;FADS2;EHHADH;ACOX1;ACOX2;ACOX3;ACSL5;FADS1;SLC27A2;HSD17B4,16 (16),1.81e-05,0.000164,1,HMDB0001388,15 (16),0.819,1,0.000179,0.00119
Regulation of actin cytoskeleton - Homo sapiens (human),KEGG,67,MYL12A;CRK;DIAPH1;HRAS;WASL;RHOA;MYH9;MYH11;CYFIP1;BAIAP2;MYLK;FN1;GNA13;GNG12;NCKAP1;IQGAP2;BRK1;ARAF;MYH14;PIK3R1;CFL1;CFL2;MYL9;ARPC1A;PPP1CC;ACTB;MAPK1;ITGA9;CYFIP2;PXN;PAK2;ACTG1;RDX;CRKL;VCL;ROCK1;ACTN4;ACTN1;ITGA1;EGFR;ITGA2B;PIP4K2C;ITGA5;MAP2K2;PFN1;RRAS2;F2;MAP2K1;ARHGEF12;CDC42;ARPC5L;ITGB1;ITGB2;ITGB3;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;KNG1;GSN;RAC1;IQGAP1;PPP1CA;PPP1CB;ARPC2,218 (218),1.5e-05,0.000137,0,,2 (5),1,1,0.000181,0.0012
Leptin signaling pathway,Wikipathways,28,KPNA4;RHOA;PTPN11;MAPK14;ACACA;ACACB;KHDRBS1;MTOR;PIK3R1;CFL2;RPS6;RPS6KA1;EIF4E;PRKAA1;PRKAA2;SHC1;HRAS;BAX;ROCK1;GRB2;RELA;MAPK1;MAP2K1;MAP2K2;CDC42;STAT3;RAC1;STAT5B,76 (76),0.000175,0.00121,0,,0 (0),1,1,0.000175,0.00121
N-Glycan biosynthesis,EHMN,20,MOGS;COPA;COPB1;STT3A;RPN1;RPN2;MGAT2;DPM1;COPG2;ST6GAL1;DDOST;DAD1;ARCN1;MGAT1;GANAB;ALG5;MAN1A1;STT3B;MAN2A1;COPE,42 (42),2.14e-05,0.000191,2,HMDB0000290;HMDB0001445,23 (51),0.725,1,0.000187,0.00124
The role of Nef in HIV-1 replication and disease pathogenesis,Reactome,14,AP2A1;AP2A2;AP1B1;AP2B1;AP1G1;ATP6V1H;PAK2;AP1M1;B2M;RAC1;ARF1;AP2M1;AP1S1;AP2S1,28 (28),0.000194,0.00128,0,,0 (1),1,1,0.000194,0.00128
Common Pathways Underlying Drug Addiction,Wikipathways,18,MAPK1;CALM1;MAP2K1;MAP2K2;GJB1;ACTB;PRKCA;ACTG1;CAMK2A;ARAF;RAP1A;RAP1B;GNAS;PPP1CA;PPP1CB;PPP1CC;PRKACA;PRKACB,41 (41),0.000203,0.00133,0,,0 (0),1,1,0.000203,0.00133
Folate Metabolism,Wikipathways,28,MPO;PLG;MTHFD1;MAT1A;FLAD1;SCARB1;ICAM1;GART;GPX1;GPX4;FGA;FGB;SHMT1;SHMT2;DHFR;APOA1;APOB;CTH;ALB;FGG;CAT;MTHFS;F2;CBS;RELA;SOD1;SOD2;AHCY,69 (69),2.33e-05,0.000207,5,HMDB0000067;HMDB0000123;HMDB0003208;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0000244,56 (66),0.734,1,0.000205,0.00135
One-carbon metabolism,Wikipathways,15,SHMT1;MAT2B;SHMT2;FTCD;MTHFD1;ATIC;MAT1A;AMT;DHFR;ALDH1L1;GLRX;GART;BHMT;MTHFS;AHCY,28 (28),4.06e-05,0.000334,3,HMDB0000123;HMDB0000244;HMDB0000043,22 (25),0.425,1,0.000206,0.00136
spliceosomal assembly,BioCarta,7,SNRNP70;SNRPA;SNRPA1;SNRPB2;U2AF2;U2AF1;SRSF2,9 (9),0.000213,0.00137,0,,0 (0),1,1,0.000213,0.00137
Nef Mediated CD4 Down-regulation,Reactome,7,AP2A1;AP2A2;AP2B1;ARF1;AP2M1;ATP6V1H;AP2S1,9 (9),0.000213,0.00137,0,,0 (0),1,1,0.000213,0.00137
Porphyrin and chlorophyll metabolism - Homo sapiens (human),KEGG,20,MMAB;UGT1A3;BLVRA;BLVRB;UGT2B15;HMBS;COX15;CP;GUSB;UROD;FXN;ALAD;PPOX;FECH;UGT2A3;HMOX1;CPOX;UGT2A1;HMOX2;UGT2B10,42 (42),2.14e-05,0.000191,3,HMDB0000123;HMDB0000054;HMDB0001149,41 (143),0.833,1,0.000213,0.0014
mRNA 3_-end processing,Reactome,25,SRRM1;U2AF1;THOC7;MAGOH;SRSF1;SRSF2;SRSF3;SRSF4;SRSF5;SRSF6;SRSF7;RNPS1;PABPN1;NUDT21;EIF4A3;CPSF1;U2AF2;ALYREF;NCBP1;RBM8A;DDX39A;SARNP;DDX39B;THOC5;CPSF7,58 (58),1.85e-05,0.000168,0,,1 (3),1,1,0.00022,0.00144
RAB geranylgeranylation,Reactome,27,RAB38;RAB10;RAB35;RAB11B;RAB18;RAB31;RAB43;RAB30;RAB8B;RAB11A;RAB7A;RAB1B;RAB14;RAB21;RAB1A;RAB2A;RAB6B;RAB4A;RAB5A;RAB5B;RAB6A;RAB13;RABGGTA;RABGGTB;RAB5C;RAB8A;RAB33B,65 (65),1.96e-05,0.000178,0,,3 (3),1,1,0.000232,0.00152
Dopamine metabolism,Wikipathways,9,COMT;MAOB;MAOA;PPP2CB;DDC;SOD1;NQO1;PRKACA;PRKACB,13 (13),0.000102,0.000742,5,HMDB0004067;HMDB0001229;HMDB0004369;HMDB0033934;HMDB0002281,29 (33),0.194,1,0.000234,0.00153
Antigen Presentation: Folding_ assembly and peptide loading of class I MHC,Reactome,14,SEC24C;TAP2;CALR;PDIA3;TAPBP;HSPA5;SEC24D;SAR1B;SEC24A;SEC23A;CANX;B2M;SEC31A;SEC13,24 (24),2.03e-05,0.000183,0,,6 (10),1,1,0.00024,0.00156
glycolysis,HumanCyc,14,PKLR;ALDOA;PKM;GAPDH;ENO1;TPI1;PGAM1;HK3;GPI;GCK;HK1;PFKL;BPGM;ALDOB,24 (25),2.03e-05,0.000183,0,,17 (20),1,1,0.00024,0.00156
Glycogen metabolism,Reactome,14,UGP2;CALM1;GBE1;PYGL;PYGB;PGM2;PHKG2;GYG1;AGL;PGM1;EPM2A;GYS2;PHKB;GAA,24 (24),2.03e-05,0.000183,0,,14 (16),1,1,0.00024,0.00156
Nicotinate metabolism,Reactome,14,NMNAT1;NADK;NNMT;NT5E;NAPRT;CYP8B1;NAXE;QPRT;NAMPT;NADK2;NADSYN1;CD38;NAXD;NMNAT3,24 (24),2.03e-05,0.000183,0,,40 (50),1,1,0.00024,0.00156
Prostaglandin formation from arachidonate,EHMN,17,MGST1;MGST2;COPB1;GSTK1;PLPP3;CBR1;GSTZ1;SLC22A1;COPA;COPG2;PTGES2;SLCO2A1;MGST3;COPE;DHRS4;ARCN1;PTGS1,33 (33),2.44e-05,0.000215,3,HMDB0004080;HMDB0001043;HMDB0003208,43 (48),0.856,1,0.000246,0.0016
Nef Mediated CD8 Down-regulation,Reactome,6,AP2A1;AP2A2;AP2B1;AP2M1;ATP6V1H;AP2S1,7 (7),0.000264,0.00164,0,,0 (0),1,1,0.000264,0.00164
Mitochondrial translation,Reactome,35,MRPL4;MRPL17;MRPS30;MRPS23;DAP3;MRPS27;OXA1L;MRPL14;MRPL16;MRPL12;MRPL47;MRPS2;MRPS18B;MRPS25;MRPL37;MRPS34;TUFM;MRPS21;MRPS26;MRPL43;MRPS11;MRPL19;MRPS5;MRPS16;MRPL3;MRPL49;MRPS36;GFM1;MRPL9;MRRF;MRPL1;MRPS22;MTRF1L;TSFM;PTCD3,94 (94),2.21e-05,0.000197,0,,5 (49),1,1,0.000259,0.00168
Association of TriC/CCT with target proteins during biosynthesis,Reactome,19,NOP56;FBXO4;SKIV2L;ARFGEF2;GBA;CCT8;LONP2;AP3M1;CCT6A;CCT7;CCT4;CCT2;CCT3;STAT3;KIFC3;CCT5;TCP1;FBXO6;XRN2,39 (39),2.29e-05,0.000204,0,,1 (1),1,1,0.000267,0.00173
Tryptophan catabolism,Reactome,10,KYAT3;AFMID;HAAO;IDO2;KYNU;KYAT1;KMO;TDO2;ACMSD;AADAT,14 (14),2.67e-05,0.000231,2,HMDB0000172;HMDB0000687,31 (34),0.861,1,0.000269,0.00173
Selenoamino acid metabolism,EHMN,18,NUP98;MAT2A;NUP133;NUP58;MAT2B;NUP210;CBS;NUP160;AHCYL1;FMO3;FMO1;FMO4;NUP93;NUP35;FMO5;RANBP2;NUP205;NUP155,36 (36),2.39e-05,0.000211,1,HMDB0033934,31 (38),0.971,1,0.000271,0.00175
Integrin-mediated Cell Adhesion,Wikipathways,34,VCL;RAP1A;RAP1B;ILK;ITGA2B;GRB2;CSK;TLN1;CAPN1;CAPN2;CAPNS1;SHC1;HRAS;PXN;PAK2;ITGB2;ROCK1;SORBS1;ITGA1;CAV1;MAPK1;ITGA5;MAP2K2;ITGA9;MAP2K1;CDC42;MAP2K3;ITGB1;TNS1;ITGB3;ZYX;ARAF;CRK;RAC1,101 (101),0.000286,0.00177,0,,0 (0),1,1,0.000286,0.00177
Regulation of Glucokinase by Glucokinase Regulatory Protein,Reactome,15,RAE1;NUP98;NUP133;TPR;NUP160;GCK;GCKR;NUP210;NUP93;NUP35;NUP58;RANBP2;SEC13;NUP205;NUP155,32 (32),0.000286,0.00177,0,,0 (0),1,1,0.000286,0.00177
Nuclear Receptors Meta-Pathway,Wikipathways,85,SLC27A5;TXNRD1;GSTM2;UGT1A3;GSTM4;BLVRB;GSTP1;CYP1A2;GSTT2;PDK4;SLC6A13;SMC1A;CYP7A1;SERPINA1;FASN;PTPA;CYP8B1;AIP;SERPINB9;CDC37;SLC10A1;SLC2A9;MGST1;ACADM;MGST3;EGFR;CUL1;FKBP5;ABCC2;GCLM;SLC39A14;SLCO2B1;SQSTM1;EHHADH;SLC27A1;ACOX1;SULT1A1;KTN1;GSR;PRDX6;BAAT;PRDX1;DNAJB1;FTH1;NQO1;SLC39A7;BAX;SCP2;ABCB11;PSMC5;MGST2;GPAM;APOA1;APOA2;FABP1;GSTT1;STOM;DBI;APOC3;HMOX1;NR3C1;CPT1A;PTGR1;CPT2;DNAJC7;ME1;PTGES3;GSTA3;PGD;APOA5;GCLC;GSTM1;GSTA5;RXRA;PCK1;SLC2A2;CAVIN2;STAT3;CBR1;HSP90AA1;GSTA1;GSTA2;ABCB4;GSTA4;HSP90AB1,317 (317),0.000287,0.00178,0,,0 (0),1,1,0.000287,0.00178
Apoptotic execution phase,Reactome,23,VIM;LMNA;LMNB1;FNTA;DSG2;DSP;TJP1;SPTAN1;DBNL;CASP3;PAK2;CASP6;ACIN1;DNM1L;ROCK1;PLEC;CTNNB1;TJP2;CDH1;GAS2;GSN;KPNA1;KPNB1,52 (52),2.39e-05,0.000211,0,,2 (5),1,1,0.000278,0.00179
ISG15 antiviral mechanism,Reactome,16,DDX58;ISG15;UBE2N;EIF2AK2;FLNB;EIF4A3;EIF4E2;EIF4G2;EIF4A2;PPM1B;EIF4E;TRIM25;ARIH1;EIF4G1;NEDD4;EIF4A1,30 (30),2.41e-05,0.000212,0,,3 (4),1,1,0.000281,0.0018
Histidine metabolism - Homo sapiens (human),KEGG,13,MAOA;AMDHD1;ALDH1B1;CNDP2;MAOB;ALDH7A1;ALDH3A2;UROC1;CARNMT1;FTCD;HAL;ASPA;ALDH9A1,22 (22),3.35e-05,0.000285,3,HMDB0004181;HMDB0012276;HMDB0003665,36 (47),0.759,1,0.000295,0.00189
Tryptophan Metabolism,SMPDB,12,AFMID;INMT;HAAO;DDC;KYNU;CAT;ACMSD;KMO;TDO2;AOX1;WARS1;AADAT,19 (19),2.66e-05,0.000231,3,HMDB0004369;HMDB0002281;HMDB0004259,58 (60),0.958,1,0.000295,0.00189
L1CAM interactions,Reactome,37,DPYSL2;AP2M1;AP2S1;ITGA2B;ANK1;AP2A1;AP2A2;AP2B1;EGFR;LYPLA2;CSNK2A2;CSNK2A1;RPS6KA1;CSNK2B;SPTAN1;SPTB;SPTBN1;SPTBN2;SPTA1;CLTA;RDX;DNM3;NUMB;DLG1;ALCAM;ITGA1;MAPK1;ITGA5;ITGA9;MAP2K1;MAP2K2;ITGB1;ITGB3;CLTC;HSPA8;RAC1;DNM2,102 (102),2.56e-05,0.000225,0,,7 (10),1,1,0.000296,0.00189
Nicotinate and Nicotinamide Metabolism,SMPDB,10,NT5C2;NADK;NNMT;AOX1;NNT;NADSYN1;ENPP1;QPRT;NAMPT;PNP,14 (14),2.67e-05,0.000231,1,HMDB0001178,34 (35),0.979,1,0.000302,0.00191
Hypoacetylaspartia,SMPDB,10,ASRGL1;NARS1;DARS1;ABAT;ASL;CAD;ASNS;ASPA;ASS1;ADSL,14 (14),2.67e-05,0.000231,1,HMDB0033934,34 (34),0.979,1,0.000302,0.00191
Aspartate Metabolism,SMPDB,10,ASRGL1;NARS1;DARS1;ABAT;ASL;CAD;ASNS;ASPA;ASS1;ADSL,14 (14),2.67e-05,0.000231,1,HMDB0033934,34 (34),0.979,1,0.000302,0.00191
Canavan Disease,SMPDB,10,ASRGL1;NARS1;DARS1;ABAT;ASL;CAD;ASNS;ASPA;ASS1;ADSL,14 (14),2.67e-05,0.000231,1,HMDB0033934,34 (34),0.979,1,0.000302,0.00191
TCR,NetPath,68,TXNRD1;PIK3AP1;STK4;RELA;ACLY;ARHGDIB;STAM2;DPYSL2;PTPN6;RAP1A;MAPK9;PTPN11;CYFIP1;MAPK14;TRIM25;LDHA;PXN;KHDRBS1;CTNNB1;GDI2;WDR1;ANXA2;PIK3R1;PI4KA;ACP1;DUSP3;CD2AP;CGN;DBNL;CLTC;AHCY;SHC1;DIAPH1;PKM;RAN;GRB2;CCT8;CALM1;ANXA11;PTPN22;NCK1;NCL;FLNB;YWHAZ;MAP2K1;MAPK1;YWHAQ;ATP1A1;HGS;SNRNP70;LYN;ADA;MAP2K2;ELP3;PGAM1;LDHB;TUBA4A;BDH1;EIF3M;TSG101;PGM1;HNRNPH3;CRK;CRKL;DNM2;DNAJB1;TFRC;HSP90AB1,243 (244),0.000311,0.00192,0,,0 (0),1,1,0.000311,0.00192
Methylation,Reactome,10,COMT;GSTO1;AS3MT;NNMT;MAT2B;CYP1A2;MAT1A;MAT2A;TPMT;AHCY,14 (14),2.67e-05,0.000231,0,,30 (38),1,1,0.000308,0.00195
Steroid hormone biosynthesis - Homo sapiens (human),KEGG,21,COMT;UGT1A3;HSD17B7;UGT2B15;CYP1A2;HSD17B8;AKR1C1;SULT1E1;CYP7A1;HSD17B12;DHRS11;CYP2E1;HSD17B2;HSD17B6;UGT2A3;HSD11B1;SRD5A1;STS;UGT2A1;AKR1D1;UGT2B10,61 (61),0.00289,0.0137,17,HMDB0000653;HMDB0000015;HMDB0006756;HMDB0002829;HMDB0000067;HMDB0000899;HMDB0001547;HMDB0006764;HMDB0000145;HMDB0004030;HMDB0004484;HMDB0000234;HMDB0000343;HMDB0000077;HMDB0006763;HMDB0003769;HMDB0000313#HMDB0000335,87 (99),0.00929,0.566,0.000309,0.00195
Alpha6Beta4Integrin,NetPath,26,RHOA;VIM;PTPN11;MAPK14;DST;YWHAQ;EGFR;DSP;MTOR;PIK3R1;EIF4E;SHC1;LAMA2;GRB2;LAMB2;PRKCA;RPSA;MAPK1;PLEC;YES1;YWHAB;YWHAE;EIF6;YWHAH;YWHAZ;RAC1,71 (71),0.000329,0.00202,0,,0 (0),1,1,0.000329,0.00202
SUMOylation of DNA replication proteins,Reactome,17,RAE1;UBE2I;NUP133;NUP98;TPR;NUP210;TOP1;NUP160;TOP2B;PCNA;NUP93;NUP35;NUP58;RANBP2;SEC13;NUP205;NUP155,39 (39),0.000337,0.00206,0,,0 (0),1,1,0.000337,0.00206
Insulin signaling pathway - Homo sapiens (human),KEGG,46,HRAS;PHKB;PHKG2;FLOT2;FASN;HK1;FBP1;HK3;ACACA;ACACB;CALM1;PCK1;MTOR;PIK3R1;RPS6;GYS2;EIF4E;PRKAA1;PRKAA2;PRKAB1;PRKACA;PRKACB;SHC1;PKLR;PRKAG1;GRB2;PRKAR2A;PYGB;PYGL;SORBS1;GCK;MAPK1;MAPK9;FLOT1;MAP2K1;MAP2K2;ARAF;PCK2;CRK;CRKL;PRKAR1A;RHEB;PPP1CA;PPP1CB;PPP1CC;EIF4E2,137 (137),2.87e-05,0.000248,0,,2 (4),1,1,0.000329,0.00207
Ebola Virus Pathway on Host,Wikipathways,41,NPC1;RHOA;EPS15;FLNB;VPS4A;CTSL;DDX58;EGFR;ACTG1;EIF2S1;PIK3R1;ASGR1;VPS33A;CLTA;ACTB;CLTC;C1QBP;RAB7A;FLNA;ACTN4;RELA;TSG101;ACTN1;ITGA1;CAV1;MAPK1;ITGA5;CTSB;CDC42;NPC2;ITGB1;CLTB;EIF2AK2;RAB5A;TOP1;GSN;RAC1;IQGAP1;KPNA1;ITGB3;NEDD4,130 (130),0.000352,0.00214,0,,0 (0),1,1,0.000352,0.00214
Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways),Wikipathways,21,ELOVL5;MSMO1;ACSL1;DHCR24;ACSL4;FADS2;MVK;FDFT1;LSS;HMGCS2;ACOT2;FASN;SOAT2;DHCR7;HSD17B7;FADS1;CYP27A1;EBP;TM7SF2;IDI1;HMGCS1,46 (46),2.99e-05,0.000258,0,,4 (4),1,1,0.000342,0.00215
Ub-specific processing proteases,Reactome,65,PSMD6;USP14;PSMD13;USP10;USP8;STAM2;IDE;PSMB10;PSMF1;SNX3;PSME4;RUVBL1;USP7;DDX58;USP5;ADRM1;USP9X;PSMA1;PSMA2;TOMM70;PSMA4;PSMA5;PSMA6;PSMA7;UFD1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;PTRH2;PSMC1;PSMC2;PSMC3;PSMC4;PSMC5;PSMC6;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;MAT2B;PSMD11;PSMD12;PSMB1;PSME1;PSME2;FKBP8;HGS;OTUB1;PSMD14;USP15;HIF1A;USP24;USP47;VDAC1;VDAC2;VDAC3;PSME3,214 (214),3e-05,0.000259,0,,1 (2),1,1,0.000343,0.00215
Deubiquitination,Reactome,83,NEDD8;RHOA;ABRAXAS2;PSMD6;DDX58;USP14;PSMD13;TOMM70;USP8;STAM2;ACTB;IDE;PSMB10;PSMF1;SNX3;TRIM25;RNF135;ACTL6A;PSME4;RUVBL1;USP7;USP47;MAVS;USP5;UCHL5;VDAC3;RAD23B;USP9X;PSMA2;PSMA1;UCHL3;BABAM1;PSMA5;PSMA6;PSMA7;UFD1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;ATXN3;PSMB8;PSMB9;PTRH2;PSMC1;PSMC2;PSMC3;PSMC4;USP10;PSMC6;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;BRCC3;PSMD7;PSMD8;MAT2B;PSMD11;PSMD12;PSMB1;PSME1;PSME2;FKBP8;HGS;OTUB1;PSMC5;PSMD14;USP15;BABAM2;ADRM1;PSMA4;HIF1A;USP24;VCP;VDAC1;VDAC2;PSMB7;VCPIP1;RAD23A;PSME3,290 (290),3.02e-05,0.00026,0,,3 (10),1,1,0.000345,0.00216
Mitochondrial translation elongation,Reactome,33,MRPL4;MRPL17;MRPS30;MRPS23;DAP3;MRPS27;OXA1L;MRPL14;MRPL16;MRPL12;MRPL47;MRPS2;MRPS18B;MRPS25;MRPL37;MRPS34;MRPS21;MRPS26;MRPL43;MRPS11;MRPL19;MRPS5;MRPS16;MRPL3;MRPL49;MRPS36;GFM1;MRPL9;MRPL1;MRPS22;TUFM;TSFM;PTCD3,88 (88),3.18e-05,0.000272,0,,3 (28),1,1,0.000361,0.00225
Tryptophan metabolism,EHMN,13,MAOA;MAOB;GSTK1;MGST1;GSTZ1;ADHFE1;KYAT1;KMO;ALDH7A1;SLC22A1;ALDH1B1;ACMSD;AADAT,22 (22),3.35e-05,0.000285,4,HMDB0004369;HMDB0033934;HMDB0004259;HMDB0000472,72 (78),0.96,1,0.000365,0.00227
Caspase-mediated cleavage of cytoskeletal proteins,Reactome,8,CASP3;VIM;GAS2;CASP6;SPTAN1;GSN;PLEC;DBNL,12 (12),0.00038,0.00229,0,,0 (0),1,1,0.00038,0.00229
Signal transduction by L1,Reactome,13,ITGA9;EGFR;MAP2K2;ITGB1;ITGB3;CSNK2A1;CSNK2A2;CSNK2B;RAC1;MAP2K1;ITGA2B;MAPK1;ITGA5,22 (22),3.35e-05,0.000285,0,,4 (4),1,1,0.000379,0.00235
leucine degradation,HumanCyc,9,IVD;AUH;DLD;BCKDHA;BCKDHB;HMGCL;MCCC2;MCCC1;DBT,12 (12),3.79e-05,0.000319,1,HMDB0000687,19 (20),0.885,1,0.000379,0.00235
Plasma lipoprotein remodeling,Reactome,10,APOA1;APOA2;APOA4;APOB;ALB;LIPC;APOC2;APOC3;LCAT;APOE,26 (26),0.0156,0.0577,5,HMDB0000067;HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,10 (16),0.00219,0.163,0.000387,0.0024
Regulation of HSF1-mediated heat shock response,Reactome,31,TPR;DNAJB1;RANBP2;ATM;MAPK1;NUP155;RAE1;FKBP4;HIKESHI;HSPH1;NUP210;BAG3;BAG1;NUP98;NUP133;CCAR2;NUP93;NUP58;DNAJC7;SERPINH1;YWHAE;HSPA4;HSPA5;NUP160;HSPA8;HSPA9;HSPB1;NUP35;SEC13;NUP205;HSPA13,81 (81),3.45e-05,0.000293,0,,6 (7),1,1,0.000389,0.00241
Aminosugars metabolism,INOH,12,CMAS;GNE;GNPNAT1;NANS;GFPT1;UAP1;GCK;PGM3;GNPDA1;HK1;HK3;MPI,20 (20),5.51e-05,0.000426,3,HMDB0000290;HMDB0013112;HMDB0033934,30 (32),0.64,1,0.000397,0.00245
Sialuria or French Type Sialuria,SMPDB,11,NPL;HEXA;CMAS;GNE;GNPNAT1;NANS;GFPT1;UAP1;PGM3;GNPDA1;HK1,17 (17),4.24e-05,0.000343,2,HMDB0000290;HMDB0033934,31 (32),0.861,1,0.00041,0.00251
Sialuria or French Type Sialuria,SMPDB,11,NPL;HEXA;CMAS;GNE;GNPNAT1;NANS;GFPT1;UAP1;PGM3;GNPDA1;HK1,17 (17),4.24e-05,0.000343,2,HMDB0000290;HMDB0033934,31 (32),0.861,1,0.00041,0.00251
Amino Sugar Metabolism,SMPDB,11,NPL;HEXA;CMAS;GNE;GNPNAT1;NANS;GFPT1;UAP1;PGM3;GNPDA1;HK1,17 (17),4.24e-05,0.000343,2,HMDB0000290;HMDB0033934,31 (32),0.861,1,0.00041,0.00251
G(M2)-Gangliosidosis: Variant B_ Tay-sachs disease,SMPDB,11,NPL;HEXA;CMAS;GNE;GNPNAT1;NANS;GFPT1;UAP1;PGM3;GNPDA1;HK1,17 (17),4.24e-05,0.000343,2,HMDB0000290;HMDB0033934,31 (32),0.861,1,0.00041,0.00251
Tay-Sachs Disease,SMPDB,11,NPL;HEXA;CMAS;GNE;GNPNAT1;NANS;GFPT1;UAP1;PGM3;GNPDA1;HK1,17 (17),4.24e-05,0.000343,2,HMDB0000290;HMDB0033934,31 (32),0.861,1,0.00041,0.00251
Salla Disease/Infantile Sialic Acid Storage Disease,SMPDB,11,NPL;HEXA;CMAS;GNE;GNPNAT1;NANS;GFPT1;UAP1;PGM3;GNPDA1;HK1,17 (17),4.24e-05,0.000343,2,HMDB0000290;HMDB0033934,31 (32),0.861,1,0.00041,0.00251
Purine ribonucleoside monophosphate biosynthesis,Reactome,9,GMPS;LHPP;PAICS;PFAS;ATIC;GART;IMPDH2;ADSL;PPAT,12 (12),3.79e-05,0.000319,1,HMDB0000123,36 (37),0.984,1,0.000417,0.00255
HSP90 chaperone cycle for steroid hormone receptors (SHR),Reactome,12,HSPA8;DNAJA1;PTGES3;DNAJB1;DNAJA4;FKBP4;FKBP5;STIP1;DNAJA2;HSP90AA1;NR3C1;HSP90AB1,20 (20),5.51e-05,0.000426,1,HMDB0000234,10 (12),0.679,1,0.000419,0.00255
mechanism of protein import into the nucleus,BioCarta,9,RAN;RANBP1;RANBP2;RCC1;RANGAP1;NUP210;NUTF2;KPNB1;KPNA2,12 (12),3.79e-05,0.000319,0,,2 (2),1,1,0.000423,0.00258
gluconeogenesis,HumanCyc,14,ALDOA;PC;GPI;GAPDH;ENO1;PGAM1;ALDOB;PCK1;PCK2;FBP1;TPI1;BPGM;MDH1;MDH2,25 (26),3.81e-05,0.000319,0,,22 (26),1,1,0.000426,0.00258
skeletal muscle hypertrophy is regulated via akt-mtor pathway,BioCarta,14,PSMC4;PABPC1;MTOR;PDK2;EIF2S1;EIF4G1;RPS6;EIF4A1;IGF1;PPP2R5D;EIF4E;PIK3R1;EIF2B5;EIF2S2,25 (25),3.81e-05,0.000319,0,,3 (3),1,1,0.000426,0.00258
SNARE interactions in vesicular transport - Homo sapiens (human),KEGG,15,VAMP8;GOSR2;USE1;STX17;STX7;VAMP2;BET1;SEC22B;BNIP1;GOSR1;STX4;STX5;YKT6;VTI1B;SNAP29,33 (33),0.000433,0.00259,0,,0 (0),1,1,0.000433,0.00259
Antiviral mechanism by IFN-stimulated genes,Reactome,18,DDX58;ISG15;UBE2N;EIF2AK2;ABCE1;FLNA;FLNB;EIF4A3;EIF4E2;EIF4G2;EIF4A2;PPM1B;EIF4E;TRIM25;ARIH1;EIF4G1;NEDD4;EIF4A1,37 (37),3.84e-05,0.000321,0,,3 (8),1,1,0.000429,0.0026
Scavenging by Class F Receptors,Reactome,5,HSPH1;HSP90AA1;APOB;CALR;HYOU1,6 (6),0.00121,0.00648,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,3 (9),0.032,1,0.000431,0.0026
TGF-beta super family signaling pathway canonical,INOH,37,PSMD6;MAPK14;HDAC6;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;PSMB10;PSMC1;PSMC2;PSMC3;PSMC4;PSMC5;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;MAPK1;MAPK9;HDAC2,115 (115),0.000435,0.0026,0,,0 (0),1,1,0.000435,0.0026
Mitotic Anaphase,Reactome,60,TNPO1;PDS5B;TUBA1B;PPP2CB;RAN;PPP2R1A;RANBP2;PPP2R2A;NUP93;NUP205;PPP2R5A;DYNC1LI1;PPP2R5D;PPP2R5E;CHMP6;NDEL1;NUP155;LMNA;LMNB1;KPNB1;SMC3;MAPRE1;DYNC1H1;VPS4A;SMC1A;TUBA1C;PAFAH1B1;STAG2;DYNLL2;NUP98;CKAP5;NUP133;CHMP3;IST1;UBE2I;TMPO;PDS5A;RCC1;TUBB2B;PPP1CC;RPS27;XPO1;TUBB4B;NUP58;ZW10;BUB3;CHMP4B;NUDC;RANGAP1;CHMP2A;TUBA4A;BANF1;RCC2;NUP160;DYNC1I2;DYNC1LI2;NUP35;SEC13;RAD21;SIRT2,195 (195),3.94e-05,0.000328,0,,11 (14),1,1,0.000439,0.00265
Mitochondrial CIV Assembly,Wikipathways,17,MT-CO1;COX6C;MT-CO3;TACO1;PNKD;COX7C;COX5B;COX5A;HIGD1A;COX15;COX4I1;COX18;COX6A1;COA6;NDUFA4;MT-CO2;COA3,34 (34),4.03e-05,0.000334,0,,2 (4),1,1,0.000448,0.00269
Rev-mediated nuclear export of HIV RNA,Reactome,17,RAE1;NUP98;NUP133;TPR;RAN;RANBP1;NUP160;RCC1;XPO1;NUP210;NUP93;NUP35;NUP58;RANBP2;SEC13;NUP205;NUP155,34 (34),4.03e-05,0.000334,0,,3 (4),1,1,0.000448,0.00269
Translocation of SLC2A4 (GLUT4) to the plasma membrane,Reactome,17,RAB14;MYO1C;YWHAE;YWHAQ;CALM1;YWHAB;RALA;RAB4A;YWHAG;YWHAH;YWHAZ;RAB13;PRKAG1;RAB8A;PRKAA2;PRKAB1;RAB10,34 (34),4.03e-05,0.000334,0,,7 (8),1,1,0.000448,0.00269
Signaling by high-kinase activity BRAF mutants,Reactome,15,VCL;IQGAP1;FGA;FGB;CSK;ITGB3;RAP1A;RAP1B;TLN1;FGG;MAP2K1;MAPK1;FN1;ITGA2B;MAP2K2,28 (28),4.06e-05,0.000334,0,,6 (15),1,1,0.000451,0.00269
Postmitotic nuclear pore complex (NPC) reformation,Reactome,15,NUP98;UBE2I;TNPO1;NUP133;RAN;KPNB1;RCC1;RANGAP1;NUP93;NUP35;NUP58;NUP160;SEC13;NUP205;NUP155,28 (28),4.06e-05,0.000334,0,,4 (5),1,1,0.000451,0.00269
Hereditary Coproporphyria (HCP),SMPDB,10,FECH;BLVRA;HMBS;COX15;GUSB;ALAD;HMOX1;PPOX;CPOX;UROD,15 (15),6.66e-05,0.000497,4,HMDB0000054;HMDB0000123;HMDB0033934;HMDB0001149,39 (39),0.616,1,0.000455,0.0027
Porphyria Variegata (PV),SMPDB,10,FECH;BLVRA;HMBS;COX15;GUSB;ALAD;HMOX1;PPOX;CPOX;UROD,15 (15),6.66e-05,0.000497,4,HMDB0000054;HMDB0000123;HMDB0033934;HMDB0001149,39 (39),0.616,1,0.000455,0.0027
Congenital Erythropoietic Porphyria (CEP) or Gunther Disease,SMPDB,10,FECH;BLVRA;HMBS;COX15;GUSB;ALAD;HMOX1;PPOX;CPOX;UROD,15 (15),6.66e-05,0.000497,4,HMDB0000054;HMDB0000123;HMDB0033934;HMDB0001149,39 (39),0.616,1,0.000455,0.0027
Acute Intermittent Porphyria,SMPDB,10,FECH;BLVRA;HMBS;COX15;GUSB;ALAD;HMOX1;PPOX;CPOX;UROD,15 (15),6.66e-05,0.000497,4,HMDB0000054;HMDB0000123;HMDB0033934;HMDB0001149,39 (39),0.616,1,0.000455,0.0027
Porphyrin Metabolism,SMPDB,10,FECH;BLVRA;HMBS;COX15;GUSB;ALAD;HMOX1;PPOX;CPOX;UROD,15 (15),6.66e-05,0.000497,4,HMDB0000054;HMDB0000123;HMDB0033934;HMDB0001149,39 (39),0.616,1,0.000455,0.0027
Transferrin endocytosis and recycling,Reactome,16,ATP6V1H;TCIRG1;TF;ATP6V1A;ATP6V1G1;ATP6V0C;ATP6V1C1;ATP6V1E1;STEAP3;ATP6V1B2;ATP6V1D;ATP6V0A1;ATP6AP1;ATP6V0D1;TFR2;TFRC,31 (31),4.11e-05,0.000337,0,,7 (9),1,1,0.000457,0.0027
Nectin adhesion pathway,PID,16,F11R;CTNNB1;CRK;CDC42;CDH1;ITGB3;RAC1;AFDN;PIK3R1;RAP1A;RAP1B;TLN1;CTNNA1;IQGAP1;NECTIN2;FARP2,31 (31),4.11e-05,0.000337,0,,2 (2),1,1,0.000457,0.0027
Pyrimidine metabolism - Homo sapiens (human),KEGG,24,DPYD;CMPK1;UPB1;CAD;CTPS2;ENTPD8;NT5E;ENPP1;ENPP3;NT5C3A;RRM2B;DHODH;ENTPD5;NUDT2;NME3;NT5C2;UMPS;DPYS;NME1;NME2;RRM1;TYMP;NT5C;PNP,57 (57),4.3e-05,0.000347,2,HMDB0001342;HMDB0003349#HMDB0000528,49 (65),0.974,1,0.000465,0.00274
ucalpain and friends in cell spread,BioCarta,11,RHOA;PXN;ITGB1;ACTN1;CAPN1;ACTN4;SPTAN1;TLN1;RAC1;ITGA1;CAPNS1,17 (17),4.24e-05,0.000343,0,,1 (1),1,1,0.000469,0.00276
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,Reactome,9,ELOVL5;ACSL1;SCP2;FADS2;ACOX1;ACOT8;ABCD1;FADS1;HSD17B4,13 (13),0.000102,0.000742,4,HMDB0001976;HMDB0002183;HMDB0001388;HMDB0006519,31 (42),0.43,1,0.000485,0.00285
Aminosugars metabolism,EHMN,22,HEXA;HEXB;RANBP2;SLC38A3;NUP155;COPA;COPB1;SLC38A4;COPE;NUP210;NUP98;NUP133;GNPNAT1;COPG2;NUP93;NUP58;CMAS;NUP160;SLC2A2;ARCN1;NUP35;NUP205,51 (51),5.71e-05,0.000435,3,HMDB0000290;HMDB0013112;HMDB0033934,37 (43),0.776,1,0.000488,0.00286
threonine degradation,HumanCyc,6,SDS;DLD;SDSL;BCKDHA;BCKDHB;DBT,6 (6),4.49e-05,0.00036,0,,8 (8),1,1,0.000495,0.00289
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA,Reactome,6,ACADM;ECHS1;HADHA;HADHB;HADH;MECR,6 (6),4.49e-05,0.00036,0,,15 (15),1,1,0.000495,0.00289
Alpha-oxidation of phytanate,Reactome,6,ALDH3A2;HACL1;SLC25A17;PHYH;PECR;SLC27A2,6 (6),4.49e-05,0.00036,0,,23 (27),1,1,0.000495,0.00289
Riboflavin metabolism - Homo sapiens (human),KEGG,7,BLVRB;ENPP1;ENPP3;FLAD1;ACP2;ACP5;ACP1,8 (8),5.65e-05,0.000432,1,HMDB0000244,14 (20),0.797,1,0.000496,0.00289
S-Adenosylhomocysteine (SAH) Hydrolase Deficiency,SMPDB,12,SRM;MAT2B;SHMT1;MSRB2;CBS;MARS1;MAT2A;CTH;CHDH;BHMT;MTAP;AHCY,20 (20),5.51e-05,0.000426,3,HMDB0000123;HMDB0033934;HMDB0000043,41 (42),0.833,1,0.000505,0.0029
Methionine Metabolism,SMPDB,12,SRM;MAT2B;SHMT1;MSRB2;CBS;MARS1;MAT2A;CTH;CHDH;BHMT;MTAP;AHCY,20 (20),5.51e-05,0.000426,3,HMDB0000123;HMDB0033934;HMDB0000043,41 (42),0.833,1,0.000505,0.0029
Methionine Adenosyltransferase Deficiency,SMPDB,12,SRM;MAT2B;SHMT1;MSRB2;CBS;MARS1;MAT2A;CTH;CHDH;BHMT;MTAP;AHCY,20 (20),5.51e-05,0.000426,3,HMDB0000123;HMDB0033934;HMDB0000043,41 (42),0.833,1,0.000505,0.0029
Glycine N-methyltransferase Deficiency,SMPDB,12,SRM;MAT2B;SHMT1;MSRB2;CBS;MARS1;MAT2A;CTH;CHDH;BHMT;MTAP;AHCY,20 (20),5.51e-05,0.000426,3,HMDB0000123;HMDB0033934;HMDB0000043,41 (42),0.833,1,0.000505,0.0029
Hypermethioninemia,SMPDB,12,SRM;MAT2B;SHMT1;MSRB2;CBS;MARS1;MAT2A;CTH;CHDH;BHMT;MTAP;AHCY,20 (20),5.51e-05,0.000426,3,HMDB0000123;HMDB0033934;HMDB0000043,41 (42),0.833,1,0.000505,0.0029
Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),SMPDB,12,SRM;MAT2B;SHMT1;MSRB2;CBS;MARS1;MAT2A;CTH;CHDH;BHMT;MTAP;AHCY,20 (20),5.51e-05,0.000426,3,HMDB0000123;HMDB0033934;HMDB0000043,41 (42),0.833,1,0.000505,0.0029
Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism_ cblG complementation type,SMPDB,12,SRM;MAT2B;SHMT1;MSRB2;CBS;MARS1;MAT2A;CTH;CHDH;BHMT;MTAP;AHCY,20 (20),5.51e-05,0.000426,3,HMDB0000123;HMDB0033934;HMDB0000043,41 (42),0.833,1,0.000505,0.0029
Cystathionine Beta-Synthase Deficiency,SMPDB,12,SRM;MAT2B;SHMT1;MSRB2;CBS;MARS1;MAT2A;CTH;CHDH;BHMT;MTAP;AHCY,20 (20),5.51e-05,0.000426,3,HMDB0000123;HMDB0033934;HMDB0000043,41 (42),0.833,1,0.000505,0.0029
Signaling by Retinoic Acid,Reactome,20,RDH16;DHRS3;RDH10;RDH11;ALDH8A1;PDHA1;DLAT;DLD;PDK1;PDK2;PDK4;CHKB;RXRA;PDHX;RDH13;DHRS4;ALDH1A1;ALDH1A3;PDHB;CPT1A,44 (44),4.98e-05,0.000393,1,HMDB0006216,23 (26),0.927,1,0.000507,0.00291
Mitotic Metaphase and Anaphase,Reactome,60,TNPO1;PDS5B;TUBA1B;PPP2CB;RAN;PPP2R1A;RANBP2;PPP2R2A;NUP93;NUP205;PPP2R5A;DYNC1LI1;PPP2R5D;PPP2R5E;CHMP6;NDEL1;NUP155;LMNA;LMNB1;KPNB1;SMC3;MAPRE1;DYNC1H1;VPS4A;SMC1A;TUBA1C;PAFAH1B1;STAG2;DYNLL2;NUP98;CKAP5;NUP133;CHMP3;IST1;UBE2I;TMPO;PDS5A;RCC1;TUBB2B;PPP1CC;RPS27;XPO1;TUBB4B;NUP58;ZW10;BUB3;CHMP4B;NUDC;RANGAP1;CHMP2A;TUBA4A;BANF1;RCC2;NUP160;DYNC1I2;DYNC1LI2;NUP35;SEC13;RAD21;SIRT2,196 (196),4.65e-05,0.000372,0,,11 (14),1,1,0.00051,0.00292
alpha-linolenic acid (ALA) metabolism,Reactome,9,ELOVL5;ACSL1;SCP2;FADS2;ACOX1;ACOT8;ABCD1;FADS1;HSD17B4,13 (13),0.000102,0.000742,3,HMDB0006519;HMDB0002183;HMDB0001388,23 (32),0.455,1,0.000511,0.00292
cysteine biosynthesis,HumanCyc,7,AHCYL1;MAT2B;CBS;MAT1A;MAT2A;CTH;AHCY,8 (8),5.65e-05,0.000432,1,HMDB0000043,16 (16),0.838,1,0.000519,0.00296
Urea cycle,Reactome,8,NAGS;ASS1;OTC;ASL;SLC25A15;ARG1;CPS1;NMRAL1,10 (10),4.97e-05,0.000393,0,,21 (23),1,1,0.000543,0.00307
Sulfur metabolism - Homo sapiens (human),KEGG,8,PAPSS2;MPST;SQOR;BPNT1;SUOX;ETHE1;TST;SELENBP1,10 (10),4.97e-05,0.000393,0,,22 (33),1,1,0.000543,0.00307
Beta Oxidation of Very Long Chain Fatty Acids,SMPDB,8,CPT2;ACSL1;CRAT;PEX13;PEX14;SLC25A20;CROT;ABCD1,10 (10),4.97e-05,0.000393,0,,13 (14),1,1,0.000543,0.00307
Adrenoleukodystrophy_ X-linked,SMPDB,8,CPT2;ACSL1;CRAT;PEX13;PEX14;SLC25A20;CROT;ABCD1,10 (10),4.97e-05,0.000393,0,,13 (14),1,1,0.000543,0.00307
Carnitine-acylcarnitine translocase deficiency,SMPDB,8,CPT2;ACSL1;CRAT;PEX13;PEX14;SLC25A20;CROT;ABCD1,10 (10),4.97e-05,0.000393,0,,13 (14),1,1,0.000543,0.00307
Trans-sulfuration pathway,Wikipathways,8,MPST;MAT2B;GCLM;CBS;CTH;CSAD;GOT1;AHCY,10 (10),4.97e-05,0.000393,0,,14 (14),1,1,0.000543,0.00307
Vasopressin-regulated water reabsorption - Homo sapiens (human),KEGG,20,DYNC1LI2;RAB5A;DYNC1LI1;NSF;DCTN1;ARHGDIA;ARHGDIB;RAB11B;RAB5B;DYNC1H1;DYNC1I2;RAB5C;DCTN2;PRKACA;STX4;DYNLL2;VAMP2;GNAS;RAB11A;PRKACB,44 (44),4.98e-05,0.000393,0,,2 (2),1,1,0.000544,0.00307
Butyrate Metabolism,SMPDB,7,ACADS;ECHS1;ACAT1;HMGCL;HMGCS2;HADH;ACSM1,8 (8),5.65e-05,0.000432,1,HMDB0001166,19 (19),0.885,1,0.000546,0.00307
Cholesterol biosynthesis via lathosterol,Reactome,3,EBP;DHCR7;DHCR24,4 (4),0.0231,0.0797,5,HMDB0000067;HMDB0001170;HMDB0006841;HMDB0000032;HMDB0006271,10 (10),0.00219,0.163,0.000551,0.0031
Betaine Metabolism,SMPDB,7,PEMT;MAT2B;AHCY;MAT2A;CHDH;BHMT;ALDH7A1,8 (8),5.65e-05,0.000432,1,HMDB0000043,20 (22),0.898,1,0.000553,0.0031
Pyrimidine nucleotides nucleosides metabolism,INOH,22,DPYD;CMPK1;ABAT;UPB1;CAD;CTPS2;NT5E;NT5C3A;DHODH;ENTPD5;NME3;NT5C2;UMPS;ITPA;DPYS;CPS1;NME1;NME2;RRM1;TYMP;NT5C;AK3,51 (51),5.71e-05,0.000435,3,HMDB0001342;HMDB0003349#HMDB0000528;HMDB0033934,53 (56),0.935,1,0.000579,0.00324
Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells,Wikipathways,10,HRAS;RAB5A;RAB5B;RRAS2;ARAF;HNRNPH1;RAB5C;MAPK1;HGS;PDCD6IP,18 (18),0.000556,0.00325,0,,0 (0),1,1,0.000556,0.00325
Other glycan degradation - Homo sapiens (human),KEGG,10,GLB1;HEXA;HEXB;ENGASE;GBA;AGA;FUCA1;MAN2C1;MAN2B1;MANBA,18 (18),0.000556,0.00325,0,,0 (0),1,1,0.000556,0.00325
Fas,INOH,12,MAPK9;FADD;BAX;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;MAP2K4;CASP3;YWHAQ;BID,24 (24),0.000558,0.00325,0,,0 (0),1,1,0.000558,0.00325
Arf1 pathway,PID,12,AP2A1;KDELR1;GOSR2;USO1;ARF1;COPA;AP2M1;RAC1;GBF1;ARFGAP1;CLTA;CLTB,20 (20),5.51e-05,0.000426,0,,6 (7),1,1,0.000596,0.00333
ABC-family proteins mediated transport,Reactome,22,SEL1L;ABCD3;ABCB7;ABCF1;ERLIN2;ABCB10;ABCC6;DERL1;ABCA6;EIF2S1;PEX3;EIF2S2;DERL2;ABCB6;OS9;APOA1;ABCD1;ABCC2;ERLEC1;ERLIN1;VCP;ABCB4,58 (58),0.000528,0.00313,3,HMDB0000067;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,11 (20),0.105,1,0.000601,0.00336
Recycling of eIF2:GDP,Reactome,7,EIF2S1;EIF2B1;EIF2B4;EIF2B3;EIF2B2;EIF2B5;EIF2S2,8 (8),5.65e-05,0.000432,0,,2 (2),1,1,0.00061,0.00339
ketogenesis,HumanCyc,7,BDH2;ACAT1;ACAT2;BDH1;HMGCL;HMGCS1;HMGCS2,8 (8),5.65e-05,0.000432,0,,12 (12),1,1,0.00061,0.00339
NS1 Mediated Effects on Host Pathways,Reactome,7,KPNA4;EIF2AK2;KPNB1;KPNA1;PABPN1;KPNA2;KPNA3,10 (10),0.000593,0.00343,0,,0 (1),1,1,0.000593,0.00343
VLDLR internalisation and degradation,Reactome,7,AP2A1;AP2A2;AP2B1;AP2M1;AP2S1;CLTA;CLTC,10 (10),0.000593,0.00343,0,,0 (0),1,1,0.000593,0.00343
RHO GTPases activate PAKs,Reactome,13,CALM1;CDC42;PAK2;CTTN;MYH14;FLNA;MYL9;MYH9;MYH11;RAC1;PPP1CB;MYL6;MYLK,23 (23),6.37e-05,0.000484,0,,6 (6),1,1,0.000679,0.00378
Lipid Metabolism Pathway,Wikipathways,14,PRKAG1;PRKAR2A;PRKAR1A;PDHA1;ACACA;ACLY;BCKDHA;FASN;ACSS2;PRKAA1;PRKAA2;PRKAB1;PRKACA;PRKACB,29 (29),0.00031,0.00191,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,8 (14),0.209,1,0.000689,0.00382
Phase I - Functionalization of compounds,Reactome,32,ADH5;ADH6;CMBL;EPHX1;PAOX;CYP1A2;CYB5B;AADAC;FMO1;FMO3;BPHL;MAOA;MAOB;CYP2E1;CYP4B1;CYP7A1;CYP8B1;FDX1;FDXR;CYP27A1;CYB5R3;POR;ALDH1A1;AIP;ALDH1B1;ACSS2;NQO2;CYP39A1;PTGES3;PTGS1;MTARC1;HSP90AB1,101 (101),0.00137,0.0071,22,HMDB0001186;HMDB0033934;HMDB0001547;HMDB0000145;HMDB0002995;HMDB0000015;HMDB0001251;HMDB0000067;HMDB0014813;HMDB0041905;HMDB0001043;HMDB0000876;HMDB0003550;HMDB0000234;HMDB0006763;HMDB0003208;HMDB0001276;HMDB0013195;HMDB0006543;HMDB0060136;HMDB0001920;HMDB0001993,143 (191),0.0484,1,0.000704,0.00388
Pentose phosphate pathway,Reactome,10,PGLS;RPE;PGD;PGM2;TALDO1;TKT;RBKS;SHPK;RPIA;DERA,15 (15),6.66e-05,0.000497,0,,27 (31),1,1,0.000707,0.00388
GRB2:SOS provides linkage to MAPK signaling for Integrins ,Reactome,10,FGA;FGB;GRB2;ITGB3;RAP1A;RAP1B;TLN1;FGG;ITGA2B;FN1,15 (15),6.66e-05,0.000497,0,,4 (6),1,1,0.000707,0.00388
p130Cas linkage to MAPK signaling for integrins,Reactome,10,FGA;FGB;TLN1;ITGB3;RAP1A;RAP1B;CRK;FGG;ITGA2B;FN1,15 (15),6.66e-05,0.000497,0,,6 (8),1,1,0.000707,0.00388
Glycolysis,SMPDB,10,PKLR;ALDOA;GAPDH;PGAM1;ENO1;BPGM;SLC2A2;GPI;GALM;TPI1,15 (15),6.66e-05,0.000497,0,,21 (24),1,1,0.000707,0.00388
Glycogenosis_ Type VII. Tarui disease,SMPDB,10,PKLR;ALDOA;GAPDH;PGAM1;ENO1;BPGM;SLC2A2;GPI;GALM;TPI1,15 (15),6.66e-05,0.000497,0,,21 (24),1,1,0.000707,0.00388
Fanconi-bickel syndrome,SMPDB,10,PKLR;ALDOA;GAPDH;PGAM1;ENO1;BPGM;SLC2A2;GPI;GALM;TPI1,15 (15),6.66e-05,0.000497,0,,21 (24),1,1,0.000707,0.00388
Gastrin,NetPath,17,SHC1;MAPK9;EGFR;PXN;ITGB1;PRKCA;RPS6;ANXA2;PIK3R1;RELA;STAT3;MAPK14;MAP2K1;MAPK1;CTNNB1;ELAVL1;GRB2,41 (41),0.000683,0.00394,0,,0 (0),1,1,0.000683,0.00394
Purine catabolism,Reactome,11,NT5C2;PNP;XDH;NT5E;GDA;NT5C;ITPA;NUDT9;NUDT5;NUDT16;DNPH1,18 (18),9.04e-05,0.000664,3,HMDB0000195;HMDB0001178;HMDB0000189,38 (51),0.791,1,0.000755,0.00413
Tyrosinemia_ transient_ of the newborn,SMPDB,11,MAOA;COMT;FAH;HGD;GSTZ1;DDC;HAAO;TAT;GOT1;MIF;HPD,18 (18),9.04e-05,0.000664,5,HMDB0001229;HMDB0000318;HMDB0033934;HMDB0002281;HMDB0004067,62 (67),0.812,1,0.000772,0.00418
Dopamine beta-hydroxylase deficiency,SMPDB,11,MAOA;COMT;FAH;HGD;GSTZ1;DDC;HAAO;TAT;GOT1;MIF;HPD,18 (18),9.04e-05,0.000664,5,HMDB0001229;HMDB0000318;HMDB0033934;HMDB0002281;HMDB0004067,62 (67),0.812,1,0.000772,0.00418
Tyrosine Metabolism,SMPDB,11,MAOA;COMT;FAH;HGD;GSTZ1;DDC;HAAO;TAT;GOT1;MIF;HPD,18 (18),9.04e-05,0.000664,5,HMDB0001229;HMDB0000318;HMDB0033934;HMDB0002281;HMDB0004067,62 (67),0.812,1,0.000772,0.00418
Alkaptonuria,SMPDB,11,MAOA;COMT;FAH;HGD;GSTZ1;DDC;HAAO;TAT;GOT1;MIF;HPD,18 (18),9.04e-05,0.000664,5,HMDB0001229;HMDB0000318;HMDB0033934;HMDB0002281;HMDB0004067,62 (67),0.812,1,0.000772,0.00418
Monoamine oxidase-a deficiency (MAO-A),SMPDB,11,MAOA;COMT;FAH;HGD;GSTZ1;DDC;HAAO;TAT;GOT1;MIF;HPD,18 (18),9.04e-05,0.000664,5,HMDB0001229;HMDB0000318;HMDB0033934;HMDB0002281;HMDB0004067,62 (67),0.812,1,0.000772,0.00418
Hawkinsinuria,SMPDB,11,MAOA;COMT;FAH;HGD;GSTZ1;DDC;HAAO;TAT;GOT1;MIF;HPD,18 (18),9.04e-05,0.000664,5,HMDB0001229;HMDB0000318;HMDB0033934;HMDB0002281;HMDB0004067,62 (67),0.812,1,0.000772,0.00418
Tyrosinemia Type I,SMPDB,11,MAOA;COMT;FAH;HGD;GSTZ1;DDC;HAAO;TAT;GOT1;MIF;HPD,18 (18),9.04e-05,0.000664,5,HMDB0001229;HMDB0000318;HMDB0033934;HMDB0002281;HMDB0004067,62 (67),0.812,1,0.000772,0.00418
glycine betaine degradation,HumanCyc,5,SHMT2;BHMT;SHMT1;SARDH;DMGDH,5 (5),0.000238,0.00149,2,HMDB0000123;HMDB0000043,11 (11),0.334,1,0.000831,0.00449
Cytoprotection by HMOX1,Reactome,25,CUL3;BLVRB;CUL1;COX6C;BLVRA;MT-CO1;MT-CO2;MT-CO3;COX4I1;COX5B;COX6A1;HELZ2;COX7C;COX5A;COX7A2L;ALB;NDUFA4;HMOX1;HMOX2;HM13;SKP1;RXRA;STAT3;FABP1;RBX1,65 (65),0.000175,0.00121,3,HMDB0001388;HMDB0000054;HMDB0001043,23 (29),0.455,1,0.000833,0.0045
G13 Signaling Pathway,Wikipathways,16,PFN1;CFL1;RHOA;IQGAP2;CDC42;DIAPH1;RAC1;ARHGDIB;ROCK1;GNA13;CFL2;CYFIP1;IQGAP1;PPP1CB;CALM1;WASL,38 (38),0.000799,0.00457,0,,0 (0),1,1,0.000799,0.00457
Valproic acid pathway,Wikipathways,9,IVD;UGT1A3;ACADSB;EHHADH;ABAT;HSD17B10;HADHA;HADHB;ACSM1,13 (13),0.000102,0.000742,1,HMDB0060682,14 (14),0.797,1,0.000849,0.00457
Galactose metabolism,INOH,9,GALT;GLB1;UGP2;PGM1;GCK;GALK1;GALK2;HK1;HK3,13 (13),0.000102,0.000742,1,HMDB0035312,14 (15),0.797,1,0.000849,0.00457
Lidocaine metabolism,Wikipathways,1,CYP1A2,2 (2),0.342,0.67,5,HMDB0060656;HMDB0060678;HMDB0014426;HMDB0060655;HMDB0060679,7 (8),0.00024,0.0302,0.000855,0.00459
B cell receptor signaling,INOH,43,PSMD6;GRB2;UBE2N;UBE2V1;PIK3R1;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;HRAS;PSMB9;PSMB10;PSMC1;PSMC2;PSMC3;PSMC4;PSMC5;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;MAPK1;RELA;MAP2K1;MAP2K2;IGHM;ARAF,134 (134),0.000167,0.00115,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,6 (7),0.494,1,0.000857,0.00459
Glycerophospholipid biosynthesis,Reactome,41,GPD1;GPD2;ACP6;PCYT1A;PLBD1;GPD1L;CEPT1;PTPMT1;PEMT;CHPT1;LPGAT1;MBOAT7;CSNK2A1;LPCAT3;CSNK2A2;CSNK2B;CDIPT;CDS2;STARD10;AGPAT2;AGPAT3;CPNE3;OSBPL8;LCLAT1;AGK;CPNE1;PCYT2;GPAM;MGLL;PITPNB;PISD;ETNPPL;HADHA;HADHB;SELENOI;CHKB;PNPLA8;PLA2G15;NDUFS3;DGAT1;PLD4,130 (130),0.000352,0.00214,7,HMDB0062321;HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0033934;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,47 (94),0.234,1,0.000857,0.00459
Mitochondrial translation termination,Reactome,32,MRPL4;MRPL17;MRPS30;MRPS23;DAP3;MRPS27;OXA1L;MRPL14;MRPL16;MRPL12;MRPL47;MRPS2;MRPS18B;MRPS25;MRPL37;MRPS34;MRPS21;MRPS26;MRPL43;MRPS11;MRPL19;MRPS5;MRPS16;MRPL3;MRPS36;MRPL49;MRPL9;MRRF;MRPL1;MRPS22;MTRF1L;PTCD3,88 (88),8.33e-05,0.00062,0,,3 (26),1,1,0.000866,0.00463
Starch and sucrose metabolism - Homo sapiens (human),KEGG,17,UGP2;GANC;GPI;GBE1;PGM2;PYGB;PYGL;ENPP1;GYG1;ENPP3;AGL;PGM1;GCK;GYS2;GAA;HK1;HK3,36 (36),0.000101,0.000739,1,HMDB0006857,16 (37),0.838,1,0.000879,0.0047
Synthesis of bile acids and bile salts via 24-hydroxycholesterol,Reactome,9,CYP39A1;AKR1C1;HSD3B7;AMACR;CYP8B1;SLC27A5;SLC27A2;CYP27A1;AKR1D1,14 (14),0.000238,0.00149,3,HMDB0062206;HMDB0000067;HMDB0060136,20 (29),0.365,1,0.0009,0.0048
Hijack of ubiquitination by SARS-CoV-2,Wikipathways,6,CUL2;ELOC;ELOB;UBA3;NAE1;RBX1,8 (8),0.000885,0.00493,0,,0 (0),1,1,0.000885,0.00493
Biotin transport and metabolism,Reactome,8,ACACB;PC;PCCA;PCCB;BTD;MCCC2;MCCC1;ACACA,11 (11),0.000152,0.00106,1,HMDB0003134,8 (9),0.597,1,0.000936,0.00498
Fructose and mannose metabolism - Homo sapiens (human),KEGG,16,GFUS;ALDOA;FBP1;ALDOB;GMPPA;AKR1B1;TPI1;PMM2;MPI;KHK;TKFC;HK1;PFKL;SORD;HK3;GMPPB,33 (33),0.000109,0.000782,2,HMDB0003539;HMDB0029931,31 (54),0.861,1,0.000964,0.00512
Validated targets of C-MYC transcriptional activation,PID,29,HSPD1;NPM1;HSPA4;CAD;RUVBL1;GAPDH;NDUFAF2;EIF2S1;UBTF;EIF4A1;PRDX3;EIF4E;EIF4G1;BAX;SHMT1;GPAM;RCC1;NCL;ACTL6A;NME1;NME2;LDHA;ENO1;RUVBL2;MTDH;TFRC;RPL11;HSP90AA1;PTMA,87 (87),0.000926,0.00514,0,,0 (0),1,1,0.000926,0.00514
Farnesoid X receptor pathway,Wikipathways,10,ABCB11;CYP7A1;CYP8B1;SLCO2B1;RXRA;FKBP5;SLC27A5;SLC10A1;ABCB4;BAAT,19 (19),0.000977,0.00539,0,,0 (1),1,1,0.000977,0.00539
N-cadherin signaling events,PID,17,CALM1;CTTN;PIK3R1;CDC42;DCTN1;CDH2;MAPRE1;ROCK1;KIF5B;RAC1;JUP;RHOA;PTPN11;GSN;CTNNA1;CTNNB1;CTNND1,36 (36),0.000101,0.000739,0,,5 (5),1,1,0.00103,0.00546
Nuclear import of Rev protein,Reactome,17,RAE1;NUP98;NUP133;NPM1;RANBP2;TPR;RAN;KPNB1;RCC1;NUP210;NUP93;NUP35;NUP58;NUP160;SEC13;NUP205;NUP155,36 (36),0.000101,0.000739,0,,2 (3),1,1,0.00103,0.00546
Processing of SMDT1,Reactome,9,MICU2;PHB2;PMPCB;MAIP1;PMPCA;MCU;AFG3L2;PHB;SPG7,13 (13),0.000102,0.000742,0,,1 (1),1,1,0.00104,0.00552
Focal adhesion - Homo sapiens (human),KEGG,60,MYL12A;COL4A2;DIAPH1;COL6A1;FLNA;COL6A3;RAP1A;RHOA;RAP1B;COL6A2;IGF1;VTN;ILK;MAPK1;MYL9;FN1;COL6A6;EGFR;GRB2;PIK3R1;MYLK;TLN1;LAMB2;CAPN2;PPP1CC;ACTB;PARVA;SHC1;HRAS;LAMA2;PXN;PAK2;ACTG1;TLN2;PRKCA;CRKL;COL6A5;VCL;ROCK1;ACTN4;FLNB;ACTN1;ITGA1;CAV1;ITGA2B;CTNNB1;ITGA5;ITGA9;MAPK9;MAP2K1;CDC42;ITGB1;ITGB3;ZYX;CRK;RAC1;PPP1CA;PPP1CB;COL1A1;COL1A2,201 (201),0.000103,0.000745,0,,1 (2),1,1,0.00105,0.00554
Synthesis of bile acids and bile salts via 27-hydroxycholesterol,Reactome,6,CYP7A1;HSD3B7;AKR1C1;CYP8B1;CYP27A1;AKR1D1,11 (11),0.00868,0.0347,5,HMDB0000067;HMDB0012455;HMDB0006281;HMDB0001231;HMDB0062420,14 (16),0.0121,0.643,0.00107,0.00564
Aminoacyl-tRNA biosynthesis - Homo sapiens (human),KEGG,25,HARS2;AARS1;FARSA;IARS2;SARS2;RARS1;AARS2;MARS1;WARS1;IARS1;YARS1;LARS1;NARS1;FARSB;DARS1;QARS1;HARS1;TARS2;CARS2;VARS1;TARS1;SEPSECS;PARS2;SARS1;YARS2,66 (66),0.000232,0.00149,3,HMDB0000123;HMDB0000172;HMDB0000687,23 (52),0.455,1,0.00107,0.00565
Metabolism of cofactors,Reactome,12,CALM1;SPR;DHFR;PTS;COQ5;GCH1;COQ7;COQ9;HSP90AA1;IDH1;COQ6;COQ3,21 (21),0.000107,0.000769,0,,41 (48),1,1,0.00108,0.00569
Fatty acid elongation - Homo sapiens (human),KEGG,14,ELOVL5;PPT1;ACOT7;HACD3;HSD17B12;ACAA2;TECR;ACOT2;HADHA;HADHB;HADH;ACOT4;MECR;ECHS1,27 (27),0.000117,0.000834,1,HMDB0003944,27 (40),0.954,1,0.00113,0.00593
Vitamins A and D - action mechanisms,Wikipathways,1,RXRA,3 (3),0.466,0.843,5,HMDB0006500;HMDB0000305;HMDB0000876;HMDB0000032;HMDB0003550,7 (10),0.00024,0.0302,0.00113,0.00593
De novo fatty acid biosynthesis,EHMN,19,NUP98;NUP133;BAAT;NUP58;CTSA;ACOT7;NUP155;NUP160;SLC27A1;RPL14;ACOT8;DBI;NUP210;NUP93;NUP35;ACOT4;RANBP2;NUP205;ACOT2,43 (43),0.000123,0.000871,1,HMDB0000944,24 (59),0.935,1,0.00115,0.00603
Acetaminophen Metabolism Pathway,SMPDB,15,PDIA4;CYP2E1;GSTP1;UGT2B15;PPIB;CYP1A2;SDF2L1;HSPA5;DNAJB11;ERP29;PDIA6;SULT1A1;GSTT1;HYOU1;SULT1E1,30 (30),0.000115,0.00082,0,,16 (16),1,1,0.00116,0.00603
Posttranslational regulation of adherens junction stability and dissassembly,PID,22,JUP;PTPN6;EGFR;DSP;GNA13;HGS;HRAS;CASP3;RAB7A;CTNNA1;CTNNB1;CTNND1;NME1;CDC42;CDH1;CDH2;RAB5A;SNX1;RAC1;DNM2;IQGAP1;ARF6,53 (53),0.000115,0.00082,0,,3 (3),1,1,0.00116,0.00603
transcription factor creb and its extracellular signals,BioCarta,14,SHC1;HRAS;PRKAR1A;PRKAR2A;PRKCA;CAMK2A;CAMK2D;RPS6KA1;GRB2;MAPK14;MAPK1;PIK3R1;GNAS;PRKACB,27 (27),0.000117,0.000834,0,,5 (5),1,1,0.00118,0.00614
Programmed Cell Death,Reactome,45,CDC37;VIM;FLOT2;DBNL;CASP3;FADD;PDCD6IP;LMNA;CD14;FNTA;DSG2;SEPTIN4;DSP;TJP1;CASP6;GSDMD;SPTAN1;GAS2;DYNLL2;C1QBP;BAX;PAK2;LMNB1;ACIN1;DNM1L;ROCK1;PLEC;MAPK1;YWHAQ;CTNNB1;TJP2;FLOT1;NMT1;CDH1;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;BID;OPA1;GSN;HSP90AA1;KPNA1;KPNB1,142 (142),0.000165,0.00114,1,HMDB0000290,11 (21),0.714,1,0.00118,0.00614
Vitamin D Metabolism,Wikipathways,4,RXRA;CYP27A1;DHCR7;GC,10 (10),0.102,0.269,5,HMDB0000067;HMDB0006500;HMDB0000876;HMDB0000032;HMDB0003550,9 (9),0.0012,0.107,0.00122,0.00636
Localization of the PINCH-ILK-PARVIN complex to focal adhesions,Reactome,4,ITGB1;ILK;PXN;PARVA,4 (4),0.00127,0.00663,0,,0 (0),1,1,0.00127,0.00663
Porphyrin metabolism,INOH,6,CPOX;HMBS;ALAD;PPOX;FECH;UROD,7 (7),0.000264,0.00164,2,HMDB0033934;HMDB0001149,15 (16),0.49,1,0.00129,0.00667
4-hydroxy-2-nonenal detoxification,HumanCyc,5,GSTA1;GSTA3;GSTA4;GSTP1;GSTA5,5 (5),0.000238,0.00149,1,HMDB0000123,7 (8),0.549,1,0.0013,0.00674
5-oxoprolinase deficiency,SMPDB,8,ANPEP;GCLC;GCLM;GGCT;OPLAH;GSR;GSS;GPX1,11 (11),0.000152,0.00106,1,HMDB0000123,20 (22),0.898,1,0.00135,0.00693
Gamma-glutamyl-transpeptidase deficiency,SMPDB,8,ANPEP;GCLC;GCLM;GGCT;OPLAH;GSR;GSS;GPX1,11 (11),0.000152,0.00106,1,HMDB0000123,20 (22),0.898,1,0.00135,0.00693
Gamma-Glutamyltransferase Deficiency,SMPDB,8,ANPEP;GCLC;GCLM;GGCT;OPLAH;GSR;GSS;GPX1,11 (11),0.000152,0.00106,1,HMDB0000123,20 (22),0.898,1,0.00135,0.00693
Glutathione Metabolism,SMPDB,8,ANPEP;GCLC;GCLM;GGCT;OPLAH;GSR;GSS;GPX1,11 (11),0.000152,0.00106,1,HMDB0000123,20 (22),0.898,1,0.00135,0.00693
Glutathione Synthetase Deficiency,SMPDB,8,ANPEP;GCLC;GCLM;GGCT;OPLAH;GSR;GSS;GPX1,11 (11),0.000152,0.00106,1,HMDB0000123,20 (22),0.898,1,0.00135,0.00693
5-Oxoprolinuria,SMPDB,8,ANPEP;GCLC;GCLM;GGCT;OPLAH;GSR;GSS;GPX1,11 (11),0.000152,0.00106,1,HMDB0000123,20 (22),0.898,1,0.00135,0.00693
Apoptotic cleavage of cell adhesion  proteins,Reactome,7,CASP3;DSG2;TJP2;CDH1;DSP;TJP1;CTNNB1,11 (11),0.00136,0.0071,0,,0 (0),1,1,0.00136,0.0071
TSH,NetPath,12,HRAS;MAP2K3;CALR;HSPA5;GNA11;GNA13;GNAI2;CANX;GNAQ;GNAS;ATP1A1;GNAI3,26 (26),0.00137,0.0071,0,,0 (0),1,1,0.00137,0.0071
Lysine metabolism,EHMN,22,RANBP2;NUP155;AASS;TMLHE;NUP210;NUP98;NUP133;PIPOX;SHMT1;SHMT2;GCDH;NUP93;NUP58;ALDH1B1;AADAT;ALDH9A1;OGDH;NUP160;ALDH7A1;NUP35;NUP205;DLST,60 (60),0.000904,0.00502,7,HMDB0013287;HMDB0033934;HMDB0001084;HMDB0000123;HMDB0012130;HMDB0001325;HMDB0000279,42 (53),0.157,1,0.0014,0.00716
Disease,Reactome,239,SEL1L;MTA2;PIK3AP1;TPR;EPS15;STAM2;MYH9;CDH1;IDH1;NUP58;IMPDH2;EIF2AK2;NCKAP1;BRK1;SIGMAR1;VPS4A;DPEP1;SPTBN1;ACTB;ACTG1;CHMP4B;NCBP1;RCC1;NCK1;TSG101;CHD4;ITGA2B;SSRP1;WASL;ITGB1;TRIP11;ITGB3;CHMP2A;F9;BANF1;ERLEC1;F12;CD163;STAT2;STAT3;DDX5;STAT5B;IQGAP1;DYNLL2;MPRIP;NUP205;PRDX2;STRN;FGA;AP2M1;AP1S1;CYFIP1;GANAB;ARPC1B;CHMP5;KITLG;AP2A1;UBE2I;GNG12;AP2B1;AP1G1;AGK;ARAF;DYNC1LI1;SUPT5H;PIK3R1;NUP210;PDCD6IP;VAMP2;HRAS;AP1M1;FGB;HNRNPK;RAB7A;CYFIP2;OS9;C3;PARP9;SLC25A4;PRKACA;BAIAP2;GNB1;GNB2;FXYD1;FKBP1A;KLKB1;RAB5A;ARPC2;FKBP4;GOLGA2;DYNC1H1;DYNC1I2;VCL;VCP;HSP90AA1;RBX1;PML;KPNA1;KPNB1;KPNA2;KPNA3;KPNA4;NPM1;AP1B1;MRC1;ELOC;ELOB;RAN;RANBP1;RANBP2;MAP2K4;VPS28;RAP1A;RAP1B;SFPQ;ABI1;CHMP6;HDAC6;FN1;RAE1;CALM1;DERL1;SLC25A5;RBBP4;ATP1A1;NT5E;CPSF6;CAMK2A;CAMK2D;VPS4B;POLR2A;CAPN1;CAPN2;CAPNS1;FGG;CANX;NUP98;DERL2;GRB2;MYO18A;B2M;VTA1;ST6GAL1;ARPC1A;RELA;LYN;ST3GAL4;NMT1;NCSTN;XPO1;CORO1A;NR3C1;XRCC5;PARP14;AP3B1;SKP1;YES1;YWHAB;YWHAE;ARPC5;ARPC4;ARPC3;AKT1S1;ACTR3;ACTR2;ERLIN1;CRK;ARF1;NUP35;CAST;PPP1CB;PPP1CC;PTPN11;CUL5;CDC37;RHOG;AP2S1;LSR;MAPK14;EEF2;TAF3;ATP6V1H;FXR1;ERLIN2;SNW1;NUP160;ITPR2;PSIP1;LMNB1;SND1;CSK;MAP2K3;PABPN1;MTOR;IGHG1;RAC1;SUGT1;TLN1;GNAS;HGS;NUP155;PRDX1;ENTPD5;SUPT16H;PRKACB;LMNA;NUP133;MOGS;CHMP3;PRKAR1A;PAK2;AP2A2;PRKAR2A;DYNC1LI2;ROCK1;TAF15;PRKCSH;NUP93;EGFR;MAPK1;CTNNB1;CTNND1;SYVN1;ATP1B1;ATP1B3;MAP2K1;MAP2K2;CDC42;ENO1;PTGES3;SEC13;CTSL;COMT;XRCC6;SHC1;HSP90AB1;LRRFIP1;HDAC2;ZC3HAV1,1029 (1029),0.000163,0.00113,7,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0033934;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0000123;HMDB0000693;HMDB0001178;HMDB0001342,91 (198),0.873,1,0.0014,0.00719
Valproic Acid Metabolism Pathway,SMPDB,8,IVD;UGT1A3;ACADSB;EHHADH;HSD17B10;HADHA;HADHB;ACSM1,11 (11),0.000152,0.00106,1,HMDB0060682,29 (30),0.963,1,0.00144,0.00736
NAD+ metabolism,Wikipathways,10,NMNAT1;NADK;NT5E;PARP1;SIRT5;SIRT3;SIRT2;NAMPT;CD38;NMNAT3,16 (16),0.000147,0.00104,0,,14 (14),1,1,0.00145,0.00738
Morphine Metabolism Pathway,SMPDB,10,PDIA4;UGT1A3;UGT2B15;PPIB;SDF2L1;HSPA5;DNAJB11;ERP29;PDIA6;HYOU1,16 (16),0.000147,0.00104,0,,6 (6),1,1,0.00145,0.00738
Glycosphingolipid biosynthesis - globoseries,EHMN,9,HEXA;HEXB;COPB1;ARCN1;COPA;COPG2;COPE;ST3GAL4;NAGA,18 (18),0.00279,0.0133,4,HMDB0006734;HMDB0000290;HMDB0004878;HMDB0000304,14 (22),0.0545,1,0.00149,0.00757
Platelet sensitization by LDL,Reactome,9,PTPN6;PPP2CB;PPP2R1A;MAPK14;APOB;PTPN11;PPP2R5D;PPP2R5E;PPP2R5A,17 (17),0.00167,0.00844,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,5 (6),0.0922,1,0.00151,0.00765
RHOH GTPase cycle,Reactome,17,NSFL1C;CSK;PAK2;RAB7A;TUBA1B;FAM91A1;ARHGDIA;ARHGDIB;ROCK1;JUP;VCP;STOM;CAV1;LAMTOR1;TFRC;DBT;OSBPL11,37 (37),0.000154,0.00107,0,,1 (1),1,1,0.00151,0.00765
Galactose metabolism - Homo sapiens (human),KEGG,14,GALT;UGP2;GANC;AKR1B1;PGM2;GALM;PFKL;GAA;GCK;GALK1;PGM1;HK1;GLB1;HK3,31 (31),0.000726,0.00417,5,HMDB0006790;HMDB0003553;HMDB0035312;HMDB0060468;HMDB0003213,30 (46),0.213,1,0.00151,0.00767
NRF2-ARE regulation,Wikipathways,11,NQO1;PGAM5;CUL3;YES1;PRKCA;GCLC;GCLM;AIMP2;RBX1;GSTA2;HMOX1,23 (23),0.00151,0.00776,0,,0 (0),1,1,0.00151,0.00776
Cholesterol Biosynthesis Pathway,Wikipathways,7,MSMO1;FDFT1;LSS;HMGCS1;MVK;IDI1;DHCR7,15 (15),0.0131,0.0503,5,HMDB0000067;HMDB0001170;HMDB0001251;HMDB0000032;HMDB0001188,14 (14),0.0121,0.643,0.00155,0.00786
Omega-3-Omega-6 FA synthesis,Wikipathways,8,ELOVL5;ACSL1;ACSL4;FADS2;ACOX1;ACOT2;ACOX3;FADS1,14 (14),0.00161,0.00816,0,,0 (1),1,1,0.00161,0.00816
Amino acids regulate mTORC1,Reactome,16,ATP6V1A;LAMTOR4;ATP6V1H;TCIRG1;LAMTOR2;MTOR;ATP6V1G1;ATP6V0C;ATP6V1C1;ATP6V1E1;ATP6V1B2;ATP6V1D;RRAGC;RHEB;ATP6V0D1;LAMTOR1,34 (34),0.00017,0.00117,0,,4 (4),1,1,0.00164,0.0083
Glucagon signaling pathway - Homo sapiens (human),KEGG,36,PHKB;PHKG2;PRKAG1;PPP3CA;FBP1;ACACA;ACACB;CALM1;PPP4C;PDHA1;PDHB;PCK2;CAMK2A;CAMK2D;GYS2;PRKAA1;PRKAA2;PRKAB1;PRKACA;PRKACB;PKM;PRMT1;PYGB;PYGL;PLCB3;GCK;GNAQ;GNAS;PFKL;CPT1A;LDHA;PGAM1;LDHB;PCK1;SLC2A2;ITPR2,107 (107),0.000194,0.00128,1,HMDB0000757,21 (26),0.909,1,0.0017,0.00859
Etoposide Action Pathway,SMPDB,11,PDIA4;PPIB;SDF2L1;MPO;HSPA5;DNAJB11;ERP29;PDIA6;TOP2B;PTGS1;HYOU1,19 (19),0.000178,0.00122,0,,14 (14),1,1,0.00172,0.00863
Etoposide Metabolism Pathway,SMPDB,11,PDIA4;PPIB;SDF2L1;MPO;HSPA5;DNAJB11;ERP29;PDIA6;TOP2B;PTGS1;HYOU1,19 (19),0.000178,0.00122,0,,14 (14),1,1,0.00172,0.00863
Metabolism of ingested SeMet_ Sec_ MeSec into H2Se,Reactome,7,GNMT;NNMT;CBS;MAT1A;CTH;SCLY;AHCY,9 (9),0.000213,0.00137,2,HMDB0000123;HMDB0033934,30 (33),0.849,1,0.00174,0.00872
Lissencephaly gene (LIS1) in neuronal migration and development,PID,15,CALM1;RHOA;IQGAP1;NUDC;YWHAE;LRPAP1;CSNK2A1;DYNC1H1;PAFAH1B1;RAC1;PPP2R5D;PAFAH1B2;PAFAH1B3;NDEL1;CDC42,31 (31),0.000184,0.00126,0,,1 (1),1,1,0.00176,0.00884
Beta oxidation of hexanoyl-CoA to butanoyl-CoA,Reactome,5,HADHB;HADH;ACADS;ECHS1;HADHA,5 (5),0.000238,0.00149,1,HMDB0003944,13 (13),0.772,1,0.00177,0.00885
RHOD GTPase cycle,Reactome,21,RHOD;LMNB1;STBD1;VAPB;CAPZB;RAB7A;ARHGAP1;HINT2;ARHGAP17;ANKFY1;TOR1AIP1;PIK3R1;ESYT1;TMPO;STEAP3;ACTN1;EFHD2;CAV1;DIAPH1;PGRMC2;LMAN1,51 (51),0.000187,0.00128,0,,4 (4),1,1,0.00179,0.00895
Recycling pathway of L1,Reactome,14,AP2A1;AP2A2;AP2B1;DNM3;NUMB;CLTC;DPYSL2;RPS6KA1;AP2M1;AP2S1;DNM2;MAPK1;CLTA;RDX,28 (28),0.000194,0.00128,0,,5 (7),1,1,0.00185,0.00923
EGF,INOH,14,SHC1;HRAS;EGFR;GRB2;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;MAP2K4;MAP2K1;MAPK1;YWHAQ;MAP2K2,28 (28),0.000194,0.00128,0,,2 (2),1,1,0.00185,0.00923
NAD+ biosynthetic pathways,Wikipathways,12,NMNAT1;TDO2;NAPRT;PARP1;SIRT5;SIRT3;QPRT;NADSYN1;SIRT2;NAMPT;CD38;ACMSD,22 (22),0.000194,0.00128,0,,13 (13),1,1,0.00185,0.00923
Lactic Acidemia,SMPDB,5,AARS1;AARS2;GPT;AGXT;PC,5 (5),0.000238,0.00149,1,HMDB0000123,16 (17),0.838,1,0.0019,0.00941
Pyruvate Carboxylase Deficiency,SMPDB,5,AARS1;AARS2;GPT;AGXT;PC,5 (5),0.000238,0.00149,1,HMDB0000123,16 (17),0.838,1,0.0019,0.00941
Primary Hyperoxaluria Type I,SMPDB,5,AARS1;AARS2;GPT;AGXT;PC,5 (5),0.000238,0.00149,1,HMDB0000123,16 (17),0.838,1,0.0019,0.00941
Alanine Metabolism,SMPDB,5,AARS1;AARS2;GPT;AGXT;PC,5 (5),0.000238,0.00149,1,HMDB0000123,16 (17),0.838,1,0.0019,0.00941
MTOR signalling,Reactome,18,RRAGC;PRKAG1;LAMTOR4;CAB39;FKBP1A;YWHAB;MTOR;PRKAB1;AKT1S1;RPS6;LAMTOR2;EIF4E;RHEB;PRKAA1;PRKAA2;LAMTOR1;EIF4G1;PPM1A,41 (41),0.000203,0.00133,0,,9 (9),1,1,0.00193,0.00953
Putative anti-Inflammatory metabolites formation from EPA,EHMN,18,NUP98;NUP133;EPHX1;EPHX2;PTGES3;CBR1;CBS;PTGS1;NUP160;NUP155;ACOX2;NUP210;NUP93;NUP35;NUP58;RANBP2;NUP205;DHRS4,41 (41),0.000203,0.00133,0,,8 (10),1,1,0.00193,0.00953
Endocrine and other factor-regulated calcium reabsorption - Homo sapiens (human),KEGG,21,AP2A1;AP2A2;AP2B1;DNM3;ATP2B1;ATP1B1;ATP1A1;PRKCA;ATP1B3;RAB11A;PLCB3;AP2M1;AP2S1;GNAQ;DNM2;GNAS;CLTA;CLTB;CLTC;PRKACA;PRKACB,53 (53),0.000352,0.00214,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,8 (8),0.597,1,0.00199,0.00979
Methylation Pathways,Wikipathways,7,COMT;TPMT;NNMT;MAT2B;MAT1A;MAT2A;INMT,9 (9),0.000213,0.00137,0,,5 (5),1,1,0.00201,0.00979
Sepiapterin reductase deficiency,SMPDB,7,QDPR;AKR1B1;SPR;PTS;CBR1;GCH1;DHFR,9 (9),0.000213,0.00137,0,,19 (20),1,1,0.00201,0.00979
Segawa syndrome,SMPDB,7,QDPR;AKR1B1;SPR;PTS;CBR1;GCH1;DHFR,9 (9),0.000213,0.00137,0,,19 (20),1,1,0.00201,0.00979
Pterine Biosynthesis,SMPDB,7,QDPR;AKR1B1;SPR;PTS;CBR1;GCH1;DHFR,9 (9),0.000213,0.00137,0,,19 (20),1,1,0.00201,0.00979
Dopa-responsive dystonia,SMPDB,7,QDPR;AKR1B1;SPR;PTS;CBR1;GCH1;DHFR,9 (9),0.000213,0.00137,0,,19 (20),1,1,0.00201,0.00979
Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency,SMPDB,7,QDPR;AKR1B1;SPR;PTS;CBR1;GCH1;DHFR,9 (9),0.000213,0.00137,0,,19 (20),1,1,0.00201,0.00979
Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps),SMPDB,7,QDPR;AKR1B1;SPR;PTS;CBR1;GCH1;DHFR,9 (9),0.000213,0.00137,0,,19 (20),1,1,0.00201,0.00979
Hyperphenylalaninemia due to dhpr-deficiency,SMPDB,7,QDPR;AKR1B1;SPR;PTS;CBR1;GCH1;DHFR,9 (9),0.000213,0.00137,0,,19 (20),1,1,0.00201,0.00979
Androgen and estrogen biosynthesis and metabolism,EHMN,28,MPO;UGT1A3;CYP1A2;GSTZ1;SLC10A1;ARSB;STS;MGST1;COPA;MGST3;GSTK1;CYP4B1;SLCO2B1;COPE;PRDX6;SRD5A1;AKR1D1;UGT2B10;UGT2B15;HSD17B12;COPB1;MGST2;COPG2;CYP2E1;HSD11B1;HSD17B2;AKR1C1;ARCN1,87 (87),0.00205,0.0102,9,HMDB0000234;HMDB0000899;HMDB0000145;HMDB0002829;HMDB0004484;HMDB0000343;HMDB0000077;HMDB0003769;HMDB0000313#HMDB0000335,53 (62),0.108,1,0.00207,0.0101
TBC/RABGAPs,Reactome,17,RAB7A;RAB6B;GABARAP;ARF6;RAB4A;RAB5A;RAB35;RAB6A;RAB5B;GGA1;RAB8B;RAB11B;RAB5C;TBC1D17;RAB8A;RAB33B;RAB11A,38 (38),0.00023,0.00148,0,,4 (4),1,1,0.00216,0.0105
Retrograde neurotrophin signalling,Reactome,9,AP2A1;AP2A2;AP2B1;DNM3;AP2M1;AP2S1;DNM2;CLTA;CLTC,14 (14),0.000238,0.00149,0,,4 (4),1,1,0.00223,0.0107
Regulation of pyruvate dehydrogenase (PDH) complex,Reactome,9,PDHA1;DLAT;DLD;PDK1;PDK2;PDK4;PDHX;PDHB;GSTZ1,14 (14),0.000238,0.00149,0,,9 (10),1,1,0.00223,0.0107
fatty acid &alpha;-oxidation,HumanCyc,5,PHYH;ALDH3A2;ACSL1;HACL1;SLC27A2,5 (5),0.000238,0.00149,0,,19 (20),1,1,0.00223,0.0107
tyrosine degradation,HumanCyc,5,FAH;HGD;HPD;TAT;GSTZ1,5 (5),0.000238,0.00149,0,,13 (13),1,1,0.00223,0.0107
Sulfide oxidation to sulfate,Reactome,5,SQOR;ETHE1;SLC25A10;SUOX;TST,5 (5),0.000238,0.00149,0,,12 (15),1,1,0.00223,0.0107
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA,Reactome,5,HADHB;ACADL;ECHS1;HADHA;HADH,5 (5),0.000238,0.00149,0,,13 (13),1,1,0.00223,0.0107
Beta oxidation of octanoyl-CoA to hexanoyl-CoA,Reactome,5,HADHB;HADH;ACADM;ECHS1;HADHA,5 (5),0.000238,0.00149,0,,13 (13),1,1,0.00223,0.0107
Fructose catabolism,Reactome,5,ALDH1A1;KHK;ALDOB;GLYCTK;TKFC,5 (5),0.000238,0.00149,0,,11 (15),1,1,0.00223,0.0107
Propionyl-CoA catabolism,Reactome,5,PCCB;MMAA;MMUT;MCEE;PCCA,5 (5),0.000238,0.00149,0,,7 (9),1,1,0.00223,0.0107
Tyrosine catabolism,Reactome,5,FAH;HGD;HPD;TAT;GSTZ1,5 (5),0.000238,0.00149,0,,14 (16),1,1,0.00223,0.0107
Signaling of Hepatocyte Growth Factor Receptor,Wikipathways,14,HRAS;MAP2K1;PXN;ITGB1;STAT3;RAP1A;RAP1B;PTPN11;GRB2;CRKL;ITGA1;MAPK1;CRK;MAP2K2,34 (34),0.00216,0.0107,0,,0 (0),1,1,0.00216,0.0107
Phenylalanine metabolism - Homo sapiens (human),KEGG,10,MAOA;MAOB;GLYAT;HPD;DDC;TAT;GOT1;GOT2;MIF;PAH,17 (17),0.000298,0.00184,3,HMDB0015451;HMDB0001943;HMDB0006344,40 (60),0.82,1,0.00227,0.0109
Lysine degradation - Homo sapiens (human),KEGG,22,PHYKPL;ACAT1;ACAT2;HYKK;EHHADH;AASS;TMLHE;PIPOX;DLD;GCDH;HADHA;HADH;ALDH1B1;COLGALT1;AADAT;ALDH9A1;ALDH3A2;ECHS1;DHTKD1;BBOX1;ALDH7A1;DLST,63 (63),0.00189,0.0094,7,HMDB0013287;HMDB0001084;HMDB0062259;HMDB0000123;HMDB0012130;HMDB0001325;HMDB0000279,40 (50),0.13,1,0.00228,0.0109
Intra-Golgi traffic,Reactome,19,GOSR1;COG5;STX5;GOLIM4;NAPG;NAPA;NSF;GOSR2;COG2;COG7;COG4;RAB30;ARF1;MAN1A1;YKT6;TRIP11;MAN2A1;RAB33B;SNAP29,45 (45),0.000254,0.00159,0,,4 (4),1,1,0.00236,0.0112
tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde,HumanCyc,6,AFMID;HAAO;IDO2;KYNU;KMO;TDO2,7 (7),0.000264,0.00164,0,,12 (13),1,1,0.00244,0.0116
Pentose Phosphate Metabolism,Wikipathways,6,PGLS;RPE;PGD;TKT;TALDO1;RPIA,7 (7),0.000264,0.00164,0,,9 (9),1,1,0.00244,0.0116
Glycine degradation,Reactome,4,DLD;AMT;GLDC;GCSH,4 (4),0.00127,0.00663,2,HMDB0000123;HMDB0033934,8 (11),0.209,1,0.00244,0.0116
Histidine degradation,INOH,12,MAOA;MAOB;ALDH1B1;ALDH3A2;HARS2;ALDH7A1;ALDH1A1;FTCD;HAL;HARS1;ALDH1A3;ALDH9A1,23 (23),0.000337,0.00206,2,HMDB0004181;HMDB0033934,26 (28),0.786,1,0.00244,0.0116
Digestion of dietary lipid,Reactome,0,,7 (7),1,1,7,HMDB0000036;HMDB0000637;HMDB0000951;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0000138,14 (17),0.000268,0.0327,0.00247,0.0117
Proximal tubule bicarbonate reclamation - Homo sapiens (human),KEGG,12,ATP1B1;ATP1B3;AQP1;SLC25A10;SLC38A3;PCK1;PCK2;GLS;GLUD1;ATP1A1;GLS2;MDH1,23 (23),0.000337,0.00206,1,HMDB0033934,15 (17),0.819,1,0.00253,0.012
IL2,NetPath,25,CRK;STAM2;PTPN6;PTPN11;NMI;MAPK14;MTOR;PIK3R1;RPS6;EIF4E;SHC1;GRB2;STAT4;RELA;EIF3B;MAPK1;NR3C1;MAP2K2;LYN;MAP2K1;ITM2B;STAT3;CRKL;HSP90AA1;STAT5B,76 (76),0.00248,0.0121,0,,0 (0),1,1,0.00248,0.0121
Prolactin Signaling Pathway,Wikipathways,25,FLNA;PTPN6;PTPN11;MAPK14;GRB2;MTOR;PIK3R1;RPS6;SHC1;HRAS;CASP3;PXN;RELA;MAPK1;CTSD;MAPK9;MAP2K1;MAP2K2;PPIB;ITGB1;YWHAG;YWHAZ;STAT3;RAC1;STAT5B,76 (76),0.00248,0.0121,0,,0 (0),1,1,0.00248,0.0121
Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human),KEGG,25,ATP6V1A;ATP6V1B2;ATP6V0C;MAP2K4;ATP6V1E1;PTPN11;ATP6V1H;ATP6V0A1;MAPK14;ATP6AP1;ATP6V0D1;F11R;EGFR;CSK;TJP1;ATP6V1D;CASP3;TCIRG1;ATP6V1G1;RELA;MAPK9;LYN;CDC42;ATP6V1C1;RAC1,70 (70),0.000656,0.00378,1,HMDB0033934,5 (7),0.433,1,0.0026,0.0123
Endosomal Sorting Complex Required For Transport (ESCRT),Reactome,15,CHMP4B;SNF8;CHMP3;STAM2;CHMP2A;VTA1;VPS4A;TSG101;VPS36;VPS4B;CHMP5;VPS28;VPS25;HGS;CHMP6,32 (32),0.000286,0.00177,0,,4 (4),1,1,0.00262,0.0123
TSLP,NetPath,10,MAPK9;MAP2K1;STAT5B;RELA;STAT3;STAT4;MAPK14;EIF4E;STAT6;MAPK1,21 (21),0.00258,0.0125,0,,0 (0),1,1,0.00258,0.0125
Role of Calcineurin-dependent NFAT signaling in lymphocytes,PID,22,RAN;MAPK14;XPO1;CALM1;CSNK1A1;CSNK2A1;PRKACA;CASP3;BAX;PRKCA;FKBP8;YWHAQ;MAPK9;FKBP1A;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;CHP1;KPNB1;KPNA2,56 (56),0.000297,0.00183,0,,1 (2),1,1,0.00271,0.0127
Gap junction trafficking,Reactome,7,MYO6;GJB1;AP2M1;DNM2;CLTA;CLTB;CLTC,12 (12),0.00274,0.0132,0,,0 (1),1,1,0.00274,0.0132
One carbon pool by folate - Homo sapiens (human),KEGG,11,SHMT1;SHMT2;MTHFD1;DHFR;ALDH1L2;AMT;ATIC;ALDH1L1;FTCD;GART;MTHFS,20 (20),0.000328,0.00202,0,,9 (9),1,1,0.00296,0.0139
links between pyk2 and map kinases,BioCarta,13,SHC1;HRAS;MAP2K1;GRB2;MAP2K3;PRKCA;RAC1;MAP2K4;MAPK14;CRKL;GNAQ;MAPK1;MAP2K2,26 (26),0.000329,0.00202,0,,2 (2),1,1,0.00296,0.0139
Formation of tubulin folding intermediates by CCT/TriC,Reactome,13,CCT3;CCT5;TCP1;CCT8;TUBA1B;CCT6A;TUBA4A;CCT7;CCT4;CCT2;TUBB2B;TUBA1C;TUBB4B,26 (26),0.000329,0.00202,0,,4 (4),1,1,0.00296,0.0139
purine nucleotides degradation,HumanCyc,8,NT5C2;ADA;XDH;NT5E;GDA;NT5C3A;PNP;IMPDH2,12 (12),0.00038,0.00229,1,HMDB0000195,19 (19),0.885,1,0.00303,0.0142
SUMOylation of SUMOylation proteins,Reactome,14,RAE1;UBE2I;NUP133;NUP98;TPR;NUP160;NUP210;NUP93;NUP35;NUP58;RANBP2;SEC13;NUP205;NUP155,35 (35),0.00299,0.0142,0,,0 (0),1,1,0.00299,0.0142
Tyrosine metabolism - Homo sapiens (human),KEGG,16,ADH5;COMT;ADH6;FAHD1;MAOB;MAOA;FAH;HGD;GSTZ1;DDC;TAT;GOT1;GOT2;MIF;AOX1;HPD,36 (36),0.000384,0.00231,4,HMDB0000318;HMDB0001229;HMDB0004366;HMDB0004067,58 (78),0.884,1,0.00305,0.0143
mechanism of acetaminophen activity and toxicity,BioCarta,5,CYP1A2;MT-CO2;MT-CO3;CYP2E1;PTGS1,6 (6),0.00121,0.00648,1,HMDB0001043,3 (3),0.289,1,0.00312,0.0146
Galactose Metabolism,SMPDB,8,GALT;UGP2;AKR1B1;PGM1;GCK;GALK1;GAA;HK1,13 (13),0.000825,0.00467,4,HMDB0006790;HMDB0035312;HMDB0003213;HMDB0003553,31 (36),0.43,1,0.00317,0.0148
Galactosemia,SMPDB,8,GALT;UGP2;AKR1B1;PGM1;GCK;GALK1;GAA;HK1,13 (13),0.000825,0.00467,4,HMDB0006790;HMDB0035312;HMDB0003213;HMDB0003553,31 (36),0.43,1,0.00317,0.0148
Selenoamino Acid Metabolism,SMPDB,8,MAT2A;MAT2B;CBS;MARS1;SEPHS2;CTH;SCLY;AHCY,12 (12),0.00038,0.00229,1,HMDB0033934,27 (28),0.954,1,0.00324,0.0151
Cholesterol biosynthesis via desmosterol,Reactome,3,EBP;DHCR7;DHCR24,4 (4),0.0231,0.0797,4,HMDB0000067;HMDB0006842;HMDB0002719;HMDB0006271,10 (10),0.0161,0.811,0.00331,0.0154
Computational Model of Aerobic Glycolysis,Wikipathways,8,ALDOA;LDHA;GAPDH;ENO1;PKM;GPI;HK1;TPI1,12 (12),0.00038,0.00229,0,,16 (20),1,1,0.00338,0.0156
Beta-oxidation of very long chain fatty acids,Reactome,8,EHHADH;ABCD1;ACOX1;ACOT8;ECI2;MLYCD;ACOT4;HSD17B4,12 (12),0.00038,0.00229,0,,16 (26),1,1,0.00338,0.0156
map kinase inactivation of smrt corepressor,BioCarta,8,SHC1;HRAS;EGFR;GRB2;MAP2K4;RAC1;MAPK14;MAP2K1,12 (12),0.00038,0.00229,0,,2 (2),1,1,0.00338,0.0156
Mitochondrial iron-sulfur cluster biogenesis,Reactome,8,LYRM4;ISCA2;GLRX5;FDX1;ISCU;FDXR;FXN;NFS1,12 (12),0.00038,0.00229,0,,6 (11),1,1,0.00338,0.0156
Pyrimidine catabolism,Reactome,8,TYMP;AGXT2;NT5E;DPYD;DPYS;NT5C;NT5C3A;UPB1,12 (12),0.00038,0.00229,0,,37 (39),1,1,0.00338,0.0156
Estrogen metabolism,Wikipathways,9,COMT;NQO1;GSTM1;UGT1A3;SULT1A1;CYP1A2;GSTA1;STS;SULT1E1,18 (18),0.00279,0.0133,4,HMDB0000145;HMDB0000343;HMDB0000313#HMDB0000335;HMDB0005895,19 (23),0.139,1,0.00342,0.0158
Metabolism of fat-soluble vitamins,Reactome,19,APOM;BCO2;RETSAT;RDH11;TTPA;TTR;AKR1C1;APOA1;APOA2;APOA4;APOB;LRP1;APOC3;VKORC1L1;APOC2;VKORC1;RBP1;APOE;RBP4,49 (49),0.000909,0.00505,4,HMDB0030020;HMDB0000067;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,31 (49),0.43,1,0.00346,0.0159
SUMOylation of ubiquitinylation proteins,Reactome,15,RAE1;UBE2I;NUP133;NUP98;RANBP2;TPR;NUP160;NUP210;NUP93;NUP35;NUP58;PML;SEC13;NUP205;NUP155,39 (39),0.00337,0.0159,0,,0 (0),1,1,0.00337,0.0159
Signaling by Receptor Tyrosine Kinases,Reactome,116,ATP6V1A;EPS15;STAM2;ATP6V0C;ATP6V1C1;ATP6V1E1;ATP6V0A1;ATP6AP1;NCKAP1;BRK1;RPS6KA1;HNRNPM;COL6A1;TCIRG1;COL6A5;NCBP1;NCK1;CHD4;ATP6V1B2;PTBP1;ITGB1;HNRNPA1;HNRNPF;HNRNPH1;STAT3;STAT5B;STAT6;ITPR2;NEDD4;PIK3R4;ESRP2;HRAS;CAV1;JUP;PTPN6;AP2M1;CYFIP1;KITLG;AP2A1;AP2A2;PTPRJ;YAP1;PIK3R1;HPN;ATP6V1D;CLTA;CLTC;DIAPH1;PXN;CALM1;CRKL;BAIAP2;PLG;EPN1;ITGB3;RAC1;HSP90AA1;DNM2;COL4A2;RALA;RALB;COL6A2;COL6A3;RAP1A;RAP1B;ABI1;ITCH;COL6A6;DUSP3;POLR2A;SHC1;GRB2;ATP6V1G1;NCSTN;APOE;YES1;EPS15L1;YWHAB;CRK;CYFIP2;PTPN11;MEMO1;CUL5;RHOA;CDC37;AP2S1;PPP2CB;USP8;PPP2R1A;PPP2R5D;ATP6V1H;IGF1;MAPK14;ATP6V0D1;TIAL1;EGFR;CSK;AAMP;MTOR;HGS;PRKACA;PRKACB;DNM3;PAK2;PRKCA;ROCK1;AP2B1;CTNNA1;FUS;MAPK1;CTNNB1;CTNND1;LYN;MAP2K1;MAP2K2;CDC42,464 (464),0.000539,0.00319,3,HMDB0000693;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000304,35 (53),0.742,1,0.00353,0.0162
EPH-Ephrin signaling,Reactome,26,MYL12A;WASL;MYH9;MYH11;RHOA;MYL9;MYH14;MYL6;CFL1;ARPC1A;ACTB;HRAS;PAK2;ACTG1;ROCK1;LYN;YES1;CDC42;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;RAC1;ARPC2,74 (74),0.000687,0.00395,1,HMDB0000123,8 (10),0.597,1,0.00361,0.0166
Synthesis_ secretion_ and inactivation of Glucagon-like Peptide-1 (GLP-1),Reactome,5,DPP4;SPCS1;SPCS2;SEC11A;SPCS3,7 (7),0.00356,0.0166,0,,0 (0),1,1,0.00356,0.0166
Beta1 integrin cell surface interactions,PID,22,TGFBI;COL6A1;TGM2;COL18A1;COL6A2;VTN;LAMA2;FN1;CD14;FGA;FGB;LAMB2;COL6A3;ITGA1;FGG;CD81;ITGA5;ITGA9;ITGB1;F13A1;COL1A1;COL1A2,66 (66),0.00366,0.0171,0,,0 (0),1,1,0.00366,0.0171
bioactive peptide induced signaling pathway,BioCarta,15,SHC1;HRAS;GRB2;PRKCA;PIK3R1;GNA11;CAMK2D;GNB1;STAT3;AGT;MAPK14;STAT5B;MAPK1;CAMK2A;MYLK,33 (33),0.000433,0.00259,0,,3 (3),1,1,0.00379,0.0174
Fat digestion and absorption - Homo sapiens (human),KEGG,14,MTTP;PLPP3;ACAT1;ACAT2;PLA2G12B;APOA4;APOA1;SLC27A1;APOB;SCARB1;DGAT1;GOT2;FABP1;AGPAT2,43 (43),0.0227,0.0797,3,HMDB0000067;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,6 (13),0.0191,0.891,0.00379,0.0174
SARS-CoV Infections,Reactome,36,MTA2;PARP14;AP2M1;AP2S1;GANAB;IMPDH2;COMT;MOGS;AP2B1;RBBP4;ATP1A1;CANX;AP2A1;UBE2I;ROCK1;ST6GAL1;ITGB1;PARP9;ST3GAL4;PRKCSH;NR3C1;ATP1B1;ATP1B3;FXYD1;PTGES3;AP2A2;CTSL;FKBP4;SIGMAR1;STAT2;DDX5;HSP90AA1;CHD4;HDAC2;FKBP1A;HSP90AB1,111 (111),0.000435,0.0026,0,,13 (26),1,1,0.0038,0.0174
Amoebiasis - Homo sapiens (human),KEGG,32,COL4A2;SERPINB9;LAMA2;FN1;CD14;PIK3R1;PRDX1;PRKACA;PRKACB;CASP3;RAB5C;RAB7A;LAMB2;PRKCA;GNA11;ACTN4;RELA;PLCB3;ACTN1;GNAQ;GNAS;C8A;C8B;C9;ITGB2;RAB5A;RAB5B;HSPB1;VCL;COL1A1;COL1A2;ARG1,101 (102),0.00137,0.0071,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0001043,11 (13),0.334,1,0.00397,0.0181
Glycogen synthetase deficiency,SMPDB,10,UGP2;GPI;GBE1;PYGL;GUSB;AGL;PGM1;GCK;GYS2;UGDH,18 (18),0.000556,0.00325,2,HMDB0006857;HMDB0000757,29 (29),0.835,1,0.00403,0.0182
Glycogenosis_ Type III. Cori disease_ Debrancher glycogenosis,SMPDB,10,UGP2;GPI;GBE1;PYGL;GUSB;AGL;PGM1;GCK;GYS2;UGDH,18 (18),0.000556,0.00325,2,HMDB0006857;HMDB0000757,29 (29),0.835,1,0.00403,0.0182
Mucopolysaccharidosis VI. Sly syndrome,SMPDB,10,UGP2;GPI;GBE1;PYGL;GUSB;AGL;PGM1;GCK;GYS2;UGDH,18 (18),0.000556,0.00325,2,HMDB0006857;HMDB0000757,29 (29),0.835,1,0.00403,0.0182
Sucrase-isomaltase deficiency,SMPDB,10,UGP2;GPI;GBE1;PYGL;GUSB;AGL;PGM1;GCK;GYS2;UGDH,18 (18),0.000556,0.00325,2,HMDB0006857;HMDB0000757,29 (29),0.835,1,0.00403,0.0182
Glycogenosis_ Type IV. Amylopectinosis_ Anderson disease,SMPDB,10,UGP2;GPI;GBE1;PYGL;GUSB;AGL;PGM1;GCK;GYS2;UGDH,18 (18),0.000556,0.00325,2,HMDB0006857;HMDB0000757,29 (29),0.835,1,0.00403,0.0182
Glycogenosis_ Type VI. Hers disease,SMPDB,10,UGP2;GPI;GBE1;PYGL;GUSB;AGL;PGM1;GCK;GYS2;UGDH,18 (18),0.000556,0.00325,2,HMDB0006857;HMDB0000757,29 (29),0.835,1,0.00403,0.0182
Starch and Sucrose Metabolism,SMPDB,10,UGP2;GPI;GBE1;PYGL;GUSB;AGL;PGM1;GCK;GYS2;UGDH,18 (18),0.000556,0.00325,2,HMDB0006857;HMDB0000757,29 (29),0.835,1,0.00403,0.0182
Arachidonate Epoxygenase - Epoxide Hydrolase,Wikipathways,3,COX5A;EPHX2;GSTP1,7 (7),0.129,0.326,5,HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314;HMDB0001043,11 (11),0.00367,0.255,0.0041,0.0185
Wnt Canonical,INOH,35,PSMD6;CUL1;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;PSMB10;PSMC1;PSMC2;PSMC3;PSMC4;PSMC5;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;CTNNB1;SKP1,120 (120),0.00401,0.0186,0,,0 (0),1,1,0.00401,0.0186
Wnt Mammals,INOH,35,PSMD6;CUL1;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PSMB7;PSMB8;PSMB9;PSMB10;PSMC1;PSMC2;PSMC3;PSMC4;PSMC5;PSMD1;PSMD2;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;CTNNB1;SKP1,120 (120),0.00401,0.0186,0,,0 (0),1,1,0.00401,0.0186
Central carbon metabolism in cancer - Homo sapiens (human),KEGG,25,MTOR;HIF1A;HK1;HK3;EGFR;PDHA1;PDHB;PDK1;SLC2A2;PIK3R1;GLS;GLS2;HRAS;PKM;GCK;IDH1;MAPK1;PFKL;LDHA;MAP2K1;MAP2K2;PGAM1;LDHB;SIRT3;IDH2,70 (70),0.000656,0.00378,3,HMDB0000123;HMDB0000172;HMDB0000687,35 (37),0.742,1,0.0042,0.0189
HIF-1 signaling pathway - Homo sapiens (human),KEGG,35,MTOR;CUL2;ELOC;ELOB;HIF1A;IGF1;HK1;PIK3R1;HK3;EGFR;GAPDH;PDHA1;PDHB;PDK1;CAMK2A;CAMK2D;RPS6;EIF4E;MAPK1;PRKCA;RELA;HMOX1;PFKL;MAP2K2;ALDOA;LDHA;MAP2K1;ALDOB;ENO1;LDHB;TF;STAT3;RBX1;TFRC;EIF4E2,109 (109),0.000638,0.00369,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,13 (15),0.772,1,0.00425,0.0191
EPHA-mediated growth cone collapse,Reactome,9,RHOA;YES1;MYH14;ROCK1;MYH9;MYH11;MYL6;MYL9;LYN,15 (15),0.000496,0.00295,0,,4 (5),1,1,0.00427,0.0192
WNT5A-dependent internalization of FZD4,Reactome,9,AP2A1;AP2A2;AP2B1;PRKCA;AP2M1;AP2S1;CLTA;CLTB;CLTC,15 (15),0.000496,0.00295,0,,4 (5),1,1,0.00427,0.0192
Mercaptopurine Metabolism Pathway,SMPDB,9,GMPS;TPMT;XDH;SLC29A1;HPRT1;RAC1;ADK;AOX1;PPAT,15 (15),0.000496,0.00295,0,,21 (24),1,1,0.00427,0.0192
Mitochondrial translation initiation,Reactome,30,MRPL4;MRPL17;MRPS30;MRPS23;DAP3;MRPS27;OXA1L;MRPL14;MRPL16;MRPL12;MRPL47;MRPS2;MRPS18B;MRPS25;MRPL37;MRPS34;MRPS21;MRPS26;MRPL43;MRPS11;MRPL19;MRPS5;MRPS16;MRPL3;MRPS36;MRPL49;MRPL9;MRPL1;MRPS22;PTCD3,88 (88),0.000499,0.00297,0,,5 (9),1,1,0.00429,0.0192
Choline catabolism,Reactome,5,SARDH;BHMT;ALDH7A1;DMGDH;CHDH,6 (6),0.00121,0.00648,2,HMDB0000123;HMDB0000043,13 (15),0.414,1,0.0043,0.0192
Tyrosine metabolism,EHMN,35,MPO;UGT1A3;CYP1A2;ACOT8;STS;UGT2B10;MAOA;MAOB;COPA;COPB1;GSTK1;EHHADH;CYP4B1;AMACR;ACOX1;COPE;PRDX6;MIF;ALDH9A1;ACOX3;DIO1;UGT2B15;COPG2;CYP2E1;HSD17B10;ACOT4;BAAT;HSD17B4;ALDH3A2;AKT1S1;ARCN1;ACOX2;GOT2;YARS2;HPD,108 (108),0.000528,0.00313,5,HMDB0001229;HMDB0000318;HMDB0004366;HMDB0033934;HMDB0004067,94 (105),0.98,1,0.00443,0.0198
Integrin signaling,Reactome,13,SHC1;FGA;FGB;CSK;ITGB3;RAP1A;RAP1B;CRK;TLN1;ITGA2B;FN1;FGG;GRB2,27 (27),0.000525,0.00312,0,,9 (12),1,1,0.00449,0.02
Necroptosis - Homo sapiens (human),KEGG,42,PARP1;CHMP3;CHMP6;CAMK2A;SLC25A4;SLC25A5;AIFM1;SQSTM1;VPS4A;CAMK2D;VPS4B;CHMP5;CAPN1;CAPN2;GLUD1;FTH1;GLUL;FADD;BAX;H2AX;PYGB;DNM1L;PYGL;HSP90AA1;MACROH2A1;STAT5B;MAPK9;CHMP4B;PPID;EIF2AK2;CHMP2A;PGAM5;FAF1;STAT2;STAT3;STAT4;VDAC1;VDAC2;STAT6;VDAC3;BID;HSP90AB1,159 (159),0.0117,0.0456,3,HMDB0004949;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0001043,8 (10),0.0454,1,0.00454,0.0203
Hypoxic and oxygen homeostasis regulation of HIF-1-alpha,PID,9,COPS5;CUL2;ELOC;ELOB;OS9;HIF1A;HSP90AA1;RBX1;RACK1,19 (19),0.00442,0.0203,0,,0 (0),1,1,0.00442,0.0203
role of mal in rho-mediated activation of srf,BioCarta,9,DIAPH1;RHOA;MAP2K1;MAP2K2;CDC42;HRAS;ROCK1;RAC1;MAPK1,19 (19),0.00442,0.0203,0,,0 (0),1,1,0.00442,0.0203
Neurodegenerative Diseases,Reactome,10,LMNA;LMNB1;YWHAE;GOLGA2;CAPN1;CAPN2;PRDX2;CAPNS1;PRDX1;CAST,18 (18),0.000556,0.00325,0,,4 (4),1,1,0.00473,0.021
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer_s disease models,Reactome,10,LMNA;LMNB1;YWHAE;GOLGA2;CAPN1;CAPN2;PRDX2;CAPNS1;PRDX1;CAST,18 (18),0.000556,0.00325,0,,4 (4),1,1,0.00473,0.021
Calnexin/calreticulin cycle,Reactome,12,SEL1L;DERL2;AMFR;RNF139;CALR;PRKCSH;PDIA3;OS9;CANX;UGGT1;GANAB;SYVN1,24 (24),0.000558,0.00325,0,,4 (17),1,1,0.00474,0.021
Gap junction degradation,Reactome,6,MYO6;AP2M1;DNM2;CLTA;CLTB;CLTC,10 (10),0.00469,0.0214,0,,0 (1),1,1,0.00469,0.0214
Cohesin Loading onto Chromatin,Reactome,6,SMC3;PDS5B;PDS5A;STAG2;SMC1A;RAD21,10 (10),0.00469,0.0214,0,,0 (1),1,1,0.00469,0.0214
Carnitine synthesis,Reactome,4,BBOX1;TMLHE;SHMT1;ALDH9A1,4 (4),0.00127,0.00663,2,HMDB0001325;HMDB0000123,14 (17),0.453,1,0.00485,0.0215
Phospholipid Biosynthesis,SMPDB,11,PEMT;CHPT1;GPD1;GPD2;PCYT1A;PLA2G15;LYPLA1;GPAM;PISD;CDIPT;PTPMT1,28 (28),0.00957,0.0379,6,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0011503;HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,27 (27),0.0616,1,0.00497,0.022
pentose phosphate pathway,HumanCyc,7,PGLS;RPE;PGD;TKT;TALDO1;RPIA;H6PD,10 (10),0.000593,0.00343,0,,14 (16),1,1,0.005,0.0221
Synthesis and degradation of ketone bodies - Homo sapiens (human),KEGG,7,BDH2;ACAT1;ACAT2;BDH1;HMGCL;HMGCS1;HMGCS2,10 (10),0.000593,0.00343,0,,6 (6),1,1,0.005,0.0221
Alpha 6 Beta 4 signaling pathway,Wikipathways,13,SHC1;HRAS;RHOA;LAMA2;GRB2;LAMB2;PRKCA;MTOR;PIK3R1;PTPN11;RAC1;MAPK14;MAPK1,33 (33),0.00487,0.0221,0,,0 (0),1,1,0.00487,0.0221
Glucose-Alanine Cycle,SMPDB,6,GPT2;SLC25A22;SLC38A4;SLC2A2;GLUD1;GPT,8 (8),0.000885,0.00493,1,HMDB0033934,10 (11),0.679,1,0.00506,0.0223
NRF2 pathway,Wikipathways,40,TXNRD1;GSTM1;GSTM2;UGT1A3;GSTM4;BLVRB;GSTP1;GSTT1;DNAJB1;SLC6A13;GSTA5;SERPINA1;SLC2A9;MGST2;MGST3;PTGR1;SLC39A14;GCLM;SLC2A2;SQSTM1;GSTT2;PRDX1;FTH1;NQO1;GSR;HMOX1;ABCC2;ME1;CBR1;PGD;RXRA;SLC39A7;PRDX6;GCLC;HSP90AA1;GSTA1;GSTA2;GSTA3;GSTA4;HSP90AB1,143 (143),0.00496,0.0223,0,,0 (1),1,1,0.00496,0.0223
Aggrephagy,Reactome,11,VCP;UBE2N;UBE2V1;DYNC1LI1;DYNC1H1;PARK7;DYNC1I2;DYNC1LI2;HSP90AA1;HDAC6;DYNLL2,26 (26),0.00497,0.0223,0,,0 (1),1,1,0.00497,0.0223
antigen processing and presentation,BioCarta,7,PSMB8;PSMB9;TAP2;CD74;B2M;PSMB5;PSMB6,13 (13),0.00498,0.0223,0,,0 (0),1,1,0.00498,0.0223
IL5,NetPath,17,SHC1;HRAS;LYN;BAX;MAP2K2;RACK1;YWHAZ;HCLS1;PTPN11;STAT3;CRKL;MAPK14;STAT5B;CTNNB1;RPS6KA1;DNM2;GRB2,48 (48),0.00505,0.0226,0,,0 (0),1,1,0.00505,0.0226
SUMOylation of RNA binding proteins,Reactome,17,RAE1;UBE2I;NUP133;NUP98;TPR;HNRNPC;NUP160;NOP58;HNRNPK;NUP210;NUP93;NUP35;NUP58;RANBP2;SEC13;NUP205;NUP155,48 (48),0.00505,0.0226,0,,0 (0),1,1,0.00505,0.0226
Brain-derived neurotrophic factor (BDNF) signaling pathway,Wikipathways,42,RHOG;DPYSL2;EEF2;PTPN11;CYFIP1;MAPK14;PIK3R1;RACK1;ACACB;NSF;MTOR;EIF2S1;SQSTM1;CAMK2A;CFL1;CSNK2A1;RPS6;RPS6KA1;EIF4E;PRKAA1;PRKAA2;EIF2S2;SHC1;HRAS;CASP3;GRB2;DLG1;NCK1;CAMK1;MAPK1;CTNNB1;RELA;MAPK9;MAP2K1;MAP2K2;CDC42;CDH2;RAP1A;MARCKS;STAT3;RAC1;STAT5B,144 (144),0.00174,0.00875,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (4),0.365,1,0.0053,0.0234
eicosapentaenoate biosynthesis,HumanCyc,8,ACSL1;ACSL4;FADS2;ACSM5;ACSM3;ACSL5;FADS1;ACSM1,13 (13),0.000825,0.00467,1,HMDB0001388,13 (17),0.772,1,0.00532,0.0234
RAF activation,Reactome,15,HRAS;MAP2K1;MAP2K2;CALM1;YWHAB;PPP2CB;PPP2R1A;CAMK2A;CAMK2D;ARAF;PPP2R5A;PPP2R5D;PPP2R5E;PPP1CB;PPP1CC,34 (34),0.000641,0.0037,0,,6 (6),1,1,0.00535,0.0235
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling,Wikipathways,10,NQO1;NQO2;EPHX1;GSTP1;GCLC;GCLM;ABCC6;MAPK14;HMOX1;ABCC2,23 (23),0.00581,0.0251,0,,0 (0),1,1,0.00581,0.0251
Threonine catabolism,Reactome,4,GCAT;SDS;SDSL;RIDA,5 (5),0.00537,0.0236,3,HMDB0000123;HMDB0033934;HMDB0006454,12 (14),0.13,1,0.00576,0.0253
Ubiquitin mediated proteolysis - Homo sapiens (human),KEGG,39,CUL5;CUL4B;CUL4A;CUL3;CUL2;CUL1;ELOC;UBE4A;ELOB;UBE2K;ITCH;UBE2D3;UBE2G1;UBE2G2;UBE2H;UBE2I;UBE2L3;UBE4B;UBE2N;UBE3A;UBE2J1;FBXO4;UBA6;UBA2;SAE1;PRPF19;UBA3;UBE2M;UBE3C;SYVN1;SKP1;TRIP12;DDB1;HERC4;UBE2Z;RBX1;PML;NEDD4;UBA1,140 (140),0.00591,0.0254,0,,0 (0),1,1,0.00591,0.0254
Triglyceride catabolism,Reactome,10,PPP1CA;GPD2;FABP7;FABP4;FABP1;MGLL;PPP1CB;PPP1CC;PRKACA;PRKACB,22 (22),0.00394,0.0183,3,HMDB0000067;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,14 (19),0.184,1,0.00595,0.0261
RAGE,NetPath,16,SHC1;HRAS;RHOA;EGFR;MAP2K2;MAPK9;RDX;AIFM1;RPS6KA1;ROCK1;RELA;HIF1A;STAT3;MAPK14;MAP2K1;MAPK1,45 (45),0.00616,0.0265,0,,0 (0),1,1,0.00616,0.0265
CXCR4-mediated signaling events,PID,29,RHOA;RALB;PTPN6;RAP1B;PTPN11;ITCH;UBQLN1;RACK1;CFL1;CSK;MTOR;STAT3;PIK3R1;GNA13;VPS4B;HGS;PXN;GNAI2;GNAI3;VPS4A;GNB1;LYN;YES1;CDC42;PLCB3;STAT2;CRK;RAC1;STAT5B,86 (86),0.000751,0.00431,0,,4 (4),1,1,0.00615,0.0269
Focal Adhesion,Wikipathways,56,VCL;RHOA;COL4A2;DIAPH1;FLNA;FLNB;RAP1A;MYL12A;RAP1B;COL6A2;IGF1;VTN;ILK;MAPK1;MYLK;GRB2;EGFR;PIK3R1;MYL9;TLN1;CAPN2;FN1;ACTB;PARVA;SHC1;HRAS;LAMA2;PXN;PAK2;ACTG1;LAMB2;PRKCA;RAC1;TLN2;ROCK1;ACTN4;COL1A1;ACTN1;ITGA1;CAV1;ITGA2B;CTNNB1;ITGA5;ITGA9;MAPK9;MAP2K1;CDC42;ITGB1;ITGB3;ZYX;CRK;CRKL;PPP1CA;PPP1CB;PPP1CC;COL1A2,198 (198),0.000764,0.00438,0,,1 (2),1,1,0.00625,0.0273
TGF-beta Signaling Pathway,Wikipathways,37,RHOA;CUL1;SKP1;MAP2K4;TRAP1;MAPK14;ITCH;SNW1;FN1;UBE2I;STRAP;PDK1;YAP1;PIK3R1;UCHL5;SPTBN1;HGS;SHC1;GRB2;PAK2;PRKAR2A;ROCK1;CAV1;MAPK1;MAP2K2;MAPK9;MAP2K1;MAP2K3;CDC42;ITGB1;ITGB3;COPS5;PPM1A;RAC1;RBX1;PML;COL1A2,132 (132),0.00646,0.0277,0,,0 (0),1,1,0.00646,0.0277
Breakdown of the nuclear lamina,Reactome,3,LMNA;LMNB1;CASP6,3 (3),0.00671,0.0279,0,,0 (0),1,1,0.00671,0.0279
Vitamin A Deficiency,SMPDB,15,RDH16;DHRS3;RETSAT;RDH11;PDIA4;SDF2L1;PPIB;HSPA5;DNAJB11;ERP29;PDIA6;DHRS4;DGAT1;ALDH1A1;HYOU1,37 (37),0.00183,0.00917,4,HMDB0006216;HMDB0006217;HMDB0006285#HMDB0006280;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,31 (32),0.43,1,0.00641,0.0279
Retinol Metabolism,SMPDB,15,RDH16;DHRS3;RETSAT;RDH11;PDIA4;SDF2L1;PPIB;HSPA5;DNAJB11;ERP29;PDIA6;DHRS4;DGAT1;ALDH1A1;HYOU1,37 (37),0.00183,0.00917,4,HMDB0006216;HMDB0006217;HMDB0006285#HMDB0006280;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,31 (32),0.43,1,0.00641,0.0279
Phenylalanine metabolism,Reactome,6,PCBD1;AKT1S1;KYAT1;ASRGL1;QDPR;PAH,8 (8),0.000885,0.00493,1,HMDB0033934,20 (22),0.898,1,0.00647,0.0282
Purine salvage,Reactome,8,APRT;ADA;PNP;AMPD2;HPRT1;DGUOK;ADK;GMPR2,13 (13),0.000825,0.00467,1,HMDB0000195,30 (31),0.967,1,0.00649,0.0282
Proteoglycans in cancer - Homo sapiens (human),KEGG,56,RHOA;FLNA;FLNB;RRAS2;MAPK14;HIF1A;PTPN11;IGF1;VTN;CAMK2A;ANK1;FN1;CTSL;EGFR;MTOR;PIK3R1;CAMK2D;RPS6;ACTB;PRKCA;PRKACA;PRKACB;HRAS;CASP3;PXN;ACTG1;RDX;DDX5;ROCK1;GRB2;PPP1CC;CAV1;MAPK1;CTNNB1;LUM;ITGA5;MAP2K2;CTTN;DCN;MAP2K1;ARHGEF12;CDC42;PTPN6;ITGB1;ITGB3;ITPR2;ARAF;PDCD4;HCLS1;STAT3;RAC1;IQGAP1;PPP1CA;PPP1CB;COL1A1;COL1A2,205 (205),0.00185,0.00923,1,HMDB0000693,5 (7),0.433,1,0.0065,0.0283
a6b1 and a6b4 Integrin signaling,PID,18,SHC1;HRAS;EGFR;GRB2;CDH1;ITGB1;LAMB2;PRKCA;YWHAE;YWHAG;YWHAH;YWHAZ;PIK3R1;RXRA;RAC1;LAMA2;YWHAQ;YWHAB,45 (45),0.000801,0.00458,0,,3 (3),1,1,0.00651,0.0283
Amino acid conjugation of benzoic acid,Wikipathways,4,GLYAT;GLYATL2;GLYATL1;ACSS2,4 (4),0.00127,0.00663,1,HMDB0000123,9 (11),0.64,1,0.00658,0.0285
lysine degradation II (pipecolate pathway),HumanCyc,5,AADAT;PIPOX;CRYM;ALDH7A1;DHTKD1,6 (6),0.00121,0.00648,2,HMDB0012130;HMDB0001084,21 (21),0.676,1,0.00662,0.0286
Cori Cycle,Wikipathways,9,LDHA;GAPDH;PGAM1;TALDO1;SLC2A2;GPI;HK1;GPT;TPI1,16 (16),0.000945,0.00523,1,HMDB0000757,18 (25),0.871,1,0.00667,0.0288
RHO GTPases activate IQGAPs,Reactome,8,CALM1;IQGAP2;CDC42;CDH1;RAC1;CTNNA1;IQGAP1;CTNNB1,13 (13),0.000825,0.00467,0,,2 (3),1,1,0.00668,0.0289
Photodynamic therapy-induced unfolded protein response,Wikipathways,11,EIF2A;NARS1;CALR;DNAJC3;HSPA5;DNAJB11;HSP90B1;PDIA6;ASNS;WARS1;SULT1E1,27 (27),0.00698,0.0289,0,,0 (0),1,1,0.00698,0.0289
Insulin resistance - Homo sapiens (human),KEGG,29,PTPA;PTPN11;ACACB;MLX;PCK1;MTOR;PCK2;PIK3R1;SLC27A1;RPS6KA1;GYS2;AGT;PRKAA1;PRKAA2;PRKAB1;PRKAG1;STAT3;PYGB;PYGL;RELA;CPT1A;MAPK9;GFPT1;SLC2A2;SLC27A5;SLC27A2;PPP1CA;PPP1CB;PPP1CC,108 (108),0.026,0.0887,4,HMDB0004949;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0000290,12 (20),0.032,1,0.00674,0.0291
Kennedy pathway from sphingolipids,Wikipathways,8,PEMT;CHKB;CHPT1;PCYT2;PCYT1A;SGPL1;PISD;CEPT1,14 (14),0.00161,0.00816,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,16 (18),0.525,1,0.00682,0.0294
methionine degradation,HumanCyc,5,AHCYL1;MAT2A;AHCY;MAT2B;MAT1A,6 (6),0.00121,0.00648,1,HMDB0000043,11 (11),0.714,1,0.00694,0.0298
Apoptosis,Reactome,39,VIM;FADD;DBNL;CASP3;LMNA;CD14;CTNNB1;DSG2;SEPTIN4;DSP;TJP1;CASP6;SPTAN1;GAS2;DYNLL2;C1QBP;BAX;PAK2;LMNB1;ACIN1;DNM1L;ROCK1;FNTA;PLEC;MAPK1;YWHAQ;TJP2;NMT1;CDH1;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;KPNB1;OPA1;GSN;KPNA1;BID,127 (127),0.000865,0.00489,0,,5 (8),1,1,0.00697,0.0299
Aflatoxin B1 metabolism,Wikipathways,6,GSTM1;AKR7A3;EPHX1;CYP1A2;GSTT1;AKR7A2,8 (8),0.000885,0.00493,0,,3 (7),1,1,0.00711,0.0302
palmitate biosynthesis,HumanCyc,6,ACOT7;FASN;OXSM;ACOT8;ACOT4;ACOT2,8 (9),0.000885,0.00493,0,,9 (10),1,1,0.00711,0.0302
sucrose degradation,HumanCyc,6,ALDOA;ALDOB;KHK;TKFC;GALM;TPI1,8 (8),0.000885,0.00493,0,,10 (12),1,1,0.00711,0.0302
Synthesis of Ketone Bodies,Reactome,6,BDH2;ACAT1;BDH1;HMGCL;HMGCS2;ACSS3,8 (8),0.000885,0.00493,0,,14 (14),1,1,0.00711,0.0302
glycogen biosynthesis,HumanCyc,6,UGP2;GBE1;PGM2;GYG1;PGM1;GYS2,8 (8),0.000885,0.00493,0,,5 (7),1,1,0.00711,0.0302
Galactosemia III,SMPDB,6,UGP2;GALT;PGM1;GCK;GALK1;UGDH,8 (8),0.000885,0.00493,0,,19 (20),1,1,0.00711,0.0302
Galactosemia II (GALK),SMPDB,6,UGP2;GALT;PGM1;GCK;GALK1;UGDH,8 (8),0.000885,0.00493,0,,19 (20),1,1,0.00711,0.0302
Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin,SMPDB,6,GNG12;MYLK;GNAS;MYL3;GNB1;PRKACB,8 (8),0.000885,0.00493,0,,9 (9),1,1,0.00711,0.0302
Nucleotide Sugars Metabolism,SMPDB,6,UGP2;GALT;PGM1;GCK;GALK1;UGDH,8 (8),0.000885,0.00493,0,,19 (20),1,1,0.00711,0.0302
Vitamin D3 (cholecalciferol) metabolism,EHMN,11,NUP98;NUP133;CYP27A1;RANBP2;NUP210;NUP93;NUP35;NUP58;NUP160;NUP205;NUP155,27 (27),0.00698,0.0289,3,HMDB0000876;HMDB0000032;HMDB0003550,12 (12),0.13,1,0.00725,0.0307
Fluid shear stress and atherosclerosis - Homo sapiens (human),KEGG,41,GSTM1;GSTM2;RHOA;GSTM4;GSTP1;GSTT1;GSTT2;HSP90B1;MAPK9;MAPK14;HMOX1;MGST1;MGST2;MGST3;CTSL;GSTA5;SQSTM1;PIK3R1;ICAM1;PRKAA1;PRKAA2;ACTB;ASS1;NQO1;ACTG1;RELA;CAV1;ITGA2B;CTNNB1;MAP2K4;TXN2;GSTO1;ITGB3;GSTA4;RAC1;HSP90AA1;GSTA1;GSTA2;GSTA3;CALM1;HSP90AB1,139 (139),0.00155,0.00793,1,HMDB0000693,8 (8),0.597,1,0.00739,0.0313
Post-translational protein phosphorylation,Reactome,34,HSP90B1;SERPINA1;PDIA6;FGG;FN1;APOA5;P4HB;CALU;MIA3;KTN1;SERPINC1;NUCB1;RCN1;FGA;LAMB2;CP;C3;APOA1;APOA2;APOB;SERPINA10;PRKCSH;CKAP4;APOE;C4A;CDH2;TF;DNAJC3;SERPIND1;ITIH2;KNG1;LGALS1;TGOLN2;ALB,107 (107),0.000932,0.00516,0,,2 (2),1,1,0.00744,0.0315
glutaryl-CoA degradation,HumanCyc,4,ACAT2;ECHS1;ACAT1;GCDH,4 (4),0.00127,0.00663,1,HMDB0062259,12 (12),0.745,1,0.00751,0.0317
heme degradation,HumanCyc,4,HMOX1;HMOX2;BLVRA;BLVRB,4 (4),0.00127,0.00663,1,HMDB0000054,12 (12),0.745,1,0.00751,0.0317
NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence,Wikipathways,11,ELAVL1;PARP1;SIRT5;SIRT3;SIRT2;GOT2;NAMPT;PRKAA1;MDH2;MDH1;GOT1,22 (22),0.000951,0.00525,0,,8 (12),1,1,0.00757,0.0319
Phosphonate and phosphinate metabolism - Homo sapiens (human),KEGG,5,PCYT2;CHPT1;PCYT1A;CEPT1;SELENOI,6 (6),0.00121,0.00648,1,HMDB0000123,14 (56),0.797,1,0.00764,0.0322
Prolactin,NetPath,22,FLNA;PTPN6;PTPN11;MAPK14;PXN;EGFR;GRB2;HMGN2;NCK1;STAT5B;MAPK1;MAP2K2;MAPK9;MAP2K1;CTSD;PPIB;ITGB1;YWHAG;RELA;YWHAZ;STAT3;DNM2,70 (70),0.008,0.0324,0,,0 (0),1,1,0.008,0.0324
AUF1 (hnRNP D0) binds and destabilizes mRNA,Reactome,5,HNRNPD;HSPA8;PABPC1;HSPB1;EIF4G1,8 (8),0.00802,0.0324,0,,0 (1),1,1,0.00802,0.0324
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components,Reactome,5,ACTN1;LIMS1;PXN;PARVA;RSU1,8 (8),0.00802,0.0324,0,,0 (0),1,1,0.00802,0.0324
Phase I biotransformations_ non P450,Wikipathways,5,PON1;ESD;LIPA;PON2;PON3,8 (8),0.00802,0.0324,0,,0 (4),1,1,0.00802,0.0324
Scavenging of heme from plasma,Reactome,7,AMBP;HP;APOA1;LRP1;CD163;ALB;HPX,12 (12),0.00274,0.0132,1,HMDB0000067,4 (6),0.365,1,0.00791,0.0333
retinol biosynthesis,HumanCyc,7,DHRS3;RDH10;RDH11;DHRS4;LIPC;RBP1;RBP4,19 (19),0.0514,0.155,6,HMDB0000944;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0003073;HMDB0001388;HMDB0001043;HMDB0002183,21 (37),0.0195,0.891,0.00792,0.0333
4-hydroxyproline degradation,HumanCyc,4,HOGA1;ALDH4A1;PRODH2;GOT2,4 (4),0.00127,0.00663,1,HMDB0240251,15 (17),0.819,1,0.00816,0.0342
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),Reactome,38,HSP90B1;SERPINA1;PDIA6;IGF1;IGFALS;FGG;FN1;APOA5;PLG;P4HB;CALU;MIA3;KTN1;SERPINC1;NUCB1;RCN1;FGA;LAMB2;CP;C3;APOA1;APOA2;APOB;SERPINA10;PRKCSH;CKAP4;APOE;C4A;F2;CDH2;TF;DNAJC3;SERPIND1;ITIH2;KNG1;LGALS1;TGOLN2;ALB,124 (124),0.00104,0.00576,0,,3 (3),1,1,0.00821,0.0344
lysine degradation I (saccharopine pathway),HumanCyc,4,AADAT;AASS;DHTKD1;ALDH7A1,4 (4),0.00127,0.00663,1,HMDB0000279,16 (16),0.838,1,0.00833,0.0348
VEGFA-VEGFR2 Pathway,Reactome,30,RHOA;JUP;ABI1;CYFIP1;MAPK14;CALM1;NCKAP1;BRK1;MTOR;PIK3R1;PRKACA;PRKACB;HRAS;PXN;PAK2;PRKCA;RAC1;ROCK1;NCK1;CTNNA1;CAV1;BAIAP2;CTNNB1;CTNND1;CDC42;ITGB3;CRK;CYFIP2;HSP90AA1;ITPR2,92 (92),0.00114,0.00627,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,25 (26),0.942,1,0.00843,0.0352
Recycling of bile acids and salts,Reactome,7,BAAT;ABCB11;RXRA;ALB;SLC27A5;SLC10A1;STARD5,16 (16),0.0196,0.0702,5,HMDB0000036;HMDB0000637;HMDB0000951;HMDB0000123;HMDB0000138,20 (20),0.0551,1,0.00846,0.0353
Rab regulation of trafficking,Reactome,36,RAB38;YWHAE;CCZ1B;GDI1;RAB10;RAB35;RAB11B;RAB3GAP1;RAB18;RAB31;TRAPPC12;RAB8B;RAB3GAP2;RAB11A;RAB7A;GABARAP;GAPVD1;RAB1B;TRAPPC3;TRAPPC8;RAB14;RAB21;RAB1A;RAB6B;GDI2;RAB4A;RAB5A;RAB5B;RAB6A;RAB13;GGA1;RAB5C;TBC1D17;RAB8A;RAB33B;ARF6,116 (116),0.00109,0.00598,0,,6 (6),1,1,0.0085,0.0354
Mitochondrial tRNA aminoacylation,Reactome,10,AARS2;CARS2;HARS2;IARS2;PARS2;QARS1;SARS2;YARS2;PPA2;TARS2,21 (21),0.00258,0.0125,3,HMDB0000123;HMDB0000172;HMDB0000687,22 (65),0.425,1,0.00858,0.0357
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,Reactome,16,GNG12;CCT3;CCT5;TCP1;CCT8;CCT6A;CCT7;CCT4;CCT2;CSNK2A1;CSNK2A2;CSNK2B;GNAQ;GNA11;GNB1;GNB2,39 (39),0.00112,0.00615,0,,3 (3),1,1,0.00873,0.0363
EPHB forward signaling,PID,16,SHC1;HRAS;MAP2K1;GRB2;CDC42;RAP1A;TF;ROCK1;PIK3R1;WASL;NCK1;RAP1B;CRK;RAC1;MAPK1;PXN,39 (39),0.00112,0.00615,0,,2 (2),1,1,0.00873,0.0363
Various types of N-glycan biosynthesis - Homo sapiens (human),KEGG,14,HEXA;HEXB;DAD1;RPN1;RPN2;ALG11;STT3A;DDOST;MGAT1;MGAT2;MAN1A1;STT3B;MAN2A1;ALG2,39 (39),0.00919,0.0366,0,,0 (31),1,1,0.00919,0.0366
Long-term depression - Homo sapiens (human),KEGG,20,PLCB3;HRAS;LYN;MAP2K1;MAP2K2;GUCY1A1;GUCY1B1;PRKCA;PPP2CB;PPP2R1A;GNA11;GNA13;ARAF;GNAI2;GNAI3;IGF1;GNAQ;MAPK1;GNAS;ITPR2,60 (60),0.00545,0.0238,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0001043,8 (9),0.209,1,0.00884,0.0367
arsenate detoxification I (glutaredoxin),HumanCyc,4,AS3MT;PNP;GSTO1;GLRX,4 (4),0.00127,0.00663,1,HMDB0000195,21 (24),0.909,1,0.00893,0.037
Heme Biosynthesis,Wikipathways,6,CPOX;HMBS;ALAD;PPOX;FECH;UROD,9 (9),0.00223,0.0109,2,HMDB0000123;HMDB0033934,16 (16),0.525,1,0.00908,0.0376
Pentose phosphate pathway,EHMN,13,NUP98;NUP133;ALDOB;RANBP2;NUP160;CD38;NUP210;NUP93;NUP35;NUP58;H6PD;NUP205;NUP155,29 (29),0.00122,0.00654,1,HMDB0001178,35 (37),0.982,1,0.00925,0.0379
urea cycle,HumanCyc,5,OTC;ASL;ASS1;CPS1;ARG1,6 (6),0.00121,0.00648,0,,17 (17),1,1,0.00931,0.0379
Benzene metabolism,Wikipathways,5,NQO1;GSTM1;CYP2E1;EPHX1;MPO,6 (6),0.00121,0.00648,0,,7 (12),1,1,0.00931,0.0379
Mitochondrial fatty acid synthesis pathway,Wikipathways,5,HSD17B12;OXSM;MCAT;MECR;ACACA,6 (6),0.00121,0.00648,0,,8 (13),1,1,0.00931,0.0379
Fluoroacetic acid toxicity,Wikipathways,5,ALDH3A2;ACO2;ALDH9A1;ACSS2;CS,6 (6),0.00121,0.00648,0,,2 (6),1,1,0.00931,0.0379
D-galactose degradation V (Leloir pathway),HumanCyc,5,GALT;PGM2;PGM1;GALM;GALK1,6 (6),0.00121,0.00648,0,,9 (11),1,1,0.00931,0.0379
Methionine salvage pathway,Reactome,5,ADI1;MTAP;GOT1;ENOPH1;MRI1,6 (6),0.00121,0.00648,0,,11 (19),1,1,0.00931,0.0379
histidine degradation,HumanCyc,5,MTHFD1;AMDHD1;HAL;UROC1;FTCD,6 (6),0.00121,0.00648,0,,12 (12),1,1,0.00931,0.0379
GDP-mannose biosynthesis,HumanCyc,5,PMM2;MPI;GPI;GMPPA;GMPPB,6 (6),0.00121,0.00648,0,,7 (8),1,1,0.00931,0.0379
GDP-glucose biosynthesis II,HumanCyc,5,PGM2;HK1;PGM1;GCK;HK3,6 (6),0.00121,0.00648,0,,10 (11),1,1,0.00931,0.0379
selenocysteine biosynthesis,HumanCyc,5,SEPHS2;SEPHS1;SARS2;SEPSECS;SARS1,6 (6),0.00121,0.00648,0,,9 (10),1,1,0.00931,0.0379
urate biosynthesis/inosine 5_-phosphate degradation,HumanCyc,5,XDH;NT5E;PNP;NT5C2;IMPDH2,6 (6),0.00121,0.00648,0,,11 (11),1,1,0.00931,0.0379
Refsum Disease,SMPDB,5,PHYH;SLC27A2;ALDH3A2;HACL1;ABCD1,6 (6),0.00121,0.00648,0,,22 (24),1,1,0.00931,0.0379
Phytanic Acid Peroxisomal Oxidation,SMPDB,5,PHYH;SLC27A2;ALDH3A2;HACL1;ABCD1,6 (6),0.00121,0.00648,0,,22 (24),1,1,0.00931,0.0379
Steroids metabolism,INOH,7,CYP7A1;FDFT1;LSS;SOAT2;DHCR7;MVK;IDI1,16 (16),0.0196,0.0702,6,HMDB0001170;HMDB0001251;HMDB0001188;HMDB0000032;HMDB0000067;HMDB0001090,27 (31),0.0616,1,0.00933,0.0379
MTHFR deficiency,Wikipathways,2,COMT;CASP3,10 (10),0.589,0.95,6,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0004949;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0000043;HMDB0013462#HMDB0012103#HMDB0012092,14 (21),0.00206,0.162,0.00936,0.038
Pantothenate and CoA biosynthesis - Homo sapiens (human),KEGG,10,ALDH3A2;ALDH1B1;PPCS;VNN1;DPYD;ENPP1;ENPP3;UPB1;DPYS;COASY,21 (21),0.00258,0.0125,3,HMDB0004231;HMDB0001416;HMDB0001016,24 (30),0.484,1,0.0096,0.0388
Amino Acid Metabolism Pathway Excerpt (Histidine catabolism extension),Wikipathways,4,FTCD;HAL;GPT2;GLUD1,4 (4),0.00127,0.00663,0,,16 (16),1,1,0.00971,0.0388
Polyol Pathway,Wikipathways,4,KHK;SORD;ALDOB;AKR1B1,4 (4),0.00127,0.00663,0,,7 (8),1,1,0.00971,0.0388
propionyl-CoA degradation,HumanCyc,4,PCCB;MMUT;MCEE;PCCA,4 (4),0.00127,0.00663,0,,8 (9),1,1,0.00971,0.0388
heme biosynthesis from uroporphyrinogen-III I,HumanCyc,4,PPOX;FECH;CPOX;UROD,4 (4),0.00127,0.00663,0,,11 (11),1,1,0.00971,0.0388
tryptophan degradation X (mammalian_ via tryptamine),HumanCyc,4,ALDH3A2;MAOB;DDC;AKR1A1,4 (4),0.00127,0.00663,0,,15 (15),1,1,0.00971,0.0388
fatty acid biosynthesis initiation,HumanCyc,4,ACACB;FASN;MCAT;ACACA,4 (4),0.00127,0.00663,0,,7 (9),1,1,0.00971,0.0388
Maturation of spike protein,Reactome,4,GANAB;MOGS;CANX;PRKCSH,4 (4),0.00127,0.00663,0,,2 (2),1,1,0.00971,0.0388
2-oxoisovalerate decarboxylation to isobutanoyl-CoA,HumanCyc,4,DLD;BCKDHA;BCKDHB;DBT,4 (4),0.00127,0.00663,0,,7 (7),1,1,0.00971,0.0388
guanosine nucleotides degradation,HumanCyc,4,XDH;PNP;NT5C2;GDA,4 (4),0.00127,0.00663,0,,12 (12),1,1,0.00971,0.0388
Maturation of spike protein,Reactome,4,GANAB;MOGS;CANX;PRKCSH,4 (4),0.00127,0.00663,0,,2 (2),1,1,0.00971,0.0388
Vitamin K Metabolism,SMPDB,4,NQO1;VKORC1;F2;GGCX,4 (4),0.00127,0.00663,0,,12 (13),1,1,0.00971,0.0388
Malate-Aspartate Shuttle,SMPDB,4,SLC25A11;SLC25A12;GOT2;MDH2,4 (4),0.00127,0.00663,0,,9 (10),1,1,0.00971,0.0388
Digestion,Reactome,1,PIR,22 (22),0.99,1,10,HMDB0000036;HMDB0000637;HMDB0000951;HMDB0035312;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000067;HMDB0003255;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0001262;HMDB0000138,32 (42),0.00129,0.113,0.00979,0.0391
IL3,NetPath,17,SHC1;HRAS;LYN;MAP2K1;GRB2;YWHAB;PRKCA;YWHAZ;PIK3R1;PTPN6;PTPN11;CRK;CRKL;STAT5B;MAPK1;PRKACA;RACK1,51 (51),0.00997,0.0394,0,,0 (0),1,1,0.00997,0.0394
Kit receptor signaling pathway,Wikipathways,19,SHC1;HRAS;LYN;MAP2K1;MAP2K2;PRKCA;STAT3;PIK3R1;PTPN6;RPS6;RPS6KA1;PTPN11;CRK;CRKL;MAPK14;STAT5B;MAPK1;KITLG;GRB2,59 (59),0.00998,0.0394,0,,0 (0),1,1,0.00998,0.0394
Vitamin B12 metabolism,Wikipathways,19,ICAM1;F2;MMAB;SHMT2;PLG;CBS;MPO;MCEE;RELA;APOA1;MMUT;APOB;CTH;ALB;SOD1;SOD2;MAT1A;APOE;SCARB1,51 (51),0.00159,0.00814,4,HMDB0000067;HMDB0003208;HMDB0000244;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,51 (61),0.814,1,0.00991,0.0395
PAR1-mediated thrombin signaling events,PID,17,F2;PIK3R1;PRKCA;ARHGDIA;ROCK1;GNA11;GNA13;SNX1;SNX2;PLCB3;GNAI3;GNAI2;GNAQ;DNM2;ZYX;RHOA;GNB1,43 (43),0.0013,0.00678,0,,4 (4),1,1,0.00991,0.0395
heme biosynthesis,HumanCyc,6,FECH;HMBS;ALAD;PPOX;CPOX;UROD,9 (9),0.00223,0.0109,2,HMDB0000123;HMDB0001149,18 (18),0.591,1,0.0101,0.04
Arachidonic acid metabolism,EHMN,30,EPHX1;EPHX2;CYP1A2;GSTZ1;RANBP2;DHRS4;NUP155;MGST1;MGST2;MGST3;GSTK1;PLA2G12B;CYP4B1;NUP210;GPX1;GPX4;NUP98;NUP133;CYP2E1;NUP93;NUP58;CBR1;PTGS1;NUP160;PRDX6;SLC27A5;PCTP;NUP35;ABCB4;NUP205,98 (98),0.00341,0.0161,6,HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,47 (53),0.392,1,0.0102,0.0404
Folate biosynthesis - Homo sapiens (human),KEGG,12,GPHN;PCBD1;AKR1B1;SPR;PTS;CBR1;MOCS1;GCH1;DHFR;QDPR;MOCOS;PAH,26 (26),0.00137,0.0071,1,HMDB0002281,32 (58),0.974,1,0.0102,0.0404
Glycogen synthesis,Reactome,7,UGP2;GBE1;PGM2;GYG1;PGM1;EPM2A;GYS2,11 (11),0.00136,0.0071,0,,9 (10),1,1,0.0104,0.041
role of ran in mitotic spindle regulation,BioCarta,7,RAN;RANBP1;RANBP2;RCC1;RANGAP1;KPNB1;KPNA2,11 (11),0.00136,0.0071,0,,2 (2),1,1,0.0104,0.041
RHO GTPases activate KTN1,Reactome,7,KLC4;RHOA;CDC42;RHOG;RAC1;KIF5B;KTN1,11 (11),0.00136,0.0071,0,,1 (1),1,1,0.0104,0.041
Insulin receptor recycling,Reactome,12,ATP6V1H;TCIRG1;ATP6V1A;ATP6V1G1;ATP6V0C;ATP6V1C1;ATP6V1E1;ATP6V1B2;ATP6V1D;ATP6V0A1;ATP6AP1;ATP6V0D1,26 (26),0.00137,0.0071,0,,2 (3),1,1,0.0104,0.0412
rho cell motility signaling pathway,BioCarta,12,PFN1;DIAPH1;RHOA;TLN1;ARHGAP1;ROCK1;ARFGAP3;CFL1;GSN;VCL;ARFGAP1;MYLK,32 (32),0.0105,0.0415,0,,0 (0),1,1,0.0105,0.0415
Gastrin signaling pathway,Wikipathways,32,RHOA;CRK;PTPN11;MAPK14;GRB2;RHOD;EGFR;TJP1;MTOR;ANXA2;PIK3R1;RPS6;ELAVL1;PRKACA;SHC1;HRAS;CASP3;PXN;PRKCA;ROCK1;RELA;GNAQ;MAPK1;CTNNB1;MAPK9;MAP2K1;YES1;CDC42;CDH1;ITGB1;STAT3;RAC1,114 (114),0.0105,0.0415,0,,0 (0),1,1,0.0105,0.0415
tRNA processing in the nucleus,Reactome,21,RAE1;NUP98;NUP133;NUP210;RTCB;CPSF1;TPR;RTRAF;RAN;NUP160;ELAC2;NUP155;DDX1;TRNT1;NUP93;NUP35;NUP58;RANBP2;SEC13;NUP205;ZBTB8OS,58 (58),0.00141,0.0073,0,,7 (10),1,1,0.0107,0.0421
Pyrimidine Metabolism,SMPDB,11,DPYS;NT5C2;TYMP;DPYD;GDA;ITPA;RRM2B;UPB1;CAD;AK3;DHODH,23 (23),0.00151,0.00776,3,HMDB0001342;HMDB0003349#HMDB0000528;HMDB0033934,56 (57),0.95,1,0.0108,0.0426
UMP Synthase Deiciency (Orotic Aciduria),SMPDB,11,DPYS;NT5C2;TYMP;DPYD;GDA;ITPA;RRM2B;UPB1;CAD;AK3;DHODH,23 (23),0.00151,0.00776,3,HMDB0001342;HMDB0003349#HMDB0000528;HMDB0033934,56 (57),0.95,1,0.0108,0.0426
MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy),SMPDB,11,DPYS;NT5C2;TYMP;DPYD;GDA;ITPA;RRM2B;UPB1;CAD;AK3;DHODH,23 (23),0.00151,0.00776,3,HMDB0001342;HMDB0003349#HMDB0000528;HMDB0033934,56 (57),0.95,1,0.0108,0.0426
Beta Ureidopropionase Deficiency,SMPDB,11,DPYS;NT5C2;TYMP;DPYD;GDA;ITPA;RRM2B;UPB1;CAD;AK3;DHODH,23 (23),0.00151,0.00776,3,HMDB0001342;HMDB0003349#HMDB0000528;HMDB0033934,56 (57),0.95,1,0.0108,0.0426
Dihydropyrimidinase Deficiency,SMPDB,11,DPYS;NT5C2;TYMP;DPYD;GDA;ITPA;RRM2B;UPB1;CAD;AK3;DHODH,23 (23),0.00151,0.00776,3,HMDB0001342;HMDB0003349#HMDB0000528;HMDB0033934,56 (57),0.95,1,0.0108,0.0426
Heme degradation,Reactome,9,BLVRA;BLVRB;SLCO2B1;ALB;FABP1;HMOX1;HMOX2;ABCC2;GSTA1,17 (17),0.00167,0.00844,1,HMDB0000054,18 (19),0.871,1,0.011,0.043
Nuclear Envelope Breakdown,Reactome,19,LMNA;LMNB1;NUP133;NUP98;NEK7;TMPO;PRKCA;TPR;NUP160;BANF1;RAE1;NUP210;NUP93;NUP35;NUP58;RANBP2;SEC13;NUP205;NUP155,53 (53),0.00267,0.0129,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,7 (9),0.549,1,0.011,0.0431
Endogenous sterols,Reactome,6,CYP39A1;CYP7A1;CYP8B1;FDX1;FDXR;CYP27A1,18 (18),0.107,0.278,8,HMDB0000015;HMDB0001251;HMDB0000067;HMDB0006763;HMDB0001547;HMDB0000145;HMDB0060136;HMDB0001993,31 (40),0.0138,0.722,0.0111,0.0433
Scavenging by Class A Receptors,Reactome,9,COL4A2;CALR;APOA1;HSP90B1;APOB;APOE;COL1A1;COL1A2;FTH1,19 (19),0.00442,0.0203,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,11 (32),0.334,1,0.0111,0.0433
Signaling events mediated by focal adhesion kinase,PID,22,RHOA;CRK;MAP2K4;RAP1A;RAP1B;PXN;PIK3R1;TLN1;CAPN2;GRB2;ACTN4;NCK1;ACTN1;MAPK1;ITGA5;MAPK9;MAP2K1;YES1;ITGB1;VCL;RAC1;WASL,62 (62),0.00149,0.00769,0,,3 (3),1,1,0.0112,0.0436
Heme biosynthesis,Reactome,8,FECH;HMBS;COX15;ALAD;ALB;PPOX;CPOX;UROD,14 (14),0.00161,0.00816,1,HMDB0000123,24 (33),0.935,1,0.0113,0.0439
Vitamin A and carotenoid metabolism,Wikipathways,14,DHRS3;RDH10;BCO2;RETSAT;SULT1A1;RXRA;CYP2E1;SCARB1;DGAT1;ALDH1A1;MAPK1;RBP1;ALDH1A3;RBP4,43 (43),0.0227,0.0797,5,HMDB0006216;HMDB0000305;HMDB0006285#HMDB0006280;HMDB0000876;HMDB0006217,21 (21),0.0662,1,0.0113,0.0439
intrinsic prothrombin activation pathway,BioCarta,11,FGA;F2;COL4A2;SERPING1;KLKB1;F9;F11;F12;KNG1;FGB;FGG,23 (23),0.00151,0.00776,0,,1 (1),1,1,0.0113,0.0441
Pyrimidine metabolism,EHMN,40,TXNRD1;PNPT1;NUP133;RANBP2;CMPK1;NUP155;COPA;COPB1;NT5C;NT5E;ENPP1;ENPP3;POLE;NT5C3A;RRM2B;POLR2A;NUP210;DHODH;ENTPD5;NUP98;NT5C2;PKM;AK4;COPG2;AQP8;NUP93;NUP58;TXNRD2;NME1;NME2;TYMP;SLC29A1;NUP160;ENTPD8;KYAT1;ARCN1;AK3;NUP35;NUP205;COPE,135 (135),0.0016,0.00816,4,HMDB0001342;HMDB0003349#HMDB0000528;HMDB0033934;HMDB0000189,69 (77),0.949,1,0.0114,0.0442
role of egf receptor transactivation by gpcrs in cardiac hypertrophy,BioCarta,14,SHC1;HRAS;RHOA;EGFR;GRB2;PRKCA;GNA11;RELA;RPS6KA1;AGT;MAP2K1;MAPK1;GNB1;MAP2K2,33 (33),0.00154,0.00787,0,,3 (3),1,1,0.0115,0.0446
internal ribosome entry pathway,BioCarta,8,CASP3;CASP6;PTBP1;EIF3A;EIF4E;EIF4G1;EIF4G2;EIF4A1,18 (18),0.0114,0.0448,0,,0 (0),1,1,0.0114,0.0448
HSF1 activation,Reactome,10,SERPINH1;PTGES3;DNAJB1;FKBP4;HSPH1;HSPB1;VCP;HSP90AA1;HDAC6;HSP90AB1,25 (25),0.0115,0.0451,0,,0 (1),1,1,0.0115,0.0451
Mitophagy - animal - Homo sapiens (human),KEGG,21,FIS1;HRAS;ATG5;CSNK2A2;MAPK9;USP15;RAB7A;GABARAP;BCL2L13;MFN2;USP8;SQSTM1;PGAM5;RRAS2;CSNK2A1;TBC1D15;HIF1A;CSNK2B;MFN1;TBC1D17;RELA,68 (68),0.0117,0.0455,0,,0 (0),1,1,0.0117,0.0455
C21-steroid hormone biosynthesis and metabolism,EHMN,17,NPC1;COPA;COPB1;CYP1A2;CYP4B1;AKR1C1;COPG2;HSD17B12;CYP2E1;ARCN1;HSD17B2;CYP27A1;HSD11B1;STS;HDLBP;AKR1D1;COPE,57 (57),0.0305,0.102,9,HMDB0000015;HMDB0006756;HMDB0000067;HMDB0006763;HMDB0001547;HMDB0006764;HMDB0004030;HMDB0000234;HMDB0000077,46 (61),0.0516,1,0.0117,0.0455
Fc gamma R-mediated phagocytosis - Homo sapiens (human),KEGG,28,SPHK2;FCGR2B;PIK3R1;CFL1;CFL2;ARPC1A;GSN;PRKCA;RAC1;ARPC5L;MARCKSL1;MAPK1;PLPP3;LYN;MAP2K1;CDC42;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;MARCKS;CRK;CRKL;DNM2;ARPC2;ARF6,96 (97),0.00939,0.0373,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0001043,7 (8),0.168,1,0.0117,0.0455
VLDL assembly,Reactome,3,P4HB;MTTP;APOB,5 (5),0.0496,0.15,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,3 (4),0.032,1,0.0118,0.0456
HDL clearance,Reactome,3,SCARB1;HDLBP;APOA1,5 (5),0.0496,0.15,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,3 (4),0.032,1,0.0118,0.0456
Formation of the cornified envelope,Reactome,8,DSC2;DSG2;PKP2;DSP;JUP;PKP3;CAPN1;CAPNS1,75 (75),0.982,1,4,HMDB0000067;HMDB0004949;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,6 (10),0.00163,0.134,0.0119,0.046
Gap junction trafficking and regulation,Reactome,8,MYO6;TJP1;GJB1;AP2M1;DNM2;CLTA;CLTB;CLTC,14 (14),0.00161,0.00816,0,,2 (3),1,1,0.0119,0.046
&gamma;-linolenate biosynthesis,HumanCyc,8,ACSL1;ACSL4;FADS2;ACSM5;ACSL5;ACSM3;SLC27A2;ACSM1,14 (14),0.00161,0.00816,0,,9 (9),1,1,0.0119,0.046
Digestion and absorption,Reactome,2,PIR;SLC2A2,26 (26),0.969,1,10,HMDB0000036;HMDB0000637;HMDB0000951;HMDB0035312;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000067;HMDB0003255;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0001262;HMDB0000138,33 (45),0.00168,0.135,0.0121,0.0465
Acyl chain remodeling of CL,Reactome,3,HADHB;HADHA;LCLAT1,6 (6),0.0854,0.234,3,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,6 (12),0.0191,0.891,0.0121,0.0465
Keratinization,Reactome,9,DSC2;KRT8;DSG2;PKP2;DSP;JUP;PKP3;CAPN1;CAPNS1,129 (129),1,1,4,HMDB0000067;HMDB0004949;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,6 (10),0.00163,0.134,0.0121,0.0465
RHOC GTPase cycle,Reactome,25,VAPB;RHOA;ABCD3;ARHGAP1;ARHGDIA;FLOT2;JUP;SLK;STX5;LMAN1;PIK3R1;ACBD5;DIAPH1;C1QBP;ARHGEF12;TJP2;TMPO;ROCK1;ARHGEF10L;CAV1;FLOT1;PKN3;STOM;IQGAP1;TFRC,74 (74),0.00164,0.0083,0,,4 (4),1,1,0.0121,0.0465
Glycogen breakdown (glycogenolysis),Reactome,9,CALM1;PGM2;PYGB;PYGL;PHKG2;GYG1;AGL;GAA;PHKB,17 (17),0.00167,0.00844,0,,9 (11),1,1,0.0124,0.0473
Doxorubicin Metabolism Pathway,SMPDB,9,NQO1;POR;CBR1;XDH;NDUFS2;NDUFS3;NDUFS7;AKR1A1;ABCC2,17 (17),0.00167,0.00844,0,,14 (15),1,1,0.0124,0.0473
HIF1A and PPARG regulation of glycolysis,Wikipathways,5,GPD1;LDHA;HIF1A;GAPDH;TPI1,8 (8),0.00802,0.0324,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,8 (10),0.209,1,0.0124,0.0473
Ascorbate and aldarate metabolism - Homo sapiens (human),KEGG,13,ALDH3A2;UGT1A3;UGT2B10;UGT2B15;AKR1A1;GUSB;RGN;ALDH7A1;UGT2A3;ALDH1B1;UGT2A1;UGDH;ALDH9A1,30 (30),0.00178,0.00896,1,HMDB0002513#HMDB0010323,28 (57),0.959,1,0.0126,0.0481
Vitamin B5 - CoA biosynthesis from pantothenate,EHMN,13,NUP98;NUP133;ENPP1;VNN1;NUP160;ENPP3;NUP210;NUP93;NUP35;NUP58;RANBP2;NUP205;NUP155,31 (31),0.00255,0.0124,2,HMDB0001416;HMDB0001016,21 (21),0.676,1,0.0127,0.0482
UDP-<i>N</i>-acetyl-D-galactosamine biosynthesis II,HumanCyc,6,GPI;GNPNAT1;UAP1;GCK;PGM3;GNPDA1,9 (9),0.00223,0.0109,1,HMDB0000290,13 (16),0.772,1,0.0127,0.0482
adenosine nucleotides degradation,HumanCyc,6,NT5C2;ADA;XDH;NT5E;NT5C3A;PNP,9 (9),0.00223,0.0109,1,HMDB0000195,13 (13),0.772,1,0.0127,0.0482
Infection with Mycobacterium tuberculosis,Reactome,12,KPNB1;ENO1;MRC1;RAB7A;RAB5A;CORO1A;SFPQ;ATP6V1H;B2M;HGS;KPNA1;MAPK1,27 (27),0.00205,0.0102,2,HMDB0001178;HMDB0033934,30 (55),0.849,1,0.0128,0.0486
Fatty acyl-CoA biosynthesis,Reactome,15,ELOVL5;PPT1;ACSL1;CBR4;ACSL4;HACD3;HSD17B12;ACSF3;ACLY;SLC25A1;FASN;HSD17B8;TECR;ACSL5;ACACA,37 (37),0.00183,0.00917,1,HMDB0001043,29 (42),0.963,1,0.0129,0.0491
Viral Messenger RNA Synthesis,Reactome,13,RAE1;NUP98;NUP133;TPR;NUP160;NUP210;NUP93;NUP35;NUP58;RANBP2;SEC13;NUP205;NUP155,30 (30),0.00178,0.00896,0,,1 (2),1,1,0.0131,0.0495
Influenza Viral RNA Transcription and Replication,Reactome,13,RAE1;NUP98;NUP133;TPR;NUP160;NUP210;NUP93;NUP35;NUP58;RANBP2;SEC13;NUP205;NUP155,30 (30),0.00178,0.00896,0,,5 (6),1,1,0.0131,0.0495
Regulation of TLR by endogenous ligand,Reactome,7,CD14;FGA;FGB;S100A8;S100A9;APOB;FGG,16 (16),0.0196,0.0702,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,5 (13),0.0922,1,0.0132,0.05
Autophagy,Wikipathways,11,PIK3R4;ATG5;PRKAG1;ATG3;MTOR;AKT1S1;WIPI2;PRKAA1;PRKAA2;PRKAB1;DEPTOR,30 (30),0.0169,0.0617,1,HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,1 (2),0.107,1,0.0132,0.0501
Insulin Signaling,Wikipathways,42,PIK3R4;FLOT2;MAP2K4;PTPN11;MAPK14;STX4;ENPP1;STXBP2;STXBP3;MYO1C;MTOR;PIK3R1;MAP4K5;GYG1;RPS6KA1;GYS2;EIF4E;PRKAA1;PRKAA2;VAMP2;CAP1;SHC1;HRAS;GRB2;GRB14;PRKCA;RAC1;SORBS1;KIF5B;MAPK1;PFKL;EHD1;MAPK9;FLOT1;MAP2K1;MAP2K2;MAP2K3;RAB4A;CRK;ARF1;RHEB;ARF6,160 (160),0.0131,0.0503,0,,0 (0),1,1,0.0131,0.0503
Synthesis of substrates in N-glycan biosythesis,Reactome,22,NPL;UAP1;NUDT14;GLB1;ST3GAL6;GNE;NANS;ALG5;DPM3;GNPNAT1;ST6GAL1;ST3GAL4;GFUS;CMAS;CTSA;GMPPB;GMPPA;DPM1;GFPT1;PGM3;PMM2;MPI,63 (63),0.00189,0.0094,2,HMDB0000290;HMDB0001090,56 (69),0.987,1,0.0136,0.0512
Integrins in angiogenesis,PID,22,RHOA;COL6A1;COL6A2;COL6A3;PTPN11;IGF1;VTN;ILK;FN1;F11R;PIK3R1;PI4KA;TLN1;PXN;ROCK1;MAPK1;ITGB3;VCL;RAC1;HSP90AA1;COL1A1;COL1A2,63 (63),0.00189,0.0094,0,,2 (2),1,1,0.0137,0.0517
Activation of C3 and C5,Reactome,4,C4A;CFB;C3;C5,6 (6),0.0137,0.052,0,,0 (2),1,1,0.0137,0.052
erk1/erk2 mapk signaling pathway,BioCarta,9,SHC1;HRAS;MAP2K1;GRB2;RPS6KA1;STAT3;PPP2R5D;MAPK1;MAP2K2,22 (22),0.0139,0.0523,0,,0 (1),1,1,0.0139,0.0523
Conjugation of carboxylic acids,Reactome,5,GLYATL1;GLYATL2;ACSM5;ACSM1;GLYAT,9 (9),0.0153,0.0565,3,HMDB0000840;HMDB0000123;HMDB0006344,12 (16),0.13,1,0.0143,0.0538
Amino Acid conjugation,Reactome,5,GLYATL1;GLYATL2;ACSM5;ACSM1;GLYAT,9 (9),0.0153,0.0565,3,HMDB0000840;HMDB0000123;HMDB0006344,12 (16),0.13,1,0.0143,0.0538
protein kinase a at the centrosome,BioCarta,6,PRKAG1;PRKAR2A;RHOA;PPP2R5D;PPP1CA;PRKACB,12 (12),0.0146,0.0549,0,,0 (1),1,1,0.0146,0.0549
Integrin,INOH,37,RHOA;COL4A2;COL6A1;COL6A2;COL18A1;RAP1A;RAP1B;ITGA2B;FN1;SMC3;DOCK8;TLN1;ACTB;SHC1;HRAS;GRB2;TLN2;VCL;PXN;ITGA1;CAV1;MAPK1;LUM;ITGA5;ITGA9;DCN;MAP2K1;MAP2K2;CDC42;ITGB1;ITGB2;ITGB3;CRK;RAC1;BGN;COL1A1;COL1A2,124 (124),0.00205,0.0102,0,,2 (2),1,1,0.0147,0.0553
Phospholipid metabolism,Reactome,55,PIK3R4;GPD1;GPD2;ACP6;GDPD1;PCYT1A;PLBD1;VAC14;GPD1L;CEPT1;PTPMT1;PEMT;CHPT1;LPGAT1;PI4KA;PIK3R1;CSNK2A1;LPCAT3;CSNK2A2;CSNK2B;CDIPT;CDS2;PIP4P1;AGPAT2;AGPAT3;CPNE3;CHKB;OSBPL8;LCLAT1;AGK;CPNE1;PCYT2;GPAM;MGLL;PITPNB;PISD;ETNPPL;HADHA;STARD10;HADHB;SELENOI;PLEKHA6;PIP4K2C;PNPLA7;RAB14;PNPLA8;MBOAT7;RAB4A;RAB5A;NDUFS3;PLA2G15;DGAT1;ARF1;PLD4;SACM1L,213 (213),0.00725,0.03,7,HMDB0062321;HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0033934;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,50 (104),0.286,1,0.0149,0.0558
mechanism of gene regulation by peroxisome proliferators via ppara,BioCarta,19,MT-CO2;SRA1;PRKAR1A;ME1;PRKAR2A;PRKCA;APOA1;RXRA;HSP90AA1;RELA;ACOX1;APOA2;FABP1;STAT5B;MAPK1;HSD17B4;EHHADH;CPT1A;PRKACB,52 (52),0.00207,0.0103,0,,1 (9),1,1,0.0149,0.0558
FOXA2 pathway,Wikipathways,7,GSTM2;MTTP;FASN;SLC27A5;GSTA1;GSTA2;ABCC2,16 (16),0.0196,0.0702,1,HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,1 (1),0.107,1,0.0151,0.0564
IL-3 signaling pathway,Wikipathways,16,SHC1;HRAS;LYN;MAP2K1;GRB2;PTPN6;YWHAB;PIK3R1;ENPP3;PTPN11;STAT3;CRKL;STAT5B;MAPK1;YWHAQ;PRKACA,49 (49),0.015,0.0565,0,,0 (0),1,1,0.015,0.0565
Pentose and glucuronate interconversions - Homo sapiens (human),KEGG,14,UGP2;UGT1A3;UGT2B10;UGT2B15;AKR1B1;RPE;AKR1A1;CRYL1;GUSB;XYLB;UGT2A3;SORD;UGT2A1;UGDH,34 (34),0.00216,0.0107,1,HMDB0002513#HMDB0010323,32 (58),0.974,1,0.0151,0.0565
Beta-mercaptolactate-cysteine disulfiduria,SMPDB,6,MPST;GCLC;GCLM;CDO1;CTH;GOT1,9 (9),0.00223,0.0109,1,HMDB0033934,26 (26),0.948,1,0.0151,0.0565
Cysteine Metabolism,SMPDB,6,MPST;GCLC;GCLM;CDO1;CTH;GOT1,9 (9),0.00223,0.0109,1,HMDB0033934,26 (26),0.948,1,0.0151,0.0565
Cystinosis_ ocular nonnephropathic,SMPDB,6,MPST;GCLC;GCLM;CDO1;CTH;GOT1,9 (9),0.00223,0.0109,1,HMDB0033934,26 (26),0.948,1,0.0151,0.0565
Cellular Proteostasis,Wikipathways,5,PFDN1;PFDN2;PFDN4;PFDN5;PFDN6,9 (9),0.0153,0.0565,0,,0 (0),1,1,0.0153,0.0565
Formation of annular gap junctions,Reactome,5,DNM2;CLTA;CLTB;AP2M1;CLTC,9 (9),0.0153,0.0565,0,,0 (1),1,1,0.0153,0.0565
lanosterol biosynthesis,HumanCyc,1,LSS,1 (1),0.189,0.429,2,HMDB0001251;HMDB0001188,2 (2),0.0115,0.641,0.0154,0.0573
Alpha4 beta1 integrin signaling events,PID,14,CD14;PXN;ITGB1;PRKAR1A;YWHAZ;CD81;FN1;ABI1;ARF6;TLN1;RAC1;CRK;PRKACA;PRKACB,34 (34),0.00216,0.0107,0,,4 (4),1,1,0.0154,0.0573
RHOU GTPase cycle,Reactome,14,IQGAP1;DST;PAK2;CDC42;TXNL1;MYO6;STAM2;USP9X;NCK1;SPTAN1;SPTBN1;HGS;PIK3R1;CLTC,34 (34),0.00216,0.0107,0,,2 (2),1,1,0.0154,0.0573
RHOV GTPase cycle,Reactome,14,TPM3;TPM4;DST;PAK2;CDC42;TXNL1;USP9X;WASL;NCK1;SPTAN1;SPTBN1;IQGAP1;PIK3R1;CLTC,34 (34),0.00216,0.0107,0,,1 (1),1,1,0.0154,0.0573
Activation of gene expression by SREBF (SREBP),Reactome,10,ACACB;TM7SF2;GPAM;FDFT1;FASN;DHCR7;MVK;LSS;IDI1;HMGCS1,26 (26),0.0156,0.0577,0,,0 (0),1,1,0.0156,0.0577
Glycosaminoglycan degradation,Wikipathways,8,GLB1;HEXA;HGSNAT;HEXB;GUSB;GNS;ARSB;NAGLU,17 (17),0.0076,0.0311,1,HMDB0000693,3 (5),0.289,1,0.0156,0.0579
cycling of ran in nucleocytoplasmic transport,BioCarta,6,RAN;RANBP1;RANBP2;RCC1;RANGAP1;NUP210,9 (9),0.00223,0.0109,0,,2 (2),1,1,0.0159,0.0587
Sulfate/Sulfite Metabolism,SMPDB,5,BPNT1;SULT1A1;PAPSS2;SUOX;SULT1E1,7 (7),0.00356,0.0166,2,HMDB0000145;HMDB0000820,20 (22),0.649,1,0.0164,0.0604
Sulfite oxidase deficiency,SMPDB,5,BPNT1;SULT1A1;PAPSS2;SUOX;SULT1E1,7 (7),0.00356,0.0166,2,HMDB0000145;HMDB0000820,20 (22),0.649,1,0.0164,0.0604
N-Glycan biosynthesis - Homo sapiens (human),KEGG,18,MOGS;DAD1;RPN1;RPN2;ALG11;STT3A;DPM1;ST6GAL1;DPM3;DDOST;MAN1A1;MGAT1;MGAT2;ALG5;GANAB;STT3B;MAN2A1;ALG2,50 (50),0.00324,0.0154,1,HMDB0001445,11 (38),0.714,1,0.0164,0.0604
mTOR signaling pathway,PID,22,EEF2;DEPTOR;MTOR;RPS6KA1;EIF4A1;EIF4E;HRAS;PRKCA;RHEB;MAPK1;YWHAQ;MAP2K1;MAP2K2;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;AKT1S1;PDCD4;RRAGC;PML,64 (64),0.00237,0.0116,0,,6 (6),1,1,0.0167,0.0616
HIF-1-alpha transcription factor network,PID,20,HIF1A;ALDOA;LDHA;HNF4A;NPM1;PKM;ENO1;HMOX1;ITGB2;TF;COPS5;CP;NT5E;PFKL;PLIN2;PGM1;GCK;HK1;FECH;TFRC,66 (66),0.0169,0.0617,0,,0 (0),1,1,0.0169,0.0617
AGE-RAGE pathway,Wikipathways,20,SHC1;MAPK9;RHOA;CASP3;STAT3;CDC42;STAT5B;PRKCA;RAC1;ROCK1;DDOST;HIF1A;DIAPH1;LGALS3;SOD1;MAPK14;MAP2K1;MAPK1;EGFR;RELA,66 (66),0.0169,0.0617,0,,0 (0),1,1,0.0169,0.0617
Budding and maturation of HIV virion,Reactome,11,CHMP4B;CHMP3;CHMP2A;VTA1;VPS4A;TSG101;VPS4B;CHMP5;VPS28;CHMP6;PDCD6IP,30 (30),0.0169,0.0617,0,,0 (2),1,1,0.0169,0.0617
Ibuprofen Metabolism Pathway,SMPDB,10,PDIA4;UGT1A3;PPIB;SDF2L1;HSPA5;DNAJB11;ERP29;PDIA6;PTGS1;HYOU1,23 (23),0.00581,0.0251,2,HMDB0001925;HMDB0002513#HMDB0010323,13 (13),0.414,1,0.0169,0.0623
Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,Reactome,27,MAPRE1;PPP2CB;PPP2R1A;RANBP2;RANGAP1;PPP2R5A;PPP2R5D;PPP2R5E;NDEL1;PAFAH1B1;DYNLL2;NUP98;CKAP5;NUP133;DYNC1LI1;RPS27;XPO1;ZW10;BUB3;NUDC;NUP160;RCC2;DYNC1H1;DYNC1I2;DYNC1LI2;SEC13;PPP1CC,96 (96),0.0173,0.0632,0,,0 (0),1,1,0.0173,0.0632
Amplification of signal from the kinetochores,Reactome,27,MAPRE1;PPP2CB;PPP2R1A;RANBP2;RANGAP1;PPP2R5A;PPP2R5D;PPP2R5E;NDEL1;PAFAH1B1;DYNLL2;NUP98;CKAP5;NUP133;DYNC1LI1;RPS27;XPO1;ZW10;BUB3;NUDC;NUP160;RCC2;DYNC1H1;DYNC1I2;DYNC1LI2;SEC13;PPP1CC,96 (96),0.0173,0.0632,0,,0 (0),1,1,0.0173,0.0632
Glycosphingolipid metabolism,EHMN,23,RANBP2;SPHK2;NUP155;GLB1;COPA;COPB1;PLPP3;ASAH1;SGPL1;COPE;NUP210;NUP98;NUP133;GBA;COPG2;NUP93;NUP58;KDSR;CERT1;NUP160;ARCN1;NUP35;NUP205,69 (69),0.003,0.0143,3,HMDB0006734;HMDB0004949;HMDB0013462#HMDB0012103#HMDB0012092,40 (52),0.82,1,0.0172,0.0634
IL-18 signaling pathway,Wikipathways,66,PTMS;DES;TGM2;PARP1;AARS1;RANGAP1;EEF2;ABCF1;FADD;PIK3R1;MAPK1;KITLG;UGT2B10;ACACB;ACADS;CLDN3;LONP2;BSG;BPGM;EPB41;UGGT1;ICAM1;PRKAA1;FN1;ANP32A;BID;RAE1;NACA;CASP3;BAX;RUSC1;ARFGAP2;ELAVL1;B2M;CD81;GRN;RELA;COL1A1;TOMM40;USP5;LMNB2;HADH;ITGA2B;CTNNB1;ARFGAP1;CPT1A;PRKCA;MAPK9;ECH1;ENO1;PYGB;DEK;KIFC3;MTCH1;NDUFC1;RPS11;ABHD16A;HSPB8;HSPB1;HMOX1;ARF6;LRRFIP1;HDGF;TF;COL1A2;ARG1,274 (274),0.0177,0.0647,0,,0 (0),1,1,0.0177,0.0647
Diseases of programmed cell death,Reactome,10,LMNA;LMNB1;YWHAE;GOLGA2;CAPN1;CAPN2;PRDX2;CAPNS1;PRDX1;CAST,22 (22),0.00394,0.0183,1,HMDB0001342,9 (11),0.64,1,0.0176,0.0648
Aspartate and asparagine metabolism,Reactome,7,ASPG;GOT1;GOT2;ASNS;ASPA;SLC25A12;SLC25A13,12 (12),0.00274,0.0132,1,HMDB0033934,23 (24),0.927,1,0.0177,0.0651
Prostaglandin formation from dihomo gama-linoleic acid,EHMN,13,NUP98;NUP133;PTGES3;CBR1;PTGS1;NUP160;NUP210;NUP93;NUP35;NUP58;RANBP2;NUP205;NUP155,31 (31),0.00255,0.0124,0,,6 (8),1,1,0.0178,0.0651
Synthesis of active ubiquitin: roles of E1 and E2 enzymes,Reactome,13,UBE2H;USP7;UBE2L3;USP5;USP9X;UBE2Z;UCHL3;UBA1;UBA6;UBE2G2;OTULIN;UBE2G1;UBE2K,31 (31),0.00255,0.0124,0,,3 (3),1,1,0.0178,0.0651
E-cadherin signaling in keratinocytes,PID,10,RHOA;EGFR;CDH1;RAC1;ZYX;PIK3R1;JUP;CTNNA1;CTNNB1;CTNND1,21 (21),0.00258,0.0125,0,,4 (4),1,1,0.018,0.0658
Cytochrome P450 - arranged by substrate type,Reactome,10,CYP2E1;CYP39A1;POR;CYP1A2;CYP4B1;CYP7A1;CYP8B1;FDX1;FDXR;CYP27A1,57 (57),0.654,1,18,HMDB0000015;HMDB0000234;HMDB0001251;HMDB0013195;HMDB0000067;HMDB0006763;HMDB0001547;HMDB0003208;HMDB0000145;HMDB0041905;HMDB0002995;HMDB0006543;HMDB0001920;HMDB0001043;HMDB0060136;HMDB0003550;HMDB0000876;HMDB0001993,87 (120),0.00401,0.269,0.0182,0.0665
Synaptic vesicle cycle - Homo sapiens (human),KEGG,25,ATP6V1A;SLC6A13;ATP6V1B2;ATP6V0C;ATP6V1C1;ATP6V1E1;AP2M1;ATP6V1H;AP2S1;ATP6V0D1;AP2A1;AP2A2;AP2B1;NSF;CLTB;ATP6V1D;CLTA;VAMP2;CLTC;DNM3;NAPA;TCIRG1;ATP6V1G1;ATP6V0A1;DNM2,78 (78),0.00368,0.0171,1,HMDB0000123,11 (12),0.714,1,0.0182,0.0666
TGF-beta receptor signaling,PID,16,SHC1;PPP1CA;EIF2A;GRB2;FKBP1A;SPTBN1;DYNLRB1;YWHAE;PPP2CB;YAP1;CAMK2A;PPP2R2A;STRAP;PML;CAV1;CTNNB1,50 (50),0.0183,0.0667,0,,0 (0),1,1,0.0183,0.0667
Glutamate and glutamine metabolism,Reactome,8,GLUL;OAT;PYCR3;KYAT1;GOT2;GLS;GLUD1;GLS2,15 (15),0.00288,0.0137,1,HMDB0002104,22 (24),0.919,1,0.0183,0.0669
Resolution of Sister Chromatid Cohesion,Reactome,33,MAPRE1;PPP2CB;PPP2R1A;RANBP2;RANGAP1;PPP2R5A;PPP2R5D;PPP2R5E;STAG2;NDEL1;SMC3;PDS5B;DYNC1H1;SMC1A;PAFAH1B1;DYNLL2;NUP98;CKAP5;NUP133;DYNC1LI1;PDS5A;RPS27;XPO1;ZW10;BUB3;NUDC;PPP1CC;RCC2;NUP160;DYNC1I2;DYNC1LI2;SEC13;RAD21,109 (109),0.00268,0.013,0,,6 (8),1,1,0.0186,0.0677
Omega-9 FA synthesis,Wikipathways,7,ELOVL5;ACSL1;ACSL4;FADS2;FASN;ACOT2;FADS1,12 (12),0.00274,0.0132,0,,1 (1),1,1,0.0189,0.0688
Iron metabolism in placenta,Wikipathways,7,STEAP3;TF;ACO1;HAMP;TFR2;TFRC;FTH1,12 (12),0.00274,0.0132,0,,2 (2),1,1,0.0189,0.0688
16p11.2 proximal deletion syndrome,Wikipathways,20,ALDOA;CCT3;CCT5;CCT8;MAP2K3;MVP;CCT6A;CDIPT;PPP2CB;CCT7;CCT4;CCT2;PPP4C;QPRT;PPP2R1A;PCNA;PPP2R5D;CORO1A;NR3C1;TCP1,79 (79),0.0957,0.255,5,HMDB0004080;HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0002088;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0004949,17 (40),0.0287,1,0.0189,0.0688
Metabolism of nitric oxide: NOS3 activation and regulation,Reactome,9,CALM1;LYPLA1;CYGB;SPR;WASL;DDAH1;DNM2;HSP90AA1;CAV1,18 (18),0.00279,0.0133,0,,26 (26),1,1,0.0192,0.0695
RHO GTPases Activate ROCKs,Reactome,9,RHOA;MYH14;ROCK1;CFL1;MYH9;MYH11;PPP1CB;MYL6;MYL9,18 (18),0.00279,0.0133,0,,5 (5),1,1,0.0192,0.0695
Lamivudine Metabolism Pathway,SMPDB,9,SULT1A1;CHPT1;PCYT2;PCYT1A;CMPK1;NT5C;SLC22A1;ABCC2;NME1,18 (18),0.00279,0.0133,0,,13 (13),1,1,0.0192,0.0695
human cytomegalovirus and map kinase pathways,BioCarta,7,MAP2K1;MAP2K2;MAP2K3;PIK3R1;RELA;MAPK14;MAPK1,16 (16),0.0196,0.0702,0,,0 (0),1,1,0.0196,0.0702
Arf6 downstream pathway,PID,8,RHOA;ARF6;ARF1;RAB11A;RAC1;MAPK1;NME1;RAB11FIP3,15 (15),0.00288,0.0137,0,,6 (6),1,1,0.0197,0.0712
Sorafenib Metabolism Pathway,SMPDB,8,PDIA4;PPIB;SDF2L1;HSPA5;DNAJB11;ERP29;PDIA6;HYOU1,15 (15),0.00288,0.0137,0,,6 (7),1,1,0.0197,0.0712
serine and glycine biosynthesis,HumanCyc,5,SHMT2;SRR;PSPH;SHMT1;VPS29,7 (7),0.00356,0.0166,1,HMDB0000123,15 (15),0.819,1,0.0199,0.072
Sphingolipid metabolism,Reactome,23,HEXA;VAPA;CERS2;VAPB;HEXB;SUMF2;ESYT2;ARSB;STS;GLB1;PLPP3;PSAP;ASAH1;SGPL1;ESYT1;GBA;GM2A;ALDH3A2;SPHK2;KDSR;CTSA;CERT1;DEGS1,87 (87),0.0515,0.155,10,HMDB0006734;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0004949;HMDB0004878;HMDB0004842;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0000077;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0000304,54 (65),0.0573,1,0.0201,0.0727
Glycosphingolipid biosynthesis - ganglioseries,EHMN,9,GLB1;HEXA;COPA;COPB1;ARCN1;HEXB;COPG2;COPE;ST3GAL4,21 (21),0.0098,0.0388,3,HMDB0006734;HMDB0004842;HMDB0000304,18 (38),0.303,1,0.0203,0.073
Retinoid metabolism and transport,Reactome,16,APOM;BCO2;RETSAT;RDH11;TTR;AKR1C1;APOA1;APOA2;APOA4;APOB;LRP1;APOC2;APOC3;RBP1;APOE;RBP4,45 (45),0.00616,0.0265,3,HMDB0000067;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,24 (37),0.484,1,0.0203,0.0731
Chylomicron clearance,Reactome,2,APOB;APOE,3 (3),0.0934,0.249,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,3 (4),0.032,1,0.0203,0.0731
L-carnitine biosynthesis,HumanCyc,3,BBOX1;TMLHE;ALDH9A1,3 (3),0.00671,0.0279,2,HMDB0001325;HMDB0000123,14 (14),0.453,1,0.0207,0.0742
Signaling by MET,Reactome,17,SHC1;HRAS;PTPRJ;GRB2;ITGB1;EPS15;USP8;STAM2;PIK3R1;HPN;RAP1A;RAP1B;PTPN11;STAT3;CRKL;HGS;CRK,46 (46),0.00304,0.0144,0,,7 (9),1,1,0.0207,0.0742
fatty acid activation,HumanCyc,4,SLC27A2;ACSL1;ACSL4;ACSL5,8 (8),0.0464,0.144,5,HMDB0003073;HMDB0001388;HMDB0000944;HMDB0001043;HMDB0002183,21 (38),0.0662,1,0.0209,0.0748
ceramide signaling pathway,BioCarta,8,FADD;BAX;AIFM1;MAP2K4;RELA;MAP2K1;MAPK1;MAP2K2,33 (33),0.275,0.581,2,HMDB0004949;HMDB0013462#HMDB0012103#HMDB0012092,2 (2),0.0115,0.641,0.0213,0.0763
Angiopoietin receptor Tie2-mediated signaling,PID,18,SHC1;F2;PXN;GRB14;RELA;PIK3R1;ITGB1;NCK1;PTPN11;CRK;RAC1;MAPK14;STAT5B;MAPK1;FN1;PLG;ITGA5;GRB2,50 (50),0.00324,0.0154,0,,10 (11),1,1,0.0218,0.078
Glycosphingolipid metabolism,Reactome,13,GLB1;HEXA;HEXB;CTSA;GBA;GM2A;STS;ASAH1;SUMF2;ESYT2;ARSB;PSAP;ESYT1,46 (46),0.0793,0.226,7,HMDB0006734;HMDB0004949;HMDB0004878;HMDB0004842;HMDB0000077;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0000304,31 (38),0.0416,1,0.0222,0.0792
CRH,NetPath,12,MAPK9;PLCB3;PRKCA;GNA11;CLTC;RELA;GNAI2;MAPK14;GNAS;MAPK1;GNB1;GNB2,35 (35),0.0224,0.0797,0,,0 (0),1,1,0.0224,0.0797
Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway,Wikipathways,15,MAPK9;LYN;MAP2K1;MAP2K2;MTOR;RELA;RPS6;PTPN11;STAT3;STAT4;MAPK14;STAT5B;STAT6;MAPK1;YES1,47 (47),0.0225,0.0797,0,,0 (0),1,1,0.0225,0.0797
multiple antiapoptotic pathways from igf-1r signaling lead to bad phosphorylation,BioCarta,6,SHC1;HRAS;GRB2;YWHAH;PIK3R1;IGF1,13 (13),0.0229,0.0797,0,,0 (0),1,1,0.0229,0.0797
b cell survival pathway,BioCarta,6,CASP3;ITGB1;MTOR;CCT4;ITGA1;PIK3R1,13 (13),0.0229,0.0797,0,,0 (0),1,1,0.0229,0.0797
il 6 signaling pathway,BioCarta,6,SHC1;HRAS;GRB2;LRPPRC;PTPN11;STAT3,13 (13),0.0229,0.0797,0,,0 (0),1,1,0.0229,0.0797
attenuation of gpcr signaling,BioCarta,6,PRKAR1A;PRKAR2A;PRKCA;GNAS;GNB1;PRKACB,13 (13),0.0229,0.0797,0,,0 (0),1,1,0.0229,0.0797
Linoleic acid metabolism known to be affected by coronavirus infection,Wikipathways,3,FADS1;ELOVL5;ACOT2,4 (4),0.0231,0.0797,0,,0 (1),1,1,0.0231,0.0797
Lipophagy,Reactome,3,HSPA8;PLIN2;PRKAA2,4 (4),0.0231,0.0797,0,,0 (0),1,1,0.0231,0.0797
Carnitine Synthesis,SMPDB,4,BBOX1;TMLHE;SHMT1;ALDH9A1,5 (5),0.00537,0.0236,2,HMDB0000123;HMDB0001325,19 (20),0.621,1,0.0224,0.0798
RHO GTPases Activate Formins,Reactome,36,BUB3;RHOA;CKAP5;PPP2CB;PPP2R1A;RANBP2;RANGAP1;PPP2R5A;DYNC1LI1;PPP2R5D;PPP2R5E;NDEL1;RHOD;MAPRE1;PAFAH1B1;ACTB;DYNLL2;NUP98;DIAPH1;NUP133;ACTG1;DYNC1LI2;RPS27;XPO1;ZW10;PFN1;NUDC;CDC42;ITGB1;NUP160;RCC2;DYNC1H1;DYNC1I2;RAC1;SEC13;PPP1CC,123 (123),0.00334,0.0158,0,,7 (8),1,1,0.0224,0.0798
TNF-alpha signaling pathway,Wikipathways,20,GLUL;MAPK9;CUL1;CASP3;BAX;MAP2K3;HRAS;PYGL;PSMD2;CDC37;MAP2K4;FADD;CSNK2A1;TRAP1;RAC1;HSP90AA1;SKP1;MAPK1;BID;GRB2,93 (93),0.295,0.611,2,HMDB0004949;HMDB0001043,2 (3),0.0115,0.641,0.0226,0.0806
Interferon type I signaling pathways,Wikipathways,19,PDCD4;STAT3;MAP2K3;MTOR;PRMT1;RAP1A;PIK3R1;PTPN6;RPS6;PTPN11;CRK;CRKL;MAPK14;EIF4E;STAT2;EIF4A1;RAC1;STAT4;RACK1,54 (54),0.0034,0.0161,0,,2 (2),1,1,0.0227,0.0808
Glycerophospholipid metabolism - Homo sapiens (human),KEGG,29,GPD1L;GPD2;PCYT1A;GPD1;CEPT1;PEMT;CHPT1;PLPP3;MBOAT7;LYPLA2;LPCAT3;CDIPT;CDS2;AGPAT2;AGPAT3;LYPLA1;LPGAT1;PCYT2;GPAM;PISD;ETNPPL;SELENOI;LCAT;PNPLA7;CHKB;PLA2G15;PLA2G12B;LCLAT1;PLD4,98 (98),0.00669,0.0279,3,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,25 (55),0.512,1,0.0229,0.0813
UDP-<i>N</i>-acetyl-D-glucosamine biosynthesis II,HumanCyc,4,GFPT1;UAP1;PGM3;GNPNAT1,5 (5),0.00537,0.0236,1,HMDB0000290,9 (11),0.64,1,0.023,0.0814
mtor signaling pathway,BioCarta,11,FKBP1A;MTOR;PDK2;PIK3R1;RPS6;EIF4A1;RHEB;PPP2R5D;EIF4E;EIF4G1;EIF3A,25 (25),0.00345,0.0162,0,,3 (3),1,1,0.023,0.0814
regulation of eif-4e and p70s6 kinase,BioCarta,11,PSMC4;PRKCA;MTOR;PDK2;EIF4G1;EIF4A1;MAPK14;EIF4E;MAPK1;PIK3R1;PABPC1,25 (25),0.00345,0.0162,0,,1 (2),1,1,0.023,0.0814
Apoptosis - Homo sapiens (human),KEGG,39,AIFM1;TUBA1B;PARP1;CTSF;CASP3;LMNA;LMNB1;HTRA2;SEPTIN4;CASP6;EIF2S1;PIK3R1;CTSC;SPTA1;SPTAN1;TUBA1C;CAPN1;CAPN2;ACTB;HRAS;FADD;BAX;ACTG1;PARP3;RELA;LMNB2;ATM;CTSB;MAPK1;CTSD;MAPK9;MAP2K1;MAP2K2;CTSH;CTSL;TUBA4A;BID;CTSZ;ITPR2,136 (136),0.00345,0.0162,0,,4 (4),1,1,0.023,0.0814
superpathway of pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis,HumanCyc,10,NME3;RRM1;UMPS;CMPK1;RRM2B;CAD;CTPS2;NTPCR;NME1;NME2,22 (22),0.00394,0.0183,2,HMDB0001342;HMDB0003349#HMDB0000528,33 (34),0.884,1,0.0232,0.082
Methionine metabolism leading to sulfur amino acids and related disorders,Wikipathways,3,CBS;ADK;CTH,3 (3),0.00671,0.0279,2,HMDB0000123;HMDB0000043,16 (21),0.525,1,0.0234,0.0828
Interconversion of nucleotide di- and triphosphates,Reactome,13,TXNRD1;RRM1;GUK1;AK2;AK4;CMPK1;RRM2B;GSR;GLRX;CTPS2;NME3;NME1;NME2,32 (32),0.00356,0.0166,1,HMDB0001342,44 (52),0.994,1,0.0235,0.0829
RAB GEFs exchange GTP for GDP on RABs,Reactome,28,RAB38;CCZ1B;RAB10;RAB35;RAB3GAP1;RAB18;RAB31;TRAPPC12;RAB8B;RAB3GAP2;RAB7A;GAPVD1;RAB1B;TRAPPC3;TRAPPC8;RAB14;RAB21;RAB1A;RAB6B;GDI2;YWHAE;RAB5A;RAB5B;RAB6A;RAB13;GDI1;RAB5C;RAB8A,90 (90),0.00355,0.0166,0,,4 (4),1,1,0.0236,0.083
TYSND1 cleaves peroxisomal proteins,Reactome,5,PHYH;HSD17B4;ACOX1;SCP2;TYSND1,7 (7),0.00356,0.0166,0,,1 (1),1,1,0.0236,0.0833
asparagine degradation,HumanCyc,4,ASPG;GOT1;ASRGL1;AGA,5 (5),0.00537,0.0236,1,HMDB0000489,10 (10),0.679,1,0.0241,0.0849
G-protein mediated events,Reactome,16,CALM1;PRKAR1A;PRKAR2A;KPNA2;PRKCA;GNA11;CAMK2D;PLCB3;GNAI3;GNAI2;GNAQ;MAPK1;CAMK2A;ITPR2;PRKACA;PRKACB,55 (55),0.0437,0.136,4,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0001043;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,16 (17),0.0837,1,0.0242,0.0849
Triglyceride metabolism,Reactome,13,PPP1CA;GPD2;AGMO;GPAM;FABP7;DGAT1;FABP4;FABP1;MGLL;PPP1CB;PPP1CC;PRKACA;PRKACB,36 (36),0.0112,0.0441,3,HMDB0000067;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,19 (28),0.334,1,0.0247,0.0868
SLBP independent Processing of Histone Pre-mRNAs,Reactome,5,SNRPF;SNRPD3;SNRPB;SNRPG;NCBP1,10 (10),0.0258,0.0881,0,,0 (2),1,1,0.0258,0.0881
regulation of splicing through sam68,BioCarta,5,KHDRBS1;MAPK1;MAP2K1;MAP2K2;HRAS,10 (10),0.0258,0.0881,0,,0 (0),1,1,0.0258,0.0881
Nef mediated downregulation of MHC class I complex cell surface expression,Reactome,5,AP1B1;AP1M1;AP1G1;AP1S1;B2M,10 (10),0.0258,0.0881,0,,0 (0),1,1,0.0258,0.0881
Collecting duct acid secretion - Homo sapiens (human),KEGG,11,TCIRG1;ATP6V1A;ATP6V1B2;ATP6V0C;ATP6V1C1;ATP6V1E1;ATP6V1G1;ATP6V1D;ATP6V0A1;SLC4A1;ATP6V0D1,27 (27),0.00698,0.0289,1,HMDB0033934,7 (8),0.549,1,0.0251,0.0881
Nuclear Receptors in Lipid Metabolism and Toxicity,Wikipathways,9,ABCD3;CYP2E1;ABCB11;CYP1A2;ABCC2;CYP4B1;CYP7A1;CYP8B1;ABCB4,35 (35),0.202,0.454,3,HMDB0000067;HMDB0001251;HMDB0000032,6 (12),0.0191,0.891,0.0253,0.0885
Cell-Cell communication,Reactome,36,ACTN1;FLNA;JUP;PTPN6;LIMS1;PTPN11;ILK;GRB2;F11R;CTNNB1;PIK3R1;SPTAN1;CD2AP;NECTIN2;PARVA;CD47;DST;PXN;SPTBN1;AFDN;ACTN4;NCK1;CLDN3;CTNNA1;PLEC;CTNND1;WASL;FERMT2;CDH1;CDH2;RSU1;ITGB1;CDH17;IQGAP1;CASK;LIMS2,124 (124),0.00387,0.018,0,,3 (4),1,1,0.0254,0.0888
mTORC1-mediated signalling,Reactome,10,LAMTOR4;RRAGC;FKBP1A;LAMTOR2;MTOR;RPS6;EIF4E;RHEB;LAMTOR1;EIF4G1,22 (22),0.00394,0.0183,0,,4 (4),1,1,0.0258,0.09
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,Reactome,10,ALDH3A2;VAPA;SEC61B;BAG6;SGTA;GET3;CYB5A;HMOX1;STX5;VAMP2,22 (22),0.00394,0.0183,0,,2 (2),1,1,0.0258,0.09
sphingomyelin metabolism/ceramide salvage,HumanCyc,0,,8 (8),1,1,9,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0004949;HMDB0000944;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0003073;HMDB0001388;HMDB0001043;HMDB0006482;HMDB0002183,31 (55),0.00395,0.269,0.0258,0.09
Phenylalanine degradation,INOH,7,MAOA;MAOB;DDC;TAT;GOT1;GOT2;ALDH1A3,13 (13),0.00498,0.0223,1,HMDB0033934,14 (14),0.797,1,0.0259,0.0903
fatty acid &beta;-oxidation (unsaturated_ odd number),HumanCyc,3,ECI1;EHHADH;ECI2,3 (3),0.00671,0.0279,1,HMDB0003944,8 (10),0.597,1,0.0261,0.0908
glycine cleavage,HumanCyc,3,DLD;AMT;GLDC,3 (3),0.00671,0.0279,1,HMDB0000123,8 (8),0.597,1,0.0261,0.0908
mevalonate pathway,HumanCyc,6,HMGCS2;ACAT1;ACAT2;HMGCS1;MVK;IDI1,10 (10),0.00469,0.0214,1,HMDB0001090,17 (17),0.856,1,0.0261,0.0908
IL3-mediated signaling events,PID,10,SHC1;GRB2;SRP9;YWHAG;YWHAZ;PIK3R1;PTPN11;STAT5B;PRKACA;PRKACB,28 (28),0.0269,0.0915,0,,0 (0),1,1,0.0269,0.0915
Exercise-induced Circadian Regulation,Wikipathways,15,PER2;UGP2;VAPA;NCKAP1;DNAJA1;GSTP1;CBX3;PPP2CB;HERPUD1;HSPA8;IDI1;PSMA4;SF3A3;STBD1;EIF4G2,48 (48),0.0272,0.0916,0,,0 (0),1,1,0.0272,0.0916
Terminal pathway of complement,Reactome,4,C8A;C8B;C5;C9,7 (7),0.0272,0.0916,0,,0 (0),1,1,0.0272,0.0916
2-LTR circle formation,Reactome,4,PSIP1;XRCC5;XRCC6;BANF1,7 (7),0.0272,0.0916,0,,0 (1),1,1,0.0272,0.0916
Nuclear Pore Complex (NPC) Disassembly,Reactome,14,RAE1;NEK7;NUP133;NUP98;TPR;NUP160;NUP210;NUP93;NUP35;NUP58;RANBP2;SEC13;NUP205;NUP155,36 (36),0.00406,0.0187,0,,2 (2),1,1,0.0264,0.0916
metabolism of anandamide an endogenous cannabinoid,BioCarta,2,BAAT;FAAH,7 (7),0.392,0.75,3,HMDB0004080;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0001043,5 (6),0.0104,0.622,0.0264,0.0916
AMPK signaling pathway - Homo sapiens (human),KEGG,34,CAB39;RAB10;PPP2CB;RAB11B;PPP2R2A;FASN;PPP2R5A;IGF1;PPP2R5D;PPP2R5E;FBP1;ACACA;ACACB;MTOR;PIK3R1;GYS2;PRKAA1;PRKAA2;PRKAB1;PRKAG1;ELAVL1;PPP2R1A;RHEB;PFKL;CPT1A;RAB14;HNF4A;RAB2A;EEF2;AKT1S1;PCK1;PCK2;MLYCD;RAB8A,120 (120),0.00737,0.0304,2,HMDB0003153;HMDB0015050,17 (23),0.559,1,0.0267,0.0926
Interleukin-11 Signaling Pathway,Wikipathways,14,HRAS;MAP2K1;MAP2K2;YES1;RELA;PIK3R1;RPS6;RPS6KA1;PTPA;PTPN11;STAT3;ICAM1;MAPK1;GRB2,44 (44),0.0277,0.093,0,,0 (0),1,1,0.0277,0.093
IL-9 signaling pathway,Wikipathways,7,MAP2K1;GRB2;PIK3R1;STAT3;STAT5B;MAPK1;MAP2K2,17 (17),0.028,0.0937,0,,0 (0),1,1,0.028,0.0937
Sphingolipid signaling pathway - Homo sapiens (human),KEGG,32,RHOA;CERS2;PPP2CB;PPP2R1A;PPP2R2A;PPP2R5D;PPP2R5A;MAPK14;PPP2R5E;SGPL1;ASAH1;PIK3R1;GNA13;KNG1;HRAS;BAX;MAPK9;PRKCA;ROCK1;RELA;PLCB3;GNAI3;GNAQ;MAPK1;CTSD;SPHK2;MAP2K1;MAP2K2;DEGS1;GNAI2;RAC1;BID,119 (119),0.0198,0.0707,3,HMDB0004949;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,15 (15),0.212,1,0.0272,0.094
Energy dependent regulation of mTOR by LKB1-AMPK,Reactome,12,PRKAG1;LAMTOR4;CAB39;LAMTOR2;MTOR;PRKAB1;PPM1A;RRAGC;RHEB;PRKAA1;PRKAA2;LAMTOR1,29 (29),0.00422,0.0195,0,,7 (7),1,1,0.0273,0.0943
Oncostatin M Signaling Pathway,Wikipathways,19,SHC1;MAPK9;MAP2K1;MAP2K2;HRAS;PRKCA;MTOR;RPS6;PIK3R1;PXN;HIF1A;PTPN11;STAT3;STAT5B;MAPK14;CASP3;MAPK1;RELA;GRB2,65 (65),0.0283,0.0945,0,,0 (0),1,1,0.0283,0.0945
Beta oxidation of butanoyl-CoA to acetyl-CoA,Reactome,4,ACSM3;HADH;ACADS;ECHS1,5 (5),0.00537,0.0236,1,HMDB0062259,14 (14),0.797,1,0.0276,0.0954
glutathione biosynthesis,HumanCyc,3,GCLC;GCLM;GSS,3 (3),0.00671,0.0279,1,HMDB0000123,9 (9),0.64,1,0.0277,0.0955
Arachidonic acid metabolism,Reactome,19,PON2;PTGR1;PON3;GPX1;CYP1A2;CBR1;PTGR2;CYP4B1;CYP8B1;LTA4H;DPEP1;PTGES2;PTGES3;PTGS1;FAAH;PON1;EPHX2;HPGDS;GPX4,60 (60),0.0121,0.047,11,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0000123;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0004080;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,89 (114),0.356,1,0.0277,0.0955
Cardiac muscle contraction - Homo sapiens (human),KEGG,27,TPM1;CYC1;TPM3;TPM4;MYL3;MT-CO1;COX5A;MT-CO3;ACTC1;ATP1A1;COX4I1;COX5B;COX6A1;COX6C;COX7C;MT-CO2;COX7A2L;UQCRQ;UQCRB;UQCRC1;UQCRC2;UQCRFS1;UQCRH;ATP1B1;ATP1B3;UQCR10;ATP2A2,87 (87),0.0043,0.0198,0,,4 (4),1,1,0.0277,0.0955
Thermogenesis,Wikipathways,28,ACSL1;ACSL4;PRKAG1;SLC25A20;MAPK14;MTOR;RPS6;RPS6KA1;PRKAA1;PRKAA2;ACTB;PRKACA;PRKACB;HRAS;SMARCA2;GRB2;ACTG1;SMARCC2;MGLL;ACTL6A;GNAS;CPT1A;CPT2;MAP2K3;PRKAB1;AKT1S1;ACSL5;RHEB,108 (108),0.0432,0.135,4,HMDB0001934;HMDB0004080;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,17 (25),0.101,1,0.028,0.0963
Complement and Coagulation Cascades,Wikipathways,20,C3;SERPINF2;CFI;CFH;FGB;SERPING1;CLU;KLKB1;F12;SERPIND1;F9;SERPINA1;F2;KNG1;CFB;SERPINC1;PLG;CLTC;LMAN1;C9,59 (59),0.0044,0.0203,0,,1 (2),1,1,0.0283,0.0971
Autophagy - animal - Homo sapiens (human),KEGG,37,PIK3R4;ATG5;MAP2K2;PPP2CB;RRAS2;HIF1A;SH3GLB1;DEPTOR;ATG3;MTOR;EIF2S1;SQSTM1;PIK3R1;PRKAA1;PRKAA2;PRKACA;PRKACB;HRAS;RAB7A;GABARAP;LAMP1;RRAGC;MAP2K1;MAPK1;CTSD;VAMP8;MAPK9;CTSB;RAB1A;STX17;CTSL;AKT1S1;WIPI2;RHEB;RAB8A;RAB33B;SNAP29,137 (137),0.0121,0.047,1,HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,4 (6),0.365,1,0.0283,0.0972
Signaling by VEGF,Reactome,30,RHOA;JUP;ABI1;CYFIP1;MAPK14;CALM1;NCKAP1;BRK1;MTOR;PIK3R1;PRKACA;PRKACB;HRAS;PXN;PAK2;PRKCA;RAC1;ROCK1;NCK1;CTNNA1;CAV1;BAIAP2;CTNNB1;CTNND1;CDC42;ITGB3;CRK;CYFIP2;HSP90AA1;ITPR2,100 (100),0.00473,0.0216,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,25 (26),0.942,1,0.0286,0.098
ErbB2/ErbB3 signaling events,PID,15,SHC1;HRAS;MAP2K1;GRB2;CDC42;MAPK9;MTOR;USP8;PIK3R1;PTPN11;STAT3;RAC1;MAPK1;PRKACA;MAP2K2,40 (40),0.00447,0.0205,0,,4 (4),1,1,0.0286,0.0981
HIV Life Cycle,Reactome,42,TPR;ELOC;ELOB;RAN;RANBP1;RANBP2;NUP93;TAF3;CHMP6;NUP58;NUP155;PSIP1;SUPT5H;VPS4A;VPS4B;POLR2A;NUP210;PDCD6IP;SUPT16H;NUP98;RAE1;NUP133;CHMP3;CHMP5;VTA1;RCC1;TSG101;TAF15;NCBP1;VPS28;XPO1;SSRP1;NUP160;XRCC5;CHMP4B;NMT1;CHMP2A;BANF1;XRCC6;NUP35;SEC13;NUP205,151 (151),0.00453,0.0208,0,,10 (16),1,1,0.029,0.0992
Adipocytokine signaling pathway - Homo sapiens (human),KEGG,17,ACACB;MAPK9;PRKAG1;ACSL1;ACSL4;MTOR;PCK2;RXRA;PCK1;RELA;PTPN11;STAT3;ACSL5;PRKAA1;PRKAA2;PRKAB1;CPT1A,69 (69),0.142,0.353,2,HMDB0004949;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,3 (7),0.032,1,0.0291,0.0994
TCA cycle in senescence,Wikipathways,6,ME1;PDHA1;PDK1;GOT1;MDH1;FH,10 (10),0.00469,0.0214,0,,10 (13),1,1,0.0298,0.102
Ketone body metabolism,Reactome,6,BDH2;ACAT1;BDH1;HMGCL;HMGCS2;ACSS3,10 (10),0.00469,0.0214,0,,15 (16),1,1,0.0298,0.102
Axon guidance,Reactome,84,SHC1;MYL12A;COL4A2;COL6A1;COL6A2;COL6A3;DPYSL2;ANK1;MYH9;MYH11;AP2S1;CLTA;MYL6;MYL9;ARHGEF12;AP2A1;AP2A2;AP2B1;EGFR;ITGA9;CSNK2A1;MYH14;SPTB;ACTR3;CFL1;LYPLA2;CSNK2A2;SPTA1;SPTAN1;TLN1;SPTBN1;ARPC1A;CSNK2B;PITPNA;RPS6KA1;ACTB;RDX;PRKACA;PRKACB;NUMB;HRAS;DNM3;GRB2;PAK2;ACTG1;PRKAR2A;PRKCA;DLG1;COL6A5;ROCK1;SPTBN2;NCK1;ALCAM;ITGA1;ITGA2B;RHOA;CAP1;ITGA5;MAPK1;PFN1;WASL;LYN;MAP2K1;MAP2K2;CDC42;ITGB1;ITGB3;YES1;ARPC5;ARPC4;ARPC3;ARPC1B;HSPA8;ACTR2;COL6A6;CLTC;PTPN11;RAC1;HSP90AA1;DNM2;FARP2;ARPC2;HSP90AB1;AP2M1,356 (356),0.0142,0.0534,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000123,11 (17),0.334,1,0.03,0.102
the visual cycle I (vertebrates),HumanCyc,6,DHRS3;RDH10;RDH11;DHRS4;RBP1;RBP4,16 (16),0.0642,0.188,7,HMDB0000944;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0003073;HMDB0001388;HMDB0001043;HMDB0006216;HMDB0002183,35 (58),0.0737,1,0.0301,0.102
Ubiquinone Biosynthesis,SMPDB,4,COQ5;COQ6;COQ3;COQ7,5 (5),0.00537,0.0236,1,HMDB0036062#HMDB0036064,19 (19),0.885,1,0.0302,0.103
Airway smooth muscle cell contraction,Wikipathways,7,RHOA;GDI1;ROCK1;GNAQ;CD38;PPP1CB;MYLK,15 (15),0.0131,0.0503,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (7),0.365,1,0.0304,0.103
guanosine nucleotides <i>de novo</i> biosynthesis,HumanCyc,8,NME3;RRM1;GMPS;GUK1;RRM2B;IMPDH2;NME1;NME2,16 (16),0.00481,0.0219,0,,17 (17),1,1,0.0305,0.103
Defective CFTR causes cystic fibrosis,Reactome,8,SEL1L;DERL2;DERL1;OS9;ERLEC1;ERLIN1;VCP;ERLIN2,16 (16),0.00481,0.0219,0,,5 (6),1,1,0.0305,0.103
the igf-1 receptor and longevity,BioCarta,8,SHC1;HRAS;GRB2;SOD1;PIK3R1;IGF1;SOD2;CAT,16 (16),0.00481,0.0219,0,,2 (2),1,1,0.0305,0.103
igf-1 signaling pathway,BioCarta,8,SHC1;HRAS;MAP2K1;GRB2;PIK3R1;CSNK2A1;PTPN11;IGF1,21 (21),0.0313,0.104,0,,0 (0),1,1,0.0313,0.104
p38 signaling mediated by MAPKAP kinases,PID,8,YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;HSPB1;MAPK14;YWHAQ,21 (21),0.0313,0.104,0,,0 (0),1,1,0.0313,0.104
CAMKK2 Pathway,Wikipathways,13,CALM1;STIM1;DNM1L;MTOR;SQSTM1;RAC1;FIS1;RELA;SMC1A;ICAM1;CAMK1;HMOX1;MAPK1,33 (33),0.00487,0.0221,0,,7 (12),1,1,0.0308,0.104
Signalling to ERKs,Reactome,13,SHC1;HRAS;MAP2K1;GRB2;YWHAB;RALA;RALB;RAP1A;CRK;CRKL;MAPK14;MAPK1;MAP2K2,33 (33),0.00487,0.0221,0,,6 (7),1,1,0.0308,0.104
KitReceptor,NetPath,20,SHC1;HRAS;LYN;GRB2;PRKCA;MTOR;RELA;PIK3R1;RPS6;RPS6KA1;PTPN11;STAT3;CRKL;MAPK14;STAT5B;MAPK1;CRK;RDX;KITLG;YES1,70 (70),0.0315,0.105,0,,0 (0),1,1,0.0315,0.105
Glucuronidation,Wikipathways,11,UGP2;UGT1A3;UGT2B10;UGT2B15;PGM2;PGM1;PGM3;UGT2A3;HK1;UGT2A1;UGDH,26 (26),0.00497,0.0223,0,,14 (14),1,1,0.0313,0.105
Signaling by EGFRvIII in Cancer,Reactome,7,SHC1;HRAS;EGFR;GRB2;PIK3R1;HSP90AA1;CDC37,13 (13),0.00498,0.0223,0,,5 (11),1,1,0.0314,0.105
stearate biosynthesis,HumanCyc,7,ACSL1;ACOT7;ACSL4;ACOT2;ACSL5;SLC27A2;ACOT4,13 (13),0.00498,0.0223,0,,15 (17),1,1,0.0314,0.105
Suppression of phagosomal maturation,Reactome,7,RAB7A;RAB5A;CORO1A;ATP6V1H;HGS;KPNA1;KPNB1,13 (13),0.00498,0.0223,0,,4 (8),1,1,0.0314,0.105
eNOS activation,Reactome,7,CALM1;LYPLA1;CYGB;SPR;DDAH1;HSP90AA1;CAV1,13 (13),0.00498,0.0223,0,,26 (26),1,1,0.0314,0.105
Constitutive Signaling by EGFRvIII,Reactome,7,SHC1;HRAS;EGFR;GRB2;PIK3R1;HSP90AA1;CDC37,13 (13),0.00498,0.0223,0,,5 (11),1,1,0.0314,0.105
adenine and adenosine salvage III,HumanCyc,3,ADA;HPRT1;PNP,3 (3),0.00671,0.0279,1,HMDB0000195,12 (12),0.745,1,0.0315,0.106
Aflatoxin activation and detoxification,Reactome,9,AKR7A3;MGST2;MGST3;MGST1;DPEP1;CYP1A2;ACY3;AKR7A2;ACY1,20 (20),0.00671,0.0279,1,HMDB0000123,13 (25),0.772,1,0.0324,0.109
Thyroid stimulating hormone (TSH) signaling pathway,Wikipathways,19,HRAS;MAP2K1;MAP2K3;APEX1;MTOR;RPS6KA1;RPS6;PIK3R1;GNA13;GNAQ;RAP1A;GNAI2;RAP1B;GNAI3;STAT3;MAPK14;GNAS;MAPK1;GNB1,66 (66),0.0329,0.109,0,,0 (0),1,1,0.0329,0.109
Phenytoin (Antiarrhythmic) Action Pathway,SMPDB,25,TPM1;PDIA4;EPHX1;CYP1A2;DNAJB11;PDIA6;HYOU1;MYLK;COMT;CALM1;CYP2E1;PRKACA;NQO1;PRKAR1A;SDF2L1;DLG1;ERP29;ATP1A1;ATP1B1;ATP1B3;TNNT3;PPIB;ATP2A2;HSPA5;SNTB2,82 (82),0.00752,0.031,2,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145;HMDB0041905,22 (22),0.701,1,0.0329,0.11
Mitotic Prometaphase,Reactome,51,PDS5B;ACTR1A;PPP2CB;PPP2R1A;RANBP2;RANGAP1;PPP2R5A;PPP2R5D;PPP2R5E;NUP160;NDEL1;SMC3;MAPRE1;DCTN2;CSNK1D;CSNK2A1;SMC1A;CSNK2B;EML4;PAFAH1B1;SSNA1;PRKACA;DYNLL2;NUP98;CKAP5;NUP133;DYNC1LI1;PDS5A;NEK7;CEP192;RPS27;XPO1;TUBB4B;ZW10;BUB3;RAD21;NUDC;DCTN1;YWHAE;YWHAG;TUBA4A;STAG2;RCC2;DYNC1H1;DYNC1I2;CSNK2A2;DYNC1LI2;HSP90AA1;DCTN3;SEC13;PPP1CC,192 (192),0.00528,0.0236,0,,6 (8),1,1,0.033,0.11
Infectious disease,Reactome,169,MTA2;TPR;EPS15;STAM2;ARF1;MYH9;IMPDH2;NCKAP1;BRK1;SIGMAR1;VPS4A;DPEP1;B2M;ACTB;ACTG1;NCBP1;RCC1;NCK1;TSG101;CHD4;NUP58;SSRP1;YES1;WASL;ITGB1;CHMP2A;BANF1;CD163;STAT2;HNRNPK;DDX5;DYNLL2;NUP205;AP2M1;AP1S1;CYFIP1;GANAB;CHMP5;SUGT1;AP2A1;UBE2I;GNG12;AP2B1;AP1G1;DYNC1LI1;SUPT5H;NUP210;VAMP2;COMT;RAB7A;AP1M1;C3;ROCK1;PARP9;PRKACA;GNAS;GNB1;GNB2;NMT1;FKBP1A;RAB5A;ITPR2;FKBP4;DYNC1H1;DYNC1I2;DYNC1LI2;HSP90AA1;RBX1;PML;KPNA1;KPNB1;KPNA2;KPNA3;KPNA4;NPM1;MRC1;ELOC;ELOB;RAN;RANBP1;RANBP2;MAP2K4;VPS28;SFPQ;ABI1;CHMP6;BAIAP2;PDCD6IP;RAE1;CALM1;SLC25A4;SLC25A5;RBBP4;CTNND1;NT5E;CANX;POLR2A;ARPC1A;VPS4B;NUP98;GRB2;VTA1;ST6GAL1;LYN;ST3GAL4;FXYD1;XPO1;NR3C1;XRCC5;PARP14;CHMP4B;SKP1;MAP2K3;CDH1;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;CRK;CYFIP2;NUP35;ARPC2;CUL5;AP2S1;CORO1A;EEF2;TAF3;ATP6V1H;MAPK14;NUP160;NUP155;PSIP1;CTSL;EGFR;PABPN1;IGHG1;HGS;ENTPD5;SUPT16H;PRKACB;NUP133;CHMP3;PRKAR1A;PAK2;AP2A2;PRKAR2A;RAC1;AP1B1;TAF15;PRKCSH;NUP93;MOGS;MAPK1;CTNNB1;ATP1A1;ATP1B1;ATP1B3;MAP2K1;MAP2K2;CDC42;ENO1;PTGES3;SEC13;EIF2AK2;XRCC6;HSP90AB1;HDAC2,750 (750),0.00547,0.0239,4,HMDB0001178;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000123;HMDB0033934,75 (127),0.968,1,0.033,0.11
Potential therapeutics for SARS,Reactome,25,MTA2;AP2M1;AP2S1;IMPDH2;COMT;AP2A2;AP2B1;RBBP4;ATP1A1;AP2A1;ROCK1;CHD4;NR3C1;ATP1B1;ATP1B3;FXYD1;PTGES3;FKBP4;ITGB1;STAT2;SIGMAR1;HSP90AA1;HDAC2;FKBP1A;HSP90AB1,80 (80),0.00532,0.0236,0,,1 (2),1,1,0.0332,0.11
&gamma;-glutamyl cycle,HumanCyc,6,CNDP2;GCLC;GCLM;GSS;GGCT;OPLAH,11 (11),0.00868,0.0347,3,HMDB0000123;HMDB0000172;HMDB0000687,29 (29),0.616,1,0.0333,0.11
purine ribonucleosides degradation to ribose-1-phosphate,HumanCyc,3,PGM2;PNP;ADA,3 (3),0.00671,0.0279,1,HMDB0000195,14 (15),0.797,1,0.0333,0.11
Long-term potentiation - Homo sapiens (human),KEGG,21,CALM1;MAP2K1;MAP2K2;PLCB3;CAMK2D;PPP1CB;PRKCA;CAMK2A;ARAF;RAP1A;RPS6KA1;RAP1B;HRAS;PPP1CC;GNAQ;PPP3CA;PPP1CA;ITPR2;MAPK1;PRKACA;PRKACB,67 (67),0.00975,0.0386,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,7 (7),0.549,1,0.0333,0.11
Deadenylation-dependent mRNA decay,Reactome,19,SKIV2L;TUT7;PABPC1;CNOT1;LSM4;PAIP1;HBS1L;TNKS1BP1;WDR61;TTC37;LSM6;EIF4A2;DDX6;EIF4E;LSM3;EIF4A3;EXOSC6;EIF4G1;EIF4A1,56 (56),0.00537,0.0236,0,,8 (11),1,1,0.0334,0.11
Synthesis and Degradation of Ketone Bodies,Wikipathways,4,BDH1;HMGCL;HMGCS2;ACAT1,5 (5),0.00537,0.0236,0,,4 (5),1,1,0.0335,0.11
Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs),Wikipathways,4,FMO3;FMO4;FMO5;FMO1,5 (5),0.00537,0.0236,0,,8 (8),1,1,0.0335,0.11
Keratan sulfate degradation,Reactome,4,GLB1;HEXA;HEXB;GNS,5 (5),0.00537,0.0236,0,,3 (10),1,1,0.0335,0.11
pyruvate decarboxylation to acetyl CoA,HumanCyc,4,PDHA1;DLAT;DLD;PDHB,5 (5),0.00537,0.0236,0,,7 (7),1,1,0.0335,0.11
NAD biosynthesis from 2-amino-3-carboxymuconate semialdehyde,HumanCyc,4,NMNAT1;QPRT;NMNAT3;NADSYN1,5 (5),0.00537,0.0236,0,,14 (14),1,1,0.0335,0.11
malate-aspartate shuttle,HumanCyc,4,GOT2;GOT1;MDH1;MDH2,5 (5),0.00537,0.0236,0,,8 (8),1,1,0.0335,0.11
Synthesis of GDP-mannose,Reactome,4,MPI;GMPPB;GMPPA;PMM2,5 (5),0.00537,0.0236,0,,6 (6),1,1,0.0335,0.11
D-Glutamine and D-glutamate metabolism - Homo sapiens (human),KEGG,4,GLS;DGLUCY;GLUD1;GLS2,5 (5),0.00537,0.0236,0,,7 (13),1,1,0.0335,0.11
ketolysis,HumanCyc,4,BDH2;ACAT1;BDH1;ACAT2,5 (5),0.00537,0.0236,0,,10 (10),1,1,0.0335,0.11
Succinyl CoA: 3-ketoacid CoA transferase deficiency,SMPDB,4,BDH1;HMGCL;HMGCS2;ACAT1,5 (5),0.00537,0.0236,0,,13 (13),1,1,0.0335,0.11
Ketone Body Metabolism,SMPDB,4,BDH1;HMGCL;HMGCS2;ACAT1,5 (5),0.00537,0.0236,0,,13 (13),1,1,0.0335,0.11
Formation of xylulose-5-phosphate,Reactome,4,SORD;CRYL1;XYLB;AKR1A1,5 (5),0.00537,0.0236,0,,15 (17),1,1,0.0335,0.11
Platelet Aggregation (Plug Formation),Reactome,14,SHC1;F2;FGB;CSK;ITGB3;RAP1A;FGA;RAP1B;CRK;TLN1;ITGA2B;FN1;FGG;GRB2,37 (37),0.00541,0.0237,0,,11 (15),1,1,0.0336,0.11
Formation of Fibrin Clot (Clotting Cascade),Reactome,14,FGA;F2;FGB;SERPING1;KLKB1;SERPIND1;SERPINC1;F11;F12;F13A1;KNG1;F9;C1QBP;FGG,37 (37),0.00541,0.0237,0,,1 (14),1,1,0.0336,0.11
GMCSF-mediated signaling events,PID,14,SHC1;HRAS;LYN;MAP2K1;GRB2;MAP2K2;YWHAZ;PIK3R1;PTPN11;STAT3;STAT5B;MAPK1;PRKACA;PRKACB,37 (37),0.00541,0.0237,0,,2 (2),1,1,0.0336,0.11
trefoil factors initiate mucosal healing,BioCarta,14,SHC1;HRAS;RHOA;EGFR;GRB2;CASP6;MAP2K1;PIK3R1;RELA;RPS6KA1;CASP3;MAPK1;CTNNB1;MAP2K2,37 (37),0.00541,0.0237,0,,2 (2),1,1,0.0336,0.11
Pantothenate and CoA Biosynthesis,SMPDB,4,COASY;VNN1;PPCS;ENPP1,6 (6),0.0137,0.052,3,HMDB0004231;HMDB0001416;HMDB0001016,21 (21),0.395,1,0.0337,0.11
phosphorylation of mek1 by cdk5/p35 down regulates the map kinase pathway,BioCarta,6,SHC1;HRAS;MAP2K1;MAP2K2;MAPK1;GRB2,14 (14),0.0338,0.111,0,,0 (0),1,1,0.0338,0.111
SARS-CoV-2 and COVID-19 Pathway,Wikipathways,2,SCARB1;ACAT1,3 (3),0.0934,0.249,2,HMDB0000693;HMDB0000067,4 (5),0.0594,1,0.0344,0.112
Lamin A-processing pathway,Wikipathways,2,LMNA;ZMPSTE24,2 (2),0.0356,0.113,0,,0 (1),1,1,0.0356,0.113
Defective factor XII causes hereditary angioedema,Reactome,2,F12;KLKB1,2 (2),0.0356,0.113,0,,0 (0),1,1,0.0356,0.113
Activation_ translocation and oligomerization of BAX,Reactome,2,BAX;BID,2 (2),0.0356,0.113,0,,0 (0),1,1,0.0356,0.113
Transport of Ribonucleoproteins into the Host Nucleus,Reactome,2,KPNA1;KPNB1,2 (2),0.0356,0.113,0,,0 (0),1,1,0.0356,0.113
Eptifibatide Action Pathway,SMPDB,2,ITGA2B;ITGB3,2 (2),0.0356,0.113,0,,0 (0),1,1,0.0356,0.113
Abciximab Action Pathway,SMPDB,2,ITGA2B;ITGB3,2 (2),0.0356,0.113,0,,0 (0),1,1,0.0356,0.113
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET),Reactome,2,CYP1A2;EPHX2,8 (8),0.463,0.843,5,HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314;HMDB0001043,14 (15),0.0121,0.643,0.0347,0.114
Human immunodeficiency virus 1 infection - Homo sapiens (human),KEGG,53,CUL5;CUL4B;CUL4A;CUL1;ELOC;ELOB;ATM;AP1S1;MAPK14;CASP3;PDIA3;PPP3CA;PXN;CALM1;GNG12;CRKL;AP1G1;CALR;SAMHD1;PIK3R1;CFL1;CFL2;B2M;HRAS;FADD;BAX;PAK2;PRKCA;AP1M1;AP1B1;GNA11;RELA;GNAI2;GNAI3;GNAQ;MAP2K1;MAPK1;MTOR;GNB1;GNB2;MAPK9;SKP1;MAP2K2;MAP2K3;DDB1;TAP2;TAPBP;BID;TRIM5;CRK;RAC1;RBX1;ITPR2,212 (212),0.0157,0.058,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (5),0.365,1,0.0354,0.115
5-aminoimidazole ribonucleotide biosynthesis,HumanCyc,3,GART;PFAS;PPAT,3 (3),0.00671,0.0279,1,HMDB0000123,17 (17),0.856,1,0.0354,0.115
Blood Clotting Cascade,Wikipathways,10,SERPINF2;FGA;FGB;KLKB1;F9;F11;F12;F2;FGG;PLG,23 (23),0.00581,0.0251,0,,1 (2),1,1,0.0357,0.116
Nephrin family interactions,Reactome,10,SPTBN1;PIK3R1;WASL;ACTN4;NCK1;SPTAN1;ACTN1;CD2AP;IQGAP1;CASK,23 (23),0.00581,0.0251,0,,2 (3),1,1,0.0357,0.116
Negative regulators of DDX58/IFIH1 signaling,Reactome,10,MAVS;DDX58;ISG15;PCBP2;ATG5;PIN1;NLRX1;ITCH;TRIM25;RNF135,23 (23),0.00581,0.0251,0,,2 (6),1,1,0.0357,0.116
Signaling events mediated by PRL,PID,10,RHOA;TUBA1B;AGT;ROCK1;ITGB1;RABGGTA;RABGGTB;RAC1;ITGA1;MAPK1,23 (23),0.00581,0.0251,0,,1 (1),1,1,0.0357,0.116
ccr3 signaling in eosinophils,BioCarta,10,HRAS;DECR1;RHOA;MAP2K1;PRKCA;CFL1;GNAQ;GNAS;MAPK1;GNB1,23 (23),0.00581,0.0251,0,,1 (1),1,1,0.0357,0.116
Response of Mtb to phagocytosis,Reactome,10,MAPK1;ENO1;RAB7A;RAB5A;CORO1A;SFPQ;ATP6V1H;HGS;KPNA1;KPNB1,23 (23),0.00581,0.0251,0,,7 (11),1,1,0.0357,0.116
Irinotecan Action Pathway,SMPDB,10,PDIA4;PPIB;SDF2L1;HSPA5;DNAJB11;ERP29;PDIA6;TOP1;ABCC2;HYOU1,23 (23),0.00581,0.0251,0,,11 (12),1,1,0.0357,0.116
Irinotecan Metabolism Pathway,SMPDB,10,PDIA4;PPIB;SDF2L1;HSPA5;DNAJB11;ERP29;PDIA6;TOP1;ABCC2;HYOU1,23 (23),0.00581,0.0251,0,,11 (12),1,1,0.0357,0.116
Trafficking of AMPA receptors,Reactome,12,AP2A1;AP2A2;AP2B1;MYO6;NSF;PRKCA;DLG1;CAMK2A;CAMK2D;EPB41L1;AP2M1;AP2S1,30 (30),0.00584,0.0252,0,,5 (6),1,1,0.0359,0.116
Glutamate binding_ activation of AMPA receptors and synaptic plasticity,Reactome,12,AP2A1;AP2A2;AP2B1;MYO6;NSF;PRKCA;DLG1;CAMK2A;CAMK2D;EPB41L1;AP2M1;AP2S1,30 (30),0.00584,0.0252,0,,7 (8),1,1,0.0359,0.116
Mitophagy,Reactome,12,TOMM22;ATG5;MFN2;TOMM70;SQSTM1;PGAM5;CSNK2A1;CSNK2A2;TOMM40;MFN1;VDAC1;CSNK2B,30 (30),0.00584,0.0252,0,,2 (2),1,1,0.0359,0.116
IGF1 pathway,PID,12,SHC1;HRAS;IGF1;GRB2;YWHAE;YWHAZ;PIK3R1;PTPN11;CRK;CRKL;RACK1;PXN,30 (30),0.00584,0.0252,0,,2 (2),1,1,0.0359,0.116
Biotin metabolism - Homo sapiens (human),KEGG,2,OXSM;BTD,3 (3),0.0934,0.249,3,HMDB0003581;HMDB0240687;HMDB0003134,9 (28),0.0629,1,0.036,0.116
Pyrimidine biosynthesis,Reactome,3,DHODH;UMPS;CAD,3 (3),0.00671,0.0279,1,HMDB0003349#HMDB0000528,21 (22),0.909,1,0.0372,0.12
Nervous system development,Reactome,88,MYH9;MYH11;MYL6;CFL1;LYPLA2;RPS6KA1;SPTA1;SPTAN1;SPTB;SPTBN1;SPTBN2;ACTB;PFN1;ACTG1;COL6A5;NCK1;ITGA1;ITGA2B;ITGA5;ITGA9;WASL;ITGB1;ITGB3;CLTC;FARP2;GJB1;PTPN11;AP2S1;MYL9;AP2A1;AP2A2;AP2B1;YAP1;PITPNA;CLTA;PRKCA;HRAS;DLG1;ALCAM;HSPA8;CAP1;HSP90AA1;DNM2;HSP90AB1;COL4A2;COL6A1;COL6A2;COL6A3;DPYSL2;RHOA;ANK1;COL6A6;ARPC1A;SHC1;LAMA2;GRB2;RDX;YES1;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;ARPC2;AP2M1;MYL12A;ARHGEF12;EGFR;MYH14;CSNK2A1;CSNK2A2;CSNK2B;TLN1;PRKACA;PRKACB;DNM3;PAK2;PRKAR2A;NUMB;RAC1;ROCK1;MAPK1;LYN;MAP2K1;MAP2K2;CDC42;HDAC2,379 (379),0.0184,0.0669,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000123,11 (17),0.334,1,0.0375,0.121
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide_ LLO) and transfer to a nascent protein,Reactome,24,NPL;UAP1;NUDT14;GLB1;ST3GAL6;GNE;NANS;ALG5;DPM3;GNPNAT1;ALG11;ST6GAL1;ST3GAL4;GFUS;CMAS;CTSA;GMPPB;GMPPA;DPM1;GFPT1;ALG2;PGM3;PMM2;MPI,77 (77),0.00647,0.0277,3,HMDB0000290;HMDB0001090;HMDB0001445,59 (82),0.961,1,0.0378,0.121
Hemostasis,Reactome,152,AAMP;PSAP;OLA1;CFL1;ABHD6;PF4;MGLL;ACTN4;NHLRC2;ACTN1;ITGA1;ITGA2B;MIF;ITGA5;YES1;PFN1;F2;ITGB1;ITGB2;ITGB3;TUBA4A;F9;F11;F12;F13A1;ITIH3;ITIH4;TTN;AK3;CEACAM1;EHD3;STIM1;PTPN6;SERPINA4;PTPN11;SERPINB8;FGB;STX4;STXBP2;STXBP3;F11R;GNG12;CLU;TEX264;BSG;GLG1;PIK3R1;EHD1;RARRES2;HRAS;FGA;C1QBP;SERPING1;MFN2;HRG;FAM3C;GNAI2;ALB;KIF5B;GNAQ;FGG;GNA11;PLG;GNB1;GNB2;SERPINF2;ALDOA;KLKB1;RAB5A;HSPA5;ITPR2;KNG1;VCL;RAC1;VTI1B;GNAI3;KIF13B;TAGLN2;FLNA;RAP1A;RAP1B;GNAS;FN1;CALM1;PPP2R5E;DOCK8;WDR1;CALU;ANXA5;CAPZA1;CAPZA2;CAPZB;GRB2;GRB14;ORM1;APOA1;APOB;LYN;CAV1;APOH;AKAP1;KLC4;ECM1;SERPINA1;TF;YWHAZ;CYRIB;MFN1;CRK;LGALS3BP;ATP2B1;SHC1;RHOA;RHOG;PPP2CB;PPP2R1A;PPP2R5D;PPP2R5A;IGF1;MAPK14;SCCPDH;CSK;SLC16A1;GUCY1B1;GNA13;IGHM;TLN1;JCHAIN;PRKACA;PRKACB;CD47;CD48;PRKAR1A;PRKAR2A;PRKCA;CAP1;CD74;SERPINC1;CHID1;MAPK1;FERMT3;ATP1B1;ATP1B3;GUCY1A1;CDC42;ATP2A2;ABHD12;SERPIND1;CXADR;SOD1;HDAC2;KIF1C,677 (677),0.0093,0.037,4,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0003208;HMDB0001043,42 (67),0.675,1,0.0381,0.122
oxidative stress induced gene expression via nrf2,BioCarta,7,HMOX2;POR;PRKCA;CRYZ;HMOX1;GSTA2;AKR7A2,18 (18),0.0386,0.122,0,,0 (0),1,1,0.0386,0.122
PLC beta mediated events,Reactome,14,CALM1;PRKAR1A;PRKAR2A;PRKCA;GNA11;CAMK2D;PLCB3;KPNA2;GNAQ;MAPK1;CAMK2A;ITPR2;PRKACA;PRKACB,50 (50),0.0752,0.214,4,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0001043;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,16 (17),0.0837,1,0.0382,0.122
Ibuprofen Action Pathway,SMPDB,15,PDIA4;UGT1A3;EPHX2;PPIB;SDF2L1;HSPA5;DNAJB11;LTA4H;ERP29;PDIA6;CYP2E1;PTGS1;CBR1;GPX1;HYOU1,50 (50),0.0387,0.123,11,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0002513#HMDB0010323;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001925;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,74 (79),0.163,1,0.0383,0.123
Metabolism of steroid hormones,Reactome,9,SERPINA6;AKR1B1;HSD17B12;HSD17B11;FDX1;FDXR;HSD11B1;SRD5A1;HSD17B2,31 (31),0.115,0.296,7,HMDB0000015;HMDB0000234;HMDB0000067;HMDB0006763;HMDB0001547;HMDB0000145;HMDB0000077,33 (35),0.0562,1,0.0389,0.125
Primary focal segmental glomerulosclerosis (FSGS),Wikipathways,23,VIM;KRT8;MYH9;VTN;ILK;MYO1E;INF2;SCARB2;CD2AP;PARVA;TLN1;LAMB2;ACTN4;NCK1;YWHAQ;CTNNB1;ITGB1;ITGB3;CDH2;LIMS1;VCL;PCNA;CTSL,73 (73),0.00657,0.0279,0,,1 (4),1,1,0.0396,0.126
Legionellosis - Homo sapiens (human),KEGG,19,HSPD1;CR1L;CASP3;RAB1A;CD14;SAR1A;BCL2L13;VCP;RELA;C3;HBS1L;HSPA8;EEF1G;SEC22B;RAB1B;ITGB2;ARF1;SAR1B;EEF1A1,57 (57),0.00666,0.0279,0,,1 (2),1,1,0.04,0.126
egf signaling pathway,BioCarta,9,SHC1;HRAS;MAP2K1;GRB2;PRKCA;PIK3R1;MAP2K4;STAT3;EGFR,20 (20),0.00671,0.0279,0,,1 (1),1,1,0.0403,0.126
Cerebral organic acidurias_ including diseases,Wikipathways,3,L2HGDH;IDH2;ALDH7A1,3 (3),0.00671,0.0279,0,,23 (27),1,1,0.0403,0.126
COVID-19_ thrombosis and anticoagulation,Wikipathways,3,FGG;FGA;FGB,3 (3),0.00671,0.0279,0,,1 (5),1,1,0.0403,0.126
2-oxoglutarate decarboxylation to succinyl-CoA,HumanCyc,3,DLD;DLST;OGDH,3 (3),0.00671,0.0279,0,,7 (7),1,1,0.0403,0.126
S-adenosyl-L-methionine biosynthesis,HumanCyc,3,MAT2A;MAT2B;MAT1A,3 (3),0.00671,0.0279,0,,6 (6),1,1,0.0403,0.126
NADH repair,HumanCyc,3,NAXE;NAXD;GAPDH,3 (3),0.00671,0.0279,0,,7 (8),1,1,0.0403,0.126
glutamine degradation/glutamate biosynthesis,HumanCyc,3,GLS;ASNS;GLS2,3 (3),0.00671,0.0279,0,,4 (4),1,1,0.0403,0.126
tetrahydrobiopterin <i>de novo</i> biosynthesis,HumanCyc,3,SPR;GCH1;PTS,3 (3),0.00671,0.0279,0,,9 (11),1,1,0.0403,0.126
Fibronectin matrix formation,Reactome,3,ITGB1;ITGA5;FN1,3 (3),0.00671,0.0279,0,,1 (2),1,1,0.0403,0.126
uracil degradation,HumanCyc,3,UPB1;DPYD;DPYS,3 (3),0.00671,0.0279,0,,10 (10),1,1,0.0403,0.126
Beta oxidation of palmitoyl-CoA to myristoyl-CoA,Reactome,3,HADHB;ACADVL;HADHA,3 (3),0.00671,0.0279,0,,13 (13),1,1,0.0403,0.126
thymine degradation,HumanCyc,3,UPB1;DPYD;DPYS,3 (3),0.00671,0.0279,0,,10 (10),1,1,0.0403,0.126
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids,Reactome,3,ECI1;DECR1;ACADM,3 (3),0.00671,0.0279,0,,11 (11),1,1,0.0403,0.126
Beta oxidation of myristoyl-CoA to lauroyl-CoA,Reactome,3,HADHB;ACADL;HADHA,3 (3),0.00671,0.0279,0,,13 (13),1,1,0.0403,0.126
Interconversion of 2-oxoglutarate and 2-hydroxyglutarate,Reactome,3,ADHFE1;L2HGDH;D2HGDH,3 (3),0.00671,0.0279,0,,5 (7),1,1,0.0403,0.126
inosine-5_-phosphate biosynthesis,HumanCyc,3,ADSL;PAICS;ATIC,3 (3),0.00671,0.0279,0,,16 (16),1,1,0.0403,0.126
Vitamins B6 activation to pyridoxal phosphate,Reactome,3,PNPO;AOX1;PDXK,3 (3),0.00671,0.0279,0,,16 (18),1,1,0.0403,0.126
taurine biosynthesis,HumanCyc,3,CSAD;ADO;CDO1,3 (3),0.00671,0.0279,0,,11 (11),1,1,0.0403,0.126
Glycerol Phosphate Shuttle,SMPDB,3,GPD1;GPD2;GAPDH,3 (3),0.00671,0.0279,0,,9 (10),1,1,0.0403,0.126
Pyruvaldehyde Degradation,SMPDB,3,LDHD;GLO1;HAGH,3 (3),0.00671,0.0279,0,,9 (9),1,1,0.0403,0.126
methylglyoxal degradation I,HumanCyc,3,LDHD;GLO1;HAGH,3 (3),0.00671,0.0279,0,,10 (11),1,1,0.0403,0.126
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,Reactome,5,SNRPF;SNRPD3;SNRPB;SNRPG;NCBP1,11 (11),0.0402,0.127,0,,0 (2),1,1,0.0402,0.127
epo signaling pathway,BioCarta,5,SHC1;HRAS;GRB2;PTPN6;STAT5B,11 (11),0.0402,0.127,0,,0 (0),1,1,0.0402,0.127
insulin signaling pathway,BioCarta,5,SHC1;HRAS;PTPN11;GRB2;PIK3R1,11 (11),0.0402,0.127,0,,0 (0),1,1,0.0402,0.127
phospholipids as signalling intermediaries,BioCarta,12,SHC1;HRAS;MAP2K1;GRB2;PRKCA;ASAH1;PIK3R1;RAC1;MAPK1;ITGB3;GNB1;MAP2K2,33 (33),0.0138,0.0522,1,HMDB0013462#HMDB0012103#HMDB0012092,6 (7),0.494,1,0.0408,0.128
Metabolism of folate and pterines,Reactome,8,SHMT1;SHMT2;MTHFD1;ALDH1L2;DHFR;ALDH1L1;MTHFS;SLC25A32,17 (17),0.0076,0.0311,1,HMDB0000123,20 (25),0.898,1,0.0408,0.128
IL-2 signaling pathway,Wikipathways,13,SHC1;HRAS;MAP2K1;MAP2K2;NMI;PIK3R1;RPS6;PTPN11;STAT3;CRKL;STAT5B;MAPK1;GRB2,42 (42),0.0412,0.13,0,,0 (0),1,1,0.0412,0.13
Extracellular vesicles in the crosstalk of cardiac cells,Wikipathways,8,PDLIM5;EGFR;STAT3;SOD1;CD81;HSPB1;SORBS2;IGF1,22 (22),0.0413,0.13,0,,0 (0),1,1,0.0413,0.13
PINK1-PRKN Mediated Mitophagy,Reactome,8,TOMM22;ATG5;MFN2;TOMM70;SQSTM1;TOMM40;MFN1;VDAC1,22 (22),0.0413,0.13,0,,0 (0),1,1,0.0413,0.13
corticosteroids and cardioprotection,BioCarta,11,F2;ANXA1;PIK3R1;RELA;KNG1;AGT;HSP90AA1;CAV1;GNAS;NR3C1;GNB1,27 (27),0.00698,0.0289,0,,7 (8),1,1,0.0416,0.13
thrombin signaling and protease-activated receptors,BioCarta,11,F2;ARFGEF2;ARFGEF1;PRKCA;ROCK1;PIK3R1;GNA13;RHOA;GNAQ;GBF1;GNB1,27 (27),0.00698,0.0289,0,,3 (3),1,1,0.0416,0.13
Amine Oxidase reactions,Reactome,3,MAOA;MAOB;PAOX,4 (4),0.0231,0.0797,3,HMDB0001276;HMDB0001186;HMDB0033934,18 (18),0.303,1,0.0417,0.13
Retinol metabolism - Homo sapiens (human),KEGG,20,ADH5;RDH16;ADH6;UGT1A3;RETSAT;RDH11;UGT2B15;DHRS3;CYP1A2;ALDH1A3;RDH10;DGAT1;RDH13;DHRS4;HSD17B6;UGT2A3;ALDH1A1;AOX1;UGT2A1;UGT2B10,68 (68),0.0233,0.0804,3,HMDB0006216;HMDB0006217;HMDB0006285#HMDB0006280,18 (25),0.303,1,0.0421,0.131
Linoleic acid (LA) metabolism,Reactome,5,FADS1;ELOVL5;ABCD1;ACSL1;FADS2,8 (8),0.00802,0.0324,1,HMDB0001976,19 (24),0.885,1,0.0422,0.131
Signaling events mediated by TCPTP,PID,14,SHC1;EIF2A;EGFR;GRB2;ITGB1;EIF2AK2;PIK3R1;LMAN1;STAT3;ITGA1;STAT5B;STAT6;KPNB1;KPNA2,38 (38),0.0071,0.0294,0,,1 (1),1,1,0.0422,0.131
zymosterol biosynthesis,HumanCyc,3,MSMO1;TM7SF2;HSD17B7,6 (6),0.0854,0.234,4,HMDB0006927#HMDB0001181;HMDB0001251;HMDB0001286;HMDB0006271,16 (22),0.0837,1,0.0425,0.132
Striated Muscle Contraction Pathway,Wikipathways,12,TPM1;TPM3;TPM4;TNNT3;ACTC1;VIM;TTN;DES;ACTG1;ACTN4;MYL3;MYL9,38 (38),0.0421,0.132,0,,0 (0),1,1,0.0421,0.132
Glycosaminoglycan degradation - Homo sapiens (human),KEGG,8,GLB1;HEXA;HGSNAT;HEXB;GUSB;GNS;ARSB;NAGLU,19 (19),0.0166,0.0608,1,HMDB0000693,5 (27),0.433,1,0.0426,0.132
ABC transporters in lipid homeostasis,Reactome,5,PEX3;ABCD3;ABCD1;ABCA6;APOA1,18 (18),0.242,0.521,3,HMDB0000067;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,7 (11),0.0308,1,0.044,0.136
Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway,Wikipathways,13,PIK3R4;ATG5;ATG3;SCP2;MTOR;CP;AKT1S1;WIPI2;RHEB;PRKAA1;COASY;DEPTOR;ACACA,44 (44),0.0582,0.172,2,HMDB0004949;HMDB0013462#HMDB0012103#HMDB0012092,6 (23),0.129,1,0.0441,0.137
1_25-dihydroxyvitamin D<sub>3</sub> biosynthesis,HumanCyc,1,POR,3 (3),0.466,0.843,4,HMDB0006500;HMDB0000876;HMDB0000032;HMDB0003550,10 (10),0.0161,0.811,0.0443,0.137
Conjugation of benzoate with glycine,Reactome,4,GLYAT;GLYATL2;GLYATL1;ACSM1,6 (6),0.0137,0.052,1,HMDB0000123,7 (8),0.549,1,0.0443,0.137
Plasma membrane estrogen receptor signaling,PID,15,SHC1;HRAS;RHOA;GRB2;GNA11;GNA13;STRN;PLCB3;GNAI3;GNAI2;IGF1;GNAQ;GNAS;PIK3R1;GNB1,42 (42),0.00752,0.031,0,,9 (9),1,1,0.0443,0.137
ABC transporter disorders,Reactome,8,SEL1L;DERL2;DERL1;OS9;ERLEC1;ERLIN1;VCP;ERLIN2,17 (17),0.0076,0.0311,0,,6 (7),1,1,0.0447,0.138
Disorders of transmembrane transporters,Reactome,8,SEL1L;DERL2;DERL1;OS9;ERLEC1;ERLIN1;VCP;ERLIN2,17 (17),0.0076,0.0311,0,,6 (7),1,1,0.0447,0.138
Intrinsic Pathway of Fibrin Clot Formation,Reactome,8,F2;C1QBP;SERPING1;KLKB1;F9;F11;F12;KNG1,17 (17),0.0076,0.0311,0,,1 (8),1,1,0.0447,0.138
endocytotic role of ndk phosphins and dynamin,BioCarta,8,AP2A1;EPN1;EPS15;PICALM;AP2M1;PPP3CA;NME1;NME2,17 (17),0.0076,0.0311,0,,3 (3),1,1,0.0447,0.138
Bile acids synthesis and enterohepatic circulation,Wikipathways,4,MAPK1;ABCB11;CYP7A1;FXR1,9 (9),0.0714,0.205,1,HMDB0000067,1 (3),0.107,1,0.045,0.138
Opioid Signalling,Reactome,24,PPP2CB;PPP2R1A;PPP2R5D;PPP3CA;CALM1;GNG12;CAMK2A;CAMK2D;PRKACA;PRKACB;PRKAR1A;PRKAR2A;PRKCA;GNA11;PLCB3;GNAI3;GNAQ;MAPK1;GNB1;GNB2;GNAI2;PPP1CA;ITPR2;KPNA2,91 (91),0.0486,0.15,4,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0001043;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,20 (23),0.159,1,0.0454,0.14
TGF_beta_Receptor,NetPath,42,RHOA;CUL1;SKP1;PPP2R2A;TRAP1;MAPK14;SNW1;UBE2D3;XPO1;PXN;UBE2I;AP2B1;SNX6;PDK1;PIK3R1;SPTBN1;HGS;CRK;PRKAR2A;DYNLRB1;ROCK1;EWSR1;STRAP;CTNNA1;CTNNA2;CAV1;MAPK1;CTNNB1;EIF3I;NME1;HNF4A;MAP2K3;FKBP1A;FNTA;COPS5;HSPA8;SNX1;SNX2;PPM1A;RBX1;PML;KPNB1,173 (173),0.0448,0.14,0,,0 (0),1,1,0.0448,0.14
Conjugation of salicylate with glycine,Reactome,4,GLYATL1;GLYATL2;ACSM5;GLYAT,8 (8),0.0464,0.144,2,HMDB0000840;HMDB0000123,7 (8),0.168,1,0.0456,0.14
Ceramide signaling pathway,PID,15,MAP2K4;EIF2A;FADD;BAX;EIF2AK2;ASAH1;AIFM1;SPHK2;RELA;IGF1;MAP2K1;MAPK1;BID;CTSD;MAP2K2,48 (48),0.0272,0.0916,1,HMDB0004949,3 (3),0.289,1,0.0459,0.141
Arrhythmogenic Right Ventricular Cardiomyopathy,Wikipathways,23,DES;ACTN1;JUP;ITGA1;DSC2;DSG2;DSP;ACTB;LMNA;LAMA2;PKP2;ACTG1;ACTN4;CDH2;CTNNA1;CTNNA2;ITGA2B;CTNNB1;ITGA5;ITGA9;ATP2A2;ITGB3;ITGB1,74 (74),0.00787,0.0322,0,,2 (2),1,1,0.046,0.141
folate transformations,HumanCyc,6,SHMT1;SHMT2;MTHFD1;ALDH1L2;ALDH1L1;MTHFS,11 (11),0.00868,0.0347,1,HMDB0000123,21 (21),0.909,1,0.0461,0.141
Regulation of cholesterol biosynthesis by SREBP (SREBF),Reactome,12,ACACB;TM7SF2;RAN;GPAM;FDFT1;FASN;DHCR7;MVK;LSS;KPNB1;IDI1;HMGCS1,31 (31),0.00792,0.0324,0,,1 (1),1,1,0.0462,0.142
FoxO family signaling,PID,17,MAPK9;USP7;YWHAQ;YWHAH;RALB;CSNK1A1;RALA;YWHAE;YWHAG;RAN;YWHAZ;CAT;YWHAB;SOD2;CSNK1D;XPO1;CTNNB1,50 (50),0.00802,0.0324,0,,2 (2),1,1,0.0467,0.142
oleate biosynthesis,HumanCyc,5,FADS1;FADS6;ACOT4;ACOT2;FADS2,8 (8),0.00802,0.0324,0,,7 (7),1,1,0.0467,0.142
Histidine catabolism,Reactome,5,AMDHD1;HAL;CARNMT1;UROC1;FTCD,8 (8),0.00802,0.0324,0,,22 (22),1,1,0.0467,0.142
Ubiquinol biosynthesis,Reactome,5,COQ9;COQ5;COQ6;COQ7;COQ3,8 (8),0.00802,0.0324,0,,22 (22),1,1,0.0467,0.142
Excitatory Neural Signalling Through 5-HTR 4 and Serotonin,SMPDB,5,GNAS;PPP1CA;GNG12;GNB1;PRKACB,8 (8),0.00802,0.0324,0,,8 (8),1,1,0.0467,0.142
Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin ,SMPDB,5,GNAS;PPP1CA;GNG12;GNB1;PRKACB,8 (8),0.00802,0.0324,0,,8 (8),1,1,0.0467,0.142
Excitatory Neural Signalling Through 5-HTR 6 and Serotonin ,SMPDB,5,GNAS;PPP1CA;GNG12;GNB1;PRKACB,8 (8),0.00802,0.0324,0,,8 (8),1,1,0.0467,0.142
Intracellular Signalling Through Histamine H2 Receptor and Histamine,SMPDB,5,GNAS;PPP1CA;GNG12;GNB1;PRKACB,8 (8),0.00802,0.0324,0,,8 (8),1,1,0.0467,0.142
Synthesis_ secretion_ and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP),Reactome,5,DPP4;SPCS1;SPCS2;SEC11A;SPCS3,8 (8),0.00802,0.0324,0,,1 (1),1,1,0.0467,0.142
Prostaglandin Synthesis and Regulation,Wikipathways,14,S100A6;ANXA4;CBR1;HPGDS;ANXA1;PTGS1;AKR1C1;ANXA3;ANXA2;ANXA5;ANXA6;S100A10;HSD11B1;PTGFRN,44 (44),0.0277,0.093,2,HMDB0001043;HMDB0003208,10 (12),0.292,1,0.0471,0.143
Dual hijack model of Vif in HIV infection,Wikipathways,4,CUL5;RBX1;ELOB;ELOC,8 (8),0.0464,0.144,0,,0 (0),1,1,0.0464,0.144
Physiological and pathological hypertrophy of the heart,Wikipathways,10,CALM1;RHOA;MAP2K3;RAC1;CAMK2D;STAT3;AGT;MAPK14;PPP3CA;MAPK1,24 (24),0.0083,0.0335,0,,2 (2),1,1,0.0481,0.146
ER-Phagosome pathway,Reactome,7,CALR;SEC61A1;SEC61B;TAP2;TAPBP;SEC22B;STX4,14 (14),0.00835,0.0336,0,,4 (7),1,1,0.0483,0.146
Golgi Cisternae Pericentriolar Stack Reorganization,Reactome,7,RAB1A;RAB2A;USO1;GOLGA2;GORASP2;RAB1B;MAPK1,14 (14),0.00835,0.0336,0,,3 (3),1,1,0.0483,0.146
pten dependent cell cycle arrest and apoptosis,BioCarta,6,SHC1;GRB2;ITGB1;PDK2;PIK3R1;ILK,15 (15),0.0475,0.146,0,,0 (0),1,1,0.0475,0.146
Biosynthesis of specialized proresolving mediators (SPMs),Reactome,7,CYP2E1;GSTM4;PTGR1;CYP1A2;LTA4H;EPHX2;GPX4,19 (19),0.0514,0.155,6,HMDB0060050;HMDB0010213;HMDB0000123;HMDB0006528;HMDB0001976;HMDB0002183,35 (143),0.166,1,0.0491,0.149
LKB1 signaling events,PID,13,MTOR;CDC37;CTSD;CAB39;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;AKT1S1;HSP90AA1;YWHAQ;PRKACA,43 (43),0.0492,0.15,0,,0 (0),1,1,0.0492,0.15
Sulindac Metabolic Pathway,Wikipathways,3,CYP1A2;MSRB2;MSRA,5 (5),0.0496,0.15,0,,0 (2),1,1,0.0496,0.15
Transport of the SLBP independent Mature mRNA,Reactome,3,EIF4E;ALYREF;NCBP1,5 (5),0.0496,0.15,0,,0 (2),1,1,0.0496,0.15
Amyotrophic lateral sclerosis (ALS),Wikipathways,13,DERL1;CASP3;MAP2K2;RAC1;RAB5A;CAT;CCS;SOD1;MAPK14;PPP3CA;GPX1;BID;BAX,35 (35),0.00865,0.0347,0,,10 (11),1,1,0.0497,0.15
angiotensin ii mediated activation of jnk pathway via pyk2 dependent signaling,BioCarta,13,SHC1;HRAS;EGFR;GRB2;PRKCA;RAC1;MAP2K4;CRKL;GNAQ;MAP2K1;MAPK1;AGT;MAP2K2,35 (35),0.00865,0.0347,0,,3 (3),1,1,0.0497,0.15
HGF,INOH,13,SHC1;HRAS;MAP2K1;GRB2;RAC1;PIK3R1;RAP1A;RAP1B;PTPN11;CRK;CRKL;MAPK1;MAP2K2,35 (35),0.00865,0.0347,0,,2 (2),1,1,0.0497,0.15
Hh mutants are degraded by ERAD,Reactome,6,SEL1L;DERL2;OS9;ERLEC1;VCP;SYVN1,11 (11),0.00868,0.0347,0,,4 (4),1,1,0.0499,0.15
Hh mutants abrogate ligand secretion,Reactome,6,SEL1L;DERL2;OS9;ERLEC1;VCP;SYVN1,11 (11),0.00868,0.0347,0,,4 (4),1,1,0.0499,0.15
Establishment of Sister Chromatid Cohesion,Reactome,6,SMC3;PDS5B;PDS5A;STAG2;SMC1A;RAD21,11 (11),0.00868,0.0347,0,,2 (3),1,1,0.0499,0.15
EML4 and NUDC in mitotic spindle formation,Reactome,29,MAPRE1;PPP2CB;PPP2R1A;RANBP2;RANGAP1;PPP2R5A;PPP2R5D;PPP2R5E;NDEL1;EML4;PAFAH1B1;DYNLL2;NUP98;CKAP5;NUP133;DYNC1LI1;NEK7;RPS27;XPO1;ZW10;BUB3;NUDC;NUP160;RCC2;DYNC1H1;DYNC1I2;DYNC1LI2;SEC13;PPP1CC,100 (100),0.00904,0.0361,0,,2 (3),1,1,0.0516,0.155
phosphatidylcholine biosynthesis,HumanCyc,4,CHKB;PCYT1A;CHPT1;CEPT1,7 (7),0.0272,0.0916,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,11 (12),0.334,1,0.0518,0.155
Thromboxane A2 receptor signaling,PID,18,GNB1;LYN;EGFR;YES1;PRKCA;ICAM1;TGM2;ROCK1;GNA11;GNA13;MAPK14;GNAI2;RAB11A;RAC1;GNAQ;SLC9A3R1;RHOA;PRKACA,56 (56),0.0122,0.0474,1,HMDB0003208,12 (12),0.745,1,0.0518,0.155
AndrogenReceptor,NetPath,35,RNF14;DDC;FLNA;RAN;PARP1;HSP90B1;SF1;CDC37;RACK1;UBE2I;SLC25A4;EGFR;STAT3;PIK3R1;COX5B;PARK7;PRDX1;BAG1;CASP3;PXN;PRMT1;CAV1;CTNNB1;DBT;XRCC5;HSPB1;HSPA4;HSPA5;TOP1;HSPA8;XRCC6;GSN;DDX5;HSP90AA1;PPP1CA,142 (142),0.0517,0.156,0,,0 (0),1,1,0.0517,0.156
Regulation of mRNA stability by proteins that bind AU-rich elements,Reactome,14,HSPA8;TNPO1;KHSRP;ANP32A;PRKCA;EIF4G1;HNRNPD;ELAVL1;HSPB1;YWHAB;MAPK14;XPO1;EXOSC6;PABPC1,39 (39),0.00919,0.0366,0,,3 (4),1,1,0.0523,0.156
Internalization of ErbB1,PID,14,SHC1;HRAS;EGFR;GRB2;CDC42;EPS15;RAB5A;USP8;PIK3R1;TSG101;EPN1;CHMP3;HGS;UBE2D3,39 (39),0.00919,0.0366,0,,2 (2),1,1,0.0523,0.156
Signaling events regulated by Ret tyrosine kinase,PID,14,SHC1;HRAS;RHOA;GRB2;PRKCA;RAP1A;PIK3R1;NCK1;PTPN11;CRK;RAC1;MAPK1;PRKACA;PXN,39 (39),0.00919,0.0366,0,,2 (2),1,1,0.0523,0.156
Steroid Biosynthesis,Wikipathways,3,HSD17B7;HSD17B2;HSD17B4,10 (10),0.288,0.599,4,HMDB0000067;HMDB0000145;HMDB0000234;HMDB0000077,12 (12),0.032,1,0.0524,0.157
induction of apoptosis through dr3 and dr4/5 death receptors,BioCarta,8,LMNA;CASP3;CASP6;PARP1;SPTAN1;FADD;GAS2;BID,23 (23),0.0532,0.16,0,,0 (0),1,1,0.0532,0.16
Netrin-UNC5B signaling pathway,Wikipathways,15,RHOA;MAP2K1;MAP2K2;PRKCA;RAC1;YAP1;PTPA;PTPN11;ICAM1;MAPK14;CASP3;MAPK1;PPP1CA;COL1A1;ARHGEF12,52 (52),0.0532,0.16,0,,0 (0),1,1,0.0532,0.16
FGFR2 alternative splicing,Reactome,9,TIAL1;ESRP2;HNRNPA1;NCBP1;HNRNPF;HNRNPH1;POLR2A;PTBP1;HNRNPM,27 (27),0.0536,0.16,0,,0 (1),1,1,0.0536,0.16
adp-ribosylation factor,BioCarta,11,KDELR1;COPA;ARFGEF2;ARFGEF1;ARHGAP1;ARFGAP3;ARF1;GBF1;ARFGAP1;CLTA;CLTB,28 (28),0.00957,0.0379,0,,2 (2),1,1,0.054,0.161
Fas ligand pathway and stress induction of heat shock proteins,Wikipathways,15,LMNA;LMNB1;CASP3;PAK2;CASP6;ACTG1;ARHGDIB;PARP1;MAP2K4;HSPB1;FAF1;SPTAN1;LMNB2;FADD;ACTB,43 (43),0.00958,0.038,0,,4 (4),1,1,0.0541,0.161
Arf6 trafficking events,PID,16,ITGA9;ARF6;CDH1;ITGB1;EXOC4;RALA;EXOC5;SPAG9;NME1;CTNNA1;ITGA1;DNM2;CTNNB1;CTNND1;CLTC;ITGA5,47 (47),0.00983,0.0389,0,,6 (6),1,1,0.0553,0.165
Insulin-mediated glucose transport,PID,10,CALM1;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;STX4;YWHAQ;VAMP2;PPP1CC,29 (29),0.0343,0.113,1,HMDB0000757,3 (3),0.289,1,0.0556,0.166
VLDL clearance,Reactome,2,APOB;LSR,6 (6),0.317,0.64,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,3 (4),0.032,1,0.0567,0.169
Neomycin_ kanamycin and gentamicin biosynthesis - Homo sapiens (human),KEGG,3,HK1;HK3;GCK,5 (5),0.0496,0.15,2,HMDB0000290;HMDB0015129,8 (81),0.209,1,0.0576,0.171
il 3 signaling pathway,BioCarta,5,SHC1;HRAS;STAT5B;GRB2;PTPN6,12 (12),0.0584,0.172,0,,0 (0),1,1,0.0584,0.172
phospho-PLA2 pathway,Reactome,1,MAPK1,2 (2),0.342,0.67,3,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0001043;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,7 (7),0.0308,1,0.0585,0.174
Signaling by NTRK1 (TRKA),Reactome,32,RHOA;RALA;RALB;PPP2CB;PPP2R1A;MAPK14;RAP1A;AP2M1;AP2S1;PPP2R5D;AP2A1;AP2A2;AP2B1;STAT3;PIK3R1;RPS6KA1;DUSP3;CLTA;CLTC;SHC1;HRAS;DNM3;GRB2;CHD4;FUS;MAPK1;MAP2K1;MAP2K2;YWHAB;CRK;CRKL;DNM2,114 (114),0.0105,0.0415,0,,10 (12),1,1,0.0585,0.174
Yersinia infection - Homo sapiens (human),KEGG,37,RHOA;RHOG;WASL;MAPK14;CDC42;MAPK1;FN1;MAP2K4;PIK3R1;RPS6KA1;ARPC1A;ACTB;PXN;ACTG1;CRKL;ROCK1;ARPC5L;RELA;GNAQ;BAIAP2;ITGA5;MAPK9;MAP2K1;MAP2K2;MAP2K3;ITGB1;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;CRK;RAC1;ARHGEF12;ARPC2;ARF6,136 (137),0.0107,0.0421,0,,4 (5),1,1,0.0593,0.176
Protein ubiquitination,Reactome,24,USP5;UBA1;PEX2;UBE2D3;OTULIN;UBE2G1;UBE2G2;UBE2H;DERL1;UBE2L3;UBE2N;UBE2V2;USP9X;UCHL3;USP7;UBA6;PEX5;PEX13;PEX14;WDR61;VCP;UBE2Z;PCNA;UBE2K,80 (80),0.0108,0.0423,0,,4 (4),1,1,0.0596,0.176
Nongenotropic Androgen signaling,PID,11,HRAS;PLCB3;MAP2K2;CDC42;PIK3R1;GNAI2;GNAI3;RAC1;MAP2K1;MAPK1;GNB1,31 (31),0.0218,0.0778,1,HMDB0000234,6 (6),0.494,1,0.0596,0.176
regulation of bad phosphorylation,BioCarta,8,PRKAR1A;PRKAR2A;YWHAH;PIK3R1;IGF1;PRKACB;KITLG;BAX,23 (23),0.0532,0.16,1,HMDB0004949,2 (4),0.203,1,0.0597,0.177
Signaling events mediated by the Hedgehog family,PID,2,LRPAP1;PIK3R1,23 (23),0.948,1,2,HMDB0000067;HMDB0000876,2 (2),0.0115,0.641,0.0601,0.178
Serotonergic synapse - Homo sapiens (human),KEGG,21,MAOA;MAOB;GNG12;CASP3;MAPK1;HRAS;PRKCA;DDC;PTGS1;ARAF;PLCB3;GNAI3;GNAI2;PRKACA;GNAQ;MAP2K1;GNAS;PRKACB;ITPR2;GNB1;GNB2,113 (115),0.569,0.931,9,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0003208;HMDB0002995;HMDB0001043;HMDB0000472;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,39 (42),0.0193,0.891,0.0605,0.179
IL-5 signaling pathway,Wikipathways,12,SHC1;LYN;MAP2K1;MAP2K2;PIK3R1;RPS6;RPS6KA1;PTPN11;STAT3;STAT5B;MAPK1;GRB2,40 (40),0.0605,0.179,0,,0 (0),1,1,0.0605,0.179
Kallmann_s Syndrome,Wikipathways,4,PTPN11;MAPK1;MAP2K2;GRB2,21 (21),0.579,0.942,3,HMDB0000693;HMDB0000234;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,6 (11),0.0191,0.891,0.0609,0.18
Target Of Rapamycin (TOR) Signaling,Wikipathways,13,PRKAG1;CDC42;FKBP1A;PRKCA;MTOR;AKT1S1;RAC1;RRAGC;RHEB;PRKAA1;PRKAA2;PRKAB1;IDI1,36 (36),0.0112,0.0441,0,,1 (1),1,1,0.0617,0.182
Synthesis of PE,Reactome,6,CHKB;PCYT2;PISD;ETNPPL;CEPT1;SELENOI,14 (14),0.0338,0.111,3,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0033934;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,19 (21),0.334,1,0.0618,0.182
Apoptosis-related network due to altered Notch3 in ovarian cancer,Wikipathways,15,CUL5;HSPD1;CUL1;PAK2;VIM;GCLC;CTNNA1;HSPA5;NQO1;HSPB1;ANXA5;SQSTM1;SERBP1;MAPK1;APOE,53 (53),0.0618,0.182,0,,0 (0),1,1,0.0618,0.182
RA biosynthesis pathway,Reactome,9,RDH16;DHRS3;RDH10;RDH11;ALDH8A1;RDH13;DHRS4;ALDH1A1;ALDH1A3,22 (22),0.0139,0.0523,1,HMDB0006216,15 (17),0.819,1,0.0621,0.183
Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione_ including diseases,Wikipathways,3,GGCT;GSS;GCLC,4 (4),0.0231,0.0797,1,HMDB0000123,6 (12),0.494,1,0.0624,0.183
MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement,Wikipathways,8,PXN;ITGB3;TJP1;VCL;ACTN1;MAPK1;LPP;MYLK,18 (18),0.0114,0.0448,0,,1 (1),1,1,0.0626,0.184
Late Phase of HIV Life Cycle,Reactome,38,TPR;ELOC;ELOB;RAN;RANBP1;RANBP2;NUP93;TAF3;CHMP6;NUP58;NUP155;RAE1;SUPT5H;VPS4A;VPS4B;POLR2A;NUP210;PDCD6IP;SUPT16H;NUP98;NUP133;CHMP3;CHMP5;VTA1;RCC1;TSG101;TAF15;NCBP1;VPS28;XPO1;SSRP1;CHMP4B;NMT1;CHMP2A;NUP160;NUP35;SEC13;NUP205,141 (141),0.0115,0.0449,0,,10 (15),1,1,0.0628,0.184
Deadenylation of mRNA,Reactome,10,EIF4A2;PABPC1;CNOT1;PAIP1;EIF4A3;TNKS1BP1;EIF4A1;TUT7;EIF4E;EIF4G1,25 (25),0.0115,0.0451,0,,2 (4),1,1,0.063,0.185
Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling,Wikipathways,11,MTOR;ITGB1;EIF2B2;PDK1;AKT1S1;WASL;IGF1;EIF4E;ILK;PRKAB1;DEPTOR,36 (36),0.0628,0.185,0,,0 (1),1,1,0.0628,0.185
Toll-like Receptor Cascades,Reactome,33,PIK3R4;CUL1;S100A8;S100A9;LGMN;PPP2CB;PPP2R1A;HSP90B1;PPP2R5D;MAPK14;FADD;UBE2D3;FGG;CD14;UBE2N;UBE2V1;MAP2K4;RPS6KA1;SKP1;DUSP3;FGA;FGB;CNPY3;APOB;FUS;MAPK1;RELA;MAPK9;CTSB;MAP2K3;ITGB2;CTSL;MAP2K1,130 (130),0.0399,0.126,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,10 (31),0.292,1,0.0635,0.186
RAC1-PAK1-p38-MMP2 Pathway,Wikipathways,21,HRAS;EGFR;GRB2;MAPK9;GRB14;STAT3;YAP1;BAX;PIK3R1;FN1;ITGB1;NCK1;PTPN11;CRK;RAC1;MAPK14;STAT5B;MAPK1;CTNNB1;RELA;PXN,68 (68),0.0117,0.0455,0,,1 (1),1,1,0.0636,0.186
B Cell Receptor Signaling Pathway,Wikipathways,25,MAPK14;PIK3AP1;PTPN6;PTPN11;ILF2;GTF2I;CAMK2A;PIK3R1;RPS6KA1;SHC1;HRAS;GRB2;CRKL;CD81;NCK1;MAPK1;MAPK9;LYN;MAP2K1;MAP2K2;CDC42;RELA;HCLS1;CRK;RAC1,98 (98),0.0636,0.187,0,,0 (0),1,1,0.0636,0.187
Synthesis of 5-eicosatetraenoic acids,Reactome,5,GPX1;PON1;PON2;PON3;GPX4,9 (9),0.0153,0.0565,1,HMDB0001043,13 (17),0.772,1,0.0641,0.188
Bile secretion - Homo sapiens (human),KEGG,26,UGT1A3;EPHX1;SLC10A1;RXRA;ATP1A1;CYP7A1;SLC22A1;SCARB1;UGT2A3;BAAT;UGT2A1;PRKACA;PRKACB;UGT2B10;UGT2B15;ABCB11;NCEH1;AQP8;GNAS;ABCC2;ATP1B1;ATP1B3;AQP1;SLC22A7;SLC27A5;ABCB4,90 (90),0.0136,0.052,9,HMDB0000036;HMDB0000637;HMDB0000951;HMDB0002513#HMDB0010323;HMDB0000067;HMDB0015224#HMDB0031448;HMDB0002995;HMDB0000054;HMDB0000138,112 (161),0.866,1,0.0642,0.188
Scavenging by Class B Receptors,Reactome,3,APOB;SCARB1;APOA1,7 (7),0.129,0.326,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,5 (16),0.0922,1,0.0646,0.189
Constitutive Androstane Receptor Pathway,Wikipathways,10,SULT1A1;DNAJC7;UGT1A3;EHHADH;RXRA;SMC1A;PTPA;HSP90AA1;GSTA2;ABCC2,32 (32),0.0647,0.189,0,,0 (1),1,1,0.0647,0.189
Phenylalanine_ tyrosine and tryptophan biosynthesis - Homo sapiens (human),KEGG,4,TAT;GOT1;GOT2;PAH,6 (6),0.0137,0.052,1,HMDB0012249,18 (34),0.871,1,0.0648,0.189
Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling,PID,15,FGA;EGFR;ITGB1;ITGB2;ITGB3;LRP1;NCL;CRK;RAC1;VTN;FGB;FGG;PLG;ITGA5;FN1,44 (44),0.0121,0.0469,0,,2 (2),1,1,0.0653,0.19
superpathway of pyrimidine ribonucleotides <i>de novo</i> biosynthesis,HumanCyc,7,NME3;UMPS;CMPK1;CAD;CTPS2;NME1;NME2,15 (15),0.0131,0.0503,1,HMDB0003349#HMDB0000528,22 (23),0.919,1,0.0654,0.19
RAC2 GTPase cycle,Reactome,25,VAPB;ARHGAP1;ARHGDIA;TAOK3;ABI1;CYFIP1;STBD1;LMAN1;NCKAP1;BRK1;PIK3R1;ESYT1;PGRMC2;PAK2;RAB7A;TMPO;ARHGAP17;SWAP70;CAV1;LAMTOR1;DSG2;CDC42;ITGB1;IQGAP1;TFRC,85 (85),0.0122,0.0474,0,,4 (4),1,1,0.0659,0.192
Processing of Capped Intronless Pre-mRNA,Reactome,9,SNRPB;CPSF1;SNRPD3;NUDT21;SNRPF;SNRPG;NCBP1;PABPN1;CPSF7,28 (28),0.0663,0.193,0,,0 (5),1,1,0.0663,0.193
Regulation of cytoplasmic and nuclear SMAD2/3 signaling,PID,7,CALM1;UBE2I;CTDSP1;PPM1A;MAPK1;KPNB1;KPNA2,20 (20),0.0666,0.193,0,,0 (0),1,1,0.0666,0.193
Histidine Metabolism,SMPDB,7,MAOA;AMDHD1;HARS2;UROC1;FTCD;HAL;HARS1,15 (15),0.0131,0.0503,2,HMDB0004181;HMDB0033934,40 (40),0.939,1,0.0666,0.193
Histidinemia,SMPDB,7,MAOA;AMDHD1;HARS2;UROC1;FTCD;HAL;HARS1,15 (15),0.0131,0.0503,2,HMDB0004181;HMDB0033934,40 (40),0.939,1,0.0666,0.193
Degradation pathway of sphingolipids_ including diseases,Wikipathways,3,GM2A;HEXA;GLB1,5 (5),0.0496,0.15,2,HMDB0004949;HMDB0004842,9 (13),0.25,1,0.0669,0.194
Terpenoid backbone biosynthesis - Homo sapiens (human),KEGG,9,FNTA;MVK;ACAT1;ACAT2;HMGCS1;HMGCS2;PCYOX1;ZMPSTE24;IDI1,22 (22),0.0139,0.0523,1,HMDB0001090,20 (45),0.898,1,0.067,0.194
VEGFR1 specific signals,PID,11,CALM1;PRKCA;PIK3R1;NCK1;HIF1A;PTPN11;CD2AP;HSP90AA1;CAV1;MAPK1;PRKACA,29 (29),0.0128,0.0498,0,,6 (6),1,1,0.0687,0.199
Gap junction - Homo sapiens (human),KEGG,25,TUBA1B;TUBB4B;MAPK1;EGFR;GUCY1A1;GUCY1B1;TJP1;CSNK1D;TUBA1C;PRKACA;PRKACB;HRAS;GRB2;PRKCA;GNA11;PLCB3;TUBB2B;GNAQ;GNAS;MAP2K1;MAP2K2;TUBA4A;GNAI2;ITPR2;GNAI3,88 (88),0.019,0.0686,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,10 (11),0.679,1,0.0689,0.199
glycine biosynthesis,HumanCyc,2,AGXT;AGXT2,2 (2),0.0356,0.113,1,HMDB0000123,4 (4),0.365,1,0.0694,0.201
Regulation of Actin Cytoskeleton,Wikipathways,40,PIK3R4;VCL;RHOA;RRAS2;MYL3;BAIAP2;MYLK;PXN;CD14;GNG12;NCKAP1;EGFR;CSK;PIK3R1;CFL1;CFL2;FN1;ACTB;DIAPH1;CRK;PAK2;ACTG1;RDX;RAC1;ROCK1;ACTN1;ITGA1;MAPK1;PIP4K2C;BRK1;PFN1;F2;MAP2K1;MAP2K2;CDC42;ARPC5;GNA13;GSN;CYFIP2;IQGAP1,151 (151),0.013,0.0503,0,,4 (5),1,1,0.0695,0.201
superpathway of geranylgeranyldiphosphate biosynthesis I (via mevalonate),HumanCyc,6,HMGCS2;ACAT1;ACAT2;HMGCS1;MVK;IDI1,12 (12),0.0146,0.0549,1,HMDB0001090,20 (21),0.898,1,0.0699,0.201
Phytochemical activity on NRF2 transcriptional activation,Wikipathways,7,NQO1;GCLC;GCLM;AIMP2;HMOX1;GSTA2;PRKCA,15 (15),0.0131,0.0503,0,,2 (3),1,1,0.07,0.201
Degradation of GLI1 by the proteasome,Reactome,7,SKP1;CUL1;NUMB;ITCH;RBX1;PRKACA;PRKACB,15 (15),0.0131,0.0503,0,,2 (2),1,1,0.07,0.201
Prolonged ERK activation events,Reactome,7,MAP2K1;MAP2K2;YWHAB;RAP1A;CRK;CRKL;MAPK1,15 (15),0.0131,0.0503,0,,5 (5),1,1,0.07,0.201
Activation of BAD and translocation to mitochondria ,Reactome,7,YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;YWHAQ;BID,15 (15),0.0131,0.0503,0,,4 (4),1,1,0.07,0.201
PAR4-mediated thrombin signaling events,PID,7,F2;ROCK1;GNA11;GNA13;RHOA;GNAQ;GNB1,15 (15),0.0131,0.0503,0,,4 (4),1,1,0.07,0.201
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,Reactome,7,SHC1;HRAS;EGFR;GRB2;PIK3R1;HSP90AA1;CDC37,15 (15),0.0131,0.0503,0,,6 (19),1,1,0.07,0.201
Signaling by Ligand-Responsive EGFR Variants in Cancer,Reactome,7,SHC1;HRAS;EGFR;GRB2;PIK3R1;HSP90AA1;CDC37,15 (15),0.0131,0.0503,0,,6 (19),1,1,0.07,0.201
Beta-catenin phosphorylation cascade,Reactome,7,CSNK1A1;PPP2CB;PPP2R1A;PPP2R5A;PPP2R5D;PPP2R5E;CTNNB1,15 (15),0.0131,0.0503,0,,2 (2),1,1,0.07,0.201
Glycosphingolipid biosynthesis - neolactoseries,EHMN,6,ST3GAL6;COPB1;COPA;COPG2;ARCN1;COPE,16 (16),0.0642,0.188,2,HMDB0000290;HMDB0000304,8 (48),0.209,1,0.0712,0.204
IL1,NetPath,15,PPP6C;ELP1;MAP2K3;MAPK9;TOLLIP;UBE2V1;SQSTM1;PIK3R1;MAP2K4;RELA;PTPN11;SOD1;MAPK14;MAPK1;UBE2N,54 (54),0.0712,0.205,0,,0 (0),1,1,0.0712,0.205
Integration of provirus,Reactome,4,PSIP1;XRCC5;XRCC6;BANF1,9 (9),0.0714,0.205,0,,0 (1),1,1,0.0714,0.205
Syndecan-2-mediated signaling events,PID,12,HRAS;RHOA;CASP3;BAX;ITGB1;EPB41;KNG1;MAPK1;FN1;CASK;PRKACA;RACK1,41 (41),0.0715,0.205,0,,0 (1),1,1,0.0715,0.205
Viral carcinogenesis - Homo sapiens (human),KEGG,47,RHOA;DNAJA3;RANBP1;VAC14;GRB2;CASP3;SNW1;HDAC6;PXN;SND1;UBE3A;MRPS18B;ATP6V0D1;PIK3R1;HPN;GSN;UBR4;PRKACA;PRKACB;HRAS;USP7;PKM;PSMC1;BAX;DLG1;C3;ACTN4;RELA;CHD4;ACTN1;MAPK1;YWHAQ;LYN;CDC42;STAT3;YWHAB;DDB1;YWHAE;YWHAG;YWHAH;YWHAZ;HNRNPK;RAC1;STAT5B;HDAC2;VDAC3;EIF2AK2,203 (204),0.0719,0.206,0,,0 (0),1,1,0.0719,0.206
Gemcitabine Metabolism Pathway,SMPDB,6,RRM1;SLC29A1;CMPK1;NT5C;RRM2B;NME1,13 (13),0.0229,0.0797,1,HMDB0033934,8 (8),0.597,1,0.0723,0.206
Gemcitabine Action Pathway,SMPDB,6,RRM1;SLC29A1;CMPK1;NT5C;RRM2B;NME1,13 (13),0.0229,0.0797,1,HMDB0033934,8 (8),0.597,1,0.0723,0.206
ethanol degradation IV,HumanCyc,4,ALDH3A2;ACSS3;ACSS2;CAT,6 (6),0.0137,0.052,0,,13 (13),1,1,0.0725,0.206
pentose phosphate pathway (non-oxidative branch),HumanCyc,4,TALDO1;RPE;RPIA;TKT,6 (6),0.0137,0.052,0,,6 (8),1,1,0.0725,0.206
Molybdenum cofactor biosynthesis,Reactome,4,MOCS1;MOCOS;GPHN;NFS1,6 (6),0.0137,0.052,0,,13 (19),1,1,0.0725,0.206
mitochondrial L-carnitine shuttle,HumanCyc,4,CPT2;CHKB;CPT1A;CRAT,6 (6),0.0137,0.052,0,,10 (12),1,1,0.0725,0.206
Intracellular Signalling Through PGD2 receptor and Prostaglandin D2,SMPDB,4,GNAS;GNG12;GNB1;PRKACB,6 (6),0.0137,0.052,0,,7 (7),1,1,0.0725,0.206
Dopamine Activation of Neurological Reward System,SMPDB,4,GNAS;GNG12;GNB1;PRKACB,6 (6),0.0137,0.052,0,,7 (7),1,1,0.0725,0.206
Netrin-mediated signaling events,PID,12,RHOA;MAP2K1;YES1;CDC42;CAMK2A;WASL;NCK1;RAC1;MAPK1;PIK3R1;PITPNA;MAP2K2,33 (33),0.0138,0.0522,0,,5 (5),1,1,0.0728,0.207
aspirin blocks signaling pathway involved in platelet activation,BioCarta,7,HRAS;F2;MAP2K1;PRKCA;PTGS1;MAPK1;GNB1,17 (17),0.028,0.0937,1,HMDB0001043,6 (6),0.494,1,0.0731,0.208
Renal cell carcinoma - Homo sapiens (human),KEGG,21,HRAS;CRKL;MAP2K1;CUL2;PAK2;ELOC;ELOB;PIK3R1;RBX1;ARAF;RAP1A;HIF1A;RAP1B;PTPN11;CRK;RAC1;CDC42;MAPK1;FH;MAP2K2;GRB2,69 (69),0.0139,0.0523,0,,3 (3),1,1,0.0731,0.208
Glycerolipids and Glycerophospholipids,Wikipathways,9,CHKB;PEMT;CHPT1;PCYT2;PCYT1A;GPAM;PISD;DGAT1;CDIPT,22 (22),0.0139,0.0523,0,,10 (11),1,1,0.0731,0.208
Thyroid cancer - Homo sapiens (human),KEGG,11,HRAS;TPM3;MAP2K1;BAX;TFG;TPR;CDH1;RXRA;MAPK1;CTNNB1;MAP2K2,37 (37),0.0747,0.213,0,,0 (0),1,1,0.0747,0.213
HSF1-dependent transactivation,Reactome,13,FKBP4;SERPINH1;PTGES3;DNAJB1;MTOR;HSPH1;AKT1S1;HSPA8;CAMK2D;HSPB1;HSP90AA1;CAMK2A;HSP90AB1,37 (37),0.0144,0.0543,0,,4 (4),1,1,0.0755,0.214
Regulation of lipid metabolism by PPARalpha,Reactome,3,FABP1;HELZ2;RXRA,20 (20),0.757,1,3,HMDB0001388;HMDB0000054;HMDB0001043,6 (7),0.0191,0.891,0.0757,0.214
Nicotinamide salvaging,Reactome,6,NNMT;NAPRT;CYP8B1;NAXE;NAMPT;NAXD,12 (12),0.0146,0.0549,0,,30 (37),1,1,0.0763,0.216
Tetrahydrobiopterin (BH4) synthesis_ recycling_ salvage and regulation,Reactome,6,CALM1;SPR;PTS;GCH1;DHFR;HSP90AA1,12 (12),0.0146,0.0549,0,,21 (27),1,1,0.0763,0.216
telomeres telomerase cellular aging and immortality,BioCarta,5,XRCC5;PPP2R5D;PRKCA;XRCC6;POLR2A,15 (15),0.136,0.341,1,HMDB0014813,1 (3),0.107,1,0.0764,0.216
C20 prostanoid biosynthesis,HumanCyc,4,PTGES3;HPGDS;PTGES2;PTGS1,9 (9),0.0714,0.205,2,HMDB0003208;HMDB0001043,8 (8),0.209,1,0.0776,0.219
LDL remodeling,Reactome,1,APOB,3 (3),0.466,0.843,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,3 (4),0.032,1,0.0776,0.219
Carnosinuria_ carnosinemia,SMPDB,5,ALDH6A1;ABAT;UPB1;DPYD;DPYS,9 (9),0.0153,0.0565,1,HMDB0033934,34 (34),0.979,1,0.0778,0.219
Ureidopropionase deficiency,SMPDB,5,ALDH6A1;ABAT;UPB1;DPYD;DPYS,9 (9),0.0153,0.0565,1,HMDB0033934,34 (34),0.979,1,0.0778,0.219
GABA-Transaminase Deficiency,SMPDB,5,ALDH6A1;ABAT;UPB1;DPYD;DPYS,9 (9),0.0153,0.0565,1,HMDB0033934,34 (34),0.979,1,0.0778,0.219
Beta-Alanine Metabolism,SMPDB,5,ALDH6A1;ABAT;UPB1;DPYD;DPYS,9 (9),0.0153,0.0565,1,HMDB0033934,34 (34),0.979,1,0.0778,0.219
Activation of NMDA receptors and postsynaptic events,Reactome,22,PPM1F;LIN7C;CALM1;CAMK2A;CAMK2D;RPS6KA1;PRKAA1;PRKAA2;PRKAB1;PRKACA;PRKACB;HRAS;PRKAG1;PRKAR1A;PRKAR2A;DLG1;CAMK1;MAPK1;RAC1;LIN7A;CASK;KPNA2,75 (75),0.0185,0.0671,1,HMDB0000123,15 (17),0.819,1,0.0787,0.221
glycogenolysis,HumanCyc,5,PGM2;AGL;PYGL;PGM1;PYGB,9 (9),0.0153,0.0565,0,,6 (7),1,1,0.0791,0.221
retinoate biosynthesis I,HumanCyc,5,RDH16;ALDH1A1;RBP1;ALDH1A3;RBP4,9 (9),0.0153,0.0565,0,,5 (6),1,1,0.0791,0.221
MAP kinase cascade,HumanCyc,5,HRAS;MAPK1;MAP2K1;MAP2K2;YWHAB,9 (9),0.0153,0.0565,0,,2 (2),1,1,0.0791,0.221
MET activates RAP1 and RAC1,Reactome,5,RAP1A;RAP1B;GRB2;CRK;CRKL,9 (9),0.0153,0.0565,0,,2 (2),1,1,0.0791,0.221
EGFR-dependent Endothelin signaling events,PID,5,SHC1;HRAS;MTOR;EGFR;GRB2,9 (9),0.0153,0.0565,0,,3 (3),1,1,0.0791,0.221
reversal of insulin resistance by leptin,BioCarta,5,PRKAA1;PRKAG1;PRKAB1;PRKAA2;ACACA,9 (9),0.0153,0.0565,0,,1 (2),1,1,0.0791,0.221
Incretin synthesis_ secretion_ and inactivation,Reactome,5,DPP4;SPCS1;SPCS2;SEC11A;SPCS3,9 (9),0.0153,0.0565,0,,1 (1),1,1,0.0791,0.221
Folate-Alcohol and Cancer Pathway Hypotheses,Wikipathways,5,ALDH1A1;ALDH1L1;ADH5;CBS;CYP2E1,9 (9),0.0153,0.0565,0,,11 (12),1,1,0.0791,0.221
glycine/serine biosynthesis,HumanCyc,2,SHMT2;SHMT1,2 (2),0.0356,0.113,1,HMDB0000123,5 (5),0.433,1,0.0798,0.222
S1P2 pathway,PID,10,RHOA;GNA11;GNA13;MAPK14;GNAI2;GNAI3;RAC1;GNAQ;MAPK1;PIK3R1,26 (26),0.0156,0.0577,0,,4 (4),1,1,0.0806,0.224
DARPP-32 events,Reactome,10,CALM1;PRKAR1A;PRKAR2A;PPP2CB;PPP2R1A;PPP2R5D;PPP3CA;PPP1CA;PRKACA;PRKACB,26 (26),0.0156,0.0577,0,,11 (13),1,1,0.0806,0.224
signaling pathway from g-protein families,BioCarta,10,HRAS;MAP2K1;PRKAR1A;PRKAR2A;PRKCA;GNAQ;PPP3CA;GNAS;GNB1;PRKACB,26 (26),0.0156,0.0577,0,,3 (3),1,1,0.0806,0.224
phenylalanine degradation/tyrosine biosynthesis,HumanCyc,3,QDPR;PCBD1;PAH,4 (4),0.0231,0.0797,1,HMDB0002281,10 (11),0.679,1,0.0807,0.224
Synthesis of glycosylphosphatidylinositol (GPI),Reactome,1,PIGN,18 (18),0.977,1,4,HMDB0000290;HMDB0011669;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,10 (19),0.0161,0.811,0.0811,0.225
Integration of energy metabolism,Reactome,26,ACSL4;PPP2CB;PPP2R1A;RAP1A;PPP2R5D;MLX;GNG12;MARCKS;TKT;PRKAA2;PRKACA;PRKACB;PRKAR1A;PRKAR2A;PRKCA;GNA11;GNAI2;GNAQ;GNAS;GNB1;GNB2;TALDO1;SLC2A2;PLCB3;IQGAP1;ITPR2,91 (91),0.0158,0.058,0,,29 (34),1,1,0.0811,0.225
Mechanoregulation and pathology of YAP-TAZ via Hippo and non-Hippo mechanisms,Wikipathways,13,MAPK9;CTNNB1;ACTC1;PAK2;CDH1;ITGB1;ITGB2;ITGB3;ACTG1;MAP4K5;CTNNA1;YWHAQ;ACTB,46 (46),0.0793,0.226,0,,0 (0),1,1,0.0793,0.226
IL-10 Anti-inflammatory Signaling Pathway,Wikipathways,5,HMOX1;BLVRA;STAT2;STAT3;BLVRB,13 (13),0.0806,0.226,0,,0 (0),1,1,0.0806,0.226
Trafficking and processing of endosomal TLR,Reactome,5,HSP90B1;LGMN;CTSL;CTSB;CNPY3,13 (13),0.0806,0.226,0,,0 (2),1,1,0.0806,0.226
regulation of p27 phosphorylation during cell cycle progression,BioCarta,5,UBE2M;RBX1;SKP1;NEDD8;CUL1,13 (13),0.0806,0.226,0,,0 (0),1,1,0.0806,0.226
BARD1 signaling events,PID,9,XRCC5;UBE2L3;NPM1;EWSR1;XRCC6;PCNA;ATM;UBE2D3;RAD50,29 (29),0.0806,0.226,0,,0 (0),1,1,0.0806,0.226
Lidocaine (Local Anaesthetic) Metabolism Pathway,SMPDB,1,CYP1A2,4 (4),0.567,0.927,5,HMDB0060679;HMDB0060678;HMDB0014426;HMDB0060655;HMDB0060656,17 (17),0.0287,1,0.0832,0.231
Global Genome Nucleotide Excision Repair (GG-NER),Reactome,21,UBE2I;CUL4B;CUL4A;COPS6;COPS2;UBE2N;UBE2V2;DDB1;COPS5;LIG3;COPS4;PARP1;COPS8;POLE;COPS3;PCNA;GPS1;RBX1;COPS7A;RAD23A;RAD23B,70 (70),0.0164,0.0602,0,,7 (10),1,1,0.0837,0.232
Cells and molecules involved in local acute inflammatory response,Wikipathways,6,ITGB1;ITGB2;ICAM1;C3;KNG1;C5,17 (17),0.084,0.234,0,,0 (0),1,1,0.084,0.234
tnfr1 signaling pathway,BioCarta,6,LMNA;LMNB1;CASP3;MAP2K4;LMNB2;FADD,17 (17),0.084,0.234,0,,0 (0),1,1,0.084,0.234
Splicing factor NOVA regulated synaptic proteins,Wikipathways,11,MAPK9;GPHN;MAP4;CDH2;ATP2B1;CASK;EPB41;EPB41L1;EPB41L2;SNW1;STXBP2,42 (42),0.154,0.38,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,1 (1),0.107,1,0.0844,0.234
Initiation of Nuclear Envelope (NE) Reformation,Reactome,8,LMNA;LMNB1;TMPO;PPP2R1A;BANF1;PPP2R2A;SIRT2;KPNB1,19 (19),0.0166,0.0608,0,,6 (9),1,1,0.0845,0.234
mir-124 predicted interactions with cell cycle and differentiation,Wikipathways,3,PRKAA1;PTBP1;CTDSP1,6 (6),0.0854,0.234,0,,0 (0),1,1,0.0854,0.234
Transport of the SLBP Dependant Mature mRNA,Reactome,3,EIF4E;ALYREF;NCBP1,6 (6),0.0854,0.234,0,,0 (2),1,1,0.0854,0.234
SUMO is transferred from E1 to E2 (UBE2I_ UBC9),Reactome,3,UBE2I;UBA2;SAE1,6 (6),0.0854,0.234,0,,0 (0),1,1,0.0854,0.234
d4gdi signaling pathway,BioCarta,3,RHOA;CASP3;ARHGDIB,6 (6),0.0854,0.234,0,,0 (0),1,1,0.0854,0.234
Thyroid hormone synthesis - Homo sapiens (human),KEGG,22,PDIA4;HSP90B1;DUOX1;ASGR1;ASGR2;CANX;IYD;GPX1;PRKACA;PRKACB;PRKCA;PLCB3;ALB;GNAQ;GNAS;ATP1A1;ATP1B1;ATP1B3;TTR;HSPA5;GSR;ITPR2,75 (75),0.0185,0.0671,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,20 (21),0.898,1,0.0847,0.234
<i>S</i>-methyl-5-thio-&alpha;-D-ribose 1-phosphate degradation,HumanCyc,3,ADI1;MRI1;ENOPH1,4 (4),0.0231,0.0797,3,HMDB0000123;HMDB0000172;HMDB0000687,34 (35),0.724,1,0.085,0.235
SUMOylation of DNA damage response and repair proteins,Reactome,20,NUP98;UBE2I;NUP133;NUP155;SMC3;RANBP2;TPR;PARP1;NUP160;SMC1A;RAE1;NUP210;NUP93;NUP35;NUP58;PML;SEC13;RAD21;STAG2;NUP205,78 (78),0.0861,0.236,0,,0 (0),1,1,0.0861,0.236
Integrin cell surface interactions,Reactome,20,F11R;CD47;FGA;COL4A2;ITGA9;CDH1;ITGB1;ITGB2;ITGB3;COL18A1;ITGA1;BSG;ICAM1;VTN;FGB;FGG;LUM;ITGA2B;ITGA5;FN1,66 (66),0.0169,0.0617,0,,1 (2),1,1,0.0857,0.236
vegf hypoxia and angiogenesis,BioCarta,11,SHC1;HRAS;HIF1A;CSK;PRKCA;PIK3R1;PXN;KNG1;HSP90AA1;CAV1;GRB2,30 (30),0.0169,0.0617,0,,6 (6),1,1,0.0858,0.236
fmlp induced chemokine gene expression in hmc-1 cells,BioCarta,11,HRAS;MAP2K1;MAP2K2;MAP2K3;PRKCA;RELA;RAC1;MAPK14;PPP3CA;MAPK1;GNB1,30 (30),0.0169,0.0617,0,,1 (3),1,1,0.0858,0.236
Vitamin B6-dependent and responsive disorders,Wikipathways,3,PNPO;ALDH7A1;AASS,4 (4),0.0231,0.0797,1,HMDB0000279,12 (19),0.745,1,0.0869,0.239
Corticotropin-releasing hormone signaling pathway,Wikipathways,23,RHOA;PARP1;JUP;RAP1B;MAPK14;GNAS;ACACA;TRIM28;CAMK2A;PRKAA2;CASP3;PRKCA;GNA11;RELA;GNAI2;GNAQ;MAPK1;CTNNB1;GNB1;GNB2;MAPK9;MAP2K1;HSP90AA1,92 (92),0.0878,0.24,0,,0 (0),1,1,0.0878,0.24
multi-drug resistance factors,BioCarta,3,ABCB4;GSTP1;ABCB11,6 (6),0.0854,0.234,1,HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,2 (2),0.203,1,0.0877,0.241
Glutathione synthesis and recycling,Reactome,6,CNDP2;GCLC;GCLM;GSS;GGCT;OPLAH,13 (13),0.0229,0.0797,1,HMDB0000123,13 (14),0.772,1,0.0889,0.244
CMP-<i>N</i>-acetylneuraminate biosynthesis I (eukaryotes),HumanCyc,3,NANS;GNE;CMAS,4 (4),0.0231,0.0797,1,HMDB0000290,13 (15),0.772,1,0.0895,0.246
Signaling by NTRKs,Reactome,34,RHOA;RALA;RALB;PPP2CB;PPP2R1A;MAPK14;RAP1A;AP2M1;AP2S1;PPP2R5D;AP2A1;AP2A2;AP2B1;STAT3;PIK3R1;RPS6KA1;DUSP3;CLTA;CLTC;SHC1;HRAS;DNM3;GRB2;CRKL;CHD4;FUS;MAPK1;MAP2K1;MAP2K2;YWHAB;CRK;RAC1;DNM2;PTPN11,127 (127),0.0178,0.0649,0,,11 (13),1,1,0.0896,0.246
Glycosphingolipid biosynthesis - globo and isoglobo series - Homo sapiens (human),KEGG,3,HEXA;HEXB;NAGA,15 (15),0.559,0.927,2,HMDB0006734;HMDB0004878,3 (23),0.032,1,0.0897,0.246
Signaling by PDGF,Reactome,17,COL6A6;COL4A2;GRB2;HRAS;COL6A5;COL6A1;COL6A2;COL6A3;PIK3R1;NCK1;PTPN11;STAT3;CRKL;STAT5B;STAT6;CRK;PLG,54 (54),0.0181,0.0658,0,,7 (17),1,1,0.0907,0.248
IL6,NetPath,19,SHC1;HRAS;LYN;MAP2K1;GRB2;HNRNPA1;MAP2K2;PIK3R1;MAP2K4;EIF4E;HSPB1;PTPN11;STAT3;RAC1;MAPK14;STAT5B;MAPK1;HSP90AA1;EIF2A,74 (74),0.0916,0.249,0,,0 (0),1,1,0.0916,0.249
ATM pathway,PID,10,UBE2N;H2AX;YWHAB;TRIM28;CTBP1;SMC1A;SMC3;ATM;BID;RAD50,34 (34),0.0924,0.249,0,,0 (0),1,1,0.0924,0.249
Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization,Reactome,2,SLC25A4;SLC25A5,3 (3),0.0934,0.249,0,,0 (0),1,1,0.0934,0.249
Integration of viral DNA into host genomic DNA,Reactome,2,PSIP1;BANF1,3 (3),0.0934,0.249,0,,0 (1),1,1,0.0934,0.249
Inhibition of nitric oxide production,Reactome,2,KPNA1;KPNB1,3 (3),0.0934,0.249,0,,0 (0),1,1,0.0934,0.249
opposing roles of aif in apoptosis and cell survival,BioCarta,2,AIFM1;PARP1,3 (3),0.0934,0.249,0,,0 (0),1,1,0.0934,0.249
Autointegration results in viral DNA circles,Reactome,2,PSIP1;BANF1,3 (3),0.0934,0.249,0,,0 (1),1,1,0.0934,0.249
Signaling events mediated by HDAC Class II,PID,13,UBE2I;TUBA1B;YWHAB;YWHAE;RAN;RANBP2;RANGAP1;HSP90AA1;NUP210;XPO1;NR3C1;HDAC6;GNB1,38 (38),0.0182,0.0662,0,,1 (1),1,1,0.0912,0.25
Synthesis of Prostaglandins (PG) and Thromboxanes (TX),Reactome,7,HPGDS;PTGES3;CBR1;PTGR2;PTGES2;CYP8B1;PTGS1,16 (16),0.0196,0.0702,2,HMDB0001043;HMDB0003208,39 (50),0.933,1,0.0915,0.25
chrebp regulation by carbohydrates and camp,BioCarta,14,PKLR;F2;PRKAR1A;PRKAA1;PRKAR2A;PRKAG1;AGT;PPP2R5D;GNAS;PRKAA2;PRKAB1;ACSM1;GNB1;PRKACB,42 (42),0.0184,0.0669,0,,8 (12),1,1,0.0921,0.251
RHOF GTPase cycle,Reactome,14,CAPZB;LMNB1;DIAPH1;ARHGAP1;RAB7A;TOR1AIP1;PIK3R1;FARP1;TMPO;STEAP3;ACTN1;CAV1;ACTB;ESYT1,42 (42),0.0184,0.0669,0,,4 (4),1,1,0.0921,0.251
RNA degradation - Homo sapiens (human),KEGG,20,HSPD1;SKIV2L;ENO1;PNPT1;LSM8;LSM4;MTREX;HSPA9;PABPC1;XRN2;TTC37;LSM6;DDX6;PABPC4;LSM3;PFKL;EXOSC6;WDR61;NUDT16;CNOT1,79 (79),0.0957,0.255,0,,0 (0),1,1,0.0957,0.255
Nucleotide salvage,Reactome,9,APRT;TYMP;ADK;PNP;AMPD2;HPRT1;DGUOK;ADA;GMPR2,23 (23),0.019,0.0686,1,HMDB0000195,44 (45),0.994,1,0.0939,0.256
GnRH signaling pathway - Homo sapiens (human),KEGG,22,MAP2K4;MAPK14;CDC42;MAPK1;CALM1;EGFR;CAMK2A;CAMK2D;PRKACA;PRKACB;HRAS;GRB2;PRKCA;GNA11;PLCB3;GNAQ;GNAS;MAPK9;MAP2K1;MAP2K2;MAP2K3;ITPR2,93 (93),0.147,0.364,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0001043,6 (6),0.129,1,0.094,0.256
Translation of structural proteins,Reactome,9,UBE2I;MOGS;PARP14;ST6GAL1;PARP9;ST3GAL4;CANX;GANAB;PRKCSH,23 (23),0.019,0.0686,0,,10 (11),1,1,0.0944,0.257
Translation of structural proteins,Reactome,9,UBE2I;MOGS;PARP14;ST6GAL1;PARP9;ST3GAL4;CANX;GANAB;PRKCSH,23 (23),0.019,0.0686,0,,10 (11),1,1,0.0944,0.257
Signaling by CSF3 (G-CSF),Reactome,9,SHC1;CUL5;LYN;GRB2;ELOC;ELOB;PTPN11;STAT3;STAT5B,23 (23),0.019,0.0686,0,,3 (3),1,1,0.0944,0.257
how progesterone initiates the oocyte maturation,BioCarta,9,HRAS;PRKAR1A;PRKAR2A;PIN1;CAP1;GNAS;MAPK1;GNB1;PRKACB,23 (23),0.019,0.0686,0,,5 (5),1,1,0.0944,0.257
phosphatidylethanolamine biosynthesis II,HumanCyc,4,CHKB;SELENOI;CEPT1;PCYT2,7 (7),0.0272,0.0916,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,11 (12),0.714,1,0.096,0.261
Triacylglyceride synthesis,Wikipathways,7,GPD1;LIPC;GPAM;DGAT1;AGPAT2;AGPAT3;PLPP3,24 (24),0.151,0.373,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,6 (10),0.129,1,0.0962,0.261
choline degradation,HumanCyc,2,CHDH;ALDH7A1,2 (2),0.0356,0.113,1,HMDB0000043,7 (7),0.549,1,0.0964,0.261
Signaling by ERBB2 ECD mutants,Reactome,7,SHC1;HRAS;EGFR;GRB2;PIK3R1;HSP90AA1;CDC37,16 (16),0.0196,0.0702,0,,6 (8),1,1,0.0967,0.262
Trafficking of GluR2-containing AMPA receptors,Reactome,7,AP2A1;AP2A2;AP2B1;NSF;PRKCA;AP2M1;AP2S1,16 (16),0.0196,0.0702,0,,5 (6),1,1,0.0967,0.262
RHO GTPases activate CIT,Reactome,7,RHOA;MYH14;MYH9;MYH11;RAC1;MYL6;MYL9,16 (16),0.0196,0.0702,0,,3 (3),1,1,0.0967,0.262
AGE-RAGE signaling pathway in diabetic complications - Homo sapiens (human),KEGG,21,MAPK1;DIAPH1;COL4A2;BAX;CDC42;HRAS;ICAM1;PRKCA;RAC1;PIK3R1;MAPK14;RELA;PLCB3;STAT3;AGT;CASP3;STAT5B;MAPK9;COL1A1;COL1A2;FN1,100 (100),0.33,0.663,2,HMDB0004949;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (9),0.0594,1,0.0968,0.262
Ca-dependent events,Reactome,10,CALM1;PRKAR1A;PRKAR2A;PRKCA;CAMK2A;CAMK2D;KPNA2;MAPK1;PRKACA;PRKACB,39 (39),0.187,0.429,3,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0001043;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,11 (11),0.105,1,0.0971,0.262
Vitamin B6 metabolism,INOH,3,PNPO;AOX1;PDXK,4 (4),0.0231,0.0797,1,HMDB0033934,17 (17),0.856,1,0.0972,0.262
D-Arginine and D-Ornithine Metabolism,SMPDB,1,DAO,1 (1),0.189,0.429,3,HMDB0004225;HMDB0006272;HMDB0033934,11 (11),0.105,1,0.0977,0.263
Pathways Regulating Hippo Signaling,Wikipathways,24,RHOA;EGFR;MTOR;PRKAA1;PRKAA2;PRKAB1;PRKACA;PRKACB;PRKAG1;PRKAR1A;PRKAR2A;PRKCA;RAC1;GNA11;GNAI2;GNAI3;GNAQ;GNAS;CTNNB1;CDC42;CDH1;CDH2;PLCB3;CDH17,98 (98),0.0998,0.265,0,,0 (0),1,1,0.0998,0.265
PI and PC transport between ER and Golgi membranes,Reactome,1,PITPNB,1 (1),0.189,0.429,1,HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,1 (2),0.107,1,0.0992,0.267
EPO Receptor Signaling,Wikipathways,8,SHC1;MAP2K1;MAP2K2;PDK1;STAT3;STAT5B;MAPK1;GRB2,26 (26),0.101,0.267,0,,0 (0),1,1,0.101,0.267
anandamide degradation,HumanCyc,1,FAAH,2 (2),0.342,0.67,2,HMDB0004080;HMDB0001043,4 (4),0.0594,1,0.0995,0.268
Vif-mediated degradation of APOBEC3G,Reactome,4,CUL5;RBX1;ELOB;ELOC,10 (10),0.102,0.269,0,,0 (0),1,1,0.102,0.269
M Phase,Reactome,88,PDS5B;TPR;VPS4A;SMC1A;CKAP5;IST1;RCC1;TUBB2B;RPS27;NUP58;DCTN1;CHMP2A;TUBA4A;BANF1;RCC2;NUP205;TUBA1B;TUBB4B;NDEL1;UBE2I;NUP210;PDS5A;RAB1A;RAB2A;NUP160;GOLGA2;DYNC1H1;DYNC1I2;DYNC1LI2;HSP90AA1;SEC13;KPNB1;TNPO1;EML4;RAN;RANBP2;RANGAP1;CHMP6;RAE1;DCTN2;TUBA1C;NUP98;NEK7;CEP192;XPO1;CHMP4B;YWHAE;YWHAG;NUP35;PPP1CC;SIRT2;MAPRE1;ACTR1A;PPP2CB;PPP2R1A;PPP2R2A;GORASP2;PPP2R5A;PPP2R5D;PPP2R5E;STAG2;NUP155;LMNA;LMNB1;SMC3;USO1;CSNK1D;CSNK2A1;CSNK2A2;CSNK2B;PAFAH1B1;SSNA1;PRKACA;DYNLL2;NUP133;CHMP3;H2AX;DYNC1LI1;TMPO;PRKCA;RAB1B;NUP93;MAPK1;ZW10;BUB3;NUDC;RAD21;DCTN3,382 (383),0.0223,0.0796,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,22 (26),0.919,1,0.1,0.269
Neurotrophic factor-mediated Trk receptor signaling,PID,19,SHC1;HRAS;RHOA;MAP2K1;GRB2;CDC42;RHOG;RAC1;SQSTM1;PIK3R1;RAP1A;RAP1B;PTPN11;STAT3;CRKL;MAPK1;CRK;EHD4;DNAJA3,63 (63),0.0205,0.0734,0,,2 (2),1,1,0.1,0.27
Androgen receptor signaling pathway,Wikipathways,22,RHOA;RNF14;FLNA;RAN;DSTN;RACK1;UBE2I;EGFR;UBE3A;CALR;PIK3R1;PARK7;PRDX1;BAG1;ROCK1;RELA;CAV1;CTNNB1;CDC42;FKBP4;STAT3;RAC1,89 (89),0.103,0.272,0,,0 (0),1,1,0.103,0.272
inhibition of cellular proliferation by gleevec,BioCarta,7,HRAS;MAP2K1;GRB2;PIK3R1;MAP2K4;CRKL;STAT5B,22 (22),0.104,0.275,0,,0 (0),1,1,0.104,0.275
Nephrotic syndrome,Wikipathways,13,LMNA;MYO1E;INF2;LAMB2;ARHGDIA;ZMPSTE24;ACTN4;MYH9;YARS1;SCARB2;CD2AP;COQ6;PMM2,48 (48),0.105,0.276,0,,0 (0),1,1,0.105,0.276
putrescine degradation III,HumanCyc,5,MAOA;MAOB;SAT2;ALDH3A2;ALDH1B1,10 (10),0.0258,0.0881,1,HMDB0002064,15 (15),0.819,1,0.103,0.276
Glycerolipid Metabolism,SMPDB,6,GPD1;GPD2;AKR1B1;GPAM;LIPC;GLYCTK,13 (13),0.0229,0.0797,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,24 (24),0.935,1,0.104,0.277
Familial lipoprotein lipase deficiency,SMPDB,6,GPD1;GPD2;AKR1B1;GPAM;LIPC;GLYCTK,13 (13),0.0229,0.0797,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,24 (24),0.935,1,0.104,0.277
Glycerol Kinase Deficiency,SMPDB,6,GPD1;GPD2;AKR1B1;GPAM;LIPC;GLYCTK,13 (13),0.0229,0.0797,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,24 (24),0.935,1,0.104,0.277
D-glyceric acidura,SMPDB,6,GPD1;GPD2;AKR1B1;GPAM;LIPC;GLYCTK,13 (13),0.0229,0.0797,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,24 (24),0.935,1,0.104,0.277
IL5-mediated signaling events,PID,5,STAT5B;LYN;PIK3R1;PTPN11;GRB2,14 (14),0.107,0.278,0,,0 (0),1,1,0.107,0.278
akap95 role in mitosis and chromosome dynamics,BioCarta,5,PPP2R5D;PRKAR2A;PRKAG1;PRKACB;DDX5,14 (14),0.107,0.278,0,,0 (0),1,1,0.107,0.278
apoptotic signaling in response to dna damage,BioCarta,5,ATM;BID;CASP3;BAX;CASP6,14 (14),0.107,0.278,0,,0 (0),1,1,0.107,0.278
Inactivation of CSF3 (G-CSF) signaling,Reactome,6,CUL5;LYN;ELOC;ELOB;STAT3;STAT5B,18 (18),0.107,0.278,0,,0 (0),1,1,0.107,0.278
Lidocaine (Antiarrhythmic) Action Pathway,SMPDB,13,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;CYP1A2;DLG1;ATP2A2;SNTB2;MYLK;ATP1A1;PRKACA,63 (63),0.409,0.774,6,HMDB0014426;HMDB0060678;HMDB0060679;HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145;HMDB0060655;HMDB0060656,26 (26),0.0524,1,0.104,0.278
Arachidonate production from DAG,Reactome,3,ABHD12;ABHD6;MGLL,5 (5),0.0496,0.15,1,HMDB0001043,5 (8),0.433,1,0.104,0.278
Neurotrophin signaling pathway - Homo sapiens (human),KEGG,26,RHOA;ARHGDIA;ARHGDIB;RAP1A;RAP1B;PTPN11;MAPK14;CAMK2A;GRB2;CALM1;PIK3R1;CAMK2D;RPS6KA1;SHC1;HRAS;BAX;RAC1;RELA;MAPK1;MAPK9;MAP2K1;MAP2K2;CDC42;YWHAE;CRK;CRKL,119 (119),0.233,0.512,2,HMDB0004949;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,5 (5),0.0922,1,0.104,0.278
Oxytocin signaling pathway - Homo sapiens (human),KEGG,37,RHOA;GNAQ;EEF2;PPP3CA;MYL6;MYLK;CALM1;EGFR;GUCY1A1;GUCY1B1;CAMK2A;CAMK2D;MYL9;CD38;PRKAA1;PRKAA2;ACTB;PRKACA;PRKACB;MAPK1;HRAS;PRKAG1;ACTG1;PRKCA;ROCK1;PLCB3;GNAI3;CAMK1;GNAS;MAP2K1;MAP2K2;PRKAB1;ITPR2;GNAI2;PPP1CA;PPP1CB;PPP1CC,154 (154),0.0647,0.189,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0001043,11 (12),0.334,1,0.104,0.279
SARS-CoV-1 Infection,Reactome,11,UBE2I;MOGS;PARP14;CTSL;ST6GAL1;PARP9;ST3GAL4;CANX;DDX5;GANAB;PRKCSH,31 (31),0.0218,0.0778,0,,13 (25),1,1,0.105,0.281
Class I PI3K signaling events mediated by Akt,PID,10,MTOR;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;HSP90AA1;YWHAQ;KPNA1;PRKACA,35 (35),0.108,0.282,0,,0 (0),1,1,0.108,0.282
Diseases of signal transduction by growth factor receptors and second messengers,Reactome,65,SEL1L;PIK3AP1;RHOG;LSR;STRN;RAP1A;RAP1B;PTPN11;FXR1;ITGA2B;CDC37;SNW1;AKT1S1;HDAC6;KITLG;FN1;LMNA;CALM1;EGFR;CSK;CAMK2A;MTOR;CPSF6;STAT3;PIK3R1;CAMK2D;ERLIN2;TLN1;SPTBN1;SYVN1;HDAC2;SHC1;HRAS;FGA;FGB;GRB2;AGK;MYO18A;VCP;OS9;NCSTN;HSP90AA1;FGG;SND1;MAPK1;TRIP11;DERL2;YES1;MPRIP;AP3B1;LYN;MAP2K1;MAP2K2;YWHAB;ITGB3;PPP1CC;ERLEC1;ARAF;VCL;RAC1;LRRFIP1;STAT5B;IQGAP1;PPP1CB;ZC3HAV1,274 (274),0.0253,0.087,1,HMDB0000693,18 (71),0.871,1,0.106,0.283
ROS and RNS production in phagocytes,Reactome,12,MPO;ATP6V1H;TCIRG1;ATP6V1A;ATP6V1G1;ATP6V0C;ATP6V1C1;ATP6V1E1;ATP6V1B2;ATP6V1D;ATP6V0A1;ATP6V0D1,35 (35),0.0224,0.0797,0,,28 (50),1,1,0.108,0.287
Leptin,NetPath,16,ACACB;KHDRBS1;MAPK14;EGFR;GRB2;PIK3R1;SHC1;CFL2;RPS6;PTPN11;STAT3;GNAQ;EIF4E;PRKAA1;PRKAA2;MAPK1,62 (62),0.111,0.287,0,,0 (0),1,1,0.111,0.287
Beta3 integrin cell surface interactions,PID,12,F11R;CD47;FGA;ITGA2B;TGFBI;ITGB3;VTN;FGB;FGG;COL1A1;COL1A2;FN1,44 (44),0.111,0.289,0,,0 (0),1,1,0.111,0.289
Enzymatic degradation of Dopamine by monoamine oxidase,Reactome,2,MAOA;COMT,2 (2),0.0356,0.113,1,HMDB0033934,9 (10),0.64,1,0.109,0.289
Estrogen Receptor Pathway,Wikipathways,6,CYP1A2;GPAM;PCK1;ACOX1;PDK4;STAT3,13 (13),0.0229,0.0797,0,,1 (2),1,1,0.109,0.289
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex,Reactome,6,YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;YWHAQ,13 (13),0.0229,0.0797,0,,2 (2),1,1,0.109,0.289
Frs2-mediated activation,Reactome,6,MAP2K1;MAP2K2;YWHAB;RAP1A;CRKL;MAPK1,13 (13),0.0229,0.0797,0,,5 (5),1,1,0.109,0.289
guanosine ribonucleotides <i>de novo</i> biosynthesis,HumanCyc,6,NME3;GMPS;GUK1;IMPDH2;NME1;NME2,13 (13),0.0229,0.0797,0,,15 (15),1,1,0.109,0.289
Mitotic Telophase/Cytokinesis,Reactome,6,SMC3;PDS5B;PDS5A;STAG2;SMC1A;RAD21,13 (13),0.0229,0.0797,0,,2 (3),1,1,0.109,0.289
melanocyte development and pigmentation pathway,BioCarta,6,HRAS;MAP2K1;MAP2K2;RPS6KA1;MAPK1;KITLG,13 (13),0.0229,0.0797,0,,2 (2),1,1,0.109,0.289
pentose phosphate pathway (oxidative branch),HumanCyc,3,PGD;H6PD;PGLS,4 (4),0.0231,0.0797,0,,9 (9),1,1,0.11,0.289
Lysosomal oligosaccharide catabolism,Reactome,3,MAN2C1;MAN2B1;MANBA,4 (4),0.0231,0.0797,0,,4 (8),1,1,0.11,0.289
thioredoxin pathway,HumanCyc,3,PRDX5;TXNRD1;TXNRD2,4 (4),0.0231,0.0797,0,,3 (4),1,1,0.11,0.289
<i>myo</i>-inositol <i>de novo</i> biosynthesis,HumanCyc,3,IMPA1;IMPA2;ISYNA1,4 (4),0.0231,0.0797,0,,5 (6),1,1,0.11,0.289
Metabolism of ingested H2SeO4 and H2SeO3 into H2Se,Reactome,3,TXNRD1;GSR;PAPSS2,4 (4),0.0231,0.0797,0,,15 (19),1,1,0.11,0.289
Mitochondrial ABC transporters,Reactome,3,ABCB10;ABCB6;ABCB7,4 (4),0.0231,0.0797,0,,5 (6),1,1,0.11,0.289
NAD salvage,HumanCyc,3,NMNAT1;NMNAT3;NAMPT,4 (4),0.0231,0.0797,0,,7 (7),1,1,0.11,0.289
Signaling by MAP2K mutants,Reactome,3,MAPK1;MAP2K1;MAP2K2,4 (4),0.0231,0.0797,0,,2 (2),1,1,0.11,0.289
Glycerolipid metabolism - Homo sapiens (human),KEGG,17,ALDH3A2;ALDH1B1;PLPP3;AGK;AKR1B1;DGAT1;AKR1A1;LCLAT1;GPAM;MGLL;AGPAT3;LIPC;TKFC;ALDH7A1;AGPAT2;GLYCTK;ALDH9A1,61 (61),0.0557,0.167,2,HMDB0006790;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,13 (38),0.414,1,0.11,0.289
Sema4D induced cell migration and growth-cone collapse,Reactome,8,RHOA;ARHGEF12;MYH14;ROCK1;MYH9;MYH11;MYL6;MYL9,20 (20),0.0231,0.0798,0,,4 (4),1,1,0.11,0.289
Signaling by Hippo,Reactome,8,MOB1A;CASP3;STK4;TJP2;YWHAB;TJP1;YWHAE;YAP1,20 (20),0.0231,0.0798,0,,2 (2),1,1,0.11,0.289
hemoglobins chaperone,BioCarta,5,HMBS;ALAD;CPOX;FECH;UROD,13 (13),0.0806,0.226,1,HMDB0000123,3 (3),0.289,1,0.111,0.291
Nitrogen metabolism - Homo sapiens (human),KEGG,7,GLUL;CA14;CA3;GLUD1;CA5A;CPS1;CA8,17 (17),0.028,0.0937,1,HMDB0033934,16 (19),0.838,1,0.112,0.292
nicotine degradation IV,HumanCyc,7,UGT2B10;INMT;FMO1;FMO3;FMO4;FMO5;AOX1,17 (17),0.028,0.0937,1,HMDB0001934,16 (28),0.838,1,0.112,0.292
Regulation of lipolysis in adipocytes - Homo sapiens (human),KEGG,9,PTGS1;MGLL;GNAI2;GNAI3;FABP4;GNAS;PIK3R1;PRKACA;PRKACB,55 (57),0.735,1,4,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0001547;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0001043,12 (14),0.032,1,0.112,0.292
RAC3 GTPase cycle,Reactome,26,ARHGAP1;ARHGDIB;TAOK3;ABI1;CYFIP1;STBD1;YKT6;LMAN1;SWAP70;DSG2;PIK3R1;ESYT1;PGRMC2;PAK2;RAB7A;TMPO;ARHGAP17;NCKAP1;CAV1;BAIAP2;LAMTOR1;BRK1;FERMT2;CDC42;ITGB1;TFRC,94 (94),0.0237,0.0817,0,,6 (6),1,1,0.112,0.294
Vitamin digestion and absorption - Homo sapiens (human),KEGG,6,SLC23A1;BTD;APOA1;APOA4;APOB;SCARB1,24 (24),0.292,0.606,6,HMDB0003134;HMDB0000244;HMDB0000067;HMDB0030020;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0000876,29 (39),0.0826,1,0.114,0.298
Organelle biogenesis and maintenance,Reactome,56,ATP5F1D;TNPO1;ATP5PB;YWHAG;MAPRE1;ATP5MG;ATP5ME;ATP5PF;PPP2R1A;TUBB4B;EXOC5;ARL3;MAPK14;GBF1;ATP5PO;HDAC6;CALM1;DYNC1H1;DCTN2;CSNK1D;RAB8A;MT-ATP8;DCTN3;ACTR1A;PAFAH1B1;GLUD1;PRKAA2;PRKAB1;SIRT3;RAB11A;DYNLL2;CKAP5;PRKAG1;DYNLRB1;ATP5MF;SSNA1;CEP192;IDH2;ATP5F1B;ACSS2;DMAC2L;DCTN1;TRIP11;TFAM;ATP5PD;TUBA4A;SIRT5;ATP5F1A;DYNC1I2;PRKACA;SOD2;ARF4;YWHAE;EXOC4;HSP90AA1;RAB11FIP3,231 (231),0.0242,0.0832,0,,13 (16),1,1,0.114,0.298
Drug Induction of Bile Acid Pathway,Wikipathways,5,SLC10A1;ABCB11;ABCC2;BAAT;CYP7A1,17 (17),0.204,0.459,4,HMDB0000036;HMDB0000067;HMDB0000054;HMDB0000138,18 (28),0.119,1,0.115,0.299
Non-genomic actions of 1_25 dihydroxyvitamin D3,Wikipathways,11,MAPK9;ISG15;HRAS;PRKCA;CAMK2A;RXRA;CAMK2D;PLCB3;STAT2;MAPK14;MAPK1,68 (68),0.761,1,2,HMDB0001043;HMDB0003550,3 (4),0.032,1,0.115,0.299
Visual phototransduction,Reactome,27,APOM;METAP1;METAP2;RDH16;CALM1;BCO2;RDH11;HSD17B6;RBP1;RBP4;RDH10;LRP1;DHRS3;PRKCA;APOA1;APOA2;APOA4;APOB;FNTA;NMT1;APOC2;APOC3;APOE;GNB1;RETSAT;TTR;AKR1C1,103 (103),0.041,0.129,5,HMDB0000067;HMDB0006216;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,48 (68),0.598,1,0.116,0.301
Post NMDA receptor activation events,Reactome,18,CALM1;PRKAG1;PRKAR1A;HRAS;PRKAR2A;DLG1;CAMK2A;CAMK2D;RPS6KA1;KPNA2;RAC1;CAMK1;MAPK1;PRKAA2;PRKAB1;PRKAA1;PRKACA;PRKACB,62 (62),0.0344,0.113,1,HMDB0000123,11 (13),0.714,1,0.116,0.301
Mitotic Spindle Checkpoint,Reactome,27,MAPRE1;PPP2CB;PPP2R1A;RANBP2;RANGAP1;PPP2R5A;PPP2R5D;PPP2R5E;NDEL1;PAFAH1B1;DYNLL2;NUP98;CKAP5;NUP133;DYNC1LI1;RPS27;XPO1;ZW10;BUB3;NUDC;NUP160;RCC2;DYNC1H1;DYNC1I2;DYNC1LI2;SEC13;PPP1CC,114 (114),0.117,0.302,0,,0 (0),1,1,0.117,0.302
Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB,Reactome,2,MAOA;MAOB,2 (2),0.0356,0.113,1,HMDB0033934,11 (11),0.714,1,0.119,0.309
Sema4D in semaphorin signaling,Reactome,9,RHOA;ARHGEF12;MYH14;ROCK1;MYH9;MYH11;RAC1;MYL6;MYL9,24 (24),0.0255,0.0875,0,,6 (6),1,1,0.119,0.309
regulation of ck1/cdk5 by type 1 glutamate receptors,BioCarta,9,PRKAR1A;PRKAR2A;CSNK1D;PPP2R5D;PPP3CA;PPP1CA;GNAS;GNB1;PRKACB,24 (24),0.0255,0.0875,0,,6 (7),1,1,0.119,0.309
Inflammatory mediator regulation of TRP channels - Homo sapiens (human),KEGG,19,CALM1;MAPK14;PPP1CA;MAP2K3;MAPK9;PRKCA;IGF1;PIK3R1;CAMK2D;PLCB3;KNG1;GNAQ;PPP1CC;GNAS;CAMK2A;PPP1CB;ITPR2;PRKACA;PRKACB,98 (98),0.489,0.863,6,HMDB0002227;HMDB0004472;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0002995;HMDB0001043;HMDB0004080,26 (35),0.0524,1,0.12,0.31
Intracellular trafficking proteins involved in CMT neuropathy,Wikipathways,8,RAB7A;RAB4A;RAB11B;MFN2;HSPB8;HSPB1;DNM2;RAB11A,27 (27),0.121,0.311,0,,0 (0),1,1,0.121,0.311
Leptin and adiponectin,Wikipathways,5,PRKAA1;PRKAG1;PRKAB1;CPT1A;ACACA,10 (10),0.0258,0.0881,0,,2 (4),1,1,0.12,0.311
Hyaluronan uptake and degradation,Reactome,5,STAB2;HEXA;HEXB;CHP1;GUSB,10 (10),0.0258,0.0881,0,,5 (7),1,1,0.12,0.311
Acetylcholine regulates insulin secretion,Reactome,5,GNAQ;MARCKS;PLCB3;PRKCA;GNA11,10 (10),0.0258,0.0881,0,,7 (10),1,1,0.12,0.311
alternative complement pathway,BioCarta,5,C8A;C8B;C5;C3;C9,10 (10),0.0258,0.0881,0,,2 (2),1,1,0.12,0.311
Constitutive Signaling by Overexpressed ERBB2,Reactome,5,SHC1;HRAS;CDC37;HSP90AA1;GRB2,10 (10),0.0258,0.0881,0,,5 (7),1,1,0.12,0.311
Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin,SMPDB,5,GNAS;PPP1CA;GNG12;GNB1;PRKACB,10 (10),0.0258,0.0881,0,,7 (7),1,1,0.12,0.311
Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone,SMPDB,5,GNAS;PPP1CA;GNG12;GNB1;PRKACB,10 (10),0.0258,0.0881,0,,7 (7),1,1,0.12,0.311
Transport of small molecules,Reactome,136,NPC1;ATP6V1A;ATP6V1B2;ATP6V0C;ATP6V1C1;ATP6V1E1;ABCB7;ABCF1;CAND1;ATP6AP1;ATP7B;SPG7;PRKAR2A;SLCO2B1;ACO1;AZGP1;PHB2;CYGB;TCIRG1;SLC30A1;HMOX1;HMOX2;CLTA;SLC26A1;ERLEC1;SLC22A7;FTH1;ABCB4;PHB;APOC3;NEDD8;ATP6V0A1;AP2M1;AP2S1;AP2A1;AP2A2;GNG12;PMPCA;BSG;LETM1;SLC27A1;ATP6V1D;AFG3L2;CLTC;EIF2S2;ABCD3;OS9;NCEH1;SLC25A4;ALB;ABCD1;GNAS;ABCC2;GNB1;GNB2;MAIP1;FXYD1;UNC79;SLC30A10;SLC38A3;SLC39A7;SOAT2;VCP;VDAC1;VDAC2;VDAC3;SEL1L;CUL1;SLC2A9;DERL1;SLC25A5;PMPCB;ATP1A1;ATP13A1;SLC38A4;SLC43A1;PEX3;DERL2;ABCB6;CP;ATP6V1G1;APOA1;APOA2;NPC2;APOB;AQP8;APOC2;ANO10;LCAT;APOE;SKP1;AQP1;TF;ABCC6;SLC2A2;ERLIN1;SLC4A1;TFR2;TFRC;LIPC;SLC25A22;SLC22A18;SLC6A13;LSR;LIPA;ATP6V1H;ERLIN2;ATP6V0D1;ABCB10;ABCA6;SLC16A1;P4HB;EIF2S1;SLCO2A1;SLC22A1;SCARB1;MCU;SLC25A10;PRKACA;PRKACB;MTTP;PRKAR1A;STEAP3;AP2B1;SLC39A14;ATP1B1;MICU2;ATP1B3;AKAP1;APOA4;ATP2A2;ATP2B1;SLC33A1;SLC29A1;STOM;HDLBP,641 (641),0.0677,0.196,20,HMDB0000036;HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0000951;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0240251;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0000067;HMDB0000123;HMDB0000172;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0000195;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0000043;HMDB0000290;HMDB0015169;HMDB0000138;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0015282;HMDB0000687;HMDB0000304,172 (219),0.384,1,0.121,0.312
superpathway of steroid hormone biosynthesis,HumanCyc,4,HSD17B11;SRD5A1;HSD17B7;HSD17B4,17 (17),0.404,0.764,7,HMDB0000015;HMDB0000234;HMDB0000067;HMDB0006763;HMDB0001547;HMDB0000145;HMDB0000077,34 (35),0.0646,1,0.121,0.312
phytol degradation,HumanCyc,2,ALDH3A2;PECR,2 (2),0.0356,0.113,1,HMDB0002019,12 (14),0.745,1,0.123,0.316
Signaling events mediated by PTP1B,PID,16,SHC1;LYN;EGFR;CSK;YES1;CDH2;ITGB3;CAPN1;STAT3;PIK3R1;RHOA;CRK;CAV1;STAT5B;ITGA2B;GRB2,52 (52),0.0266,0.0905,0,,1 (1),1,1,0.123,0.317
role of erbb2 in signal transduction and oncology,BioCarta,10,SHC1;HRAS;EGFR;GRB2;PIK3R1;LRPPRC;STAT3;MAP2K1;MAPK1;MAP2K2,28 (28),0.0269,0.0915,0,,2 (2),1,1,0.124,0.319
VEGFR2 mediated vascular permeability,Reactome,10,CALM1;MTOR;PAK2;RAC1;JUP;CTNNA1;HSP90AA1;CAV1;CTNNB1;CTNND1,28 (28),0.0269,0.0915,0,,16 (16),1,1,0.124,0.319
Signaling by EGFR,Reactome,15,SHC1;HRAS;EGFR;CSK;CDC42;AAMP;EPS15;STAM2;PIK3R1;EPS15L1;PTPN11;GRB2;EPN1;HGS;PXN,48 (48),0.0272,0.0916,0,,8 (9),1,1,0.125,0.32
RHOA GTPase cycle,Reactome,38,VAPB;RHOA;ABCD3;ARHGAP1;ARHGDIA;ARHGDIB;FLOT2;JUP;SLK;EMC3;ATP6AP1;STBD1;YKT6;FAF2;LMAN1;STX5;TJP2;PIK3R1;FARP1;DDRGK1;KTN1;PGRMC2;ACBD5;DIAPH1;C1QBP;ARHGEF12;ACTC1;TMPO;ROCK1;ARHGEF10L;SCFD1;CAV1;HMOX2;FLOT1;PKN3;STOM;IQGAP1;TFRC,149 (149),0.0272,0.0916,0,,4 (4),1,1,0.125,0.32
oxidative ethanol degradation III,HumanCyc,4,ALDH3A2;CYP2E1;ACSS2;ACSS3,7 (7),0.0272,0.0916,0,,15 (15),1,1,0.125,0.32
ubiquinol-10 biosynthesis,HumanCyc,4,COQ5;COQ6;COQ7;COQ3,7 (7),0.0272,0.0916,0,,20 (21),1,1,0.125,0.32
Corticotropin Activation of Cortisol Production,SMPDB,4,GNAS;GNG12;GNB1;PRKACB,7 (7),0.0272,0.0916,0,,7 (7),1,1,0.125,0.32
Vasopressin Regulation of Water Homeostasis,SMPDB,4,GNG12;GNAS;GNB1;PRKACB,7 (7),0.0272,0.0916,0,,7 (7),1,1,0.125,0.32
Ethanol Degradation,SMPDB,4,CYP2E1;ALDH1B1;ACSS2;CAT,7 (7),0.0272,0.0916,0,,18 (18),1,1,0.125,0.32
dopamine degradation,HumanCyc,4,COMT;MAOB;ALDH3A2;MAOA,7 (7),0.0272,0.0916,0,,17 (17),1,1,0.125,0.32
Proline catabolism,Reactome,2,ALDH4A1;PRODH2,3 (3),0.0934,0.249,2,HMDB0240251;HMDB0002104,10 (11),0.292,1,0.126,0.321
chondroitin sulfate degradation (metazoa),HumanCyc,3,HEXA;HEXB;ARSB,7 (7),0.129,0.326,10,HMDB0035312;HMDB0013112;HMDB0001399;HMDB0012254;HMDB0001178;HMDB0001296;HMDB0003213;HMDB0000290;HMDB0001262;HMDB0003553,70 (131),0.212,1,0.126,0.321
Scavenging by Class H Receptors,Reactome,2,STAB2;APOB,4 (4),0.164,0.395,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,7 (11),0.168,1,0.126,0.322
Host-pathogen interaction of human coronaviruses - MAPK signaling,Wikipathways,10,MAPK9;MAP2K1;MAP2K2;MAP2K3;IFITM3;MAP2K4;RPS6KA1;MAPK14;EIF4E;MAPK1,36 (36),0.126,0.324,0,,0 (0),1,1,0.126,0.324
SARS-CoV-2 Infection,Reactome,11,UBE2I;MOGS;PARP14;CTSL;ST6GAL1;PARP9;ST3GAL4;CANX;DDX5;GANAB;PRKCSH,32 (32),0.0277,0.093,0,,13 (24),1,1,0.127,0.324
IL11,NetPath,7,PRKCA;RELA;PIK3R1;RPS6;RPS6KA1;STAT3;MAPK1,23 (23),0.127,0.324,0,,0 (0),1,1,0.127,0.324
caspase cascade in apoptosis,BioCarta,7,LMNA;LMNB1;CASP3;CASP6;ARHGDIB;PARP1;LMNB2,23 (23),0.127,0.324,0,,0 (0),1,1,0.127,0.324
TGF-Ncore,Signalink,12,CTNNB1;CTDSP1;PPP1CC;UCHL5;PPM1A;EIF4E;ITCH;HGS;PPP1CA;NR3C1;XPO1;PML,45 (45),0.127,0.325,0,,0 (0),1,1,0.127,0.325
Sulfation Biotransformation Reaction,Wikipathways,7,SULT1A1;SULT1C2;PAPSS2;SULT1B1;SULT1C3;GSR;SULT1E1,17 (17),0.028,0.0937,0,,10 (10),1,1,0.128,0.326
Trk receptor signaling mediated by PI3K and PLC-gamma,PID,12,SHC1;HRAS;GRB2;CAMK2A;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;PIK3R1;EPB41L1;YWHAQ,36 (36),0.028,0.0937,0,,3 (3),1,1,0.128,0.326
Signal amplification,Reactome,10,GNG12;AAMP;GNA11;GNA13;MAPK14;GNAI2;GNAI3;GNAQ;GNB1;GNB2,32 (32),0.0647,0.189,1,HMDB0003208,5 (5),0.433,1,0.128,0.326
DDX1 as a regulatory component of the Drosha microprocessor,Wikipathways,3,ATM;DDX1;RAD50,7 (7),0.129,0.326,0,,0 (0),1,1,0.129,0.326
Aryl hydrocarbon receptor signalling,Reactome,3,PTGES3;AIP;HSP90AB1,7 (7),0.129,0.326,0,,0 (1),1,1,0.129,0.326
Vitamin D-sensitive calcium signaling in depression,Wikipathways,6,GCLC;ATP2B1;RXRA;GSR;CYP27A1;ITPR2,35 (35),0.67,1,4,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000876;HMDB0000032;HMDB0003550,13 (15),0.0424,1,0.13,0.329
Globo Sphingolipid Metabolism,Wikipathways,2,ST6GAL1;GALNT2,19 (19),0.898,1,2,HMDB0006734;HMDB0004878,3 (3),0.032,1,0.131,0.332
p53 pathway,PID,15,USP7;MAPK9;NEDD8;PIN1;RPL23;TRIM28;CSNK1A1;CSNK1D;RPL5;MAPK14;PTPA;RPL11;ATM;KAT8;CSE1L,59 (59),0.132,0.334,0,,0 (0),1,1,0.132,0.334
PDGF,INOH,13,SHC1;HRAS;MAP2K1;GRB2;CDC42;PIK3R1;MAP2K4;NCK1;PTPN11;CRK;STAT5B;MAPK1;MAP2K2,45 (45),0.0682,0.197,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,5 (6),0.433,1,0.134,0.339
double stranded rna induced gene expression,BioCarta,5,EIF2AK2;RELA;DNAJC3;EIF2S1;EIF2S2,15 (15),0.136,0.341,0,,0 (0),1,1,0.136,0.341
Dissolution of Fibrin Clot,Reactome,4,SERPINF2;HRG;PLG;SERPINB8,11 (11),0.137,0.341,0,,0 (1),1,1,0.137,0.341
regulation of eif2,BioCarta,4,EIF2AK2;EIF2S1;EIF2S2;EIF2B5,11 (11),0.137,0.341,0,,0 (0),1,1,0.137,0.341
granzyme a mediated apoptosis pathway,BioCarta,4,APEX1;CASP3;ANP32A;NME1,11 (11),0.137,0.341,0,,0 (0),1,1,0.137,0.341
cxcr4 signaling pathway,BioCarta,4,GNAQ;HRAS;GNB1;PIK3R1,11 (11),0.137,0.341,0,,0 (0),1,1,0.137,0.341
Antigen processing and presentation - Homo sapiens (human),KEGG,19,TAP2;CTSB;IFI30;LGMN;CTSL;CALR;TAPBP;HSPA4;HSPA5;HSPA8;HSP90AA1;CANX;B2M;PSME1;PSME2;PDIA3;CD74;HSP90AB1;PSME3,78 (78),0.137,0.341,0,,0 (0),1,1,0.137,0.341
Assembly of active LPL and LIPC lipase complexes,Reactome,1,LIPC,13 (13),0.934,1,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,3 (6),0.032,1,0.135,0.341
T-Cell Receptor and Co-stimulatory Signaling,Wikipathways,6,CALM1;PRKCA;PDK1;CSNK1A1;PTPN6;PPP3CA,30 (30),0.51,0.878,2,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (4),0.0594,1,0.136,0.345
Caspase Cascade in Apoptosis,PID,17,LMNA;LMNB1;FADD;BAX;CASP6;PARP1;VIM;ARHGDIB;TOP1;CFL2;SLK;SPTAN1;GSN;LMNB2;CASP3;GAS2;BID,57 (57),0.0305,0.102,0,,1 (2),1,1,0.137,0.347
NGF,INOH,7,SHC1;HRAS;MAP2K1;MAP2K2;ARAF;MAPK1;GRB2,21 (21),0.0843,0.234,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (5),0.365,1,0.138,0.349
Glucuronidation,Reactome,7,UGP2;UGT1A3;UGT2B10;UGT2B15;UGT2A3;UGT2A1;UGDH,25 (25),0.178,0.418,5,HMDB0001934;HMDB0000290;HMDB0006543;HMDB0000054;HMDB0014813,28 (31),0.174,1,0.139,0.351
Leukocyte transendothelial migration - Homo sapiens (human),KEGG,30,MYL12A;CTNNA1;RAP1A;RHOA;RAP1B;PTPN11;MAPK14;MYL9;F11R;PIK3R1;ICAM1;ACTB;PXN;ACTG1;PRKCA;AFDN;ROCK1;ACTN4;GNAI2;CLDN3;ACTN1;CTNNA2;CTNNB1;CTNND1;CDC42;ITGB1;ITGB2;VCL;RAC1;GNAI3,114 (114),0.0311,0.103,0,,3 (4),1,1,0.139,0.351
FLT3 signaling in disease,Reactome,8,HRAS;GRB2;MYO18A;TRIP11;PIK3R1;PTPN11;SPTBN1;STAT5B,21 (21),0.0313,0.104,0,,9 (12),1,1,0.14,0.352
downregulated of mta-3 in er-negative breast tumors,BioCarta,8,ALDOA;CTSD;CDH1;TUBA4A;HSPB1;TUBA1C;PDZK1;GAPDH,21 (21),0.0313,0.104,0,,2 (2),1,1,0.14,0.352
CTLA4 inhibitory signaling,Reactome,8,LYN;YES1;PPP2CB;PPP2R1A;PTPN11;PPP2R5D;PPP2R5E;PPP2R5A,21 (21),0.0313,0.104,0,,4 (4),1,1,0.14,0.352
influence of ras and rho proteins on g1 to s transition,BioCarta,8,HRAS;RHOA;MAP2K1;MAP2K2;PIK3R1;RELA;RAC1;MAPK1,28 (28),0.143,0.354,0,,0 (0),1,1,0.143,0.354
UMP biosynthesis,HumanCyc,2,UMPS;CAD,2 (2),0.0356,0.113,1,HMDB0003349#HMDB0000528,19 (20),0.885,1,0.14,0.354
Non-small cell lung cancer,Wikipathways,19,FHIT;HRAS;CASP3;MAP2K2;RXRA;PRKCA;PDK1;EML4;MAP2K1;BAX;PIK3R1;STK4;ARAF;STAT3;STAT5B;MAPK1;EGFR;BID;GRB2,72 (72),0.073,0.209,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,5 (7),0.433,1,0.141,0.354
Fc Epsilon Receptor I Signaling in Mast Cells,SMPDB,13,HRAS;LYN;MAP2K1;GRB2;MAP2K3;PRKCA;PDK1;PIK3R1;MAP2K4;RAC1;MAPK14;MAPK1;MAP2K2,42 (42),0.0412,0.13,1,HMDB0001043,13 (13),0.772,1,0.141,0.355
Post-translational modification: synthesis of GPI-anchored proteins,Reactome,4,DPM3;VNN1;PIGN;DPM1,94 (94),1,1,4,HMDB0000290;HMDB0011669;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,12 (22),0.032,1,0.142,0.357
The alternative pathway of fetal androgen synthesis,Wikipathways,0,,8 (8),1,1,4,HMDB0000067;HMDB0000899;HMDB0000234;HMDB0000077,12 (17),0.032,1,0.142,0.357
Aryl Hydrocarbon Receptor Netpath,Wikipathways,12,NQO1;HRAS;MAP2K1;CYP1A2;GCLC;HPGDS;CDC37;RELA;HSP90AA1;AIP;MAPK1;EGFR,46 (46),0.144,0.357,0,,0 (2),1,1,0.144,0.357
Regulation of Microtubule Cytoskeleton,Wikipathways,12,DIAPH1;TPPP;CDC42;MAPRE1;PRKCA;ROCK1;DPYSL2;CFL2;STAT3;RAC1;GNAQ;PRKACA,46 (46),0.144,0.357,0,,0 (0),1,1,0.144,0.357
ras signaling pathway,BioCarta,6,HRAS;RHOA;CDC42;RALA;PIK3R1;RAC1,20 (20),0.16,0.392,1,HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,2 (2),0.203,1,0.144,0.361
Disorders of Folate Metabolism and Transport,Wikipathways,2,MTHFD1;MTHFS,2 (2),0.0356,0.113,1,HMDB0000123,23 (26),0.927,1,0.146,0.365
triacylglycerol degradation,HumanCyc,4,ABHD12;LIPC;ABHD6;MGLL,15 (15),0.31,0.634,6,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000944;HMDB0003073;HMDB0001388;HMDB0001043;HMDB0002183,31 (54),0.107,1,0.146,0.366
SARS-CoV-2 mitochondrial interactions,Wikipathways,9,DDX58;BCS1L;CTSL;TOMM70;MAVS;ACAD9;NLRX1;NDUFAF1;ECSIT,25 (26),0.0333,0.11,0,,3 (7),1,1,0.147,0.367
tpo signaling pathway,BioCarta,9,SHC1;HRAS;MAP2K1;GRB2;PRKCA;PIK3R1;CSNK2A1;STAT3;STAT5B,25 (25),0.0333,0.11,0,,3 (3),1,1,0.147,0.367
Composition of Lipid Particles,Wikipathways,1,LCAT,4 (4),0.567,0.927,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,4 (10),0.0594,1,0.148,0.369
MET promotes cell motility,Reactome,6,GRB2;ITGB1;RAP1A;RAP1B;CRK;CRKL,14 (14),0.0338,0.111,0,,4 (4),1,1,0.148,0.369
Advanced glycosylation endproduct receptor signaling,Reactome,6,DDOST;PRKCSH;LGALS3;MAPK1;CAPZA1;CAPZA2,14 (14),0.0338,0.111,0,,1 (3),1,1,0.148,0.369
S1P4 pathway,PID,6,RHOA;CDC42;GNA13;GNAI2;GNAI3;MAPK1,14 (14),0.0338,0.111,0,,3 (3),1,1,0.148,0.369
fibrinolysis pathway,BioCarta,6,F2;FGB;FGA;UBA1;FGG;PLG,14 (14),0.0338,0.111,0,,1 (1),1,1,0.148,0.369
p73 transcription factor network,PID,19,BUB3;ADA;PIN1;TP53I3;BAX;RACK1;YAP1;FLOT2;NDUFS2;SERPINA1;FASN;PFDN5;HAGH;MAPK14;ITCH;PML;RELA;UBE4B;PRKACB,79 (79),0.15,0.371,0,,0 (0),1,1,0.15,0.371
GABA receptor Signaling,Wikipathways,7,AP2A1;AP2A2;AP2B1;GPHN;AP2M1;AP2S1;ALDH9A1,24 (24),0.151,0.373,0,,0 (0),1,1,0.151,0.373
Synthesis of PC,Reactome,9,PEMT;CHKB;CHPT1;PCYT1A;CSNK2A1;CSNK2A2;CSNK2B;CEPT1;STARD10,29 (29),0.0806,0.226,3,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,22 (28),0.425,1,0.15,0.374
fc epsilon receptor i signaling in mast cells,BioCarta,10,SHC1;HRAS;LYN;MAP2K1;GRB2;PAK2;PIK3R1;MAP2K4;MAPK1;MAP2K2,29 (29),0.0343,0.113,0,,1 (1),1,1,0.15,0.374
Longevity regulating pathway - multiple species - Homo sapiens (human),KEGG,18,HRAS;CLPB;PRKAG1;SOD1;MTOR;ATG5;AKT1S1;HSPA8;SOD2;IGF1;CAT;HDAC2;PRKAA1;PIK3R1;PRKAB1;PRKAA2;PRKACA;PRKACB,62 (62),0.0344,0.113,0,,2 (2),1,1,0.15,0.374
fas signaling pathway (cd95),BioCarta,5,FADD;CASP3;FAF1;MAP2K4;PAK2,20 (20),0.321,0.647,1,HMDB0004949,1 (1),0.107,1,0.151,0.374
Sealing of the nuclear envelope (NE) by ESCRT-III,Reactome,11,CHMP4B;CHMP6;CHMP3;IST1;TUBA1B;CHMP2A;TUBA4A;TUBB4B;TUBB2B;TUBA1C;VPS4A,33 (33),0.0347,0.113,0,,7 (8),1,1,0.151,0.374
EPO signaling pathway,PID,11,SHC1;HRAS;LYN;GRB2;PIK3R1;PTPN6;RAP1A;PTPN11;CRKL;MAPK14;STAT5B,33 (33),0.0347,0.113,0,,3 (3),1,1,0.151,0.374
Galactose metabolism,EHMN,12,GLB1;COPA;COPB1;AKR1B1;GAA;COPG2;SLC2A2;ARCN1;GANAB;PFKL;SLC2A9;COPE,44 (44),0.111,0.289,6,HMDB0006790;HMDB0035312;HMDB0060468;HMDB0000189;HMDB0003213;HMDB0003553,43 (47),0.312,1,0.151,0.374
Nephrin/Neph1 signaling in the kidney podocyte,PID,9,WASL;GRB2;MAPK9;TJP1;CD2AP;PIK3R1;MAP2K4;NCK1;RAC1,29 (29),0.0806,0.226,1,HMDB0000067,5 (5),0.433,1,0.152,0.374
dTMP <i>de novo</i> biosynthesis (mitochondrial),HumanCyc,3,SHMT2;SHMT1;DHFR,5 (5),0.0496,0.15,1,HMDB0000123,11 (11),0.714,1,0.154,0.374
Taurine and Hypotaurine Metabolism,SMPDB,3,CSAD;ADO;CDO1,5 (5),0.0496,0.15,1,HMDB0011182,11 (12),0.714,1,0.154,0.374
purine deoxyribonucleosides degradation,HumanCyc,2,ADA;PNP,2 (2),0.0356,0.113,0,,9 (10),1,1,0.154,0.374
2-amino-3-carboxymuconate semialdehyde degradation to glutaryl-CoA,HumanCyc,2,ACMSD;DHTKD1,2 (2),0.0356,0.113,0,,12 (12),1,1,0.154,0.374
cysteine biosynthesis/homocysteine degradation (trans-sulfuration),HumanCyc,2,CBS;CTH,2 (2),0.0356,0.113,0,,7 (7),1,1,0.154,0.374
glycerol-3-phosphate shuttle,HumanCyc,2,GPD1;GPD2,2 (2),0.0356,0.113,0,,8 (9),1,1,0.154,0.374
ascorbate recycling (cytosolic),HumanCyc,2,GLRX;GSTO1,2 (2),0.0356,0.113,0,,9 (10),1,1,0.154,0.374
Fructose biosynthesis,Reactome,2,SORD;AKR1B1,2 (2),0.0356,0.113,0,,8 (10),1,1,0.154,0.374
guanine and guanosine salvage,HumanCyc,2,HPRT1;PNP,2 (2),0.0356,0.113,0,,7 (7),1,1,0.154,0.374
&beta;-alanine degradation,HumanCyc,2,ALDH6A1;ABAT,2 (2),0.0356,0.113,0,,11 (11),1,1,0.154,0.374
Insulin effects increased synthesis of Xylulose-5-Phosphate,Reactome,2,TALDO1;TKT,2 (2),0.0356,0.113,0,,7 (8),1,1,0.154,0.374
hydrogen sulfide biosynthesis (trans-sulfuration),HumanCyc,2,CBS;CTH,2 (2),0.0356,0.113,0,,6 (6),1,1,0.154,0.374
glutathione redox reactions II,HumanCyc,2,GSR;GLRX,2 (2),0.0356,0.113,0,,5 (5),1,1,0.154,0.374
L-cysteine degradation II,HumanCyc,2,GOT1;MPST,2 (2),0.0356,0.113,0,,8 (8),1,1,0.154,0.374
Pyrophosphate hydrolysis,Reactome,2,PPA1;PPA2,2 (2),0.0356,0.113,0,,3 (3),1,1,0.154,0.374
4-aminobutyrate degradation,HumanCyc,2,ABAT;ALDH5A1,2 (2),0.0356,0.113,0,,9 (9),1,1,0.154,0.374
L-cysteine degradation I,HumanCyc,2,CDO1;GOT1,2 (2),0.0356,0.113,0,,9 (10),1,1,0.154,0.374
NAD phosphorylation and dephosphorylation,HumanCyc,2,NNT;NADK,2 (2),0.0356,0.113,0,,7 (7),1,1,0.154,0.374
MAPK1 (ERK2) activation,Reactome,2,MAPK1;MAP2K2,2 (2),0.0356,0.113,0,,2 (2),1,1,0.154,0.374
Degradation of GABA,Reactome,2,ABAT;ALDH5A1,2 (2),0.0356,0.113,0,,8 (10),1,1,0.154,0.374
NEP/NS2 Interacts with the Cellular Export Machinery,Reactome,2,XPO1;RAN,2 (2),0.0356,0.113,0,,3 (3),1,1,0.154,0.374
Export of Viral Ribonucleoproteins from Nucleus,Reactome,2,XPO1;RAN,2 (2),0.0356,0.113,0,,3 (3),1,1,0.154,0.374
Synthesis of dolichyl-phosphate-glucose,Reactome,2,ALG5;NUDT14,2 (2),0.0356,0.113,0,,7 (7),1,1,0.154,0.374
Stimulation of the cell death response by PAK-2p34,Reactome,2,CASP3;PAK2,2 (2),0.0356,0.113,0,,2 (2),1,1,0.154,0.374
formaldehyde oxidation,HumanCyc,2,ADH5;ESD,2 (2),0.0356,0.113,0,,11 (11),1,1,0.154,0.374
Alanine metabolism,Reactome,2,GPT2;GPT,2 (2),0.0356,0.113,0,,4 (4),1,1,0.154,0.374
anthrax toxin mechanism of action,BioCarta,2,MAP2K1;MAP2K2,2 (2),0.0356,0.113,0,,2 (2),1,1,0.154,0.374
alanine biosynthesis/degradation,HumanCyc,2,GPT2;GPT,2 (2),0.0356,0.113,0,,4 (4),1,1,0.154,0.374
Tirofiban Action Pathway,SMPDB,2,ITGA2B;ITGB3,2 (2),0.0356,0.113,0,,1 (1),1,1,0.154,0.374
Prednisolone Action Pathway,SMPDB,2,HSP90AA1;NR3C1,2 (2),0.0356,0.113,0,,1 (1),1,1,0.154,0.374
Prednisolone Metabolism Pathway,SMPDB,2,HSP90AA1;NR3C1,2 (2),0.0356,0.113,0,,1 (1),1,1,0.154,0.374
Fatty Acid Biosynthesis,SMPDB,2,FASN;ACACA,2 (2),0.0356,0.113,0,,31 (33),1,1,0.154,0.374
Hedgehog ligand biogenesis,Reactome,7,SEL1L;DERL2;P4HB;OS9;ERLEC1;VCP;SYVN1,20 (20),0.0666,0.193,1,HMDB0000067,7 (7),0.549,1,0.158,0.381
Senescence and Autophagy in Cancer,Wikipathways,22,ATG5;VTN;IGF1;MAPK14;SH3GLB1;FKBP8;FN1;ATG3;MTOR;RSL1D1;SQSTM1;HRAS;GABARAP;LAMP1;CREG1;MAPK1;MAP2K1;MAP2K3;AKT1S1;GSN;PCNA;COL1A1,106 (106),0.346,0.676,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,1 (1),0.107,1,0.16,0.386
spermine and spermidine degradation I,HumanCyc,2,SAT2;PAOX,5 (5),0.24,0.518,3,HMDB0001276;HMDB0001186;HMDB0062210,13 (13),0.156,1,0.16,0.387
Thiamine metabolism - Homo sapiens (human),KEGG,6,TPK1;AK2;AK4;ACP1;NTPCR;NFS1,15 (16),0.0475,0.146,1,HMDB0000123,14 (31),0.797,1,0.162,0.391
Syndecan interactions,Reactome,6,PRKCA;ITGB1;ITGB3;ACTN1;VTN;CASK,20 (20),0.16,0.392,0,,0 (3),1,1,0.16,0.392
lissencephaly gene (lis1) in neuronal migration and development,BioCarta,6,DCTN1;DCTN2;CSNK2A1;PAFAH1B1;DCTN3;NDEL1,20 (20),0.16,0.392,0,,0 (0),1,1,0.16,0.392
Regulation of insulin secretion,Reactome,19,GNG12;PRKAR1A;ACSL4;PRKAR2A;SLC2A2;PRKCA;IQGAP1;RAP1A;GNA11;MARCKS;PLCB3;GNB1;GNAI2;GNAQ;GNAS;GNB2;ITPR2;PRKACA;PRKACB,67 (67),0.0381,0.121,0,,22 (26),1,1,0.163,0.392
folate polyglutamylation,HumanCyc,3,SHMT2;MTHFD1;SHMT1,5 (5),0.0496,0.15,1,HMDB0000123,13 (13),0.772,1,0.163,0.393
eIF5A regulation in response to inhibition of the nuclear export system,Wikipathways,2,EIF5A;XPO1,4 (4),0.164,0.395,0,,0 (0),1,1,0.164,0.395
HCMV Late Events,Reactome,2,HNRNPK;VPS4A,4 (4),0.164,0.395,0,,0 (1),1,1,0.164,0.395
Activation_ myristolyation of BID and translocation to mitochondria,Reactome,2,NMT1;BID,4 (4),0.164,0.395,0,,0 (0),1,1,0.164,0.395
ahr signal transduction pathway,BioCarta,2,HSP90AA1;AIP,4 (4),0.164,0.395,0,,0 (1),1,1,0.164,0.395
antisense pathway,BioCarta,2,SFPQ;MATR3,4 (4),0.164,0.395,0,,0 (0),1,1,0.164,0.395
Fatty acid transporters,Wikipathways,7,ACSL1;ACSL4;FABP4;DBI;ACSL5;FABP1;FABP7,18 (18),0.0386,0.122,0,,1 (2),1,1,0.164,0.395
Signaling by FLT3 fusion proteins,Reactome,7,HRAS;GRB2;MYO18A;TRIP11;PIK3R1;SPTBN1;STAT5B,18 (18),0.0386,0.122,0,,9 (9),1,1,0.164,0.395
Signaling by cytosolic FGFR1 fusion mutants,Reactome,7,GRB2;MYO18A;CPSF6;PIK3R1;STAT3;LRRFIP1;STAT5B,18 (18),0.0386,0.122,0,,3 (8),1,1,0.164,0.395
Oncostatin_M,NetPath,10,SHC1;HRAS;PXN;MTOR;PIK3R1;RELA;STAT3;STAT5B;MAPK1;GRB2,38 (38),0.165,0.398,0,,0 (0),1,1,0.165,0.398
Eicosanoid metabolism via lipooxygenases (LOX),Wikipathways,8,PTGR1;DPEP1;PTGR2;LTA4H;ACOX1;ACOX2;ACOX3;EHHADH,29 (29),0.166,0.399,0,,0 (0),1,1,0.166,0.399
D-Arginine and D-ornithine metabolism - Homo sapiens (human),KEGG,1,DAO,1 (1),0.189,0.429,2,HMDB0004225;HMDB0006272,8 (11),0.209,1,0.167,0.401
Vitamin B2 (riboflavin) metabolism,EHMN,3,ENPP3;ACP6;ENPP1,5 (5),0.0496,0.15,1,HMDB0000244,14 (14),0.797,1,0.167,0.401
Abacavir metabolism,Reactome,3,PCK1;NT5C2;GUK1,5 (5),0.0496,0.15,1,HMDB0000195,14 (18),0.797,1,0.167,0.401
Oligodendrocyte specification and differentiation_ leading to myelin components for CNS,Wikipathways,0,,0 (0),1,1,4,HMDB0000067;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,8 (11),0.0064,0.402,0.0064,0.402
Separation of Sister Chromatids,Reactome,33,MAPRE1;PPP2CB;PPP2R1A;RANBP2;RANGAP1;PPP2R5A;PPP2R5D;PPP2R5E;STAG2;NDEL1;SMC3;PDS5B;DYNC1H1;SMC1A;PAFAH1B1;DYNLL2;NUP98;CKAP5;NUP133;DYNC1LI1;PDS5A;RPS27;XPO1;ZW10;BUB3;NUDC;PPP1CC;RCC2;NUP160;DYNC1I2;DYNC1LI2;SEC13;RAD21,130 (130),0.0399,0.126,0,,2 (4),1,1,0.168,0.404
LPA receptor mediated events,PID,18,HRAS;RHOA;EGFR;PXN;PLCB3;SLC9A3R2;GNA11;GNA13;RELA;GNAI2;GNAI3;CRK;RAC1;GNAQ;CASP3;PIK3R1;GNB1;LYN,63 (63),0.0399,0.126,0,,5 (5),1,1,0.169,0.404
NAD metabolism_ sirtuins and aging,Wikipathways,5,SIRT3;HIF1A;TFAM;PARP1;NAMPT,11 (11),0.0402,0.127,0,,3 (4),1,1,0.169,0.405
Carnitine metabolism,Reactome,5,CPT2;CHKB;PRKAA2;SLC25A20;CPT1A,11 (11),0.0402,0.127,0,,9 (13),1,1,0.169,0.405
Synthesis of UDP-N-acetyl-glucosamine,Reactome,4,GFPT1;UAP1;PGM3;GNPNAT1,8 (8),0.0464,0.144,1,HMDB0000290,18 (21),0.871,1,0.17,0.407
Choline metabolism in cancer - Homo sapiens (human),KEGG,19,CHKB;HRAS;LYPLA1;EGFR;GRB2;MAPK9;PCYT1A;MTOR;CHPT1;PIK3R1;MAP2K2;HIF1A;SLC22A1;MAP2K1;RAC1;RHEB;MAPK1;PRKCA;PLPP3,98 (98),0.489,0.863,3,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,10 (11),0.0829,1,0.17,0.407
IL2 signaling events mediated by PI3K,PID,11,SHC1;CALM1;GRB2;MTOR;RELA;PIK3R1;RPS6;PTPN11;RAC1;HSP90AA1;EIF3A,37 (37),0.0747,0.213,1,HMDB0004949,7 (7),0.549,1,0.172,0.411
phospholipases,HumanCyc,3,PNPLA8;PLD4;PLCB3,41 (41),0.99,1,7,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000944;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0003073;HMDB0001388;HMDB0001043;HMDB0002183,31 (55),0.0416,1,0.173,0.412
cystic fibrosis transmembrane conductance regulator (cftr) and beta 2 adrenergic receptor (b2ar) pathway,BioCarta,8,F2;PRKAR1A;PRKAR2A;AGT;SLC9A3R1;GNAS;GNB1;PRKACB,22 (22),0.0413,0.13,0,,5 (7),1,1,0.173,0.412
Post-chaperonin tubulin folding pathway,Reactome,8,TBCB;TUBA1C;TUBA1B;TUBA4A;TUBB4B;TUBB2B;TBCA;TBCD,22 (22),0.0413,0.13,0,,2 (2),1,1,0.173,0.412
Insulin Signalling,SMPDB,6,SHC1;HRAS;MAP2K1;GRB2;MAPK1;MAP2K2,17 (17),0.084,0.234,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,6 (7),0.494,1,0.174,0.414
IL-6 signaling pathway,Wikipathways,11,SHC1;MAP2K1;MAP2K2;RAC1;PIK3R1;MAP2K4;PTPN11;STAT3;AGT;MAPK1;GRB2,43 (43),0.174,0.417,0,,0 (0),1,1,0.174,0.417
1q21.1 copy number variation syndrome,Wikipathways,12,F11R;CTNNB1;ACP6;TJP2;TJP1;AFDN;PRKAG1;PRKAA1;PRKAA2;PRKAB1;FMO5;TJP3,38 (38),0.0421,0.132,0,,7 (10),1,1,0.176,0.418
CXCR3-mediated signaling events,PID,12,HRAS;MAP2K1;MAP2K2;MAP2K3;MTOR;PF4;PIK3R1;GNAI2;GNAI3;MAPK14;MAPK1;GNB1,38 (38),0.0421,0.132,0,,3 (3),1,1,0.176,0.418
mapkinase signaling pathway,BioCarta,14,HRAS;MAP2K1;PAK2;MAP2K3;MAPK9;MAP4K5;MAP2K4;ARAF;RPS6KA1;GCK;RAC1;MAPK14;MAPK1;MAP2K2,57 (57),0.174,0.418,0,,0 (0),1,1,0.174,0.418
IL9,NetPath,4,STAT5B;STAT6;MAPK1;STAT3,12 (12),0.176,0.418,0,,0 (0),1,1,0.176,0.418
Transport of Mature mRNA Derived from an Intronless Transcript,Reactome,4,EIF4E;CPSF1;NCBP1;ALYREF,12 (12),0.176,0.418,0,,0 (1),1,1,0.176,0.418
RalA downstream regulated genes,Wikipathways,4,HRAS;RALA;CDC42;RAC1,12 (12),0.176,0.418,0,,0 (0),1,1,0.176,0.418
C-MYC pathway,PID,7,PAK2;RUVBL2;PIN1;PPP2R5A;ACTL6A;PML;RUVBL1,25 (25),0.178,0.418,0,,0 (0),1,1,0.178,0.418
Recruitment of NuMA to mitotic centrosomes,Reactome,19,CKAP5;MAPRE1;DCTN2;YWHAE;YWHAG;TUBA4A;PPP2R1A;TUBB4B;ACTR1A;HSP90AA1;DYNC1H1;DYNC1I2;PRKACA;PAFAH1B1;CSNK1D;DCTN3;SSNA1;DCTN1;CEP192,81 (81),0.178,0.418,0,,0 (1),1,1,0.178,0.418
cell to cell adhesion signaling,BioCarta,3,CSK;PTPN11;PXN,8 (8),0.179,0.418,0,,0 (0),1,1,0.179,0.418
stat3 signaling pathway,BioCarta,3,MAPK1;MTOR;STAT3,8 (8),0.179,0.418,0,,0 (0),1,1,0.179,0.418
west nile virus,BioCarta,3,EEF1A1;CASP3;CASP6,8 (8),0.179,0.418,0,,0 (0),1,1,0.179,0.418
Biosynthesis of electrophilic ?-3 PUFA oxo-derivatives,Reactome,0,,2 (2),1,1,4,HMDB0006528;HMDB0010213;HMDB0060050;HMDB0002183,13 (28),0.0424,1,0.176,0.419
Acyl chain remodeling of DAG and TAG,Reactome,2,DGAT1;MGLL,8 (8),0.463,0.843,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,5 (10),0.0922,1,0.177,0.421
Autophagy - other - Homo sapiens (human),KEGG,7,PIK3R4;ATG5;ATG3;GABARAP;MTOR;PPP2CB;WIPI2,32 (32),0.4,0.763,1,HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,1 (3),0.107,1,0.178,0.423
Downstream signal transduction,Reactome,10,HRAS;GRB2;PIK3R1;NCK1;PTPN11;STAT3;CRKL;STAT5B;STAT6;CRK,30 (30),0.0431,0.135,0,,5 (6),1,1,0.178,0.424
Hypertrophic cardiomyopathy - Homo sapiens (human),KEGG,24,TPM1;TPM3;TPM4;DES;ACTB;IGF1;MYL3;LMNA;AGT;PRKAA1;PRKAA2;PRKAB1;PRKAG1;LAMA2;ACTC1;ACTG1;ITGA1;ITGA2B;ITGA5;ITGA9;ITGB1;TTN;ITGB3;ATP2A2,90 (90),0.0433,0.135,0,,3 (3),1,1,0.179,0.425
Growth hormone synthesis_ secretion and action - Homo sapiens (human),KEGG,28,MAP2K4;IGF1;MAPK14;IGFALS;MAPK1;MTOR;STAT3;PIK3R1;PRKACA;PRKACB;SHC1;HRAS;GRB2;PRKCA;GNA11;PLCB3;GNAI3;GNAQ;GNAS;MAPK9;MAP2K1;MAP2K2;MAP2K3;GNAI2;CRK;CRKL;STAT5B;ITPR2,119 (119),0.119,0.307,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (4),0.365,1,0.18,0.426
Thromboxane signalling through TP receptor,Reactome,7,GNG12;AAMP;GNA11;GNA13;GNAQ;GNB1;GNB2,24 (24),0.151,0.373,1,HMDB0003208,3 (3),0.289,1,0.18,0.427
Cytosolic sulfonation of small molecules,Reactome,8,SULT1A1;SULT1C2;PAPSS2;BPNT1;SLC26A1;SULT1B1;ABHD14B;SULT1E1,25 (25),0.0829,0.232,4,HMDB0000145;HMDB0000067;HMDB0000653;HMDB0000077,35 (47),0.527,1,0.181,0.427
Hypophosphatasia,SMPDB,3,PNPO;AOX1;PDXK,5 (5),0.0496,0.15,1,HMDB0033934,19 (20),0.885,1,0.181,0.428
Vitamin B6 Metabolism,SMPDB,3,PNPO;AOX1;PDXK,5 (5),0.0496,0.15,1,HMDB0033934,19 (20),0.885,1,0.181,0.428
Riboflavin Metabolism,SMPDB,3,ACP1;FLAD1;ENPP1,5 (5),0.0496,0.15,1,HMDB0000244,19 (19),0.885,1,0.181,0.428
Epstein-Barr virus infection - Homo sapiens (human),KEGG,48,PDIA3;PSMD6;VIM;MAP2K4;MAPK14;CASP3;SNW1;BAX;DDX58;ISG15;ADRM1;CALR;PIK3R1;B2M;USP7;PSMC1;PSMC2;PSMC3;MAPK9;PSMC4;PSMC5;PSMC6;PSMD1;PSMD2;MAVS;PSMD4;PSMD3;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;FADD;ICAM1;LYN;PSMD14;MAP2K3;EIF2AK2;TAP2;TAPBP;RELA;ENTPD8;STAT2;STAT3;RAC1;HDAC2;BID;NEDD4,201 (202),0.044,0.137,0,,3 (3),1,1,0.181,0.428
Ghrelin,NetPath,10,GRB2;PRKCA;PIK3R1;RELA;GNAI2;AP2M1;GNAQ;MAPK1;PRKAA2;ACACA,39 (39),0.187,0.429,0,,0 (0),1,1,0.187,0.429
hiv-1 nef: negative effector of fas and tnf,BioCarta,13,LMNA;LMNB1;FADD;PAK2;CASP6;ARHGDIB;PARP1;RELA;SPTAN1;GSN;LMNB2;CASP3;BID,53 (53),0.187,0.429,0,,0 (0),1,1,0.187,0.429
DNA IR-damage and cellular response via ATR,Wikipathways,1,ATM,1 (1),0.189,0.429,0,,0 (0),1,1,0.189,0.429
Inhibition of PKR,Reactome,1,EIF2AK2,1 (1),0.189,0.429,0,,0 (1),1,1,0.189,0.429
Inhibition of membrane repair,Reactome,1,HGS,1 (1),0.189,0.429,0,,0 (0),1,1,0.189,0.429
Blockage of phagosome acidification,Reactome,1,ATP6V1H,1 (1),0.189,0.429,0,,0 (0),1,1,0.189,0.429
Panitumumab Action Pathway,SMPDB,1,EGFR,1 (1),0.189,0.429,0,,0 (0),1,1,0.189,0.429
Cetuximab Action Pathway,SMPDB,1,EGFR,1 (1),0.189,0.429,0,,0 (0),1,1,0.189,0.429
Trastuzumab Action Pathway,SMPDB,1,EGFR,1 (1),0.189,0.429,0,,0 (0),1,1,0.189,0.429
Gefitinib Action Pathway,SMPDB,1,EGFR,1 (1),0.189,0.429,0,,0 (1),1,1,0.189,0.429
Ethanol effects on histone modifications,Wikipathways,10,CYP2E1;ELP3;MAT1A;DHFR;ALDH1A1;HDAC2;ALDH1A3;HDAC6;ACSS2;AHCY,31 (31),0.0532,0.16,1,HMDB0000123,16 (21),0.838,1,0.183,0.432
Eicosanoid metabolism via cyclooxygenases (COX),Wikipathways,8,PTGR1;AKR1B1;PTGR2;PTGS1;ACOX1;ACOX2;ACOX3;EHHADH,30 (30),0.191,0.433,0,,0 (1),1,1,0.191,0.433
Arrhythmogenic right ventricular cardiomyopathy - Homo sapiens (human),KEGG,21,LMNA;DSC2;LAMA2;DSG2;PKP2;ACTG1;DSP;ITGB1;DES;ITGA1;JUP;CDH2;ITGB3;CTNNA1;CTNNA2;ITGA9;ATP2A2;CTNNB1;ACTB;ITGA2B;ITGA5,77 (77),0.0451,0.141,0,,2 (2),1,1,0.185,0.436
Recruitment of mitotic centrosome proteins and complexes,Reactome,19,CKAP5;MAPRE1;DCTN2;YWHAE;YWHAG;CSNK1D;PPP2R1A;TUBB4B;PAFAH1B1;DYNC1H1;TUBA4A;DYNC1I2;ACTR1A;HSP90AA1;DCTN1;DCTN3;SSNA1;PRKACA;CEP192,82 (82),0.194,0.438,0,,0 (0),1,1,0.194,0.438
Synaptic Vesicle Pathway,Wikipathways,15,AP2A1;AP2A2;AP2B1;DNM3;NAPA;NSF;DNM1L;SLC25A4;PARK7;AP2M1;AP2S1;DNM2;CLTA;VAMP2;CLTC,51 (51),0.0455,0.142,0,,6 (7),1,1,0.186,0.439
Structural Pathway of Interleukin 1 (IL-1),Wikipathways,11,MAPK9;MAP2K1;MAP2K2;MAP2K3;TOLLIP;MAP2K4;RELA;SAFB;MAPK14;EIF4E;MAPK1,44 (44),0.195,0.44,0,,0 (0),1,1,0.195,0.44
Semaphorin interactions,Reactome,18,CFL1;RHOA;ARHGEF12;PAK2;MYH14;ITGB1;ROCK1;DPYSL2;ITGA1;MYH9;MYH11;TLN1;RAC1;HSP90AA1;HSP90AB1;MYL6;MYL9;FARP2,64 (64),0.0461,0.144,0,,6 (6),1,1,0.188,0.441
Cysteine formation from homocysteine,Reactome,2,CBS;CTH,3 (3),0.0934,0.249,1,HMDB0033934,6 (8),0.494,1,0.188,0.441
Glycine Metabolism,Wikipathways,2,SHMT2;SHMT1,3 (3),0.0934,0.249,1,HMDB0000123,6 (10),0.494,1,0.188,0.441
sphingosine and sphingosine-1-phosphate metabolism,HumanCyc,3,SPHK2;ASAH1;PTGR1,9 (9),0.232,0.51,6,HMDB0004949;HMDB0000944;HMDB0003073;HMDB0001388;HMDB0001043;HMDB0002183,37 (59),0.199,1,0.189,0.441
Axonal growth inhibition (RHOA activation),Reactome,4,RHOA;ARHGDIA;RTN4;OMG,8 (8),0.0464,0.144,0,,2 (3),1,1,0.189,0.441
Thiamine metabolic pathways,Wikipathways,4,PDHA1;TPK1;TKT;OGDH,8 (8),0.0464,0.144,0,,13 (21),1,1,0.189,0.441
GABA shunt,HumanCyc,4,GLUL;GLUD1;ALDH5A1;ABAT,8 (8),0.0464,0.144,0,,13 (13),1,1,0.189,0.441
HuR (ELAVL1) binds and stabilizes mRNA,Reactome,4,ELAVL1;PRKCA;XPO1;ANP32A,8 (8),0.0464,0.144,0,,2 (3),1,1,0.189,0.441
Mitochondrial CII Assembly,Wikipathways,4,SDHD;SDHA;SDHB;SDHC,8 (8),0.0464,0.144,0,,1 (1),1,1,0.189,0.441
Vitamin C (ascorbate) metabolism,Reactome,4,CYB5A;SLC23A1;GSTO1;CYB5R3,8 (8),0.0464,0.144,0,,13 (18),1,1,0.189,0.441
Rapid glucocorticoid signaling,PID,4,MAPK14;MAPK9;GNAS;GNB1,8 (8),0.0464,0.144,0,,3 (3),1,1,0.189,0.441
sumoylation as a mechanism to modulate ctbp-dependent gene responses,BioCarta,4,UBE3A;CDH1;UBA1;CTBP1,8 (8),0.0464,0.144,0,,1 (1),1,1,0.189,0.441
GLI3 is processed to GLI3R by the proteasome,Reactome,6,SKP1;CUL1;CSNK1A1;RBX1;PRKACA;PRKACB,15 (15),0.0475,0.146,0,,2 (2),1,1,0.192,0.448
Degradation of GLI2 by the proteasome,Reactome,6,SKP1;CUL1;CSNK1A1;RBX1;PRKACA;PRKACB,15 (15),0.0475,0.146,0,,2 (2),1,1,0.192,0.448
Sumoylation by RanBP2 regulates transcriptional repression,PID,6,UBE2I;RAN;RANBP2;RANGAP1;NUP210;XPO1,15 (15),0.0475,0.146,0,,1 (1),1,1,0.192,0.448
gamma-aminobutyric acid receptor life cycle pathway,BioCarta,6,GPHN;GABARAP;NSF;UBA1;UBE3A;UBQLN1,15 (15),0.0475,0.146,0,,1 (1),1,1,0.192,0.448
Overview of leukocyte-intrinsic Hippo pathway functions,Wikipathways,9,MOB1A;RHOA;YAP1;RAB13;RAP1A;RAC1;MAPK14;FERMT3;YWHAQ,35 (35),0.202,0.454,0,,0 (0),1,1,0.202,0.454
Synthesis of PG,Reactome,4,CDS2;PLD4;PTPMT1;NDUFS3,9 (9),0.0714,0.205,1,HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,10 (13),0.679,1,0.195,0.454
TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer,Wikipathways,3,MAPK1;EGFR;STAT3,5 (5),0.0496,0.15,0,,4 (4),1,1,0.199,0.459
Disinhibition of SNARE formation,Reactome,3,STX4;PRKCA;STXBP3,5 (5),0.0496,0.15,0,,4 (5),1,1,0.199,0.459
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS),Reactome,3,F12;KLKB1;F9,5 (5),0.0496,0.15,0,,1 (1),1,1,0.199,0.459
Diseases of hemostasis,Reactome,3,F12;KLKB1;F9,5 (5),0.0496,0.15,0,,1 (1),1,1,0.199,0.459
PERK regulates gene expression,Reactome,3,HSPA5;EIF2S2;EIF2S1,5 (5),0.0496,0.15,0,,2 (3),1,1,0.199,0.459
retinoate biosynthesis II,HumanCyc,3,XDH;RBP1;RBP4,5 (5),0.0496,0.15,0,,5 (6),1,1,0.199,0.459
Degradation of Superoxides,SMPDB,3,SOD2;CAT;SOD1,5 (5),0.0496,0.15,0,,10 (10),1,1,0.199,0.459
Galactose catabolism,Reactome,3,GALK1;GALT;PGM2,5 (5),0.0496,0.15,0,,9 (10),1,1,0.199,0.459
Adefovir Dipivoxil Metabolism Pathway,SMPDB,3,AK2;NME1;NME2,5 (5),0.0496,0.15,0,,4 (5),1,1,0.199,0.459
Tenofovir Metabolism Pathway,SMPDB,3,AK2;NME1;NME2,5 (5),0.0496,0.15,0,,3 (4),1,1,0.199,0.459
Biosynthesis of DHA-derived SPMs,Reactome,6,CYP2E1;GSTM4;EPHX2;CYP1A2;LTA4H;GPX4,17 (17),0.084,0.234,2,HMDB0000123;HMDB0002183,18 (75),0.591,1,0.199,0.459
glutathione redox reactions I,HumanCyc,3,GSR;GPX1;GPX4,9 (9),0.232,0.51,9,HMDB0001170;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000032;HMDB0001188;HMDB0004949;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0006482;HMDB0006216;HMDB0006221,62 (100),0.215,1,0.199,0.46
RHO GTPases Activate NADPH Oxidases,Reactome,8,PIK3R4;S100A8;S100A9;PRKCA;PIN1;RAC1;MAPK14;MAPK1,24 (24),0.0671,0.194,1,HMDB0001043,12 (14),0.745,1,0.2,0.46
superpathway of melatonin degradation,HumanCyc,5,MAOA;SULT1A1;UGT2B10;CYP1A2;POR,13 (13),0.0806,0.226,2,HMDB0004259;HMDB0004095,19 (24),0.621,1,0.2,0.461
Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism,Wikipathways,2,HSD11B1;H6PD,14 (14),0.772,1,5,HMDB0000067;HMDB0000015;HMDB0000234;HMDB0001547;HMDB0000077,21 (29),0.0662,1,0.203,0.466
methionine salvage,HumanCyc,2,BHMT;BHMT2,3 (3),0.0934,0.249,1,HMDB0000043,7 (8),0.549,1,0.203,0.466
Biotin Metabolism,SMPDB,2,SPCS1;BTD,3 (3),0.0934,0.249,1,HMDB0003134,7 (7),0.549,1,0.203,0.466
Metabolism of vitamin K,Reactome,2,VKORC1;VKORC1L1,3 (3),0.0934,0.249,1,HMDB0030020,7 (12),0.549,1,0.203,0.466
phosphatidylcholine biosynthesis pathway,BioCarta,2,PCYT1A;CEPT1,3 (3),0.0934,0.249,1,HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,7 (8),0.549,1,0.203,0.466
Multiple carboxylase deficiency_ neonatal or early onset form,SMPDB,2,SPCS1;BTD,3 (3),0.0934,0.249,1,HMDB0003134,7 (7),0.549,1,0.203,0.466
Homocysteine Degradation,SMPDB,2,CBS;CTH,3 (3),0.0934,0.249,1,HMDB0033934,7 (8),0.549,1,0.203,0.466
Gamma-cystathionase deficiency (CTH),SMPDB,2,CBS;CTH,3 (3),0.0934,0.249,1,HMDB0033934,7 (8),0.549,1,0.203,0.466
Homocystinuria_ cystathionine beta-synthase deficiency,SMPDB,2,CBS;CTH,3 (3),0.0934,0.249,1,HMDB0033934,7 (8),0.549,1,0.203,0.466
Biotinidase Deficiency,SMPDB,2,SPCS1;BTD,3 (3),0.0934,0.249,1,HMDB0003134,7 (7),0.549,1,0.203,0.466
Nucleotide metabolism,Wikipathways,7,RRM1;SRM;HPRT1;RRM2B;DHFR;ADSL;NME2,19 (19),0.0514,0.155,0,,16 (18),1,1,0.204,0.466
Listeria monocytogenes entry into host cells,Reactome,7,GRB2;CDH1;EPS15;STAM2;HGS;CTNNB1;CTNND1,19 (19),0.0514,0.155,0,,4 (4),1,1,0.204,0.466
ER Quality Control Compartment (ERQC),Reactome,7,SEL1L;DERL2;RNF139;AMFR;OS9;UGGT1;SYVN1,19 (19),0.0514,0.155,0,,3 (13),1,1,0.204,0.466
Glycosphingolipid biosynthesis - ganglio series - Homo sapiens (human),KEGG,4,GLB1;HEXA;HEXB;SLC33A1,15 (15),0.31,0.634,2,HMDB0006734;HMDB0004842,7 (31),0.168,1,0.206,0.47
FOXO-mediated transcription of oxidative stress_ metabolic and neuronal genes,Reactome,8,ABCA6;CAT;PCK1;GCK;SOD2;HDAC2;NR3C1;ATXN3,28 (28),0.143,0.354,1,HMDB0001547,4 (4),0.365,1,0.206,0.47
tRNA processing,Reactome,26,TPR;RAN;RANBP2;TRNT1;NUP58;NUP155;RAE1;RTCB;RTRAF;NUP210;TPRKB;ZBTB8OS;NUP98;NUP133;CPSF1;HSD17B10;NUP93;TP53RK;OSGEP;NSUN2;NUP160;ELAC2;DDX1;NUP35;SEC13;NUP205,103 (103),0.0663,0.193,2,HMDB0001495;HMDB0033934,26 (52),0.786,1,0.206,0.47
amb2 Integrin signaling,PID,10,RHOA;ITGB2;ROCK1;APOB;LRP1;RAP1B;TLN1;ICAM1;RAP1A;PLG,31 (31),0.0532,0.16,0,,2 (2),1,1,0.209,0.476
Regulation of p38-alpha and p38-beta,PID,10,LYN;MAP2K3;PAK2;RALA;RALB;MAP2K4;RAC1;MAPK14;CDC42;YES1,31 (31),0.0532,0.16,0,,2 (2),1,1,0.209,0.476
TLR ECSIT MEKK1 p38,INOH,8,CD14;MAP2K1;MAP2K2;MAP2K3;TOLLIP;MAP2K4;MAPK14;ECSIT,23 (23),0.0532,0.16,0,,1 (1),1,1,0.209,0.476
Developmental Biology,Reactome,110,MYH9;MYH11;MYL6;CFL1;LYPLA2;RPS6KA1;SPTA1;SPTAN1;SPTB;SPTBN1;SPTBN2;ACTB;PFN1;ACTG1;COL6A5;NCK1;ITGA1;ITGA2B;PKP3;ITGA5;ITGA9;DPYSL2;ITGB1;ITGB3;CLTC;RXRA;STAT3;FABP4;FARP2;JUP;GJB1;AP2M1;AP2S1;MYL9;AP2A1;AP2A2;AP2B1;YAP1;PITPNA;CLTA;PRKCA;HRAS;PKP2;DLG1;ALCAM;DEK;THRAP3;HSPA8;RAC1;HSP90AA1;DNM2;PML;HSP90AB1;WASL;COL4A2;COL6A1;COL6A2;COL6A3;KRT8;MYL12A;ANK1;DSC2;COL6A6;DSG2;DSP;CAPN1;ARPC1A;CAPNS1;SHC1;LAMA2;GRB2;RDX;SPAG9;YES1;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;ARPC2;PTPN11;RHOA;MAPK14;ARHGEF12;EGFR;MYH14;CSNK2A1;CSNK2A2;CSNK2B;TLN1;PRKACA;PRKACB;HELZ2;DNM3;PAK2;PRKAR2A;NUMB;CAP1;ROCK1;CTNNA1;CTNNA2;MAPK1;CTNNB1;LYN;MAP2K1;MAP2K2;CDC42;CDH2;HDAC2,676 (676),0.968,1,5,HMDB0000067;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000123;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0004949,20 (30),0.0551,1,0.21,0.477
FAS (CD95) signaling pathway,PID,7,MAPK9;FADD;CLTC;MAPK14;CASP3;PIK3R1;BID,35 (35),0.5,0.878,1,HMDB0004949,1 (2),0.107,1,0.21,0.478
Transcriptional activation of mitochondrial biogenesis,Reactome,9,CALM1;ATP5F1B;TFAM;SIRT5;SIRT3;SOD2;GLUD1;IDH2;ACSS2,27 (27),0.0536,0.16,0,,6 (7),1,1,0.211,0.478
pdgf signaling pathway,BioCarta,9,SHC1;HRAS;MAP2K1;GRB2;PRKCA;PIK3R1;MAP2K4;CSNK2A1;STAT3,27 (27),0.0536,0.16,0,,3 (3),1,1,0.211,0.478
Signaling by ERBB2,Reactome,14,MEMO1;HRAS;RHOA;CDC37;GRB2;CUL5;PRKCA;USP8;PIK3R1;SHC1;HSP90AA1;EGFR;DIAPH1;YES1,50 (50),0.0752,0.214,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,11 (15),0.714,1,0.211,0.478
Tamoxifen metabolism,Wikipathways,7,SULT1A1;CYP2E1;UGT2B15;CYP1A2;FMO1;FMO3;SULT1E1,21 (21),0.0843,0.234,1,HMDB0014813,9 (16),0.64,1,0.212,0.48
Nanoparticle triggered regulated necrosis,Wikipathways,2,FADD;PARP1,10 (10),0.589,0.95,2,HMDB0004949;HMDB0001043,5 (8),0.0922,1,0.212,0.481
Dopaminergic synapse - Homo sapiens (human),KEGG,32,PPP2CB;PPP2R1A;PPP2R2A;MAPK14;PPP2R5A;PPP2R5D;PPP2R5E;PPP3CA;MAOA;MAOB;GNG12;CAMK2A;CAMK2D;PRKACA;PRKACB;COMT;CALM1;PRKCA;PLCB3;GNAI3;KIF5B;GNAQ;GNAS;GNB1;GNB2;MAPK9;DDC;PPP1CC;GNAI2;PPP1CA;PPP1CB;ITPR2,132 (132),0.0734,0.21,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,12 (12),0.745,1,0.214,0.483
Sphingolipid de novo biosynthesis,Reactome,10,ALDH3A2;SPHK2;VAPA;KDSR;CERS2;PLPP3;CERT1;SGPL1;DEGS1;VAPB,41 (41),0.234,0.513,5,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0004949;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,31 (35),0.234,1,0.214,0.483
pyrimidine deoxyribonucleotides biosynthesis from CTP,HumanCyc,6,RRM1;NME3;RRM2B;NTPCR;NME1;NME2,16 (16),0.0642,0.188,1,HMDB0001342,17 (17),0.856,1,0.214,0.485
ErbB4 signaling events,PID,8,SHC1;GRB2;YAP1;PIK3R1;ITCH;STAT5B;MAPK1;NEDD4,31 (31),0.218,0.486,0,,0 (0),1,1,0.218,0.486
Transport of Mature mRNAs Derived from Intronless Transcripts,Reactome,4,EIF4E;CPSF1;NCBP1;ALYREF,13 (13),0.219,0.486,0,,0 (2),1,1,0.219,0.486
erythropoietin mediated neuroprotection through nf-kb,BioCarta,4,SOD2;RELA;HIF1A;COPS5,13 (13),0.219,0.486,0,,0 (0),1,1,0.219,0.486
Osteopontin Signaling,Wikipathways,4,MAPK1;ITGB3;MAP2K1;RELA,13 (13),0.219,0.486,0,,0 (0),1,1,0.219,0.486
Oocyte meiosis - Homo sapiens (human),KEGG,32,CUL1;PPP2CB;PPP2R1A;MAPK14;SLK;PPP2R5A;IGF1;PPP2R5D;PPP2R5E;PPP3CA;CALM1;SMC3;CAMK2A;CAMK2D;SMC1A;PRKACA;PRKACB;RPS6KA1;SKP1;MAPK1;YWHAQ;MAP2K1;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;ITPR2;RBX1;PPP1CA;PPP1CB;PPP1CC,129 (129),0.0563,0.168,0,,4 (4),1,1,0.218,0.493
Vitamin D in inflammatory diseases,Wikipathways,6,MAP2K3;RXRA;RELA;MAPK14;PPP3CA;NR3C1,22 (22),0.223,0.494,0,,0 (1),1,1,0.223,0.494
Vascular smooth muscle contraction - Homo sapiens (human),KEGG,31,RHOA;MYH9;MYH11;MYL6;MYLK;CALD1;CALM1;GUCY1A1;PLA2G12B;MYH14;GNA13;MYL9;AGT;PRKACA;PRKACB;MAPK1;ARHGEF12;PRKCA;ROCK1;GNA11;PLCB3;GNAQ;GNAS;MAP2K1;MAP2K2;GUCY1B1;ITPR2;ARAF;PPP1CA;PPP1CB;PPP1CC,133 (133),0.116,0.3,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0001043,15 (16),0.49,1,0.22,0.496
pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis,HumanCyc,6,RRM1;NME3;RRM2B;NTPCR;NME1;NME2,16 (16),0.0642,0.188,1,HMDB0001342,19 (19),0.885,1,0.22,0.496
The canonical retinoid cycle in rods (twilight vision),Reactome,7,RDH16;RDH10;RDH11;TTR;HSD17B6;RBP1;RBP4,21 (21),0.0843,0.234,2,HMDB0006216;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,21 (34),0.676,1,0.22,0.497
Integrated breast cancer pathway,Wikipathways,15,CASP3;BAX;DHTKD1;CDH1;GDI1;MTOR;ANXA1;CSNK1D;GRN;RAP1A;FADD;MAPK1;IMPA1;PHB;CDC42,67 (67),0.273,0.579,2,HMDB0001547;HMDB0014813,8 (19),0.209,1,0.22,0.497
Loss of Nlp from mitotic centrosomes,Reactome,19,CKAP5;MAPRE1;DCTN2;YWHAE;YWHAG;CSNK1D;PPP2R1A;TUBB4B;PAFAH1B1;DYNC1H1;TUBA4A;DYNC1I2;ACTR1A;HSP90AA1;DCTN1;DCTN3;SSNA1;PRKACA;CEP192,70 (70),0.0571,0.17,0,,2 (2),1,1,0.221,0.497
Loss of proteins required for interphase microtubule organization from the centrosome,Reactome,19,CKAP5;MAPRE1;DCTN2;YWHAE;YWHAG;CSNK1D;PPP2R1A;TUBB4B;PAFAH1B1;DYNC1H1;TUBA4A;DYNC1I2;ACTR1A;HSP90AA1;DCTN1;DCTN3;SSNA1;PRKACA;CEP192,70 (70),0.0571,0.17,0,,2 (2),1,1,0.221,0.497
Regulation of PLK1 Activity at G2/M Transition,Reactome,23,CUL1;MAPRE1;ACTR1A;PPP2R1A;TUBB4B;DCTN2;CSNK1D;PAFAH1B1;SSNA1;PRKACA;CKAP5;CEP192;RAB8A;SKP1;DCTN1;YWHAE;YWHAG;TUBA4A;DYNC1H1;DYNC1I2;HSP90AA1;DCTN3;PPP1CB,88 (88),0.0577,0.172,0,,5 (5),1,1,0.222,0.5
Negative regulation of MAPK pathway,Reactome,13,PPP5C;HRAS;MAP2K1;MAP2K2;YWHAB;PPP2CB;PEBP1;PPP2R1A;ARAF;PPP2R5A;PPP2R5D;PPP2R5E;MAPK1,44 (44),0.0582,0.172,0,,5 (5),1,1,0.224,0.5
Morphine Action Pathway,SMPDB,13,PDIA4;UGT1A3;UGT2B15;PPIB;SDF2L1;HSPA5;DNAJB11;ATP1B3;ERP29;PDIA6;ATP1B1;ATP1A1;HYOU1,44 (44),0.0582,0.172,0,,16 (16),1,1,0.224,0.5
Hyaluronan metabolism,Reactome,5,STAB2;HEXA;HEXB;CHP1;GUSB,12 (12),0.0584,0.172,0,,5 (7),1,1,0.224,0.5
Ethanol oxidation,Reactome,5,ADH5;ALDH1A1;ADH6;ALDH1B1;ACSS2,12 (12),0.0584,0.172,0,,15 (15),1,1,0.224,0.5
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10,Reactome,5,TRIM25;DDX58;FADD;RNF135;MAVS,12 (12),0.0584,0.172,0,,1 (4),1,1,0.224,0.5
guanosine deoxyribonucleotides <i>de novo</i> biosynthesis,HumanCyc,5,RRM1;NME3;RRM2B;NME1;NME2,12 (12),0.0584,0.172,0,,6 (6),1,1,0.224,0.5
Receptor Mediated Mitophagy,Reactome,5,CSNK2A1;ATG5;CSNK2A2;CSNK2B;PGAM5,12 (12),0.0584,0.172,0,,2 (2),1,1,0.224,0.5
adenosine deoxyribonucleotides <i>de novo</i> biosynthesis,HumanCyc,5,RRM1;NME3;RRM2B;NME1;NME2,12 (12),0.0584,0.172,0,,5 (5),1,1,0.224,0.5
PECAM1 interactions,Reactome,5,PTPN6;ITGB3;LYN;PTPN11;YES1,12 (12),0.0584,0.172,0,,2 (2),1,1,0.224,0.5
Regulation of glycolysis by fructose 2_6-bisphosphate metabolism,Reactome,5,PPP2R5D;PPP2CB;PRKACA;PPP2R1A;PRKACB,12 (12),0.0584,0.172,0,,6 (6),1,1,0.224,0.5
lectin induced complement pathway,BioCarta,5,C8A;C8B;C5;C3;C9,12 (12),0.0584,0.172,0,,2 (2),1,1,0.224,0.5
ERKs are inactivated,Reactome,5,PPP2R5D;MAPK1;PPP2CB;DUSP3;PPP2R1A,12 (12),0.0584,0.172,0,,2 (2),1,1,0.224,0.5
Activation of AMPK downstream of NMDARs,Reactome,5,CALM1;PRKAA1;PRKAG1;PRKAB1;PRKAA2,12 (12),0.0584,0.172,0,,3 (4),1,1,0.224,0.5
Trehalose Degradation,SMPDB,5,ATP1B1;SLC2A2;ATP1B3;ATP1A1;GCK,12 (12),0.0584,0.172,0,,10 (10),1,1,0.224,0.5
Sphingolipid pathway,Wikipathways,8,KDSR;CERS2;GBA;CERT1;ASAH1;SGPL1;SPHK2;PPP1CA,28 (28),0.143,0.354,2,HMDB0006734;HMDB0004949,13 (14),0.414,1,0.226,0.504
Ovarian steroidogenesis - Homo sapiens (human),KEGG,9,HSD17B2;ACOT2;SCARB1;HSD17B7;IGF1;ACOT4;GNAS;PRKACA;PRKACB,51 (51),0.644,1,5,HMDB0000145;HMDB0000067;HMDB0000234;HMDB0001043;HMDB0000077,23 (24),0.0919,1,0.227,0.505
Acute viral myocarditis,Wikipathways,18,LAMA2;BAX;AIF1;ITGB2;PABPC1;CASP6;PARP1;PIK3R1;KRT8;CXADR;STAT3;CAV1;CASP3;MAPK1;ILK;ACTB;EIF4G1;EIF4G2,78 (78),0.207,0.464,1,HMDB0003213,3 (7),0.289,1,0.228,0.507
Phenylacetate Metabolism,SMPDB,2,GLYAT;ACSM1,3 (3),0.0934,0.249,1,HMDB0006344,9 (9),0.64,1,0.228,0.507
Synthesis of very long-chain fatty acyl-CoAs,Reactome,8,ELOVL5;ACSL1;ACSL4;HACD3;HSD17B12;ACSF3;TECR;ACSL5,24 (24),0.0671,0.194,1,HMDB0001043,20 (27),0.898,1,0.229,0.509
Macrophage markers,Wikipathways,3,CD163;CD74;CD14,9 (9),0.232,0.51,0,,0 (0),1,1,0.232,0.51
IL4-mediated signaling events,PID,15,SHC1;PARP14;PIGR;GRB2;ITGB3;MTOR;IGHG1;PIK3R1;PTPN6;MAPK14;STAT5B;STAT6;COL1A1;COL1A2;ARG1,65 (65),0.234,0.513,0,,0 (0),1,1,0.234,0.513
Vitamin H (biotin) metabolism,EHMN,3,SLC16A1;BTD;SLC25A15,6 (6),0.0854,0.234,1,HMDB0003134,11 (11),0.714,1,0.232,0.514
ErbB signaling pathway - Homo sapiens (human),KEGG,20,SHC1;HRAS;EGFR;GRB2;PAK2;MAPK9;PRKCA;MTOR;ARAF;CAMK2A;MAP2K4;CAMK2D;NCK1;STAT5B;CRK;CRKL;MAP2K1;MAPK1;PIK3R1;MAP2K2,85 (85),0.167,0.402,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (4),0.365,1,0.232,0.514
Neurotransmitter release cycle,Reactome,13,MAOA;ALDH5A1;SLC6A13;GLS2;HSPA8;ABAT;PPFIA1;GLS;LIN7A;VAMP2;CASK;SLC22A1;LIN7C,50 (50),0.135,0.339,5,HMDB0004080;HMDB0002088;HMDB0033934;HMDB0001043;HMDB0000043,41 (45),0.453,1,0.232,0.514
leukotriene biosynthesis,HumanCyc,2,LTA4H;DPEP1,6 (6),0.317,0.64,5,HMDB0002995;HMDB0000123;HMDB0001043;HMDB0000687;HMDB0000172,29 (30),0.194,1,0.233,0.515
Intraflagellar transport proteins binding to dynein,Wikipathways,7,DYNC1LI1;DYNLRB1;DYNLT3;DYNC1H1;DYNC1I2;DYNC1LI2;DYNLL2,27 (27),0.236,0.516,0,,0 (0),1,1,0.236,0.516
IL-7,NetPath,7,SHC1;MAP2K1;MAP2K2;PIK3R1;STAT3;STAT5B;MAPK1,27 (27),0.236,0.516,0,,0 (0),1,1,0.236,0.516
Follicle Stimulating Hormone (FSH) signaling pathway,Wikipathways,7,PRKCA;MTOR;RPS6;MAPK14;RHEB;MAPK1;PRKACA,27 (27),0.236,0.516,0,,0 (0),1,1,0.236,0.516
Aryl Hydrocarbon Receptor Pathway,Wikipathways,11,NQO1;MGST1;UGT1A3;EGFR;BAX;CYP1A2;PTGES3;HSP90AA1;AIP;CDC37;GSTA2,46 (46),0.24,0.518,0,,0 (1),1,1,0.24,0.518
Envelope proteins and their potential roles in EDMD physiopathology,Wikipathways,11,HRAS;RHOA;MAP2K1;GRB2;TMPO;BANF1;CFL1;KIF5B;MAPK1;PLEC;MAP2K2,46 (46),0.24,0.518,0,,0 (0),1,1,0.24,0.518
MET activates PTPN11,Reactome,2,PTPN11;GRB2,5 (5),0.24,0.518,0,,0 (0),1,1,0.24,0.518
Class IB PI3K non-lipid kinase events,PID,2,MAPK1;MAP2K1,5 (5),0.24,0.518,0,,0 (0),1,1,0.24,0.518
basic mechanism of action of ppara pparb(d) and pparg and effects on gene expression,BioCarta,2,RXRA;PTGS1,5 (5),0.24,0.518,0,,0 (1),1,1,0.24,0.518
Sphingolipid metabolism - Homo sapiens (human),KEGG,10,GLB1;DEGS1;KDSR;CERS2;PLPP3;ASAH1;SGPL1;SPHK2;PSAP;GBA,49 (49),0.448,0.837,4,HMDB0006734;HMDB0006482;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0004949,19 (25),0.139,1,0.235,0.52
Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway,Wikipathways,5,NQO1;CDC37;FN1;ANXA5;ECSIT,18 (18),0.242,0.521,0,,0 (0),1,1,0.242,0.521
regulation of cell cycle progression by plk3,BioCarta,5,ATM;CASP3;YWHAH;BAX;CASP6,18 (18),0.242,0.521,0,,0 (0),1,1,0.242,0.521
Transport of organic anions,Reactome,3,SLCO2A1;ALB;SLCO2B1,12 (12),0.401,0.763,3,HMDB0000036;HMDB0000951;HMDB0000138,13 (15),0.156,1,0.236,0.522
GPCR Adenosine A2A receptor,INOH,11,MAP2K1;PRKAR1A;PRKAR2A;MAP2K2;RAP1A;RAP1B;CRKL;MAPK1;GNAS;PRKACA;PRKACB,36 (36),0.0628,0.185,0,,4 (4),1,1,0.237,0.523
Formation of the active cofactor_ UDP-glucuronate,Reactome,2,UGP2;UGDH,3 (3),0.0934,0.249,1,HMDB0000290,10 (10),0.679,1,0.238,0.526
Enzymatic degradation of dopamine by COMT,Reactome,2,COMT;MAOA,3 (3),0.0934,0.249,1,HMDB0033934,10 (10),0.679,1,0.238,0.526
Gastric Cancer Network 2,Wikipathways,8,CD48;EGFR;S100A6;FAM91A1;MTDH;LMNB2;CTNNB1;CACYBP,32 (32),0.246,0.529,0,,0 (0),1,1,0.246,0.529
Regulation of KIT signaling,Reactome,6,LYN;GRB2;PRKCA;PTPN6;KITLG;YES1,16 (16),0.0642,0.188,0,,2 (2),1,1,0.241,0.53
cadmium induces dna synthesis and proliferation in macrophages,BioCarta,6,HRAS;MAP2K1;MAP2K2;PRKCA;RELA;MAPK1,16 (16),0.0642,0.188,0,,6 (9),1,1,0.241,0.53
Rap1 signalling,Reactome,6,YWHAB;YWHAZ;RAP1A;RAP1B;PRKACA;PRKACB,16 (16),0.0642,0.188,0,,7 (8),1,1,0.241,0.53
Endothelin Pathways,Wikipathways,9,MT-CO2;MAP2K1;CALM1;ATP2A2;PRKCA;CAD;GNAS;MAPK1;MYLK,33 (33),0.155,0.381,2,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145;HMDB0001043,13 (13),0.414,1,0.241,0.53
Lipid particle organization,Reactome,2,HSD17B13;FITM2,6 (6),0.317,0.64,1,HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,2 (3),0.203,1,0.241,0.53
Cell junction organization,Reactome,23,ACTN1;FLNA;JUP;LIMS1;DST;F11R;CTNNB1;ILK;NECTIN2;PARVA;PXN;AFDN;CLDN3;CTNNA1;PLEC;CTNND1;FERMT2;CDH1;CDH2;RSU1;ITGB1;CDH17;LIMS2,89 (89),0.0644,0.189,0,,1 (2),1,1,0.241,0.53
RAS and bradykinin pathways in COVID-19,Wikipathways,8,RHOA;SERPING1;KLKB1;ROCK1;F12;KNG1;AGT;MAPK1,28 (28),0.143,0.354,2,HMDB0001043;HMDB0000876,14 (16),0.453,1,0.241,0.531
16p11.2 distal deletion syndrome,Wikipathways,10,RABEP2;GRB2;RAB5A;RAB4A;PRMT1;C3;CD81;SPNS1;TUFM;ATXN2L,32 (32),0.0647,0.189,0,,3 (4),1,1,0.242,0.531
TGF-beta receptor signaling activates SMADs,Reactome,10,NEDD8;STRAP;USP15;FKBP1A;UBE2M;UCHL5;XPO1;PPP1CA;PPP1CB;PPP1CC,32 (32),0.0647,0.189,0,,4 (4),1,1,0.242,0.531
bcr signaling pathway,BioCarta,10,SHC1;HRAS;LYN;MAP2K1;GRB2;PRKCA;CSNK2A1;RAC1;MAPK14;PPP3CA,32 (32),0.0647,0.189,0,,3 (3),1,1,0.242,0.531
Syndecan-4-mediated signaling events,PID,10,F2;ITGB1;PRKCA;ACTN1;RHOA;RAC1;DNM2;PLG;ITGA5;FN1,32 (32),0.0647,0.189,0,,2 (2),1,1,0.242,0.531
estradiol biosynthesis I,HumanCyc,3,HSD17B11;HSD17B7;HSD17B4,6 (6),0.0854,0.234,1,HMDB0000145,13 (13),0.772,1,0.245,0.538
Nanomaterial induced apoptosis,Wikipathways,7,FADD;BAX;CASP6;AIFM1;CASP3;BID;HTRA2,20 (20),0.0666,0.193,0,,1 (2),1,1,0.247,0.54
Signaling by phosphorylated juxtamembrane_ extracellular and kinase domain KIT mutants,Reactome,7,HRAS;LYN;YES1;PIK3R1;STAT3;STAT5B;GRB2,20 (20),0.0666,0.193,0,,5 (6),1,1,0.247,0.54
Signaling by KIT in disease,Reactome,7,HRAS;LYN;YES1;PIK3R1;STAT3;STAT5B;GRB2,20 (20),0.0666,0.193,0,,5 (12),1,1,0.247,0.54
Common Pathway of Fibrin Clot Formation,Reactome,7,FGA;FGB;SERPIND1;SERPINC1;F13A1;F2;FGG,20 (20),0.0666,0.193,0,,1 (7),1,1,0.247,0.54
sprouty regulation of tyrosine kinase signals,BioCarta,7,SHC1;HRAS;MAP2K1;GRB2;EGFR;MAPK1;MAP2K2,20 (20),0.0666,0.193,0,,3 (4),1,1,0.247,0.54
snRNP Assembly,Reactome,8,SNRPB;SNRPD1;SNRPD2;SNRPD3;SNRPF;SNRPG;NCBP1;CLNS1A,24 (24),0.0671,0.194,0,,4 (4),1,1,0.248,0.542
Metabolism of non-coding RNA,Reactome,8,SNRPB;SNRPD1;SNRPD2;SNRPD3;SNRPF;SNRPG;NCBP1;CLNS1A,24 (24),0.0671,0.194,0,,4 (4),1,1,0.248,0.542
inactivation of gsk3 by akt causes accumulation of b-catenin in alveolar macrophages,BioCarta,9,CD14;TOLLIP;EIF2AK2;PIK3R1;CSNK2A1;RELA;PPP2R5D;CTNNB1;EHHADH,40 (40),0.337,0.67,1,HMDB0004949,2 (2),0.203,1,0.252,0.55
Pertussis - Homo sapiens (human),KEGG,20,MAPK9;RHOA;CASP3;SERPING1;CALM1;ITGB1;ITGB2;RELA;C3;CFL1;CFL2;C4BPA;GNAI2;GNAI3;C5;MAPK14;MAPK1;C4A;ITGA5;CD14,76 (76),0.0688,0.199,0,,7 (10),1,1,0.253,0.551
N-glycan trimming and elongation in the cis-Golgi,Reactome,2,MAN1A1;MGAT1,5 (5),0.24,0.518,1,HMDB0000290,3 (13),0.289,1,0.254,0.553
FMO oxidises nucleophiles,Reactome,2,FMO3;FMO1,3 (3),0.0934,0.249,1,HMDB0014813,12 (13),0.745,1,0.255,0.555
Estrogen biosynthesis,Reactome,2,HSD17B11;HSD17B2,5 (5),0.24,0.518,2,HMDB0000145;HMDB0000234,10 (10),0.292,1,0.256,0.557
Energy Metabolism,Wikipathways,11,PRKAG1;TFAM;PRMT1;SIRT3;RXRA;MYBBP1A;MAPK14;PRKAA1;PRKAA2;PRKAB1;PPP3CA,47 (47),0.263,0.56,0,,0 (1),1,1,0.263,0.56
JNK signaling in the CD4+ TCR pathway,PID,4,MAP2K4;DBNL;CRK;CRKL,14 (14),0.263,0.56,0,,0 (0),1,1,0.263,0.56
il 2 signaling pathway,BioCarta,4,SHC1;HRAS;GRB2;STAT5B,14 (14),0.263,0.56,0,,0 (0),1,1,0.263,0.56
transcription regulation by methyltransferase of carm1,BioCarta,4,RXRA;PRKAR2A;PRKAR1A;PRKACB,14 (14),0.263,0.56,0,,0 (0),1,1,0.263,0.56
p75NTR regulates axonogenesis,Reactome,4,RHOA;ARHGDIA;RTN4;OMG,9 (9),0.0714,0.205,0,,2 (3),1,1,0.26,0.563
Signaling by MRAS-complex mutants,Reactome,4,ARAF;PPP1CB;PPP1CC;YWHAB,9 (9),0.0714,0.205,0,,3 (3),1,1,0.26,0.563
SHC-related events triggered by IGF1R,Reactome,4,SHC1;HRAS;GRB2;IGF1,9 (9),0.0714,0.205,0,,4 (4),1,1,0.26,0.563
ROBO receptors bind AKAP5,Reactome,4,PRKAR2A;PRKCA;PRKACA;PRKACB,9 (9),0.0714,0.205,0,,2 (2),1,1,0.26,0.563
CHL1 interactions,Reactome,4,ITGA1;HSPA8;ANK1;ITGB1,9 (9),0.0714,0.205,0,,1 (1),1,1,0.26,0.563
Uptake and function of anthrax toxins,Reactome,4,MAP2K4;MAP2K1;MAP2K2;MAP2K3,9 (9),0.0714,0.205,0,,5 (5),1,1,0.26,0.563
Prevention of phagosomal-lysosomal fusion,Reactome,4,HGS;CORO1A;RAB5A;RAB7A,9 (9),0.0714,0.205,0,,4 (8),1,1,0.26,0.563
noradrenaline and adrenaline degradation,HumanCyc,5,ALDH3A2;MAOB;ADH6;MAOA;COMT,13 (13),0.0806,0.226,1,HMDB0000318,20 (20),0.898,1,0.262,0.568
Synaptic adhesion-like molecules,Reactome,5,RTN3;FLOT1;PTPRD;DLG1;FLOT2,21 (21),0.362,0.703,1,HMDB0000123,2 (2),0.203,1,0.266,0.574
ABC transporters - Homo sapiens (human),KEGG,11,ABCB10;ABCD3;ABCA6;ABCB11;ABCB4;ABCB6;TAP2;ABCC6;ABCB7;ABCD1;ABCC2,45 (45),0.217,0.484,11,HMDB0035312;HMDB0000244;HMDB0000725;HMDB0003213;HMDB0000123;HMDB0000172;HMDB0000195;HMDB0000043;HMDB0001149;HMDB0001262;HMDB0000687,88 (138),0.342,1,0.267,0.577
PI3K-AKT-mTOR signaling pathway and therapeutic opportunities,Wikipathways,5,PDK1;RHEB;MTOR;PIK3R1;HRAS,30 (30),0.693,1,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,1 (1),0.107,1,0.268,0.578
Caffeine metabolism - Homo sapiens (human),KEGG,3,CYP1A2;NAT1;XDH,6 (6),0.0854,0.234,1,HMDB0029198,18 (22),0.871,1,0.268,0.578
Carbohydrate digestion and absorption - Homo sapiens (human),KEGG,9,ATP1B1;ATP1B3;SLC37A4;PIK3R1;SLC2A2;PLCB3;HK1;ATP1A1;HK3,47 (47),0.539,0.909,4,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0035312;HMDB0003539;HMDB0001262,19 (27),0.139,1,0.269,0.58
Metabolic pathway of LDL_ HDL and TG_ including diseases,Wikipathways,1,LCAT,6 (6),0.715,1,1,HMDB0000067,1 (5),0.107,1,0.274,0.59
Glypican 3 network,PID,1,MAPK9,6 (6),0.715,1,1,HMDB0000067,1 (1),0.107,1,0.274,0.59
Apoptosis Modulation by HSP70,Wikipathways,5,FADD;AIFM1;CASP3;BID;CASP6,19 (19),0.281,0.59,0,,0 (0),1,1,0.281,0.59
Processing of Intronless Pre-mRNAs,Reactome,5,CPSF1;PABPN1;NUDT21;CPSF7;NCBP1,19 (19),0.281,0.59,0,,0 (3),1,1,0.281,0.59
Degradation of beta catenin,PID,5,CSNK1A1;CTNNB1;SKP1;CSNK1D;CUL1,19 (19),0.281,0.59,0,,0 (0),1,1,0.281,0.59
Methylenetetrahydrofolate Reductase Deficiency (MTHFRD),SMPDB,5,ALDH1L1;FTCD;MTHFD1;MTHFS;DHFR,13 (13),0.0806,0.226,1,HMDB0033934,28 (28),0.959,1,0.275,0.592
Folate malabsorption_ hereditary,SMPDB,5,ALDH1L1;FTCD;MTHFD1;MTHFS;DHFR,13 (13),0.0806,0.226,1,HMDB0033934,28 (28),0.959,1,0.275,0.592
Folate Metabolism,SMPDB,5,ALDH1L1;FTCD;MTHFD1;MTHFS;DHFR,13 (13),0.0806,0.226,1,HMDB0033934,28 (28),0.959,1,0.275,0.592
Relationship between inflammation_ COX-2 and EGFR,Wikipathways,4,HRAS;MAPK1;EGFR;PTGES2,25 (25),0.721,1,1,HMDB0001043,1 (2),0.107,1,0.275,0.592
Methotrexate Action Pathway,SMPDB,5,ALDH1L1;FTCD;MTHFD1;MTHFS;DHFR,13 (13),0.0806,0.226,1,HMDB0033934,29 (29),0.963,1,0.276,0.593
MAPK Cascade,Wikipathways,10,HRAS;MAP2K1;MAP2K2;MAP2K3;MAP2K4;ARAF;PLCB3;MAPK14;MAPK1;GRB2,33 (33),0.0778,0.222,0,,2 (2),1,1,0.277,0.593
Phosphatidylinositol phosphate metabolism,EHMN,23,RANBP2;PTPMT1;NUP155;COPA;COPB1;PI4KA;COPE;CDIPT;NUP210;NUP98;NUP133;COPG2;PLCB3;NUP93;NUP58;PIP4K2C;SLC37A4;NUP160;NDUFS3;OXSM;ARCN1;NUP35;NUP205,93 (93),0.0967,0.257,3,HMDB0000290;HMDB0011669;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,39 (48),0.806,1,0.277,0.594
Syndecan-1-mediated signaling events,PID,10,PPIB;BSG;COL6A1;COL6A2;COL6A3;CASK;COL1A2;MAPK1;COL1A1;PRKACA,43 (43),0.285,0.597,0,,0 (1),1,1,0.285,0.597
GP1b-IX-V activation signalling,Reactome,3,FLNA;YWHAZ;PIK3R1,10 (10),0.288,0.599,0,,0 (1),1,1,0.288,0.599
Mammary gland development pathway - Involution (Stage 4 of 4),Wikipathways,3,BAX;STAT3;CDH1,10 (10),0.288,0.599,0,,0 (1),1,1,0.288,0.599
Liver X receptor pathway,Wikipathways,3,RXRA;FASN;CYP7A1,10 (10),0.288,0.599,0,,0 (1),1,1,0.288,0.599
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,Reactome,3,RBX1;SKP1;CUL1,10 (10),0.288,0.599,0,,0 (0),1,1,0.288,0.599
MyD88:MAL(TIRAP) cascade initiated on plasma membrane,Reactome,23,CUL1;S100A8;S100A9;PPP2CB;PPP2R1A;MAP2K4;PPP2R5D;FUS;MAPK14;FGG;CD14;UBE2N;UBE2V1;RPS6KA1;DUSP3;FGA;FGB;RELA;MAP2K1;MAPK1;MAPK9;SKP1;MAP2K3,91 (91),0.0795,0.226,0,,6 (14),1,1,0.281,0.601
Toll Like Receptor TLR1:TLR2 Cascade,Reactome,23,CUL1;S100A8;S100A9;PPP2CB;PPP2R1A;MAP2K4;PPP2R5D;FUS;MAPK14;FGG;CD14;UBE2N;UBE2V1;RPS6KA1;DUSP3;FGA;FGB;RELA;MAP2K1;MAPK1;MAPK9;SKP1;MAP2K3,91 (91),0.0795,0.226,0,,6 (14),1,1,0.281,0.601
Toll Like Receptor TLR6:TLR2 Cascade,Reactome,23,CUL1;S100A8;S100A9;PPP2CB;PPP2R1A;MAP2K4;PPP2R5D;FUS;MAPK14;FGG;CD14;UBE2N;UBE2V1;RPS6KA1;DUSP3;FGA;FGB;RELA;MAP2K1;MAPK1;MAPK9;SKP1;MAP2K3,91 (91),0.0795,0.226,0,,6 (14),1,1,0.281,0.601
Toll Like Receptor 2 (TLR2) Cascade,Reactome,23,CUL1;S100A8;S100A9;PPP2CB;PPP2R1A;MAP2K4;PPP2R5D;FUS;MAPK14;FGG;CD14;UBE2N;UBE2V1;RPS6KA1;DUSP3;FGA;FGB;RELA;MAP2K1;MAPK1;MAPK9;SKP1;MAP2K3,91 (91),0.0795,0.226,0,,6 (14),1,1,0.281,0.601
FGFR1 mutant receptor activation,Reactome,8,GRB2;MYO18A;CPSF6;PIK3R1;ERLIN2;STAT3;LRRFIP1;STAT5B,31 (31),0.218,0.486,1,HMDB0000693,4 (15),0.365,1,0.281,0.601
APOBEC3G mediated resistance to HIV-1 infection,Reactome,2,PSIP1;BANF1,7 (7),0.392,0.75,1,HMDB0033934,2 (4),0.203,1,0.281,0.601
Kaposi sarcoma-associated herpesvirus infection - Homo sapiens (human),KEGG,31,MAP2K4;HIF1A;MAPK14;CASP3;PPP3CA;CALM1;GNG12;ATG3;MTOR;PIK3R1;ICAM1;HRAS;FADD;BAX;GABARAP;C3;RELA;MAPK1;CTNNB1;GNB1;GNB2;MAPK9;LYN;MAP2K1;MAP2K2;EIF2AK2;BID;STAT2;STAT3;RAC1;ITPR2,193 (193),0.865,1,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,5 (5),0.0922,1,0.281,0.601
il-10 anti-inflammatory signaling pathway,BioCarta,4,MAPK14;HMOX1;BLVRA;BLVRB,13 (13),0.219,0.486,1,HMDB0000054,4 (4),0.365,1,0.282,0.601
tetrapyrrole biosynthesis,HumanCyc,2,HMBS;ALAD,5 (5),0.24,0.518,2,HMDB0000123;HMDB0001149,11 (11),0.334,1,0.282,0.602
Initiation of transcription and translation elongation at the HIV-1 LTR,Wikipathways,5,HDAC2;RELA;HEXIM1;SUPT5H;PPP3CA,32 (32),0.748,1,1,HMDB0041901,1 (1),0.107,1,0.283,0.603
UTP and CTP <i>de novo</i> biosynthesis,HumanCyc,5,NME3;CTPS2;NME2;NME1;CMPK1,13 (13),0.0806,0.226,0,,11 (11),1,1,0.284,0.603
trka receptor signaling pathway,BioCarta,5,SHC1;HRAS;PRKCA;GRB2;PIK3R1,13 (13),0.0806,0.226,0,,1 (1),1,1,0.284,0.603
purine deoxyribonucleosides salvage,HumanCyc,5,NME3;GUK1;DGUOK;NME1;NME2,13 (13),0.0806,0.226,0,,11 (11),1,1,0.284,0.603
Attenuation phase,Reactome,9,FKBP4;SERPINH1;PTGES3;DNAJB1;HSPA8;HSPH1;HSPB1;HSP90AA1;HSP90AB1,29 (29),0.0806,0.226,0,,2 (2),1,1,0.284,0.603
Beta2 integrin cell surface interactions,PID,9,F11R;FGA;FGB;TGFBI;ITGB2;C3;KNG1;ICAM1;FGG,29 (29),0.0806,0.226,0,,1 (1),1,1,0.284,0.603
Hepatocellular carcinoma - Homo sapiens (human),KEGG,38,TXNRD1;GSTM1;GSTM2;GSTM4;GSTP1;GSTT1;GSTT2;MAPK1;GRB2;MGST1;MGST2;MGST3;EGFR;MTOR;CSNK1A1;GSTA5;PIK3R1;ACTB;NQO1;HRAS;SMARCA2;BAX;ACTG1;SMARCC2;PRKCA;SHC1;ACTL6A;HMOX1;TXNRD2;CTNNB1;MAP2K1;MAP2K2;GSTO1;ARAF;GSTA1;GSTA2;GSTA3;GSTA4,168 (168),0.126,0.324,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,9 (14),0.64,1,0.284,0.603
Taurine and hypotaurine metabolism - Homo sapiens (human),KEGG,4,CSAD;ADO;CDO1;BAAT,11 (11),0.137,0.341,2,HMDB0000036;HMDB0011182,18 (22),0.591,1,0.284,0.603
Formation of TC-NER Pre-Incision Complex,Reactome,15,CUL4B;CUL4A;COPS6;COPS2;COPS8;DDB1;COPS5;COPS4;COPS3;POLR2A;USP7;GPS1;RBX1;COPS7A;PRPF19,55 (55),0.0815,0.229,0,,1 (2),1,1,0.286,0.606
IL-1 signaling pathway,Wikipathways,15,MAPK9;UBE2N;MAP2K1;MAP2K2;MAP2K3;UBE2V1;TOLLIP;SQSTM1;PIK3R1;MAP2K4;RELA;PTPN11;MAPK14;MAPK1;ECSIT,55 (55),0.0815,0.229,0,,1 (1),1,1,0.286,0.606
Lactose Degradation,SMPDB,4,ATP1B1;SLC2A2;ATP1B3;ATP1A1,11 (11),0.137,0.341,1,HMDB0035312,8 (9),0.597,1,0.287,0.607
Lactose Intolerance,SMPDB,4,ATP1B1;SLC2A2;ATP1B3;ATP1A1,11 (11),0.137,0.341,1,HMDB0035312,8 (9),0.597,1,0.287,0.607
AURKA Activation by TPX2,Reactome,19,CKAP5;MAPRE1;DCTN2;YWHAE;YWHAG;CSNK1D;PPP2R1A;TUBB4B;PAFAH1B1;DYNC1H1;TUBA4A;DYNC1I2;ACTR1A;HSP90AA1;DCTN1;DCTN3;SSNA1;PRKACA;CEP192,73 (73),0.0819,0.23,0,,2 (2),1,1,0.287,0.607
HCMV Infection,Reactome,24,TPR;RANBP2;NUP155;RAE1;EGFR;RBBP4;VPS4A;NUP210;DYNLL2;NUP98;NUP133;DYNC1LI1;NUP93;NUP58;ITGB1;NUP160;DYNC1H1;DYNC1I2;HNRNPK;DYNC1LI2;NUP35;PML;SEC13;NUP205,113 (113),0.293,0.608,0,,0 (3),1,1,0.293,0.608
Endothelins,PID,17,HRAS;RHOA;MAP2K1;MAP2K2;CDC42;PRKCA;GNA11;MAPK14;PLCB3;GNAI3;GNAI2;RAC1;GNAQ;MAPK1;CRK;GNAS;COL1A2,64 (64),0.0822,0.23,0,,5 (5),1,1,0.288,0.608
HDL assembly,Reactome,3,PRKACB;PRKACA;APOA1,7 (7),0.129,0.326,1,HMDB0000067,9 (10),0.64,1,0.289,0.609
Alpha9 beta1 integrin signaling events,PID,8,ITGA9;PXN;PAOX;ITGB1;TGM2;F13A1;RAC1;FN1,25 (25),0.0829,0.232,0,,11 (11),1,1,0.289,0.609
dermatan sulfate degradation (metazoa),HumanCyc,2,HEXA;HEXB,7 (7),0.392,0.75,10,HMDB0035312;HMDB0013112;HMDB0001399;HMDB0012254;HMDB0001178;HMDB0001296;HMDB0003213;HMDB0000290;HMDB0001262;HMDB0003553,70 (131),0.212,1,0.29,0.609
Modulators of TCR signaling and T cell activation,Wikipathways,10,CUL5;GRB2;PCBP2;ELOB;NDUFB10;PIK3R1;GNA13;PTPN6;RELA;RPRD1B,63 (63),0.775,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,1 (1),0.107,1,0.29,0.609
Abacavir transport and metabolism,Reactome,4,PCK1;NT5C2;GUK1;SLC22A1,10 (10),0.102,0.269,1,HMDB0000195,15 (19),0.819,1,0.29,0.609
Steroidogenesis,SMPDB,2,HSD11B1;AKR1D1,11 (11),0.643,1,7,HMDB0000015;HMDB0006756;HMDB0000067;HMDB0006763;HMDB0001547;HMDB0006764;HMDB0004030,40 (42),0.13,1,0.291,0.609
Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH,SMPDB,2,HSD11B1;AKR1D1,11 (11),0.643,1,7,HMDB0000015;HMDB0006756;HMDB0000067;HMDB0006763;HMDB0001547;HMDB0006764;HMDB0004030,40 (42),0.13,1,0.291,0.609
Apparent mineralocorticoid excess syndrome,SMPDB,2,HSD11B1;AKR1D1,11 (11),0.643,1,7,HMDB0000015;HMDB0006756;HMDB0000067;HMDB0006763;HMDB0001547;HMDB0006764;HMDB0004030,40 (42),0.13,1,0.291,0.609
3-Beta-Hydroxysteroid Dehydrogenase Deficiency,SMPDB,2,HSD11B1;AKR1D1,11 (11),0.643,1,7,HMDB0000015;HMDB0006756;HMDB0000067;HMDB0006763;HMDB0001547;HMDB0006764;HMDB0004030,40 (42),0.13,1,0.291,0.609
21-hydroxylase deficiency (CYP21),SMPDB,2,HSD11B1;AKR1D1,11 (11),0.643,1,7,HMDB0000015;HMDB0006756;HMDB0000067;HMDB0006763;HMDB0001547;HMDB0006764;HMDB0004030,40 (42),0.13,1,0.291,0.609
Corticosterone methyl oxidase I deficiency (CMO I),SMPDB,2,HSD11B1;AKR1D1,11 (11),0.643,1,7,HMDB0000015;HMDB0006756;HMDB0000067;HMDB0006763;HMDB0001547;HMDB0006764;HMDB0004030,40 (42),0.13,1,0.291,0.609
Corticosterone methyl oxidase II deficiency - CMO II,SMPDB,2,HSD11B1;AKR1D1,11 (11),0.643,1,7,HMDB0000015;HMDB0006756;HMDB0000067;HMDB0006763;HMDB0001547;HMDB0006764;HMDB0004030,40 (42),0.13,1,0.291,0.609
Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency,SMPDB,2,HSD11B1;AKR1D1,11 (11),0.643,1,7,HMDB0000015;HMDB0006756;HMDB0000067;HMDB0006763;HMDB0001547;HMDB0006764;HMDB0004030,40 (42),0.13,1,0.291,0.609
Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency,SMPDB,2,HSD11B1;AKR1D1,11 (11),0.643,1,7,HMDB0000015;HMDB0006756;HMDB0000067;HMDB0006763;HMDB0001547;HMDB0006764;HMDB0004030,40 (42),0.13,1,0.291,0.609
17-alpha-hydroxylase deficiency (CYP17),SMPDB,2,HSD11B1;AKR1D1,11 (11),0.643,1,7,HMDB0000015;HMDB0006756;HMDB0000067;HMDB0006763;HMDB0001547;HMDB0006764;HMDB0004030,40 (42),0.13,1,0.291,0.609
11-beta-hydroxylase deficiency (CYP11B1),SMPDB,2,HSD11B1;AKR1D1,11 (11),0.643,1,7,HMDB0000015;HMDB0006756;HMDB0000067;HMDB0006763;HMDB0001547;HMDB0006764;HMDB0004030,40 (42),0.13,1,0.291,0.609
IFN-gamma pathway,PID,12,CALM1;MAP2K1;MTOR;PTGES2;CAMK2A;CAMK2D;RAP1A;RAP1B;PTPN11;CRKL;MAPK1;PIK3R1,42 (42),0.0836,0.234,0,,3 (3),1,1,0.291,0.609
RND3 GTPase cycle,Reactome,12,CKB;DST;TMOD3;DSP;ROCK1;PICALM;FLOT2;TXNL1;KTN1;CAV1;CKAP4;PIK3R1,42 (42),0.0836,0.234,0,,1 (1),1,1,0.291,0.609
Regulation of Telomerase,PID,15,XRCC5;MTOR;EGFR;PTGES3;RBBP4;UBE3A;YWHAE;HNRNPC;ATM;NCL;XRCC6;HSP90AA1;MAPK1;HDAC2;RAD50,68 (68),0.294,0.609,0,,0 (0),1,1,0.294,0.609
4-hydroxytamoxifen_ Dexamethasone_ and Retinoic Acids Regulation of p27 Expression,Wikipathways,6,MAP2K1;MAP2K2;MAP2K3;MTOR;EIF4E;MAPK1,17 (17),0.084,0.234,0,,4 (12),1,1,0.292,0.61
Regulation of HMOX1 expression and activity,Reactome,6,CUL3;CUL1;SKP1;HMOX1;RBX1;HM13,17 (17),0.084,0.234,0,,3 (3),1,1,0.292,0.61
GAB1 signalosome,Reactome,6,EGFR;CSK;PIK3R1;PTPN11;GRB2;PXN,17 (17),0.084,0.234,0,,5 (6),1,1,0.292,0.61
VxPx cargo-targeting to cilium,Reactome,7,EXOC5;GBF1;RAB8A;EXOC4;ARF4;RAB11A;RAB11FIP3,21 (21),0.0843,0.234,0,,4 (4),1,1,0.293,0.61
Sphingosine 1-phosphate (S1P) pathway,PID,7,GNA13;GNA11;SPHK2;GNAI2;GNAI3;GNAQ;SGPL1,21 (21),0.0843,0.234,0,,4 (5),1,1,0.293,0.61
ERK/MAPK targets,Reactome,7,PPP2CB;PPP2R1A;MAPK14;RPS6KA1;DUSP3;PPP2R5D;MAPK1,21 (21),0.0843,0.234,0,,4 (4),1,1,0.293,0.61
Signaling by EGFR in Cancer,Reactome,7,SHC1;HRAS;CDC37;GRB2;PIK3R1;HSP90AA1;EGFR,21 (21),0.0843,0.234,0,,6 (19),1,1,0.293,0.61
TNF receptor signaling pathway ,PID,7,FADD;MAP2K3;SQSTM1;MAP4K5;RELA;CAV1;RACK1,46 (46),0.791,1,1,HMDB0004949,1 (1),0.107,1,0.294,0.612
Protein repair,Reactome,3,MSRB2;MSRA;PCMT1,6 (6),0.0854,0.234,0,,9 (13),1,1,0.296,0.612
pyrimidine ribonucleosides degradation,HumanCyc,3,UPB1;DPYD;DPYS,6 (6),0.0854,0.234,0,,14 (14),1,1,0.296,0.612
CD163 mediating an anti-inflammatory response,Reactome,3,MAPK14;MYH9;CD163,6 (6),0.0854,0.234,0,,3 (3),1,1,0.296,0.612
Vitamin B6 metabolism - Homo sapiens (human),KEGG,3,PNPO;AOX1;PDXK,6 (6),0.0854,0.234,0,,19 (29),1,1,0.296,0.612
basic mechanisms of sumoylation,BioCarta,3,UBE2I;UBA2;SAE1,6 (6),0.0854,0.234,0,,2 (2),1,1,0.296,0.612
NOSTRIN mediated eNOS trafficking,Reactome,3,WASL;CAV1;DNM2,6 (6),0.0854,0.234,0,,4 (4),1,1,0.296,0.612
2_-deoxy-&alpha;-D-ribose 1-phosphate degradation,HumanCyc,3,ALDH1B1;PGM2;DERA,6 (6),0.0854,0.234,0,,7 (8),1,1,0.296,0.612
Spermidine and Spermine Biosynthesis,SMPDB,3,MAT2A;SRM;MAT2B,6 (6),0.0854,0.234,0,,18 (18),1,1,0.296,0.612
Sensing of DNA Double Strand Breaks,Reactome,3,ATM;KPNA2;RAD50,6 (6),0.0854,0.234,0,,4 (5),1,1,0.296,0.612
Acyl chain remodelling of PE,Reactome,3,PNPLA8;LPCAT3;PLBD1,29 (29),0.931,1,2,HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,5 (13),0.0922,1,0.297,0.613
Xenobiotics metabolism,EHMN,14,MGST1;MGST2;UGT1A3;EPHX1;UGT2B10;UGT2B15;CYP1A2;GSTZ1;CYP4B1;AKR1C1;CYP2E1;MGST3;GSTK1;EPHX2,51 (51),0.0864,0.236,0,,75 (93),1,1,0.298,0.616
Glioma - Homo sapiens (human),KEGG,17,SHC1;CALM1;EGFR;GRB2;HRAS;PRKCA;MTOR;ARAF;BAX;PIK3R1;CAMK2D;IGF1;CAMK1;MAP2K1;MAPK1;CAMK2A;MAP2K2,75 (75),0.239,0.518,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (4),0.365,1,0.3,0.619
Nanoparticle triggered autophagic cell death,Wikipathways,3,ATG5;SH3GLB1;ATG3,22 (22),0.813,1,1,HMDB0011600,1 (1),0.107,1,0.3,0.619
PTK6 Expression,Reactome,2,HIF1A;NR3C1,5 (5),0.24,0.518,1,HMDB0001547,4 (4),0.365,1,0.301,0.62
Vitamin B2 (riboflavin) metabolism,Reactome,3,FLAD1;ACP5;ENPP1,7 (7),0.129,0.326,1,HMDB0000244,10 (10),0.679,1,0.301,0.621
Degradation of beta-catenin by the destruction complex,Reactome,11,SKP1;CUL1;CSNK1A1;PPP2CB;PPP2R1A;CTBP1;PPP2R5A;PPP2R5D;PPP2R5E;RBX1;CTNNB1,38 (38),0.088,0.24,0,,2 (3),1,1,0.302,0.622
Fc-epsilon receptor I signaling in mast cells,PID,15,SHC1;HRAS;LYN;MAP2K1;GRB2;PAK2;FCGR2B;MAP2K2;PIK3R1;MAP2K4;RELA;HCLS1;PTPN11;MAPK1;PXN,62 (62),0.179,0.419,1,HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,6 (8),0.494,1,0.303,0.625
O-Glycan biosynthesis,EHMN,7,COPA;COPB1;COPG2;ARCN1;ST3GAL4;GALNT2;COPE,36 (36),0.532,0.9,2,HMDB0000290;HMDB0000304,7 (17),0.168,1,0.305,0.628
p38 MAPK Signaling Pathway,Wikipathways,8,SHC1;HRAS;GRB2;CDC42;MAP2K4;HSPB1;RAC1;MAPK14,34 (34),0.305,0.628,0,,0 (0),1,1,0.305,0.628
triacylglycerol biosynthesis,HumanCyc,8,PLPP3;MBOAT7;DGAT1;GPAM;LPCAT3;LCLAT1;AGPAT2;AGPAT3,27 (27),0.121,0.311,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,24 (43),0.746,1,0.307,0.632
Hedgehog signaling events mediated by Gli proteins,PID,11,MAP2K1;RBBP4;CSNK1A1;CSNK1D;GNAI2;GNB1;LGALS3;XPO1;HDAC2;PRKACA;GNAI3,49 (49),0.313,0.64,1,HMDB0000067,3 (3),0.289,1,0.307,0.632
acyl-CoA hydrolysis,HumanCyc,2,ACOT7;ACOT8,3 (3),0.0934,0.249,1,HMDB0000944,30 (39),0.967,1,0.307,0.632
EGFR Tyrosine Kinase Inhibitor Resistance,Wikipathways,18,SHC1;HRAS;MAP2K1;GRB2;PRKCA;MTOR;BAX;PIK3R1;RRAS2;ARAF;RPS6;STAT3;IGF1;EIF4E;MAPK1;EGFR;EIF4E2;MAP2K2,84 (84),0.314,0.64,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,3 (5),0.289,1,0.308,0.633
Nucleotide Excision Repair,Reactome,24,CUL4B;CUL4A;LIG3;USP7;PARP1;UBE2I;UBE2N;COPS8;POLE;POLR2A;GPS1;COPS4;PRPF19;COPS3;COPS6;COPS2;DDB1;COPS5;UBE2V2;PCNA;RBX1;COPS7A;RAD23A;RAD23B,97 (97),0.0909,0.248,0,,7 (10),1,1,0.309,0.634
Regulation of sister chromatid separation at the metaphase-anaphase transition,Wikipathways,4,BUB3;SMC1A;RAD21;SMC3,15 (15),0.31,0.634,0,,0 (0),1,1,0.31,0.634
il-7 signal transduction,BioCarta,4,STAT5B;ITGA2B;NMI;PIK3R1,15 (15),0.31,0.634,0,,0 (0),1,1,0.31,0.634
Collagen chain trimerization,Reactome,10,COL6A6;COL4A2;COL6A5;COL6A1;COL6A2;COL18A1;COL6A3;COL14A1;COL1A1;COL1A2,44 (44),0.311,0.636,0,,0 (0),1,1,0.311,0.636
Acetylcholine Synthesis,Wikipathways,3,PDHA1;PEMT;PCYT1A,7 (7),0.129,0.326,1,HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,11 (11),0.714,1,0.312,0.638
Synthesis of PS,Reactome,0,,2 (2),1,1,2,HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,5 (6),0.0922,1,0.312,0.638
Ceramide signalling,Reactome,0,,3 (3),1,1,2,HMDB0004949;HMDB0013462#HMDB0012103#HMDB0012092,5 (5),0.0922,1,0.312,0.638
FGFR3c ligand binding and activation,Reactome,0,,13 (13),1,1,2,HMDB0000693;HMDB0000304,5 (5),0.0922,1,0.312,0.638
FGFR3 ligand binding and activation,Reactome,0,,13 (13),1,1,2,HMDB0000693;HMDB0000304,5 (5),0.0922,1,0.312,0.638
Fluoropyrimidine Activity,Wikipathways,10,RRM1;TYMP;UMPS;DPYD;SLC29A1;DPYS;SLC22A7;UPB1;DHFR;PPAT,34 (34),0.0924,0.249,0,,11 (16),1,1,0.312,0.638
Nicotine Metabolism,Wikipathways,2,FMO3;AOX1,6 (6),0.317,0.64,2,HMDB0001934;HMDB0001497,10 (10),0.292,1,0.313,0.638
Non-small cell lung cancer - Homo sapiens (human),KEGG,17,FHIT;HRAS;EGFR;BAX;STAT5B;PRKCA;MAP2K2;EML4;STAT3;PIK3R1;RXRA;ARAF;GRB2;KIF5B;MAP2K1;MAPK1;STK4,72 (72),0.187,0.429,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,6 (6),0.494,1,0.313,0.638
Association Between Physico-Chemical Features and Toxicity Associated Pathways,Wikipathways,17,PFN1;ACTR3;RHOA;MAP2K1;GRB2;MAP2K4;ACTR2;NCK1;SHC1;SOD1;CAMK1;EGFR;MAPK1;CTNNB1;GPX1;MYLK;FN1,65 (65),0.0926,0.249,0,,9 (9),1,1,0.313,0.638
Signaling events mediated by HDAC Class I,PID,15,UBE2I;MTA2;RBBP4;RAN;FKBP3;TFCP2;RANGAP1;RELA;CHD4;STAT3;NUP210;XPO1;RANBP2;HDAC2;PRKACA,56 (56),0.0928,0.249,0,,1 (1),1,1,0.313,0.638
RHOJ GTPase cycle,Reactome,15,WASL;CDC42;PAK2;RAB7A;ARHGAP1;CDC42BPB;DOCK8;JUP;STEAP3;TMPO;STOM;CAV1;PIK3R1;LAMTOR1;TFRC,56 (56),0.0928,0.249,0,,4 (4),1,1,0.313,0.638
Histidine metabolism,EHMN,10,MAOA;MAOB;HARS2;SLC38A3;SLC38A4;ABAT;ALDH7A1;HAL;ALDH1B1;ALDH9A1,35 (35),0.108,0.282,3,HMDB0004181;HMDB0000123;HMDB0033934,43 (45),0.856,1,0.314,0.638
UTP and CTP dephosphorylation I,HumanCyc,2,CTPS2;NTPCR,3 (3),0.0934,0.249,0,,15 (15),1,1,0.315,0.638
fatty acid &alpha;-oxidation III,HumanCyc,2,ALDH3A2;HACL1,3 (3),0.0934,0.249,0,,18 (23),1,1,0.315,0.638
acetate conversion to acetyl-CoA,HumanCyc,2,ACSS3;ACSS2,3 (3),0.0934,0.249,0,,6 (6),1,1,0.315,0.638
biotin-carboxyl carrier protein assembly,HumanCyc,2,ACACB;ACACA,3 (3),0.0934,0.249,0,,9 (11),1,1,0.315,0.638
Biosynthesis of aspirin-triggered D-series resolvins,Reactome,2,LTA4H;GPX4,3 (3),0.0934,0.249,0,,7 (21),1,1,0.315,0.638
methylglyoxal degradation III,HumanCyc,2,CYP2E1;AKR1B1,3 (3),0.0934,0.249,0,,8 (8),1,1,0.315,0.638
asparagine biosynthesis,HumanCyc,2,ASNS;GOT1,3 (3),0.0934,0.249,0,,11 (11),1,1,0.315,0.638
Synthesis of dolichyl-phosphate mannose,Reactome,2,DPM3;DPM1,3 (3),0.0934,0.249,0,,4 (4),1,1,0.315,0.638
tetrahydrofolate salvage from 5_10-methenyltetrahydrofolate,HumanCyc,2,MTHFD1;GART,3 (3),0.0934,0.249,0,,7 (7),1,1,0.315,0.638
Electron transport from NADPH to Ferredoxin,Reactome,2,FDXR;FDX1,3 (3),0.0934,0.249,0,,5 (7),1,1,0.315,0.638
IL-4 signaling pathway,Wikipathways,12,SHC1;GRB2;FLNA;PIK3R1;PTPN6;RELA;PTPN11;STAT3;MAPK14;STAT5B;STAT6;MAPK1,54 (54),0.314,0.64,0,,0 (0),1,1,0.314,0.64
Wnt,NetPath,15,ILK;JUP;RHOA;YES1;CDH1;YWHAB;PRKCA;CSNK1A1;CTBP1;MESD;LRP1;PIN1;GCKR;RAC1;CTNNB1,69 (69),0.315,0.64,0,,0 (0),1,1,0.315,0.64
IL-23 signaling,INOH,2,STAT3;STAT4,6 (6),0.317,0.64,0,,0 (0),1,1,0.317,0.64
NADE modulates death signalling,Reactome,2,YWHAE;CASP3,6 (6),0.317,0.64,0,,0 (0),1,1,0.317,0.64
JAK STAT pathway and regulation,INOH,68,PSMD6;MAP2K4;PTPN6;PSMB10;PTPN11;MAPK14;KITLG;PRKAR1A;PSMD2;PRKAR2A;EGFR;PAK2;MTOR;CSNK1A1;CSNK1D;CAMK2A;CAMK2D;PSMA1;PSMA2;PSMA4;PSMA5;PSMA6;PSMA7;PSMB1;PSMB2;PSMB3;PSMB4;PSMB5;PSMB6;PRKACB;PSMB8;HRAS;PSMB9;PRKAG1;PSMC1;PSMC2;PSMC3;PSMC4;PSMC5;PRKCA;PSMD1;RPS6KA1;PSMD3;PSMD4;PSMD5;PSMD7;PSMD8;PSMD11;PSMD12;PSMD13;MAPK1;PRKAA1;CSK;MAPK9;PRKAA2;MAP2K1;MAP2K2;MAP2K3;STAT3;PRKAB1;ARAF;STAT2;GRB2;PRKACA;STAT5B;STAT6;PSMB7;STAT4,310 (310),0.0947,0.252,0,,2 (2),1,1,0.318,0.643
G Protein Signaling Pathways,Wikipathways,20,GNB1;HRAS;GNG12;RHOA;PRKAR1A;CALM1;PRKAR2A;PRKCA;AKAP1;GNA11;GNA13;PLCB3;GNAI3;GNAI2;GNAQ;GNAS;PRKACB;PPP3CA;PRKACA;GNB2,91 (91),0.26,0.556,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (4),0.365,1,0.319,0.645
Phosphatidylinositol Phosphate Metabolism,SMPDB,6,PIK3R4;EGFR;PI4KA;PIK3R1;VAC14;CDIPT,23 (23),0.257,0.55,2,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145;HMDB0007102,12 (12),0.374,1,0.322,0.65
Joubert syndrome,SMPDB,6,PIK3R4;EGFR;PI4KA;PIK3R1;VAC14;CDIPT,23 (23),0.257,0.55,2,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145;HMDB0007102,12 (12),0.374,1,0.322,0.65
Valine_ leucine and isoleucine biosynthesis - Homo sapiens (human),KEGG,2,SDS;SDSL,4 (4),0.164,0.395,2,HMDB0000172;HMDB0000687,18 (23),0.591,1,0.323,0.651
Signaling by SCF-KIT,Reactome,12,HRAS;LYN;GRB2;PRKCA;PIK3R1;PTPN6;PTPN11;STAT3;RAC1;STAT5B;KITLG;YES1,43 (43),0.0969,0.258,0,,5 (12),1,1,0.323,0.652
p75(NTR)-mediated signaling,PID,15,SHC1;MAPK9;RHOA;CASP3;CASP6;YWHAE;ARHGDIA;SQSTM1;PIK3R1;OMG;RTN4;RAC1;NCSTN;PLG;PRKACB,70 (70),0.337,0.67,1,HMDB0004949,3 (3),0.289,1,0.324,0.653
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways,Wikipathways,34,HSPD1;GPD1L;YWHAQ;YWHAG;HSP90B1;HIF1A;FMO3;CASP3;MAOA;ACADM;SLC25A4;GAPDH;SPTBN1;VAMP2;PAH;PRKACA;PRKACB;TPPP;PRKAR1A;PRKAR2A;C4A;GCK;HADHA;HADHB;CTNNB1;NR3C1;CPT1A;ALDOA;YWHAB;TF;YWHAE;DDC;YWHAH;YWHAZ,159 (159),0.235,0.514,2,HMDB0001934;HMDB0000472,13 (15),0.414,1,0.324,0.653
Hippo-Merlin Signaling Dysregulation,Wikipathways,25,CUL4A;EGFR;PRKACA;PRKACB;HRAS;PRKAR1A;PAK2;PRKAR2A;CTNNA1;ITGA1;ITGA2B;CTNNB1;ITGA5;ITGA9;CDH1;CDH2;ITGB2;DDB1;PPP1CC;ITGB1;CDH17;RBX1;PPP1CA;PPP1CB;ITGB3,120 (120),0.325,0.653,0,,0 (0),1,1,0.325,0.653
Heme signaling,Reactome,3,XPO1;APOB;APOA1,20 (20),0.757,1,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,6 (10),0.129,1,0.324,0.653
Signaling by Insulin receptor,Reactome,19,SHC1;HRAS;ATP6V1B2;ATP6V1H;PIK3R4;TCIRG1;ATP6V1A;ATP6V1G1;ATP6V0C;ATP6V1C1;ATP6V1E1;PTPN11;ATP6V1D;ATP6V0A1;ATP6AP1;ATP6V0D1;PIK3R1;MAPK1;GRB2,78 (78),0.137,0.341,1,HMDB0000693,11 (15),0.714,1,0.325,0.655
Signal Transduction,Reactome,433,PIK3AP1;SRRM1;EPS15;STAM2;TPM4;USP9X;RPS6;SMC1A;ACTB;ABHD6;ACTC1;ACTG1;TCIRG1;FAM91A1;COL6A5;RDH13;AAMP;ACTN1;RPS27;F2;PICALM;RXRA;PPID;PIK3R4;ESRP2;S100A8;S100A9;PARP1;FASN;TAOK3;OTULIN;MYL9;RACK1;AP2A1;AP2A2;ST3GAL6;AP2B1;RAB7A;YAP1;UCHL5;ATP6V1D;AGT;PGRMC2;CGN;LYPLA1;FGA;FGB;PPM1A;ALDH1A1;FGG;ALDH1A3;ALDH3A2;FKBP1A;FKBP4;FKBP5;GNAI2;SEC13;SEL1L;CUL3;CUL1;FLNA;FLOT2;RRAS2;GNAQ;SFPQ;ANKFY1;LAMTOR2;CKAP4;FN1;TRA2B;FNTA;MAPRE1;ANXA1;RPS6KA1;ARPC1A;TUBA1B;SHC1;SHMT2;ARHGDIA;CCT7;CCT2;ST3GAL4;APOC2;APOE;SKP1;AKT1S1;ARAF;MFN1;CYFIP2;RHOA;WDR91;RHOG;ARHGAP1;ARFGAP2;ARHGDIB;MAPK14;ATP6V1H;SNW1;YKT6;RUVBL1;RDH16;KHDRBS1;LAMTOR4;MTOR;GNA13;VPS35;NUP133;DDRGK1;NUMB;DYNC1LI2;FUS;SYVN1;NUDC;PTGES3;STAG2;VPS29;CAB39;ATP6V1A;ATP6V1B2;ATP6V0C;ATP6V1C1;ATP6V1E1;MYH9;SNX3;MYH11;ATP6V0A1;ATP6AP1;MYL6;MYLK;NCKAP1;IQGAP2;BRK1;MYO6;SPTA1;SPTAN1;SPTB;SPTBN1;SPTBN2;HNRNPM;PFN1;FADD;NCBP1;NCK1;NDUFA5;ERLEC1;NDUFS3;STAT3;RRAGC;STAT6;DYNLL2;NEDD4;NEDD8;STK4;STRN;DHRS4;CYFIP1;STX5;FAF2;NSFL1C;GNG12;SQSTM1;C1QBP;COL6A6;HINT2;OS9;C3;GNA11;STIP1;GNAI3;C5;SCFD1;GNAS;YWHAQ;GNB1;GNB2;FERMT2;NUP160;DSP;STAT5B;WASL;STBD1;CALM1;CAMK2A;ESYT1;CAMK2D;GPS1;CAPZB;CASP3;GRB2;UBE2M;NLN;CAV1;NR3C1;CTSD;OMG;TFRC;NUP98;CDC37;AP2S1;CCT6A;USP8;ATP6V0D1;ARHGEF12;TIAL1;STRAP;SMC3;P4HB;PEBP1;KITLG;TLN1;PAFAH1B1;HGS;PAK2;TMPO;SEPTIN7;ZW10;BUB3;CDC42;CDH1;PCK1;HDAC2;VAPB;TPM3;MTA2;HIF1A;NCSTN;DHRS3;PDHA1;PDHB;PDK1;PDK2;PDK4;CFL1;ALDH8A1;TMOD3;PF4;MGLL;CHD4;HMOX2;CHKB;COPS2;HNRNPA1;HNRNPC;HNRNPF;HNRNPH1;CKB;TXNL1;EMC3;EPS15L1;AP2M1;AGO2;OSBPL11;LETM1;PIK3R1;HPN;PIN1;CLTA;CLTB;CLTC;HRAS;TJP2;PRMT1;SWAP70;PLG;EPN1;HSPB1;PLCB3;PKN3;VCL;VCP;HSP90AA1;HSP90AB1;COL4A2;VIM;HSPE1;DNAJB1;COL6A1;COL6A2;COL6A3;BAIAP2;RHOD;RBBP4;POLR2A;ACBD5;EFHD2;ATP6V1G1;VPS26A;XPO1;CPT1A;YES1;YWHAB;CDC42BPB;YWHAE;YWHAG;YWHAH;YWHAZ;CRK;CRKL;PPP1CA;PPP1CB;PPP1CC;UGT1A3;PPP2CB;PPP2R1A;PPP2R5A;IGF1;PPP2R5D;PPP2R5E;PPP3CA;PPP5C;CSK;CSNK1A1;CSNK2A1;CSNK2A2;CSNK2B;PRKAA1;PRKAA2;PRKAB1;PRKACA;PRKACB;PRKAG1;DNM3;PRKAR1A;PRKAR2A;PRKCA;CTBP1;ABI1;CTNNA1;MAPK1;CTNNB1;CTNND1;MAP2K1;MAP2K2;ABHD12;TOR1AIP1;TJP1;SLK;PSAP;PTBP1;CKAP5;DIAPH1;ITGA2B;DBT;ITGB1;ITGB3;DDX5;TWF1;ITPR2;FARP2;JUP;PTPN6;PTPN11;NDEL1;F11R;RCC2;PTPRJ;H2AX;ARFGAP3;HEBP1;ABCD3;USP7;PXMP2;PXN;MFN2;DLAT;DLD;DLG1;KIF5B;LAMTOR1;IQGAP1;USP15;DDX39B;DYNC1H1;KNG1;DYNC1I2;RAC1;DNM2;RBX1;RAD21;KPNA2;RALA;RALB;RANBP2;RANGAP1;RAP1A;RAP1B;RAP1GDS1;ITCH;HDAC6;GOPC;DSG2;DOCK8;DUSP3;RTN4;KTN1;DERL2;RDH10;ARHGAP17;RELA;LYN;KLC4;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;PDHX;ARHGEF10L;RHEB;ARPC2;MEMO1;CUL5;LMAN1;LMNB1;DST;EGFR;RDH11;MYH14;FARP1;EIF4E;EIF4G1;MOB1A;COPS4;DYNC1LI1;STEAP3;ROCK1;GPAM;PIP4K2C;CTTN;FLOT1;STOM;CPSF7,2431 (2432),0.934,1,28,HMDB0000123;HMDB0001547;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0000145;HMDB0002995;HMDB0000067;HMDB0033941;HMDB0003073;HMDB0001388;HMDB0015095;HMDB0006528;HMDB0001043;HMDB0004080;HMDB0000290;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0002183;HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0000234;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0003208;HMDB0000693;HMDB0006216;HMDB0015464;HMDB0015697;HMDB0005096;HMDB0004949;HMDB0036836;HMDB0000304,206 (290),0.105,1,0.326,0.655
Biosynthesis of maresins,Reactome,3,CYP1A2;CYP2E1;EPHX2,8 (8),0.179,0.418,1,HMDB0002183,7 (23),0.549,1,0.326,0.655
DDX58/IFIH1-mediated induction of interferon-alpha/beta,Reactome,16,ATG5;DDX58;ISG15;PCBP2;NLRX1;TOMM70;MAVS;FADD;RELA;PIN1;TKFC;HSP90AA1;ITCH;TRIM25;RNF135;HSP90AB1,61 (61),0.0986,0.262,0,,3 (7),1,1,0.327,0.657
Intrinsic Pathway for Apoptosis,Reactome,14,C1QBP;BAX;SEPTIN4;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;NMT1;CASP3;MAPK1;YWHAQ;BID;DYNLL2,52 (52),0.0986,0.262,0,,4 (5),1,1,0.327,0.657
Coregulation of Androgen receptor activity,PID,12,XRCC5;UBE2I;UBE3A;HNRNPA1;PA2G4;CTDSP1;UBA3;FKBP4;XRCC6;GSN;CTNNB1;PRDX1,61 (61),0.488,0.863,1,HMDB0000234,2 (2),0.203,1,0.328,0.659
Signal Transduction of S1P Receptor,Wikipathways,6,PLCB3;ASAH1;SPHK2;GNAI2;GNAI3;MAPK1,25 (25),0.328,0.66,0,,0 (0),1,1,0.328,0.66
Assembly and cell surface presentation of NMDA receptors,Reactome,6,DLG1;CAMK2A;CAMK2D;LIN7A;CASK;LIN7C,25 (25),0.328,0.66,0,,0 (1),1,1,0.328,0.66
IL-7 signaling pathway,Wikipathways,6,MAP2K1;MAP2K2;PIK3R1;STAT3;STAT5B;MAPK1,25 (25),0.328,0.66,0,,0 (0),1,1,0.328,0.66
TLR ECSIT MEKK1 JNK,INOH,8,CD14;MAP2K1;MAP2K2;MAP2K3;MAPK9;TOLLIP;MAP2K4;ECSIT,26 (26),0.101,0.267,0,,1 (1),1,1,0.332,0.666
S1P3 pathway,PID,8,RHOA;GNA11;GNA13;GNAI2;GNAI3;RAC1;GNAQ;MAPK1,26 (26),0.101,0.267,0,,4 (4),1,1,0.332,0.666
ErbB signaling pathway,Wikipathways,20,SHC1;MAPK9;EGFR;MAP2K2;PAK2;ARAF;HRAS;MTOR;CAMK2A;MAP2K4;CAMK2D;NCK1;STAT5B;CRK;CRKL;MAP2K1;MAPK1;PIK3R1;PRKCA;GRB2,92 (92),0.278,0.585,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (5),0.365,1,0.333,0.668
Tuberculosis - Homo sapiens (human),KEGG,38,HSPD1;RHOA;CD14;MRC1;ATP6V0C;SPHK2;MAPK14;ATP6V1H;ATP6V0A1;CASP3;ATP6AP1;ATP6V0D1;PPP3CA;ARHGEF12;CALM1;CORO1A;FCGR2B;CAMK2A;CAMK2D;FADD;BAX;RAB7A;TCIRG1;CD74;LAMP1;C3;RELA;MAPK1;EEA1;MAPK9;CR1L;CTSD;ITGB2;RAB5A;RAB5B;HSPA9;RAB5C;BID,179 (180),0.234,0.513,1,HMDB0003550,5 (18),0.433,1,0.334,0.668
Activation of PPARGC1A (PGC-1alpha) by phosphorylation,Reactome,4,MAPK14;PRKAG1;PRKAB1;PRKAA2,10 (10),0.102,0.269,0,,3 (3),1,1,0.334,0.669
EGFR Transactivation by Gastrin,Reactome,4,HRAS;PRKCA;EGFR;GRB2,10 (10),0.102,0.269,0,,2 (3),1,1,0.334,0.669
Bladder cancer,Wikipathways,9,HRAS;TYMP;MAP2K1;MAP2K2;CDH1;PIK3R1;ARAF;EGFR;MAPK1,40 (40),0.337,0.67,0,,0 (0),1,1,0.337,0.67
Novel intracellular components of RIG-I-like receptor (RLR) pathway,Wikipathways,13,MAPK9;ATG5;FADD;MAVS;TKFC;DDX58;RELA;PIN1;NLRX1;MAPK14;ISG15;TRIM25;SNW1,60 (60),0.338,0.67,0,,0 (0),1,1,0.338,0.67
Validated transcriptional targets of TAp63 isoforms,PID,12,NQO1;DHRS3;DST;TP53I3;BAX;ADA;YWHAQ;FLOT2;FDXR;ITCH;PML;SSRP1,55 (55),0.338,0.67,0,,0 (0),1,1,0.338,0.67
FABP4 in ovarian cancer,Wikipathways,1,FABP4,2 (2),0.342,0.67,0,,0 (0),1,1,0.342,0.67
tRNA-derived small RNA (tsRNA or tRNA-related fragment_ tRF) biogenesis,Reactome,1,ELAC2,2 (2),0.342,0.67,0,,0 (0),1,1,0.342,0.67
ChREBP activates metabolic gene expression,Reactome,1,MLX,2 (2),0.342,0.67,0,,0 (0),1,1,0.342,0.67
Abasic sugar-phosphate removal via the single-nucleotide replacement pathway,Reactome,1,APEX1,2 (2),0.342,0.67,0,,0 (2),1,1,0.342,0.67
Nef mediated downregulation of CD28 cell surface expression,Reactome,1,AP2M1,2 (2),0.342,0.67,0,,0 (0),1,1,0.342,0.67
Inhibition of Host mRNA Processing and RNA Silencing,Reactome,1,PABPN1,2 (2),0.342,0.67,0,,0 (0),1,1,0.342,0.67
Activation and oligomerization of BAK protein,Reactome,1,BID,2 (2),0.342,0.67,0,,0 (0),1,1,0.342,0.67
Manipulation of host energy metabolism,Reactome,1,ENO1,2 (2),0.342,0.67,0,,0 (0),1,1,0.342,0.67
degradation of the rar and rxr by the proteasome,BioCarta,1,RXRA,2 (2),0.342,0.67,0,,0 (0),1,1,0.342,0.67
Regulation of PAK-2p34 activity by PS-GAP/RHG10,Reactome,1,PAK2,2 (2),0.342,0.67,0,,0 (0),1,1,0.342,0.67
Regulation of BACH1 activity,Reactome,3,RBX1;SKP1;CUL1,11 (11),0.345,0.673,0,,0 (0),1,1,0.345,0.673
Nucleotide Excision Repair ,SMPDB,3,POLE;RAD23A;PCNA,11 (11),0.345,0.673,0,,0 (0),1,1,0.345,0.673
Phosphate bond hydrolysis by NUDT proteins,Reactome,3,NUDT5;NUDT16;NUDT9,7 (7),0.129,0.326,1,HMDB0001178,14 (24),0.797,1,0.337,0.673
COX reactions,Reactome,1,PTGS1,1 (1),0.189,0.429,1,HMDB0001043,7 (8),0.549,1,0.338,0.676
Retinoic acid receptors-mediated signaling,PID,6,PRKCA;RXRA;MAPK14;MAPK1;RBP1;PRKACA,30 (30),0.51,0.878,1,HMDB0000876,2 (2),0.203,1,0.339,0.676
PI3K-AKT-mTOR - VitD3 signaling,Wikipathways,7,LDHA;PDHA1;MTOR;RXRA;RELA;PRKAA2;HK3,22 (22),0.104,0.275,0,,7 (8),1,1,0.34,0.677
Complement Activation,Wikipathways,7,C3;C4A;CFB;C5;C8A;C8B;C9,22 (22),0.104,0.275,0,,1 (1),1,1,0.34,0.677
CDP-diacylglycerol biosynthesis,HumanCyc,7,MBOAT7;GPAM;LPCAT3;LCLAT1;CDS2;AGPAT2;AGPAT3,22 (22),0.104,0.275,0,,14 (19),1,1,0.34,0.677
PDGFR-alpha signaling pathway,PID,7,SHC1;GRB2;PIK3R1;CSNK2A1;CRK;CRKL;CAV1,22 (22),0.104,0.275,0,,2 (2),1,1,0.34,0.677
Chaperone Mediated Autophagy,Reactome,7,PLIN2;HSPA8;PARK7;HSP90AA1;EEF1A1;HDAC6;HSP90AB1,22 (22),0.104,0.275,0,,1 (2),1,1,0.34,0.677
Inositol Metabolism,SMPDB,7,PIK3R4;VAC14;INPP1;PI4KA;ISYNA1;PTPMT1;IMPA1,22 (22),0.104,0.275,0,,27 (31),1,1,0.34,0.677
Glycosphingolipid biosynthesis - lacto and neolacto series - Homo sapiens (human),KEGG,2,ST3GAL6;ST3GAL4,27 (27),0.974,1,1,HMDB0006734,1 (54),0.107,1,0.341,0.677
pyrimidine deoxyribonucleotide phosphorylation,HumanCyc,4,NME3;NME2;NME1;CMPK1,12 (12),0.176,0.418,1,HMDB0001342,8 (8),0.597,1,0.342,0.68
Gamma-carboxylation of protein precursors,Reactome,3,F2;GGCX;F9,10 (10),0.288,0.599,1,HMDB0030020,4 (6),0.365,1,0.342,0.68
TRAIL signaling pathway,PID,5,MAP2K4;MAPK1;FADD;DAP3;PIK3R1,25 (25),0.523,0.895,1,HMDB0004949,2 (2),0.203,1,0.344,0.68
Signaling by Erythropoietin,Reactome,7,SHC1;HRAS;LYN;GRB2;PIK3R1;CRKL;STAT5B,25 (25),0.178,0.418,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,8 (9),0.597,1,0.344,0.68
Erythropoietin activates RAS,Reactome,5,SHC1;HRAS;LYN;GRB2;CRKL,14 (14),0.107,0.278,0,,4 (4),1,1,0.345,0.68
CREB1 phosphorylation through the activation of Adenylate Cyclase,Reactome,5,PRKAR2A;CALM1;PRKAR1A;PRKACA;PRKACB,14 (14),0.107,0.278,0,,5 (5),1,1,0.345,0.68
Neuroinflammation,Wikipathways,5,MAPK14;MT-CO2;RELA;MTOR;MT-CO1,14 (14),0.107,0.278,0,,9 (11),1,1,0.345,0.68
PTK6 Regulates RHO GTPases_ RAS GTPase and MAP kinases,Reactome,5,HRAS;RHOA;PXN;CRK;RAC1,14 (14),0.107,0.278,0,,5 (5),1,1,0.345,0.68
serotonin degradation,HumanCyc,5,ALDH3A2;SULT1A1;ADH6;UGT2B10;MAOA,14 (14),0.107,0.278,0,,16 (20),1,1,0.345,0.68
Prolactin receptor signaling,Reactome,5,STAT5B;RBX1;SKP1;PTPN11;CUL1,14 (14),0.107,0.278,0,,3 (3),1,1,0.345,0.68
classical complement pathway,BioCarta,5,C8A;C8B;C5;C3;C9,14 (14),0.107,0.278,0,,2 (2),1,1,0.345,0.68
Signalling to RAS,Reactome,6,SHC1;HRAS;GRB2;RALA;RALB;MAPK14,18 (18),0.107,0.278,0,,5 (5),1,1,0.345,0.68
Regulation of signaling by CBL,Reactome,6,LYN;YES1;PIK3R1;CRK;CRKL;GRB2,18 (18),0.107,0.278,0,,2 (2),1,1,0.345,0.68
nerve growth factor pathway (ngf),BioCarta,6,SHC1;HRAS;MAP2K1;GRB2;PIK3R1;CSNK2A1,18 (18),0.107,0.278,0,,2 (2),1,1,0.345,0.68
Tie2 Signaling,Reactome,6,SHC1;HRAS;GRB2;GRB14;PIK3R1;PTPN11,18 (18),0.107,0.278,0,,4 (4),1,1,0.345,0.68
EPHA2 forward signaling,PID,6,SHC1;RHOA;GRB2;PIK3R1;ACP1;RAC1,18 (18),0.107,0.278,0,,3 (3),1,1,0.345,0.68
Mucin type O-glycan biosynthesis - Homo sapiens (human),KEGG,1,GALNT2,32 (32),0.999,1,1,HMDB0000304,1 (16),0.107,1,0.346,0.68
Basal cell carcinoma - Homo sapiens (human),KEGG,2,CTNNB1;BAX,63 (63),1,1,1,HMDB0000067,1 (1),0.107,1,0.347,0.68
Host-pathogen interaction of human coronaviruses - autophagy,Wikipathways,0,,1 (1),1,1,1,HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,1 (1),0.107,1,0.347,0.68
Signaling by FGFR2 IIIa TM,Reactome,0,,3 (3),1,1,1,HMDB0000693,1 (2),0.107,1,0.347,0.68
UDP-<i>N</i>-acetyl-D-galactosamine biosynthesis I,HumanCyc,0,,1 (1),1,1,1,HMDB0000290,1 (2),0.107,1,0.347,0.68
FGFRL1 modulation of FGFR1 signaling,Reactome,0,,13 (13),1,1,1,HMDB0000693,1 (1),0.107,1,0.347,0.68
Intestinal lipid absorption,Reactome,0,,1 (1),1,1,1,HMDB0000067,1 (3),0.107,1,0.347,0.68
Reactions specific to the hybrid N-glycan synthesis pathway,Reactome,0,,1 (1),1,1,1,HMDB0000290,1 (3),0.107,1,0.347,0.68
Aldosterone synthesis and secretion - Homo sapiens (human),KEGG,18,CAMK1;CALM1;ATP1B3;ATP2B1;ATP1B1;PRKCA;GNA11;CAMK2D;PLCB3;SCARB1;AGT;GNAQ;GNAS;CAMK2A;ATP1A1;ITPR2;PRKACA;PRKACB,98 (98),0.592,0.954,4,HMDB0000067;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0001547;HMDB0001043,21 (22),0.181,1,0.347,0.68
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,Reactome,10,GNG12;PRKAR1A;PRKAR2A;RAP1A;PRKACA;GNAS;PRKACB;IQGAP1;GNB1;GNB2,35 (35),0.108,0.282,0,,5 (5),1,1,0.349,0.685
C-MYB transcription factor network,PID,21,GSTM1;UBE2I;COPA;SMARCA2;SND1;HRAS;MAT2A;PPID;ATP2B1;CASP6;MPO;TRIM28;HSPA8;COL1A2;CLTA;ANPEP;ADA;IQGAP1;TOM1;PPP3CA;KITLG,85 (85),0.11,0.285,0,,2 (2),1,1,0.352,0.689
mTOR signaling pathway - Homo sapiens (human),KEGG,32,RHOA;CAB39;ATP6V1A;ATP6V1B2;ATP6V1C1;ATP6V1E1;ATP6V1H;IGF1;LAMTOR2;DEPTOR;LAMTOR4;MTOR;PIK3R1;RPS6;RPS6KA1;ATP6V1D;EIF4E;PRKAA1;PRKAA2;HRAS;GRB2;PRKCA;ATP6V1G1;RRAGC;MAPK1;LAMTOR1;MAP2K1;MAP2K2;AKT1S1;RHEB;SEC13;EIF4E2,154 (155),0.301,0.622,1,HMDB0000687,4 (4),0.365,1,0.353,0.69
Regulation of necroptotic cell death,Reactome,6,FLOT1;FADD;FLOT2;HSP90AA1;CDC37;PDCD6IP,22 (22),0.223,0.494,1,HMDB0000290,6 (10),0.494,1,0.353,0.691
Vitamin D (calciferol) metabolism,Reactome,2,UBE2I;GC,9 (9),0.529,0.897,2,HMDB0000876;HMDB0003550,8 (9),0.209,1,0.354,0.691
chromatin remodeling by hswi/snf atp-dependent complexes,BioCarta,4,NR3C1;ACTB;POLR2A;SMARCC2,16 (16),0.357,0.693,0,,0 (0),1,1,0.357,0.693
Late endosomal microautophagy,Reactome,4,HSPA8;PARK7;PLIN2;HDAC6,16 (16),0.357,0.693,0,,0 (2),1,1,0.357,0.693
IGF-Ncore,Signalink,4,PPP4C;PTPN11;NEDD4;RACK1,16 (16),0.357,0.693,0,,0 (0),1,1,0.357,0.693
Interleukin-3_ Interleukin-5 and GM-CSF signaling,Reactome,12,SHC1;LYN;GRB2;YWHAZ;PIK3R1;PTPN6;PTPN11;CRK;CRKL;STAT5B;PRKACA;YES1,44 (44),0.111,0.289,0,,2 (3),1,1,0.356,0.695
Sensory processing of sound by inner hair cells of the cochlea,Reactome,14,CAPZB;MYO1C;ATP2B1;EPS8L2;RDX;PLS1;CAPZA1;MYH9;EPB41L1;SPTAN1;SPTBN1;TWF1;CASK;CAPZA2,53 (53),0.112,0.29,0,,5 (6),1,1,0.357,0.697
Ether lipid metabolism - Homo sapiens (human),KEGG,10,GDPD1;CHPT1;PLPP3;PLA2G12B;CEPT1;SELENOI;PAFAH1B1;PAFAH1B2;PAFAH1B3;PLD4,49 (49),0.448,0.837,2,HMDB0011149;HMDB0011148,9 (25),0.25,1,0.358,0.698
Intracellular Signalling Through Adenosine Receptor A2b and Adenosine,SMPDB,10,HRAS;GNG12;MAP2K2;CDC42;RAP1A;RPS6KA1;GNAS;MAPK1;GNB1;PRKACB,38 (38),0.165,0.398,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,10 (10),0.679,1,0.358,0.698
Intracellular Signalling Through Adenosine Receptor A2a and Adenosine,SMPDB,10,HRAS;GNG12;MAP2K2;CDC42;RAP1A;RPS6KA1;GNAS;MAPK1;GNB1;PRKACB,38 (38),0.165,0.398,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,10 (10),0.679,1,0.358,0.698
Leucine Stimulation on Insulin Signaling,SMPDB,3,RHEB;MTOR;EIF4E,15 (15),0.559,0.927,1,HMDB0000687,2 (2),0.203,1,0.36,0.702
Host-pathogen interaction of human coronaviruses - apoptosis,Wikipathways,5,MAPK14;FADD;CASP3;BID;BAX,21 (21),0.362,0.703,0,,0 (1),1,1,0.362,0.703
PAOs oxidise polyamines to amines,Reactome,1,PAOX,2 (2),0.342,0.67,2,HMDB0001276;HMDB0001186,11 (11),0.334,1,0.362,0.704
Melatonin metabolism and effects,Wikipathways,8,PER2;SULT1A1;MAOA;CYP1A2;PRKCA;CSNK1D;CAMK2A;CALM1,34 (34),0.305,0.628,2,HMDB0004095;HMDB0041842,12 (15),0.374,1,0.362,0.704
PD-L1 expression and PD-1 checkpoint pathway in cancer - Homo sapiens (human),KEGG,19,HRAS;EGFR;MAP2K2;MAP2K3;PTPN6;MTOR;EML4;CSNK2A2;PIK3R1;CSNK2A1;RELA;HIF1A;CSNK2B;PTPN11;STAT3;MAPK14;MAP2K1;PPP3CA;MAPK1,89 (89),0.314,0.64,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (4),0.365,1,0.363,0.704
Circadian rhythm - Homo sapiens (human),KEGG,9,PER2;PRKAG1;SKP1;CUL1;CSNK1D;PRKAA1;PRKAA2;PRKAB1;RBX1,31 (31),0.115,0.296,0,,2 (2),1,1,0.363,0.704
Adherens junctions interactions,Reactome,9,NECTIN2;CDH1;CDH2;CDH17;AFDN;JUP;CTNNA1;CTNNB1;CTNND1,31 (31),0.115,0.296,0,,1 (2),1,1,0.363,0.704
MAPK targets/ Nuclear events mediated by MAP kinases,Reactome,9,MAPK9;PPP2CB;PPP2R1A;PPP2R5D;RPS6KA1;DUSP3;MAPK14;FUS;MAPK1,31 (31),0.115,0.296,0,,4 (4),1,1,0.363,0.704
Wnt Signaling Pathway,Wikipathways,11,MAPK9;RHOA;PRKCA;MTOR;CSNK1A1;CSNK1D;CTBP1;GCKR;RAC1;MAPK1;CTNNB1,51 (51),0.364,0.707,0,,0 (0),1,1,0.364,0.707
Basigin interactions,Reactome,6,ATP1B1;ATP1B3;SLC16A1;ITGB1;BSG;CAV1,26 (26),0.365,0.707,0,,0 (0),1,1,0.365,0.707
Photodynamic therapy-induced HIF-1 survival signaling,Wikipathways,8,HIF1A;LDHA;BAX;SLC16A1;PKM;HK1;PFKL;BID,36 (36),0.366,0.709,0,,0 (0),1,1,0.366,0.709
GPCR GroupI metabotropic glutamate receptor,INOH,7,MAP2K1;MAP2K2;PRKCA;ARAF;PLCB3;GNAQ;MAPK1,28 (28),0.267,0.568,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,5 (6),0.433,1,0.366,0.71
Dilated cardiomyopathy - Homo sapiens (human),KEGG,23,TPM1;TPM3;TPM4;DES;IGF1;MYL3;ITGA2B;LMNA;AGT;ACTB;PRKACA;PRKACB;LAMA2;ACTC1;ACTG1;ITGA1;GNAS;ITGA5;ITGA9;ITGB1;TTN;ITGB3;ATP2A2,95 (96),0.116,0.3,0,,3 (3),1,1,0.366,0.711
Acyl chain remodelling of PC,Reactome,3,PNPLA8;LPCAT3;PLBD1,27 (27),0.907,1,2,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,6 (13),0.129,1,0.368,0.712
GLUT-1 deficiency syndrome,SMPDB,4,UGP2;GALT;CMPK1;NME2,11 (11),0.137,0.341,1,HMDB0035312,17 (19),0.856,1,0.368,0.713
Congenital disorder of glycosylation CDG-IId,SMPDB,4,UGP2;GALT;CMPK1;NME2,11 (11),0.137,0.341,1,HMDB0035312,17 (19),0.856,1,0.368,0.713
Lactose Synthesis,SMPDB,4,UGP2;GALT;CMPK1;NME2,11 (11),0.137,0.341,1,HMDB0035312,17 (19),0.856,1,0.368,0.713
Regulation of nuclear beta catenin signaling and target gene transcription,PID,15,MT-CO2;YWHAQ;SKP1;CUL1;CDH1;RUVBL2;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;CTBP1;XPO1;CTNNB1;HDAC2,81 (81),0.577,0.942,1,HMDB0000234,2 (2),0.203,1,0.369,0.713
Sensory processing of sound,Reactome,15,CAPZB;MYO1C;ATP2B1;RDX;PLS1;CAPZA1;MYH9;EPS8L2;EPB41L1;SPTAN1;GSN;SPTBN1;TWF1;CASK;CAPZA2,58 (58),0.118,0.305,0,,6 (7),1,1,0.37,0.716
Retrograde transport at the Trans-Golgi-Network,Reactome,13,COG5;NAPG;NAPA;RAB6B;NSF;M6PR;COG2;COG7;RAB6A;COG4;ARL1;RAB43;TGOLN2,49 (49),0.119,0.307,0,,6 (6),1,1,0.373,0.72
Leishmaniasis - Homo sapiens (human),KEGG,10,CR1L;ITGB1;ITGB2;C3;PTPN6;RELA;MARCKSL1;MAPK14;MAPK1;EEF1A1,76 (77),0.928,1,2,HMDB0004949;HMDB0001043,6 (6),0.129,1,0.373,0.721
Lidocaine (Local Anaesthetic) Action Pathway,SMPDB,4,CYP1A2;ATP1B1;ATP1B3;ATP1A1,31 (31),0.863,1,5,HMDB0060679;HMDB0060678;HMDB0014426;HMDB0060655;HMDB0060656,26 (26),0.139,1,0.373,0.721
Androgen and Estrogen Metabolism,SMPDB,4,SRD5A1;STS;AKR1D1;SULT1E1,12 (12),0.176,0.418,3,HMDB0000145;HMDB0000234;HMDB0000077,32 (32),0.684,1,0.375,0.723
17-Beta Hydroxysteroid Dehydrogenase III Deficiency,SMPDB,4,SRD5A1;STS;AKR1D1;SULT1E1,12 (12),0.176,0.418,3,HMDB0000145;HMDB0000234;HMDB0000077,32 (32),0.684,1,0.375,0.723
Aromatase deficiency,SMPDB,4,SRD5A1;STS;AKR1D1;SULT1E1,12 (12),0.176,0.418,3,HMDB0000145;HMDB0000234;HMDB0000077,32 (32),0.684,1,0.375,0.723
role of erk5 in neuronal survival pathway,BioCarta,8,SHC1;HRAS;MAP2K1;GRB2;PIK3R1;RPS6KA1;MAPK1;MAP2K2,27 (27),0.121,0.311,0,,2 (2),1,1,0.376,0.724
Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2,Reactome,1,CYP1A2,1 (1),0.189,0.429,1,HMDB0013195,9 (10),0.64,1,0.376,0.724
Signaling by FGFR2,Reactome,17,SHC1;TIAL1;ESRP2;GRB2;HRAS;HNRNPA1;PPP2CB;NCBP1;PIK3R1;HNRNPF;HNRNPH1;PPP2R1A;PTPN11;POLR2A;MAPK1;PTBP1;HNRNPM,74 (74),0.221,0.491,1,HMDB0000693,7 (9),0.549,1,0.377,0.725
Dopamine clearance from the synaptic cleft,Reactome,2,MAOA;COMT,4 (4),0.164,0.395,1,HMDB0033934,12 (13),0.745,1,0.378,0.727
Porphyrin metabolism,EHMN,9,FECH;UGT2B10;UGT2B15;SLC38A4;UGT1A3;DBI;HMOX1;CPOX;PPOX,34 (34),0.178,0.418,4,HMDB0000054;HMDB0000123;HMDB0033934;HMDB0001149,43 (48),0.693,1,0.381,0.732
Protein-protein interactions at synapses,Reactome,16,PDLIM5;FLOT1;EPB41L5;RTN3;DLG1;CASK;PPFIBP1;EPB41;PPFIA1;EPB41L2;LIN7A;EPB41L1;FLOT2;DBNL;PTPRD;LIN7C,88 (88),0.609,0.976,1,HMDB0000123,2 (2),0.203,1,0.382,0.733
SUMOylation of chromatin organization proteins,Reactome,15,NUP98;UBE2I;NUP133;TPR;NUP160;HDAC2;RAE1;NUP210;NUP93;NUP35;NUP58;RANBP2;SEC13;NUP205;NUP155,72 (72),0.38,0.734,0,,0 (0),1,1,0.38,0.734
Lipid and atherosclerosis - Homo sapiens (human),KEGG,41,HSPD1;RHOA;CD14;MAP2K4;RAP1A;MAPK9;RAP1B;MAPK14;PPP3CA;PIK3R1;HSPA8;CAMK2D;MAP2K3;CASP6;EIF2S1;CAMK2A;ERO1A;ICAM1;HRAS;CASP3;BAX;CALM1;PRKCA;APOA1;APOA4;APOB;PLCB3;MAPK1;RELA;HSP90B1;LYN;SOD2;CDC42;HSPA4;HSPA5;RXRA;STAT3;RAC1;HSP90AA1;BID;HSP90AB1,215 (215),0.498,0.876,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,9 (14),0.25,1,0.384,0.737
lactose degradation III,HumanCyc,1,GLB1,2 (2),0.342,0.67,1,HMDB0035312,4 (4),0.365,1,0.384,0.737
Biosynthesis of maresin conjugates in tissue regeneration (MCTR),Reactome,1,GSTM4,2 (2),0.342,0.67,1,HMDB0000123,4 (9),0.365,1,0.384,0.737
Apelin signaling pathway - Homo sapiens (human),KEGG,30,PIK3R4;RRAS2;MYL3;MYLK;CALM1;GNG12;MTOR;GNA13;RPS6;PRKAA1;PRKAA2;PRKAB1;PRKACA;PRKACB;HRAS;PRKAG1;GABARAP;PLCB3;GNAI3;GNAQ;MAPK1;GNB1;GNB2;SPHK2;MAP2K1;MAP2K2;CDH1;TFAM;GNAI2;ITPR2,137 (137),0.209,0.469,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,8 (9),0.597,1,0.385,0.737
Signaling by FGFR,Reactome,17,SHC1;TIAL1;ESRP2;GRB2;HRAS;HNRNPA1;PPP2CB;PPP2R1A;PIK3R1;HNRNPF;HNRNPH1;NCBP1;POLR2A;MAPK1;PTBP1;HNRNPM;PTPN11,88 (88),0.5,0.878,2,HMDB0000693;HMDB0000304,9 (11),0.25,1,0.385,0.738
Surfactant metabolism,Reactome,2,CTSH;CKAP4,26 (26),0.969,1,3,HMDB0000195;HMDB0033934;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,12 (13),0.13,1,0.386,0.739
Gamma-carboxylation_ transport_ and amino-terminal cleavage of proteins,Reactome,3,F2;GGCX;F9,11 (11),0.345,0.673,1,HMDB0030020,4 (6),0.365,1,0.387,0.74
IL2-mediated signaling events,PID,14,SHC1;HRAS;RHOA;MAP2K1;GRB2;MAPK9;STAM2;PIK3R1;PTPN11;STAT3;MAPK14;STAT5B;MAPK1;MAP2K2,54 (54),0.126,0.324,0,,2 (2),1,1,0.387,0.74
Sphingolipid Metabolism (general overview),Wikipathways,7,SPHK2;KDSR;CERS2;PLPP3;ASAH1;SGPL1;DEGS1,23 (23),0.127,0.324,0,,7 (10),1,1,0.389,0.74
Estrogen signaling pathway,Wikipathways,7,MAPK9;MAP2K1;GNB1;MAPK14;GNAS;MAPK1;PRKACA,23 (23),0.127,0.324,0,,2 (2),1,1,0.389,0.74
Canonical NF-kappaB pathway,PID,7,PRKCA;RAN;ERC1;RELA;ATM;XPO1;UBE2D3,23 (23),0.127,0.324,0,,1 (1),1,1,0.389,0.74
Renin-angiotensin system - Homo sapiens (human),KEGG,7,ANPEP;CTSA;ENPEP;PREP;NLN;AGT;THOP1,23 (23),0.127,0.324,0,,4 (11),1,1,0.389,0.74
growth hormone signaling pathway,BioCarta,7,SHC1;GRB2;PRKCA;PIK3R1;PTPN6;RPS6KA1;STAT5B,23 (23),0.127,0.324,0,,1 (1),1,1,0.389,0.74
Negative regulation of NMDA receptor-mediated neuronal transmission,Reactome,6,CALM1;DLG1;CAMK2A;CAMK2D;CAMK1;PPM1F,23 (23),0.257,0.55,1,HMDB0000123,6 (6),0.494,1,0.389,0.741
Transcriptional Regulation by TP53,Reactome,77,TXNRD1;CNOT1;GPI;RRAGC;ELOC;MTA2;ELOB;PPP2CB;PPP2R1A;AIFM2;TAF3;NDUFA4;MAPK14;AGO2;LAMTOR2;GLS2;NPM1;MT-CO1;COX5A;MT-CO3;LAMTOR4;COX5B;RBBP4;PIP4K2C;MTOR;SUPT5H;COX4I1;CSNK2A1;CSNK2A2;RRM2B;POLR2A;GLS;CSNK2B;PRKAA1;PRKAA2;PRDX1;SUPT16H;COX6C;USP7;PRKAG1;TP53I3;BAX;COX7C;CASP6;STEAP3;PIP4P1;PRMT1;COX7A2L;TNKS1BP1;CHD4;PIN1;COX6A1;ATM;PRDX2;TP53RK;YWHAQ;LAMTOR1;SSRP1;PRDX5;PRKAB1;DNA2;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;RHEB;MT-CO2;RABGGTA;RABGGTB;PCNA;GSR;TAF15;HDAC2;PML;BID;RAD50,361 (361),0.127,0.326,0,,30 (39),1,1,0.39,0.742
Adrenergic signaling in cardiomyocytes - Homo sapiens (human),KEGG,33,TPM1;TPM3;TPM4;PPP2CB;PPP2R1A;PPP2R2A;PPP2R5D;PPP2R5A;MAPK14;PPP2R5E;MYL3;MAPK1;CALM1;CAMK2A;CAMK2D;AGT;PRKACA;PRKACB;ACTC1;PRKCA;PLCB3;GNAI3;GNAQ;GNAS;ATP1A1;ATP1B1;ATP1B3;ATP2A2;ATP2B1;GNAI2;PPP1CA;PPP1CB;PPP1CC,150 (150),0.188,0.429,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,10 (10),0.679,1,0.39,0.743
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis - Homo sapiens (human),KEGG,1,PIGN,26 (26),0.996,1,2,HMDB0000290;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,6 (16),0.129,1,0.391,0.743
melatonin degradation II,HumanCyc,1,MAOA,1 (1),0.189,0.429,1,HMDB0004095,10 (11),0.679,1,0.391,0.743
Human cytomegalovirus infection - Homo sapiens (human),KEGG,46,PDIA3;CRK;MAP2K2;RHOA;MAPK14;CASP3;PPP3CA;MAPK1;PXN;CALM1;GNG12;EGFR;CALR;PIK3R1;GNA13;B2M;PRKACA;PRKACB;HRAS;FADD;BAX;PRKCA;RAC1;ROCK1;GNA11;GRB2;RELA;GNAI2;GNAI3;GNAQ;GNAS;CTNNB1;MTOR;GNB1;GNB2;MAP2K1;ARHGEF12;ITGB3;TAP2;TAPBP;ITPR2;PLCB3;STAT3;CRKL;RHEB;BID,225 (225),0.296,0.613,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,5 (6),0.433,1,0.392,0.743
Signaling by TGF-beta Receptor Complex,Reactome,17,F11R;NEDD8;RHOA;USP15;FKBP1A;PARP1;USP9X;UBE2M;UCHL5;STRAP;XPO1;PPM1A;CGN;SNW1;PPP1CA;PPP1CB;PPP1CC,68 (68),0.129,0.326,0,,7 (7),1,1,0.392,0.743
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,Reactome,10,FCGR2B;CDH1;ITGB1;ITGB2;ICAM1;C3;CD81;CXADR;B2M;NECTIN2,215 (215),1,1,2,HMDB0004949;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,6 (20),0.129,1,0.393,0.743
Glycolysis in senescence,Wikipathways,3,LDHA;GAPDH;PKM,7 (7),0.129,0.326,0,,3 (7),1,1,0.393,0.743
RHOT2 GTPase cycle,Reactome,3,MFN1;RAP1GDS1;MFN2,7 (7),0.129,0.326,0,,4 (4),1,1,0.393,0.743
CS/DS degradation,Reactome,3,HEXA;HEXB;ARSB,7 (7),0.129,0.326,0,,4 (15),1,1,0.393,0.743
PP2A-mediated dephosphorylation of key metabolic factors,Reactome,3,PPP2R5D;PPP2CB;PPP2R1A,7 (7),0.129,0.326,0,,2 (2),1,1,0.393,0.743
Arylamine metabolism,Wikipathways,3,CYP1A2;SULT1A1;NAT1,7 (7),0.129,0.326,0,,3 (5),1,1,0.393,0.743
Negative feedback regulation of MAPK pathway,Reactome,3,MAPK1;MAP2K1;MAP2K2,7 (7),0.129,0.326,0,,2 (2),1,1,0.393,0.743
thyroid hormone metabolism II (via conjugation and/or degradation),HumanCyc,3,SULT1A1;DIO1;UGT2B10,7 (7),0.129,0.326,0,,9 (22),1,1,0.393,0.743
STAT5 Activation,Reactome,3,STAT5B;PTPN11;GRB2,7 (7),0.129,0.326,0,,2 (2),1,1,0.393,0.743
Caffeine Metabolism,SMPDB,3,CYP1A2;XDH;CYP2E1,7 (7),0.129,0.326,0,,23 (24),1,1,0.393,0.743
Digestion of dietary carbohydrate,Reactome,0,,10 (10),1,1,3,HMDB0035312;HMDB0003255;HMDB0001262,12 (17),0.13,1,0.395,0.745
Assembly of collagen fibrils and other multimeric structures,Reactome,11,COL6A6;DST;COL4A2;COL6A5;CTSL;COL6A1;COL6A2;COL18A1;COL6A3;CTSB;PLEC,47 (47),0.263,0.56,1,HMDB0033934,6 (7),0.494,1,0.396,0.746
Signaling by FGFR3,Reactome,8,SHC1;HRAS;GRB2;PPP2CB;PPP2R1A;PIK3R1;PTPN11;MAPK1,41 (41),0.521,0.894,2,HMDB0000693;HMDB0000304,9 (10),0.25,1,0.396,0.747
MECP2 and Associated Rett Syndrome,Wikipathways,17,PSIP1;GAMT;HNRNPH1;IGF1;SMC3;FKBP5;UBE3A;MTOR;TARDBP;CAMK2A;HNRNPF;RPS6;CNP;CSRP1;APOC2;FUS;DHX9,73 (73),0.204,0.459,1,HMDB0000123,9 (11),0.64,1,0.396,0.747
NrCAM interactions,Reactome,2,DLG1;ANK1,7 (7),0.392,0.75,0,,0 (0),1,1,0.392,0.75
DEx/H-box helicases activate type I IFN and inflammatory cytokines production ,Reactome,2,RELA;DHX9,7 (7),0.392,0.75,0,,0 (1),1,1,0.392,0.75
Modulation by Mtb of host immune system,Reactome,2,MRC1;B2M,7 (7),0.392,0.75,0,,0 (0),1,1,0.392,0.75
tsp-1 induced apoptosis in microvascular endothelial cell,BioCarta,2,MAPK14;CASP3,7 (7),0.392,0.75,0,,0 (0),1,1,0.392,0.75
cdc25 and chk1 regulatory pathway in response to dna damage,BioCarta,2,ATM;YWHAH,7 (7),0.392,0.75,0,,0 (0),1,1,0.392,0.75
TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation,Reactome,2,HSPD1;NPM1,7 (7),0.392,0.75,0,,0 (0),1,1,0.392,0.75
Validated transcriptional targets of deltaNp63 isoforms,PID,10,RAB38;ADA;ADRM1;YAP1;FASN;SEC14L2;ATM;ITCH;RACK1;PPP2R5A,47 (47),0.393,0.751,0,,0 (0),1,1,0.393,0.751
Serotonin Receptor 4-6-7 and NR3C Signaling,Wikipathways,6,MAP2K1;MAP2K2;RAP1A;GNAS;NR3C1;MAPK1,19 (19),0.132,0.334,0,,2 (2),1,1,0.4,0.752
Gastrin-CREB signalling pathway via PKC and MAPK,Reactome,6,HRAS;EGFR;GRB2;PRKCA;RPS6KA1;MAPK1,19 (19),0.132,0.334,0,,4 (5),1,1,0.4,0.752
gata3 participate in activating the th2 cytokine genes expression,BioCarta,6,PRKAR1A;MAP2K3;PRKAR2A;MAPK14;GNAS;PRKACB,19 (19),0.132,0.334,0,,3 (5),1,1,0.4,0.752
RIPK1-mediated regulated necrosis,Reactome,6,FLOT1;FADD;FLOT2;HSP90AA1;CDC37;PDCD6IP,22 (22),0.223,0.494,1,HMDB0000290,8 (14),0.597,1,0.402,0.755
Non-integrin membrane-ECM interactions,Reactome,9,PRKCA;LAMA2;ITGB1;LAMB2;ITGB3;TTR;ACTN1;VTN;CASK,42 (42),0.395,0.756,0,,0 (3),1,1,0.395,0.756
SUMO E3 ligases SUMOylate target proteins,Reactome,37,SMC1A;NPM1;TPR;PARP1;RANBP2;RANGAP1;NOP58;SAFB;STAG2;NUP155;RAE1;UBE2I;SMC3;TRIM28;PARK7;NUP210;NUP98;NUP133;PCNA;CTBP1;RELA;NUP93;NUP58;NR3C1;NUP160;TOP1;HNRNPC;RXRA;TOP2B;HNRNPK;DDX5;NUP35;HDAC2;PML;SEC13;RAD21;NUP205,177 (177),0.27,0.573,1,HMDB0001547,6 (8),0.494,1,0.402,0.756
Pregnenolone biosynthesis,Reactome,3,FDXR;FDX1;AKR1B1,12 (12),0.401,0.763,2,HMDB0000067;HMDB0006763,11 (13),0.334,1,0.403,0.756
Osteopontin-mediated events,PID,9,RHOA;CDC42;ITGB3;PIK3R1;RELA;GSN;RAC1;MAPK1;ILK,32 (32),0.134,0.338,0,,4 (4),1,1,0.403,0.756
Noncanonical Wnt signaling pathway,PID,9,MAPK9;RHOA;YES1;CDC42;CSNK1A1;FLNA;ROCK1;CAMK2A;RAC1,32 (32),0.134,0.338,0,,3 (3),1,1,0.403,0.756
Alpha-synuclein signaling,PID,9,MAOB;LYN;UBE2L3;TOR1A;FKBP1A;CSNK2A1;PARK7;PPP2R5D;YES1,32 (32),0.134,0.338,0,,2 (3),1,1,0.403,0.756
Eicosanoid Synthesis,Wikipathways,5,LTA4H;PNPLA8;PTGES2;PTGS1;DPEP1,23 (23),0.444,0.83,3,HMDB0002995;HMDB0003208;HMDB0001043,18 (23),0.303,1,0.404,0.758
Neurotransmitter Disorders,Wikipathways,1,MAOA,1 (1),0.189,0.429,1,HMDB0000472,11 (16),0.714,1,0.405,0.758
Sialic acid metabolism,Reactome,9,NPL;GLB1;ST3GAL6;CMAS;GNE;NANS;ST6GAL1;ST3GAL4;CTSA,33 (33),0.155,0.381,1,HMDB0000290,18 (27),0.871,1,0.406,0.759
Gastric acid secretion - Homo sapiens (human),KEGG,18,CALM1;ATP1B3;PLCB3;ATP1B1;ATP1A1;PRKCA;ACTG1;CAMK2A;CAMK2D;GNAI3;GNAI2;PRKACA;GNAQ;GNAS;ACTB;ITPR2;MYLK;PRKACB,76 (76),0.175,0.418,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,13 (14),0.772,1,0.406,0.759
SUMOylation,Reactome,39,SMC1A;NPM1;TPR;PARP1;RANBP2;RANGAP1;NOP58;SAFB;STAG2;NUP155;RAE1;UBE2I;SMC3;TRIM28;PARK7;NUP210;NUP98;NUP133;UBA2;SAE1;PCNA;CTBP1;RELA;NUP93;NUP58;NR3C1;NUP160;TOP1;HNRNPC;RXRA;TOP2B;HNRNPK;DDX5;NUP35;HDAC2;PML;SEC13;RAD21;NUP205,182 (182),0.212,0.474,1,HMDB0001547,9 (11),0.64,1,0.407,0.76
Aurora B signaling,PID,11,RHOA;CUL3;NPM1;VIM;NSUN2;DES;PEBP1;NCL;PPP2R5D;PPP1CC;MYLK,41 (41),0.136,0.341,0,,2 (2),1,1,0.407,0.76
Signaling by FLT3 ITD and TKD mutants,Reactome,5,HRAS;STAT5B;PTPN11;GRB2;PIK3R1,15 (15),0.136,0.341,0,,9 (9),1,1,0.408,0.761
superoxide radicals degradation,HumanCyc,4,SOD2;SOD1;GPX1;CAT,11 (11),0.137,0.341,0,,10 (11),1,1,0.409,0.762
CMP phosphorylation,HumanCyc,4,NME3;NME2;NME1;CMPK1,11 (11),0.137,0.341,0,,5 (5),1,1,0.409,0.762
Synthesis_ secretion_ and deacylation of Ghrelin,Reactome,4,SPCS1;SPCS2;SEC11A;SPCS3,11 (11),0.137,0.341,0,,3 (3),1,1,0.409,0.762
p38MAPK events,Reactome,4,MAPK14;HRAS;RALA;RALB,11 (11),0.137,0.341,0,,5 (5),1,1,0.409,0.762
Free fatty acids regulate insulin secretion,Reactome,4,GNAQ;PLCB3;ACSL4;GNA11,11 (11),0.137,0.341,0,,14 (17),1,1,0.409,0.762
rho-selective guanine exchange factor akap13 mediates stress fiber formation,BioCarta,4,PRKAR2A;PRKAG1;RHOA;PRKACB,11 (11),0.137,0.341,0,,3 (3),1,1,0.409,0.762
Apoptosis - multiple species - Homo sapiens (human),KEGG,7,MAPK9;FADD;HTRA2;SEPTIN4;CASP3;BID;BAX,32 (32),0.4,0.763,0,,0 (0),1,1,0.4,0.763
HCMV Early Events,Reactome,22,TPR;RANBP2;NUP155;RAE1;EGFR;RBBP4;NUP210;DYNLL2;NUP98;NUP133;DYNC1LI1;NUP93;NUP58;ITGB1;NUP160;DYNC1H1;DYNC1I2;DYNC1LI2;NUP35;PML;SEC13;NUP205,109 (109),0.4,0.763,0,,0 (2),1,1,0.4,0.763
Signaling by FGFR1 in disease,Reactome,9,HRAS;GRB2;MYO18A;CPSF6;PIK3R1;ERLIN2;STAT3;LRRFIP1;STAT5B,38 (38),0.281,0.59,1,HMDB0000693,6 (17),0.494,1,0.413,0.763
Pyrimidine metabolism,Wikipathways,20,RRM1;NME3;TYMP;DHODH;POLR2A;ENPP3;PNPT1;UMPS;DPYD;ENPP1;NT5C;POLE;RRM2B;UPB1;CAD;CMPK1;CTPS2;DPYS;NME1;NME2,84 (84),0.154,0.378,2,HMDB0001342;HMDB0003349#HMDB0000528,35 (40),0.903,1,0.413,0.763
Arachidonic Acid Metabolism,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,66 (71),0.272,1,0.413,0.763
Salicylate-sodium Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,66 (72),0.272,1,0.413,0.763
Rofecoxib Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,66 (72),0.272,1,0.413,0.763
Valdecoxib Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,66 (72),0.272,1,0.413,0.763
Bromfenac Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,66 (72),0.272,1,0.413,0.763
Leukotriene C4 Synthesis Deficiency,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,66 (71),0.272,1,0.413,0.763
Flurbiprofen Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,66 (72),0.272,1,0.413,0.763
Lumiracoxib Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,66 (72),0.272,1,0.413,0.763
Trisalicylate-choline Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,66 (71),0.272,1,0.413,0.763
Nepafenac Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,66 (72),0.272,1,0.413,0.763
Salsalate Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,66 (72),0.272,1,0.413,0.763
Tiaprofenic Acid Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,66 (72),0.272,1,0.413,0.763
Nabumetone Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,66 (72),0.272,1,0.413,0.763
FGFR3 signaling in chondrocyte proliferation and terminal differentiation,Wikipathways,6,ATG5;MAP2K1;MAP2K2;CNP;MAPK14;MAPK1,27 (27),0.402,0.764,0,,0 (1),1,1,0.402,0.764
Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome,Wikipathways,5,RBBP4;HDAC2;MTA2;CHD4;CBX3,22 (22),0.403,0.764,0,,0 (0),1,1,0.403,0.764
ras-independent pathway in nk cell-mediated cytotoxicity,BioCarta,5,PTPN6;PIK3R1;MAP2K1;B2M;RAC1,22 (22),0.403,0.764,0,,0 (0),1,1,0.403,0.764
RANKL-RANK signaling pathway,Wikipathways,14,MAPK9;LYN;MAP2K1;CDC42;MTOR;SQSTM1;PIK3R1;RAC1;RELA;ACP5;ICAM1;MAPK14;PAPSS2;MAPK1,55 (55),0.141,0.351,0,,1 (2),1,1,0.418,0.771
Calcium Regulation in the Cardiac Cell,Wikipathways,33,GJB1;CALM1;GNG12;CALR;CAMK2A;CAMK2D;ANXA6;PRKACA;PRKACB;PRKAR1A;PRKAR2A;PRKCA;GNA11;GNAI2;GNAI3;GNAQ;GNAS;YWHAQ;GNB1;GNB2;CAMK1;ATP1B1;ATP1B3;FKBP1A;YWHAB;ATP2B1;YWHAE;YWHAG;YWHAH;YWHAZ;ATP2A2;PLCB3;ITPR2,151 (151),0.199,0.45,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.42,0.774
dolichyl-diphosphooligosaccharide biosynthesis,HumanCyc,3,ALG5;DPM3;DPM1,10 (10),0.288,0.599,1,HMDB0000290,6 (7),0.494,1,0.42,0.774
Insulin Pathway,PID,12,SHC1;HRAS;GRB2;GRB14;PIK3R1;EXOC5;NCK1;SORBS1;PTPN11;CRK;CAV1;EXOC4,46 (46),0.144,0.357,0,,5 (5),1,1,0.423,0.778
MAPK family signaling cascades,Reactome,54,IQGAP1;CUL3;DNAJB1;PPP2CB;PPP2R1A;RAP1A;RAP1B;PPP2R5A;PPP2R5D;PPP2R5E;TLN1;PIK3R1;LAMTOR2;FGG;KITLG;FN1;PPP5C;CALM1;FNTA;EGFR;CSK;PEBP1;CAMK2A;CAMK2D;SPTA1;SPTAN1;SPTB;SPTBN1;SPTBN2;PRKACA;PRKACB;SHC1;HRAS;LYPLA1;FGA;FGB;GRB2;PAK2;DLG1;MAPK1;SEPTIN7;MAP2K1;MAP2K2;CDC42;YWHAB;ITGB3;ARAF;HSPB1;VCL;RAC1;ITGA2B;RBX1;PPP1CB;PPP1CC,270 (270),0.339,0.67,3,HMDB0000693;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000123,22 (36),0.425,1,0.424,0.778
Toll Like Receptor 4 (TLR4) Cascade,Reactome,26,CUL1;S100A8;S100A9;PPP2CB;PPP2R1A;MAP2K4;MAPK14;FUS;PPP2R5D;FADD;UBE2D3;FGG;CD14;UBE2N;UBE2V1;RPS6KA1;DUSP3;FGA;FGB;RELA;SKP1;MAPK1;MAPK9;MAP2K1;MAP2K3;ITGB2,112 (112),0.145,0.36,0,,6 (14),1,1,0.426,0.778
Diclofenac Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Naproxen Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Phenylbutazone Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Tenoxicam Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Etodolac Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Ketoprofen Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Acetylsalicylic Acid Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Diflunisal Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Acetaminophen  Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Sulindac Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Ketorolac Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Etoricoxib Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Carprofen Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Fenoprofen Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Antrafenine Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Antipyrine Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Magnesium salicylate Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Lornoxicam Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Tolmetin Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Salicylic Acid Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Oxaprozin Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Meloxicam Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Suprofen Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Mefenamic Acid Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
Piroxicam Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,30 (30),0.51,0.878,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.428,0.778
RHOQ GTPase cycle,Reactome,15,GOPC;WASL;CDC42;PAK2;RAB7A;ARHGAP1;ARHGAP17;JUP;STEAP3;STOM;CAV1;IQGAP1;CDC42BPB;LAMTOR1;TFRC,60 (60),0.147,0.364,0,,4 (4),1,1,0.429,0.778
PKC-gamma calcium signaling pathway in ataxia,Wikipathways,5,GNAQ;PDK1;PLCB3;GNA11;CA8,22 (22),0.403,0.764,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (4),0.365,1,0.429,0.778
Vitamin B5 (pantothenate) metabolism,Reactome,4,FASN;COASY;VNN1;PPCS,14 (14),0.263,0.56,2,HMDB0001416;HMDB0001016,17 (17),0.559,1,0.429,0.778
Notch,NetPath,12,SKP1;CUL1;RBX1;NUMB;PIK3R1;HDAC2;RELA;STAT3;ITCH;NCSTN;MAPK1;SNW1,58 (58),0.413,0.781,0,,0 (0),1,1,0.413,0.781
Linoleate metabolism,EHMN,15,UGT1A3;EPHX1;UGT2B10;UGT2B15;PLA2G12B;CYP1A2;GPX1;SLC23A1;CYP4B1;PTGS1;CYP2E1;FADS1;EPHX2;FADS2;GPX4,72 (72),0.38,0.734,3,HMDB0003073;HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,21 (24),0.395,1,0.435,0.789
Sphingolipid Metabolism (integrated pathway),Wikipathways,7,SPHK2;KDSR;CERS2;PLPP3;ASAH1;SGPL1;DEGS1,24 (24),0.151,0.373,0,,7 (10),1,1,0.437,0.791
Signaling by Hedgehog,Reactome,18,SEL1L;DERL2;SKP1;PRKAR1A;CUL1;PRKAR2A;OS9;NUMB;VCP;CSNK1A1;ERLEC1;ITCH;CUL3;RBX1;SYVN1;P4HB;PRKACA;PRKACB,79 (79),0.223,0.494,1,HMDB0000067,10 (11),0.679,1,0.438,0.792
Chromosomal and microsatellite instability in colorectal cancer,Wikipathways,12,MAPK9;RHOA;CASP3;BAX;RALA;RALB;CSNK1A1;ARAF;RAC1;MAP2K1;MAPK1;CTNNB1,73 (73),0.747,1,1,HMDB0001043,2 (2),0.203,1,0.438,0.792
MAP kinase activation,Reactome,16,MAPK9;MAP2K1;CUL1;MAP2K3;UBE2V1;SKP1;PPP2CB;PPP2R1A;MAP2K4;MAPK14;RPS6KA1;DUSP3;PPP2R5D;FUS;MAPK1;UBE2N,65 (65),0.152,0.375,0,,4 (7),1,1,0.438,0.792
Interleukin-17 signaling,Reactome,16,MAPK9;MAP2K1;CUL1;MAP2K3;UBE2V1;SKP1;PPP2CB;PPP2R1A;MAP2K4;MAPK14;RPS6KA1;DUSP3;PPP2R5D;FUS;MAPK1;UBE2N,65 (65),0.152,0.375,0,,4 (7),1,1,0.438,0.792
Citalopram Metabolism Pathway,SMPDB,3,MAOA;MAOB;AOX1,8 (8),0.179,0.418,1,HMDB0033934,17 (18),0.856,1,0.44,0.795
eicosanoid metabolism,BioCarta,6,MT-CO2;EPHX1;EPHX2;MPO;HPGDS;PTGS1,23 (23),0.257,0.55,1,HMDB0001043,8 (9),0.597,1,0.441,0.796
actions of nitric oxide in the heart,BioCarta,11,PRKAR1A;GUCY1A1;GUCY1B1;PRKAR2A;PIK3R1;HSP90AA1;KNG1;GNAQ;CAV1;GNB1;PRKACB,42 (42),0.154,0.38,0,,9 (10),1,1,0.443,0.799
Prion disease pathway,Wikipathways,9,RXRA;CASP3;SMC3;PDIA3;HSPA5;HSP90B1;STAT3;MAPK1;RAD21,33 (33),0.155,0.381,0,,1 (2),1,1,0.444,0.8
Type I collagen synthesis in the context of Osteogenesis imperfecta,Wikipathways,9,SERPINH1;P4HB;PPIB;TMEM38B;MIA3;COL1A1;SERPINF1;COLGALT1;COL1A2,33 (33),0.155,0.381,0,,2 (2),1,1,0.444,0.8
Trk receptor signaling mediated by the MAPK pathway,PID,9,HRAS;MAP2K1;MAP2K3;RUSC1;RAP1A;RPS6KA1;RAP1B;MAPK14;MAPK1,33 (33),0.155,0.381,0,,1 (1),1,1,0.444,0.8
VEGF signaling pathway - Homo sapiens (human),KEGG,13,HRAS;MAP2K1;PXN;CDC42;PRKCA;PIK3R1;SPHK2;HSPB1;RAC1;MAPK14;PPP3CA;MAPK1;MAP2K2,59 (59),0.315,0.64,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,6 (6),0.494,1,0.445,0.801
Biosynthesis of maresin-like SPMs,Reactome,2,CYP1A2;CYP2E1,6 (6),0.317,0.64,1,HMDB0002183,6 (17),0.494,1,0.447,0.804
Indomethacin Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,31 (31),0.545,0.917,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,67 (72),0.288,1,0.447,0.804
Na+/Cl- dependent neurotransmitter transporters,Reactome,2,SLC6A13;SLC22A1,19 (19),0.898,1,5,HMDB0240251;HMDB0000123;HMDB0000172;HMDB0000687;HMDB0000043,28 (32),0.174,1,0.447,0.804
Osteoblast Signaling,Wikipathways,2,ITGB3;COL1A1,14 (14),0.772,1,1,HMDB0000876,2 (3),0.203,1,0.447,0.804
FGF signaling pathway,PID,14,SHC1;CTTN;GRB2;CDH1;CDH2;CAMK2A;RPS6KA1;PTPN11;STAT3;MAPK14;STAT5B;MAPK1;PIK3R1;CTNND1,56 (56),0.157,0.386,0,,3 (4),1,1,0.448,0.805
mBDNF and proBDNF regulation of GABA neurotransmission,Wikipathways,8,AP2A1;AP2A2;AP2B1;ROCK1;PIK3R1;SHC1;RHOA;STAT3,38 (38),0.429,0.808,0,,0 (0),1,1,0.429,0.808
Pathways in cancer - Homo sapiens (human),KEGG,100,TPM3;TPR;HSP90B1;HIF1A;HMOX1;RALB;FADD;BAX;ITGA2B;F2;TFG;ITGB1;RXRA;STAT2;STAT3;STAT4;STAT5B;STAT6;BID;TXNRD1;STK4;JUP;KITLG;MGST1;MGST2;MGST3;GSTA5;PIK3R1;AGT;NQO1;HRAS;ROCK1;GNA11;GNAI2;GNAI3;GNAQ;GNAS;GNB1;GNB2;GSTO1;PLCB3;RAC1;HSP90AA1;RBX1;PML;HSP90AB1;COL4A2;CUL2;CUL1;ELOC;RALA;ELOB;FN1;CALM1;EML4;CAMK2A;CAMK2D;FH;CASP3;GRB2;LAMB2;RELA;TXNRD2;SKP1;ARAF;CRK;CRKL;GSTA1;GSTA2;GSTA3;GSTA4;GSTM1;GSTM2;RHOA;GSTM4;GSTP1;GSTT1;GSTT2;IGF1;LAMA2;ARHGEF12;EGFR;MTOR;GNA13;KNG1;PRKACA;PRKACB;PRKCA;GNG12;CTBP1;CTNNA1;CTNNA2;MAPK1;CTNNB1;MAPK9;MAP2K1;MAP2K2;CDC42;CDH1;HDAC2,531 (531),0.527,0.897,4,HMDB0000067;HMDB0000234;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000077,26 (31),0.302,1,0.452,0.811
Parathyroid hormone synthesis_ secretion and action - Homo sapiens (human),KEGG,19,MAPK1;GNA13;NACA;EGFR;PLCB3;ARAF;PRKCA;RHOA;GNA11;RXRA;GNAQ;GNAI2;GNAI3;SLC9A3R1;MAP2K1;GNAS;ITPR2;PRKACA;PRKACB,106 (106),0.638,1,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0003550,9 (10),0.25,1,0.452,0.811
Protein methylation,Reactome,6,CALM1;HSPA8;EEF2;VCP;EEF1A1;ETFB,20 (20),0.16,0.392,0,,2 (2),1,1,0.454,0.811
DNA Damage Bypass,Reactome,12,CUL4B;CUL4A;ISG15;DDB1;PCNA;USP10;NPLOC4;POLE;VCP;UFD1;TRIM25;RBX1,47 (47),0.162,0.395,0,,8 (11),1,1,0.457,0.811
PCP/CE pathway,Reactome,12,AP2A1;AP2A2;AP2B1;PFN1;PRKCA;AP2S1;RHOA;AP2M1;RAC1;CLTA;CLTB;CLTC,47 (47),0.162,0.395,0,,6 (8),1,1,0.457,0.811
coenzyme A biosynthesis,HumanCyc,2,COASY;PPCS,7 (7),0.392,0.75,2,HMDB0001416;HMDB0001016,13 (13),0.414,1,0.458,0.811
Procainamide (Antiarrhythmic) Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,2,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145;HMDB0015169,11 (11),0.334,1,0.458,0.811
Bupranolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,2,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145;HMDB0015697,11 (11),0.334,1,0.458,0.811
Tocainide Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,2,HMDB0015189;HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.334,1,0.458,0.811
Dobutamine Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,2,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145;HMDB0014979,11 (11),0.334,1,0.458,0.811
Mexiletine Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,2,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145;HMDB0014523,11 (11),0.334,1,0.458,0.811
Pindolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,2,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145;HMDB0015095,11 (11),0.334,1,0.458,0.811
Penbutolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,2,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145;HMDB0015447,11 (11),0.334,1,0.458,0.811
N-Glycan antennae elongation,Reactome,2,ST6GAL1;ST3GAL4,15 (15),0.805,1,1,HMDB0000290,2 (6),0.203,1,0.46,0.811
Role of second messengers in netrin-1 signaling,Reactome,1,PITPNA,4 (4),0.567,0.927,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,3 (4),0.289,1,0.46,0.811
Caffeine and Theobromine metabolism,Wikipathways,2,CYP1A2;XDH,4 (4),0.164,0.395,0,,11 (11),1,1,0.46,0.811
Drug-mediated inhibition of ERBB2 signaling,Reactome,2,HSP90AA1;CDC37,4 (4),0.164,0.395,0,,1 (3),1,1,0.46,0.811
Serotonin Receptor 2 and STAT3 Signaling,Wikipathways,2,GNAQ;STAT3,4 (4),0.164,0.395,0,,1 (1),1,1,0.46,0.811
Rapoport-Luebering glycolytic shunt,HumanCyc,2,BPGM;PGAM1,4 (5),0.164,0.395,0,,7 (7),1,1,0.46,0.811
molybdenum cofactor biosynthesis,HumanCyc,2,GPHN;NFS1,4 (4),0.164,0.395,0,,9 (13),1,1,0.46,0.811
Resolution of AP sites via the single-nucleotide replacement pathway,Reactome,2,APEX1;LIG3,4 (4),0.164,0.395,0,,1 (4),1,1,0.46,0.811
Regulation of Apoptosis,Reactome,2,OPA1;PAK2,4 (4),0.164,0.395,0,,1 (1),1,1,0.46,0.811
Biosynthesis of E-series 18(R)-resolvins,Reactome,2,LTA4H;GPX4,4 (4),0.164,0.395,0,,8 (15),1,1,0.46,0.811
Synthesis of PIPs in the nucleus,Reactome,2,PIP4P1;PIP4K2C,4 (4),0.164,0.395,0,,4 (6),1,1,0.46,0.811
cardiolipin biosynthesis,HumanCyc,2,NDUFS3;PTPMT1,4 (4),0.164,0.395,0,,5 (9),1,1,0.46,0.811
trehalose degradation,HumanCyc,2,GCK;GALM,4 (4),0.164,0.395,0,,8 (8),1,1,0.46,0.811
Utilization of Ketone Bodies,Reactome,2,BDH1;ACAT1,4 (4),0.164,0.395,0,,9 (10),1,1,0.46,0.811
Lipoic acid metabolism - Homo sapiens (human),KEGG,2,LIAS;ACSM1,4 (4),0.164,0.395,0,,5 (13),1,1,0.46,0.811
Biosynthesis of D-series resolvins,Reactome,2,LTA4H;GPX4,4 (4),0.164,0.395,0,,10 (25),1,1,0.46,0.811
Biosynthesis of protectins,Reactome,2,CYP1A2;LTA4H,4 (4),0.164,0.395,0,,7 (14),1,1,0.46,0.811
Alternative complement activation,Reactome,2,CFB;C3,4 (4),0.164,0.395,0,,1 (3),1,1,0.46,0.811
Axonal growth stimulation,Reactome,2,RHOA;ARHGDIA,4 (4),0.164,0.395,0,,1 (1),1,1,0.46,0.811
Thiamine Metabolism,SMPDB,2,TPK1;NTPCR,4 (4),0.164,0.395,0,,9 (9),1,1,0.46,0.811
serine biosynthesis (phosphorylated route),HumanCyc,2,PSPH;VPS29,4 (4),0.164,0.395,0,,11 (11),1,1,0.46,0.811
mRNA Editing: C to U Conversion,Reactome,1,A1CF,8 (8),0.812,1,1,HMDB0033934,2 (3),0.203,1,0.462,0.815
Pregnane X receptor pathway,Wikipathways,7,DNAJC7;UGT1A3;PSMC5;RXRA;HSP90AA1;GSTA2;ABCC2,33 (33),0.434,0.815,0,,0 (1),1,1,0.434,0.815
GnRH secretion - Homo sapiens (human),KEGG,10,HRAS;MAP2K1;MAP2K2;PRKCA;GNA11;PLCB3;GNAQ;MAPK1;PIK3R1;ITPR2,64 (64),0.792,1,2,HMDB0000234;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,8 (9),0.209,1,0.463,0.816
Riboflavin and CoQ disorders,Wikipathways,1,ETFDH,1 (1),0.189,0.429,1,HMDB0000244,19 (26),0.885,1,0.466,0.821
Endohydrolysis of 1_4-alpha-D-glucosidic linkages in polysaccharides by alpha-amylase,EHMN,0,,6 (6),1,1,2,HMDB0001262;HMDB0001296,7 (7),0.168,1,0.467,0.822
pregnenolone biosynthesis,HumanCyc,0,,1 (1),1,1,2,HMDB0000067;HMDB0006763,7 (7),0.168,1,0.467,0.822
Viral myocarditis - Homo sapiens (human),KEGG,12,CASP3;ACTG1;ITGB2;RAC1;CAV1;BID;CXADR;ICAM1;LAMA2;ACTB;EIF4G1;EIF4G2,59 (60),0.438,0.823,0,,0 (0),1,1,0.438,0.823
Reelin signaling pathway,PID,6,ITGB1;LRPAP1;PIK3R1;RAP1A;CRKL;PAFAH1B1,28 (28),0.439,0.823,0,,0 (0),1,1,0.439,0.823
TWEAK,NetPath,6,MAPK9;FADD;RELA;CD163;RAC1;MAPK1,28 (28),0.439,0.823,0,,0 (0),1,1,0.439,0.823
Fc epsilon RI signaling pathway - Homo sapiens (human),KEGG,13,HRAS;LYN;MAP2K1;MAP2K2;MAP2K3;MAPK9;PRKCA;PIK3R1;MAP2K4;RAC1;MAPK14;MAPK1;GRB2,67 (68),0.505,0.878,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0001043,11 (11),0.334,1,0.469,0.823
TRAF6 mediated NF-kB activation,Reactome,5,TRIM25;DDX58;RELA;RNF135;MAVS,16 (16),0.169,0.405,0,,2 (5),1,1,0.469,0.823
mRNA decay by 3_ to 5_ exoribonuclease,Reactome,5,EXOSC6;SKIV2L;TTC37;WDR61;HBS1L,16 (16),0.169,0.405,0,,8 (10),1,1,0.469,0.823
Sema3A PAK dependent Axon repulsion,Reactome,5,HSP90AA1;CFL1;PAK2;HSP90AB1;RAC1,16 (16),0.169,0.405,0,,3 (3),1,1,0.469,0.823
hypoxia-inducible factor in the cardivascular system,BioCarta,5,HSP90AA1;P4HB;LDHA;HIF1A;COPS5,16 (16),0.169,0.405,0,,2 (3),1,1,0.469,0.823
calcium signaling by hbx of hepatitis b virus,BioCarta,5,SHC1;HRAS;MAP2K1;GRB2;CSNK2A1,16 (16),0.169,0.405,0,,3 (6),1,1,0.469,0.823
POLB-Dependent Long Patch Base Excision Repair,Reactome,2,APEX1;PARP1,7 (7),0.392,0.75,1,HMDB0001178,5 (7),0.433,1,0.471,0.826
The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies,Wikipathways,11,MAOA;LMNA;FNTA;MAOB;NAP1L1;TMPO;CSNK1A1;AGO2;CTNNB1;ACTB;ZMPSTE24,54 (54),0.443,0.83,0,,0 (1),1,1,0.443,0.83
Proteoglycan biosynthesis,EHMN,5,ARCN1;COPA;COPB1;COPE;COPG2,30 (30),0.693,1,2,HMDB0000290;HMDB0000304,9 (19),0.25,1,0.477,0.837
DAG and IP3 signaling,Reactome,10,CALM1;PRKAR1A;PRKAR2A;PRKCA;CAMK2A;CAMK2D;KPNA2;ITPR2;PRKACA;PRKACB,42 (42),0.259,0.553,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,10 (11),0.679,1,0.482,0.838
melatonin degradation I,HumanCyc,4,CYP1A2;SULT1A1;UGT2B10;POR,12 (12),0.176,0.418,0,,10 (13),1,1,0.482,0.838
Negative regulation of NOTCH4 signaling,Reactome,4,RBX1;SKP1;CUL1;YWHAZ,12 (12),0.176,0.418,0,,2 (2),1,1,0.482,0.838
Josephin domain DUBs,Reactome,4,VCP;ATXN3;RAD23A;RAD23B,12 (12),0.176,0.418,0,,1 (2),1,1,0.482,0.838
Signaling by PDGFRA transmembrane_ juxtamembrane and kinase domain mutants,Reactome,4,HRAS;GRB2;STAT3;PIK3R1,12 (12),0.176,0.418,0,,5 (6),1,1,0.482,0.838
Signaling by PDGFRA extracellular domain mutants,Reactome,4,HRAS;GRB2;STAT3;PIK3R1,12 (12),0.176,0.418,0,,5 (6),1,1,0.482,0.838
Regulation of localization of FOXO transcription factors,Reactome,4,YWHAB;YWHAQ;YWHAG;YWHAZ,12 (12),0.176,0.418,0,,2 (2),1,1,0.482,0.838
Early Phase of HIV Life Cycle,Reactome,4,XRCC5;PSIP1;XRCC6;BANF1,12 (12),0.176,0.418,0,,1 (5),1,1,0.482,0.838
CaMK IV-mediated phosphorylation of CREB,Reactome,4,CALM1;CAMK2D;KPNA2;CAMK2A,12 (12),0.176,0.418,0,,3 (3),1,1,0.482,0.838
phospholipase c-epsilon pathway,BioCarta,4,PRKAR2A;GNAS;PRKAR1A;PRKACB,12 (12),0.176,0.418,0,,4 (6),1,1,0.482,0.838
g-protein signaling through tubby proteins,BioCarta,4,GNAQ;F2;GNB1;AGT,12 (12),0.176,0.418,0,,1 (2),1,1,0.482,0.838
CD28 dependent Vav1 pathway,Reactome,4,CDC42;GRB2;PAK2;RAC1,12 (12),0.176,0.418,0,,5 (5),1,1,0.482,0.838
Neutrophil extracellular trap formation - Homo sapiens (human),KEGG,33,MPO;MAPK14;FGG;SLC25A4;SLC25A5;MTOR;PIK3R1;GSDMD;ACTB;HDAC6;MAPK1;FGA;FGB;H2AX;ACTG1;PRKCA;C3;RELA;MACROH2A1;C5;ITGA2B;CR1L;MAP2K1;MAP2K2;ITGB2;ITGB3;PPIF;PLCB3;RAC1;VDAC1;VDAC2;HDAC2;VDAC3,188 (190),0.707,1,2,HMDB0029931;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,9 (13),0.25,1,0.484,0.838
RAF/MAP kinase cascade,Reactome,46,CUL3;PPP2CB;PPP2R1A;PPP2R5D;RAP1A;RAP1B;PPP2R5A;ITGA2B;PPP2R5E;TLN1;PIK3R1;LAMTOR2;FGG;KITLG;FN1;PPP5C;CALM1;FNTA;EGFR;CSK;PEBP1;CAMK2A;CAMK2D;SPTA1;SPTAN1;SPTB;SPTBN1;SPTBN2;SHC1;HRAS;LYPLA1;FGA;FGB;GRB2;DLG1;MAPK1;IQGAP1;MAP2K1;MAP2K2;YWHAB;ITGB3;ARAF;VCL;RBX1;PPP1CB;PPP1CC,235 (235),0.417,0.787,3,HMDB0000693;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000123,22 (36),0.425,1,0.484,0.838
IL8- and CXCR2-mediated signaling events,PID,9,LYN;RAB7A;PRKCA;RAB5A;PPP2R1A;PLCB3;RAB11A;GNAI2;GNB1,34 (34),0.178,0.418,0,,4 (4),1,1,0.485,0.838
Signaling by ERBB2 KD Mutants,Reactome,7,SHC1;HRAS;EGFR;GRB2;PIK3R1;HSP90AA1;CDC37,25 (25),0.178,0.418,0,,6 (10),1,1,0.485,0.838
Signaling by ERBB2 in Cancer,Reactome,7,SHC1;HRAS;EGFR;GRB2;PIK3R1;HSP90AA1;CDC37,25 (25),0.178,0.418,0,,6 (10),1,1,0.485,0.838
stathmin and breast cancer resistance to antimicrotubule agents,BioCarta,7,PRKAR1A;PRKAR2A;TUBA4A;CAMK2A;CAMK2D;TUBA1C;PRKACB,25 (25),0.178,0.418,0,,2 (2),1,1,0.485,0.838
mRNA Editing,Reactome,1,A1CF,10 (10),0.877,1,1,HMDB0033934,2 (4),0.203,1,0.485,0.838
Miro GTPase Cycle,Reactome,3,MFN1;RAP1GDS1;MFN2,8 (8),0.179,0.418,0,,4 (4),1,1,0.486,0.838
ARMS-mediated activation,Reactome,3,YWHAB;RAP1A;CRK,8 (8),0.179,0.418,0,,5 (5),1,1,0.486,0.838
OAS antiviral response,Reactome,3,DDX58;ABCE1;FLNA,8 (8),0.179,0.418,0,,2 (6),1,1,0.486,0.838
Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion,Reactome,3,GNAQ;PLCB3;GNA11,8 (8),0.179,0.418,0,,9 (12),1,1,0.486,0.838
EPH-ephrin mediated repulsion of cells,Reactome,3,LYN;YES1;RAC1,8 (8),0.179,0.418,0,,4 (5),1,1,0.486,0.838
InlA-mediated entry of Listeria monocytogenes into host cells,Reactome,3,CTNNB1;CTNND1;CDH1,8 (8),0.179,0.418,0,,2 (2),1,1,0.486,0.838
S1P5 pathway,PID,3,RHOA;GNAI3;GNAI2,8 (8),0.179,0.418,0,,3 (3),1,1,0.486,0.838
a4b7 Integrin signaling,PID,3,ITGB1;RHOA;PXN,8 (8),0.179,0.418,0,,1 (1),1,1,0.486,0.838
Sulfur relay system - Homo sapiens (human),KEGG,3,MPST;NFS1;TST,8 (8),0.179,0.418,0,,7 (11),1,1,0.486,0.838
visceral fat deposits and the metabolic syndrome,BioCarta,3,RXRA;HSD11B1;NR3C1,8 (8),0.179,0.418,0,,2 (3),1,1,0.486,0.838
role of parkin in ubiquitin-proteasomal pathway,BioCarta,3,UBE2L3;UBE2G1;UBE2G2,8 (8),0.179,0.418,0,,2 (2),1,1,0.486,0.838
cbl mediated ligand-induced downregulation of egf receptors pathway,BioCarta,3,PRKCA;EGFR;GRB2,8 (8),0.179,0.418,0,,1 (2),1,1,0.486,0.838
Thyroxine biosynthesis,Reactome,3,DUOX1;IYD;DIO1,8 (8),0.179,0.418,0,,16 (17),1,1,0.486,0.838
ethanol degradation II,HumanCyc,3,ALDH3A2;ACSS3;ACSS2,8 (8),0.179,0.418,0,,12 (12),1,1,0.486,0.838
Effects of nitric oxide,Wikipathways,3,MT-CO1;XDH;AOX1,8 (8),0.179,0.418,0,,7 (7),1,1,0.486,0.838
Regulated Necrosis,Reactome,7,FLOT1;FADD;FLOT2;GSDMD;HSP90AA1;CDC37;PDCD6IP,29 (29),0.3,0.619,1,HMDB0000290,8 (16),0.597,1,0.487,0.838
SREBF and miR33 in cholesterol and lipid homeostasis,Wikipathways,4,PRKAA1;MTOR;FASN;HMGCS1,18 (18),0.45,0.839,0,,0 (0),1,1,0.45,0.839
Metabolism of Angiotensinogen to Angiotensins,Reactome,5,CTSZ;ANPEP;ENPEP;CTSD;AGT,18 (18),0.242,0.521,1,HMDB0060579,12 (28),0.745,1,0.489,0.841
Apoptosis induced DNA fragmentation,Reactome,3,KPNA1;CASP3;KPNB1,13 (13),0.456,0.843,0,,0 (3),1,1,0.456,0.843
Non-homologous end-joining - Homo sapiens (human),KEGG,3,XRCC5;XRCC6;RAD50,13 (13),0.456,0.843,0,,0 (0),1,1,0.456,0.843
role of mitochondria in apoptotic signaling,BioCarta,3,AIFM1;BAX;BID,13 (13),0.456,0.843,0,,0 (0),1,1,0.456,0.843
the 41bb-dependent immune response,BioCarta,3,MAPK14;RELA;MAP2K3,13 (13),0.456,0.843,0,,0 (0),1,1,0.456,0.843
Interleukin-15 signaling,Reactome,2,SHC1;GRB2,8 (8),0.463,0.843,0,,0 (0),1,1,0.463,0.843
IL-4 signaling,INOH,2,PTPN6;STAT6,8 (8),0.463,0.843,0,,0 (0),1,1,0.463,0.843
SMAC_ XIAP-regulated apoptotic response,Reactome,2,CASP3;SEPTIN4,8 (8),0.463,0.843,0,,0 (0),1,1,0.463,0.843
Nef and signal transduction,Reactome,2,PAK2;RAC1,8 (8),0.463,0.843,0,,0 (1),1,1,0.463,0.843
Glial Cell Differentiation,Wikipathways,2,CNP;TPPP,8 (8),0.463,0.843,0,,0 (0),1,1,0.463,0.843
Circadian rhythm related genes,Wikipathways,1,GNAQ,3 (3),0.466,0.843,0,,0 (0),1,1,0.466,0.843
DNA IR-double strand breaks and cellular response via ATM,Wikipathways,1,ATM,3 (3),0.466,0.843,0,,0 (0),1,1,0.466,0.843
RUNX2 regulates genes involved in differentiation of myeloid cells,Reactome,1,LGALS3,3 (3),0.466,0.843,0,,0 (0),1,1,0.466,0.843
Oligomerization of connexins into connexons,Reactome,1,GJB1,3 (3),0.466,0.843,0,,0 (0),1,1,0.466,0.843
Gap junction assembly,Reactome,1,GJB1,3 (3),0.466,0.843,0,,0 (1),1,1,0.466,0.843
Progressive trimming of alpha-1_2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2,Reactome,1,MAN1A1,3 (3),0.466,0.843,0,,0 (7),1,1,0.466,0.843
Transport of connexins along the secretory pathway,Reactome,1,GJB1,3 (3),0.466,0.843,0,,0 (0),1,1,0.466,0.843
AlphaE beta7 integrin cell surface interactions,PID,1,CDH1,3 (3),0.466,0.843,0,,0 (0),1,1,0.466,0.843
Mitochondrial transcription initiation,Reactome,1,TFAM,3 (3),0.466,0.843,0,,0 (1),1,1,0.466,0.843
Platelet homeostasis,Reactome,19,STIM1;ATP2A2;GUCY1A1;GUCY1B1;PPP2R5A;ATP2B1;PPP2CB;GNG12;PPP2R1A;PPP2R5D;PTPN6;APOB;PTPN11;MAPK14;PPP2R5E;GNAS;ITPR2;GNB1;GNB2,85 (85),0.242,0.521,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,24 (28),0.746,1,0.49,0.843
il-2 receptor beta chain in t cell activation,BioCarta,12,SHC1;HRAS;MAP2K1;GRB2;NMI;PIK3R1;PTPN6;CRKL;PCNA;STAT5B;MAPK1;MAP2K2,48 (48),0.181,0.423,0,,2 (2),1,1,0.491,0.843
Glucose Homeostasis,Wikipathways,0,,1 (1),1,1,4,HMDB0000637;HMDB0000951;HMDB0000172;HMDB0000138,21 (21),0.181,1,0.491,0.844
Peptide hormone metabolism,Reactome,12,ANPEP;CTSD;SPCS1;DPP4;ENPEP;SPCS3;ERO1A;CTSZ;SEC11A;AGT;SPCS2;ERO1B,50 (50),0.222,0.493,1,HMDB0060579,15 (31),0.819,1,0.492,0.845
MAPK1/MAPK3 signaling,Reactome,46,CUL3;PPP2CB;PPP2R1A;PPP2R5D;RAP1A;RAP1B;PPP2R5A;ITGA2B;PPP2R5E;TLN1;PIK3R1;LAMTOR2;FGG;KITLG;FN1;PPP5C;CALM1;FNTA;EGFR;CSK;PEBP1;CAMK2A;CAMK2D;SPTA1;SPTAN1;SPTB;SPTBN1;SPTBN2;SHC1;HRAS;LYPLA1;FGA;FGB;GRB2;DLG1;MAPK1;IQGAP1;MAP2K1;MAP2K2;YWHAB;ITGB3;ARAF;VCL;RBX1;PPP1CB;PPP1CC,236 (236),0.429,0.808,3,HMDB0000693;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000123,22 (36),0.425,1,0.493,0.846
Acute myeloid leukemia - Homo sapiens (human),KEGG,16,PER2;MPO;MAP2K1;GRB2;CD14;HRAS;MTOR;PIK3R1;JUP;ARAF;RELA;STAT3;STAT5B;MAPK1;PML;MAP2K2,67 (67),0.184,0.429,0,,1 (1),1,1,0.495,0.847
FGF,INOH,13,HRAS;MAP2K1;GRB2;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;PIK3R1;ARAF;MAPK1;YWHAQ;MAP2K2,67 (67),0.505,0.878,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (5),0.365,1,0.496,0.847
FOXO-mediated transcription,Reactome,14,ABCA6;YWHAB;YWHAG;YWHAZ;CAT;PCK1;SIRT3;GCK;SOD2;CAV1;HDAC2;YWHAQ;NR3C1;ATXN3,62 (62),0.272,0.576,1,HMDB0001547,10 (12),0.679,1,0.496,0.847
Reactions specific to the complex N-glycan synthesis pathway,Reactome,3,MAN2A1;FUCA1;MGAT2,10 (10),0.288,0.599,1,HMDB0000290,9 (19),0.64,1,0.497,0.847
Amino acid transport across the plasma membrane,Reactome,3,SLC38A4;SLC43A1;SLC38A3,32 (32),0.956,1,5,HMDB0240251;HMDB0000123;HMDB0000172;HMDB0000687;HMDB0000043,29 (32),0.194,1,0.497,0.847
keratinocyte differentiation,BioCarta,13,SHC1;HRAS;EGFR;GRB2;MAP2K3;PRKCA;MAP2K4;PPP2R5D;RELA;MAPK14;MAP2K1;MAPK1;MAP2K2,53 (53),0.187,0.429,0,,3 (3),1,1,0.501,0.847
flavin biosynthesis,HumanCyc,1,FLAD1,2 (2),0.342,0.67,1,HMDB0000244,7 (7),0.549,1,0.501,0.847
Conjugation of phenylacetate with glutamine,Reactome,1,ACSM1,2 (2),0.342,0.67,1,HMDB0006344,7 (9),0.549,1,0.501,0.847
Biosynthesis of DHA-derived sulfido conjugates,Reactome,1,GSTM4,2 (2),0.342,0.67,1,HMDB0000123,7 (22),0.549,1,0.501,0.847
Metabolism of Dichloroethylene by CYP450,Wikipathways,1,CYP2E1,1 (1),0.189,0.429,0,,9 (10),1,1,0.503,0.847
Acrylamide Biotransformation and Exposure Biomarkers,Wikipathways,1,CYP2E1,1 (1),0.189,0.429,0,,3 (4),1,1,0.503,0.847
Disorders of the Krebs cycle,Wikipathways,1,FH,1 (1),0.189,0.429,0,,12 (15),1,1,0.503,0.847
Molybdenum cofactor (Moco) biosynthesis,Wikipathways,1,MOCS1,1 (1),0.189,0.429,0,,4 (11),1,1,0.503,0.847
sulfite oxidation,HumanCyc,1,SUOX,1 (1),0.189,0.429,0,,4 (5),1,1,0.503,0.847
thiosulfate disproportionation III (rhodanese),HumanCyc,1,TST,1 (1),0.189,0.429,0,,3 (5),1,1,0.503,0.847
Oleoyl-phe metabolism,Reactome,1,PM20D1,1 (1),0.189,0.429,0,,2 (4),1,1,0.503,0.847
adenine and adenosine salvage II,HumanCyc,1,ADK,1 (1),0.189,0.429,0,,5 (5),1,1,0.503,0.847
NADPH regeneration,Reactome,1,IDH1,1 (1),0.189,0.429,0,,7 (8),1,1,0.503,0.847
L-dopa degradation,HumanCyc,1,COMT,1 (1),0.189,0.429,0,,13 (13),1,1,0.503,0.847
glutamine biosynthesis,HumanCyc,1,GLUL,1 (1),0.189,0.429,0,,7 (7),1,1,0.503,0.847
thio-molybdenum cofactor biosynthesis,HumanCyc,1,MOCOS,1 (1),0.189,0.429,0,,4 (6),1,1,0.503,0.847
adenine and adenosine salvage I,HumanCyc,1,APRT,1 (1),0.189,0.429,0,,7 (7),1,1,0.503,0.847
D-mannose degradation,HumanCyc,1,MPI,1 (1),0.189,0.429,0,,1 (2),1,1,0.503,0.847
methylglyoxal degradation VI,HumanCyc,1,LDHD,1 (1),0.189,0.429,0,,9 (9),1,1,0.503,0.847
acetyl-CoA biosynthesis from citrate,HumanCyc,1,ACLY,1 (1),0.189,0.429,0,,7 (7),1,1,0.503,0.847
Metabolism of ingested MeSeO2H into MeSeH,Reactome,1,TXNRD1,1 (1),0.189,0.429,0,,7 (8),1,1,0.503,0.847
L-serine degradation,HumanCyc,1,SDSL,1 (1),0.189,0.429,0,,6 (7),1,1,0.503,0.847
Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate,Reactome,1,IDH1,1 (1),0.189,0.429,0,,5 (5),1,1,0.503,0.847
tRNA processing in the mitochondrion,Reactome,1,TRNT1,1 (1),0.189,0.429,0,,3 (5),1,1,0.503,0.847
Diseases of metabolism,Reactome,1,IDH1,1 (1),0.189,0.429,0,,5 (5),1,1,0.503,0.847
Methylation of MeSeH for excretion,Reactome,1,INMT,1 (1),0.189,0.429,0,,5 (6),1,1,0.503,0.847
thiamin salvage III,HumanCyc,1,TPK1,1 (1),0.189,0.429,0,,5 (5),1,1,0.503,0.847
Vitamin E,Reactome,1,TTPA,1 (1),0.189,0.429,0,,1 (1),1,1,0.503,0.847
iron-sulfur cluster biosynthesis,HumanCyc,1,NFS1,1 (1),0.189,0.429,0,,6 (6),1,1,0.503,0.847
Toxicity of tetanus toxin (tetX),Reactome,1,VAMP2,1 (1),0.189,0.429,0,,3 (3),1,1,0.503,0.847
<i>S</i>-methyl-5_-thioadenosine degradation,HumanCyc,1,MTAP,1 (1),0.189,0.429,0,,4 (4),1,1,0.503,0.847
sorbitol degradation I,HumanCyc,1,SORD,1 (1),0.189,0.429,0,,4 (5),1,1,0.503,0.847
4-hydroxybenzoate biosynthesis,HumanCyc,1,TAT,1 (1),0.189,0.429,0,,17 (17),1,1,0.503,0.847
Thioguanine Metabolism Pathway,SMPDB,1,HPRT1,1 (1),0.189,0.429,0,,5 (5),1,1,0.503,0.847
PDGF Pathway,Wikipathways,3,MAP2K4;HRAS;MAPK1,11 (11),0.345,0.673,1,HMDB0001043,7 (8),0.549,1,0.504,0.848
Depolymerisation of the Nuclear Lamina,Reactome,3,LMNA;LMNB1;PRKCA,11 (11),0.345,0.673,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,7 (7),0.549,1,0.504,0.848
Negative regulation of MET activity,Reactome,6,PTPRJ;GRB2;EPS15;USP8;STAM2;HGS,21 (21),0.191,0.433,0,,4 (5),1,1,0.507,0.85
pkc-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase,BioCarta,6,PRKCA;ROCK1;GNA13;MYLK;GNAQ;GNB1,21 (21),0.191,0.433,0,,1 (3),1,1,0.507,0.85
phosphoinositides and their downstream targets,BioCarta,6,LYN;RAC1;RAB5A;EEA1;ARF1;PFKL,21 (21),0.191,0.433,0,,1 (1),1,1,0.507,0.85
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,Reactome,6,CUL2;ELOC;ELOB;HIF1A;RBX1;UBE2D3,21 (21),0.191,0.433,0,,5 (7),1,1,0.507,0.85
EGFR downregulation,Reactome,8,EGFR;GRB2;CDC42;EPS15;STAM2;EPS15L1;EPN1;HGS,30 (30),0.191,0.433,0,,5 (6),1,1,0.508,0.851
Activation of BH3-only proteins,Reactome,8,YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;YWHAQ;BID;DYNLL2,30 (30),0.191,0.433,0,,4 (5),1,1,0.508,0.851
Regulation of TP53 Activity through Acetylation,Reactome,8,MTA2;RBBP4;CHD4;PIN1;PIP4P1;HDAC2;PML;PIP4K2C,30 (30),0.191,0.433,0,,7 (9),1,1,0.508,0.851
T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection,Wikipathways,11,CALM1;PDK1;MAP2K1;MAP2K2;AHSA1;MAPK9;DLG1;PTPN6;NCK1;CHP1;GRB2,63 (63),0.663,1,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,3 (3),0.289,1,0.508,0.851
Coenzyme A biosynthesis,Reactome,2,COASY;PPCS,8 (8),0.463,0.843,2,HMDB0001416;HMDB0001016,13 (13),0.414,1,0.509,0.852
RUNX2 regulates osteoblast differentiation,Reactome,5,MAPK1;YES1;HDAC6;COL1A1;YAP1,23 (23),0.444,0.83,1,HMDB0000234,5 (6),0.433,1,0.509,0.852
Endometrial cancer - Homo sapiens (human),KEGG,14,HRAS;CTNNB1;EGFR;BAX;CDH1;MAP2K2;PIK3R1;ARAF;CTNNA1;CTNNA2;MAP2K1;MAPK1;ILK;GRB2,58 (58),0.192,0.436,0,,1 (1),1,1,0.509,0.852
Interconversion of polyamines,Reactome,1,PAOX,3 (3),0.466,0.843,2,HMDB0001276;HMDB0001186,13 (13),0.414,1,0.511,0.854
Centrosome maturation,Reactome,19,CKAP5;MAPRE1;DCTN2;YWHAE;YWHAG;CSNK1D;PPP2R1A;TUBB4B;PAFAH1B1;DYNC1H1;TUBA4A;DYNC1I2;ACTR1A;HSP90AA1;DCTN1;DCTN3;SSNA1;PRKACA;CEP192,82 (82),0.194,0.438,0,,2 (2),1,1,0.511,0.854
Human papillomavirus infection - Homo sapiens (human),KEGG,69,PPP2R5D;ATP6AP1;ATP6V1A;COL6A2;COL6A3;ATP6V1B2;ATP6V0C;ATP6V1C1;ATP6V1E1;PPP2R5A;ATP6V1H;ATP6V0A1;SLC9A3R1;FADD;PPP2CB;GNAS;PXN;PPP2R5E;COL6A6;ISG15;COL4A2;UBE3A;MTOR;CSNK1A1;ATP6V0D1;PIK3R1;PSMC1;ATP6V1D;VTN;UBR4;EIF2AK2;FN1;PRKACA;PRKACB;MAPK1;HRAS;PKM;CASP3;BAX;TCIRG1;LAMB2;DLG1;COL6A5;ATP6V1G1;COL6A1;RELA;CHD4;PPP2R1A;ITGA1;EGFR;ITGA2B;CTNNB1;ITGA5;ITGA9;PPP2R2A;ATM;MAP2K2;CDC42;ITGB1;ITGB3;MAP2K1;LLGL2;STAT2;GRB2;LAMA2;RHEB;HDAC2;COL1A1;COL1A2,331 (331),0.194,0.439,0,,3 (3),1,1,0.512,0.856
FOXA1 transcription factor network,PID,11,AP1B1;NFIA;PISD;ATP5PF;COL18A1;NFIB;SERPINA1;APOB;SOD1;VTN;NDUFV3,44 (44),0.195,0.44,0,,3 (3),1,1,0.514,0.857
Ganglio Sphingolipid Metabolism,Wikipathways,1,SLC33A1,13 (13),0.934,1,2,HMDB0006734;HMDB0004842,8 (19),0.209,1,0.514,0.857
Fcgamma receptor (FCGR) dependent phagocytosis,Reactome,30,WASL;ABI1;CYFIP1;BAIAP2;ITPR2;NCKAP1;BRK1;IGHG1;PIK3R1;CFL1;ARPC1A;ACTB;GRB2;ACTG1;CYFIP2;NCK1;MAPK1;CDC42;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;CRK;RAC1;HSP90AA1;PLD4;ARPC2;HSP90AB1,155 (155),0.471,0.851,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,13 (16),0.414,1,0.514,0.857
BCR,NetPath,25,PTPN6;PTPN11;MAPK14;GTF2I;GRB2;FCGR2B;STAT3;PIK3R1;RPS6;RPS6KA1;HNRNPK;SHC1;BAX;CD81;NCK1;MAPK1;CTNNB1;RELA;PIP4K2C;LYN;IGHM;HCLS1;CRK;CRKL;ITPR2,129 (129),0.477,0.859,0,,0 (0),1,1,0.477,0.859
ornithine <i>de novo </i> biosynthesis,HumanCyc,2,GLUD1;OAT,5 (5),0.24,0.518,1,HMDB0002104,15 (15),0.819,1,0.516,0.86
Angiopoietin Like Protein 8 Regulatory Pathway,Wikipathways,29,PIK3R4;FLOT2;MAP2K4;FASN;MAPK14;FBP1;MTOR;CYP7A1;MAP4K5;RPS6KA1;EIF4E;PRKAA1;PRKAA2;PRKAB1;SHC1;HRAS;PRKAG1;MAPK1;MAPK9;FLOT1;MAP2K1;MAP2K2;MAP2K3;PIK3R1;RXRA;PCK1;CRK;CAP1;RHEB,131 (131),0.196,0.443,0,,5 (9),1,1,0.516,0.86
Rheumatoid arthritis - Homo sapiens (human),KEGG,16,ICAM1;ACP5;ATP6V1H;TCIRG1;ITGB2;CTSL;ATP6V1A;ATP6V1B2;ATP6V0C;ATP6V1C1;ATP6V1E1;ATP6V1G1;ATP6V1D;ATP6V0A1;ATP6AP1;ATP6V0D1,92 (93),0.683,1,1,HMDB0000876,3 (3),0.289,1,0.517,0.861
Ras activation upon Ca2+ influx through NMDA receptor,Reactome,5,CALM1;CAMK2A;CAMK2D;DLG1;HRAS,22 (22),0.403,0.764,1,HMDB0000123,6 (6),0.494,1,0.521,0.867
BCR signaling pathway,PID,16,SHC1;CALM1;LYN;MAP2K1;FCGR2B;CSNK2A1;CSK;HRAS;PIK3R1;PTPN6;RELA;RAC1;MAPK14;PPP3CA;MAPK1;GRB2,68 (68),0.201,0.452,0,,4 (4),1,1,0.523,0.869
AMP-activated protein kinase (AMPK) signaling,Wikipathways,16,ACACB;PRKAG1;HNF4A;CAB39;ACACA;ELAVL1;MTOR;EEF2;PIK3R1;FASN;GYS2;PRKAA1;PRKAA2;PRKAB1;CPT1A;PRKACB,68 (68),0.201,0.452,0,,7 (7),1,1,0.523,0.869
Cannabinoid receptor signaling,Wikipathways,4,FAAH;PRKAR1A;PRKACA;PRKACB,20 (20),0.538,0.908,2,HMDB0004080;HMDB0001043,12 (23),0.374,1,0.524,0.871
Arf6 signaling events,PID,9,EGFR;PXN;KIF13B;ITGB3;GNA11;NCK1;GNAQ;ITGA2B;ARF6,35 (35),0.202,0.454,0,,4 (4),1,1,0.525,0.871
Striated Muscle Contraction,Reactome,9,TPM1;TPM3;TPM4;TNNT3;TMOD3;VIM;TTN;DES;MYL3,35 (35),0.202,0.454,0,,4 (5),1,1,0.525,0.871
thyroid hormone metabolism I (via deiodination),HumanCyc,1,DIO1,3 (3),0.466,0.843,1,HMDB0000667,5 (11),0.433,1,0.525,0.871
Prostaglandin Leukotriene metabolism,INOH,5,LTA4H;CBR1;HPGDS;PTGES2;PTGS1,23 (23),0.444,0.83,3,HMDB0002995;HMDB0001043;HMDB0003208,23 (25),0.455,1,0.525,0.871
Eicosanoids,Reactome,2,CYP4B1;CYP8B1,12 (12),0.692,1,2,HMDB0002995;HMDB0003208,10 (13),0.292,1,0.525,0.871
prion pathway,BioCarta,4,RPSA;LAMA2;HSPA5;LAMB2,19 (19),0.495,0.872,0,,0 (0),1,1,0.495,0.872
akt signaling pathway,BioCarta,4,HSP90AA1;RELA;YWHAH;PIK3R1,19 (19),0.495,0.872,0,,0 (0),1,1,0.495,0.872
EGF-Ncore,Signalink,11,SNX9;ELP1;PRKCA;FLNA;PEBP1;PPP2R2A;SPAG9;DUSP3;EIF4E;PRKACA;PTPN11,56 (56),0.495,0.872,0,,0 (0),1,1,0.495,0.872
Prader-Willi and Angelman Syndrome,Wikipathways,2,UBE3A;CYFIP1,42 (43),0.998,1,1,HMDB0001229,2 (3),0.203,1,0.526,0.872
Heroin metabolism,Wikipathways,0,,3 (3),1,1,1,HMDB0041812,2 (3),0.203,1,0.527,0.872
C6 deamination of adenosine,Reactome,0,,2 (2),1,1,1,HMDB0033934,2 (4),0.203,1,0.527,0.872
mRNA Editing: A to I Conversion,Reactome,0,,2 (2),1,1,1,HMDB0033934,2 (4),0.203,1,0.527,0.872
creatine biosynthesis,HumanCyc,1,GAMT,2 (2),0.342,0.67,1,HMDB0000123,8 (8),0.597,1,0.528,0.874
PKA activation in glucagon signalling,Reactome,5,PRKAR2A;GNAS;PRKAR1A;PRKACA;PRKACB,17 (17),0.204,0.459,0,,5 (5),1,1,0.529,0.874
Keratan sulfate/keratin metabolism,Reactome,8,GLB1;HEXA;HEXB;ST3GAL6;PRELP;GNS;ST3GAL4;LUM,33 (33),0.275,0.581,1,HMDB0000290,12 (19),0.745,1,0.529,0.875
Elastic fibre formation,Reactome,7,ITGB1;ITGB3;MFAP4;FBLN1;FBLN5;VTN;ITGA5,35 (35),0.5,0.878,0,,0 (1),1,1,0.5,0.878
TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition,Wikipathways,3,MAPK1;FN1;VIM,14 (14),0.509,0.878,0,,0 (0),1,1,0.509,0.878
Atypical NF-kappaB pathway,PID,3,MAPK14;RELA;PIK3R1,14 (14),0.509,0.878,0,,0 (0),1,1,0.509,0.878
Molecules associated with elastic fibres,Reactome,6,ITGB1;ITGB3;MFAP4;FBLN1;FBLN5;VTN,30 (30),0.51,0.878,0,,0 (1),1,1,0.51,0.878
Recognition of DNA damage by PCNA-containing replication complex,Reactome,6,CUL4B;CUL4A;DDB1;POLE;PCNA;RBX1,30 (30),0.51,0.878,0,,0 (1),1,1,0.51,0.878
Downregulation of TGF-beta receptor signaling,Reactome,7,STRAP;USP15;UCHL5;XPO1;PPP1CA;PPP1CB;PPP1CC,26 (26),0.206,0.463,0,,2 (2),1,1,0.532,0.879
Cardiac Hypertrophic Response,Wikipathways,13,CALM1;MAP2K1;MAP2K2;MAP2K3;PRKCA;MTOR;RAC1;MAP2K4;CAMK2D;IGF1;MAPK14;MAPK1;PPP3CA,54 (54),0.207,0.464,0,,4 (5),1,1,0.532,0.879
Intestinal absorption,Reactome,1,SLC2A2,4 (4),0.567,0.927,1,HMDB0000067,4 (8),0.365,1,0.533,0.879
O-linked glycosylation of mucins,Reactome,3,ST6GAL1;ST3GAL4;GALNT2,66 (66),1,1,2,HMDB0000290;HMDB0000304,8 (8),0.209,1,0.536,0.883
L-dopachrome biosynthesis,HumanCyc,0,,1 (1),1,1,2,HMDB0001229;HMDB0004067,8 (8),0.209,1,0.536,0.883
Biosynthesis of DPA-derived SPMs,Reactome,0,,4 (4),1,1,2,HMDB0001976;HMDB0006528,8 (34),0.209,1,0.536,0.883
Transmission across Chemical Synapses,Reactome,50,NPTN;ABAT;AP2M1;AP2S1;PPM1F;GLS2;LIN7C;MAOA;CALM1;GNG12;AP2B1;MYO6;NSF;CAMK2A;CAMK2D;RPS6KA1;SLC22A1;GLS;PPFIA1;PRKAA1;PRKAA2;VAMP2;PRKACA;PRKACB;GLUL;HRAS;PRKAG1;PRKAR1A;AP2A2;PRKAR2A;SLC6A13;PRKCA;DLG1;GNAI2;GNAI3;CAMK1;MAPK1;GNB1;GNB2;PRKAB1;ALDH5A1;COMT;HSPA8;PLCB3;EPB41L1;RAC1;AP2A1;LIN7A;CASK;KPNA2,249 (249),0.336,0.67,7,HMDB0033934;HMDB0015124;HMDB0000123;HMDB0001043;HMDB0000043;HMDB0004080;HMDB0002088,69 (78),0.622,1,0.536,0.883
Antigen processing-Cross presentation,Reactome,10,CALR;SEC61A1;MRC1;CTSL;TAP2;TAPBP;SEC61B;SEC22B;B2M;STX4,40 (40),0.21,0.471,0,,9 (14),1,1,0.538,0.885
Triglyceride biosynthesis,Reactome,3,AGMO;DGAT1;GPAM,14 (14),0.509,0.878,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,13 (18),0.414,1,0.539,0.887
Hepatitis C - Homo sapiens (human),KEGG,34,PPP2CB;PPP2R1A;PPP2R2A;CASP3;GRB2;MAVS;CTNNB1;EGFR;EIF2S1;PIK3R1;SCARB1;HRAS;FADD;BAX;DDX58;CD81;RELA;CLDN3;MAPK1;YWHAQ;MAP2K1;MAP2K2;YWHAB;EIF2AK2;YWHAE;YWHAG;YWHAH;YWHAZ;RXRA;ARAF;STAT2;STAT3;BID;PSME3,157 (157),0.211,0.473,0,,1 (2),1,1,0.539,0.887
NCAM signaling for neurite out-growth,Reactome,14,COL6A6;COL4A2;GRB2;HRAS;COL6A5;COL6A1;COL6A2;COL6A3;SPTA1;SPTAN1;SPTB;SPTBN1;SPTBN2;MAPK1,59 (59),0.211,0.473,0,,5 (7),1,1,0.54,0.887
Interferon Signaling,Reactome,35,FLNA;FLNB;PTPN6;PTPN11;MT2A;TRIM25;CAMK2A;DDX58;ISG15;UBE2N;IFITM3;ABCE1;EIF4A3;CAMK2D;EIF4A1;EIF4A2;B2M;EIF4E;EIF4G1;EIF4G2;PSMB8;IFI30;GBP2;ICAM1;SAMHD1;ARIH1;NEDD4;TRIM14;IFI35;EIF2AK2;TRIM5;STAT2;PPM1B;PML;EIF4E2,162 (162),0.211,0.473,0,,6 (12),1,1,0.54,0.887
Influenza A - Homo sapiens (human),KEGG,37,DNAJB1;RAB11B;CASP3;TRIM25;MAPK1;RAE1;DDX58;SLC25A4;SLC25A5;HNRNPUL1;PABPN1;EIF2S1;PIK3R1;ICAM1;ACTB;RAB11A;NUP98;FADD;BAX;ACTG1;PRKCA;NLRX1;MAVS;KPNA6;RELA;XPO1;PLG;MAP2K1;MAP2K2;EIF2AK2;DNAJC3;STAT2;VDAC1;PML;KPNA1;BID;KPNA2,172 (172),0.212,0.474,0,,3 (3),1,1,0.54,0.887
MFAP5-mediated ovarian cancer cell motility and invasiveness,Wikipathways,2,MAPK1;ITGB3,13 (13),0.735,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,3 (3),0.289,1,0.541,0.887
Cell-type Dependent Selectivity of CCK2R Signaling,Wikipathways,2,CD38;GNAQ,13 (13),0.735,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,3 (7),0.289,1,0.541,0.887
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,Reactome,7,CALM1;HRAS;DLG1;CAMK2A;CAMK2D;RPS6KA1;MAPK1,30 (30),0.333,0.668,1,HMDB0000123,9 (10),0.64,1,0.543,0.889
Transcriptional regulation by RUNX2,Reactome,13,RBM14;SKP1;BAX;CUL1;RBX1;YAP1;COL1A1;LGALS3;MAPK1;NR3C1;HDAC6;ITGA5;YES1,73 (73),0.639,1,2,HMDB0000234;HMDB0001547,11 (13),0.334,1,0.543,0.889
Phosphatidylcholine catabolism,Wikipathways,0,,0 (0),1,1,3,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0008048,6 (9),0.0191,0.891,0.0191,0.891
Validated nuclear estrogen receptor alpha network,PID,15,NEDD8;PHB2;CTSD;SRA1;ATP5PF;SOD1;AP1B1;C3;COL18A1;UBE2M;UBA3;SAFB;PCNA;NDUFV3;ANP32A,64 (64),0.215,0.481,0,,1 (1),1,1,0.545,0.894
Bladder cancer - Homo sapiens (human),KEGG,8,HRAS;TYMP;MAP2K1;MAP2K2;CDH1;ARAF;EGFR;MAPK1,41 (41),0.521,0.894,0,,0 (0),1,1,0.521,0.894
Downregulation of ERBB4 signaling,Reactome,2,ITCH;NEDD4,9 (9),0.529,0.897,0,,0 (0),1,1,0.529,0.897
cyclin e destruction pathway,BioCarta,2,SKP1;CUL1,9 (9),0.529,0.897,0,,0 (0),1,1,0.529,0.897
Type I hemidesmosome assembly,Reactome,2,DST;PLEC,9 (9),0.529,0.897,0,,0 (1),1,1,0.529,0.897
Small interfering RNA (siRNA) biogenesis,Reactome,2,AGO2;TSN,9 (9),0.529,0.897,0,,0 (2),1,1,0.529,0.897
Class I PI3K signaling events,PID,11,HRAS;LYN;YES1;RAC1;PIK3R1;RAP1A;RHOA;ARF1;HSP90AA1;ARF5;ARF6,45 (45),0.217,0.484,0,,4 (4),1,1,0.548,0.897
RhoA signaling pathway,PID,11,DIAPH1;RHOA;VCL;MAP2K3;CFL1;ITGB1;RDX;ROCK1;MAP2K4;TLN1;CDC42,45 (45),0.217,0.484,0,,1 (1),1,1,0.548,0.897
Rap1 signaling pathway - Homo sapiens (human),KEGG,40,RHOA;RALA;RALB;RAP1A;RAP1B;IGF1;MAPK14;CDC42;GNAS;KITLG;CALM1;EGFR;PIK3R1;TLN1;ACTB;MAPK1;HRAS;ACTG1;PRKCA;CRKL;TLN2;AFDN;GNAI2;GNAI3;GNAQ;ITGA2B;CTNNB1;CTNND1;PFN1;MAP2K1;MAP2K2;MAP2K3;CDH1;ITGB1;ITGB2;ITGB3;PLCB3;CRK;RAC1;FARP2,210 (210),0.502,0.878,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,5 (5),0.433,1,0.549,0.898
Signal regulatory protein family interactions,Reactome,4,PTPN6;CD47;PTPN11;GRB2,13 (13),0.219,0.486,0,,2 (3),1,1,0.551,0.899
activation of pkc through g-protein coupled receptors,BioCarta,4,GNAQ;PRKCA;F2;AGT,13 (13),0.219,0.486,0,,2 (3),1,1,0.551,0.899
extrinsic prothrombin activation pathway,BioCarta,4,FGG;F2;FGB;FGA,13 (13),0.219,0.486,0,,1 (1),1,1,0.551,0.899
effects of calcineurin in keratinocyte differentiation,BioCarta,4,GNAQ;PPP3CA;MARCKS;PRKCA,13 (13),0.219,0.486,0,,1 (3),1,1,0.551,0.899
African trypanosomiasis - Homo sapiens (human),KEGG,8,PRKCA;IDO2;APOA1;GNAQ;PLCB3;KNG1;ICAM1;THOP1,36 (37),0.366,0.709,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,8 (8),0.597,1,0.551,0.899
Gamma carboxylation_ hypusine formation and arylsulfatase activation,Reactome,10,EIF5A;ARSB;F2;F9;SUMF2;EEF2;GGCX;FN3KRP;DPH5;STS,41 (41),0.234,0.513,1,HMDB0030020,24 (34),0.935,1,0.551,0.899
proline degradation,HumanCyc,1,ALDH4A1,2 (2),0.342,0.67,1,HMDB0002104,9 (10),0.64,1,0.551,0.899
Sterols are 12-hydroxylated by CYP8B1,Reactome,1,CYP8B1,2 (2),0.342,0.67,1,HMDB0001993,9 (12),0.64,1,0.551,0.899
The influence of laminopathies on Wnt signaling,Wikipathways,7,LMNA;FNTA;CSNK1A1;TOR1AIP1;AGO2;CTNNB1;ZMPSTE24,36 (36),0.532,0.9,0,,0 (1),1,1,0.532,0.9
IL1-mediated signaling events,PID,7,UBE2N;UBE2V1;TOLLIP;ERC1;SQSTM1;PIK3R1;RELA,36 (36),0.532,0.9,0,,0 (0),1,1,0.532,0.9
rac1 cell motility signaling pathway,BioCarta,7,ARHGAP1;ARFGAP3;PIK3R1;CFL1;RAC1;ARFGAP1;MYLK,36 (36),0.532,0.9,0,,0 (0),1,1,0.532,0.9
SHC1 events in ERBB2 signaling,Reactome,5,SHC1;HRAS;PRKCA;EGFR;GRB2,22 (22),0.403,0.764,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,7 (8),0.549,1,0.555,0.904
Synthesis of PA,Reactome,8,GPD1;GPD2;ACP6;GPAM;GPD1L;LCLAT1;AGPAT2;AGPAT3,37 (37),0.398,0.76,2,HMDB0062321;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,17 (27),0.559,1,0.556,0.906
Phospholipase D signaling pathway - Homo sapiens (human),KEGG,30,RHOA;RALA;RALB;RRAS2;PTPN11;GNAS;KITLG;EGFR;PLPP3;MTOR;PIK3R1;GNA13;AGT;AGPAT2;AGPAT3;SHC1;HRAS;DNM3;GRB2;PRKCA;PLCB3;DNM2;MAPK1;SPHK2;F2;MAP2K1;MAP2K2;ARF1;RHEB;ARF6,147 (148),0.348,0.678,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,9 (11),0.64,1,0.557,0.906
Regulation of Androgen receptor activity,PID,8,MAP2K4;SMARCA2;DNAJA1;RXRA;MAPK14;HSP90AA1;NR3C1;RACK1,51 (51),0.772,1,1,HMDB0000234,3 (3),0.289,1,0.557,0.906
Signaling by ERBB2 TMD/JMD mutants,Reactome,6,SHC1;HRAS;EGFR;GRB2;HSP90AA1;CDC37,22 (22),0.223,0.494,0,,5 (6),1,1,0.558,0.906
Cellular roles of Anthrax toxin,PID,6,CALM1;MAP2K1;MAP2K2;MAP2K3;MAP2K4;MAPK1,22 (22),0.223,0.494,0,,4 (4),1,1,0.558,0.906
Transcription-Coupled Nucleotide Excision Repair (TC-NER),Reactome,18,COPS4;USP7;CUL4A;COPS6;COPS2;PRPF19;COPS8;DDB1;COPS5;LIG3;CUL4B;POLE;COPS3;POLR2A;PCNA;GPS1;RBX1;COPS7A,79 (79),0.223,0.494,0,,5 (7),1,1,0.558,0.907
HH-Ncore,Signalink,4,CUL3;RBX1;CDO1;CUL1,20 (20),0.538,0.908,0,,0 (0),1,1,0.538,0.908
TGF-beta signaling TAK1,INOH,4,MAPK14;MAPK9;MAP2K3;MAP2K4,20 (20),0.538,0.908,0,,0 (0),1,1,0.538,0.908
Canonical Wnt signaling pathway,PID,4,CAV1;CTNNB1;CUL3;PPP2R5A,20 (20),0.538,0.908,0,,0 (0),1,1,0.538,0.908
Proximal tubule transport,Wikipathways,13,ATP1B1;ATP6V1H;AQP1;ABCC2;ATP6V1A;ATP6V1G1;ATP6V0C;ATP6V1C1;ATP6V1E1;SLC2A2;ATP6V1D;SLC22A7;ATP1A1,57 (57),0.27,0.572,1,HMDB0000123,16 (28),0.838,1,0.562,0.912
IGF signaling,INOH,9,SHC1;HRAS;MAP2K1;GRB2;PIK3R1;ARAF;IGF1;MAPK1;MAP2K2,36 (36),0.227,0.502,0,,3 (4),1,1,0.564,0.914
TRIF(TICAM1)-mediated TLR4 signaling ,Reactome,20,CD14;FADD;MAP2K3;CUL1;MAPK9;SKP1;UBE2V1;PPP2CB;MAP2K1;PPP2R1A;MAP2K4;MAPK14;RELA;RPS6KA1;DUSP3;PPP2R5D;FUS;MAPK1;UBE2D3;UBE2N,89 (89),0.227,0.502,0,,5 (8),1,1,0.564,0.914
Free fatty acid receptors,Reactome,0,,5 (5),1,1,4,HMDB0003073;HMDB0001388;HMDB0006528;HMDB0002183,23 (24),0.228,1,0.565,0.916
Beta-catenin independent WNT signaling,Reactome,21,PFN1;CALM1;GNG12;AP2B1;AP2A2;PRKCA;RAC1;RHOA;CAMK2A;CLTC;PLCB3;AP2M1;AP2S1;AP2A1;CTNNB1;PPP3CA;CLTA;CLTB;ITPR2;GNB1;GNB2,94 (94),0.229,0.505,0,,14 (18),1,1,0.566,0.917
Prolactin signaling pathway - Homo sapiens (human),KEGG,15,GALT;HRAS;MAP2K1;GRB2;MAPK9;SLC2A2;PIK3R1;SHC1;RELA;GCK;STAT3;MAPK14;STAT5B;MAPK1;MAP2K2,70 (70),0.337,0.67,1,HMDB0000145,10 (11),0.679,1,0.566,0.917
p38 mapk signaling pathway,BioCarta,6,HRAS;CDC42;MAP2K4;HSPB1;RAC1;MAPK14,31 (31),0.545,0.917,0,,0 (0),1,1,0.545,0.917
GABA synthesis_ release_ reuptake and degradation,Reactome,5,HSPA8;VAMP2;ABAT;ALDH5A1;SLC6A13,19 (19),0.281,0.59,1,HMDB0000043,15 (17),0.819,1,0.568,0.92
Interleukin-1 Induced Activation of NF-kappa-B,Wikipathways,3,SQSTM1;UBE2N;UBE2V1,9 (9),0.232,0.51,0,,2 (2),1,1,0.571,0.921
Caloric restriction and aging,Wikipathways,3,MTOR;IGF1;NAMPT,9 (9),0.232,0.51,0,,3 (3),1,1,0.571,0.921
Ethanol metabolism resulting in production of ROS by CYP2E1,Wikipathways,3,CYP2E1;MAP2K1;MAP2K2,9 (9),0.232,0.51,0,,13 (16),1,1,0.571,0.921
STAT5 activation downstream of FLT3 ITD mutants,Reactome,3,STAT5B;PTPN11;GRB2,9 (9),0.232,0.51,0,,7 (7),1,1,0.571,0.921
Activated NTRK2 signals through RAS,Reactome,3,SHC1;HRAS;GRB2,9 (9),0.232,0.51,0,,4 (4),1,1,0.571,0.921
Activation of RAC1 downstream of NMDARs,Reactome,3,CAMK1;CALM1;RAC1,9 (9),0.232,0.51,0,,5 (5),1,1,0.571,0.921
Interleukin-23 signaling,Reactome,3,P4HB;STAT3;STAT4,9 (9),0.232,0.51,0,,2 (2),1,1,0.571,0.921
Benzo(a)pyrene metabolism,Wikipathways,3,EPHX1;AKR1C1;AKR1A1,9 (9),0.232,0.51,0,,1 (5),1,1,0.571,0.921
Processing and activation of SUMO,Reactome,3,UBE2I;UBA2;SAE1,9 (9),0.232,0.51,0,,3 (3),1,1,0.571,0.921
PI5P Regulates TP53 Acetylation,Reactome,3,PIP4P1;PIN1;PIP4K2C,9 (9),0.232,0.51,0,,6 (8),1,1,0.571,0.921
GPR40 Pathway,Wikipathways,2,PLCB3;GNA11,15 (15),0.805,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,3 (3),0.289,1,0.572,0.921
Celecoxib Action Pathway,SMPDB,6,CYP2E1;EPHX2;CBR1;PTGS1;LTA4H;GPX1,36 (36),0.698,1,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,70 (76),0.334,1,0.573,0.922
Muscle contraction,Reactome,37,TPM1;STIM1;TPM4;VIM;DES;TPM3;AHCYL1;MYL12A;MYH11;MYL3;MYL6;MYL9;CALD1;CALM1;GUCY1A1;GUCY1B1;ANXA1;ANXA2;MYLK;TLN1;PRKACA;ANXA6;PXN;TMOD3;SORBS1;ITGA1;FXYD1;ATP1A1;ATP1B1;ATP1B3;TNNT3;ATP2A2;TTN;ATP2B1;SORBS3;VCL;ITPR2,174 (174),0.234,0.513,0,,15 (16),1,1,0.574,0.924
Relaxin signaling pathway - Homo sapiens (human),KEGG,25,COL4A2;MAP2K4;MAPK14;MAPK1;GNG12;EGFR;PIK3R1;PRKACA;PRKACB;SHC1;HRAS;GRB2;PRKCA;RELA;PLCB3;GNAI3;GNAS;GNB1;GNB2;MAPK9;MAP2K1;MAP2K2;GNAI2;COL1A1;COL1A2,129 (129),0.477,0.859,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,6 (6),0.494,1,0.576,0.926
RUNX2 regulates bone development,Reactome,6,RBM14;YES1;YAP1;COL1A1;MAPK1;HDAC6,31 (31),0.545,0.917,1,HMDB0000234,5 (6),0.433,1,0.577,0.927
Spinal Cord Injury,Wikipathways,22,RHOA;VIM;PPP3CA;EGFR;ANXA1;RTN4;ICAM1;MIF;CD47;CASP3;AIF1;APEX1;PRKCA;C5;MAPK1;AQP1;CDC42;FKBP1A;OMG;LGALS3;RAC1;ARG1,117 (117),0.545,0.917,1,HMDB0001043,5 (9),0.433,1,0.577,0.927
H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity,Wikipathways,3,MACROH2A1;CTNNB1;CDH1,15 (15),0.559,0.927,0,,0 (0),1,1,0.559,0.927
Cancer immunotherapy by CTLA4 blockade,Wikipathways,3,PTPN6;PTPN11;PIK3R1,15 (15),0.559,0.927,0,,0 (0),1,1,0.559,0.927
ALK1 signaling events,PID,5,FKBP1A;CAV1;MAPK1;PPP1CA;CSNK2B,26 (26),0.56,0.927,0,,0 (0),1,1,0.56,0.927
Pathways of nucleic acid metabolism and innate immune sensing,Wikipathways,1,DDX58,4 (4),0.567,0.927,0,,0 (4),1,1,0.567,0.927
Regulation of gene expression by Hypoxia-inducible Factor,Reactome,1,HIF1A,4 (4),0.567,0.927,0,,0 (0),1,1,0.567,0.927
ATF6 (ATF6-alpha) activates chaperones,Reactome,1,HSPA5,4 (4),0.567,0.927,0,,0 (1),1,1,0.567,0.927
RORA activates gene expression,Reactome,1,CPT1A,4 (4),0.567,0.927,0,,0 (0),1,1,0.567,0.927
IkBA variant leads to EDA-ID,Reactome,1,RELA,4 (4),0.567,0.927,0,,0 (0),1,1,0.567,0.927
Diseases associated with the TLR signaling cascade,Reactome,1,RELA,4 (4),0.567,0.927,0,,0 (0),1,1,0.567,0.927
Diseases of Immune System,Reactome,1,RELA,4 (4),0.567,0.927,0,,0 (0),1,1,0.567,0.927
TPO signaling,INOH,1,STAT3,4 (4),0.567,0.927,0,,0 (0),1,1,0.567,0.927
transcriptional activation of dbpb from mrna,BioCarta,1,F2,4 (4),0.567,0.927,0,,0 (0),1,1,0.567,0.927
Transcription from mitochondrial promoters,Reactome,1,TFAM,4 (4),0.567,0.927,0,,0 (1),1,1,0.567,0.927
RHOB GTPase cycle,Reactome,16,TJP2;DIAPH1;FLOT1;ARHGEF12;ACTC1;ARHGAP1;ROCK1;PIK3R1;JUP;STOM;SLK;PKN3;ARHGEF10L;CAV1;FLOT2;TFRC,70 (70),0.236,0.517,0,,4 (4),1,1,0.577,0.927
Globoid Cell Leukodystrophy,SMPDB,4,SPHK2;KDSR;GBA;SGPL1,22 (22),0.619,0.987,5,HMDB0006790;HMDB0004949;HMDB0006734;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,38 (40),0.387,1,0.581,0.927
Fabry disease,SMPDB,4,SPHK2;KDSR;GBA;SGPL1,22 (22),0.619,0.987,5,HMDB0006790;HMDB0004949;HMDB0006734;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,38 (40),0.387,1,0.581,0.927
Sphingolipid Metabolism,SMPDB,4,SPHK2;KDSR;GBA;SGPL1,22 (22),0.619,0.987,5,HMDB0006790;HMDB0004949;HMDB0006734;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,38 (40),0.387,1,0.581,0.927
Gaucher Disease,SMPDB,4,SPHK2;KDSR;GBA;SGPL1,22 (22),0.619,0.987,5,HMDB0006790;HMDB0004949;HMDB0006734;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,38 (40),0.387,1,0.581,0.927
Metachromatic Leukodystrophy (MLD),SMPDB,4,SPHK2;KDSR;GBA;SGPL1,22 (22),0.619,0.987,5,HMDB0006790;HMDB0004949;HMDB0006734;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,38 (40),0.387,1,0.581,0.927
Krabbe disease,SMPDB,4,SPHK2;KDSR;GBA;SGPL1,22 (22),0.619,0.987,5,HMDB0006790;HMDB0004949;HMDB0006734;HMDB0013462#HMDB0012103#HMDB0012092;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,38 (40),0.387,1,0.581,0.927
SUMO is conjugated to E1 (UBA2:SAE1),Reactome,2,UBA2;SAE1,5 (5),0.24,0.518,0,,3 (3),1,1,0.582,0.927
PTK6 Regulates Proteins Involved in RNA Processing,Reactome,2,KHDRBS1;SFPQ,5 (5),0.24,0.518,0,,2 (2),1,1,0.582,0.927
Biosynthesis of E-series 18(S)-resolvins,Reactome,2,LTA4H;GPX4,5 (5),0.24,0.518,0,,11 (20),1,1,0.582,0.927
citrulline-nitric oxide cycle,HumanCyc,2,ASL;ASS1,5 (5),0.24,0.518,0,,14 (14),1,1,0.582,0.927
PKA-mediated phosphorylation of key metabolic factors,Reactome,2,PRKACA;PRKACB,5 (5),0.24,0.518,0,,2 (2),1,1,0.582,0.927
pyridoxal 5_-phosphate salvage,HumanCyc,2,PNPO;PDXK,5 (5),0.24,0.518,0,,14 (14),1,1,0.582,0.927
lactate fermentation (reoxidation of cytosolic NADH),HumanCyc,2,LDHB;LDHA,5 (5),0.24,0.518,0,,5 (5),1,1,0.582,0.927
creatine-phosphate biosynthesis,HumanCyc,2,CKB;CKM,5 (5),0.24,0.518,0,,5 (5),1,1,0.582,0.927
NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis ,Reactome,2,RXRA;PCK1,5 (5),0.24,0.518,0,,3 (4),1,1,0.582,0.927
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production,Reactome,2,LRRFIP1;CTNNB1,5 (5),0.24,0.518,0,,2 (4),1,1,0.582,0.927
Synthesis of PIPs at the ER membrane,Reactome,2,PI4KA;SACM1L,5 (5),0.24,0.518,0,,4 (9),1,1,0.582,0.927
Toll Like Receptor 9 (TLR9) Cascade,Reactome,18,MAPK9;SKP1;CUL1;MAP2K3;UBE2V1;PIK3R4;PPP2CB;MAP2K1;PPP2R1A;MAP2K4;PPP2R5D;RELA;RPS6KA1;DUSP3;MAPK14;FUS;MAPK1;UBE2N,80 (80),0.241,0.52,0,,5 (11),1,1,0.583,0.929
Glucocorticoid receptor regulatory network,PID,18,PPP5C;MAPK9;BAX;MAPK1;SMARCC2;ICAM1;PCK2;FKBP4;FKBP5;RELA;HDAC2;MAPK14;STAT5B;FGG;NR3C1;HSP90AA1;PRKACA;PRKACB,80 (80),0.241,0.52,0,,1 (1),1,1,0.583,0.929
Cell surface interactions at the vascular wall,Reactome,31,CD47;PTPN6;PTPN11;FN1;F11R;SLC16A1;BSG;GLG1;PIK3R1;IGHM;JCHAIN;MIF;SHC1;HRAS;CD48;GRB2;GRB14;CD74;APOB;F2;CAV1;ITGA5;ATP1B1;LYN;YES1;ITGB1;ITGB2;ITGB3;ATP1B3;CXADR;CEACAM1,215 (215),0.965,1,2,HMDB0000067;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,9 (13),0.25,1,0.585,0.93
Synthesis of PIPs at the Golgi membrane,Reactome,5,ARF1;PIK3R4;PI4KA;SACM1L;VAC14,18 (18),0.242,0.521,0,,8 (15),1,1,0.585,0.931
SARS-CoV-2 innate immunity evasion and cell-specific immune response,Wikipathways,11,NUP98;RAE1;DDX58;FADD;LARP1;PF4;MAVS;STAT2;TP53I3;HDAC2;TRIM25,59 (60),0.57,0.932,0,,0 (0),1,1,0.57,0.932
Androgen biosynthesis,Reactome,2,HSD17B12;SRD5A1,8 (8),0.463,0.843,2,HMDB0000234;HMDB0000077,16 (16),0.525,1,0.587,0.933
MyD88-independent TLR4 cascade ,Reactome,20,CD14;FADD;MAP2K3;CUL1;MAPK9;SKP1;UBE2V1;PPP2CB;MAP2K1;PPP2R1A;MAP2K4;MAPK14;RELA;RPS6KA1;DUSP3;PPP2R5D;FUS;MAPK1;UBE2D3;UBE2N,90 (90),0.243,0.524,0,,5 (8),1,1,0.587,0.933
B cell receptor signaling pathway - Homo sapiens (human),KEGG,14,HRAS;LYN;PIK3AP1;FCGR2B;MAP2K2;PIK3R1;PTPN6;RELA;RAC1;MAP2K1;PPP3CA;CD81;MAPK1;GRB2,80 (82),0.668,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (4),0.365,1,0.588,0.933
Metabolism of serotonin,Reactome,1,MAOA,2 (2),0.342,0.67,1,HMDB0033934,11 (11),0.714,1,0.588,0.933
epoxysqualene biosynthesis,HumanCyc,1,FDFT1,2 (2),0.342,0.67,1,HMDB0001188,11 (11),0.714,1,0.588,0.933
22q11.2 copy number variation syndrome,Wikipathways,30,TNPO1;CUL3;RAN;RANBP1;RANGAP1;COMT;EGFR;ARVCF;SLC25A1;PI4KA;POLR2A;UFD1;GLUD1;RTN4;ACTC1;SEPTIN11;EMC10;OAT;RCC1;ALDH4A1;CLDN3;XPO1;TXNRD2;CDC42;SERPIND1;CRKL;RBX1;PPP1CB;KPNB1;SNAP29,149 (149),0.378,0.73,2,HMDB0006285#HMDB0006280;HMDB0002104,20 (30),0.649,1,0.59,0.936
Thrombin signalling through proteinase activated receptors (PARs),Reactome,8,GNG12;F2;GNA11;GNA13;GNAQ;MAPK1;GNB1;GNB2,32 (32),0.246,0.529,0,,3 (3),1,1,0.591,0.936
CD28 co-stimulation,Reactome,8,LYN;YES1;CDC42;MTOR;PIK3R1;RAC1;PAK2;GRB2,32 (32),0.246,0.529,0,,5 (6),1,1,0.591,0.936
t cell receptor signaling pathway,BioCarta,13,SHC1;HRAS;MAP2K1;GRB2;ARHGAP1;PRKCA;ARFGAP3;PIK3R1;MAP2K4;RELA;RAC1;PPP3CA;ARFGAP1,56 (56),0.248,0.533,0,,3 (5),1,1,0.594,0.94
Mineral absorption - Homo sapiens (human),KEGG,12,ATP1B1;ATOX1;SLC30A1;ATP1A1;TF;ATP1B3;MT2A;HMOX1;HMOX2;ATP7B;ATP2B1;FTH1,59 (59),0.438,0.823,3,HMDB0000123;HMDB0000172;HMDB0000687,27 (29),0.566,1,0.594,0.94
Neurotransmitter clearance,Reactome,3,MAOA;COMT;SLC22A1,10 (10),0.288,0.599,2,HMDB0015124;HMDB0033934,31 (33),0.861,1,0.594,0.94
miRNA targets in ECM and membrane receptors,Wikipathways,8,COL4A2;LAMB2;COL6A1;COL6A2;COL6A3;ITGA1;COL1A2;FN1,43 (43),0.579,0.942,0,,0 (0),1,1,0.579,0.942
Nucleotide Excision Repair,Wikipathways,8,CUL4B;CUL4A;DDB1;POLE;PCNA;RBX1;RAD23A;RAD23B,43 (43),0.579,0.942,0,,0 (0),1,1,0.579,0.942
cell cycle: g2/m checkpoint,BioCarta,4,ATM;PI4KA;RPS6KA1;YWHAH,21 (21),0.579,0.942,0,,0 (0),1,1,0.579,0.942
Renin-angiotensin-aldosterone system (RAAS),Wikipathways,7,CAMK1;CALM1;CAMK2A;CAMK2D;AGT;GNAQ;ITPR2,44 (44),0.75,1,2,HMDB0000067;HMDB0001547,11 (12),0.334,1,0.597,0.944
Venlafaxine Metabolism Pathway,SMPDB,0,,6 (6),1,1,2,HMDB0060852;HMDB0013892,9 (10),0.25,1,0.597,0.944
T-cell receptor (TCR) signaling pathway,Wikipathways,17,SHC1;MAPK9;MAP2K1;MAP2K2;CDC42;VIM;HRAS;NCK1;PIK3R1;RELA;PTPN11;CRK;CRKL;MAPK14;MAPK1;DBNL;GRB2,92 (92),0.581,0.944,0,,0 (0),1,1,0.581,0.944
PI-3K cascade:FGFR3,Reactome,3,PTPN11;GRB2;PIK3R1,18 (18),0.688,1,1,HMDB0000693,4 (5),0.365,1,0.598,0.945
Negative regulation of FGFR3 signaling,Reactome,5,MAPK1;PPP2CB;PTPN11;PPP2R1A;GRB2,30 (30),0.693,1,1,HMDB0000693,4 (4),0.365,1,0.601,0.948
CaM pathway,Reactome,9,CALM1;PRKAR1A;PRKAR2A;PRKCA;CAMK2A;CAMK2D;KPNA2;PRKACA;PRKACB,37 (37),0.253,0.544,0,,8 (8),1,1,0.601,0.948
Calmodulin induced events,Reactome,9,CALM1;PRKAR1A;PRKAR2A;PRKCA;CAMK2A;CAMK2D;KPNA2;PRKACA;PRKACB,37 (37),0.253,0.544,0,,8 (8),1,1,0.601,0.948
Growth hormone signaling,INOH,2,STAT5B;PTPN11,10 (10),0.589,0.95,0,,0 (0),1,1,0.589,0.95
Non-homologous end joining,Wikipathways,2,XRCC5;XRCC6,10 (10),0.589,0.95,0,,0 (0),1,1,0.589,0.95
SCF-beta-TrCP mediated degradation of Emi1,Reactome,2,SKP1;CUL1,10 (10),0.589,0.95,0,,0 (0),1,1,0.589,0.95
regulation of transcriptional activity by pml,BioCarta,2,UBE2I;PML,10 (10),0.589,0.95,0,,0 (0),1,1,0.589,0.95
Interleukin-27 signaling,Reactome,2,CANX;STAT3,10 (10),0.589,0.95,0,,0 (0),1,1,0.589,0.95
Removal of aminoterminal propeptides from gamma-carboxylated proteins,Reactome,2,F2;F9,10 (10),0.589,0.95,0,,0 (0),1,1,0.589,0.95
e2f1 destruction pathway,BioCarta,2,SKP1;CUL1,10 (10),0.589,0.95,0,,0 (0),1,1,0.589,0.95
Prostate cancer - Homo sapiens (human),KEGG,16,HRAS;EGFR;GRB2;GSTP1;MTOR;PIK3R1;HSP90B1;ARAF;RELA;IGF1;HSP90AA1;MAP2K1;MAPK1;CTNNB1;HSP90AB1;MAP2K2,97 (97),0.763,1,2,HMDB0000234;HMDB0000077,11 (11),0.334,1,0.603,0.951
Vindesine Action Pathway,SMPDB,2,TUBA1B;ABCC2,10 (10),0.589,0.95,1,HMDB0014454,5 (5),0.433,1,0.604,0.952
Uptake and actions of bacterial toxins,Reactome,6,MAP2K1;MAP2K2;MAP2K3;MAP2K4;EEF2;VAMP2,23 (23),0.257,0.55,0,,9 (11),1,1,0.606,0.954
Laminin interactions,Reactome,6,LAMA2;ITGB1;LAMB2;NID2;COL18A1;ITGA1,23 (23),0.257,0.55,0,,1 (2),1,1,0.606,0.954
Cellular response to hypoxia,Reactome,6,CUL2;ELOC;ELOB;HIF1A;RBX1;UBE2D3,23 (23),0.257,0.55,0,,5 (7),1,1,0.606,0.954
Downstream signaling of activated FGFR3,Reactome,5,SHC1;HRAS;PIK3R1;PTPN11;GRB2,25 (25),0.523,0.895,1,HMDB0000693,6 (7),0.494,1,0.608,0.956
Tamoxifen Action Pathway,SMPDB,3,FMO3;SULT1A1;FMO1,10 (10),0.288,0.599,1,HMDB0014813,20 (20),0.898,1,0.609,0.956
Tamoxifen Metabolism Pathway,SMPDB,3,FMO3;SULT1A1;FMO1,10 (10),0.288,0.599,1,HMDB0014813,20 (20),0.898,1,0.609,0.956
Hedgehog _off_ state,Reactome,10,SKP1;PRKAR1A;CUL1;PRKAR2A;NUMB;CSNK1A1;ITCH;RBX1;PRKACA;PRKACB,42 (42),0.259,0.553,0,,5 (6),1,1,0.609,0.956
RND1 GTPase cycle,Reactome,10,ALDH3A2;DST;DSP;FLOT2;RRAS2;TXNL1;STIP1;CAV1;PIK3R1;TFRC,42 (42),0.259,0.553,0,,1 (1),1,1,0.609,0.956
p75 NTR receptor-mediated signalling,Reactome,14,RHOA;CASP3;ARHGEF12;YWHAE;ARHGDIA;SQSTM1;GNA13;RELA;OMG;RTN4;RAC1;ARHGEF10L;NCSTN;HDAC2,96 (96),0.889,1,2,HMDB0004949;HMDB0013462#HMDB0012103#HMDB0012092,10 (11),0.292,1,0.61,0.958
Notch-mediated HES/HEY network,PID,6,PARP1;CTBP1;CAMK2D;HIF1A;GAA;STAT3,48 (48),0.912,1,1,HMDB0000234,3 (3),0.289,1,0.615,0.962
agrin in postsynaptic differentiation,BioCarta,11,CTTN;EGFR;CDC42;PAK2;ITGB1;LAMB2;RAC1;ITGA1;LAMA2;MAPK1;PXN,47 (47),0.263,0.56,0,,2 (2),1,1,0.615,0.962
TRAF3-dependent IRF activation pathway,Reactome,4,TRIM25;DDX58;RNF135;MAVS,14 (14),0.263,0.56,0,,2 (5),1,1,0.615,0.962
SHC1 events in EGFR signaling,Reactome,4,SHC1;HRAS;EGFR;GRB2,14 (14),0.263,0.56,0,,4 (4),1,1,0.615,0.962
Ras signaling in the CD4+ TCR pathway,PID,4,HRAS;MAPK1;MAP2K1;PRKCA,14 (14),0.263,0.56,0,,1 (1),1,1,0.615,0.962
Synthesis of IP2_ IP_ and Ins in the cytosol,Reactome,4,IMPA1;INPP1;ISYNA1;IMPA2,14 (14),0.263,0.56,0,,18 (19),1,1,0.615,0.962
sumoylation by ranbp2 regulates transcriptional repression,BioCarta,4,NUP210;HDAC6;RAN;RANBP2,14 (14),0.263,0.56,0,,1 (1),1,1,0.615,0.962
Biogenic Amine Synthesis,Wikipathways,4,MAOA;COMT;DDC;PAH,15 (15),0.31,0.634,1,HMDB0000472,17 (18),0.856,1,0.617,0.965
Synthesis of 15-eicosatetraenoic acid derivatives,Reactome,2,GPX1;GPX4,6 (6),0.317,0.64,1,HMDB0001043,16 (18),0.838,1,0.618,0.966
Signaling by FGFR in disease,Reactome,9,HRAS;GRB2;MYO18A;CPSF6;PIK3R1;ERLIN2;STAT3;LRRFIP1;STAT5B,47 (47),0.539,0.909,1,HMDB0000693,6 (23),0.494,1,0.619,0.967
Signaling events mediated by Stem cell factor receptor (c-Kit),PID,12,SHC1;HRAS;LYN;MAP2K1;GRB2;PIK3R1;PTPN6;PTPN11;STAT3;CRKL;KITLG;MAP2K2,52 (52),0.267,0.566,0,,2 (2),1,1,0.619,0.967
Metabolism of Spingolipids in ER and Golgi apparatus,Wikipathways,1,SPHK2,12 (12),0.919,1,2,HMDB0004949;HMDB0004842,10 (21),0.292,1,0.621,0.97
Norepinephrine Neurotransmitter Release Cycle,Reactome,4,MAOA;PPFIA1;VAMP2;SLC22A1,18 (18),0.45,0.839,1,HMDB0033934,8 (8),0.597,1,0.622,0.97
Interactome of polycomb repressive complex 2 (PRC2),Wikipathways,3,RBBP4;BCLAF1;THRAP3,16 (16),0.605,0.971,0,,0 (0),1,1,0.605,0.971
MAP3K1 role in promoting and blocking gonadal determination,Wikipathways,3,MAPK1;RHOA;ROCK1,16 (16),0.605,0.971,0,,0 (0),1,1,0.605,0.971
il 4 signaling pathway,BioCarta,3,SHC1;STAT6;GRB2,16 (16),0.605,0.971,0,,0 (0),1,1,0.605,0.971
Kisspeptin-kisspeptin receptor system in the ovary,Wikipathways,7,HRAS;MAP2K1;MAP2K2;PRKCA;PDK1;PLCB3;MAPK1,39 (39),0.623,0.993,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,5 (6),0.433,1,0.623,0.972
Inflammatory Response Pathway,Wikipathways,6,LAMB2;IGHM;VTN;COL1A1;COL1A2;FN1,33 (33),0.61,0.977,0,,0 (0),1,1,0.61,0.977
Base excision repair - Homo sapiens (human),KEGG,6,APEX1;PARP3;LIG3;PARP1;POLE;PCNA,33 (33),0.61,0.977,0,,0 (0),1,1,0.61,0.977
Negative regulation of FGFR4 signaling,Reactome,5,MAPK1;PPP2CB;PTPN11;PPP2R1A;GRB2,32 (32),0.748,1,1,HMDB0000693,4 (4),0.365,1,0.628,0.979
Hepatitis B infection,Wikipathways,32,MAP2K4;MAPK14;ATP6AP1;SLC10A1;GRB2;MAVS;PIK3R1;HRAS;CASP3;BAX;PRKCA;PCNA;DDX58;RELA;FADD;MAPK1;YWHAQ;MAPK9;MAP2K1;MAP2K2;MAP2K3;YWHAB;DDB1;YWHAZ;ARAF;STAT2;STAT3;STAT4;STAT5B;STAT6;VDAC3;BID,152 (152),0.274,0.58,0,,1 (1),1,1,0.629,0.98
BDNF-TrkB Signaling,Wikipathways,8,SHC1;HRAS;MAP2K1;GRB2;MTOR;RPS6KA1;RHEB;MAPK1,33 (33),0.275,0.581,0,,2 (2),1,1,0.63,0.98
Glucagon signaling in metabolic regulation,Reactome,8,GNG12;PRKAR1A;PRKAR2A;PRKACA;GNAS;PRKACB;GNB1;GNB2,33 (33),0.275,0.581,0,,6 (6),1,1,0.63,0.98
GPVI-mediated activation cascade,Reactome,8,LYN;CDC42;RHOG;PIK3R1;PTPN6;RHOA;PTPN11;RAC1,33 (33),0.275,0.581,0,,6 (9),1,1,0.63,0.98
Toll Like Receptor 5 (TLR5) Cascade,Reactome,17,MAPK9;SKP1;CUL1;MAP2K3;UBE2V1;PPP2CB;MAP2K1;PPP2R1A;MAP2K4;PPP2R5D;RELA;RPS6KA1;DUSP3;MAPK14;FUS;MAPK1;UBE2N,77 (77),0.276,0.582,0,,4 (8),1,1,0.631,0.98
Toll Like Receptor 10 (TLR10) Cascade,Reactome,17,MAPK9;SKP1;CUL1;MAP2K3;UBE2V1;PPP2CB;MAP2K1;PPP2R1A;MAP2K4;PPP2R5D;RELA;RPS6KA1;DUSP3;MAPK14;FUS;MAPK1;UBE2N,77 (77),0.276,0.582,0,,4 (8),1,1,0.631,0.98
MyD88 cascade initiated on plasma membrane,Reactome,17,MAPK9;SKP1;CUL1;MAP2K3;UBE2V1;PPP2CB;MAP2K1;PPP2R1A;MAP2K4;PPP2R5D;RELA;RPS6KA1;DUSP3;MAPK14;FUS;MAPK1;UBE2N,77 (77),0.276,0.582,0,,4 (8),1,1,0.631,0.98
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,Reactome,17,MAPK9;MAP2K1;CUL1;MAP2K3;UBE2V1;SKP1;PPP2CB;PPP2R1A;MAP2K4;MAPK14;RELA;RPS6KA1;DUSP3;PPP2R5D;FUS;MAPK1;UBE2N,77 (77),0.276,0.582,0,,5 (11),1,1,0.631,0.98
PI-3K cascade:FGFR4,Reactome,3,PTPN11;GRB2;PIK3R1,20 (20),0.757,1,1,HMDB0000693,4 (5),0.365,1,0.632,0.981
VEGF,INOH,27,MAP2K4;MAPK14;CAMK2A;EGFR;CSK;MTOR;CSNK1A1;CSNK1D;PIK3R1;CAMK2D;RPS6KA1;PRKAA1;PRKAA2;PRKAB1;PRKACA;PRKACB;PRKAG1;PRKAR1A;PAK2;PRKAR2A;PRKCA;MAPK1;MAPK9;MAP2K1;MAP2K2;MAP2K3;ARAF,188 (188),0.958,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,3 (4),0.289,1,0.632,0.981
Toll Like Receptor 3 (TLR3) Cascade,Reactome,19,MAPK9;FADD;MAP2K3;CUL1;UBE2V1;SKP1;PPP2CB;MAP2K1;PPP2R1A;MAP2K4;MAPK14;RELA;RPS6KA1;DUSP3;PPP2R5D;FUS;MAPK1;UBE2D3;UBE2N,87 (87),0.277,0.584,0,,4 (9),1,1,0.633,0.982
Anchoring of the basal body to the plasma membrane,Reactome,21,CKAP5;YWHAE;DCTN1;ACTR1A;MAPRE1;YWHAG;CSNK1D;PPP2R1A;TUBA4A;PAFAH1B1;DYNC1H1;DYNC1I2;PRKACA;DCTN2;HSP90AA1;RAB8A;TUBB4B;SSNA1;DCTN3;RAB11A;CEP192,97 (97),0.278,0.585,0,,2 (3),1,1,0.634,0.982
Mammalian disorder of sexual development,Wikipathways,2,SRD5A1;CTNNB1,25 (25),0.964,1,1,HMDB0000234,3 (3),0.289,1,0.634,0.983
NF-kappa B signaling pathway - Homo sapiens (human),KEGG,13,CD14;DDX58;LYN;UBE2I;ERC1;PARP1;CSNK2A1;RELA;CSNK2A2;CSNK2B;ICAM1;ATM;TRIM25,103 (104),0.966,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,3 (3),0.289,1,0.635,0.983
Neurotransmitter receptors and postsynaptic signal transmission,Reactome,38,NPTN;AP2M1;AP2S1;PPM1F;LIN7C;AP2A1;CALM1;GNG12;AP2B1;MYO6;NSF;CAMK2A;CAMK2D;RPS6KA1;PRKAA1;PRKAA2;PRKAB1;PRKACA;PRKACB;HRAS;PRKAG1;PRKAR1A;AP2A2;PRKAR2A;PRKCA;DLG1;GNAI2;GNAI3;CAMK1;MAPK1;GNB1;GNB2;PLCB3;EPB41L1;RAC1;LIN7A;CASK;KPNA2,185 (185),0.307,0.632,1,HMDB0000123,21 (24),0.909,1,0.635,0.983
GPCR downstream signalling,Reactome,49,RHOA;PPP2CB;PPP2R1A;GNAI2;PPP2R5D;PPP3CA;CAMK2A;PSAP;GNAS;PRKAR1A;CALM1;GNG12;EGFR;HEBP1;ANXA1;PIK3R1;GNA13;CAMK2D;RPS6KA1;AGT;ABHD6;PRKACB;HRAS;PXMP2;GRB2;PRKAR2A;PRKCA;PF4;ROCK1;C3;MGLL;PLCB3;GNAI3;C5;GNAQ;MAPK1;GNA11;GNB1;GNB2;F2;CDC42;ABHD12;KNG1;PRKACA;ARHGEF12;ARHGEF10L;PPP1CA;ITPR2;KPNA2,633 (633),1,1,15,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005096;HMDB0003208;HMDB0033941;HMDB0003073;HMDB0001388;HMDB0002995;HMDB0006528;HMDB0036836;HMDB0001043;HMDB0004080;HMDB0015464;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002183,118 (152),0.279,1,0.635,0.983
Synthesis of 12-eicosatetraenoic acid derivatives,Reactome,2,GPX1;GPX4,7 (7),0.392,0.75,1,HMDB0001043,11 (13),0.714,1,0.636,0.983
Reuptake of GABA,Reactome,1,SLC6A13,4 (4),0.567,0.927,1,HMDB0000043,6 (6),0.494,1,0.637,0.983
CD209 (DC-SIGN) signaling,Reactome,5,HRAS;RELA;PAK2;PRKACA;PRKACB,19 (19),0.281,0.59,0,,6 (7),1,1,0.638,0.983
nitric oxide signaling pathway,BioCarta,5,PRKAR2A;PRKCA;PRKACB;PPP3CA;PRKAR1A,19 (19),0.281,0.59,0,,5 (5),1,1,0.638,0.983
Creatine metabolism,Reactome,3,CKB;GAMT;CKM,11 (11),0.345,0.673,1,HMDB0000123,15 (15),0.819,1,0.64,0.983
Formation of Incision Complex in GG-NER,Reactome,10,UBE2I;CUL4B;CUL4A;UBE2N;UBE2V2;DDB1;PARP1;RBX1;RAD23A;RAD23B,43 (43),0.285,0.597,0,,4 (5),1,1,0.642,0.983
RND2 GTPase cycle,Reactome,10,ALDH3A2;NUDC;TXNL1;PIK3R1;ARHGAP1;KTN1;CAV1;CKAP4;DST;TFRC,43 (43),0.285,0.597,0,,1 (1),1,1,0.642,0.983
Death Receptor Signalling,Reactome,17,RHOA;FADD;ARHGEF12;YWHAE;ARHGDIA;SQSTM1;GNA13;RELA;OMG;RTN4;RAC1;ARHGEF10L;NCSTN;HDAC2;OTULIN;CASP3;RACK1,134 (134),0.979,1,2,HMDB0004949;HMDB0013462#HMDB0012103#HMDB0012092,10 (12),0.292,1,0.644,0.983
PI-3K cascade:FGFR1,Reactome,3,PIK3R1;PTPN11;GRB2,21 (21),0.787,1,1,HMDB0000693,4 (5),0.365,1,0.645,0.983
STING pathway in Kawasaki-like disease and COVID-19,Wikipathways,3,GSDMD;RELA;NLRX1,21 (21),0.787,1,1,HMDB0000876,4 (4),0.365,1,0.645,0.983
Dectin-2 family,Reactome,1,LYN,29 (29),0.998,1,1,HMDB0029931,3 (4),0.289,1,0.646,0.983
Th1 and Th2 cell differentiation - Homo sapiens (human),KEGG,8,MAPK1;MAPK9;RELA;STAT4;MAPK14;STAT5B;STAT6;PPP3CA,92 (92),0.998,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,3 (3),0.289,1,0.647,0.983
Signaling by FGFR3 fusions in cancer,Reactome,3,HRAS;GRB2;PIK3R1,10 (10),0.288,0.599,0,,5 (6),1,1,0.647,0.983
WNT mediated activation of DVL,Reactome,3,CSNK2A1;CSNK2A2;CSNK2B,10 (10),0.288,0.599,0,,2 (4),1,1,0.647,0.983
Pexophagy,Reactome,3,ATM;PEX5;SQSTM1,10 (10),0.288,0.599,0,,1 (1),1,1,0.647,0.983
HDR through MMEJ (alt-NHEJ),Reactome,3,LIG3;PARP1;RAD50,10 (10),0.288,0.599,0,,4 (6),1,1,0.647,0.983
Calcineurin activates NFAT,Reactome,3,FKBP1A;CALM1;PPP3CA,10 (10),0.288,0.599,0,,3 (4),1,1,0.647,0.983
Signal attenuation,Reactome,3,SHC1;MAPK1;GRB2,10 (10),0.288,0.599,0,,3 (4),1,1,0.647,0.983
regulation of spermatogenesis by crem,BioCarta,3,XPO1;GNAS;GNB1,10 (10),0.288,0.599,0,,4 (4),1,1,0.647,0.983
Activation of the AP-1 family of transcription factors,Reactome,3,MAPK14;MAPK9;MAPK1,10 (10),0.288,0.599,0,,2 (2),1,1,0.647,0.983
Maturation of nucleoprotein,Reactome,3,PARP14;PARP9;UBE2I,10 (10),0.288,0.599,0,,5 (5),1,1,0.647,0.983
Maturation of nucleoprotein,Reactome,3,PARP14;PARP9;UBE2I,10 (10),0.288,0.599,0,,5 (5),1,1,0.647,0.983
FGFR2 ligand binding and activation,Reactome,0,,20 (20),1,1,1,HMDB0000693,3 (4),0.289,1,0.647,0.983
Biosynthesis of DPAn-6 SPMs,Reactome,0,,2 (2),1,1,1,HMDB0001976,3 (7),0.289,1,0.647,0.983
betaKlotho-mediated ligand binding,Reactome,0,,3 (3),1,1,1,HMDB0000693,3 (3),0.289,1,0.647,0.983
FGFR4 ligand binding and activation,Reactome,0,,14 (14),1,1,1,HMDB0000693,3 (3),0.289,1,0.647,0.983
Signaling by activated point mutants of FGFR3,Reactome,0,,12 (12),1,1,1,HMDB0000693,3 (3),0.289,1,0.647,0.983
aspirin triggered resolvin D biosynthesis,HumanCyc,0,,2 (2),1,1,1,HMDB0002183,3 (7),0.289,1,0.647,0.983
FGFR3 mutant receptor activation,Reactome,0,,12 (12),1,1,1,HMDB0000693,3 (13),0.289,1,0.647,0.983
Signaling by activated point mutants of FGFR1,Reactome,0,,11 (11),1,1,1,HMDB0000693,3 (3),0.289,1,0.647,0.983
FGFR1b ligand binding and activation,Reactome,0,,6 (6),1,1,1,HMDB0000693,3 (3),0.289,1,0.647,0.983
FGFR1c ligand binding and activation,Reactome,0,,12 (12),1,1,1,HMDB0000693,3 (3),0.289,1,0.647,0.983
FGFR1c and Klotho ligand binding and activation,Reactome,0,,3 (3),1,1,1,HMDB0000693,3 (3),0.289,1,0.647,0.983
FGFR2b ligand binding and activation,Reactome,0,,10 (10),1,1,1,HMDB0000693,3 (4),0.289,1,0.647,0.983
FGFR2c ligand binding and activation,Reactome,0,,13 (13),1,1,1,HMDB0000693,3 (4),0.289,1,0.647,0.983
FGFR3b ligand binding and activation,Reactome,0,,7 (7),1,1,1,HMDB0000693,3 (3),0.289,1,0.647,0.983
FGFR1 ligand binding and activation,Reactome,0,,16 (16),1,1,1,HMDB0000693,3 (3),0.289,1,0.647,0.983
resolvin D biosynthesis,HumanCyc,0,,2 (2),1,1,1,HMDB0002183,3 (5),0.289,1,0.647,0.983
Activated point mutants of FGFR2,Reactome,0,,17 (17),1,1,1,HMDB0000693,3 (12),0.289,1,0.647,0.983
phosphatidylserine biosynthesis I,HumanCyc,0,,1 (1),1,1,1,HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,3 (4),0.289,1,0.647,0.983
FGFR2 mutant receptor activation,Reactome,0,,17 (17),1,1,1,HMDB0000693,3 (13),0.289,1,0.647,0.983
Ramipril Metabolism Pathway,SMPDB,0,,1 (1),1,1,1,HMDB0060579,3 (4),0.289,1,0.647,0.983
Spirapril Metabolism Pathway,SMPDB,0,,1 (1),1,1,1,HMDB0015438,3 (3),0.289,1,0.647,0.983
G2/M Transition,Reactome,29,CUL1;MAPRE1;ACTR1A;PPP2CB;PPP2R1A;TUBB4B;PPP2R2A;RBBP4;DCTN2;CSNK1D;DCTN3;PAFAH1B1;SSNA1;PRKACA;CKAP5;PPME1;CEP192;RBX1;SKP1;DCTN1;YWHAE;YWHAG;TUBA4A;DYNC1H1;DYNC1I2;HSP90AA1;RAB8A;PPP1CB;HSP90AB1,138 (138),0.29,0.602,0,,8 (9),1,1,0.649,0.985
Negative regulation of FGFR1 signaling,Reactome,5,MAPK1;PPP2CB;PTPN11;PPP2R1A;GRB2,34 (34),0.796,1,1,HMDB0000693,4 (4),0.365,1,0.65,0.985
Thyroid hormone signaling pathway - Homo sapiens (human),KEGG,24,HIF1A;PFKL;MTOR;PIK3R1;ACTB;PRKACA;PRKACB;HRAS;DIO1;ACTG1;PRKCA;PLCB3;MAPK1;CTNNB1;ATP1A1;ATP1B1;ATP1B3;MAP2K1;MAP2K2;ATP2A2;ITGB3;RXRA;RHEB;HDAC2,121 (121),0.429,0.808,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,10 (11),0.679,1,0.651,0.987
p53 transcriptional gene network,Wikipathways,13,XRCC5;ACAD11;ISG15;BAX;GPX1;ALDH4A1;RRM2B;FUCA1;ICAM1;TP53I3;PML;PRKAB1;GLS2,72 (72),0.618,0.987,0,,0 (0),1,1,0.618,0.987
Unfolded protein response,Wikipathways,4,BID;RTCB;HSPA5;EIF2S1,22 (22),0.619,0.987,0,,0 (0),1,1,0.619,0.987
hypoxia and p53 in the cardiovascular system,BioCarta,4,HSP90AA1;ATM;HIF1A;BAX,22 (22),0.619,0.987,0,,0 (0),1,1,0.619,0.987
Tramadol Metabolism Pathway,SMPDB,2,ABCC2;SLC22A1,7 (7),0.392,0.75,1,HMDB0014339,12 (12),0.745,1,0.651,0.987
Eicosanoid ligand-binding receptors,Reactome,0,,15 (15),1,1,2,HMDB0002995;HMDB0003208,10 (10),0.292,1,0.652,0.987
ADP signalling through P2Y purinoceptor 1,Reactome,6,GNG12;GNA11;MAPK14;GNAQ;GNB1;GNB2,24 (24),0.292,0.606,0,,4 (4),1,1,0.652,0.987
Endometrial cancer,Wikipathways,14,HRAS;CTNNB1;MAP2K1;MAP2K2;CDH1;BAX;PIK3R1;ARAF;CTNNA1;CTNNA2;EGFR;MAPK1;ILK;GRB2,63 (63),0.293,0.608,0,,1 (4),1,1,0.653,0.988
serotonin and melatonin biosynthesis,HumanCyc,1,DDC,5 (5),0.649,1,2,HMDB0002281;HMDB0000472,14 (15),0.453,1,0.653,0.989
Downstream signaling of activated FGFR4,Reactome,5,SHC1;HRAS;PIK3R1;PTPN11;GRB2,27 (27),0.596,0.96,1,HMDB0000693,6 (7),0.494,1,0.655,0.99
MyD88 dependent cascade initiated on endosome,Reactome,17,MAPK9;SKP1;CUL1;MAP2K3;UBE2V1;PPP2CB;MAP2K1;PPP2R1A;MAP2K4;PPP2R5D;RELA;RPS6KA1;DUSP3;MAPK14;FUS;MAPK1;UBE2N,78 (78),0.295,0.611,0,,5 (11),1,1,0.655,0.99
ECM-receptor interaction - Homo sapiens (human),KEGG,19,ITGA9;COL6A6;COL4A2;CD47;ITGB1;COL6A2;ITGB3;COL6A1;COL6A5;COL6A3;VTN;COL1A2;LAMB2;ITGA1;LAMA2;ITGA2B;COL1A1;ITGA5;FN1,88 (88),0.295,0.611,0,,1 (1),1,1,0.655,0.99
Metabolism of polyamines,Reactome,3,NQO1;SRM;PAOX,13 (13),0.456,0.843,2,HMDB0001276;HMDB0001186,20 (20),0.649,1,0.657,0.992
SHC-mediated cascade:FGFR3,Reactome,3,SHC1;HRAS;GRB2,18 (18),0.688,1,1,HMDB0000693,5 (5),0.433,1,0.659,0.994
Negative regulation of FGFR2 signaling,Reactome,5,MAPK1;PPP2CB;PTPN11;PPP2R1A;GRB2,35 (35),0.817,1,1,HMDB0000693,4 (5),0.365,1,0.659,0.994
Resolution of AP sites via the multiple-nucleotide patch replacement pathway,Reactome,4,APEX1;POLE;PARP1;PCNA,24 (24),0.69,1,1,HMDB0001178,5 (7),0.433,1,0.66,0.995
Myogenesis,Reactome,7,CDC42;CDH2;MAPK14;SPAG9;CTNNA1;CTNNA2;CTNNB1,29 (29),0.3,0.619,0,,3 (3),1,1,0.661,0.995
Disassembly of the destruction complex and recruitment of AXIN to the membrane,Reactome,7,CSNK1A1;PPP2CB;PPP2R1A;PPP2R5A;PPP2R5D;PPP2R5E;CTNNB1,29 (29),0.3,0.619,0,,2 (2),1,1,0.661,0.995
Pre-NOTCH Processing in Golgi,Reactome,2,ST3GAL6;ST3GAL4,12 (12),0.692,1,1,HMDB0000290,5 (5),0.433,1,0.661,0.995
Signaling by PTK6,Reactome,11,HRAS;RHOA;EGFR;PXN;KHDRBS1;HIF1A;SFPQ;STAT3;RAC1;CRK;NR3C1,54 (54),0.443,0.83,1,HMDB0001547,10 (10),0.679,1,0.662,0.996
Signaling by Non-Receptor Tyrosine Kinases,Reactome,11,HRAS;RHOA;EGFR;PXN;KHDRBS1;HIF1A;SFPQ;STAT3;RAC1;CRK;NR3C1,54 (54),0.443,0.83,1,HMDB0001547,10 (10),0.679,1,0.662,0.996
Chemokine signaling pathway,Wikipathways,29,WASL;RAP1A;RAP1B;GRB2;GNG12;CSK;STAT3;PIK3R1;PRKACB;SHC1;HRAS;PXN;RAC1;PF4;ROCK1;RELA;PLCB3;GNAI3;MAPK1;GNB1;GNB2;LYN;MAP2K1;CDC42;GNAI2;STAT2;CRK;CRKL;STAT5B,165 (165),0.696,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,5 (5),0.433,1,0.663,0.997
Signaling by FGFR4,Reactome,8,SHC1;HRAS;GRB2;PPP2CB;PPP2R1A;PIK3R1;PTPN11;MAPK1,42 (42),0.551,0.926,1,HMDB0000693,7 (8),0.549,1,0.664,0.998
Cortisol synthesis and secretion - Homo sapiens (human),KEGG,10,GNA11;NCEH1;PLCB3;SCARB1;AGT;GNAQ;GNAS;ITPR2;PRKACA;PRKACB,65 (65),0.808,1,2,HMDB0000067;HMDB0000015,12 (12),0.374,1,0.664,0.999
Blood clotting and drug effects,Wikipathways,0,,0 (0),1,1,2,HMDB0001043;HMDB0003208,4 (10),0.0594,1,0.0594,1
Biochemical Pathways Part I,Wikipathways,0,,0 (0),1,1,58,HMDB0001170;HMDB0006756;HMDB0006454;HMDB0060460;HMDB0000123;HMDB0000172;HMDB0006271;HMDB0000145;HMDB0035312;HMDB0000343;HMDB0006764;HMDB0000279;HMDB0000036;HMDB0000015;HMDB0003974;HMDB0001286;HMDB0001188;HMDB0001084;HMDB0000067;HMDB0004231;HMDB0001416;HMDB0001016;HMDB0006272;HMDB0003255;HMDB0000077;HMDB0006763;HMDB0000290;HMDB0001231;HMDB0000687;HMDB0000951;HMDB0000234;HMDB0001547;HMDB0000472;HMDB0000899;HMDB0000304;HMDB0006203;HMDB0006888;HMDB0000601;HMDB0002719;HMDB0001149;HMDB0001342;HMDB0001251;HMDB0000043;HMDB0000138;HMDB0001229;HMDB0003349#HMDB0000528;HMDB0000032;HMDB0012130;HMDB0002104;HMDB0001090;HMDB0000725;HMDB0000195;HMDB0001052;HMDB0000876;HMDB0003769;HMDB0006887;HMDB0000313#HMDB0000335;HMDB0001993,465 (469),0.105,1,0.105,1
Glycosylphosphatidylinositol(GPI)-anchor biosynthesis,EHMN,0,,0 (0),1,1,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,6 (14),0.129,1,0.129,1
Metabolism of alpha-linolenic acid,Wikipathways,0,,0 (0),1,1,3,HMDB0003073;HMDB0001388;HMDB0001043,14 (17),0.184,1,0.184,1
Methacycline Action Pathway,SMPDB,0,,0 (0),1,1,3,HMDB0000687;HMDB0015066;HMDB0000172,20 (20),0.365,1,0.365,1
Gentamicin Action Pathway,SMPDB,0,,0 (0),1,1,3,HMDB0000687;HMDB0014936;HMDB0000172,20 (20),0.365,1,0.365,1
Netilmicin Action Pathway,SMPDB,0,,0 (0),1,1,3,HMDB0015090;HMDB0000687;HMDB0000172,20 (20),0.365,1,0.365,1
Neomycin Action Pathway,SMPDB,0,,0 (0),1,1,3,HMDB0015129;HMDB0000172;HMDB0000687,20 (20),0.365,1,0.365,1
Azithromycin Action Pathway,SMPDB,0,,0 (0),1,1,3,HMDB0014352;HMDB0000687;HMDB0000172,20 (20),0.365,1,0.365,1
Biosynthesis and regeneration of tetrahydrobiopterin and catabolism of phenylalanine,Wikipathways,0,,0 (0),1,1,1,HMDB0002281,5 (11),0.433,1,0.433,1
Phagocyte cell death caused by cytosolic Mtb,Reactome,0,,0 (0),1,1,1,HMDB0001178,5 (5),0.433,1,0.433,1
Amino acid conjugation,Wikipathways,0,,0 (0),1,1,1,HMDB0000123,5 (6),0.433,1,0.433,1
Escape of Mtb from the phagocyte,Reactome,0,,0 (0),1,1,1,HMDB0001178,5 (5),0.433,1,0.433,1
Abacavir Action Pathway,SMPDB,0,,0 (0),1,1,1,HMDB0015182,5 (5),0.433,1,0.433,1
melatonin degradation III,HumanCyc,0,,0 (0),1,1,1,HMDB0004259,6 (7),0.494,1,0.494,1
Demeclocycline Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,19 (21),0.621,1,0.621,1
Arbekacin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,19 (20),0.621,1,0.621,1
Rolitetracycline Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,19 (20),0.621,1,0.621,1
Lymecycline Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,19 (20),0.621,1,0.621,1
Clomocycline Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,19 (20),0.621,1,0.621,1
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway,Wikipathways,55,PIK3R4;CDC37;CAB39;RAB14;RAB10;PPP2CB;PPP2R1A;HSP90B1;PPP2R5D;HIF1A;PPP2R5A;IGF1;VTN;PPP2R5E;MAPK1;KITLG;ACACA;GNG12;EGFR;COL4A2;MTOR;PIK3R1;RPS6;GNB1;GYS2;LAMB2;EIF4E;PRKAA1;PRKAA2;HRAS;LAMA2;GRB2;COL6A2;ELAVL1;RAB11B;ITGA2B;ITGA5;GNB2;ITGA9;MAP2K1;MAP2K2;RAB2A;ITGB1;ITGB2;ITGB3;AKT1S1;FN1;COL1A2;SLC2A2;HSP90AB1;HSP90AA1;RHEB;RAB8A;COL1A1;EIF4E2,302 (302),0.639,1,0,,0 (2),1,1,0.639,1
SUMOylation of immune response proteins,Reactome,2,UBE2I;RELA,11 (11),0.643,1,0,,0 (1),1,1,0.643,1
IL-5 signaling,INOH,2,SHC1;STAT5B,11 (11),0.643,1,0,,0 (0),1,1,0.643,1
Alpha6 beta4 integrin-ligand interactions,PID,2,LAMB2;LAMA2,11 (11),0.643,1,0,,0 (0),1,1,0.643,1
il22 soluble receptor signaling pathway,BioCarta,2,STAT5B;STAT3,11 (11),0.643,1,0,,0 (0),1,1,0.643,1
miR-517 relationship with ARCN1 and USP1,Wikipathways,1,ARCN1,5 (5),0.649,1,0,,0 (0),1,1,0.649,1
RUNX1 regulates expression of components of tight junctions,Reactome,1,TJP1,5 (5),0.649,1,0,,0 (0),1,1,0.649,1
MET interacts with TNS proteins,Reactome,1,ITGB1,5 (5),0.649,1,0,,0 (0),1,1,0.649,1
role of ppar-gamma coactivators in obesity and thermogenesis,BioCarta,1,RXRA,5 (5),0.649,1,0,,0 (0),1,1,0.649,1
phospholipase c signaling pathway,BioCarta,1,PIK3R1,5 (5),0.649,1,0,,0 (0),1,1,0.649,1
acetylation and deacetylation of rela in nucleus,BioCarta,1,RELA,5 (5),0.649,1,0,,0 (1),1,1,0.649,1
Cross-presentation of soluble exogenous antigens (endosomes),Reactome,1,MRC1,5 (5),0.649,1,0,,0 (1),1,1,0.649,1
FasL/ CD95L signaling,Reactome,1,FADD,5 (5),0.649,1,0,,0 (1),1,1,0.649,1
Interleukin-37 signaling,Reactome,1,SIGIRR,5 (5),0.649,1,0,,0 (0),1,1,0.649,1
Streptomycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Roxithromycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Erythromycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Spectinomycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Kanamycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Tobramycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Tigecycline Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Troleandomycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Josamycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Amikacin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Telithromycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Paromomycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Doxycycline Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Oxytetracycline Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Minocycline Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Tetracycline Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Lincomycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Chloramphenicol Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Clarithromycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Clindamycin Action Pathway,SMPDB,0,,0 (0),1,1,2,HMDB0000172;HMDB0000687,20 (20),0.649,1,0.649,1
Type I interferon induction and signaling during SARS-CoV-2 infection,Wikipathways,4,DDX58;MAVS;EIF2AK2;STAT2,23 (23),0.655,1,0,,0 (0),1,1,0.655,1
Validated targets of C-MYC transcriptional repression,PID,13,CSDE1;TJP2;CLU;ITGB1;TMEM126A;NDRG2;ALDH9A1;LGALS1;HMGCS2;PTPA;FTH1;COL1A2;SFXN3,74 (74),0.659,1,0,,0 (0),1,1,0.659,1
BDNF,NetPath,8,SHC1;MAPK9;GRB2;NSF;NCK1;RELA;PTPN11;MAPK1,46 (46),0.66,1,0,,0 (0),1,1,0.66,1
the information processing pathway at the ifn beta enhancer,BioCarta,5,SMARCC2;RELA;NR3C1;POLR2A;ACTB,29 (29),0.663,1,0,,0 (0),1,1,0.663,1
IL4,NetPath,11,SHC1;SND1;GRB2;PIK3R1;PTPN6;PTPN11;STAT3;MAPK14;STAT5B;MAPK1;STAT6,63 (63),0.663,1,0,,0 (0),1,1,0.663,1
Type 2 papillary renal cell carcinoma,Wikipathways,8,DIAPH1;CUL2;ELOC;ELOB;HIF1A;SFPQ;RBX1;FH,34 (34),0.305,0.628,0,,3 (3),1,1,0.667,1
PI-3K cascade:FGFR2,Reactome,3,PIK3R1;PTPN11;GRB2,23 (23),0.837,1,1,HMDB0000693,4 (6),0.365,1,0.668,1
Arachidonic acid metabolism - Homo sapiens (human),KEGG,10,CYP2E1;EPHX2;PLA2G12B;PTGES3;CBR1;HPGDS;PTGES2;LTA4H;PTGS1;GPX1,61 (61),0.739,1,8,HMDB0003208;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002995;HMDB0001043;HMDB0002311;HMDB0002343;HMDB0002265;HMDB0002314,66 (75),0.414,1,0.668,1
ERK Pathway in Huntington_s Disease,Wikipathways,4,EGFR;MAPK1;CASP3;HRAS,15 (15),0.31,0.634,0,,1 (1),1,1,0.673,1
ERBB2 Regulates Cell Motility,Reactome,4,MEMO1;DIAPH1;RHOA;EGFR,15 (15),0.31,0.634,0,,1 (1),1,1,0.673,1
Spry regulation of FGF signaling,Reactome,4,PPP2CB;PTPN11;PPP2R1A;GRB2,15 (15),0.31,0.634,0,,3 (3),1,1,0.673,1
mRNA decay by 5_ to 3_ exoribonuclease,Reactome,4,DDX6;LSM3;LSM4;LSM6,15 (15),0.31,0.634,0,,6 (7),1,1,0.673,1
repression of pain sensation by the transcriptional regulator dream,BioCarta,4,PRKAR2A;PRKAR1A;POLR2A;PRKACB,15 (15),0.31,0.634,0,,1 (1),1,1,0.673,1
DCC mediated attractive signaling,Reactome,4,WASL;NCK1;CDC42;RAC1,15 (15),0.31,0.634,0,,4 (5),1,1,0.673,1
InlB-mediated entry of Listeria monocytogenes into host cell,Reactome,4,HGS;EPS15;GRB2;STAM2,15 (15),0.31,0.634,0,,2 (2),1,1,0.673,1
Validated nuclear estrogen receptor beta network,PID,4,UBE2M;NEDD8;C3;UBA3,15 (15),0.31,0.634,0,,1 (1),1,1,0.673,1
Fatty Acid Omega Oxidation,Wikipathways,4,ALDH1A1;CYP1A2;ADH6;CYP2E1,15 (15),0.31,0.634,0,,2 (4),1,1,0.673,1
T cell receptor signaling pathway - Homo sapiens (human),KEGG,16,HRAS;RHOA;MAP2K1;GRB2;PAK2;MAPK9;DLG1;RELA;PIK3R1;PTPN6;NCK1;MAPK14;CDC42;PPP3CA;MAPK1;MAP2K2,104 (104),0.851,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (4),0.365,1,0.674,1
Ramipril Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,1,HMDB0060579,7 (8),0.549,1,0.674,1
Spirapril Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,1,HMDB0015438,7 (7),0.549,1,0.674,1
Linoleic acid metabolism - Homo sapiens (human),KEGG,3,CYP1A2;CYP2E1;PLA2G12B,29 (29),0.931,1,3,HMDB0003073;HMDB0001043;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,19 (28),0.334,1,0.674,1
Ion homeostasis,Reactome,10,ATP1B1;STIM1;ATP1B3;FXYD1;ATP2A2;ATP2B1;AHCYL1;ATP1A1;ITPR2;PRKACA,44 (44),0.311,0.636,0,,10 (11),1,1,0.674,1
Synthesis of Leukotrienes (LT) and Eoxins (EX),Reactome,4,LTA4H;DPEP1;CYP4B1;PTGR1,21 (21),0.579,0.942,3,HMDB0002995;HMDB0000123;HMDB0001043,26 (32),0.54,1,0.676,1
Longevity regulating pathway - Homo sapiens (human),KEGG,19,HRAS;ATG5;PRKAA2;BAX;MTOR;PRKAG1;CAT;EIF4E;RELA;AKT1S1;PRKACA;IGF1;SOD2;RHEB;PRKAA1;PIK3R1;PRKAB1;EIF4E2;PRKACB,89 (89),0.314,0.64,0,,8 (8),1,1,0.677,1
Dual Incision in GG-NER,Reactome,7,CUL4B;CUL4A;DDB1;PARP1;POLE;PCNA;RBX1,41 (41),0.678,1,0,,0 (1),1,1,0.678,1
TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway,Wikipathways,7,MAPK9;FADD;RELA;RAC1;MAPK14;MAPK1;CTNNB1,41 (41),0.678,1,0,,0 (0),1,1,0.678,1
SHP2 signaling,PID,13,SHC1;HRAS;RHOA;EGFR;GRB2;AFDN;PIK3R1;GNAI3;PTPN11;IGF1;MAP2K1;PRKACA;MAP2K2,59 (59),0.315,0.64,0,,6 (6),1,1,0.679,1
Toll Like Receptor 7/8 (TLR7/8) Cascade,Reactome,17,MAPK9;SKP1;CUL1;MAP2K3;UBE2V1;PPP2CB;MAP2K1;PPP2R1A;MAP2K4;PPP2R5D;RELA;RPS6KA1;DUSP3;MAPK14;FUS;MAPK1;UBE2N,79 (79),0.315,0.64,0,,5 (11),1,1,0.679,1
CD4 T cell receptor signaling-ERK cascade,INOH,6,HRAS;MAP2K1;GRB2;ARAF;MAPK1;MAP2K2,44 (44),0.863,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (5),0.365,1,0.679,1
Renin secretion - Homo sapiens (human),KEGG,15,CALM1;CTSB;AQP1;GUCY1A1;GUCY1B1;ITPR2;PLCB3;GNAI3;GNAI2;AGT;GNAQ;PPP3CA;GNAS;PRKACA;PRKACB,69 (69),0.315,0.64,0,,17 (17),1,1,0.679,1
Amphetamine addiction - Homo sapiens (human),KEGG,15,MAOA;MAOB;CALM1;PRKCA;DDC;CAMK2A;CAMK2D;PPP1CC;HDAC2;PPP3CA;PPP1CA;PPP1CB;GNAS;PRKACA;PRKACB,69 (69),0.315,0.64,0,,10 (10),1,1,0.679,1
Metal sequestration by antimicrobial proteins,Reactome,2,S100A9;S100A8,6 (6),0.317,0.64,0,,6 (8),1,1,0.681,1
Peroxiredoxin 2 induced ovarian failure,Wikipathways,2,CASP3;BAX,6 (6),0.317,0.64,0,,2 (4),1,1,0.681,1
MET activates PI3K/AKT signaling,Reactome,2,GRB2;PIK3R1,6 (6),0.317,0.64,0,,3 (4),1,1,0.681,1
Biosynthesis of EPA-derived SPMs,Reactome,2,LTA4H;GPX4,6 (6),0.317,0.64,0,,13 (28),1,1,0.681,1
allopregnanolone biosynthesis,HumanCyc,2,SRD5A1;AKR1C1,6 (6),0.317,0.64,0,,8 (8),1,1,0.681,1
Transport and synthesis of PAPS,Reactome,2,PAPSS2;SLC26A1,6 (6),0.317,0.64,0,,7 (7),1,1,0.681,1
deregulation of cdk5 in alzheimers disease,BioCarta,2,PPP2R5D;CAPN1,6 (6),0.317,0.64,0,,1 (1),1,1,0.681,1
Proton-coupled monocarboxylate transport,Reactome,2,BSG;SLC16A1,6 (6),0.317,0.64,0,,4 (5),1,1,0.681,1
platelet amyloid precursor protein pathway,BioCarta,2,PLG;F9,6 (6),0.317,0.64,0,,1 (1),1,1,0.681,1
PTK6 promotes HIF1A stabilization,Reactome,2,HIF1A;EGFR,6 (6),0.317,0.64,0,,2 (2),1,1,0.681,1
Pilocytic astrocytoma,Wikipathways,2,GRB2;PTPN11,6 (6),0.317,0.64,0,,1 (1),1,1,0.681,1
Hydrolysis of LPC,Reactome,2,PLA2G15;PLBD1,11 (11),0.643,1,1,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375,6 (9),0.494,1,0.682,1
Mitotic G2-G2/M phases,Reactome,29,CUL1;MAPRE1;ACTR1A;PPP2CB;PPP2R1A;TUBB4B;PPP2R2A;RBBP4;DCTN2;CSNK1D;DCTN3;PAFAH1B1;SSNA1;PRKACA;CKAP5;PPME1;CEP192;RBX1;SKP1;DCTN1;YWHAE;YWHAG;TUBA4A;DYNC1H1;DYNC1I2;HSP90AA1;RAB8A;PPP1CB;HSP90AB1,140 (140),0.319,0.645,0,,8 (9),1,1,0.684,1
Nucleotide excision repair - Homo sapiens (human),KEGG,8,CUL4B;CUL4A;DDB1;POLE;PCNA;RBX1;RAD23A;RAD23B,47 (47),0.685,1,0,,0 (0),1,1,0.685,1
Ras signaling,Wikipathways,34,RHOA;STK4;RALA;RALB;RRAS2;RAP1A;RAP1B;PTPN11;CALM1;GNG12;EGFR;PLA2G12B;PIK3R1;PRKACA;PRKACB;SHC1;HRAS;GRB2;PAK2;PRKCA;AFDN;RELA;MAPK1;GNB1;GNB2;MAPK9;MAP2K1;MAP2K2;CDC42;RAB5A;RAB5B;RAB5C;RAC1;ARF6,184 (184),0.584,0.95,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,7 (7),0.549,1,0.685,1
Serotonin Receptor 2 and ELK-SRF-GATA4 signaling,Wikipathways,5,GNAQ;HRAS;MAPK1;MAP2K1;MAP2K2,20 (20),0.321,0.647,0,,3 (3),1,1,0.686,1
Signaling by NTRK2 (TRKB),Reactome,5,SHC1;HRAS;PTPN11;GRB2;RAC1,20 (20),0.321,0.647,0,,4 (4),1,1,0.686,1
Signaling by PDGFR in disease,Reactome,5,STRN;HRAS;GRB2;STAT3;PIK3R1,20 (20),0.321,0.647,0,,5 (12),1,1,0.686,1
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release,Reactome,5,ATM;STEAP3;AIFM2;BAX;BID,20 (20),0.321,0.647,0,,3 (3),1,1,0.686,1
S1P1 pathway,PID,5,MAPK1;RHOA;GNAI3;GNAI2;RAC1,20 (20),0.321,0.647,0,,4 (4),1,1,0.686,1
Purinergic signaling in leishmaniasis infection,Reactome,5,HSP90AB1;NT5E;SUGT1;C3;ENTPD5,20 (20),0.321,0.647,0,,16 (20),1,1,0.686,1
Cell recruitment (pro-inflammatory response),Reactome,5,HSP90AB1;NT5E;SUGT1;C3;ENTPD5,20 (20),0.321,0.647,0,,16 (20),1,1,0.686,1
miR-509-3p alteration of YAP1-ECM axis,Wikipathways,3,YAP1;COL1A1;FN1,18 (18),0.688,1,0,,0 (0),1,1,0.688,1
JAK-STAT-Ncore,Signalink,3,PTPN6;PTPN11;RACK1,18 (18),0.688,1,0,,0 (0),1,1,0.688,1
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,Reactome,3,PRMT1;BAX;PCNA,18 (18),0.688,1,0,,0 (0),1,1,0.688,1
Extracellular matrix organization,Reactome,57,COL4A2;BSG;COL6A1;COL6A2;COL18A1;MFAP4;FBLN1;FBLN5;VTN;LAMA2;DST;FGG;FN1;F11R;COL6A6;ACTN1;CTSL;PHYKPL;PLG;P4HB;ASPN;ICAM1;CAPN2;CAPNS1;CD47;FGA;FGB;LAMB2;PRKCA;CAPN1;COL6A5;COL14A1;COL6A3;CASP3;ITGA1;NCSTN;ITGA2B;PLEC;LUM;COLGALT1;ITGA5;ITGA9;DCN;CTSB;ITGB3;SERPINH1;ITGB1;ITGB2;KLKB1;PPIB;TTR;CASK;NID2;BGN;CDH1;COL1A1;COL1A2,287 (287),0.356,0.693,1,HMDB0033934,21 (30),0.909,1,0.688,1
Long-term potentiation,Reactome,4,CALM1;DLG1;CAMK2A;CAMK2D,23 (23),0.655,1,1,HMDB0000123,6 (6),0.494,1,0.689,1
IL1 and megakaryocytes in obesity,Wikipathways,4,S100A9;F2;SELENBP1;ICAM1,24 (24),0.69,1,0,,0 (0),1,1,0.69,1
tumor suppressor arf inhibits ribosomal biogenesis,BioCarta,4,ATM;HSP90AA1;PIK3R1;RAC1,24 (24),0.69,1,0,,0 (0),1,1,0.69,1
Phosphate bond hydrolysis by NTPDase proteins,Reactome,2,ENTPD8;ENTPD5,8 (8),0.463,0.843,2,HMDB0001342;HMDB0000189,22 (26),0.701,1,0.69,1
RIG-I-like receptor signaling pathway - Homo sapiens (human),KEGG,12,MAPK9;ATG5;ISG15;MAVS;NLRX1;DDX58;RELA;PIN1;TKFC;MAPK14;FADD;TRIM25,70 (70),0.691,1,0,,0 (0),1,1,0.691,1
FOXP3 in COVID-19,Wikipathways,2,STAT5B;STAT3,12 (12),0.692,1,0,,0 (0),1,1,0.692,1
Degradation of DVL,Reactome,2,RBX1;CUL3,12 (12),0.692,1,0,,0 (0),1,1,0.692,1
IL2 signaling events mediated by STAT5,PID,5,SHC1;STAT5B;PIK3R1;PTPN11;GRB2,30 (30),0.693,1,0,,0 (0),1,1,0.693,1
FRS-mediated FGFR3 signaling,Reactome,3,HRAS;GRB2;PTPN11,20 (20),0.757,1,1,HMDB0000693,5 (5),0.433,1,0.694,1
SHC-mediated cascade:FGFR4,Reactome,3,SHC1;HRAS;GRB2,20 (20),0.757,1,1,HMDB0000693,5 (5),0.433,1,0.694,1
Cushing syndrome - Homo sapiens (human),KEGG,24,USP8;RAP1A;RAP1B;GNAS;EGFR;CAMK2A;CAMK2D;SCARB1;AGT;PRKACA;PRKACB;GNA11;NCEH1;PLCB3;GNAI3;GNAQ;AIP;MAPK1;CTNNB1;FH;MAP2K1;MAP2K2;GNAI2;ITPR2,155 (155),0.884,1,2,HMDB0000067;HMDB0000015,12 (13),0.374,1,0.697,1
Arbutamine Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,10 (11),0.679,1,0.697,1
Alprenolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,10 (11),0.679,1,0.697,1
Muscle/Heart Contraction,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,10 (10),0.679,1,0.697,1
Felodipine Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,10 (11),0.679,1,0.697,1
Erythropoietin activates Phospholipase C gamma (PLCG),Reactome,1,LYN,7 (7),0.769,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,5 (6),0.433,1,0.699,1
Role of phospholipids in phagocytosis,Reactome,4,PLD4;IGHG1;ITPR2;PIK3R1,105 (105),1,1,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,11 (13),0.334,1,0.7,1
Vitamins,Reactome,0,,6 (6),1,1,2,HMDB0000876;HMDB0003550,11 (13),0.334,1,0.7,1
toll-like receptor pathway,BioCarta,8,CD14;MAP2K3;TOLLIP;EIF2AK2;MAP2K4;RELA;MAPK14;ECSIT,35 (35),0.335,0.67,0,,1 (1),1,1,0.702,1
Organic cation transport,Reactome,2,SLC22A18;SLC22A1,8 (8),0.463,0.843,2,HMDB0015169;HMDB0015282,23 (28),0.725,1,0.702,1
DNA damage response (only ATM dependent),Wikipathways,19,SCP2;MAPK9;RHOA;BAX;CDC42;PIK3R4;HRAS;PDK1;PIK3R1;CAT;SHC1;ATM;PCK2;RAC1;SOD2;PPP2R5E;MAPK1;CTNNB1;GRB2,110 (110),0.703,1,0,,0 (0),1,1,0.703,1
Vasopressin regulates renal water homeostasis via Aquaporins,Reactome,9,GNG12;PRKAR1A;AQP1;PRKAR2A;GNB1;GNAS;PRKACB;PRKACA;GNB2,40 (40),0.337,0.67,0,,8 (8),1,1,0.704,1
GPCR Dopamine D1like receptor,INOH,11,PRKAR1A;PRKAR2A;PPP2R1A;PTPA;PPP2R5A;PPP2R5D;PPP2R5E;GNAS;PPP1CC;PRKACA;PRKACB,50 (50),0.338,0.67,0,,4 (4),1,1,0.705,1
Sensory processing of sound by outer hair cells of the cochlea,Reactome,11,MYO1C;EPS8L2;RDX;PLS1;MYH9;EPB41L1;SPTAN1;GSN;SPTBN1;TWF1;CASK,50 (50),0.338,0.67,0,,6 (7),1,1,0.705,1
cGMP-PKG signaling pathway - Homo sapiens (human),KEGG,34,RHOA;GTF2I;PPP3CA;MYLK;CALM1;SLC25A4;SLC25A5;GUCY1A1;GUCY1B1;ATP1B3;GNA13;KNG1;MYL9;ROCK1;GNA11;PLCB3;GNAI3;VDAC2;GNAQ;MAPK1;ATP1A1;ATP1B1;VDAC3;MAP2K1;MAP2K2;ATP2A2;ATP2B1;ITPR2;GNAI2;VDAC1;PPIF;PPP1CA;PPP1CB;PPP1CC,167 (167),0.34,0.67,0,,10 (10),1,1,0.707,1
SHC-mediated cascade:FGFR1,Reactome,3,SHC1;HRAS;GRB2,21 (21),0.787,1,1,HMDB0000693,5 (5),0.433,1,0.708,1
Felbamate Metabolism,Wikipathways,1,CYP2E1,2 (2),0.342,0.67,0,,4 (4),1,1,0.709,1
thyroid hormone biosynthesis,HumanCyc,1,CTSD,2 (2),0.342,0.67,0,,6 (6),1,1,0.709,1
diphthamide biosynthesis,HumanCyc,1,DPH5,2 (2),0.342,0.67,0,,9 (9),1,1,0.709,1
D-glucuronate degradation,HumanCyc,1,CRYL1,2 (2),0.342,0.67,0,,10 (12),1,1,0.709,1
aspartate biosynthesis,HumanCyc,1,GOT1,2 (2),0.342,0.67,0,,4 (4),1,1,0.709,1
spermidine biosynthesis,HumanCyc,1,SRM,2 (2),0.342,0.67,0,,7 (7),1,1,0.709,1
IRE1alpha activates chaperones,Reactome,1,HSPA5,2 (2),0.342,0.67,0,,2 (4),1,1,0.709,1
Transfer of LPS from LBP carrier to CD14,Reactome,1,CD14,2 (2),0.342,0.67,0,,1 (1),1,1,0.709,1
Acetylation,Reactome,1,NAT1,2 (2),0.342,0.67,0,,9 (14),1,1,0.709,1
GDP-L-fucose biosynthesis I (from GDP-D-mannose),HumanCyc,1,GFUS,2 (2),0.342,0.67,0,,6 (7),1,1,0.709,1
RNA Polymerase I Promoter Opening,Reactome,1,UBTF,2 (2),0.342,0.67,0,,2 (3),1,1,0.709,1
fatty acid elongation -- saturated,HumanCyc,1,FASN,2 (2),0.342,0.67,0,,5 (5),1,1,0.709,1
Suppression of autophagy,Reactome,1,RAB7A,2 (2),0.342,0.67,0,,3 (3),1,1,0.709,1
UDP-D-xylose and UDP-D-glucuronate biosynthesis,HumanCyc,1,UGDH,2 (2),0.342,0.67,0,,7 (8),1,1,0.709,1
Events associated with phagocytolytic activity of PMN cells,Reactome,1,MPO,2 (2),0.342,0.67,0,,8 (17),1,1,0.709,1
sulfate activation for sulfonation,HumanCyc,1,PAPSS2,2 (2),0.342,0.67,0,,7 (7),1,1,0.709,1
putrescine biosynthesis II,HumanCyc,1,AGMAT,2 (2),0.342,0.67,0,,7 (7),1,1,0.709,1
Downstream signaling of activated FGFR2,Reactome,5,SHC1;HRAS;PIK3R1;PTPN11;GRB2,30 (30),0.693,1,1,HMDB0000693,6 (8),0.494,1,0.71,1
Miscellaneous substrates,Reactome,1,CYP4B1,12 (12),0.919,1,2,HMDB0000234;HMDB0001043,12 (15),0.374,1,0.711,1
VEGFR2 mediated cell proliferation,Reactome,4,HRAS;PRKCA;ITPR2;CALM1,20 (20),0.538,0.908,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,9 (10),0.64,1,0.712,1
Signaling by FGFR4 in disease,Reactome,3,HRAS;GRB2;PIK3R1,11 (11),0.345,0.673,0,,5 (7),1,1,0.712,1
Signaling by Leptin,Reactome,3,STAT5B;PTPN11;STAT3,11 (11),0.345,0.673,0,,2 (2),1,1,0.712,1
MET activates RAS signaling,Reactome,3,SHC1;HRAS;GRB2,11 (11),0.345,0.673,0,,4 (4),1,1,0.712,1
cardiac protection against ros,BioCarta,3,SOD2;GPX1;SOD1,11 (11),0.345,0.673,0,,6 (10),1,1,0.712,1
The role of GTSE1 in G2/M progression after G2 checkpoint,Reactome,3,HSP90AA1;HSP90AB1;MAPRE1,11 (11),0.345,0.673,0,,2 (3),1,1,0.712,1
Serotonin Transporter Activity,Wikipathways,3,MAOA;ITGB3;PPP2CB,11 (11),0.345,0.673,0,,3 (3),1,1,0.712,1
EGF-Core,Signalink,18,SHC1;HRAS;TAOK3;STK4;MAP2K3;MAPK9;MAP2K1;MAP4K5;MAP2K4;RPS6KA1;CRK;RAC1;MAPK14;EGFR;MAPK1;PAK2;CDC42;MAP2K2,105 (105),0.713,1,0,,0 (0),1,1,0.713,1
Natural killer cell mediated cytotoxicity - Homo sapiens (human),KEGG,18,SHC1;HRAS;CD48;CASP3;GRB2;MAPK1;ARAF;ITGB2;PRKCA;ICAM1;PIK3R1;PTPN6;PTPN11;RAC1;MAP2K1;PPP3CA;BID;MAP2K2,130 (131),0.948,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (4),0.365,1,0.713,1
Plasmalogen biosynthesis,Reactome,1,DHRS7B,3 (3),0.466,0.843,1,HMDB0062325,12 (12),0.745,1,0.714,1
exRNA mechanism of action and biogenesis,Wikipathways,1,AGO2,6 (6),0.715,1,0,,0 (1),1,1,0.715,1
RUNX1 regulates estrogen receptor mediated transcription,Reactome,1,GPAM,6 (6),0.715,1,0,,0 (1),1,1,0.715,1
Robo4 and VEGF Signaling Pathways Crosstalk,Wikipathways,1,RAC1,6 (6),0.715,1,0,,0 (0),1,1,0.715,1
Somatroph axis (GH) and its relationship to dietary restriction and aging,Wikipathways,1,MTOR,6 (6),0.715,1,0,,0 (1),1,1,0.715,1
IL-10 signaling,INOH,1,STAT3,6 (6),0.715,1,0,,0 (0),1,1,0.715,1
IL-6 signaling,INOH,1,STAT3,6 (6),0.715,1,0,,0 (0),1,1,0.715,1
TLR3-mediated TICAM1-dependent programmed cell death,Reactome,1,FADD,6 (6),0.715,1,0,,0 (2),1,1,0.715,1
Regulation of ornithine decarboxylase (ODC),Reactome,1,NQO1,6 (6),0.715,1,0,,0 (0),1,1,0.715,1
p75NTR negatively regulates cell cycle via SC1,Reactome,1,HDAC2,6 (6),0.715,1,0,,0 (0),1,1,0.715,1
TNFR1-mediated ceramide production,Reactome,1,RACK1,6 (6),0.715,1,0,,0 (0),1,1,0.715,1
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells,Reactome,1,LGALS3,6 (6),0.715,1,0,,0 (0),1,1,0.715,1
superpathway of pyrimidine deoxyribonucleoside salvage,HumanCyc,4,NME3;NME2;NME1;CMPK1,17 (17),0.404,0.764,2,HMDB0001342;HMDB0000189,31 (31),0.861,1,0.715,1
androgen biosynthesis,HumanCyc,1,SRD5A1,7 (7),0.769,1,2,HMDB0000234;HMDB0000077,14 (15),0.453,1,0.715,1
Disopyramide Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Amiodarone Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Amlodipine Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Ibutilide Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Nadolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Bopindolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Timolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Carteolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Bevantolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Practolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Isoprenaline Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Levobunolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Metipranolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Quinidine Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Sotalol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Epinephrine Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Betaxolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Atenolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Acebutolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Diltiazem Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Propranolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Oxprenolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Metoprolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Esmolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Bisoprolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Nebivolol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Verapamil Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Nitrendipine Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Nisoldipine Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Nimodipine Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Flecainide Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Isradipine Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Nifedipine Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.715,1
Metabolism of amine-derived hormones,Reactome,4,DUOX1;IYD;DDC;DIO1,16 (16),0.357,0.693,1,HMDB0000472,34 (39),0.979,1,0.717,1
Collagen formation,Reactome,18,COL6A6;COL6A1;CTSB;PPIB;COL18A1;COL6A5;P4HB;SERPINH1;COL6A2;COL14A1;COL1A1;DST;COL6A3;CTSL;COL4A2;PLEC;COLGALT1;COL1A2,91 (91),0.454,0.843,1,HMDB0033934,13 (16),0.772,1,0.718,1
C-type lectin receptors (CLRs),Reactome,11,CALM1;LYN;SKP1;CUL1;PAK2;HRAS;RELA;PPP3CA;ITPR2;PRKACA;PRKACB,84 (84),0.938,1,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0029931,12 (18),0.374,1,0.719,1
TYROBP causal network in microglia,Wikipathways,10,RBM47;TCIRG1;ITGB2;C3;NPC2;RPS6KA1;DPYD;CAPG;GPX1;HCLS1,60 (60),0.719,1,0,,0 (0),1,1,0.719,1
Signaling by GPCR,Reactome,50,RHOA;PPP2CB;PPP2R1A;GNAI2;PPP2R5D;PPP3CA;CAMK2A;PSAP;GNAS;PRKAR1A;CALM1;GNG12;EGFR;HEBP1;ANXA1;NLN;PIK3R1;GNA13;CAMK2D;RPS6KA1;AGT;ABHD6;PRKACB;HRAS;PXMP2;GRB2;PRKAR2A;PRKCA;PF4;ROCK1;C3;MGLL;PLCB3;GNAI3;C5;GNAQ;MAPK1;GNA11;GNB1;GNB2;F2;CDC42;ABHD12;KNG1;PRKACA;ARHGEF12;ARHGEF10L;PPP1CA;ITPR2;KPNA2,706 (706),1,1,17,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005096;HMDB0002995;HMDB0003208;HMDB0033941;HMDB0003073;HMDB0001388;HMDB0015095;HMDB0006528;HMDB0036836;HMDB0001043;HMDB0004080;HMDB0015697;HMDB0015464;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304;HMDB0002183,142 (190),0.351,1,0.719,1
FRS-mediated FGFR4 signaling,Reactome,3,HRAS;PTPN11;GRB2,22 (22),0.813,1,1,HMDB0000693,5 (5),0.433,1,0.72,1
Hypothesized Pathways in Pathogenesis of Cardiovascular Disease,Wikipathways,4,MAPK14;SHC1;MAPK1;FLNA,25 (25),0.721,1,0,,0 (0),1,1,0.721,1
Collagen degradation,Reactome,5,CTSL;COL14A1;CTSB;COL18A1;PHYKPL,35 (35),0.817,1,1,HMDB0033934,5 (6),0.433,1,0.722,1
Base Excision Repair,Wikipathways,5,APEX1;POLE;LIG3;PARP1;PCNA,31 (31),0.722,1,0,,0 (0),1,1,0.722,1
Aurora A signaling,PID,5,PPP2R5D;CKAP5;RAN;PRKACA;NDEL1,31 (31),0.722,1,0,,0 (0),1,1,0.722,1
Type II interferon signaling (IFNG),Wikipathways,6,PSMB9;ISG15;EIF2AK2;STAT2;ICAM1;PTPN11,37 (37),0.724,1,0,,0 (0),1,1,0.724,1
signal transduction through il1r,BioCarta,6,MAP2K3;TOLLIP;PEBP1;RELA;MAPK14;ECSIT,37 (37),0.724,1,0,,0 (0),1,1,0.724,1
Th17 cell differentiation - Homo sapiens (human),KEGG,13,MAPK1;MAPK9;MTOR;RXRA;MAPK14;RELA;HIF1A;STAT3;HSP90AA1;STAT5B;STAT6;PPP3CA;HSP90AB1,107 (107),0.977,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (4),0.365,1,0.724,1
Apoptotic factor-mediated response,Reactome,4,C1QBP;MAPK1;CASP3;SEPTIN4,16 (16),0.357,0.693,0,,2 (2),1,1,0.724,1
MAP3K8 (TPL2)-dependent MAPK1/3 activation,Reactome,4,MAP2K4;MAP2K1;SKP1;CUL1,16 (16),0.357,0.693,0,,2 (2),1,1,0.724,1
Osteoclast Signaling,Wikipathways,4,ITGB3;ATP6V1G1;AIMP2;ACP5,16 (16),0.357,0.693,0,,3 (4),1,1,0.724,1
Downstream signaling of activated FGFR1,Reactome,5,SHC1;HRAS;PIK3R1;PTPN11;GRB2,31 (31),0.722,1,1,HMDB0000693,6 (7),0.494,1,0.724,1
Chronic myeloid leukemia - Homo sapiens (human),KEGG,16,SHC1;HRAS;MAP2K1;MAP2K2;BAX;PIK3R1;ARAF;RELA;PTPN11;CRK;CRKL;STAT5B;MAPK1;CTBP1;HDAC2;GRB2,76 (76),0.357,0.693,0,,1 (1),1,1,0.724,1
Mitotic Prophase,Reactome,29,TPR;PPP2CB;PPP2R1A;RANBP2;GORASP2;NUP160;NUP58;NUP155;LMNA;LMNB1;USO1;NUP210;NUP98;RAE1;NUP133;H2AX;TMPO;PRKCA;NEK7;RAB1B;NUP93;MAPK1;RAB1A;RAB2A;BANF1;GOLGA2;NUP35;SEC13;NUP205,147 (148),0.428,0.807,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,16 (19),0.838,1,0.726,1
Serotonin clearance from the synaptic cleft,Reactome,1,MAOA,3 (3),0.466,0.843,1,HMDB0033934,13 (13),0.772,1,0.728,1
Male infertility,Wikipathways,17,NQO1;XRCC5;PON1;PON2;SHMT1;CLU;MTHFD1;PEMT;USP8;PARP1;CAT;ATM;APOB;SOD2;AGO2;BHMT;GPX1,145 (145),0.993,1,1,HMDB0014936,4 (4),0.365,1,0.73,1
FRS-mediated FGFR1 signaling,Reactome,3,HRAS;PTPN11;GRB2,23 (23),0.837,1,1,HMDB0000693,5 (5),0.433,1,0.73,1
SHC-mediated cascade:FGFR2,Reactome,3,SHC1;HRAS;GRB2,23 (23),0.837,1,1,HMDB0000693,5 (6),0.433,1,0.73,1
Fosphenytoin (Antiarrhythmic) Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,61 (61),0.488,0.863,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,12 (12),0.745,1,0.731,1
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane,Reactome,3,SLC25A4;SLC25A5;SLC29A1,12 (12),0.401,0.763,1,HMDB0000195,21 (21),0.909,1,0.733,1
Melanogenesis - Homo sapiens (human),KEGG,17,HRAS;MAP2K1;MAP2K2;CALM1;PRKCA;CAMK2A;CAMK2D;PLCB3;GNAI3;GNAI2;PRKACA;GNAQ;GNAS;CTNNB1;MAPK1;KITLG;PRKACB,101 (101),0.738,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,6 (6),0.494,1,0.733,1
Cleavage of the damaged purine,Reactome,1,H2AX,59 (60),1,1,1,HMDB0011600,4 (9),0.365,1,0.733,1
Depurination,Reactome,1,H2AX,59 (60),1,1,1,HMDB0011600,4 (9),0.365,1,0.733,1
FCERI mediated NF-kB activation,Reactome,2,RELA;LYN,98 (98),1,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,4 (6),0.365,1,0.733,1
Proton-coupled neutral amino acid transporters,Reactome,0,,2 (2),1,1,1,HMDB0000123,4 (4),0.365,1,0.733,1
Phospholipase C-mediated cascade; FGFR2,Reactome,0,,18 (18),1,1,1,HMDB0000693,4 (5),0.365,1,0.733,1
Phospholipase C-mediated cascade; FGFR4,Reactome,0,,15 (15),1,1,1,HMDB0000693,4 (4),0.365,1,0.733,1
Phospholipase C-mediated cascade; FGFR3,Reactome,0,,13 (13),1,1,1,HMDB0000693,4 (4),0.365,1,0.733,1
Phospholipase C-mediated cascade: FGFR1,Reactome,0,,16 (16),1,1,1,HMDB0000693,4 (4),0.365,1,0.733,1
protein <i>O</i>-[<i>N</i>-acetyl]-glucosylation,HumanCyc,0,,2 (2),1,1,1,HMDB0000290,4 (5),0.365,1,0.733,1
Leukotriene receptors,Reactome,0,,5 (5),1,1,1,HMDB0002995,4 (4),0.365,1,0.733,1
Heroin Metabolism Pathway,SMPDB,0,,4 (4),1,1,1,HMDB0041812,4 (5),0.365,1,0.733,1
Lactose synthesis,Reactome,0,,3 (3),1,1,1,HMDB0035312,4 (4),0.365,1,0.733,1
Endogenous TLR signaling,PID,6,CD14;RHOA;HSPD1;S100A9;S100A8;BGN,26 (26),0.365,0.707,0,,2 (2),1,1,0.733,1
ATM Signaling Network in Development and Disease,Wikipathways,10,PPP5C;TRIM28;H2AX;HSPB1;MTOR;SMC1A;PTPA;ATM;PRKAA1;RAD50,46 (46),0.365,0.707,0,,1 (1),1,1,0.733,1
Type II diabetes mellitus - Homo sapiens (human),KEGG,10,MAPK1;PKLR;PKM;MAPK9;MTOR;PIK3R1;SLC2A2;GCK;HK1;HK3,46 (46),0.365,0.707,0,,4 (6),1,1,0.733,1
Carvedilol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,62 (62),0.512,0.88,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.734,1
Labetalol Action Pathway,SMPDB,12,TPM1;ATP1B1;ATP1B3;TNNT3;PRKAR1A;CALM1;ATP2A2;DLG1;SNTB2;MYLK;ATP1A1;PRKACA,62 (62),0.512,0.88,1,HMDB0010139#HMDB0010126#HMDB0010083#HMDB0009947#HMDB0009779#HMDB0010131#HMDB0010106#HMDB0010107#HMDB0010142#HMDB0010049#HMDB0010050#HMDB0010058#HMDB0010096#HMDB0010097#HMDB0010084#HMDB0009970#HMDB0010138#HMDB0010135#HMDB0010134#HMDB0010146#HMDB0010145,11 (11),0.714,1,0.734,1
activation of camp-dependent protein kinase pka,BioCarta,7,F2;PRKAR1A;PRKAR2A;AGT;GNAS;GNB1;PRKACB,31 (31),0.366,0.709,0,,5 (6),1,1,0.734,1
roles of  arrestin dependent recruitment of src kinases in gpcr signaling,BioCarta,8,HRAS;F2;MAP2K1;MAP2K2;AGT;MAPK1;GNAS;GNB1,36 (36),0.366,0.709,0,,3 (4),1,1,0.734,1
Mammary gland development pathway - Puberty (Stage 2 of 4),Wikipathways,2,VIM;FN1,13 (13),0.735,1,0,,0 (1),1,1,0.735,1
Endosomal/Vacuolar pathway,Reactome,2,CTSL;B2M,13 (13),0.735,1,0,,0 (3),1,1,0.735,1
Homologous recombination,Wikipathways,2,ATM;RAD50,13 (13),0.735,1,0,,0 (0),1,1,0.735,1
rb tumor suppressor/checkpoint signaling in response to dna damage,BioCarta,2,ATM;YWHAH,13 (13),0.735,1,0,,0 (0),1,1,0.735,1
Circadian entrainment - Homo sapiens (human),KEGG,18,PER2;CALM1;GNG12;GUCY1A1;GUCY1B1;PRKCA;CAMK2A;CAMK2D;PLCB3;GNAI3;GNAI2;PRKACA;GNAQ;GNAS;GNB2;MAPK1;GNB1;PRKACB,97 (97),0.573,0.936,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,9 (9),0.64,1,0.735,1
Thyroid hormones production and their peripheral downstream signaling effects,Wikipathways,13,HRAS;GRB2;ITGB3;MTOR;MGLL;RXRA;RPS6;AKT1S1;RHEB;IYD;CTNNB1;ITPR2;DIO1,74 (74),0.659,1,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,17 (25),0.559,1,0.736,1
Cell Cycle_ Mitotic,Reactome,101,PDS5B;KPNB1;TPR;VPS4A;SMC1A;CKAP5;IST1;RCC1;TUBB2B;RPS27;NUP58;DCTN1;CHMP2A;TUBA4A;BANF1;RCC2;RAB8A;NUP205;TUBA1B;TUBB4B;NDEL1;UBE2I;DHFR;NUP210;PPME1;PDS5A;DNA2;RAB1A;RAB2A;NUP160;GOLGA2;DYNC1H1;DYNC1I2;DYNC1LI2;HSP90AA1;RBX1;SEC13;RAD21;HSP90AB1;TNPO1;CUL1;EML4;RAN;RANBP2;RANGAP1;CHMP6;RAE1;RBBP4;DCTN2;POLE;TUBA1C;NUP98;NEK7;CEP192;XPO1;CHMP4B;SKP1;YWHAE;YWHAG;NUP35;PPP1CB;PPP1CC;SIRT2;MAPRE1;ACTR1A;PPP2CB;PPP2R1A;PPP2R2A;GORASP2;PPP2R5A;PPP2R5D;PPP2R5E;NUP155;LMNA;LMNB1;SMC3;USO1;CSNK1D;CSNK2A1;CSNK2A2;CSNK2B;PAFAH1B1;SSNA1;PRKACA;DYNLL2;NUP133;CHMP3;H2AX;DYNC1LI1;TMPO;PRKCA;RAB1B;NUP93;MAPK1;ZW10;BUB3;LYN;NUDC;STAG2;PCNA;DCTN3,523 (524),0.414,0.783,2,HMDB0001342;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,34 (40),0.894,1,0.738,1
Notch Signaling Pathway Netpath,Wikipathways,10,SKP1;CUL1;NUMB;PIK3R1;HIF1A;STAT3;NCSTN;ITCH;HDAC2;SNW1,61 (61),0.739,1,0,,0 (0),1,1,0.739,1
Nicotine Activity on Dopaminergic Neurons,Wikipathways,4,PPP1CA;DDC;GNB1;PRKACA,21 (21),0.579,0.942,1,HMDB0001934,9 (9),0.64,1,0.739,1
Unblocking of NMDA receptors_ glutamate binding and activation,Reactome,3,CAMK2D;DLG1;CAMK2A,20 (20),0.757,1,1,HMDB0000123,6 (6),0.494,1,0.742,1
Transport of vitamins_ nucleosides_ and related molecules,Reactome,8,SLC25A4;SLC25A5;SLCO2B1;SLC29A1;SLC33A1;SLC27A1;SLCO2A1;ALB,44 (44),0.607,0.974,6,HMDB0000036;HMDB0000951;HMDB0000195;HMDB0000290;HMDB0000304;HMDB0000138,59 (63),0.619,1,0.744,1
Costimulation by the CD28 family,Reactome,16,LYN;YES1;PAK2;MTOR;PPP2CB;PPP2R1A;PIK3R1;PTPN11;PTPN6;PPP2R5A;GRB2;RAC1;PPP2R5D;PPP2R5E;CDC42;CSK,77 (77),0.378,0.73,0,,8 (10),1,1,0.746,1
Xenobiotics,Reactome,2,CYP1A2;CYP2E1,21 (21),0.927,1,5,HMDB0041905;HMDB0006543;HMDB0000234;HMDB0001920;HMDB0013195,39 (51),0.409,1,0.747,1
FRS-mediated FGFR2 signaling,Reactome,3,HRAS;PTPN11;GRB2,25 (25),0.877,1,1,HMDB0000693,5 (6),0.433,1,0.747,1
N-glycan antennae elongation in the medial/trans-Golgi,Reactome,5,ST6GAL1;MAN2A1;ST3GAL4;FUCA1;MGAT2,26 (26),0.56,0.927,1,HMDB0000290,10 (22),0.679,1,0.748,1
3q29 copy number variation syndrome,Wikipathways,14,UBE2N;PXN;PAK2;DYNLRB1;DLG1;TF;DYNLT3;PCYT1A;HIF1A;NCBP1;HAMP;STAT5B;TFRC;DYNLL2,86 (86),0.771,1,1,HMDB0000036,6 (17),0.494,1,0.749,1
Collagen biosynthesis and modifying enzymes,Reactome,14,COL6A6;PPIB;COL4A2;COLGALT1;SERPINH1;COL6A5;P4HB;COL6A1;COL6A2;COL18A1;COL14A1;COL6A3;COL1A1;COL1A2,67 (67),0.383,0.739,0,,8 (10),1,1,0.75,1
Syndecan-3-mediated signaling events,PID,4,CTTN;EGFR;CASK;NCSTN,26 (26),0.751,1,0,,0 (1),1,1,0.751,1
EGR2 and SOX10-mediated initiation of Schwann cell myelination,Reactome,4,GJB1;HDAC2;LAMA2;YAP1,26 (26),0.751,1,0,,0 (0),1,1,0.751,1
Maturity onset diabetes of the young - Homo sapiens (human),KEGG,4,PKLR;SLC2A2;HNF4A;GCK,26 (26),0.751,1,0,,0 (0),1,1,0.751,1
ID,NetPath,4,MAPK1;MAP2K1;MAP2K2;PSMD4,26 (26),0.751,1,0,,0 (0),1,1,0.751,1
Regulation of RUNX2 expression and activity,Reactome,4,SKP1;RBX1;NR3C1;CUL1,27 (27),0.778,1,1,HMDB0001547,6 (7),0.494,1,0.752,1
Organic cation/anion/zwitterion transport,Reactome,3,SLC22A7;SLC22A18;SLC22A1,13 (13),0.456,0.843,2,HMDB0015169;HMDB0015282,30 (35),0.849,1,0.755,1
Hepatitis C and Hepatocellular Carcinoma,Wikipathways,9,CTTN;CASP3;GRB2;HIF1A;PTPN11;STAT3;RAC1;MAPK14;COL4A2,56 (56),0.755,1,0,,0 (0),1,1,0.755,1
Chemokine signaling pathway - Homo sapiens (human),KEGG,30,RHOA;RAP1A;RAP1B;PXN;GNG12;STAT3;PIK3R1;PRKACA;PRKACB;SHC1;HRAS;GRB2;RAC1;PF4;ROCK1;RELA;PLCB3;GNAI3;GNAQ;MAPK1;GNB1;GNB2;LYN;MAP2K1;CDC42;GNAI2;STAT2;CRK;CRKL;STAT5B,192 (192),0.897,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,5 (5),0.433,1,0.756,1
Receptor-type tyrosine-protein phosphatases,Reactome,3,PPFIBP1;PPFIA1;PTPRD,20 (20),0.757,1,0,,0 (0),1,1,0.757,1
Angiogenesis,Wikipathways,3,MAPK14;MAPK1;HIF1A,20 (20),0.757,1,0,,0 (0),1,1,0.757,1
TICAM1_ RIP1-mediated IKK complex recruitment,Reactome,3,UBE2D3;UBE2N;UBE2V1,20 (20),0.757,1,0,,0 (3),1,1,0.757,1
tgf beta signaling pathway,BioCarta,3,SAR1A;MAP2K1;CDH1,20 (20),0.757,1,0,,0 (0),1,1,0.757,1
TP53 network,Wikipathways,3,ATM;BAX;BID,20 (20),0.757,1,0,,0 (0),1,1,0.757,1
Erythropoietin activates STAT5,Reactome,2,STAT5B;LYN,7 (7),0.392,0.75,0,,2 (2),1,1,0.759,1
Synthesis of diphthamide-EEF2,Reactome,2,EEF2;DPH5,7 (7),0.392,0.75,0,,7 (7),1,1,0.759,1
SOS-mediated signalling,Reactome,2,HRAS;GRB2,7 (7),0.392,0.75,0,,2 (2),1,1,0.759,1
Suppression of apoptosis,Reactome,2,MAPK1;SFPQ,7 (7),0.392,0.75,0,,2 (2),1,1,0.759,1
Glycerophospholipid catabolism,Reactome,2,GDPD1;PNPLA7,7 (7),0.392,0.75,0,,6 (11),1,1,0.759,1
RSK activation,Reactome,2,MAPK1;RPS6KA1,7 (7),0.392,0.75,0,,3 (4),1,1,0.759,1
Docetaxel Action Pathway,SMPDB,2,TUBA1B;ABCC2,7 (7),0.392,0.75,0,,5 (5),1,1,0.759,1
Paclitaxel Action Pathway,SMPDB,2,TUBA1B;ABCC2,7 (7),0.392,0.75,0,,6 (6),1,1,0.759,1
G alpha (q) signalling events,Reactome,21,ANXA1;HRAS;GNG12;F2;EGFR;GRB2;PLCB3;PRKCA;AGT;PIK3R1;GNA11;RPS6KA1;GNB1;KNG1;GNAQ;MAPK1;MGLL;ABHD12;ITPR2;ABHD6;GNB2,221 (221),1,1,7,HMDB0003208;HMDB0003073;HMDB0001388;HMDB0002995;HMDB0006528;HMDB0001043;HMDB0002183,56 (64),0.395,1,0.762,1
Chondroitin sulfate biosynthesis,Reactome,2,BGN;DCN,20 (20),0.914,1,1,HMDB0000304,5 (5),0.433,1,0.763,1
Aldosterone-regulated sodium reabsorption - Homo sapiens (human),KEGG,8,ATP1B1;ATP1B3;SLC9A3R2;PRKCA;PIK3R1;IGF1;MAPK1;ATP1A1,37 (37),0.398,0.76,0,,8 (8),1,1,0.764,1
Cell Cycle,Reactome,119,PDS5B;KPNB1;TPR;VPS4A;SMC1A;CKAP5;IST1;SIRT2;RCC1;TUBB2B;RPS27;NUP58;DCTN1;CHMP2A;TUBA4A;BANF1;RCC2;BABAM2;RAB8A;NUP205;TUBA1B;TUBB4B;SYCP2;NDEL1;UBE2I;UBE2N;UBE2V2;DYNC1LI1;DHFR;NUP210;RANGAP1;PPME1;ANKRD28;PDS5A;YWHAQ;DNA2;RAB1A;RAB2A;NUP160;GOLGA2;DYNC1H1;DYNC1I2;DYNC1LI2;HSP90AA1;RBX1;SEC13;RAD21;HSP90AB1;TNPO1;NPM1;CUL1;EML4;RAN;RANBP2;ATM;CHMP6;RAE1;RBBP4;DCTN2;POLE;TUBA1C;NUP98;NEK7;BRCC3;CEP192;XPO1;CHMP4B;SKP1;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;GAR1;NUP35;PPP1CB;PPP1CC;RAD50;MAPRE1;ACTR1A;PPP2CB;PPP2R1A;PPP2R2A;GORASP2;PPP2R5A;PPP2R5D;PPP2R5E;BABAM1;RUVBL1;LMNA;PPP6C;SMC3;USO1;CSNK1D;CSNK2A1;CSNK2A2;CSNK2B;PAFAH1B1;NUP155;SSNA1;PRKACA;DYNLL2;NUP133;CHMP3;H2AX;LMNB1;TMPO;PRKCA;RAB1B;NUP93;MAPK1;ZW10;BUB3;LYN;NUDC;STAG2;PCNA;DCTN3;PPP6R3,621 (622),0.441,0.827,2,HMDB0001342;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,35 (44),0.903,1,0.765,1
FLT3 Signaling,Reactome,7,HRAS;PTPRJ;CSK;PIK3R1;PTPN11;STAT5B;GRB2,32 (32),0.4,0.763,0,,6 (9),1,1,0.766,1
role of -arrestins in the activation and targeting of map kinases,BioCarta,7,F2;MAP2K1;MAP2K2;AGT;MAPK1;GNAS;GNB1,32 (32),0.4,0.763,0,,3 (4),1,1,0.766,1
CLEC7A (Dectin-1) induces NFAT activation,Reactome,3,CALM1;PPP3CA;ITPR2,12 (12),0.401,0.763,0,,4 (5),1,1,0.768,1
Reversible hydration of carbon dioxide,Reactome,3,CA14;CA3;CA5A,12 (12),0.401,0.763,0,,4 (5),1,1,0.768,1
Condensation of Prometaphase Chromosomes,Reactome,3,CSNK2A1;CSNK2A2;CSNK2B,12 (12),0.401,0.763,0,,4 (5),1,1,0.768,1
Signaling by FGFR3 in disease,Reactome,3,HRAS;GRB2;PIK3R1,22 (22),0.813,1,1,HMDB0000693,6 (17),0.494,1,0.768,1
Signaling by FGFR3 point mutants in cancer,Reactome,3,HRAS;GRB2;PIK3R1,22 (22),0.813,1,1,HMDB0000693,6 (17),0.494,1,0.768,1
Hfe effect on hepcidin production,Wikipathways,1,HAMP,7 (7),0.769,1,0,,0 (0),1,1,0.769,1
Binding of TCF/LEF:CTNNB1 to target gene promoters,Reactome,1,CTNNB1,7 (7),0.769,1,0,,0 (0),1,1,0.769,1
Activation of NLRP3 Inflammasome by SARS-CoV-2,Wikipathways,1,RELA,7 (7),0.769,1,0,,0 (0),1,1,0.769,1
MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma,Wikipathways,1,HIF1A,7 (7),0.769,1,0,,0 (0),1,1,0.769,1
Vpu mediated degradation of CD4,Reactome,1,SKP1,7 (7),0.769,1,0,,0 (0),1,1,0.769,1
IL-12 signaling,INOH,1,STAT4,7 (7),0.769,1,0,,0 (0),1,1,0.769,1
RUNX3 regulates YAP1-mediated transcription,Reactome,1,YAP1,7 (7),0.769,1,0,,0 (0),1,1,0.769,1
TNFR1-induced proapoptotic signaling,Reactome,1,FADD,7 (7),0.769,1,0,,0 (0),1,1,0.769,1
IL-2 signaling,INOH,1,STAT5B,7 (7),0.769,1,0,,0 (0),1,1,0.769,1
IL-3 signaling,INOH,1,STAT5B,7 (7),0.769,1,0,,0 (0),1,1,0.769,1
TRAIL  signaling,Reactome,1,FADD,7 (7),0.769,1,0,,0 (0),1,1,0.769,1
Post-transcriptional silencing by small RNAs,Reactome,1,AGO2,7 (7),0.769,1,0,,0 (1),1,1,0.769,1
Nectin/Necl  trans heterodimerization,Reactome,1,NECTIN2,7 (7),0.769,1,0,,0 (0),1,1,0.769,1
SMAC (DIABLO) binds to IAPs ,Reactome,1,CASP3,7 (7),0.769,1,0,,0 (0),1,1,0.769,1
SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes ,Reactome,1,CASP3,7 (7),0.769,1,0,,0 (0),1,1,0.769,1
srebp control of lipid synthesis,BioCarta,1,HMGCS1,7 (7),0.769,1,0,,0 (0),1,1,0.769,1
rna polymerase iii transcription,BioCarta,1,NR3C1,7 (7),0.769,1,0,,0 (0),1,1,0.769,1
ADP signalling through P2Y purinoceptor 12,Reactome,5,GNG12;GNAI2;GNAI3;GNB1;GNB2,22 (22),0.403,0.764,0,,3 (3),1,1,0.77,1
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),Reactome,4,FKBP1A;F11R;CGN;RHOA,17 (17),0.404,0.764,0,,3 (3),1,1,0.77,1
PKA activation,Reactome,4,PRKAR2A;PRKAR1A;PRKACA;PRKACB,17 (17),0.404,0.764,0,,4 (4),1,1,0.77,1
MAPK Signaling Pathway,Wikipathways,38,STK4;FLNA;FLNB;RRAS2;RAP1A;TAOK3;RAP1B;MAPK14;PPP3CA;GRB2;PPP5C;CD14;GNG12;EGFR;MAP2K4;RAC1;DUSP3;ECSIT;PRKACA;PRKACB;HRAS;CASP3;CRK;PAK2;PRKCA;PPM1B;RELA;MAPK1;MAP2K2;MAPK9;MAP2K1;MAP2K3;CDC42;HSPA8;ARAF;HSPB1;PPM1A;CRKL,246 (246),0.932,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,5 (5),0.433,1,0.77,1
CD4 T cell receptor signaling-JNK cascade,INOH,7,MAPK9;MAP2K1;MAP2K2;CALM1;RAC1;PPP3CA;MAPK1,57 (57),0.932,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,5 (6),0.433,1,0.77,1
Neural Crest Cell Migration during Development,Wikipathways,6,PIK3R4;RHOA;PAK2;RAC1;STAT3;ARF1,39 (39),0.771,1,0,,0 (0),1,1,0.771,1
Signaling events mediated by HDAC Class III,PID,6,BAX;TUBA1B;SIRT3;XRCC6;SIRT2;ACSS2,39 (39),0.771,1,0,,0 (0),1,1,0.771,1
Serine Metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB0004949,13 (27),0.772,1,0.772,1
chaperones modulate interferon signaling pathway,BioCarta,2,RELA;DNAJA3,14 (14),0.772,1,0,,0 (0),1,1,0.772,1
Signal transduction through IL1R,Wikipathways,5,TOLLIP;MAPK14;RELA;MAP2K3;ECSIT,33 (33),0.773,1,0,,0 (0),1,1,0.773,1
Host-pathogen interaction of human coronaviruses - interferon induction,Wikipathways,5,MAPK14;DDX58;MAVS;EIF2AK2;STAT2,33 (33),0.773,1,0,,0 (0),1,1,0.773,1
Neurexins and neuroligins,Reactome,9,EPB41L5;PDLIM5;EPB41L1;EPB41L2;LIN7A;LIN7C;DBNL;CASK;EPB41,57 (57),0.773,1,0,,0 (0),1,1,0.773,1
Serine biosynthesis,Reactome,2,SRR;PSPH,9 (9),0.529,0.897,1,HMDB0033934,13 (15),0.772,1,0.774,1
IL12-mediated signaling events,PID,10,MAP2K3;RAB7A;B2M;MTOR;SPHK2;RELA;STAT3;STAT4;MAPK14;STAT6,63 (63),0.775,1,0,,0 (0),1,1,0.775,1
Interleukin receptor SHC signaling,Reactome,4,SHC1;PTPN6;GRB2;PIK3R1,27 (27),0.778,1,0,,0 (0),1,1,0.778,1
Estrogen signaling pathway - Homo sapiens (human),KEGG,24,HSPA8;HSP90B1;MAPK1;CALM1;EGFR;PIK3R1;PRKACA;PRKACB;SHC1;HRAS;GRB2;PLCB3;GNAI3;GNAQ;GNAS;CTSD;MAP2K1;MAP2K2;FKBP4;FKBP5;GNAI2;HSP90AA1;ITPR2;HSP90AB1,137 (138),0.691,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,8 (8),0.597,1,0.778,1
Pancreatic adenocarcinoma pathway,Wikipathways,18,MAPK9;RHOA;EGFR;PAK2;CDC42;RALB;RALA;MTOR;PEBP1;BAX;PIK3R1;ARAF;RELA;STAT3;RAC1;MAP2K1;MAPK1;MAP2K2,89 (89),0.414,0.782,0,,1 (2),1,1,0.779,1
Transport of nucleotide sugars,Reactome,0,,9 (9),1,1,2,HMDB0000290;HMDB0000304,13 (13),0.414,1,0.779,1
D-<i>myo</i>-inositol-5-phosphate metabolism,HumanCyc,3,PIP4P1;PLCB3;PIP4K2C,20 (20),0.757,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,7 (8),0.549,1,0.78,1
Hepatitis B - Homo sapiens (human),KEGG,32,MAP2K4;ATP6AP1;MAPK14;CASP3;SLC10A1;GRB2;DDX58;PIK3R1;HRAS;FADD;BAX;PRKCA;PCNA;MAVS;RELA;MAPK1;YWHAQ;MAPK9;MAP2K1;MAP2K2;MAP2K3;YWHAB;DDB1;YWHAZ;ARAF;STAT2;STAT3;STAT4;STAT5B;STAT6;VDAC3;BID,162 (162),0.418,0.789,0,,1 (1),1,1,0.782,1
acetone degradation I (to methylglyoxal),HumanCyc,2,CYP2E1;AKR1B1,10 (10),0.589,0.95,1,HMDB0000863,11 (11),0.714,1,0.785,1
LTC4-CYSLTR mediated IL4 production,Reactome,1,DPEP1,7 (7),0.769,1,1,HMDB0000123,7 (7),0.549,1,0.786,1
Resolution of Abasic Sites (AP sites),Reactome,5,APEX1;POLE;LIG3;PARP1;PCNA,37 (37),0.853,1,1,HMDB0001178,6 (9),0.494,1,0.786,1
Constitutive Signaling by Aberrant PI3K in Cancer,Reactome,9,EGFR;GRB2;RHOG;PIK3R1;STRN;PTPN11;RAC1;PIK3AP1;KITLG,79 (79),0.974,1,1,HMDB0000693,5 (18),0.433,1,0.786,1
Regulation of apoptosis by parathyroid hormone-related protein,Wikipathways,3,BCL2L13;BID;BAX,21 (21),0.787,1,0,,0 (0),1,1,0.787,1
the co-stimulatory signal during t-cell activation,BioCarta,3,PTPN11;GRB2;PIK3R1,21 (21),0.787,1,0,,0 (0),1,1,0.787,1
Signaling by FGFR1,Reactome,8,SHC1;HRAS;GRB2;PPP2CB;PPP2R1A;PIK3R1;PTPN11;MAPK1,51 (51),0.772,1,1,HMDB0000693,7 (8),0.549,1,0.787,1
Head and Neck Squamous Cell Carcinoma,Wikipathways,15,HRAS;PRKAA2;FADD;CUL3;FKBP1A;NUMB;MTOR;RELA;PIK3R1;RHEB;RPS6;EIF4E;EGFR;PRKAA1;CTNNB1,74 (74),0.425,0.802,0,,2 (4),1,1,0.789,1
Presenilin action in Notch and Wnt signaling,PID,7,CSNK1A1;CTBP1;CSNK2A1;PPP2R5D;NCSTN;MAPK1;CTNNB1,46 (46),0.791,1,0,,0 (0),1,1,0.791,1
G alpha (12/13) signalling events,Reactome,8,GNG12;RHOA;ARHGEF12;ROCK1;GNA13;ARHGEF10L;GNB1;GNB2,80 (80),0.99,1,1,HMDB0003208,5 (5),0.433,1,0.792,1
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,Reactome,8,ISG15;PCNA;USP10;POLE;NPLOC4;VCP;UFD1;TRIM25,38 (38),0.429,0.808,0,,8 (11),1,1,0.792,1
Ovarian tumor domain proteases,Reactome,8,MAVS;RHOA;DDX58;VCP;TRIM25;OTUB1;VCPIP1;RNF135,38 (38),0.429,0.808,0,,3 (9),1,1,0.792,1
MAPK signaling pathway - Homo sapiens (human),KEGG,41,STK4;FLNA;FLNB;MAP2K4;RAP1A;TAOK3;RAP1B;IGF1;MAPK14;CDC42;PPP3CA;KITLG;GRB2;PPP5C;CD14;GNG12;CRKL;EGFR;RPS6KA1;DUSP3;PRKACA;PRKACB;HRAS;CASP3;PPM1A;PAK2;MAPK9;PRKCA;PPM1B;RELA;MAPK1;ECSIT;RRAS2;MAP2K1;MAP2K2;MAP2K3;HSPA8;ARAF;HSPB1;CRK;RAC1,294 (294),0.99,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,5 (5),0.433,1,0.792,1
PI3K/AKT Signaling in Cancer,Reactome,11,EGFR;GRB2;RHOG;MTOR;PIK3R1;STRN;PTPN11;RAC1;PIK3AP1;AKT1S1;KITLG,106 (106),0.994,1,1,HMDB0000693,5 (21),0.433,1,0.794,1
Generation of second messenger molecules,Reactome,2,NCK1;PAK2,42 (42),0.998,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,5 (7),0.433,1,0.795,1
Estrogen-dependent gene expression,Reactome,11,CTSD;H2AX;PRMT1;GPAM;STAG2;SMC1A;POLR2A;DDX5;AGO2;SMC3;RAD21,142 (143),1,1,1,HMDB0000145,5 (7),0.433,1,0.796,1
GPCR signaling-G alpha q,INOH,13,MAP2K1;MAP2K2;PLCB3;PRKCA;IGF1;ARAF;GNAI2;DBI;KNG1;GNAQ;MAPK1;AGT;KITLG,274 (274),1,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,5 (6),0.433,1,0.796,1
Biosynthesis of A2E_ implicated in retinal degradation,Reactome,0,,1 (1),1,1,1,HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,5 (7),0.433,1,0.796,1
Prostanoid ligand receptors,Reactome,0,,9 (9),1,1,1,HMDB0003208,5 (5),0.433,1,0.796,1
Retinoid cycle disease events,Reactome,0,,1 (1),1,1,1,HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,5 (7),0.433,1,0.796,1
Asthma - Homo sapiens (human),KEGG,0,,30 (31),1,1,1,HMDB0011148,5 (5),0.433,1,0.796,1
bupropion degradation,HumanCyc,0,,5 (5),1,1,1,HMDB0000123,5 (10),0.433,1,0.796,1
Defective pyroptosis,Reactome,0,,4 (4),1,1,1,HMDB0001342,5 (7),0.433,1,0.796,1
fosb gene expression and drug abuse,BioCarta,0,,5 (5),1,1,1,HMDB0001934,5 (7),0.433,1,0.796,1
Diseases associated with visual transduction,Reactome,0,,1 (1),1,1,1,HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,5 (7),0.433,1,0.796,1
Diseases of the neuronal system,Reactome,0,,1 (1),1,1,1,HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,5 (7),0.433,1,0.796,1
Biosynthesis of DPAn-3-derived protectins and resolvins,Reactome,0,,2 (2),1,1,1,HMDB0006528,5 (16),0.433,1,0.796,1
Nicotine Activity on Chromaffin Cells,Wikipathways,0,,4 (4),1,1,1,HMDB0001934,5 (5),0.433,1,0.796,1
Disruption of postsynaptic signaling by CNV,Wikipathways,7,TJP1;DLG1;YWHAG;CAMK2A;CAMK2D;CYFIP1;MAPK1,33 (33),0.434,0.815,0,,1 (1),1,1,0.796,1
Downstream signaling events of B Cell Receptor (BCR),Reactome,7,CALM1;SKP1;CUL1;HRAS;FKBP1A;RELA;PPP3CA,33 (33),0.434,0.815,0,,8 (10),1,1,0.796,1
Tyrosine Metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB0001149,14 (17),0.797,1,0.797,1
Tolerance by Mtb to nitric oxide produced by macrophages,Reactome,0,,0 (0),1,1,1,HMDB0033934,14 (26),0.797,1,0.797,1
proline biosynthesis,HumanCyc,1,PYCR3,4 (4),0.567,0.927,1,HMDB0002104,13 (14),0.772,1,0.799,1
E3 ubiquitin ligases ubiquitinate target proteins,Reactome,12,DERL1;PEX2;UBE2N;PEX5;UBE2V2;PEX13;PCNA;PEX14;VCP;UBE2L3;UBE2D3;WDR61,59 (59),0.438,0.823,0,,1 (1),1,1,0.8,1
IL8- and CXCR1-mediated signaling events,PID,6,LYN;PLCB3;PRKCA;RAB5A;GNAI2;GNB1,28 (28),0.439,0.823,0,,4 (4),1,1,0.8,1
NOTCH-Ncore,Signalink,4,NUMB;GALM;RAB11A;CTBP1,28 (28),0.802,1,0,,0 (0),1,1,0.802,1
PI5P_ PP2A and IER3 Regulate PI3K/AKT Signaling,Reactome,16,PPP2R5E;EGFR;GRB2;RHOG;PPP2CB;PPP2R1A;PIK3R1;STRN;PPP2R5A;RAC1;PPP2R5D;PIK3AP1;MAPK1;PIP4K2C;KITLG;PTPN11,100 (100),0.805,1,1,HMDB0000693,7 (12),0.549,1,0.802,1
Degradation of the extracellular matrix,Reactome,15,DCN;CTSB;CDH1;KLKB1;COL14A1;COL18A1;BSG;CAPN1;CAPN2;NCSTN;CAPNS1;PHYKPL;PLG;CTSL;CASP3,103 (103),0.897,1,1,HMDB0033934,6 (8),0.494,1,0.804,1
Dopamine Neurotransmitter Release Cycle,Reactome,5,LIN7A;VAMP2;PPFIA1;CASK;LIN7C,23 (23),0.444,0.83,0,,1 (1),1,1,0.804,1
Class I MHC mediated antigen processing & presentation,Reactome,61,CUL5;HERC4;UBA5;CUL2;CUL1;MRC1;ELOC;UBE4A;ELOB;SEC24D;PDIA3;UBA1;ITCH;STX4;UBE2D3;FBXO6;UBE2G2;SEC24C;UBE2L3;UBE2N;UBE2V1;UBE2V2;UBE3A;RNF14;CALR;SEC24A;CANX;B2M;UBR4;SEC61A1;UFL1;FBXO7;UBA6;SEC61B;UBA3;UBE2M;SAR1B;SEC22B;DTX3L;CUL3;SEC31A;UBE3C;UBE2J1;UBE2H;RNF114;SKP1;HECTD1;TRIP12;CTSL;TAP2;TAPBP;HSPA5;UBE2G1;UBE2Z;LMO7;SEC23A;RBX1;FBXO4;SEC13;NEDD4;UBE2K,316 (316),0.444,0.83,0,,14 (21),1,1,0.805,1
the prc2 complex sets long-term gene silencing through modification of histone tails,BioCarta,2,RBBP4;HDAC2,15 (15),0.805,1,0,,0 (0),1,1,0.805,1
BMP2 signaling TAK1,INOH,2,MAPK14;MAP2K3,15 (15),0.805,1,0,,0 (0),1,1,0.805,1
ErbB receptor signaling network,PID,2,HSP90AA1;EGFR,15 (15),0.805,1,0,,0 (0),1,1,0.805,1
il12 and stat4 dependent signaling pathway in th1 development,BioCarta,2,MAPK14;STAT4,15 (15),0.805,1,0,,0 (0),1,1,0.805,1
Netrin-1 signaling,Reactome,6,CDC42;WASL;NCK1;PTPN11;RAC1;PITPNA,41 (41),0.812,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,7 (8),0.549,1,0.806,1
Adaptive Immune System,Reactome,128,UBA5;LGMN;CTSF;UBE2K;PIK3AP1;PTPN11;SEC24A;CTSC;B2M;PTPN22;NCK1;DTX3L;SKP1;RNF114;CLTA;TRIP12;ITGB2;ITGB1;ITPR2;NEDD4;STIM1;HRAS;UBE4A;SEC24D;PTPN6;UBA1;AP1S1;AP2S1;DNM3;STX4;UBE2D3;FBXO6;UBE2G2;UBE2H;AP2A2;AP1B1;PTPRJ;AP1G1;FCGR2B;UBE2N;UBE2V1;UBE2V2;UBE3A;PIK3R1;NECTIN2;CLTC;SEC61A1;FBXO7;IFI30;SEC61B;AP1M1;C3;HECTD1;FKBP1A;TAP2;TAPBP;HSPA5;UBE2Z;SEC23A;RAC1;DNM2;RBX1;SEC13;CUL3;CUL2;CUL1;MRC1;ELOC;ELOB;RAP1A;RAP1B;ITCH;CALM1;CALR;CANX;ICAM1;UBR4;GRB2;XDH;UBA3;UBE2M;SEC22B;SEC31A;UBE2J1;CTSA;YES1;YWHAB;PDIA3;YWHAZ;ARF1;AP2M1;CUL5;RNF14;PPP2CB;PPP2R1A;PPP2R5A;PPP2R5D;PPP2R5E;PPP3CA;SEC24C;CSK;LMO7;MTOR;IGHM;UBE2G1;SAR1B;PRKACA;PRKACB;AP2A1;UBA6;PAK2;CD74;CD81;AP2B1;UBE2L3;UBE3C;UFL1;LYN;CTSB;CTSD;CDC42;CDH1;CTSH;CTSL;HERC4;RELA;CXADR;FBXO4,719 (719),0.787,1,3,HMDB0004949;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,27 (51),0.566,1,0.806,1
G alpha (i) signalling events,Reactome,34,PPP2CB;PPP2R1A;PPP2R5D;PPP3CA;PSAP;GNAS;CALM1;GNG12;HEBP1;ANXA1;CAMK2A;CAMK2D;AGT;PRKACA;PRKACB;PXMP2;PRKAR1A;PRKAR2A;PRKCA;PF4;C3;GNA11;GNAI2;GNAI3;C5;GNAQ;MAPK1;GNB1;GNB2;PLCB3;KNG1;PPP1CA;ITPR2;KPNA2,316 (316),1,1,9,HMDB0012108#HMDB0010408#HMDB0010404#HMDB0010403#HMDB0010402#HMDB0010401#HMDB0010398#HMDB0010392#HMDB0010391#HMDB0010390#HMDB0010381#HMDB0010382#HMDB0010383#HMDB0010384#HMDB0010387#HMDB0010375;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0005096;HMDB0033941;HMDB0036836;HMDB0001043;HMDB0004080;HMDB0015464;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,77 (106),0.446,1,0.806,1
Aquaporin-mediated transport,Reactome,10,GNG12;PRKAR1A;AQP1;PRKAR2A;GNB1;AQP8;GNAS;PRKACB;PRKACA;GNB2,49 (49),0.448,0.837,0,,15 (15),1,1,0.808,1
Signaling by FGFR2 in disease,Reactome,3,HRAS;GRB2;PIK3R1,27 (27),0.907,1,1,HMDB0000693,6 (17),0.494,1,0.808,1
Interleukin-12 family signaling,Reactome,4,P4HB;CANX;STAT3;STAT4,18 (18),0.45,0.839,0,,2 (2),1,1,0.809,1
SUMOylation of transcription cofactors,Reactome,7,UBE2I;NPM1;TRIM28;CTBP1;PARK7;SAFB;DDX5,47 (47),0.81,1,0,,0 (0),1,1,0.81,1
Regulation of actin dynamics for phagocytic cup formation,Reactome,27,WASL;ABI1;CYFIP1;MAPK1;NCKAP1;BRK1;IGHG1;CFL1;ARPC1A;ACTB;GRB2;ACTG1;CYFIP2;NCK1;BAIAP2;CDC42;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;CRK;RAC1;HSP90AA1;ARPC2;HSP90AB1,138 (138),0.451,0.841,0,,6 (9),1,1,0.81,1
catecholamine biosynthesis,HumanCyc,1,DDC,4 (4),0.567,0.927,1,HMDB0002281,14 (16),0.797,1,0.811,1
Glucocorticoid biosynthesis,Reactome,2,HSD11B1;SERPINA6,9 (9),0.529,0.897,1,HMDB0000015,17 (17),0.856,1,0.811,1
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,Reactome,6,UBE2I;EGFR;NPM1;HSPD1;DEK;APOE,41 (41),0.812,1,0,,0 (0),1,1,0.812,1
Nucleotide-binding Oligomerization Domain (NOD) pathway,Wikipathways,6,COPS6;AAMP;RELA;RAC1;HSP90AA1;SUGT1,41 (41),0.812,1,0,,0 (0),1,1,0.812,1
Homologous recombination - Homo sapiens (human),KEGG,6,BABAM2;BRCC3;SSBP1;ATM;BABAM1;RAD50,41 (41),0.812,1,0,,0 (0),1,1,0.812,1
TP53 Regulates Transcription of Cell Death Genes,Reactome,9,TP53I3;BAX;CASP6;STEAP3;RABGGTA;RABGGTB;ATM;AIFM2;BID,44 (44),0.454,0.843,0,,8 (10),1,1,0.812,1
nfat and hypertrophy of the heart ,BioCarta,9,SHC1;HRAS;GRB2;ATP2A2;CALR;YWHAH;PIK3R1;IGF1;PPP3CA,44 (44),0.454,0.843,0,,3 (5),1,1,0.812,1
MAPK and NFkB signaling pathways inhibited by Yersinia YopJ,Wikipathways,1,MAPK1,8 (8),0.812,1,0,,0 (0),1,1,0.812,1
Canonical NF-KB pathway,Wikipathways,1,RELA,8 (8),0.812,1,0,,0 (0),1,1,0.812,1
Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway,Wikipathways,1,EPHX2,8 (8),0.812,1,0,,0 (0),1,1,0.812,1
Formation of the Editosome,Reactome,1,A1CF,8 (8),0.812,1,0,,0 (1),1,1,0.812,1
RUNX3 regulates WNT signaling,Reactome,1,CTNNB1,8 (8),0.812,1,0,,0 (0),1,1,0.812,1
Competing endogenous RNAs (ceRNAs) regulate PTEN translation,Reactome,1,AGO2,8 (8),0.812,1,0,,0 (0),1,1,0.812,1
Regulation of PTEN mRNA translation,Reactome,1,AGO2,8 (8),0.812,1,0,,0 (0),1,1,0.812,1
LDLRAD4 and what we know about it,Wikipathways,1,NEDD4,8 (8),0.812,1,0,,0 (0),1,1,0.812,1
Inhibition of Signaling by Overexpressed EGFR,Reactome,1,EGFR,8 (8),0.812,1,0,,0 (4),1,1,0.812,1
Signaling by Overexpressed Wild-Type EGFR in Cancer,Reactome,1,EGFR,8 (8),0.812,1,0,,0 (4),1,1,0.812,1
BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members,Reactome,1,BID,8 (8),0.812,1,0,,0 (0),1,1,0.812,1
RUNX1 regulates transcription of genes involved in differentiation of keratinocytes,Reactome,1,CTSL,8 (8),0.812,1,0,,0 (0),1,1,0.812,1
g-secretase mediated erbb4 signaling pathway,BioCarta,1,PRKCA,8 (8),0.812,1,0,,0 (0),1,1,0.812,1
nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells,BioCarta,1,RXRA,8 (8),0.812,1,0,,0 (0),1,1,0.812,1
SUMOylation of intracellular receptors,Reactome,3,RXRA;UBE2I;NR3C1,28 (28),0.92,1,1,HMDB0001547,6 (7),0.494,1,0.813,1
nicotine degradation III,HumanCyc,2,AOX1;UGT2B10,10 (10),0.589,0.95,1,HMDB0001934,13 (24),0.772,1,0.813,1
Transcription factor regulation in adipogenesis,Wikipathways,3,RXRA;PCK2;NR3C1,22 (22),0.813,1,0,,0 (1),1,1,0.813,1
Immune response to tuberculosis,Wikipathways,3,PSMB8;STAT2;IFI35,22 (22),0.813,1,0,,0 (0),1,1,0.813,1
GRB2 events in EGFR signaling,Reactome,3,HRAS;EGFR;GRB2,13 (13),0.456,0.843,0,,2 (2),1,1,0.814,1
Platelet Adhesion to exposed collagen,Reactome,3,ITGA1;ITGB1;LYN,13 (13),0.456,0.843,0,,1 (2),1,1,0.814,1
Activation of RAC1,Reactome,3,NCK1;PAK2;RAC1,13 (13),0.456,0.843,0,,2 (2),1,1,0.814,1
The activation of arylsulfatases,Reactome,3,ARSB;STS;SUMF2,13 (13),0.456,0.843,0,,4 (4),1,1,0.814,1
D-<i>myo</i>-inositol (1_4_5)-trisphosphate degradation,HumanCyc,3,IMPA1;INPP1;IMPA2,13 (13),0.456,0.843,0,,6 (6),1,1,0.814,1
Insulin secretion - Homo sapiens (human),KEGG,15,ATP1B1;ATP1B3;ATP1A1;PRKCA;GNA11;CAMK2D;SLC2A2;PLCB3;GCK;GNAQ;GNAS;CAMK2A;VAMP2;PRKACA;PRKACB,86 (86),0.675,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,10 (12),0.679,1,0.816,1
Colorectal cancer - Homo sapiens (human),KEGG,17,HRAS;RHOA;CASP3;BAX;MAPK9;RALA;RALB;MAP2K1;PIK3R1;ARAF;MAP2K2;RAC1;EGFR;MAPK1;CTNNB1;MTOR;GRB2,86 (86),0.459,0.843,0,,1 (1),1,1,0.816,1
HIV-1 Nef: Negative effector of Fas and TNF-alpha,PID,5,FADD;RELA;CASP3;BID;CASP6,35 (35),0.817,1,0,,0 (0),1,1,0.817,1
MAPK6/MAPK4 signaling,Reactome,8,CDC42;PAK2;DNAJB1;HSPB1;RAC1;SEPTIN7;PRKACA;PRKACB,39 (39),0.46,0.843,0,,5 (6),1,1,0.817,1
Cysteine and methionine catabolism,Wikipathways,0,,0 (0),1,1,1,HMDB0000043,15 (39),0.819,1,0.819,1
Doxepin Metabolism Pathway,SMPDB,1,CYP1A2,5 (5),0.649,1,1,HMDB0015273,11 (11),0.714,1,0.819,1
Urea cycle and metabolism of amino groups,Wikipathways,0,,0 (0),1,1,2,HMDB0033934;HMDB0002104,28 (32),0.82,1,0.82,1
NIK-->noncanonical NF-kB signaling,Reactome,2,SKP1;CUL1,8 (8),0.463,0.843,0,,2 (2),1,1,0.82,1
Sema4D mediated inhibition of cell attachment and migration,Reactome,2,RHOA;RAC1,8 (8),0.463,0.843,0,,6 (6),1,1,0.82,1
Dectin-1 mediated noncanonical NF-kB signaling,Reactome,2,SKP1;CUL1,8 (8),0.463,0.843,0,,2 (2),1,1,0.82,1
Inactivation of CDC42 and RAC1,Reactome,2,CDC42;RAC1,8 (8),0.463,0.843,0,,4 (4),1,1,0.82,1
Regulation of PTEN localization,Reactome,2,USP7;NEDD4,8 (8),0.463,0.843,0,,1 (1),1,1,0.82,1
ca-calmodulin-dependent protein kinase activation,BioCarta,2,CAMK2D;CAMK2A,8 (8),0.463,0.843,0,,1 (1),1,1,0.82,1
CREB phosphorylation,Reactome,2,FUS;RPS6KA1,8 (8),0.463,0.843,0,,2 (2),1,1,0.82,1
D-<i>myo</i>-inositol (1_4_5)-trisphosphate biosynthesis,HumanCyc,4,PI4KA;PLCB3;PIP4K2C;CDIPT,27 (27),0.778,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,8 (13),0.597,1,0.821,1
Kynurenine Pathway and links to Cellular Senescence,Wikipathways,1,QPRT,3 (3),0.466,0.843,0,,23 (25),1,1,0.822,1
Defective factor IX causes thrombophilia,Reactome,1,F9,3 (3),0.466,0.843,0,,1 (1),1,1,0.822,1
Intracellular oxygen transport,Reactome,1,CYGB,3 (3),0.466,0.843,0,,2 (2),1,1,0.822,1
Signaling by MST1,Reactome,1,HPN,3 (3),0.466,0.843,0,,3 (3),1,1,0.822,1
Signalling to STAT3,Reactome,1,STAT3,3 (3),0.466,0.843,0,,2 (2),1,1,0.822,1
Signaling by cytosolic PDGFRA and PDGFRB fusion proteins,Reactome,1,STRN,3 (3),0.466,0.843,0,,2 (2),1,1,0.822,1
MTF1 activates gene expression,Reactome,1,CSRP1,3 (3),0.466,0.843,0,,1 (1),1,1,0.822,1
Regulation of gap junction activity,Reactome,1,TJP1,3 (3),0.466,0.843,0,,2 (2),1,1,0.822,1
glutamate dependent acid resistance,HumanCyc,1,GLUL,3 (3),0.466,0.843,0,,4 (4),1,1,0.822,1
Regulation of thyroid hormone activity,Reactome,1,DIO1,3 (3),0.466,0.843,0,,5 (6),1,1,0.822,1
Signaling by plasma membrane FGFR1 fusions,Reactome,1,ERLIN2,3 (3),0.466,0.843,0,,2 (2),1,1,0.822,1
Activated NTRK3 signals through RAS,Reactome,1,SHC1,3 (3),0.466,0.843,0,,2 (2),1,1,0.822,1
Attachment and Entry,Reactome,1,CTSL,3 (3),0.466,0.843,0,,1 (8),1,1,0.822,1
Intestinal hexose absorption,Reactome,1,SLC2A2,3 (3),0.466,0.843,0,,3 (5),1,1,0.822,1
STAT6-mediated induction of chemokines,Reactome,1,STAT6,3 (3),0.466,0.843,0,,2 (2),1,1,0.822,1
Activation of BMF and translocation to mitochondria,Reactome,1,DYNLL2,3 (3),0.466,0.843,0,,2 (3),1,1,0.822,1
Intracellular metabolism of fatty acids regulates insulin secretion,Reactome,1,ACSL4,3 (3),0.466,0.843,0,,6 (6),1,1,0.822,1
glutamate biosynthesis/degradation,HumanCyc,1,GLUD1,3 (3),0.466,0.843,0,,9 (9),1,1,0.822,1
Toxicity of botulinum toxin type G (botG),Reactome,1,VAMP2,3 (3),0.466,0.843,0,,1 (2),1,1,0.822,1
Uptake and function of diphtheria toxin,Reactome,1,EEF2,3 (3),0.466,0.843,0,,2 (2),1,1,0.822,1
Toxicity of botulinum toxin type B (botB),Reactome,1,VAMP2,3 (3),0.466,0.843,0,,1 (2),1,1,0.822,1
<i>N</i>-acetylglucosamine degradation I,HumanCyc,1,GNPDA1,3 (3),0.466,0.843,0,,3 (5),1,1,0.822,1
MET activates STAT3,Reactome,1,STAT3,3 (3),0.466,0.843,0,,2 (2),1,1,0.822,1
MAPK3 (ERK1) activation,Reactome,1,MAP2K1,3 (3),0.466,0.843,0,,2 (2),1,1,0.822,1
lipoate biosynthesis and incorporation,HumanCyc,1,LIAS,3 (3),0.466,0.843,0,,8 (8),1,1,0.822,1
thyronamine and iodothyronamine metabolism,HumanCyc,1,DIO1,3 (3),0.466,0.843,0,,2 (11),1,1,0.822,1
Erlotinib Action Pathway,SMPDB,1,EGFR,3 (3),0.466,0.843,0,,4 (5),1,1,0.822,1
RHO GTPases regulate CFTR trafficking,Reactome,1,GOPC,3 (3),0.466,0.843,0,,1 (1),1,1,0.822,1
C-type lectin receptor signaling pathway - Homo sapiens (human),KEGG,14,MAPK1;HRAS;RHOA;ARHGEF12;CALM1;PIK3R1;RRAS2;RELA;MAPK9;PTPN11;MAPK14;PPP3CA;ITPR2;STAT2,104 (104),0.943,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,6 (12),0.494,1,0.822,1
Gastric Cancer Network 1,Wikipathways,4,GATD3A;CEP192;ACTL6A;RUVBL1,29 (29),0.824,1,0,,0 (0),1,1,0.824,1
Adipogenesis,Wikipathways,21,LMNA;CELF1;CTNNB1;MBNL1;STAT6;CISD1;AGPAT2;AGT;NAMPT;RXRA;PCK1;PCK2;HIF1A;STAT2;STAT3;IGF1;STAT5B;MIF;PLIN2;NR3C1;ZMPSTE24,131 (131),0.828,1,0,,0 (0),1,1,0.828,1
p38 MAPK signaling pathway,PID,6,CALM1;MAP2K3;MAPK14;TAOK3;RAC1;ATM,29 (29),0.475,0.857,0,,1 (1),1,1,0.828,1
Interaction between L1 and Ankyrins,Reactome,6,SPTA1;SPTAN1;SPTB;SPTBN1;SPTBN2;ANK1,29 (29),0.475,0.857,0,,2 (3),1,1,0.828,1
DAP12 signaling,Reactome,6,SHC1;HRAS;GRB2;RAC1;PIK3R1;B2M,29 (29),0.475,0.857,0,,5 (6),1,1,0.828,1
Nicotine Metabolism Pathway,SMPDB,2,FMO3;AOX1,9 (9),0.529,0.897,1,HMDB0001497,20 (22),0.898,1,0.828,1
Synaptic signaling pathways associated with autism spectrum disorder,Wikipathways,10,HRAS;PRKAG1;UBE3A;MTOR;PIK3R1;RHEB;PRKAA1;PRKAA2;PRKAB1;MAPK1,50 (50),0.476,0.858,0,,4 (4),1,1,0.829,1
Interleukin-1 signaling,Reactome,10,MAP2K1;UBE2N;CUL1;UBE2V1;TOLLIP;SQSTM1;MAP2K4;RELA;SKP1;RBX1,50 (50),0.476,0.858,0,,2 (5),1,1,0.829,1
Neural Crest Cell Migration in Cancer,Wikipathways,6,PIK3R4;RHOA;PAK2;RAC1;STAT3;ARF1,42 (42),0.83,1,0,,0 (0),1,1,0.83,1
Transcription of E2F targets under negative control by DREAM complex,Reactome,2,RBBP4;PCNA,16 (16),0.834,1,0,,0 (0),1,1,0.834,1
Lewis blood group biosynthesis,Reactome,2,ST3GAL6;ST3GAL4,18 (18),0.88,1,1,HMDB0000304,7 (21),0.549,1,0.834,1
Ephrin B reverse signaling,PID,5,MAP2K4;LYN;PIK3R1;YES1;RAC1,24 (24),0.484,0.863,0,,2 (2),1,1,0.835,1
Plexin-D1 Signaling,PID,5,ITGA1;ITGA9;ITGA5;ARF6;ITGB1,24 (24),0.484,0.863,0,,2 (2),1,1,0.835,1
G-protein activation,Reactome,5,GNAQ;GNG12;GNB2;GNB1;GNA11,24 (24),0.484,0.863,0,,2 (2),1,1,0.835,1
CLEC7A (Dectin-1) signaling,Reactome,6,CALM1;SKP1;CUL1;RELA;PPP3CA;ITPR2,41 (41),0.812,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,8 (12),0.597,1,0.836,1
DNA replication initiation,Reactome,1,POLE,8 (8),0.812,1,1,HMDB0001342,8 (10),0.597,1,0.836,1
mucin core 1 and core 2 <i>O</i>-glycosylation,HumanCyc,2,ST3GAL4;GALNT2,29 (29),0.982,1,1,HMDB0000290,6 (8),0.494,1,0.836,1
Ebstein-Barr virus LMP1 signaling,Wikipathways,3,HSP90AA1;MAPK1;RELA,23 (23),0.837,1,0,,0 (0),1,1,0.837,1
RANKL,NetPath,3,MAPK14;ATP6V1E1;SQSTM1,23 (23),0.837,1,0,,0 (0),1,1,0.837,1
tnf/stress related signaling,BioCarta,3,MAP2K4;MAPK14;MAP2K3,23 (23),0.837,1,0,,0 (0),1,1,0.837,1
ctcf: first multivalent nuclear factor,BioCarta,3,PPP2R5D;MTOR;PIK3R1,23 (23),0.837,1,0,,0 (0),1,1,0.837,1
Cellular senescence - Homo sapiens (human),KEGG,30,RRAS2;MAPK14;PPP3CA;CALM1;SLC25A4;SLC25A5;RBBP4;MTOR;SQSTM1;PIK3R1;MCU;CAPN1;CAPN2;HRAS;RELA;VDAC2;ATM;MAPK1;VDAC3;MAP2K1;MAP2K2;MAP2K3;PPID;PPP1CC;VDAC1;RHEB;PPP1CA;PPP1CB;ITPR2;RAD50,156 (156),0.486,0.863,0,,4 (5),1,1,0.837,1
Vitamin B6 (pyridoxine) metabolism,EHMN,0,,0 (0),1,1,1,HMDB0033934,16 (16),0.838,1,0.838,1
Base Excision Repair,Reactome,6,H2AX;APEX1;LIG3;PARP1;POLE;PCNA,93 (94),1,1,2,HMDB0001178;HMDB0011600,15 (26),0.49,1,0.839,1
O-linked glycosylation,Reactome,3,ST6GAL1;ST3GAL4;GALNT2,115 (115),1,1,2,HMDB0000290;HMDB0000304,15 (18),0.49,1,0.839,1
Melanin biosynthesis,Reactome,0,,3 (3),1,1,2,HMDB0001229;HMDB0004067,15 (23),0.49,1,0.839,1
Adrenoceptors,Reactome,0,,9 (9),1,1,2,HMDB0015095;HMDB0015697,15 (23),0.49,1,0.839,1
Downstream TCR signaling,Reactome,4,RELA;PIK3R1;UBE2N;UBE2V1,52 (52),0.993,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,6 (9),0.494,1,0.84,1
RXR and RAR heterodimerization with other nuclear receptor,PID,1,RXRA,26 (26),0.996,1,1,HMDB0000876,6 (6),0.494,1,0.841,1
Pancreatic secretion - Homo sapiens (human),KEGG,18,ATP1B1;RHOA;ATP2A2;ATP2B1;PLA2G12B;GNAS;PRKCA;ATP1B3;CD38;RAP1A;PLCB3;RAP1B;RAC1;GNAQ;RAB8A;ATP1A1;ITPR2;RAB11A,102 (102),0.664,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,12 (15),0.745,1,0.842,1
Crosslinking of collagen fibrils,Reactome,0,,10 (10),1,1,1,HMDB0033934,6 (7),0.494,1,0.843,1
ABO blood group biosynthesis,Reactome,0,,3 (3),1,1,1,HMDB0000304,6 (15),0.494,1,0.843,1
Biosynthesis of DPAn-3-derived maresins,Reactome,0,,2 (2),1,1,1,HMDB0006528,6 (14),0.494,1,0.843,1
Overview of nanoparticle effects,Wikipathways,4,HMOX1;BAX;PTGS1;FN1,19 (19),0.495,0.872,0,,1 (3),1,1,0.843,1
Translesion Synthesis by POLH,Reactome,4,UFD1;NPLOC4;VCP;PCNA,19 (19),0.495,0.872,0,,4 (6),1,1,0.843,1
Growth hormone receptor signaling,Reactome,4,STAT5B;LYN;STAT3;PTPN6,19 (19),0.495,0.872,0,,4 (4),1,1,0.843,1
PKA-mediated phosphorylation of CREB,Reactome,4,PRKAR2A;PRKAR1A;PRKACA;PRKACB,19 (19),0.495,0.872,0,,5 (5),1,1,0.843,1
Prostacyclin signalling through prostacyclin receptor,Reactome,4,GNAS;GNG12;GNB1;GNB2,19 (19),0.495,0.872,0,,3 (3),1,1,0.843,1
ECM proteoglycans,Reactome,11,ITGA9;DCN;LAMA2;ITGB1;LAMB2;ITGB3;ASPN;VTN;BGN;ITGA2B;LUM,56 (56),0.495,0.872,0,,2 (4),1,1,0.843,1
Glutamatergic synapse - Homo sapiens (human),KEGG,18,GLUL;GNG12;PLCB3;PRKCA;PRKACB;MAPK1;ITPR2;GNAQ;GNAI2;GNAI3;PRKACA;GLS;GNAS;SLC38A3;PPP3CA;GLS2;GNB1;GNB2,114 (114),0.832,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,8 (8),0.597,1,0.844,1
Extracellular vesicle-mediated signaling in recipient cells,Wikipathways,4,HRAS;MTOR;EGFR;CTNNB1,30 (30),0.845,1,0,,0 (0),1,1,0.845,1
Cell migration and invasion through p75NTR,Wikipathways,4,ARF1;RHOA;STAT3;RAC1,30 (30),0.845,1,0,,0 (0),1,1,0.845,1
Genes controlling nephrogenesis,Wikipathways,6,CTNNB1;ITGB1;LAMB2;NCK1;CD2AP;ILK,43 (43),0.847,1,0,,0 (0),1,1,0.847,1
Supression of HMGB1 mediated inflammation by THBD,Wikipathways,1,RELA,9 (9),0.848,1,0,,0 (0),1,1,0.848,1
Displacement of DNA glycosylase by APEX1,Reactome,1,APEX1,9 (9),0.848,1,0,,0 (1),1,1,0.848,1
Role of Altered Glycolysation of MUC1 in Tumour Microenvironment,Wikipathways,1,RELA,9 (9),0.848,1,0,,0 (0),1,1,0.848,1
NOTCH4 Activation and Transmission of Signal to the Nucleus,Reactome,1,NCSTN,9 (9),0.848,1,0,,0 (0),1,1,0.848,1
FSH,NetPath,1,MAP2K2,9 (9),0.848,1,0,,0 (0),1,1,0.848,1
YAP1- and WWTR1 (TAZ)-stimulated gene expression,Reactome,1,YAP1,9 (9),0.848,1,0,,0 (0),1,1,0.848,1
cd40l signaling pathway,BioCarta,1,RELA,9 (9),0.848,1,0,,0 (0),1,1,0.848,1
regulation of map kinase pathways through dual specificity phosphatases,BioCarta,1,MAPK14,9 (9),0.848,1,0,,0 (0),1,1,0.848,1
sonic hedgehog receptor ptc1 regulates cell cycle,BioCarta,1,XPO1,9 (9),0.848,1,0,,0 (0),1,1,0.848,1
btg family proteins and cell cycle regulation,BioCarta,1,PRMT1,9 (9),0.848,1,0,,0 (0),1,1,0.848,1
MicroRNAs in cardiomyocyte hypertrophy,Wikipathways,20,CALM1;RHOA;MAP2K1;MAP2K2;MAP2K3;PIK3R1;MTOR;ROCK1;RAC1;MAP2K4;CAMK2D;AGT;STAT3;IGF1;MAPK14;MAPK1;CTNNB1;PPP3CA;EIF2B5;MYLK,104 (104),0.502,0.878,0,,3 (3),1,1,0.848,1
terminal <i>O</i>-glycans residues modification,HumanCyc,1,ST6GAL1,12 (12),0.919,1,1,HMDB0000290,7 (9),0.549,1,0.849,1
Class A/1 (Rhodopsin-like receptors),Reactome,11,F2;AGT;PF4;ANXA1;C3;HEBP1;PXMP2;KNG1;NLN;C5;PSAP,346 (346),1,1,10,HMDB0015697;HMDB0005096;HMDB0002995;HMDB0003208;HMDB0003073;HMDB0001388;HMDB0015095;HMDB0006528;HMDB0004080;HMDB0002183,90 (113),0.504,1,0.85,1
TCR signaling in na&#xef;ve CD4+ T cells,PID,13,SHC1;HRAS;STIM1;CSK;CDC42;PRKCA;FLNA;RAP1A;PTPN6;NCK1;PTPN11;DBNL;GRB2,67 (67),0.505,0.878,0,,4 (4),1,1,0.85,1
Ras signaling pathway - Homo sapiens (human),KEGG,36,RHOA;STK4;RALA;RALB;RRAS2;RAP1A;RAP1B;PTPN11;IGF1;KITLG;CALM1;GNG12;EGFR;PLA2G12B;PIK3R1;PRKACA;PRKACB;SHC1;HRAS;GRB2;PAK2;PRKCA;AFDN;RELA;MAPK1;GNB1;GNB2;MAPK9;MAP2K1;MAP2K2;CDC42;RAB5A;RAB5B;RAB5C;RAC1;ARF6,232 (232),0.922,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,7 (7),0.549,1,0.851,1
SHC1 events in ERBB4 signaling,Reactome,3,SHC1;HRAS;GRB2,14 (14),0.509,0.878,0,,4 (4),1,1,0.853,1
Response of EIF2AK1 (HRI) to heme deficiency,Reactome,3,ASNS;EIF2S1;EIF2S2,14 (14),0.509,0.878,0,,2 (3),1,1,0.853,1
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion,Reactome,3,FARP2;TLN1;RAC1,14 (14),0.509,0.878,0,,5 (5),1,1,0.853,1
MAPK pathway in congenital thyroid cancer,Wikipathways,3,SHC1;MAP2K1;MAP2K2,14 (14),0.509,0.878,0,,2 (2),1,1,0.853,1
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain,Reactome,3,TP53I3;RABGGTA;RABGGTB,14 (14),0.509,0.878,0,,5 (7),1,1,0.853,1
Inositol Phosphate Metabolism,SMPDB,3,IMPA1;INPP1;ISYNA1,14 (14),0.509,0.878,0,,23 (23),1,1,0.853,1
IL23-mediated signaling events,PID,5,MPO;RELA;PIK3R1;STAT3;STAT4,37 (37),0.853,1,0,,0 (0),1,1,0.853,1
Regulation of CDC42 activity,PID,6,CDC42;ARHGAP1;ARHGAP17;ARHGDIA;NME1;FARP2,30 (30),0.51,0.878,0,,3 (3),1,1,0.854,1
-arrestins in gpcr desensitization,BioCarta,6,AP2A1;F2;AP2M1;AGT;GNAS;GNB1,30 (30),0.51,0.878,0,,3 (4),1,1,0.854,1
Imipramine Metabolism Pathway,SMPDB,1,CYP1A2,6 (6),0.715,1,1,HMDB0015282,11 (11),0.714,1,0.854,1
FoxO signaling pathway - Homo sapiens (human),KEGG,25,STK4;IGF1;MAPK14;EGFR;PCK1;PIK3R1;PRKAA1;PRKAA2;PRKAB1;HRAS;USP7;PRKAG1;GRB2;GABARAP;PRMT1;CAT;ATM;MAPK1;MAPK9;MAP2K1;MAP2K2;ARAF;PCK2;STAT3;SOD2,131 (131),0.511,0.878,0,,4 (5),1,1,0.854,1
Oxidation by Cytochrome P450,Wikipathways,12,CYP2E1;CYP39A1;POR;CYP1A2;CYB5B;CYP4B1;CYP7A1;CYP8B1;CYB5A;CYP27A1;CYP20A1;CYB5R3,62 (62),0.512,0.88,0,,8 (8),1,1,0.855,1
EPO signaling,INOH,30,MAP2K4;MAPK14;CAMK2A;EGFR;CSK;MTOR;CSNK1A1;CSNK1D;PIK3R1;CAMK2D;RPS6KA1;PRKAA1;PRKAA2;PRKAB1;PRKACA;PRKACB;PRKAG1;PRKAR1A;PAK2;PRKAR2A;PRKCA;MAPK1;YWHAQ;MAPK9;MAP2K1;MAP2K2;MAP2K3;ARAF;STAT3;STAT5B,186 (186),0.855,1,0,,0 (0),1,1,0.855,1
Purine metabolism,Wikipathways,0,,0 (0),1,1,1,HMDB0000195,17 (36),0.856,1,0.856,1
Keratan sulfate biosynthesis,Reactome,4,LUM;ST3GAL6;ST3GAL4;PRELP,28 (28),0.802,1,1,HMDB0000290,9 (9),0.64,1,0.856,1
Serotonin and melatonin biosynthesis,Reactome,1,DDC,5 (5),0.649,1,1,HMDB0000472,14 (16),0.797,1,0.858,1
Plasmalogen Synthesis,SMPDB,1,CEPT1,5 (5),0.649,1,1,HMDB0002350,14 (14),0.797,1,0.858,1
Neuroactive ligand-receptor interaction - Homo sapiens (human),KEGG,7,F2;NR3C1;AGT;C3;KNG1;C5;PLG,341 (341),1,1,5,HMDB0004080;HMDB0011148;HMDB0002995;HMDB0000123;HMDB0003208,44 (52),0.518,1,0.859,1
NOTCH1 regulation of endothelial cell calcification,Wikipathways,2,ITGA1;CALU,17 (17),0.859,1,0,,0 (0),1,1,0.859,1
Canonical and non-canonical TGF-B signaling,Wikipathways,2,MAPK14;MAPK9,17 (17),0.859,1,0,,0 (0),1,1,0.859,1
G1/S-Specific Transcription,Reactome,2,DHFR;PCNA,17 (17),0.859,1,0,,0 (0),1,1,0.859,1
Beta5 beta6 beta7 and beta8 integrin cell surface interactions,PID,2,VTN;FN1,17 (17),0.859,1,0,,0 (0),1,1,0.859,1
role of nicotinic acetylcholine receptors in the regulation of apoptosis,BioCarta,2,YWHAH;PIK3R1,17 (17),0.859,1,0,,0 (0),1,1,0.859,1
Extra-nuclear estrogen signaling,Reactome,14,CALM1;GNG12;EGFR;HRAS;PRMT1;PIK3R1;STRN;GNAI2;GNAI3;HSP90AA1;CAV1;MAPK1;GNB1;GNB2,73 (73),0.521,0.894,0,,22 (24),1,1,0.86,1
GABAergic synapse - Homo sapiens (human),KEGG,17,GLUL;GNG12;GPHN;GABARAP;PRKCA;SLC6A13;SLC38A3;ABAT;GNAI2;GNAI3;NSF;GLS;PRKACA;PRKACB;GLS2;GNB1;GNB2,89 (89),0.521,0.894,0,,9 (9),1,1,0.861,1
TCR signaling,Reactome,9,PTPRJ;CSK;PAK2;UBE2V1;RELA;PTPN22;NCK1;PIK3R1;UBE2N,73 (73),0.95,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,7 (10),0.549,1,0.861,1
Leishmania phagocytosis,Reactome,26,WASL;ABI1;CYFIP1;MAPK1;NCKAP1;BRK1;IGHG1;ARPC1A;ACTB;GRB2;ACTG1;RAC1;NCK1;BAIAP2;LYN;YES1;CDC42;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;CRK;CYFIP2;ARPC2,137 (137),0.522,0.895,0,,6 (10),1,1,0.861,1
FCGR3A-mediated phagocytosis,Reactome,26,WASL;ABI1;CYFIP1;MAPK1;NCKAP1;BRK1;IGHG1;ARPC1A;ACTB;GRB2;ACTG1;RAC1;NCK1;BAIAP2;LYN;YES1;CDC42;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;CRK;CYFIP2;ARPC2,137 (137),0.522,0.895,0,,6 (10),1,1,0.861,1
Parasite infection,Reactome,26,WASL;ABI1;CYFIP1;MAPK1;NCKAP1;BRK1;IGHG1;ARPC1A;ACTB;GRB2;ACTG1;RAC1;NCK1;BAIAP2;LYN;YES1;CDC42;ARPC5;ARPC4;ARPC3;ARPC1B;ACTR3;ACTR2;CRK;CYFIP2;ARPC2,137 (137),0.522,0.895,0,,6 (10),1,1,0.861,1
PI Metabolism,Reactome,15,RAB14;GDPD1;VAC14;PIK3R4;RAB4A;RAB5A;PIK3R1;PITPNB;PI4KA;ARF1;PIP4P1;PLEKHA6;SACM1L;PIP4K2C;PNPLA7,84 (84),0.638,1,1,HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,15 (29),0.819,1,0.861,1
The retinoid cycle in cones (daylight vision),Reactome,1,DHRS3,7 (7),0.769,1,1,HMDB0006216,10 (12),0.679,1,0.861,1
wnt signaling pathway,BioCarta,4,PPP2R5D;CSNK2A1;CTNNB1;CTBP1,31 (31),0.863,1,0,,0 (0),1,1,0.863,1
Signaling by Nuclear Receptors,Reactome,55,UGT1A3;ALDH8A1;STRN;FASN;RXRA;DHRS4;AGO2;PPP5C;CALM1;GNG12;EGFR;RDH11;SMC3;PCK1;PDHA1;ALDH1A3;PDHB;PDK1;PDK2;PDK4;PIK3R1;SMC1A;CPT1A;POLR2A;HRAS;RDH10;H2AX;DHRS3;DLAT;DLD;PRMT1;GPAM;GNAI2;RDH13;GNAI3;ALDH1A1;CAV1;MAPK1;APOE;GNB1;GNB2;CHKB;APOC2;CTSD;PTGES3;PPID;RDH16;STAG2;FKBP4;FKBP5;PDHX;DDX5;HSP90AA1;RAD21;HSP90AB1,294 (295),0.553,0.927,2,HMDB0000145;HMDB0006216,42 (49),0.95,1,0.863,1
Negative regulation of the PI3K/AKT network,Reactome,16,EGFR;GRB2;RHOG;PPP2CB;KITLG;PIK3R1;STRN;PPP2R5A;PPP2R1A;RAC1;PPP2R5D;PPP2R5E;MAPK1;PIP4K2C;PIK3AP1;PTPN11,107 (107),0.88,1,1,HMDB0000693,8 (14),0.597,1,0.864,1
Effects of PIP2 hydrolysis,Reactome,4,ABHD12;ITPR2;ABHD6;MGLL,27 (27),0.778,1,1,HMDB0001043,10 (13),0.679,1,0.865,1
Ion transport by P-type ATPases,Reactome,8,ATP1B1;ATP1B3;FXYD1;ATP2A2;ATP7B;ATP2B1;ATP1A1;ATP13A1,47 (47),0.685,1,1,HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,13 (17),0.772,1,0.866,1
ApoE and miR-146 in inflammation and atherosclerosis,Wikipathways,2,RELA;APOE,9 (9),0.529,0.897,0,,1 (3),1,1,0.866,1
Interleukin-9 signaling,Reactome,2,STAT5B;STAT3,9 (9),0.529,0.897,0,,2 (2),1,1,0.866,1
Maturation of protein 3a,Reactome,2,ST6GAL1;ST3GAL4,9 (9),0.529,0.897,0,,4 (5),1,1,0.866,1
TRIF-mediated programmed cell death,Reactome,2,CD14;FADD,9 (9),0.529,0.897,0,,1 (1),1,1,0.866,1
NR1H2 & NR1H3 regulate gene expression linked to lipogenesis,Reactome,2,RXRA;FASN,9 (9),0.529,0.897,0,,3 (4),1,1,0.866,1
NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis,Reactome,2,RXRA;UGT1A3,9 (9),0.529,0.897,0,,3 (4),1,1,0.866,1
Effects of Botulinum toxin,PID,2,VAMP2;RAB3GAP2,9 (9),0.529,0.897,0,,1 (2),1,1,0.866,1
PI3K/AKT activation,Reactome,2,RHOA;PIK3R1,9 (9),0.529,0.897,0,,3 (4),1,1,0.866,1
Signaling by NTRK3 (TRKC),Reactome,2,SHC1;PIK3R1,9 (9),0.529,0.897,0,,2 (2),1,1,0.866,1
Erythrocytes take up oxygen and release carbon dioxide,Reactome,2,SLC4A1;AQP1,9 (9),0.529,0.897,0,,7 (8),1,1,0.866,1
polyadenylation of mrna,BioCarta,2,PABPN1;CPSF1,9 (9),0.529,0.897,0,,2 (2),1,1,0.866,1
ROS sensing by NFE2L2,Reactome,2,RBX1;CUL3,9 (9),0.529,0.897,0,,3 (3),1,1,0.866,1
Interleukin-12 signaling,Reactome,2,P4HB;STAT4,9 (9),0.529,0.897,0,,2 (2),1,1,0.866,1
CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,Reactome,2,CALM1;KPNA2,9 (9),0.529,0.897,0,,3 (3),1,1,0.866,1
Maturation of protein 3a,Reactome,2,ST6GAL1;ST3GAL4,9 (9),0.529,0.897,0,,4 (5),1,1,0.866,1
Clopidogrel Metabolism Pathway,SMPDB,2,CYP1A2;PON1,9 (9),0.529,0.897,0,,9 (9),1,1,0.866,1
Clopidogrel Action Pathway,SMPDB,2,CYP1A2;PON1,9 (9),0.529,0.897,0,,9 (9),1,1,0.866,1
Cyclophosphamide Action Pathway,SMPDB,2,ALDH1A1;GSTM1,9 (9),0.529,0.897,0,,22 (23),1,1,0.866,1
Cyclophosphamide Metabolism Pathway,SMPDB,2,ALDH1A1;GSTM1,9 (9),0.529,0.897,0,,22 (23),1,1,0.866,1
Inactivation_ recovery and regulation of the phototransduction cascade,Reactome,7,CALM1;FNTA;NMT1;METAP1;PRKCA;METAP2;GNB1,36 (36),0.532,0.9,0,,16 (18),1,1,0.868,1
PI3K Cascade,Reactome,4,PIK3R4;PIK3R1;PTPN11;GRB2,44 (44),0.977,1,1,HMDB0000693,7 (10),0.549,1,0.87,1
RAS processing,Reactome,4,CALM1;LYPLA1;FNTA;HRAS,23 (23),0.655,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,15 (19),0.819,1,0.871,1
G beta:gamma signalling through PLC beta,Reactome,4,GNG12;PLCB3;GNB1;GNB2,20 (20),0.538,0.908,0,,1 (3),1,1,0.872,1
JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,Reactome,4,MAP2K4;MAPK9;UBE2N;UBE2V1,20 (20),0.538,0.908,0,,2 (5),1,1,0.872,1
G beta:gamma signalling through CDC42,Reactome,4,GNG12;GNB1;CDC42;GNB2,20 (20),0.538,0.908,0,,1 (1),1,1,0.872,1
alpha-Linolenic acid metabolism - Homo sapiens (human),KEGG,4,ACOX1;PLA2G12B;ACOX3;FADS2,25 (25),0.721,1,2,HMDB0001388;HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,24 (44),0.746,1,0.872,1
IL6-mediated signaling events,PID,9,HSP90B1;GRB2;PIK3R1;MAP2K4;PTPN11;STAT3;RAC1;MAPK14;FGG,47 (47),0.539,0.909,0,,2 (2),1,1,0.872,1
ion channels and their functional role in vascular endothelium,BioCarta,9,F2;GUCY1A1;GUCY1B1;KNG1;AGT;HSP90AA1;CAV1;GNAS;GNB1,47 (47),0.539,0.909,0,,10 (11),1,1,0.872,1
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE),Reactome,1,CYP1A2,9 (9),0.848,1,1,HMDB0001043,9 (11),0.64,1,0.875,1
Vitamin A (retinol) metabolism,EHMN,4,CYP1A2;UGT1A3;UGT2B10;UGT2B15,26 (26),0.751,1,2,HMDB0006216;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,23 (28),0.725,1,0.875,1
Blood group systems biosynthesis,Reactome,2,ST3GAL6;ST3GAL4,20 (20),0.914,1,1,HMDB0000304,8 (29),0.597,1,0.876,1
NLR Proteins,Wikipathways,1,RELA,10 (10),0.877,1,0,,0 (0),1,1,0.877,1
IL-13 signaling,INOH,1,STAT6,10 (10),0.877,1,0,,0 (0),1,1,0.877,1
LIF signaling,INOH,1,STAT3,10 (10),0.877,1,0,,0 (0),1,1,0.877,1
Dimerization of procaspase-8,Reactome,1,FADD,10 (10),0.877,1,0,,0 (0),1,1,0.877,1
ifn alpha signaling pathway,BioCarta,1,STAT2,10 (10),0.877,1,0,,0 (0),1,1,0.877,1
Negative regulation of activity of TFAP2 (AP-2) family transcription factors,Reactome,1,UBE2I,10 (10),0.877,1,0,,0 (0),1,1,0.877,1
Type III interferon signaling,Wikipathways,1,STAT2,10 (10),0.877,1,0,,0 (0),1,1,0.877,1
Hedgehog,NetPath,3,YWHAE;PRKACA;CTNNB1,25 (25),0.877,1,0,,0 (0),1,1,0.877,1
Biosynthesis of DPAn-3 SPMs,Reactome,0,,4 (4),1,1,1,HMDB0006528,7 (30),0.549,1,0.878,1
Glycosphingolipid biosynthesis - lactoseries,EHMN,0,,7 (7),1,1,1,HMDB0000304,7 (19),0.549,1,0.878,1
lipoxin biosynthesis,HumanCyc,0,,3 (3),1,1,1,HMDB0001043,7 (7),0.549,1,0.878,1
Synthesis of Hepoxilins (HX) and Trioxilins (TrX),Reactome,0,,1 (1),1,1,1,HMDB0001043,7 (10),0.549,1,0.878,1
Biosynthesis of protectin and resolvin conjugates in tissue regeneration (PCTR and RCTR),Reactome,0,,1 (1),1,1,1,HMDB0000123,7 (18),0.549,1,0.878,1
Nicotine addiction - Homo sapiens (human),KEGG,0,,40 (40),1,1,1,HMDB0001934,7 (7),0.549,1,0.878,1
aspirin-triggered lipoxin biosynthesis,HumanCyc,0,,2 (2),1,1,1,HMDB0001043,7 (9),0.549,1,0.878,1
Desipramine Metabolism Pathway,SMPDB,0,,3 (3),1,1,1,HMDB0015282,7 (7),0.549,1,0.878,1
Cargo trafficking to the periciliary membrane,Reactome,8,EXOC5;ARL3;GBF1;RAB8A;EXOC4;ARF4;RAB11A;RAB11FIP3,42 (42),0.551,0.926,0,,4 (4),1,1,0.879,1
Mammary gland development pathway - Embryonic development (Stage 1 of 4),Wikipathways,2,ITGB1;CDH1,18 (18),0.88,1,0,,0 (1),1,1,0.88,1
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma,Wikipathways,2,RELA;STAT3,18 (18),0.88,1,0,,0 (0),1,1,0.88,1
MECP2 regulates neuronal receptors and channels,Reactome,2,FKBP5;HDAC2,18 (18),0.88,1,0,,0 (0),1,1,0.88,1
atm signaling pathway,BioCarta,2,ATM;RELA,18 (18),0.88,1,0,,0 (0),1,1,0.88,1
Transport of bile salts and organic acids_ metal ions and amine compounds,Reactome,11,SLC30A1;SLC16A1;SLC30A10;SLC22A18;CP;SLC22A7;SLC39A7;SLC22A1;SLC6A13;SLC39A14;BSG,84 (84),0.938,1,7,HMDB0000123;HMDB0000172;HMDB0240251;HMDB0000043;HMDB0015169;HMDB0015282;HMDB0000687,67 (79),0.59,1,0.881,1
Biopterin metabolism,EHMN,3,SLC38A4;PCBD1;PTS,15 (15),0.559,0.927,0,,23 (24),1,1,0.884,1
Unfolded Protein Response (UPR),Reactome,3,EIF2S1;EIF2S2;HSPA5,15 (15),0.559,0.927,0,,2 (4),1,1,0.884,1
Transport of inorganic cations/anions and amino acids/oligopeptides,Reactome,7,SLC25A22;SLC26A1;SLC38A3;SLC38A4;SLC43A1;SLC4A1;SLC25A10,102 (102),1,1,5,HMDB0240251;HMDB0000123;HMDB0000172;HMDB0000687;HMDB0000043,46 (55),0.559,1,0.884,1
Metal ion SLC transporters,Reactome,5,CP;SLC39A14;SLC39A7;SLC30A1;SLC30A10,26 (26),0.56,0.927,0,,6 (8),1,1,0.885,1
The phototransduction cascade,Reactome,7,CALM1;FNTA;NMT1;METAP1;PRKCA;METAP2;GNB1,37 (37),0.563,0.927,0,,19 (22),1,1,0.887,1
Regucalcin in proximal tubule epithelial kidney cells,Wikipathways,3,MAPK1;MTOR;BAX,20 (20),0.757,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,12 (22),0.745,1,0.887,1
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),Reactome,1,PCNA,14 (14),0.947,1,1,HMDB0001342,8 (9),0.597,1,0.888,1
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),Reactome,1,PCNA,14 (14),0.947,1,1,HMDB0001342,8 (9),0.597,1,0.888,1
Chagas disease - Homo sapiens (human),KEGG,19,PPP2R2A;MAPK9;FADD;CALR;PPP2CB;C3;PIK3R1;MAP2K4;MAPK14;RELA;PLCB3;PPP2R1A;GNAI3;GNAI2;KNG1;GNAQ;GNAS;GNA11;MAPK1,102 (102),0.565,0.927,0,,6 (6),1,1,0.888,1
PLCG1 events in ERBB2 signaling,Reactome,1,EGFR,4 (4),0.567,0.927,0,,2 (2),1,1,0.889,1
<i>trans_ trans</i>-farnesyl diphosphate biosynthesis,HumanCyc,1,IDI1,4 (4),0.567,0.927,0,,4 (5),1,1,0.889,1
ALKBH3 mediated reversal of alkylation damage,Reactome,1,ASCC3,4 (4),0.567,0.927,0,,7 (9),1,1,0.889,1
PTK6 Activates STAT3,Reactome,1,STAT3,4 (4),0.567,0.927,0,,2 (2),1,1,0.889,1
MET Receptor Activation,Reactome,1,HPN,4 (4),0.567,0.927,0,,3 (3),1,1,0.889,1
phenylethylamine degradation I,HumanCyc,1,ALDH3A2,4 (4),0.567,0.927,0,,10 (10),1,1,0.889,1
Astrocytic Glutamate-Glutamine Uptake And Metabolism,Reactome,1,GLUL,4 (4),0.567,0.927,0,,6 (6),1,1,0.889,1
Neurotransmitter uptake and metabolism In glial cells,Reactome,1,GLUL,4 (4),0.567,0.927,0,,6 (6),1,1,0.889,1
Ion influx/efflux at host-pathogen interface,Reactome,1,ATOX1,4 (4),0.567,0.927,0,,9 (12),1,1,0.889,1
phospholipase c delta in phospholipid associated cell signaling,BioCarta,1,TGM2,4 (4),0.567,0.927,0,,1 (1),1,1,0.889,1
SLIT2:ROBO1 increases RHOA activity,Reactome,1,RHOA,4 (4),0.567,0.927,0,,4 (4),1,1,0.889,1
UTP and CTP dephosphorylation II,HumanCyc,1,CTPS2,4 (4),0.567,0.927,0,,11 (11),1,1,0.889,1
Hypusine synthesis from eIF5A-lysine,Reactome,1,EIF5A,4 (4),0.567,0.927,0,,8 (9),1,1,0.889,1
Catecholamine Biosynthesis,SMPDB,1,DDC,4 (4),0.567,0.927,0,,16 (18),1,1,0.889,1
Trandolapril Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,7 (7),1,1,0.889,1
Lisinopril Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,7 (7),1,1,0.889,1
Candesartan Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,7 (7),1,1,0.889,1
Catecholamine biosynthesis,Reactome,1,DDC,4 (4),0.567,0.927,0,,15 (19),1,1,0.889,1
Teniposide Action Pathway,SMPDB,1,MPO,4 (4),0.567,0.927,0,,9 (9),1,1,0.889,1
ionomycin and phorbal ester signaling pathway,BioCarta,1,PRKCA,4 (4),0.567,0.927,0,,1 (2),1,1,0.889,1
<i>N</i>-acetylglucosamine degradation II,HumanCyc,1,GNPDA1,4 (4),0.567,0.927,0,,7 (9),1,1,0.889,1
pyrimidine deoxyribonucleosides degradation,HumanCyc,1,TYMP,4 (4),0.567,0.927,0,,9 (10),1,1,0.889,1
Enalapril Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,8 (8),1,1,0.889,1
Fosphenytoin (Antiarrhythmic) Metabolism Pathway,SMPDB,1,SNTB2,4 (4),0.567,0.927,0,,2 (2),1,1,0.889,1
Tyrosine hydroxylase deficiency,SMPDB,1,DDC,4 (4),0.567,0.927,0,,16 (18),1,1,0.889,1
Temocapril Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,7 (7),1,1,0.889,1
Olmesartan Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,7 (7),1,1,0.889,1
Losartan Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,7 (7),1,1,0.889,1
Irbesartan Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,7 (7),1,1,0.889,1
Forasartan Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,7 (7),1,1,0.889,1
Valsartan Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,6 (7),1,1,0.889,1
Telmisartan Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,7 (7),1,1,0.889,1
Angiotensin Metabolism,SMPDB,1,AGT,4 (4),0.567,0.927,0,,6 (6),1,1,0.889,1
Attachment and Entry,Reactome,1,CTSL,4 (4),0.567,0.927,0,,1 (7),1,1,0.889,1
Rescinnamine Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,7 (7),1,1,0.889,1
Perindopril Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,8 (8),1,1,0.889,1
Quinapril Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,8 (8),1,1,0.889,1
Moexipril Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,7 (7),1,1,0.889,1
Eprosartan Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,7 (7),1,1,0.889,1
Felbamate Metabolism Pathway,SMPDB,1,CYP2E1,4 (4),0.567,0.927,0,,18 (18),1,1,0.889,1
Clomipramine Metabolism Pathway,SMPDB,1,CYP1A2,4 (4),0.567,0.927,0,,12 (12),1,1,0.889,1
Fosinopril Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,7 (8),1,1,0.889,1
Benazepril Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,8 (8),1,1,0.889,1
Cilazapril Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,7 (8),1,1,0.889,1
Captopril Action Pathway,SMPDB,1,AGT,4 (4),0.567,0.927,0,,6 (7),1,1,0.889,1
Teniposide Metabolism Pathway,SMPDB,1,MPO,4 (4),0.567,0.927,0,,9 (9),1,1,0.889,1
Aromatic L-Aminoacid Decarboxylase Deficiency,SMPDB,1,DDC,4 (4),0.567,0.927,0,,16 (18),1,1,0.889,1
IL-7 signaling,INOH,29,MAP2K4;MAPK14;CAMK2A;EGFR;CSK;MTOR;CSNK1A1;CSNK1D;PIK3R1;CAMK2D;RPS6KA1;PRKAA1;PRKAA2;PRKAB1;PRKACA;PRKACB;PRKAG1;PRKAR1A;PAK2;PRKAR2A;PRKCA;MAPK1;YWHAQ;MAPK9;MAP2K1;MAP2K2;MAP2K3;ARAF;STAT5B,185 (185),0.889,1,0,,0 (0),1,1,0.889,1
Mismatch Repair,Reactome,1,PCNA,15 (15),0.957,1,1,HMDB0001342,8 (9),0.597,1,0.891,1
Salivary secretion - Homo sapiens (human),KEGG,16,ATP1B1;CALM1;ATP1B3;GUCY1A1;GUCY1B1;ATP1A1;PRKCA;ATP2B1;CD38;PLCB3;GNAQ;GNAS;VAMP2;ITPR2;PRKACA;PRKACB,93 (93),0.7,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,15 (17),0.819,1,0.892,1
IGF1R signaling cascade,Reactome,7,SHC1;HRAS;GRB2;PIK3R4;PIK3R1;PTPN11;IGF1,53 (53),0.896,1,1,HMDB0000693,9 (12),0.64,1,0.892,1
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),Reactome,7,SHC1;HRAS;GRB2;PIK3R4;PIK3R1;PTPN11;IGF1,53 (53),0.896,1,1,HMDB0000693,9 (12),0.64,1,0.892,1
IL27-mediated signaling events,PID,3,STAT2;STAT3;STAT4,26 (26),0.893,1,0,,0 (0),1,1,0.893,1
Resistin as a regulator of inflammation,Wikipathways,4,MAPK14;MAPK1;PLCB3;RELA,33 (33),0.894,1,0,,0 (0),1,1,0.894,1
Monoamine Transport,Wikipathways,6,ITGB3;AGT;PPP2CB;TDO2;MAPK14;NECTIN2,32 (32),0.578,0.942,0,,9 (13),1,1,0.895,1
Activation of kainate receptors upon glutamate binding,Reactome,6,CALM1;GNG12;DLG1;PLCB3;GNB1;GNB2,32 (32),0.578,0.942,0,,4 (4),1,1,0.895,1
G-protein beta:gamma signalling,Reactome,6,GNG12;RHOA;CDC42;PLCB3;GNB1;GNB2,32 (32),0.578,0.942,0,,5 (7),1,1,0.895,1
Presynaptic function of Kainate receptors,Reactome,4,GNG12;PLCB3;GNB1;GNB2,21 (21),0.579,0.942,0,,2 (2),1,1,0.896,1
regulation of pgc-1a,BioCarta,4,CAMK2D;PPP3CA;YWHAH;CAMK2A,21 (21),0.579,0.942,0,,1 (1),1,1,0.896,1
Fructose and mannose metabolism,EHMN,4,SLC2A2;HK1;ALDOB;SLC2A9,21 (21),0.579,0.942,0,,28 (34),1,1,0.896,1
activated TAK1 mediates p38 MAPK activation,Reactome,4,MAPK14;MAP2K3;UBE2N;UBE2V1,21 (21),0.579,0.942,0,,2 (5),1,1,0.896,1
Oxidative Damage,Wikipathways,5,MAP2K4;C5;CASP3;CDC42;PCNA,40 (40),0.897,1,0,,0 (0),1,1,0.897,1
Hippo signaling pathway - Homo sapiens (human),KEGG,24,PPP2CB;PPP2R1A;CSNK1D;PPP2R2A;LLGL2;CTNNB1;YAP1;ACTB;MOB1A;ACTG1;DLG1;CTNNA1;CTNNA2;YWHAQ;CDH1;ITGB2;YWHAE;YWHAG;YWHAH;YWHAZ;YWHAB;PPP1CA;PPP1CB;PPP1CC,157 (157),0.898,1,0,,0 (0),1,1,0.898,1
ATM Signaling Pathway,Wikipathways,2,ATM;MAPK9,19 (19),0.898,1,0,,0 (0),1,1,0.898,1
Transcriptional Regulation by VENTX,Reactome,2,RELA;CTNNB1,19 (19),0.898,1,0,,0 (0),1,1,0.898,1
HH-Core,Signalink,2,MAP2K1;PRKACA,19 (19),0.898,1,0,,0 (0),1,1,0.898,1
Other semaphorin interactions,Reactome,2,ITGA1;ITGB1,19 (19),0.898,1,0,,0 (0),1,1,0.898,1
Cholinergic synapse - Homo sapiens (human),KEGG,18,HRAS;GNG12;MAP2K1;CAMK2A;PRKCA;PRKACB;GNA11;CAMK2D;PLCB3;GNAI3;GNAI2;PRKACA;GNAQ;MAPK1;PIK3R1;ITPR2;GNB1;GNB2,113 (113),0.821,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,11 (12),0.714,1,0.899,1
Pancreatic cancer - Homo sapiens (human),KEGG,14,MAPK9;MTOR;EGFR;BAX;CDC42;RALA;RALB;PIK3R1;ARAF;RELA;STAT3;RAC1;MAP2K1;MAPK1,76 (76),0.586,0.95,0,,2 (2),1,1,0.899,1
PTF1A related regulatory pathway,Wikipathways,1,CTNNB1,11 (11),0.9,1,0,,0 (0),1,1,0.9,1
Regulation by c-FLIP,Reactome,1,FADD,11 (11),0.9,1,0,,0 (0),1,1,0.9,1
ALK2 signaling events,PID,1,FKBP1A,11 (11),0.9,1,0,,0 (0),1,1,0.9,1
Signaling mediated by p38-gamma and p38-delta,PID,1,MAP2K3,11 (11),0.9,1,0,,0 (0),1,1,0.9,1
CASP8 activity is inhibited,Reactome,1,FADD,11 (11),0.9,1,0,,0 (1),1,1,0.9,1
apoptotic dna-fragmentation and tissue homeostasis,BioCarta,1,CASP3,11 (11),0.9,1,0,,0 (0),1,1,0.9,1
NOTCH-Core,Signalink,1,NCSTN,11 (11),0.9,1,0,,0 (0),1,1,0.9,1
Carboxyterminal post-translational modifications of tubulin,Reactome,5,TUBA1B;TTLL12;TUBB2B;TUBA1C;TUBB4B,42 (42),0.919,1,1,HMDB0000123,9 (10),0.64,1,0.901,1
RHOBTB3 ATPase cycle,Reactome,2,HGS;CUL3,10 (10),0.589,0.95,0,,4 (4),1,1,0.901,1
The NLRP3 inflammasome,Reactome,2,SUGT1;HSP90AB1,10 (10),0.589,0.95,0,,2 (3),1,1,0.901,1
Insulin processing,Reactome,2,ERO1A;ERO1B,10 (10),0.589,0.95,0,,3 (3),1,1,0.901,1
MASTL Facilitates Mitotic Progression,Reactome,2,PPP2CB;PPP2R1A,10 (10),0.589,0.95,0,,2 (2),1,1,0.901,1
Organic anion transporters,Reactome,2,SLC25A10;SLC25A22,10 (10),0.589,0.95,0,,13 (15),1,1,0.901,1
Formyl peptide receptors bind formyl peptides and many other ligands,Reactome,2,HEBP1;ANXA1,10 (10),0.589,0.95,0,,1 (2),1,1,0.901,1
Vincristine Action Pathway,SMPDB,2,TUBA1B;ABCC2,10 (10),0.589,0.95,0,,5 (5),1,1,0.901,1
Reduction of cytosolic Ca++ levels,Reactome,2,ATP2A2;ATP2B1,10 (10),0.589,0.95,0,,3 (3),1,1,0.901,1
Zinc influx into cells by the SLC39 gene family,Reactome,2,SLC39A7;SLC39A14,10 (10),0.589,0.95,0,,1 (1),1,1,0.901,1
Differentiation Pathway,Wikipathways,4,TF;NT5E;KITLG;IGF1,48 (48),0.987,1,1,HMDB0014842,8 (12),0.597,1,0.901,1
ATF-2 transcription factor network,PID,8,MAPK9;CUL3;RUVBL2;PRKCA;MACROH2A1;MAPK14;MAPK1;ARG1,60 (60),0.902,1,0,,0 (0),1,1,0.902,1
GPCR ligand binding,Reactome,15,GNG12;F2;AGT;PF4;ANXA1;C3;HEBP1;PXMP2;KNG1;NLN;C5;GNAS;PSAP;GNB1;GNB2,476 (476),1,1,13,HMDB0015697;HMDB0005096;HMDB0002995;HMDB0003208;HMDB0033941;HMDB0003073;HMDB0001388;HMDB0015095;HMDB0006528;HMDB0036836;HMDB0004080;HMDB0015464;HMDB0002183,125 (168),0.593,1,0.903,1
Cocaine addiction - Homo sapiens (human),KEGG,9,MAOA;MAOB;DDC;RELA;GNAI2;GNAI3;GNAS;PRKACA;PRKACB,49 (49),0.594,0.956,0,,8 (8),1,1,0.903,1
Intracellular signaling by second messengers,Reactome,43,MTA2;PIK3AP1;RHOG;PPP2CB;PPP2R1A;STRN;PPP2R5A;PPP2R5E;PPP2R5D;AGO2;PIK3R1;LAMTOR2;KITLG;GRB2;CALM1;EGFR;LAMTOR4;CAMK2D;RBBP4;MTOR;CAMK2A;CSNK2A1;CSNK2A2;CSNK2B;PRKACA;PRKACB;USP7;PRKAR1A;PRKAR2A;PRKCA;CHD4;RRAGC;MAPK1;LAMTOR1;PIP4K2C;AKT1S1;NEDD4;RAC1;RHEB;HDAC2;ITPR2;KPNA2;PTPN11,259 (259),0.847,1,2,HMDB0000693;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,22 (28),0.701,1,0.903,1
Calcium signaling pathway - Homo sapiens (human),KEGG,29,STIM1;PHKB;PHKG2;SPHK2;GNAQ;PPP3CA;MYLK;CALM1;SLC25A4;SLC25A5;CAMK2A;CAMK2D;MCU;CD38;PRKACA;PRKACB;PRKCA;GNA11;PLCB3;VDAC2;CAMK1;EGFR;GNAS;ATP2A2;ATP2B1;VDAC1;PPIF;VDAC3;ITPR2,239 (240),0.998,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,8 (11),0.597,1,0.904,1
p53 signaling pathway - Homo sapiens (human),KEGG,10,EI24;CASP3;BAX;STEAP3;AIFM2;RRM2B;IGF1;ATM;TP53I3;BID,73 (73),0.904,1,0,,0 (0),1,1,0.904,1
Signaling by NOTCH4,Reactome,5,NCSTN;RBX1;SKP1;CUL1;YWHAZ,27 (27),0.596,0.96,0,,2 (2),1,1,0.904,1
RHO GTPases activate PKNs,Reactome,16,RHOA;H2AX;MYH14;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;MYH9;PKN3;RAC1;YWHAQ;PPP1CB;MYL6;MYL9;MYH11,96 (97),0.749,1,1,HMDB0000234,14 (15),0.797,1,0.905,1
heparan sulfate biosynthesis (late stages),HumanCyc,0,,22 (22),1,1,1,HMDB0000290,8 (8),0.597,1,0.905,1
estradiol biosynthesis II,HumanCyc,0,,2 (2),1,1,1,HMDB0000234,8 (8),0.597,1,0.905,1
Telomere C-strand synthesis initiation,Reactome,0,,13 (13),1,1,1,HMDB0001342,8 (11),0.597,1,0.905,1
Methadone Metabolism Pathway,SMPDB,0,,11 (11),1,1,1,HMDB0014477,8 (8),0.597,1,0.905,1
Regulation of TP53 Activity through Phosphorylation,Reactome,17,DNA2;ATM;TAF15;CSNK2A2;SSRP1;CSNK2A1;PRKAG1;CSNK2B;PIN1;MAPK14;TAF3;PRKAA1;PRKAA2;PRKAB1;TP53RK;SUPT16H;RAD50,93 (93),0.6,0.966,0,,3 (4),1,1,0.906,1
Neuronal System,Reactome,60,NPTN;FLOT2;DBNL;ABAT;AP2M1;GNAI2;AP2S1;PPM1F;GLS2;LIN7C;MAOA;AP2A2;GNG12;AP2B1;MYO6;NSF;EPB41L5;CAMK2A;PPFIBP1;CAMK2D;PDLIM5;PPFIA1;RTN3;GLS;SLC22A1;PRKAA1;PRKAA2;PTPRD;PRKACA;PRKACB;GLUL;HRAS;PRKAG1;PRKAR1A;CALM1;PRKAR2A;SLC6A13;PRKCA;DLG1;RPS6KA1;PLCB3;GNAI3;CAMK1;MAPK1;GNB1;GNB2;FLOT1;PRKAB1;ALDH5A1;COMT;HSPA8;EPB41;EPB41L1;EPB41L2;VAMP2;RAC1;AP2A1;LIN7A;CASK;KPNA2,391 (391),0.972,1,7,HMDB0033934;HMDB0015124;HMDB0000123;HMDB0001043;HMDB0000043;HMDB0004080;HMDB0002088,69 (78),0.622,1,0.909,1
GRB2 events in ERBB2 signaling,Reactome,3,HRAS;EGFR;GRB2,16 (16),0.605,0.971,0,,2 (2),1,1,0.909,1
PI3K events in ERBB2 signaling,Reactome,3,EGFR;GRB2;PIK3R1,16 (16),0.605,0.971,0,,3 (4),1,1,0.909,1
RAF-independent MAPK1/3 activation,Reactome,3,MAPK1;MAP2K1;MAP2K2,16 (16),0.605,0.971,0,,4 (4),1,1,0.909,1
KSRP (KHSRP) binds and destabilizes mRNA,Reactome,3,MAPK14;KHSRP;EXOSC6,16 (16),0.605,0.971,0,,3 (4),1,1,0.909,1
control of skeletal myogenesis by hdac and calcium/calmodulin-dependent kinase (camk),BioCarta,3,MAPK14;YWHAH;PIK3R1,16 (16),0.605,0.971,0,,1 (1),1,1,0.909,1
IRS-related events triggered by IGF1R,Reactome,6,PIK3R4;GRB2;HRAS;PIK3R1;PTPN11;IGF1,52 (52),0.945,1,1,HMDB0000693,9 (12),0.64,1,0.909,1
Ca2+ pathway,Reactome,10,CALM1;GNG12;PRKCA;CAMK2A;PLCB3;PPP3CA;CTNNB1;ITPR2;GNB1;GNB2,55 (55),0.606,0.973,0,,13 (16),1,1,0.91,1
PLK1 signaling events,PID,8,RHOA;RAB1A;NUDC;TPT1;PPP2R1A;STAG2;GOLGA2;PPP1CB,44 (44),0.607,0.974,0,,1 (1),1,1,0.91,1
Regulation of Ras family activation,PID,6,CALM1;GRB2;HRAS;PRKCA;LGALS1;LGALS3,33 (33),0.61,0.977,0,,5 (5),1,1,0.912,1
EPHA forward signaling,PID,6,LYN;YES1;ROCK1;RHOA;CRK;CRKL,33 (33),0.61,0.977,0,,2 (2),1,1,0.912,1
Rett syndrome causing genes,Wikipathways,6,SMARCA2;SMC1A;CHD4;CRK;EIF2B2;IMPDH2,48 (48),0.912,1,0,,0 (0),1,1,0.912,1
Wax and plasmalogen biosynthesis,Reactome,1,DHRS7B,7 (7),0.769,1,1,HMDB0062325,14 (18),0.797,1,0.913,1
BMP Signaling Pathway in Eyelid Development,Wikipathways,2,MAPK9;EGFR,20 (20),0.914,1,0,,0 (0),1,1,0.914,1
Hypertrophy Model,Wikipathways,2,EIF4E;WDR1,20 (20),0.914,1,0,,0 (0),1,1,0.914,1
Insulin receptor signalling cascade,Reactome,7,SHC1;HRAS;GRB2;PIK3R4;PIK3R1;PTPN11;MAPK1,54 (54),0.906,1,1,HMDB0000693,10 (14),0.679,1,0.914,1
IRS-mediated signalling,Reactome,5,PIK3R4;HRAS;PIK3R1;PTPN11;GRB2,48 (48),0.963,1,1,HMDB0000693,9 (12),0.64,1,0.915,1
Sensory Perception,Reactome,42,APOM;METAP1;TTR;AKR1C1;EPS8L2;RDH16;MYO1C;RDX;BCO2;RDH11;SPTAN1;HSD17B6;SPTBN1;RBP1;CAPZA1;CAPZA2;CAPZB;RDH10;LRP1;DHRS3;PRKCA;APOA1;APOA2;APOA4;APOB;FNTA;NMT1;APOC2;APOC3;APOE;GNB1;RETSAT;ATP2B1;METAP2;PLS1;CALM1;MYH9;EPB41L1;RBP4;GSN;TWF1;CASK,585 (585),1,1,5,HMDB0000067;HMDB0006216;HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741,49 (69),0.617,1,0.915,1
Telomere Extension By Telomerase,Reactome,4,GAR1;PPP6R3;ANKRD28;PPP6C,22 (22),0.619,0.987,0,,5 (6),1,1,0.916,1
HIF-2-alpha transcription factor network,PID,4,ELOB;APEX1;FXN;ELOC,35 (35),0.918,1,0,,0 (0),1,1,0.918,1
Purine metabolism and related disorders,Wikipathways,0,,0 (0),1,1,1,HMDB0000195,22 (49),0.919,1,0.919,1
LncRNA-mediated mechanisms of therapeutic resistance,Wikipathways,1,HIF1A,12 (12),0.919,1,0,,0 (0),1,1,0.919,1
Butyrophilin (BTN) family interactions,Reactome,1,XDH,12 (12),0.919,1,0,,0 (1),1,1,0.919,1
POU5F1 (OCT4)_ SOX2_ NANOG activate genes related to proliferation,Reactome,1,STAT3,12 (12),0.919,1,0,,0 (0),1,1,0.919,1
tnfr2 signaling pathway,BioCarta,1,RELA,12 (12),0.919,1,0,,0 (0),1,1,0.919,1
CDC42 GTPase cycle,Reactome,29,WDR91;ARHGAP1;ARHGDIA;ARHGDIB;WASL;YKT6;GNA13;IQGAP2;DOCK8;ARFGAP3;PIK3R1;FARP1;STEAP3;KTN1;ARHGEF12;PAK2;RAB7A;TMPO;ARFGAP2;ARHGAP17;CAV1;BAIAP2;LAMTOR1;JUP;CDC42;CDC42BPB;STOM;IQGAP1;TFRC,160 (160),0.628,1,0,,4 (4),1,1,0.92,1
Notch-HLH transcription pathway,Reactome,3,HDAC2;SNW1;HDAC6,28 (28),0.92,1,0,,0 (0),1,1,0.92,1
multi-step regulation of transcription by pitx2,BioCarta,3,PPP2R5D;CSNK2A1;CTNNB1,28 (28),0.92,1,0,,0 (0),1,1,0.92,1
3-phosphoinositide biosynthesis,HumanCyc,5,PIK3R4;PI4KA;CDIPT;SACM1L;PIK3R1,28 (28),0.63,1,0,,7 (11),1,1,0.921,1
IL-17 signaling pathway - Homo sapiens (human),KEGG,13,MAPK9;FADD;S100A8;S100A9;ELAVL1;HSP90B1;MAPK14;RELA;HSP90AA1;CASP3;SRSF1;MAPK1;HSP90AB1,94 (94),0.922,1,0,,0 (0),1,1,0.922,1
Myometrial relaxation and contraction pathways,Wikipathways,28,CALD1;CALM1;GNG12;GUCY1A1;CAMK2A;CAMK2D;ACTB;PRKACA;PRKACB;PRKAR1A;ACTC1;ACTG1;PRKAR2A;PRKCA;PLCB3;GNAQ;GNAS;YWHAQ;GNB1;GNB2;GSTO1;ATP2A2;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;ITPR2,155 (155),0.634,1,0,,4 (4),1,1,0.923,1
DNA Repair Pathways Full Network,Wikipathways,17,XRCC5;CUL4B;CUL4A;H2AX;APEX1;DDB1;LIG3;POLE;PARP1;RAP1A;XRCC6;PCNA;ATM;RBX1;RAD23B;RAD23A;RAD50,119 (119),0.924,1,0,,0 (0),1,1,0.924,1
Metabolism overview,Wikipathways,0,,0 (0),1,1,5,HMDB0062259;HMDB0000757;HMDB0033934;HMDB0005383#HMDB0005410#HMDB0045873#HMDB0005459#HMDB0005454#HMDB0005437#HMDB0005424#HMDB0005440#HMDB0005376#HMDB0005403#HMDB0005388#HMDB0005390#HMDB0005393#HMDB0005442#HMDB0005363#HMDB0005397#HMDB0045741;HMDB0003944,76 (114),0.924,1,0.924,1
FCERI mediated Ca+2 mobilization,Reactome,6,SHC1;CALM1;LYN;GRB2;PPP3CA;ITPR2,108 (108),1,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,9 (13),0.64,1,0.926,1
Base-Excision Repair_ AP Site Formation,Reactome,1,H2AX,66 (67),1,1,1,HMDB0011600,9 (18),0.64,1,0.926,1
tRNA splicing,HumanCyc,0,,5 (5),1,1,1,HMDB0001178,9 (11),0.64,1,0.926,1
glucocorticoid biosynthesis,HumanCyc,0,,3 (3),1,1,1,HMDB0000015,9 (9),0.64,1,0.926,1
HS-GAG biosynthesis,Reactome,0,,31 (31),1,1,1,HMDB0000290,9 (9),0.64,1,0.926,1
Regulation of MECP2 expression and activity,Reactome,6,CALM1;CAMK2A;CAMK2D;AGO2;HDAC2;PRKACA,34 (34),0.641,1,0,,3 (3),1,1,0.926,1
CD40/CD40L signaling,PID,6,MAPK9;RELA;PIK3R1;MAP2K4;C4BPA;MAPK14,34 (34),0.641,1,0,,1 (1),1,1,0.926,1
Aspirin and miRNAs,Wikipathways,2,PDK1;PTGS1,11 (11),0.643,1,0,,1 (1),1,1,0.927,1
Autosomal recessive Osteopetrosis pathways,Wikipathways,2,TCIRG1;RAB7A,11 (11),0.643,1,0,,2 (2),1,1,0.927,1
Dermatan sulfate biosynthesis,Reactome,2,BGN;DCN,11 (11),0.643,1,0,,2 (2),1,1,0.927,1
Interleukin-6 signaling,Reactome,2,PTPN11;STAT3,11 (11),0.643,1,0,,2 (2),1,1,0.927,1
Vinblastine Action Pathway,SMPDB,2,TUBA1B;ABCC2,11 (11),0.643,1,0,,6 (6),1,1,0.927,1
Negative regulation of FLT3,Reactome,2,PTPRJ;CSK,11 (11),0.643,1,0,,4 (4),1,1,0.927,1
regulators of bone mineralization,BioCarta,2,COL4A2;ENPP1,11 (11),0.643,1,0,,3 (4),1,1,0.927,1
Synthesis of PIPs at the late endosome membrane,Reactome,2,PIK3R4;VAC14,11 (11),0.643,1,0,,7 (12),1,1,0.927,1
Regulated proteolysis of p75NTR,Reactome,2,NCSTN;RELA,11 (11),0.643,1,0,,1 (1),1,1,0.927,1
Vinorelbine Action Pathway,SMPDB,2,TUBA1B;ABCC2,11 (11),0.643,1,0,,5 (6),1,1,0.927,1
IFN alpha signaling,INOH,2,STAT2;STAT3,21 (21),0.927,1,0,,0 (0),1,1,0.927,1
Galanin receptor pathway,Wikipathways,2,VAMP2;YAP1,21 (21),0.927,1,0,,0 (0),1,1,0.927,1
Other interleukin signaling,Reactome,2,STX4;CASP3,21 (21),0.927,1,0,,0 (0),1,1,0.927,1
Pathways affected in adenoid cystic carcinoma,Wikipathways,8,HRAS;SMARCA2;MAP2K2;NFIB;CTBP1;SMC1A;MYCBP;ATM,63 (63),0.928,1,0,,0 (0),1,1,0.928,1
DNA replication - Homo sapiens (human),KEGG,4,POLE;DNA2;SSBP1;PCNA,36 (36),0.929,1,0,,0 (0),1,1,0.929,1
Hedgehog Signaling Pathway,Wikipathways,5,CSNK1A1;CUL3;CSNK1D;PRKACA;PRKACB,43 (43),0.929,1,0,,0 (0),1,1,0.929,1
Regulation of Wnt-B-catenin Signaling by Small Molecule Compounds,Wikipathways,3,CTNNB1;CSNK1A1;LRP1,17 (17),0.648,1,0,,2 (12),1,1,0.929,1
Tristetraprolin (TTP_ ZFP36) binds and destabilizes mRNA,Reactome,3,YWHAB;TNPO1;EXOSC6,17 (17),0.648,1,0,,2 (3),1,1,0.929,1
Zinc transporters,Reactome,3,SLC39A7;SLC30A1;SLC39A14,17 (17),0.648,1,0,,1 (1),1,1,0.929,1
Regulation of RUNX1 Expression and Activity,Reactome,3,AGO2;PML;PTPN11,17 (17),0.648,1,0,,4 (4),1,1,0.929,1
Cell cycle,Wikipathways,17,BUB3;SKP1;SMC3;CUL1;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;STAG2;HDAC2;SMC1A;PCNA;ATM;RBX1;YWHAQ;RAD21,120 (120),0.929,1,0,,0 (0),1,1,0.929,1
Activation of RAS in B cells,Reactome,1,HRAS,5 (5),0.649,1,0,,2 (3),1,1,0.929,1
RHOT1 GTPase cycle,Reactome,1,RAP1GDS1,5 (5),0.649,1,0,,4 (4),1,1,0.929,1
Estrogen-stimulated signaling through PRKCZ,Reactome,1,HRAS,5 (5),0.649,1,0,,4 (4),1,1,0.929,1
glycerol degradation,HumanCyc,1,GPD2,5 (5),0.649,1,0,,9 (10),1,1,0.929,1
Trafficking of myristoylated proteins to the cilium,Reactome,1,ARL3,5 (5),0.649,1,0,,2 (2),1,1,0.929,1
Abacavir transmembrane transport,Reactome,1,SLC22A1,5 (5),0.649,1,0,,4 (4),1,1,0.929,1
Extrinsic Pathway of Fibrin Clot Formation,Reactome,1,F9,5 (5),0.649,1,0,,1 (1),1,1,0.929,1
NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake ,Reactome,1,RXRA,5 (5),0.649,1,0,,3 (4),1,1,0.929,1
Organic anion transport,Reactome,1,SLC22A7,5 (5),0.649,1,0,,8 (8),1,1,0.929,1
Vitamin B1 (thiamin) metabolism,Reactome,1,TPK1,5 (5),0.649,1,0,,9 (10),1,1,0.929,1
Activation of caspases through apoptosome-mediated cleavage,Reactome,1,CASP3,5 (5),0.649,1,0,,2 (2),1,1,0.929,1
Toxicity of botulinum toxin type D (botD),Reactome,1,VAMP2,5 (5),0.649,1,0,,1 (2),1,1,0.929,1
Synthesis of PI,Reactome,1,CDIPT,5 (5),0.649,1,0,,7 (10),1,1,0.929,1
Toxicity of botulinum toxin type F (botF),Reactome,1,VAMP2,5 (5),0.649,1,0,,1 (2),1,1,0.929,1
NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose,Reactome,1,RXRA,5 (5),0.649,1,0,,3 (4),1,1,0.929,1
Capecitabine Action Pathway,SMPDB,1,TYMP,5 (5),0.649,1,0,,9 (9),1,1,0.929,1
Capecitabine Metabolism Pathway,SMPDB,1,TYMP,5 (5),0.649,1,0,,9 (9),1,1,0.929,1
miRNA Biogenesis,Wikipathways,1,RAN,5 (5),0.649,1,0,,1 (1),1,1,0.929,1
Cilium Assembly,Reactome,32,TNPO1;MAPRE1;ACTR1A;PPP2R1A;TUBB4B;EXOC5;ARL3;GBF1;HDAC6;DCTN2;CSNK1D;DCTN3;PAFAH1B1;SSNA1;PRKACA;DYNLL2;CKAP5;DYNLRB1;CEP192;RAB8A;DCTN1;TRIP11;YWHAE;YWHAG;TUBA4A;DYNC1H1;DYNC1I2;RAB11A;HSP90AA1;ARF4;EXOC4;RAB11FIP3,178 (178),0.65,1,0,,6 (8),1,1,0.93,1
Melanoma,Wikipathways,12,HRAS;MAP2K1;BAX;ARAF;CDH1;PIK3R1;GRB2;VCL;RAC1;MAPK1;CALM1;MAP2K2,68 (68),0.65,1,0,,2 (5),1,1,0.93,1
Fibrin Complement Receptor 3 Signaling Pathway,Wikipathways,7,CD14;FGA;FGB;ITGB2;RHOA;FGG;PLG,40 (40),0.651,1,0,,1 (2),1,1,0.93,1
Cytosolic sensors of pathogen-associated DNA ,Reactome,7,XRCC5;RELA;XRCC6;LRRFIP1;STAT6;CTNNB1;DHX9,40 (40),0.651,1,0,,6 (10),1,1,0.93,1
Interleukin-2 family signaling,Reactome,7,SHC1;GRB2;PIK3R1;PTPN6;STAT3;STAT5B;LGALS9,40 (40),0.651,1,0,,2 (2),1,1,0.93,1
Neovascularisation processes,Wikipathways,3,MAPK1;HIF1A;KITLG,29 (29),0.931,1,0,,0 (0),1,1,0.931,1
Ribosome biogenesis in eukaryotes - Homo sapiens (human),KEGG,15,NOP56;GAR1;CSNK2A2;GTPBP4;SNU13;FBL;EIF6;RAN;EFL1;CSNK2A1;NOP58;XRN2;CSNK2B;XPO1;SBDS,108 (110),0.931,1,0,,0 (0),1,1,0.931,1
Glutamate Neurotransmitter Release Cycle,Reactome,4,GLS;VAMP2;PPFIA1;GLS2,23 (23),0.655,1,0,,8 (8),1,1,0.932,1
IKK complex recruitment mediated by RIP1,Reactome,4,CD14;UBE2D3;UBE2N;UBE2V1,23 (23),0.655,1,0,,1 (2),1,1,0.932,1
Adrenaline_noradrenaline inhibits insulin secretion,Reactome,4,GNG12;GNAI2;GNB1;GNB2,23 (23),0.655,1,0,,4 (4),1,1,0.932,1
Signaling by TGFB family members,Reactome,17,F11R;NEDD8;STRAP;USP15;FKBP1A;PPP1CA;PARP1;PPP1CC;UBE2M;UCHL5;RHOA;PPM1A;CGN;USP9X;PPP1CB;XPO1;SNW1,96 (96),0.655,1,0,,7 (8),1,1,0.932,1
ceramide <i>de novo</i> biosynthesis,HumanCyc,1,KDSR,7 (7),0.769,1,1,HMDB0004949,17 (20),0.856,1,0.933,1
Development of pulmonary dendritic cells and macrophage subsets,Wikipathways,1,STAT3,13 (13),0.934,1,0,,0 (0),1,1,0.934,1
BMAL1:CLOCK_NPAS2 activates circadian gene expression,Reactome,1,NAMPT,13 (13),0.934,1,0,,0 (0),1,1,0.934,1
p53 signaling pathway,BioCarta,1,PCNA,13 (13),0.934,1,0,,0 (0),1,1,0.934,1
activation of csk by camp-dependent protein kinase inhibits signaling through the t cell receptor,BioCarta,8,F2;PRKAR1A;PRKAR2A;AGT;GNAS;PRKACB;GNB1;CSK,46 (46),0.66,1,0,,5 (6),1,1,0.934,1
Citalopram Action Pathway,SMPDB,6,MAOA;MAOB;ATP1B3;ATP1B1;ATP1A1;AOX1,36 (36),0.698,1,1,HMDB0033934,26 (27),0.948,1,0.935,1
Downregulation of ERBB2 signaling,Reactome,5,HSP90AA1;EGFR;CDC37;USP8;CUL5,29 (29),0.663,1,0,,4 (4),1,1,0.935,1
Synthesis of IP3 and IP4 in the cytosol,Reactome,3,CALM1;PLD4;PLCB3,29 (29),0.931,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,11 (14),0.714,1,0.936,1
Buprenorphine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,1,HMDB0015057,11 (11),0.714,1,0.936,1
Mepivacaine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,1,HMDB0015096,11 (11),0.714,1,0.936,1
Tramadol Action Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,1,HMDB0014339,11 (11),0.714,1,0.936,1
Naltrexone Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,1,HMDB0014842,11 (11),0.714,1,0.936,1
Naloxone Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,1,HMDB0015314,11 (11),0.714,1,0.936,1
Chloroprocaine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,1,HMDB0015292,11 (11),0.714,1,0.936,1
Dibucaine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,1,HMDB0014668,11 (11),0.714,1,0.936,1
Propoxyphene Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,1,HMDB0014785,11 (11),0.714,1,0.936,1
Prilocaine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,1,HMDB0014888,11 (11),0.714,1,0.936,1
Protein digestion and absorption - Homo sapiens (human),KEGG,14,COL6A6;COL6A1;COL4A2;ATP1B1;COL18A1;COL6A2;DPP4;COL6A5;COL14A1;COL6A3;ATP1B3;ATP1A1;COL1A1;COL1A2,103 (103),0.938,1,4,HMDB0000123;HMDB0033934;HMDB0000687;HMDB0000172,44 (47),0.711,1,0.937,1
Glucocorticoid Receptor Pathway,Wikipathways,9,CUL1;PTGES3;RXRA;SERPINB9;CAVIN2;STOM;KTN1;HSP90AA1;NR3C1,71 (71),0.938,1,0,,0 (1),1,1,0.938,1
RAC1 GTPase cycle,Reactome,33,ARHGAP1;ARHGDIA;ARHGDIB;WASL;ESYT1;TAOK3;ABI1;CYFIP1;YKT6;GNA13;SWAP70;IQGAP2;BRK1;DOCK8;PIK3R1;FARP1;KTN1;PAK2;RAB7A;TMPO;ARHGAP17;CYFIP2;NCKAP1;CAV1;BAIAP2;LAMTOR1;FERMT2;CDC42;ITGB1;RAC1;IQGAP1;TFRC;FARP2,185 (185),0.67,1,0,,6 (6),1,1,0.938,1
Tat-mediated HIV elongation arrest and recovery,Reactome,6,ELOC;ELOB;SUPT5H;POLR2A;SSRP1;SUPT16H,35 (35),0.67,1,0,,4 (5),1,1,0.938,1
Pausing and recovery of Tat-mediated HIV elongation,Reactome,6,ELOC;ELOB;SUPT5H;POLR2A;SSRP1;SUPT16H,35 (35),0.67,1,0,,4 (5),1,1,0.938,1
RET signaling,Reactome,6,SHC1;GRB2;PRKCA;PTPN11;PRKACA;PRKACB,35 (35),0.67,1,0,,2 (2),1,1,0.938,1
Signaling mediated by p38-alpha and p38-beta,PID,6,GDI1;RAB5A;KRT8;HSPB1;MAPK14;EIF4E,35 (35),0.67,1,0,,1 (1),1,1,0.938,1
IGF-Core,Signalink,2,CDC42;IGF1,22 (22),0.939,1,0,,0 (0),1,1,0.939,1
role of brca1 brca2 and atr in cancer susceptibility,BioCarta,2,ATM;RAD50,22 (22),0.939,1,0,,0 (0),1,1,0.939,1
Amine ligand-binding receptors,Reactome,0,,43 (43),1,1,2,HMDB0015095;HMDB0015697,21 (29),0.676,1,0.941,1
Signaling by ERBB4,Reactome,10,SHC1;HRAS;EGFR;GRB2;YAP1;PIK3R1;NCSTN;ITCH;APOE;NEDD4,58 (58),0.677,1,0,,7 (9),1,1,0.941,1
Regulatory circuits of the STAT3 signaling pathway,Wikipathways,10,MAPK9;TRIM28;EGFR;MTOR;AKT1S1;STAT3;MAPK14;MAPK1;PTPRD;DEPTOR,78 (78),0.941,1,0,,0 (0),1,1,0.941,1
Inositol phosphate metabolism,INOH,7,INPP1;PIP4K2C;PI4KA;PLCB3;ISYNA1;IMPA1;IMPA2,41 (41),0.678,1,0,,19 (25),1,1,0.941,1
FCGR3A-mediated IL10 synthesis,Reactome,9,CALM1;LYN;PRKAR1A;YES1;PRKAR2A;IGHG1;ITPR2;PRKACA;PRKACB,121 (121),1,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,10 (13),0.679,1,0.942,1
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,Reactome,1,H2AX,70 (71),1,1,1,HMDB0000234,10 (11),0.679,1,0.942,1
heparan sulfate biosynthesis,HumanCyc,0,,29 (29),1,1,1,HMDB0000290,10 (10),0.679,1,0.942,1
mineralocorticoid biosynthesis,HumanCyc,0,,3 (3),1,1,1,HMDB0001547,10 (10),0.679,1,0.942,1
Cell-cell junction organization,Reactome,11,F11R;NECTIN2;CDH1;CDH2;CDH17;AFDN;JUP;CLDN3;CTNNA1;CTNNB1;CTNND1,64 (64),0.684,1,0,,1 (2),1,1,0.944,1
NO-cGMP-PKG mediated Neuroprotection,Wikipathways,8,CALM1;GUCY1A1;GUCY1B1;PPID;CNGA3;CAMK2A;CAMK2D;RELA,47 (47),0.685,1,0,,12 (15),1,1,0.944,1
Notch Signaling,Wikipathways,5,NCSTN;HDAC2;DTX3L;NUMB;CTBP1,45 (45),0.945,1,0,,0 (0),1,1,0.945,1
Cobalamin (Cbl_ vitamin B12) transport and metabolism,Reactome,3,MMAA;MMUT;MMAB,18 (18),0.688,1,0,,22 (29),1,1,0.945,1
Activation of NF-kappaB in B cells,Reactome,3,RELA;SKP1;CUL1,18 (18),0.688,1,0,,4 (5),1,1,0.945,1
G beta:gamma signalling through BTK,Reactome,3,GNG12;GNB1;GNB2,18 (18),0.688,1,0,,1 (1),1,1,0.945,1
Cyclin A/B1/B2 associated events during G2/M transition,Reactome,4,PPP2R2A;PPME1;PPP2CB;PPP2R1A,24 (24),0.69,1,0,,7 (8),1,1,0.946,1
RUNX3 regulates NOTCH signaling,Reactome,1,SNW1,14 (14),0.947,1,0,,0 (0),1,1,0.947,1
Repression of WNT target genes,Reactome,1,CTBP1,14 (14),0.947,1,0,,0 (0),1,1,0.947,1
Erythropoietin activates Phosphoinositide-3-kinase (PI3K),Reactome,2,LYN;PIK3R1,12 (12),0.692,1,0,,3 (4),1,1,0.947,1
Interleukin-2 signaling,Reactome,2,SHC1;STAT5B,12 (12),0.692,1,0,,2 (2),1,1,0.947,1
Activation of Ca-permeable Kainate Receptor,Reactome,2,CALM1;DLG1,12 (12),0.692,1,0,,3 (3),1,1,0.947,1
Ionotropic activity of kainate receptors,Reactome,2,CALM1;DLG1,12 (12),0.692,1,0,,4 (4),1,1,0.947,1
IRAK1 recruits IKK complex,Reactome,2,UBE2N;UBE2V1,12 (12),0.692,1,0,,2 (3),1,1,0.947,1
Cytochrome c-mediated apoptotic response,Reactome,2,MAPK1;CASP3,12 (12),0.692,1,0,,2 (2),1,1,0.947,1
TP53 Regulates Transcription of Caspase Activators and Caspases,Reactome,2,ATM;CASP6,12 (12),0.692,1,0,,2 (2),1,1,0.947,1
carm1 and regulation of the estrogen receptor,BioCarta,2,NR3C1;POLR2A,12 (12),0.692,1,0,,1 (1),1,1,0.947,1
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,Reactome,2,UBE2N;UBE2V1,12 (12),0.692,1,0,,2 (3),1,1,0.947,1
MicroRNA (miRNA) biogenesis,Reactome,2,AGO2;RAN,12 (12),0.692,1,0,,5 (6),1,1,0.947,1
Processive synthesis on the C-strand of the telomere,Reactome,2,DNA2;PCNA,19 (19),0.898,1,1,HMDB0001342,13 (17),0.772,1,0.947,1
Mismatch repair - Homo sapiens (human),KEGG,2,SSBP1;PCNA,23 (23),0.948,1,0,,0 (0),1,1,0.948,1
Cell cycle - Homo sapiens (human),KEGG,17,BUB3;SKP1;SMC3;CUL1;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;STAG2;HDAC2;SMC1A;PCNA;ATM;RBX1;YWHAQ;RAD21,124 (124),0.949,1,0,,0 (0),1,1,0.949,1
Toll-like Receptor Signaling related to MyD88,Wikipathways,3,TOLLIP;MAPK1;RELA,31 (31),0.949,1,0,,0 (0),1,1,0.949,1
Tumor suppressor activity of SMARCB1,Wikipathways,3,RBBP4;SMARCC2;ACTL6A,31 (31),0.949,1,0,,0 (0),1,1,0.949,1
SARS coronavirus and innate immunity,Wikipathways,3,DDX58;STAT2;MAVS,31 (31),0.949,1,0,,0 (0),1,1,0.949,1
IL12 signaling mediated by STAT4,PID,3,MAPK9;STAT3;STAT4,31 (31),0.949,1,0,,0 (0),1,1,0.949,1
tRNA modification in the nucleus and cytosol,Reactome,4,NSUN2;TPRKB;OSGEP;TP53RK,41 (41),0.964,1,2,HMDB0001495;HMDB0033934,23 (48),0.725,1,0.949,1
Mycophenolic Acid Metabolism Pathway,SMPDB,2,ABCC2;IMPDH2,16 (16),0.834,1,1,HMDB0060650,16 (16),0.838,1,0.949,1
PTEN Regulation,Reactome,16,CHD4;USP7;MTA2;LAMTOR4;RRAGC;RBBP4;LAMTOR1;MTOR;CSNK2A1;CSNK2A2;CSNK2B;AGO2;RHEB;HDAC2;LAMTOR2;NEDD4,93 (93),0.7,1,0,,11 (11),1,1,0.95,1
Signaling by ROBO receptors,Reactome,11,PFN1;RHOA;CDC42;PAK2;PRKAR2A;PRKCA;CAP1;NCK1;RAC1;PRKACA;PRKACB,65 (65),0.705,1,0,,6 (9),1,1,0.951,1
Carbamazepine Metabolism Pathway,SMPDB,1,EPHX1,8 (8),0.812,1,1,HMDB0060673,18 (19),0.871,1,0.952,1
Visual signal transduction: Rods,PID,1,GNB1,24 (24),0.993,1,1,HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,11 (13),0.714,1,0.953,1
Parkinson_s disease pathway,Wikipathways,12,CASP3;HTRA2;CASP6;UBE2J1;ATXN2;DDC;PARK7;UBA1;MAPK14;UBE2L3;UBE2G1;UBE2G2,71 (71),0.711,1,0,,3 (4),1,1,0.953,1
Fatty acids,Reactome,1,CYP4B1,15 (15),0.957,1,1,HMDB0001043,12 (14),0.745,1,0.954,1
Fc epsilon receptor (FCERI) signaling,Reactome,14,SHC1;HRAS;LYN;GRB2;PAK2;CALM1;PIK3R1;MAP2K4;RELA;MAPK9;RAC1;MAPK1;ITPR2;PPP3CA,150 (150),1,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,11 (16),0.714,1,0.954,1
Copper homeostasis,Wikipathways,9,CASP3;SCO1;STEAP3;STEAP4;CCS;MT2A;SOD1;ATOX1;ATP7B,54 (54),0.714,1,0,,1 (2),1,1,0.954,1
Pre-NOTCH Expression and Processing,Reactome,5,AGO2;ST3GAL6;ST3GAL4;SNW1;H2AX,107 (108),1,1,1,HMDB0000290,11 (12),0.714,1,0.954,1
Activated NTRK2 signals through FRS2 and FRS3,Reactome,1,PTPN11,6 (6),0.715,1,0,,2 (2),1,1,0.955,1
Activated NTRK2 signals through CDK5,Reactome,1,RAC1,6 (6),0.715,1,0,,4 (4),1,1,0.955,1
tRNA modification in the mitochondrion,Reactome,1,HSD17B10,6 (6),0.715,1,0,,4 (8),1,1,0.955,1
Mitochondrial Uncoupling,Reactome,1,PM20D1,6 (6),0.715,1,0,,3 (7),1,1,0.955,1
Replication of the SARS-CoV-1 genome,Reactome,1,DDX5,6 (6),0.715,1,0,,5 (11),1,1,0.955,1
Activated NTRK3 signals through PI3K,Reactome,1,PIK3R1,6 (6),0.715,1,0,,2 (2),1,1,0.955,1
Replication of the SARS-CoV-2 genome,Reactome,1,DDX5,6 (6),0.715,1,0,,5 (11),1,1,0.955,1
Interleukin-10 signaling,Reactome,1,STAT3,6 (6),0.715,1,0,,2 (2),1,1,0.955,1
Synthesis of Lipoxins (LX),Reactome,1,PTGR1,6 (6),0.715,1,0,,17 (20),1,1,0.955,1
GDP-fucose biosynthesis,Reactome,1,GFUS,6 (6),0.715,1,0,,15 (15),1,1,0.955,1
SARS-CoV-1 Genome Replication and Transcription,Reactome,1,DDX5,6 (6),0.715,1,0,,5 (11),1,1,0.955,1
SARS-CoV-2 Genome Replication and Transcription,Reactome,1,DDX5,6 (6),0.715,1,0,,5 (11),1,1,0.955,1
Glibenclamide Action Pathway,SMPDB,1,SLC2A2,6 (6),0.715,1,0,,4 (5),1,1,0.955,1
Gliclazide Action Pathway,SMPDB,1,SLC2A2,6 (6),0.715,1,0,,3 (5),1,1,0.955,1
Pancreas Function,SMPDB,1,SLC2A2,6 (6),0.715,1,0,,3 (4),1,1,0.955,1
Repaglinide Action Pathway,SMPDB,1,SLC2A2,6 (6),0.715,1,0,,4 (5),1,1,0.955,1
Nateglinide Action Pathway,SMPDB,1,SLC2A2,6 (6),0.715,1,0,,4 (5),1,1,0.955,1
Epithelial to mesenchymal transition in colorectal cancer,Wikipathways,28,COL4A2;JUP;VTN;HIF1A;MAPK14;FN1;PDCD6;STRAP;DSP;TJP1;PIK3R1;SHC1;HRAS;GRB2;PKP2;CTDSP1;CLDN3;MAPK1;CTNNB1;ITGA5;NUBPL;MAP2K4;MAP2K1;MAP2K2;MAP2K3;CDH1;CDH2;RBBP4,161 (161),0.716,1,0,,1 (1),1,1,0.955,1
Regulation of PTEN gene transcription,Reactome,10,MTA2;LAMTOR4;RBBP4;LAMTOR2;MTOR;CHD4;RRAGC;RHEB;HDAC2;LAMTOR1,60 (60),0.719,1,0,,8 (8),1,1,0.956,1
IL17 signaling pathway,Wikipathways,3,MAPK1;RELA;STAT3,32 (32),0.956,1,0,,0 (0),1,1,0.956,1
segmentation clock,BioCarta,2,CSNK2A1;CTNNB1,24 (24),0.957,1,0,,0 (0),1,1,0.957,1
COVID-19 adverse outcome pathway,Wikipathways,1,AGT,15 (15),0.957,1,0,,0 (0),1,1,0.957,1
TFs regulate miRNAs related to cardiac hypertrophy,Wikipathways,1,STAT3,15 (15),0.957,1,0,,0 (0),1,1,0.957,1
WNT ligand biogenesis and trafficking,Reactome,4,VPS35;VPS29;SNX3;VPS26A,25 (25),0.721,1,0,,2 (2),1,1,0.957,1
G beta:gamma signalling through PI3Kgamma,Reactome,4,GNG12;RHOA;GNB1;GNB2,25 (25),0.721,1,0,,3 (4),1,1,0.957,1
Regulation of PTEN stability and activity,Reactome,4,CSNK2A1;CSNK2A2;CSNK2B;NEDD4,25 (25),0.721,1,0,,5 (5),1,1,0.957,1
Termination of translesion DNA synthesis,Reactome,5,ISG15;TRIM25;USP10;POLE;PCNA,31 (31),0.722,1,0,,2 (4),1,1,0.957,1
role of mef2d in t-cell apoptosis,BioCarta,5,CAPN2;HDAC2;PPP3CA;CAPNS1;PRKCA,31 (31),0.722,1,0,,1 (1),1,1,0.957,1
Chondroitin sulfate/dermatan sulfate metabolism,Reactome,5,BGN;HEXB;ARSB;DCN;HEXA,50 (50),0.971,1,1,HMDB0000304,12 (24),0.745,1,0.958,1
Class C/3 (Metabotropic glutamate/pheromone receptors),Reactome,0,,40 (40),1,1,3,HMDB0015464;HMDB0036836;HMDB0033941,34 (54),0.724,1,0.958,1
NCAM1 interactions,Reactome,6,COL6A6;COL4A2;COL6A2;COL6A1;COL6A5;COL6A3,37 (37),0.724,1,0,,1 (3),1,1,0.958,1
HIV elongation arrest and recovery,Reactome,6,ELOC;ELOB;SUPT5H;POLR2A;SSRP1;SUPT16H,37 (37),0.724,1,0,,4 (5),1,1,0.958,1
Pausing and recovery of HIV elongation,Reactome,6,ELOC;ELOB;SUPT5H;POLR2A;SSRP1;SUPT16H,37 (37),0.724,1,0,,4 (5),1,1,0.958,1
Ephrin signaling,Reactome,3,MYL12A;PAK2;RAC1,19 (19),0.724,1,0,,4 (4),1,1,0.958,1
Wnt signaling pathway and pluripotency,Wikipathways,13,MAPK9;RHOA;PRKCA;PPP2CB;MAP2K4;CTBP1;PPP2R2A;PTPA;PPP2R1A;PAFAH1B1;PPP2R5E;CTNNB1;CTNND1,101 (101),0.958,1,0,,0 (1),1,1,0.958,1
TCR signaling in na&#xef;ve CD8+ T cells,PID,9,SHC1;HRAS;STIM1;CSK;PRKCA;PTPN6;RAP1A;B2M;GRB2,55 (55),0.735,1,0,,4 (4),1,1,0.961,1
NO metabolism in cystic fibrosis,Wikipathways,2,DDAH1;PRMT1,13 (13),0.735,1,0,,5 (9),1,1,0.961,1
Passive transport by Aquaporins,Reactome,2,AQP1;AQP8,13 (13),0.735,1,0,,8 (8),1,1,0.961,1
Irinotecan pathway,Wikipathways,2,NPC1;ABCC2,13 (13),0.735,1,0,,3 (4),1,1,0.961,1
Inhibition of replication initiation of damaged DNA by RB1/E2F1,Reactome,2,PPP2CB;PPP2R1A,13 (13),0.735,1,0,,2 (4),1,1,0.961,1
O2/CO2 exchange in erythrocytes,Reactome,2,SLC4A1;AQP1,13 (13),0.735,1,0,,9 (11),1,1,0.961,1
visual signal transduction,BioCarta,2,GNB1;SLC25A22,13 (13),0.735,1,0,,6 (6),1,1,0.961,1
DNA-PK pathway in nonhomologous end joining,PID,2,XRCC5;XRCC6,13 (13),0.735,1,0,,1 (1),1,1,0.961,1
Erythrocytes take up carbon dioxide and release oxygen,Reactome,2,SLC4A1;AQP1,13 (13),0.735,1,0,,9 (11),1,1,0.961,1
NF-kB is activated and signals survival,Reactome,2,RELA;SQSTM1,13 (13),0.735,1,0,,2 (2),1,1,0.961,1
Heroin Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,32 (32),0.956,1,1,HMDB0041812,13 (14),0.772,1,0.962,1
Visual signal transduction: Cones,PID,1,CNGA3,23 (23),0.992,1,1,HMDB0008431#HMDB0008065#HMDB0008658#HMDB0008129#HMDB0008800#HMDB0000564#HMDB0007886#HMDB0008691#HMDB0008522#HMDB0007940#HMDB0008145#HMDB0008400#HMDB0008401#HMDB0008768#HMDB0008002#HMDB0008324#HMDB0008322#HMDB0008304,12 (14),0.745,1,0.962,1
Nuclear Events (kinase and transcription factor activation),Reactome,10,PPP2CB;PPP2R1A;PPP2R5D;RPS6KA1;CHD4;DUSP3;FUS;MAPK14;DNM2;MAPK1,61 (61),0.739,1,0,,4 (4),1,1,0.962,1
FBXL10 enhancement of MAP-ERK signaling in diffuse large B-cell lymphoma,Wikipathways,3,MAPK1;MACROH2A1;H2AX,33 (33),0.963,1,0,,0 (0),1,1,0.963,1
Regulation of TP53 Activity,Reactome,28,MTA2;PPP2CB;PPP2R1A;TAF3;MAPK14;RBBP4;MTOR;PIP4K2C;CSNK2A1;CSNK2A2;CSNK2B;PIN1;PRKAA1;PRKAA2;PRKAB1;SUPT16H;USP7;PRKAG1;CHD4;PIP4P1;ATM;TP53RK;SSRP1;DNA2;TAF15;HDAC2;PML;RAD50,163 (163),0.74,1,0,,11 (15),1,1,0.963,1
Cancer immunotherapy by PD-1 blockade,Wikipathways,2,PTPN11;STAT3,25 (25),0.964,1,0,,0 (0),1,1,0.964,1
cell cycle: g1/s check point,BioCarta,2,ATM;DHFR,25 (25),0.964,1,0,,0 (0),1,1,0.964,1
Signaling by NOTCH,Reactome,16,ST3GAL6;EGFR;CUL1;H2AX;SKP1;NUMB;YWHAZ;AGO2;HDAC2;HIF1A;ST3GAL4;NCSTN;ITCH;RBX1;SNW1;HDAC6,189 (190),1,1,1,HMDB0000290,12 (13),0.745,1,0.964,1
SLC-mediated transmembrane transport,Reactome,28,SLC25A22;SLC22A18;SLC6A13;SLC26A1;SLC2A9;SLC25A4;SLC25A5;SLC16A1;SLC38A4;BSG;SLCO2B1;SLC27A1;SLCO2A1;SLC22A1;SLC43A1;SLC25A10;CP;ALB;SLC39A7;SLC39A14;SLC30A1;SLC30A10;SLC33A1;SLC29A1;SLC38A3;SLC22A7;SLC2A2;SLC4A1,243 (243),0.999,1,13,HMDB0000036;HMDB0000951;HMDB0240251;HMDB0000123;HMDB0000172;HMDB0000195;HMDB0000043;HMDB0000290;HMDB0015169;HMDB0000138;HMDB0015282;HMDB0000687;HMDB0000304,139 (164),0.746,1,0.964,1
Intraflagellar transport,Reactome,4,TRIP11;DYNLRB1;TNPO1;DYNLL2,41 (41),0.964,1,0,,0 (1),1,1,0.964,1
BMP receptor signaling,PID,4,MAPK1;PPP1CA;CTDSP1;PPM1A,41 (41),0.964,1,0,,0 (0),1,1,0.964,1
TLR4 Signaling and Tolerance,Wikipathways,1,TRAM1,16 (16),0.965,1,0,,0 (0),1,1,0.965,1
FOXO-mediated transcription of cell cycle genes,Reactome,1,CAV1,16 (16),0.965,1,0,,0 (0),1,1,0.965,1
bone remodeling,BioCarta,1,RELA,16 (16),0.965,1,0,,0 (0),1,1,0.965,1
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors,Reactome,1,EGFR,16 (16),0.965,1,0,,0 (0),1,1,0.965,1
miRNA regulation of p53 pathway in prostate cancer,Wikipathways,5,ATM;EI24;CASP3;BID;BAX,32 (32),0.748,1,0,,1 (2),1,1,0.965,1
Regulation of RAC1 activity,PID,6,RAP1GDS1;ARHGAP1;ARHGAP17;ARHGDIA;ABI1;RAC1,38 (38),0.748,1,0,,3 (3),1,1,0.965,1
Toll-like Receptor Signaling Pathway,Wikipathways,13,CD14;MAP2K1;MAP2K2;MAP2K3;MAPK9;TOLLIP;PIK3R1;MAP2K4;RELA;RAC1;MAPK14;FADD;MAPK1,103 (103),0.966,1,0,,0 (5),1,1,0.966,1
Platelet calcium homeostasis,Reactome,4,ATP2A2;ATP2B1;ITPR2;STIM1,26 (26),0.751,1,0,,6 (7),1,1,0.966,1
NOD-like receptor signaling pathway - Homo sapiens (human),KEGG,31,ATG5;RHOA;NAMPT;MAPK14;SUGT1;MAVS;GSDMD;MCU;NLRX1;MFN1;NEK7;FADD;MFN2;GABARAP;GBP2;DNM1L;BRCC3;HSP90AA1;RELA;PLCB3;CTSB;MAPK1;MAPK9;TXN2;YWHAE;STAT2;VDAC1;VDAC2;VDAC3;ITPR2;HSP90AB1,181 (181),0.755,1,0,,6 (6),1,1,0.967,1
Glycerophospholipid Biosynthetic Pathway,Wikipathways,0,,0 (0),1,1,1,HMDB0011148,30 (49),0.967,1,0.967,1
superpathway of D-<i>myo</i>-inositol (1_4_5)-trisphosphate metabolism,HumanCyc,3,IMPA1;INPP1;IMPA2,20 (20),0.757,1,0,,11 (11),1,1,0.968,1
3-phosphoinositide degradation,HumanCyc,3,PIP4P1;PMPCA;SACM1L,20 (20),0.757,1,0,,2 (5),1,1,0.968,1
PI3K-Akt signaling pathway - Homo sapiens (human),KEGG,62,PIK3AP1;COL6A1;COL6A2;COL6A3;PPP2R1A;HSP90B1;PPP2R5D;PPP2R5A;IGF1;VTN;CDC37;ITGA2B;KITLG;FN1;PPP2R5E;COL6A6;GNG12;EGFR;COL4A2;MTOR;PIK3R1;RPS6;ITGA5;GYS2;COL1A2;EIF4E;PRKAA1;PRKAA2;EIF4E2;HRAS;LAMA2;GRB2;PPP2CB;PRKCA;COL6A5;RELA;ITGA1;MAPK1;YWHAQ;GNB1;GNB2;ITGA9;PPP2R2A;MAP2K1;MAP2K2;ITGB1;YWHAB;ITGB3;YWHAE;YWHAG;YWHAH;YWHAZ;RXRA;PCK1;PCK2;LAMB2;PKN3;RAC1;HSP90AA1;RHEB;COL1A1;HSP90AB1,353 (354),0.757,1,0,,3 (4),1,1,0.968,1
Interleukin-1 family signaling,Reactome,11,MAP2K1;UBE2N;CUL1;UBE2V1;TOLLIP;SIGIRR;SQSTM1;MAP2K4;RELA;SKP1;RBX1,68 (68),0.761,1,0,,2 (5),1,1,0.969,1
Toll-like receptor signaling pathway - Homo sapiens (human),KEGG,13,CD14;FADD;MAP2K2;MAP2K3;MAPK9;TOLLIP;PIK3R1;MAP2K4;RELA;RAC1;MAPK14;MAP2K1;MAPK1,104 (104),0.969,1,0,,0 (0),1,1,0.969,1
Genotoxicity pathway,Wikipathways,7,SEL1L;EI24;TP53I3;RRM2B;NLRX1;RPS27;PRKAB1,64 (64),0.97,1,0,,0 (0),1,1,0.97,1
Endoderm differentiation,Wikipathways,8,RAB38;EPB41L5;MAP2K3;PABPC1;CAND1;CTNNB1;NR3C1;ELAVL1,71 (71),0.97,1,0,,0 (0),1,1,0.97,1
PIP3 activates AKT signaling,Reactome,33,MTA2;PIK3AP1;RHOG;PPP2CB;PPP2R1A;STRN;PPP2R5A;PPP2R5E;PPP2R5D;AGO2;LAMTOR2;KITLG;EGFR;LAMTOR4;RBBP4;MTOR;PIK3R1;CSNK2A1;CSNK2A2;CSNK2B;USP7;GRB2;CHD4;RRAGC;MAPK1;LAMTOR1;PIP4K2C;AKT1S1;RAC1;RHEB;HDAC2;NEDD4;PTPN11,218 (218),0.937,1,1,HMDB0000693,15 (21),0.819,1,0.971,1
SARS-CoV-2 and angiotensin-converting enzyme 2 receptor- molecular mechanisms,Wikipathways,1,AGT,7 (7),0.769,1,0,,2 (6),1,1,0.971,1
Reversal of alkylation damage by DNA dioxygenases,Reactome,1,ASCC3,7 (7),0.769,1,0,,9 (11),1,1,0.971,1
Lipoate metabolism,EHMN,1,SLC38A4,7 (7),0.769,1,0,,11 (12),1,1,0.971,1
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway,Reactome,1,LIG3,7 (7),0.769,1,0,,3 (6),1,1,0.971,1
Activation of NIMA Kinases NEK9_ NEK6_ NEK7,Reactome,1,NEK7,7 (7),0.769,1,0,,2 (2),1,1,0.971,1
Neurofascin interactions,Reactome,1,ANK1,7 (7),0.769,1,0,,2 (3),1,1,0.971,1
STING mediated induction of host immune responses,Reactome,1,STAT6,7 (7),0.769,1,0,,5 (8),1,1,0.971,1
DSCAM interactions,Reactome,1,RAC1,7 (7),0.769,1,0,,3 (3),1,1,0.971,1
Zinc efflux and compartmentalization by the SLC30 family,Reactome,1,SLC30A1,7 (7),0.769,1,0,,1 (1),1,1,0.971,1
Pyroptosis,Reactome,1,GSDMD,7 (7),0.769,1,0,,1 (5),1,1,0.971,1
Autodegradation of the E3 ubiquitin ligase COP1,Reactome,1,ATM,7 (7),0.769,1,0,,2 (2),1,1,0.971,1
Synthesis of DNA,Reactome,6,DNA2;SKP1;CUL1;POLE;PCNA;RBX1,76 (76),0.998,1,1,HMDB0001342,13 (15),0.772,1,0.971,1
JAK STAT MolecularVariation 2,INOH,5,STAT5B;STAT6;STAT2;STAT3;STAT4,50 (50),0.971,1,0,,0 (0),1,1,0.971,1
SUMOylation of DNA methylation proteins,Reactome,1,UBE2I,17 (17),0.971,1,0,,0 (0),1,1,0.971,1
SRF and miRs in Smooth Muscle Differentiation and Proliferation,Wikipathways,1,CAMK2D,17 (17),0.971,1,0,,0 (0),1,1,0.971,1
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,Reactome,6,SMARCA2;SMARCC2;CSNK2A1;CSNK2A2;CSNK2B;ACTL6A,39 (39),0.771,1,0,,2 (2),1,1,0.972,1
Synthesis And Processing Of GAG_ GAGPOL Polyproteins,Reactome,2,VPS28;TSG101,14 (14),0.772,1,0,,2 (2),1,1,0.972,1
Regulation of IFNG signaling,Reactome,2,PTPN6;PTPN11,14 (14),0.772,1,0,,2 (2),1,1,0.972,1
Adenylate cyclase inhibitory pathway,Reactome,2,GNAI2;GNAI3,14 (14),0.772,1,0,,4 (4),1,1,0.972,1
Removal of the Flap Intermediate,Reactome,2,DNA2;PCNA,14 (14),0.772,1,0,,4 (6),1,1,0.972,1
Membrane binding and targetting of GAG proteins,Reactome,2,VPS28;TSG101,14 (14),0.772,1,0,,2 (2),1,1,0.972,1
stress induction of hsp regulation,BioCarta,2,HSPB1;CASP3,14 (14),0.772,1,0,,1 (1),1,1,0.972,1
Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4),Wikipathways,5,CAV1;TPM3;EGFR;NR3C1;EIF4E,33 (33),0.773,1,0,,2 (3),1,1,0.972,1
Trichlormethiazide Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,8 (9),1,1,0.972,1
Hydrochlorothiazide Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,8 (9),1,1,0.972,1
Polythiazide Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,8 (9),1,1,0.972,1
Methyclothiazide Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,8 (9),1,1,0.972,1
Furosemide Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,8 (9),1,1,0.972,1
Ethacrynic Acid Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,7 (9),1,1,0.972,1
Indapamide Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,7 (9),1,1,0.972,1
Cyclothiazide Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,8 (9),1,1,0.972,1
Bumetanide Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,7 (9),1,1,0.972,1
Spironolactone Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,8 (9),1,1,0.972,1
Eplerenone Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,8 (9),1,1,0.972,1
Triamterene Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,8 (9),1,1,0.972,1
Amiloride Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,8 (9),1,1,0.972,1
Quinethazone Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,8 (9),1,1,0.972,1
Bendroflumethiazide Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,8 (9),1,1,0.972,1
Chlorthalidone Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,7 (9),1,1,0.972,1
Iminoglycinuria,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,7 (8),1,1,0.972,1
Blue diaper syndrome,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,7 (8),1,1,0.972,1
Lysinuric protein intolerance (LPI),SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,7 (8),1,1,0.972,1
Cystinuria,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,7 (8),1,1,0.972,1
Torsemide Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,7 (9),1,1,0.972,1
Hartnup Disorder,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,7 (8),1,1,0.972,1
Glucose Transporter Defect (SGLT2),SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,7 (8),1,1,0.972,1
Kidney Function,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,7 (8),1,1,0.972,1
Glucose Transporter Defect (SGLT2),SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,7 (8),1,1,0.972,1
Metolazone Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,7 (9),1,1,0.972,1
Hydroflumethiazide Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,8 (9),1,1,0.972,1
Chlorothiazide Action Pathway,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,8 (9),1,1,0.972,1
Lysinuric Protein Intolerance,SMPDB,5,ATP1B1;ATP1B3;ATP1A1;AQP1;SLC38A4,33 (33),0.773,1,0,,7 (8),1,1,0.972,1
TNF signaling pathway - Homo sapiens (human),KEGG,14,MAPK9;FADD;MAP2K3;DNM1L;MAP2K1;PIK3R1;MAP2K4;MAPK14;RELA;ICAM1;CASP3;ITCH;MAPK1;PGAM5,112 (112),0.973,1,0,,0 (0),1,1,0.973,1
Transcriptional regulation of granulopoiesis,Reactome,4,RXRA;DEK;PML;STAT3,27 (27),0.778,1,0,,1 (1),1,1,0.973,1
Kinesins,Reactome,4,KLC4;KIF13B;KIF1C;KIF5B,43 (43),0.973,1,0,,0 (1),1,1,0.973,1
Glycosaminoglycan metabolism,Reactome,17,GLB1;HEXA;DCN;PAPSS2;ST3GAL6;CHP1;PRELP;GUSB;SLC26A1;ST3GAL4;HEXB;STAB2;BGN;ARSB;LUM;NAGLU;GNS,119 (119),0.924,1,2,HMDB0000290;HMDB0000304,30 (60),0.849,1,0.975,1
DNA Repair,Reactome,45,CUL4B;CUL4A;LIG3;USP7;PARP1;PCNA;TRIM25;PPP4C;BABAM1;PPP5C;UBE2I;ISG15;UBE2N;COPS8;POLE;POLR2A;UFD1;COPS4;H2AX;APEX1;USP10;PRPF19;BRCC3;COPS3;GPS1;ATM;UBXN1;ASCC3;XRCC5;DNA2;COPS6;COPS2;BABAM2;DDB1;COPS5;UBE2V2;NPLOC4;XRCC6;RAD23A;VCP;RBX1;RAD23B;COPS7A;KPNA2;RAD50,322 (323),0.992,1,3,HMDB0001342;HMDB0001178;HMDB0011600,38 (54),0.791,1,0.975,1
Signaling by Interleukins,Reactome,41,CUL1;PPP2CB;PPP2R1A;MAP2K4;PPP2R5D;PTPN11;MAPK14;STX4;UBE2N;UBE2V1;P4HB;SIGIRR;STAT3;SQSTM1;PIK3R1;RPS6KA1;CANX;PRKACA;DUSP3;SHC1;CASP3;GRB2;TOLLIP;STAT4;RELA;FUS;MAPK1;STAT6;MAPK9;LYN;SKP1;YES1;MAP2K3;PTPN6;MAP2K1;YWHAZ;CRK;CRKL;STAT5B;RBX1;LGALS9,240 (240),0.786,1,0,,4 (7),1,1,0.975,1
Extension of Telomeres,Reactome,6,GAR1;DNA2;PPP6C;ANKRD28;PCNA;PPP6R3,51 (51),0.938,1,1,HMDB0001342,16 (20),0.838,1,0.975,1
HS-GAG degradation,Reactome,3,GLB1;NAGLU;GUSB,21 (21),0.787,1,0,,10 (22),1,1,0.975,1
Downregulation of SMAD2/3:SMAD4 transcriptional activity,Reactome,3,PPM1A;PARP1;USP9X,21 (21),0.787,1,0,,4 (4),1,1,0.975,1
PCNA-Dependent Long Patch Base Excision Repair,Reactome,3,APEX1;POLE;PCNA,21 (21),0.787,1,0,,1 (3),1,1,0.975,1
Desipramine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,30 (30),0.941,1,1,HMDB0015282,16 (16),0.838,1,0.976,1
Microglia Pathogen Phagocytosis Pathway,Wikipathways,6,LYN;ITGB2;ARPC1B;PTPN6;RAC1;PIK3R1,40 (40),0.793,1,0,,2 (2),1,1,0.977,1
cdk regulation of dna replication,BioCarta,1,KITLG,18 (18),0.977,1,0,,0 (0),1,1,0.977,1
Genes targeted by miRNAs in adipocytes,Wikipathways,1,IGF1,18 (18),0.977,1,0,,0 (0),1,1,0.977,1
WNT-Core,Signalink,4,CTNNB1;RPS6KA1;CSNK1D;PRKACA,44 (44),0.977,1,0,,0 (0),1,1,0.977,1
Notch signaling pathway - Homo sapiens (human),KEGG,6,NUMB;CTBP1;DTX3L;NCSTN;HDAC2;SNW1,59 (59),0.977,1,0,,0 (0),1,1,0.977,1
DNA Replication,Reactome,6,DNA2;SKP1;CUL1;POLE;PCNA;RBX1,81 (81),0.999,1,1,HMDB0001342,14 (17),0.797,1,0.978,1
NOD1/2 Signaling Pathway,Reactome,5,MAPK14;ITCH;UBE2N;AAMP;UBE2V1,34 (34),0.796,1,0,,2 (5),1,1,0.978,1
Staphylococcus aureus infection - Homo sapiens (human),KEGG,11,CFI;CFH;FCGR2B;ITGB2;ICAM1;C3;C4A;CFB;C5;FGG;PLG,94 (96),0.978,1,0,,0 (2),1,1,0.978,1
Mineralocorticoid biosynthesis,Reactome,0,,4 (4),1,1,1,HMDB0001547,14 (14),0.797,1,0.978,1
Imipramine Action Pathway,SMPDB,4,CYP1A2;ATP1B1;ATP1B3;ATP1A1,33 (33),0.894,1,1,HMDB0015282,20 (20),0.898,1,0.979,1
Processive synthesis on the lagging strand,Reactome,2,DNA2;PCNA,15 (15),0.805,1,0,,4 (6),1,1,0.98,1
Interleukin-4 and Interleukin-13 signaling,Reactome,2,STAT6;STAT3,15 (15),0.805,1,0,,2 (2),1,1,0.98,1
Response to metal ions,Reactome,2,CSRP1;MT2A,15 (15),0.805,1,0,,3 (4),1,1,0.98,1
Inflammasomes,Reactome,2,HSP90AB1;SUGT1,15 (15),0.805,1,0,,2 (5),1,1,0.98,1
Nicotine Action Pathway,SMPDB,5,FMO3;ATP1A1;ATP1B3;AOX1;ATP1B1,36 (36),0.836,1,1,HMDB0001497,29 (31),0.963,1,0.98,1
Cell Cycle Checkpoints,Reactome,42,MAPRE1;PPP2CB;PPP2R1A;RANBP2;ATM;PPP2R5A;PPP2R5D;PPP2R5E;NDEL1;BABAM1;UBE2N;UBE2V2;PAFAH1B1;DYNLL2;NUP98;CKAP5;NUP133;H2AX;DYNC1LI1;BRCC3;RPS27;XPO1;YWHAQ;ZW10;BUB3;DNA2;NUDC;RANGAP1;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;NUP160;RCC2;DYNC1H1;DYNC1I2;DYNC1LI2;RAD50;SEC13;PPP1CC;BABAM2,248 (249),0.806,1,0,,3 (5),1,1,0.98,1
Ion channel transport,Reactome,23,ATP6V1A;ATP6V1B2;ATP6V0C;ATP6V1C1;ATP6V1E1;ATP6V1H;ATP6V0A1;ATP6AP1;ATP6V0D1;ATP7B;ATP13A1;ATP6V1D;TCIRG1;ATP6V1G1;ANO10;ATP1A1;ATP1B1;ATP1B3;FXYD1;ATP2A2;ATP2B1;STOM;UNC79,165 (165),0.962,1,1,HMDB0008843#HMDB0009152#HMDB0009150#HMDB0009363#HMDB0009557#HMDB0009556#HMDB0009571#HMDB0008976#HMDB0008974,16 (22),0.838,1,0.98,1
Overview of interferons-mediated signaling pathway,Wikipathways,3,PRKCA;STAT2;PIK3R1,37 (37),0.98,1,0,,0 (0),1,1,0.98,1
ATR signaling pathway,PID,3,YWHAB;PPP2R1A;YWHAZ,37 (37),0.98,1,0,,0 (0),1,1,0.98,1
Validated transcriptional targets of AP1 family members Fra1 and Fra2,PID,3,DCN;HMOX1;COL1A2,37 (37),0.98,1,0,,0 (0),1,1,0.98,1
Notch signaling pathway,PID,8,ENO1;NUMB;EPS15;CTBP1;MYCBP;ITCH;NCSTN;RAB11A,53 (53),0.808,1,0,,1 (1),1,1,0.98,1
Formation of HIV-1 elongation complex containing HIV-1 Tat,Reactome,7,ELOC;ELOB;SUPT5H;NCBP1;POLR2A;SSRP1;SUPT16H,47 (47),0.81,1,0,,2 (3),1,1,0.981,1
Tat-mediated elongation of the HIV-1 transcript,Reactome,7,ELOC;ELOB;SUPT5H;NCBP1;POLR2A;SSRP1;SUPT16H,47 (47),0.81,1,0,,5 (6),1,1,0.981,1
HIV Transcription Elongation,Reactome,7,ELOC;ELOB;SUPT5H;NCBP1;POLR2A;SSRP1;SUPT16H,47 (47),0.81,1,0,,5 (6),1,1,0.981,1
NR1H2 and NR1H3-mediated signaling,Reactome,7,UGT1A3;RXRA;PCK1;FASN;APOC2;AGO2;APOE,47 (47),0.81,1,0,,3 (4),1,1,0.981,1
Hypothetical Craniofacial Development Pathway,Wikipathways,1,RHOA,8 (8),0.812,1,0,,2 (2),1,1,0.981,1
DNA Damage Reversal,Reactome,1,ASCC3,8 (8),0.812,1,0,,10 (12),1,1,0.981,1
RUNX2 regulates genes involved in cell migration,Reactome,1,ITGA5,8 (8),0.812,1,0,,2 (2),1,1,0.981,1
AMPK inhibits chREBP transcriptional activation activity,Reactome,1,PRKAA2,8 (8),0.812,1,0,,3 (3),1,1,0.981,1
Transport of fatty acids,Reactome,1,SLC27A1,8 (8),0.812,1,0,,9 (10),1,1,0.981,1
Netrin mediated repulsion signals,Reactome,1,PTPN11,8 (8),0.812,1,0,,2 (2),1,1,0.981,1
Role of ABL in ROBO-SLIT signaling,Reactome,1,CAP1,8 (8),0.812,1,0,,2 (2),1,1,0.981,1
Ifosfamide Action Pathway,SMPDB,1,ALDH1A1,8 (8),0.812,1,0,,21 (22),1,1,0.981,1
Celecoxib Metabolism Pathway,SMPDB,1,PTGS1,8 (8),0.812,1,0,,10 (11),1,1,0.981,1
Nevirapine Metabolism Pathway,SMPDB,1,ALDH1A1,8 (8),0.812,1,0,,15 (15),1,1,0.981,1
Ifosfamide Metabolism Pathway,SMPDB,1,ALDH1A1,8 (8),0.812,1,0,,21 (22),1,1,0.981,1
Hematopoietic Stem Cell Gene Regulation by GABP alpha-beta Complex,Wikipathways,1,ATM,19 (19),0.981,1,0,,0 (0),1,1,0.981,1
TAK1 activates NFkB by phosphorylation and activation of IKKs complex,Reactome,3,RELA;UBE2N;UBE2V1,22 (22),0.813,1,0,,2 (5),1,1,0.981,1
Type II diabetes mellitus,Wikipathways,3,SLC2A2;MTOR;MAPK1,22 (22),0.813,1,0,,4 (4),1,1,0.981,1
G2/M DNA damage checkpoint,Reactome,15,DNA2;UBE2N;H2AX;UBE2V2;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;BRCC3;BABAM2;ATM;YWHAQ;BABAM1;RAD50,95 (96),0.815,1,0,,3 (4),1,1,0.982,1
Hippo signaling pathway - multiple species - Homo sapiens (human),KEGG,2,MOB1A;YAP1,29 (29),0.982,1,0,,0 (0),1,1,0.982,1
Activation of Matrix Metalloproteinases,Reactome,2,KLKB1;PLG,29 (29),0.982,1,0,,0 (0),1,1,0.982,1
Chromatin modifying enzymes,Reactome,16,SMARCA2;ELP3;ELP1;RBBP4;SMARCC2;PRMT1;ELP2;RUVBL2;RELA;MTA2;CHD4;ACTL6A;KAT8;HDAC2;ACTB;RUVBL1,271 (271),1,1,1,HMDB0033934,15 (17),0.819,1,0.982,1
Chromatin organization,Reactome,16,SMARCA2;ELP3;ELP1;RBBP4;SMARCC2;PRMT1;ELP2;RUVBL2;RELA;MTA2;CHD4;ACTL6A;KAT8;HDAC2;ACTB;RUVBL1,271 (271),1,1,1,HMDB0033934,15 (17),0.819,1,0.982,1
Gap-filling DNA repair synthesis and ligation in TC-NER,Reactome,10,CUL4B;CUL4A;DDB1;PRPF19;LIG3;USP7;POLE;POLR2A;PCNA;RBX1,66 (66),0.823,1,0,,1 (3),1,1,0.983,1
DNA Double Strand Break Response,Reactome,12,PPP5C;UBE2I;UBE2N;H2AX;UBE2V2;BABAM2;BRCC3;KPNA2;ATM;UBXN1;BABAM1;RAD50,78 (79),0.824,1,0,,9 (10),1,1,0.984,1
TRAF6 mediated IRF7 activation,Reactome,4,TRIM25;DDX58;RNF135;MAVS,29 (29),0.824,1,0,,2 (5),1,1,0.984,1
nfkb activation by nontypeable hemophilus influenzae,BioCarta,4,MAPK14;RELA;NR3C1;MAP2K3,29 (29),0.824,1,0,,1 (1),1,1,0.984,1
Calcium signaling in the CD4+ TCR pathway,PID,4,FKBP1A;CALM1;CHP1;PRKACA,29 (29),0.824,1,0,,1 (2),1,1,0.984,1
Retinoblastoma gene in cancer,Wikipathways,10,RRM1;SMARCA2;SMC3;RBBP4;PCNA;POLE;SMC1A;FAF1;DHFR;RBP1,90 (90),0.984,1,0,,0 (0),1,1,0.984,1
NOTCH1 Intracellular Domain Regulates Transcription,Reactome,7,SKP1;CUL1;RBX1;HDAC6;HIF1A;HDAC2;SNW1,48 (48),0.827,1,0,,2 (2),1,1,0.984,1
Nucleotide-binding domain_ leucine rich repeat containing receptor (NLR) signaling pathways,Reactome,7,UBE2N;UBE2V1;AAMP;HSP90AB1;MAPK14;ITCH;SUGT1,48 (48),0.827,1,0,,3 (7),1,1,0.984,1
cAMP signaling pathway - Homo sapiens (human),KEGG,34,RHOA;RRAS2;RAP1A;RAP1B;CAMK2A;MAPK1;MYL9;CALM1;PIK3R1;CAMK2D;ACOX1;PRKACA;PRKACB;MAPK9;AFDN;ROCK1;RELA;GNAI2;GNAI3;MAP2K1;GNAS;ATP1A1;ATP1B1;ATP1B3;FXYD1;MAP2K2;ATP2A2;ATP2B1;CNGA3;ACOX3;RAC1;PPP1CA;PPP1CB;PPP1CC,216 (216),0.901,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,22 (25),0.919,1,0.984,1
SUMOylation of transcription factors,Reactome,1,UBE2I,20 (20),0.985,1,0,,0 (0),1,1,0.985,1
NOTCH3 Intracellular Domain Regulates Transcription,Reactome,1,SNW1,20 (20),0.985,1,0,,0 (0),1,1,0.985,1
Telomere C-strand (Lagging Strand) Synthesis,Reactome,2,DNA2;PCNA,35 (35),0.994,1,1,HMDB0001342,16 (20),0.838,1,0.985,1
Caspase activation via Death Receptors in the presence of ligand,Reactome,2,CD14;FADD,16 (16),0.834,1,0,,1 (1),1,1,0.985,1
Elevation of cytosolic Ca2+ levels,Reactome,2,STIM1;ITPR2,16 (16),0.834,1,0,,5 (6),1,1,0.985,1
p75NTR signals via NF-kB,Reactome,2,RELA;SQSTM1,16 (16),0.834,1,0,,2 (3),1,1,0.985,1
Synthesis of PIPs at the early endosome membrane,Reactome,2,PIK3R4;VAC14,16 (16),0.834,1,0,,8 (16),1,1,0.985,1
LPA4-mediated signaling events,PID,2,GNAS;PRKACA,16 (16),0.834,1,0,,1 (1),1,1,0.985,1
Acyl chain remodelling of PI,Reactome,2,MBOAT7;PLBD1,16 (16),0.834,1,0,,3 (8),1,1,0.985,1
Removal of the Flap Intermediate from the C-strand,Reactome,2,DNA2;PCNA,16 (16),0.834,1,0,,4 (6),1,1,0.985,1
NRIF signals cell death from the nucleus,Reactome,2,NCSTN;SQSTM1,16 (16),0.834,1,0,,2 (2),1,1,0.985,1
Codeine and Morphine Metabolism,Wikipathways,2,UGT1A3;ABCC2,16 (16),0.834,1,0,,7 (7),1,1,0.985,1
Hematopoietic cell lineage - Homo sapiens (human),KEGG,11,CD14;ANPEP;CR1L;CD59;ITGB3;CD38;ITGA5;ITGA1;ITGA2B;TFRC;KITLG,98 (99),0.986,1,0,,0 (0),1,1,0.986,1
Methadone Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,36 (36),0.977,1,1,HMDB0014477,17 (17),0.856,1,0.986,1
Metalloprotease DUBs,Reactome,5,BRCC3;BABAM2;ABRAXAS2;PSMD14;BABAM1,36 (36),0.836,1,0,,1 (2),1,1,0.986,1
Regulation of TP53 Degradation,Reactome,5,ATM;USP7;MTOR;PPP2CB;PPP2R1A,36 (36),0.836,1,0,,5 (6),1,1,0.986,1
TGF-beta Receptor Signaling,Wikipathways,5,FKBP1A;MAPK9;CTNNB1;STAT3;HRAS,55 (55),0.986,1,0,,0 (0),1,1,0.986,1
Regulation of RAS by GAPs,Reactome,3,HRAS;RBX1;CUL3,23 (23),0.837,1,0,,2 (2),1,1,0.986,1
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,Reactome,3,TNKS1BP1;CNOT1;NPM1,23 (23),0.837,1,0,,2 (2),1,1,0.986,1
Abortive elongation of HIV-1 transcript in the absence of Tat,Reactome,3,NCBP1;POLR2A;SUPT5H,23 (23),0.837,1,0,,4 (5),1,1,0.986,1
Inositol phosphate metabolism - Homo sapiens (human),KEGG,11,ALDH6A1;INPP1;PIP4K2C;PI4KA;PLCB3;ISYNA1;CDIPT;SACM1L;IMPA1;IMPA2;TPI1,73 (73),0.837,1,0,,25 (47),1,1,0.986,1
Regulation of toll-like receptor signaling pathway,Wikipathways,18,CD14;USP7;MAP2K1;MAP2K2;MAP2K3;MAPK9;TOLLIP;SIGIRR;SQSTM1;PIK3R1;MAP2K4;PTPN6;RELA;TMED7;RAC1;MAPK14;FADD;MAPK1,145 (145),0.986,1,0,,0 (2),1,1,0.986,1
Telomere Maintenance,Reactome,7,PPP6C;DNA2;H2AX;GAR1;ANKRD28;PCNA;PPP6R3,104 (105),1,1,1,HMDB0001342,16 (21),0.838,1,0.986,1
Chromosome Maintenance,Reactome,10,PPP6C;DNA2;NPM1;H2AX;GAR1;RBBP4;ANKRD28;PCNA;PPP6R3;RUVBL1,133 (134),1,1,1,HMDB0001342,16 (22),0.838,1,0.986,1
S Phase,Reactome,12,DNA2;SKP1;SMC3;CUL1;PDS5B;PDS5A;STAG2;POLE;SMC1A;PCNA;RBX1;RAD21,104 (104),0.984,1,1,HMDB0001342,17 (21),0.856,1,0.987,1
superpathway of inositol phosphate compounds,HumanCyc,8,PIK3R4;PIK3R1;PI4KA;PLCB3;CDIPT;PIP4P1;SACM1L;PIP4K2C,70 (70),0.967,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,18 (26),0.871,1,0.987,1
Formation of HIV elongation complex in the absence of HIV Tat,Reactome,7,ELOC;ELOB;SUPT5H;NCBP1;POLR2A;SSRP1;SUPT16H,49 (49),0.843,1,0,,2 (3),1,1,0.987,1
Inositol phosphate metabolism,Reactome,7,CALM1;INPP1;PLCB3;ISYNA1;PLD4;IMPA1;IMPA2,51 (51),0.871,1,1,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112,31 (44),0.971,1,0.988,1
Tight junction interactions,Reactome,2,F11R;CLDN3,31 (31),0.988,1,0,,0 (0),1,1,0.988,1
Multifunctional anion exchangers,Reactome,1,SLC26A1,9 (9),0.848,1,0,,8 (10),1,1,0.988,1
RHO GTPases Activate Rhotekin and Rhophilins,Reactome,1,RHOA,9 (9),0.848,1,0,,1 (1),1,1,0.988,1
Bicarbonate transporters,Reactome,1,SLC4A1,9 (9),0.848,1,0,,3 (4),1,1,0.988,1
signal dependent regulation of myogenesis by corepressor mitr,BioCarta,1,YWHAH,9 (9),0.848,1,0,,1 (1),1,1,0.988,1
Regulation of FOXO transcriptional activity by acetylation,Reactome,1,SIRT3,9 (9),0.848,1,0,,4 (6),1,1,0.988,1
p75NTR recruits signalling complexes,Reactome,1,SQSTM1,9 (9),0.848,1,0,,2 (3),1,1,0.988,1
EGFR interacts with phospholipase C-gamma,Reactome,1,EGFR,9 (9),0.848,1,0,,2 (2),1,1,0.988,1
no2-dependent il-12 pathway in nk cells,BioCarta,1,STAT4,9 (9),0.848,1,0,,3 (3),1,1,0.988,1
Thyroid hormone synthesis,SMPDB,1,DUOX1,9 (9),0.848,1,0,,13 (13),1,1,0.988,1
Lung fibrosis,Wikipathways,6,DSP;SERPINA1;MT2A;IGF1;HMOX1;DPP9,64 (64),0.988,1,0,,0 (1),1,1,0.988,1
Transcriptional regulation by small RNAs,Reactome,17,RAE1;NUP98;NUP133;AGO2;H2AX;TPR;RAN;RANBP2;POLR2A;NUP35;NUP93;NUP210;NUP58;NUP160;SEC13;NUP205;NUP155,110 (111),0.852,1,0,,1 (3),1,1,0.988,1
Zinc homeostasis,Wikipathways,5,SLC30A10;SLC39A7;SLC30A1;SLC39A14;MT2A,37 (37),0.853,1,0,,1 (1),1,1,0.989,1
Hedgehog _on_ state,Reactome,5,ITCH;NUMB;CSNK1A1;CUL3;RBX1,37 (37),0.853,1,0,,2 (2),1,1,0.989,1
Regulation of TP53 Expression and Degradation,Reactome,5,ATM;USP7;MTOR;PPP2CB;PPP2R1A,37 (37),0.853,1,0,,5 (6),1,1,0.989,1
Synthesis of Dolichyl-phosphate,Reactome,0,,6 (6),1,1,1,HMDB0001090,17 (19),0.856,1,0.989,1
Simplified Depiction of MYD88 Distinct Input-Output Pathway,Wikipathways,2,UBE2N;UBE2V1,17 (17),0.859,1,0,,1 (1),1,1,0.989,1
ACE Inhibitor Pathway,Wikipathways,2,KNG1;AGT,17 (17),0.859,1,0,,6 (10),1,1,0.989,1
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA,Reactome,2,YWHAB;EXOSC6,17 (17),0.859,1,0,,2 (3),1,1,0.989,1
Acetylcholine Neurotransmitter Release Cycle,Reactome,2,VAMP2;PPFIA1,17 (17),0.859,1,0,,7 (7),1,1,0.989,1
Assembly Of The HIV Virion,Reactome,2,VPS28;TSG101,17 (17),0.859,1,0,,2 (3),1,1,0.989,1
WNT-Ncore,Signalink,2,YWHAB;MACF1,32 (32),0.99,1,0,,0 (0),1,1,0.99,1
TGF-beta signaling pathway - Homo sapiens (human),KEGG,10,DCN;RHOA;SKP1;CUL1;PPP2CB;ROCK1;PPP2R1A;HAMP;RBX1;MAPK1,94 (94),0.99,1,0,,0 (0),1,1,0.99,1
Apoptosis,Wikipathways,9,CASP3;BAX;CASP6;PIK3R1;MAP2K4;RELA;IGF1;FADD;BID,87 (87),0.99,1,0,,0 (0),1,1,0.99,1
pyrimidine deoxyribonucleosides salvage,HumanCyc,0,,5 (5),1,1,2,HMDB0001342;HMDB0000189,31 (31),0.861,1,0.99,1
Inactivation of APC/C via direct inhibition of the APC/C complex,Reactome,1,BUB3,22 (22),0.99,1,0,,0 (0),1,1,0.99,1
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,Reactome,1,BUB3,22 (22),0.99,1,0,,0 (0),1,1,0.99,1
Cyclin D associated events in G1,Reactome,6,LYN;SKP1;CUL1;PPP2CB;PPP2R1A;PPP2R2A,44 (44),0.863,1,0,,4 (4),1,1,0.99,1
G1 Phase,Reactome,6,LYN;SKP1;CUL1;PPP2CB;PPP2R1A;PPP2R2A,44 (44),0.863,1,0,,4 (4),1,1,0.99,1
Nonhomologous End-Joining (NHEJ),Reactome,10,XRCC5;UBE2N;H2AX;UBE2V2;BABAM2;BRCC3;XRCC6;ATM;BABAM1;RAD50,69 (70),0.863,1,0,,4 (7),1,1,0.99,1
rRNA processing in the nucleus and cytosol,Reactome,8,NOP56;GAR1;RPS14;SNU13;FBL;NOP58;RPS6;RPS9,57 (58),0.868,1,0,,3 (11),1,1,0.991,1
rRNA modification in the nucleus and cytosol,Reactome,8,NOP56;GAR1;RPS14;SNU13;FBL;NOP58;RPS6;RPS9,57 (58),0.868,1,0,,3 (11),1,1,0.991,1
TGF-Core,Signalink,3,MAPK14;ACTR2;MAPK1,42 (42),0.991,1,0,,0 (0),1,1,0.991,1
Anti-inflammatory response favouring Leishmania parasite infection,Reactome,17,CALM1;GNG12;LYN;PRKAR1A;YES1;PRKAR2A;IGHG1;DPEP1;MYH9;CD163;GNB1;MAPK14;GNAS;GNB2;ITPR2;PRKACA;PRKACB,247 (247),1,1,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000123,32 (35),0.873,1,0.992,1
Leishmania parasite growth and survival,Reactome,17,CALM1;GNG12;LYN;PRKAR1A;YES1;PRKAR2A;IGHG1;DPEP1;MYH9;CD163;GNB1;MAPK14;GNAS;GNB2;ITPR2;PRKACA;PRKACB,247 (247),1,1,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000123,32 (35),0.873,1,0.992,1
GPCRs_ Class B Secretin-like,Wikipathways,1,ADGRL2,23 (23),0.992,1,0,,0 (0),1,1,0.992,1
Hippo-Yap signaling pathway,Wikipathways,1,YWHAQ,23 (23),0.992,1,0,,0 (0),1,1,0.992,1
GDNF-RET signaling axis,Wikipathways,1,CTNNB1,23 (23),0.992,1,0,,0 (0),1,1,0.992,1
Pre-implantation embryo,Wikipathways,5,KHSRP;ATP1A1;ELAVL1;HNRNPAB;CDH1,59 (59),0.992,1,0,,0 (0),1,1,0.992,1
TGF-beta receptor signaling in skeletal dysplasias,Wikipathways,5,FKBP1A;MAPK9;CTNNB1;STAT3;HRAS,59 (59),0.992,1,0,,0 (0),1,1,0.992,1
15q11.2 copy number variation syndrome,Wikipathways,1,CYFIP1,10 (10),0.877,1,0,,1 (1),1,1,0.992,1
PI3K events in ERBB4 signaling,Reactome,1,PIK3R1,10 (10),0.877,1,0,,3 (4),1,1,0.992,1
Caspase activation via Dependence Receptors in the absence of ligand,Reactome,1,CASP3,10 (10),0.877,1,0,,2 (2),1,1,0.992,1
Stabilization of p53,Reactome,1,ATM,10 (10),0.877,1,0,,2 (2),1,1,0.992,1
TRAF6-mediated induction of TAK1 complex within TLR4 complex,Reactome,1,CD14,10 (10),0.877,1,0,,3 (4),1,1,0.992,1
Neurotoxicity of clostridium toxins,Reactome,1,VAMP2,10 (10),0.877,1,0,,3 (5),1,1,0.992,1
Activation of SMO,Reactome,1,CSNK1A1,10 (10),0.877,1,0,,2 (2),1,1,0.992,1
Regulation of the apoptosome activity,Reactome,1,MAPK1,10 (10),0.877,1,0,,2 (2),1,1,0.992,1
Formation of apoptosome,Reactome,1,MAPK1,10 (10),0.877,1,0,,2 (2),1,1,0.992,1
Activation of the phototransduction cascade,Reactome,1,GNB1,10 (10),0.877,1,0,,8 (9),1,1,0.992,1
Gap-filling DNA repair synthesis and ligation in GG-NER,Reactome,3,POLE;LIG3;PCNA,25 (25),0.877,1,0,,1 (4),1,1,0.992,1
Regulation of TNFR1 signaling,Reactome,3,OTULIN;FADD;RACK1,25 (25),0.877,1,0,,2 (3),1,1,0.992,1
DAP12 interactions,Reactome,6,SHC1;HRAS;GRB2;RAC1;PIK3R1;B2M,45 (45),0.877,1,0,,5 (7),1,1,0.992,1
Vitamin D Receptor Pathway,Wikipathways,23,TPM1;S100A4;S100A6;S100A8;S100A9;ORM1;CLPTM1L;CLMN;HIF1A;STS;CD14;SULT1C2;CYP7A1;LPGAT1;STEAP4;ABCD1;HSD17B2;ATP2B1;CBS;RXRA;KNG1;CEACAM1;LGALS9,184 (184),0.992,1,0,,0 (1),1,1,0.992,1
SCF(Skp2)-mediated degradation of p27/p21,Reactome,2,SKP1;CUL1,18 (18),0.88,1,0,,2 (2),1,1,0.992,1
Interleukin-20 family signaling,Reactome,2,PTPN11;STAT3,18 (18),0.88,1,0,,2 (2),1,1,0.992,1
mets affect on macrophage differentiation,BioCarta,2,HRAS;HDAC2,18 (18),0.88,1,0,,2 (2),1,1,0.992,1
Serotonin Neurotransmitter Release Cycle,Reactome,2,VAMP2;PPFIA1,18 (18),0.88,1,0,,1 (1),1,1,0.992,1
Deposition of new CENPA-containing nucleosomes at the centromere,Reactome,3,RBBP4;NPM1;RUVBL1,43 (43),0.993,1,0,,0 (1),1,1,0.993,1
Nucleosome assembly,Reactome,3,RBBP4;NPM1;RUVBL1,43 (43),0.993,1,0,,0 (1),1,1,0.993,1
E2F transcription factor network,PID,7,RRM1;SMARCA2;RBBP4;TRIM28;RANBP1;DHFR;ATM,75 (75),0.993,1,0,,0 (0),1,1,0.993,1
Glioblastoma signaling pathways,Wikipathways,12,HRAS;MAP2K1;GRB2;MAP2K3;PRKCA;PIK3R1;MAP2K4;ARAF;ATM;EGFR;MAPK1;MAP2K2,83 (83),0.882,1,0,,1 (3),1,1,0.993,1
LncRNA involvement in canonical Wnt signaling and colorectal cancer,Wikipathways,10,CSNK1A1;CTBP1;CSNK2A1;CSNK2A2;CSNK2B;HNRNPK;SERPINF1;HNRNPU;CTNNB1;RUVBL1,97 (97),0.993,1,0,,0 (0),1,1,0.993,1
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,Reactome,11,PPP5C;UBE2I;UBE2N;H2AX;UBE2V2;BABAM2;BRCC3;ATM;UBXN1;BABAM1;RAD50,77 (78),0.883,1,0,,7 (8),1,1,0.993,1
ncRNAs involved in Wnt signaling in hepatocellular carcinoma,Wikipathways,9,CSNK1A1;ELAVL1;MTDH;CTBP1;CSNK2A1;CSNK2A2;CSNK2B;SERPINF1;CTNNB1,90 (90),0.993,1,0,,0 (0),1,1,0.993,1
Metastatic brain tumor,Wikipathways,1,CDC42,24 (24),0.993,1,0,,0 (0),1,1,0.993,1
Small cell lung cancer,Wikipathways,14,FHIT;CASP3;BAX;COL4A2;ITGB1;LAMB2;PIK3R1;RXRA;RELA;LAMA2;SKP1;ITGA2B;BID;FN1,96 (96),0.889,1,0,,2 (3),1,1,0.994,1
Regulation of RhoA activity,PID,6,RHOA;ARHGEF12;ARHGDIA;ARHGDIB;FARP1;ARHGEF10L,46 (46),0.89,1,0,,3 (3),1,1,0.994,1
Meiotic synapsis,Reactome,6,H2AX;SMC3;STAG2;SMC1A;SYCP2;RAD21,46 (47),0.89,1,0,,2 (3),1,1,0.994,1
Photodynamic therapy-induced NF-kB survival signaling,Wikipathways,2,RELA;ICAM1,35 (35),0.994,1,0,,0 (0),1,1,0.994,1
Orc1 removal from chromatin,Reactome,3,RBX1;SKP1;CUL1,26 (26),0.893,1,0,,2 (3),1,1,0.994,1
Caspase activation via extrinsic apoptotic signalling pathway,Reactome,3,CASP3;CD14;FADD,26 (26),0.893,1,0,,3 (3),1,1,0.994,1
Glypican 1 network,PID,3,LYN;YES1;SERPINC1,26 (26),0.893,1,0,,2 (2),1,1,0.994,1
Regulation of IFNA signaling,Reactome,3,PTPN6;STAT2;PTPN11,26 (26),0.893,1,0,,2 (2),1,1,0.994,1
Glucagon-type ligand receptors,Reactome,4,GNAS;GNG12;GNB1;GNB2,33 (33),0.894,1,0,,1 (1),1,1,0.994,1
Circadian Clock,Reactome,4,PER2;CSNK1D;CPT1A;NAMPT,33 (33),0.894,1,0,,2 (3),1,1,0.994,1
Heparan sulfate/heparin (HS-GAG) metabolism,Reactome,5,GLB1;BGN;DCN;NAGLU;GUSB,54 (54),0.984,1,1,HMDB0000290,21 (34),0.909,1,0.994,1
Cytokine Signaling in Immune system,Reactome,79,CUL5;PPP2R5D;SIGIRR;CUL1;ELOC;ELOB;PPP2CB;FLNB;PPP2R1A;MAP2K4;PTPN6;PRKACA;PTPN11;MT2A;MAPK14;TRIM25;PIK3R1;STX4;IFI30;DDX58;PTPRJ;ISG15;CSK;UBE2N;UBE2V1;MAP2K3;P4HB;ABCE1;STAT3;SQSTM1;CAMK2A;CAMK2D;RPS6KA1;SKP1;CANX;EIF4A2;IFITM3;PSMB8;EIF4E;EIF4G1;EIF4G2;DUSP3;SHC1;HRAS;CASP3;GRB2;TOLLIP;FLNA;GBP2;ICAM1;EIF4A1;CRKL;RELA;SAMHD1;STAT4;EIF4A3;NEDD4;FUS;MAPK1;ARIH1;RBX1;YES1;MAPK9;LYN;MAP2K1;IFI35;TRIM14;B2M;EIF2AK2;YWHAZ;TRIM5;STAT2;CRK;PPM1B;STAT5B;STAT6;PML;LGALS9;EIF4E2,471 (471),0.895,1,0,,9 (21),1,1,0.994,1
Joubert Syndrome,Wikipathways,10,RHOA;MYO6;MTOR;FLNA;PARP1;ARL3;ATM;RHEB;RAB8A;RAD50,72 (72),0.895,1,0,,3 (9),1,1,0.994,1
Interferon alpha/beta signaling,Reactome,10,PSMB8;ISG15;IFI35;GBP2;ABCE1;PTPN6;SAMHD1;STAT2;IFITM3;PTPN11,72 (72),0.895,1,0,,4 (4),1,1,0.994,1
Melanoma - Homo sapiens (human),KEGG,10,HRAS;EGFR;BAX;CDH1;PIK3R1;ARAF;IGF1;MAP2K1;MAPK1;MAP2K2,72 (72),0.895,1,0,,1 (1),1,1,0.994,1
Synthesis of PIPs at the plasma membrane,Reactome,7,RAB14;RAB4A;RAB5A;PIK3R1;ARF1;PLEKHA6;PIP4K2C,53 (53),0.896,1,0,,9 (17),1,1,0.994,1
Regulation of nuclear SMAD2/3 signaling,PID,7,HNF4A;RBBP4;CTBP1;HSPA8;HDAC2;NR3C1;COL1A2,77 (77),0.994,1,0,,0 (0),1,1,0.994,1
Measles - Homo sapiens (human),KEGG,21,FCGR2B;DDX58;FADD;BAX;MAPK9;EIF2S1;EIF2AK2;MAVS;PIK3R1;HSPA8;CSNK2A1;RELA;CSNK2A2;CSNK2B;STAT2;STAT3;CASP3;STAT5B;EIF3H;BID;RACK1,139 (139),0.897,1,0,,1 (1),1,1,0.994,1
Factors involved in megakaryocyte development and platelet production,Reactome,22,KIF13B;DOCK8;EHD1;CAPZA1;CAPZA2;PRKACB;CAPZB;PRKAR1A;MFN2;PRKAR2A;KIF5B;PRKACA;KLC4;AKAP1;CDC42;RAB5A;KIF1C;MFN1;RAC1;AK3;HDAC2;EHD3,145 (145),0.897,1,0,,10 (13),1,1,0.995,1
Phosphatidylinositol signaling system - Homo sapiens (human),KEGG,14,PIP4K2C;CALM1;SACM1L;PRKCA;INPP1;IMPA2;PI4KA;PLCB3;CDIPT;CDS2;PIP4P1;PIK3R1;IMPA1;ITPR2,97 (97),0.898,1,0,,19 (29),1,1,0.995,1
Mitochondrial Gene Expression,Wikipathways,2,PPP3CA;TFAM,19 (19),0.898,1,0,,3 (3),1,1,0.995,1
Basal transcription factors - Homo sapiens (human),KEGG,3,GTF2I;TAF3;TAF15,45 (45),0.995,1,0,,0 (0),1,1,0.995,1
BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation,Wikipathways,1,DCN,11 (11),0.9,1,0,,1 (1),1,1,0.995,1
RIP-mediated NFkB activation via ZBP1,Reactome,1,RELA,11 (11),0.9,1,0,,2 (3),1,1,0.995,1
Pyrimidine salvage,Reactome,1,TYMP,11 (11),0.9,1,0,,23 (23),1,1,0.995,1
CYP2E1 reactions,Reactome,1,CYP2E1,11 (11),0.9,1,0,,14 (20),1,1,0.995,1
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,Reactome,1,CD14,11 (11),0.9,1,0,,3 (3),1,1,0.995,1
pertussis toxin-insensitive ccr5 signaling in macrophage,BioCarta,1,GNAQ,11 (11),0.9,1,0,,1 (2),1,1,0.995,1
Fanconi anemia pathway,PID,3,ATM;H2AX;RAD50,46 (46),0.996,1,0,,0 (0),1,1,0.996,1
Dual incision in TC-NER,Reactome,9,CUL4B;CUL4A;DDB1;PRPF19;USP7;POLE;POLR2A;PCNA;RBX1,67 (67),0.907,1,0,,3 (4),1,1,0.996,1
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA),Reactome,3,ATM;DNA2;RAD50,27 (27),0.907,1,0,,4 (6),1,1,0.996,1
G alpha (z) signalling events,Reactome,5,PRKCA;GNG12;GNAS;GNB1;GNB2,41 (41),0.909,1,0,,12 (13),1,1,0.996,1
Primary immunodeficiency - Homo sapiens (human),KEGG,2,TAP2;ADA,37 (38),0.996,1,0,,0 (0),1,1,0.996,1
PI3K-Akt signaling pathway,Wikipathways,55,CDC37;COL6A1;PPP2CB;COL6A3;PPP2R1A;PPP2R2A;PPP2R5D;PPP2R5A;COL6A2;IGF1;VTN;PPP2R5E;MAPK1;KITLG;FN1;COL6A6;GNG12;EGFR;COL4A2;MTOR;PIK3R1;RPS6;GNB1;GYS2;COL1A2;EIF4E;PRKAA1;PRKAA2;PKN3;HRAS;LAMA2;GRB2;LAMB2;PRKCA;COL6A5;RELA;ITGA1;ITGA2B;ITGA5;GNB2;ITGA9;HSP90B1;MAP2K1;MAP2K2;ITGB1;ITGB3;PIK3AP1;PCK1;PCK2;HSP90AB1;RAC1;HSP90AA1;RHEB;COL1A1;EIF4E2,339 (340),0.91,1,0,,3 (4),1,1,0.996,1
Signaling by NOTCH1,Reactome,10,SKP1;CUL1;RBX1;NUMB;HDAC2;HIF1A;NCSTN;ITCH;SNW1;HDAC6,74 (74),0.913,1,0,,3 (3),1,1,0.996,1
Lagging Strand Synthesis,Reactome,2,DNA2;PCNA,20 (20),0.914,1,0,,6 (8),1,1,0.996,1
Cellular hexose transport,Reactome,2,SLC2A2;SLC2A9,20 (20),0.914,1,0,,4 (7),1,1,0.996,1
Allograft Rejection,Wikipathways,13,C8A;CASP3;VIM;TUBA1B;BHMT2;C3;C4A;PECR;CSNK2A2;C5;HARS1;C8B;C9,93 (93),0.915,1,0,,4 (10),1,1,0.996,1
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,Reactome,3,TAF3;TAF15;POLR2A,47 (47),0.996,1,0,,0 (1),1,1,0.996,1
Development of ureteric collection system,Wikipathways,3,ITGB1;ILK;CTNNB1,47 (47),0.996,1,0,,0 (1),1,1,0.996,1
Other types of O-glycan biosynthesis - Homo sapiens (human),KEGG,3,ST6GAL1;COLGALT1;GALNT2,47 (47),0.996,1,0,,0 (0),1,1,0.996,1
Heart Development,Wikipathways,3,MAPK1;CTNNB1;PTPN11,47 (47),0.996,1,0,,0 (0),1,1,0.996,1
Downstream signaling in na&#xef;ve CD8+ T cells,PID,9,HRAS;MAP2K1;MAP2K2;MAPK9;PRKCA;B2M;STAT4;MAPK1;CALM1,68 (68),0.916,1,0,,2 (2),1,1,0.996,1
DNA damage response,Wikipathways,9,CASP3;BAX;H2AX;SMC1A;RRM2B;ATM;PML;BID;RAD50,68 (68),0.916,1,0,,1 (2),1,1,0.996,1
Direct p53 effectors,PID,21,EGFR;BAX;CASP6;STEAP3;GPX1;DDX5;PRMT1;COL18A1;CAV1;HDAC2;TP53I3;AIFM2;RRM2B;PCNA;FDXR;RPS27L;CSE1L;PML;PRKAB1;BID;CTSD,142 (142),0.916,1,0,,1 (1),1,1,0.996,1
APC-Cdc20 mediated degradation of Nek2A,Reactome,1,BUB3,27 (27),0.996,1,0,,0 (0),1,1,0.996,1
WNT5:FZD7-mediated leishmania damping,Reactome,1,RAC1,12 (12),0.919,1,0,,8 (9),1,1,0.997,1
Killing mechanisms,Reactome,1,RAC1,12 (12),0.919,1,0,,8 (9),1,1,0.997,1
Metallothioneins bind metals,Reactome,1,MT2A,12 (12),0.919,1,0,,3 (4),1,1,0.997,1
Formation of RNA Pol II elongation complex ,Reactome,8,ELOC;ELOB;SUPT5H;NCBP1;SSRP1;POLR2A;WDR61;SUPT16H,62 (62),0.92,1,0,,2 (4),1,1,0.997,1
RNA Polymerase II Transcription Elongation,Reactome,8,ELOC;ELOB;SUPT5H;NCBP1;SSRP1;POLR2A;WDR61;SUPT16H,62 (62),0.92,1,0,,5 (7),1,1,0.997,1
Progesterone-mediated oocyte maturation - Homo sapiens (human),KEGG,14,MAPK9;MAPK14;MAP2K1;PIK3R1;ARAF;RPS6KA1;GNAI3;GNAI2;IGF1;HSP90AA1;PRKACA;MAPK1;HSP90AB1;PRKACB,100 (100),0.92,1,0,,3 (4),1,1,0.997,1
Transcriptional regulation of pluripotent stem cells,Reactome,1,STAT3,28 (28),0.997,1,0,,0 (0),1,1,0.997,1
nf-kb signaling pathway,BioCarta,2,RELA;FADD,21 (21),0.927,1,0,,1 (1),1,1,0.997,1
CD28 dependent PI3K/Akt signaling,Reactome,2,MTOR;PIK3R1,21 (21),0.927,1,0,,3 (4),1,1,0.997,1
Latent infection - Other responses of Mtb to phagocytosis,Reactome,0,,1 (1),1,1,1,HMDB0033934,23 (43),0.927,1,0.997,1
Endochondral Ossification,Wikipathways,8,CALM1;SERPINH1;CAB39;ENPP1;HMGCS1;IGF1;STAT5B;PRKACA,63 (63),0.928,1,0,,2 (4),1,1,0.997,1
Endochondral Ossification with Skeletal Dysplasias,Wikipathways,8,CALM1;SERPINH1;CAB39;ENPP1;HMGCS1;IGF1;STAT5B;PRKACA,63 (63),0.928,1,0,,2 (4),1,1,0.997,1
rRNA processing,Reactome,8,NOP56;GAR1;RPS14;SNU13;FBL;NOP58;RPS6;RPS9,63 (64),0.928,1,0,,3 (11),1,1,0.997,1
NHR,Signalink,3,RXRA;NR3C1;HNF4A,49 (49),0.997,1,0,,0 (0),1,1,0.997,1
Activation of GABAB receptors,Reactome,5,GNG12;GNAI2;GNAI3;GNB1;GNB2,43 (43),0.929,1,0,,6 (6),1,1,0.997,1
GABA B receptor activation,Reactome,5,GNG12;GNAI2;GNAI3;GNB1;GNB2,43 (43),0.929,1,0,,6 (6),1,1,0.997,1
Dihydromorphine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Hydromorphone Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,Reactome,3,GNG12;GNB1;GNB2,29 (29),0.931,1,0,,2 (2),1,1,0.998,1
G protein gated Potassium channels,Reactome,3,GNG12;GNB1;GNB2,29 (29),0.931,1,0,,2 (2),1,1,0.998,1
Activation of G protein gated Potassium channels,Reactome,3,GNG12;GNB1;GNB2,29 (29),0.931,1,0,,2 (2),1,1,0.998,1
Bupivacaine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
mRNA Capping,Reactome,3,NCBP1;POLR2A;SUPT5H,29 (29),0.931,1,0,,6 (9),1,1,0.998,1
Levomethadyl Acetate Action Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Dezocine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Oxymorphone Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Escitalopram Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,10 (11),1,1,0.998,1
Levallorphan Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Dimethylthiambutene Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Ethylmorphine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Pentazocine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Alvimopan Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Ketobemidone  Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Cocaine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Levobupivacaine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Benzocaine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Levorphanol Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Diphenoxylate Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Anileridine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,10 (11),1,1,0.998,1
Oxycodone Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Oxybuprocaine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,10 (11),1,1,0.998,1
Procaine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Proparacaine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Ropivacaine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Alfentanil Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Hydrocodone Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Sufentanil Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Remifentanil Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Fentanyl Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,10 (11),1,1,0.998,1
Carfentanil Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,10 (11),1,1,0.998,1
3-Methylthiofentanyl Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
Methadyl Acetate Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,29 (29),0.931,1,0,,11 (11),1,1,0.998,1
AP-1 transcription factor network,PID,9,COPS5;AGT;HIF1A;MT2A;FABP4;CTNNB1;NR3C1;BAG1;COL1A2,70 (70),0.931,1,0,,1 (1),1,1,0.998,1
Signaling by WNT,Reactome,44,RHOA;CUL3;CUL1;PPP2CB;USP8;PPP2R1A;SNX3;AP2M1;AP2S1;PPP2R5D;PPP2R5E;PPP3CA;RUVBL1;AP2A1;AP2A2;GNG12;AP2B1;CSNK1A1;CAMK2A;CSNK2A1;CSNK2A2;CSNK2B;VPS35;CLTA;CLTB;CLTC;H2AX;CALM1;PRKCA;CTBP1;PLCB3;VPS26A;XPO1;CTNNB1;GNB1;GNB2;PFN1;SKP1;YWHAZ;VPS29;RAC1;RBX1;ITPR2;PPP2R5A,281 (282),0.932,1,0,,21 (26),1,1,0.998,1
Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex,Wikipathways,1,IGHG1,29 (29),0.998,1,0,,0 (0),1,1,0.998,1
Cdc20:Phospho-APC/C mediated degradation of Cyclin A,Reactome,1,BUB3,29 (29),0.998,1,0,,0 (0),1,1,0.998,1
Regulation of Complement cascade,Reactome,18,CFI;CFH;CFHR1;CD59;CLU;IGHG1;C3;CD81;C4A;SERPING1;C4BPA;F2;CFB;C5;VTN;C8A;C8B;C9,127 (127),0.934,1,0,,2 (6),1,1,0.998,1
ESR-mediated signaling,Reactome,30,STRN;AGO2;PPP5C;CALM1;GNG12;EGFR;SMC3;PIK3R1;SMC1A;POLR2A;HRAS;H2AX;PRMT1;GPAM;GNAI2;GNAI3;CAV1;MAPK1;GNB1;GNB2;CTSD;PTGES3;PPID;STAG2;FKBP4;FKBP5;DDX5;HSP90AA1;RAD21;HSP90AB1,216 (217),0.979,1,1,HMDB0000145,27 (30),0.954,1,0.998,1
Serotonin and anxiety-related events,Wikipathways,1,PPP3CA,13 (13),0.934,1,0,,1 (2),1,1,0.998,1
ERBB2 Activates PTK6 Signaling,Reactome,1,EGFR,13 (13),0.934,1,0,,2 (2),1,1,0.998,1
ZBP1(DAI) mediated induction of type I IFNs,Reactome,1,RELA,13 (13),0.934,1,0,,2 (3),1,1,0.998,1
Downregulation of ERBB2:ERBB3 signaling,Reactome,1,USP8,13 (13),0.934,1,0,,2 (2),1,1,0.998,1
Estrogen-dependent nuclear events downstream of ESR-membrane signaling,Reactome,1,MAPK1,13 (13),0.934,1,0,,2 (2),1,1,0.998,1
Interferon gamma signaling,Reactome,13,IFI30;TRIM14;PTPN6;GBP2;ICAM1;CAMK2A;CAMK2D;TRIM5;PTPN11;MT2A;B2M;TRIM25;PML,96 (96),0.934,1,0,,4 (5),1,1,0.998,1
Transcriptional Regulation by MECP2,Reactome,8,CALM1;GAMT;FKBP5;CAMK2A;CAMK2D;AGO2;HDAC2;PRKACA,64 (64),0.935,1,0,,3 (4),1,1,0.998,1
Antigen processing: Ubiquitination & Proteasome degradation,Reactome,41,CUL5;UBA5;CUL2;CUL1;ELOC;UBE4A;ELOB;UBA1;ITCH;UBE2D3;FBXO6;UBE2G2;UBE2H;UBE2L3;UBE2N;CUL3;UBE2V2;UBE3A;RNF14;UBE2G1;UBE2J1;UBR4;UFL1;FBXO7;UBA6;UBA3;UBE2M;DTX3L;UBE3C;RNF114;SKP1;HECTD1;TRIP12;HERC4;UBE2Z;LMO7;RBX1;FBXO4;UBE2V1;NEDD4;UBE2K,265 (265),0.937,1,0,,4 (5),1,1,0.998,1
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,Reactome,4,APOC2;RXRA;APOE;AGO2,37 (37),0.938,1,0,,3 (4),1,1,0.998,1
Eukaryotic Transcription Initiation,Wikipathways,2,ILK;POLR2A,41 (41),0.998,1,0,,0 (0),1,1,0.998,1
TP53 Regulates Transcription of Cell Cycle Genes,Reactome,6,NPM1;CNOT1;PRMT1;TNKS1BP1;PCNA;BAX,51 (51),0.938,1,0,,2 (2),1,1,0.998,1
Wnt-beta-catenin signaling pathway in leukemia,Wikipathways,2,PML;CSNK1A1,22 (22),0.939,1,0,,1 (1),1,1,0.998,1
Acyl chain remodelling of PS,Reactome,2,LPCAT3;OSBPL8,22 (22),0.939,1,0,,4 (9),1,1,0.998,1
E2F mediated regulation of DNA replication,Reactome,2,PPP2CB;PPP2R1A,22 (22),0.939,1,0,,2 (4),1,1,0.998,1
Interleukin-6 family signaling,Reactome,2,PTPN11;STAT3,22 (22),0.939,1,0,,2 (2),1,1,0.998,1
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,Reactome,1,BUB3,30 (30),0.998,1,0,,0 (0),1,1,0.998,1
Dopaminergic Neurogenesis,Wikipathways,3,ALDH1A1;DDC;STAT3,30 (30),0.941,1,0,,1 (1),1,1,0.998,1
Nalbuphine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,30 (30),0.941,1,0,,11 (11),1,1,0.998,1
Deactivation of the beta-catenin transactivating complex,Reactome,3,XPO1;CTNNB1;YWHAZ,30 (30),0.941,1,0,,2 (2),1,1,0.998,1
Generic Transcription Pathway,Reactome,131,TRIM28;SUPT5H;MTA2;CAV1;AGO2;GLS2;GPI;GAMT;NR3C1;USP9X;ZKSCAN8;BAX;CBX3;PF4;CHD4;GCK;ACTL6A;NDUFA4;ITGA2B;SSRP1;ITGA5;HNF4A;PRKAB1;RXRA;PRKACA;RRAGC;BID;TXNRD1;PARP1;PRKAG1;PTPN11;MYL9;COX5A;YAP1;PIN1;GLS;PIP4P1;ATXN3;RBM14;USP7;PPM1A;PRMT1;TP53RK;YWHAQ;LAMTOR1;PRDX5;DNA2;DEK;FKBP5;RABGGTA;RABGGTB;RBX1;PML;COL1A1;HSPD1;NPM1;CUL1;ELOC;ELOB;ITCH;COX4I1;LAMTOR2;HDAC6;CALM1;COX5B;RBBP4;CAMK2A;CAMK2D;RRM2B;POLR2A;COX6A1;COX6C;TP53I3;COX7C;CASP6;GPAM;CAT;RELA;PRDX2;APOE;SKP1;YES1;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;SIRT3;LGALS3;GSR;RHEB;RAD50;PPP2CB;PPP2R1A;AIFM2;TAF3;MAPK14;SNW1;MT-CO1;MT-CO2;MT-CO3;ABCA6;LAMTOR4;TJP1;MTOR;CSNK2A1;CSNK2A2;CSNK2B;PRKAA1;PRKAA2;PRDX1;SUPT16H;SMARCA2;H2AX;UBE2I;STEAP3;SMARCC2;COX7A2L;TNKS1BP1;TAF15;ATM;EGFR;MAPK1;CTNNB1;PIP4K2C;CTSL;CNOT1;PCK1;PCNA;SOD2;HDAC2,1177 (1178),1,1,2,HMDB0000234;HMDB0001547,41 (55),0.945,1,0.998,1
Ovarian infertility,Wikipathways,1,ATM,31 (31),0.998,1,0,,0 (0),1,1,0.998,1
RNA Polymerase I Transcription Termination,Reactome,1,UBTF,31 (31),0.998,1,0,,0 (0),1,1,0.998,1
RNA polymerase - Homo sapiens (human),KEGG,1,POLR2A,31 (31),0.998,1,0,,0 (0),1,1,0.998,1
Matrix Metalloproteinases,Wikipathways,1,BSG,31 (31),0.998,1,0,,0 (0),1,1,0.998,1
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,Reactome,4,SNW1;PARP1;PPM1A;USP9X,38 (38),0.946,1,0,,6 (6),1,1,0.999,1
Polymerase switching,Reactome,1,PCNA,14 (14),0.947,1,0,,2 (4),1,1,0.999,1
Leading Strand Synthesis,Reactome,1,PCNA,14 (14),0.947,1,0,,2 (4),1,1,0.999,1
AKT phosphorylates targets in the cytosol,Reactome,1,AKT1S1,14 (14),0.947,1,0,,2 (2),1,1,0.999,1
Small cell lung cancer - Homo sapiens (human),KEGG,12,FHIT;COL4A2;BAX;ITGB1;LAMB2;PIK3R1;RXRA;RELA;CASP3;LAMA2;ITGA2B;FN1,92 (92),0.947,1,0,,3 (3),1,1,0.999,1
Apoptosis Modulation and Signaling,Wikipathways,12,PTRH2;CASP3;HTRA2;CASP6;TOLLIP;AIFM1;AIFM2;FADD;CAPNS1;BAG3;BID;BAX,92 (92),0.947,1,0,,1 (1),1,1,0.999,1
DNA Mismatch Repair,Wikipathways,2,POLE;PCNA,23 (23),0.948,1,0,,1 (1),1,1,0.999,1
Nitric oxide stimulates guanylate cyclase,Reactome,2,GUCY1A1;GUCY1B1,23 (23),0.948,1,0,,11 (11),1,1,0.999,1
Nuclear Receptor transcription pathway,Reactome,3,RXRA;HNF4A;NR3C1,53 (53),0.999,1,0,,0 (0),1,1,0.999,1
Nuclear signaling by ERBB4,Reactome,3,NCSTN;APOE;YAP1,31 (31),0.949,1,0,,1 (2),1,1,0.999,1
Activated NOTCH1 Transmits Signal to the Nucleus,Reactome,3,ITCH;NUMB;NCSTN,31 (31),0.949,1,0,,1 (1),1,1,0.999,1
Phosphorylation of CD3 and TCR zeta chains,Reactome,3,PTPRJ;CSK;PTPN22,31 (31),0.949,1,0,,4 (5),1,1,0.999,1
APC/C:Cdc20 mediated degradation of mitotic proteins,Reactome,1,BUB3,32 (32),0.999,1,0,,0 (0),1,1,0.999,1
Toxoplasmosis - Homo sapiens (human),KEGG,15,MAPK9;LAMA2;MAP2K3;ITGB1;LAMB2;IRGM;HSPA8;RELA;GNAI2;GNAI3;STAT3;MAPK14;PPIF;MAPK1;CASP3,112 (112),0.951,1,0,,3 (3),1,1,0.999,1
Alzheimer_s disease,Wikipathways,20,CALM1;LRP1;CASP3;GAPDH;PLCB3;ATP2A2;GNAQ;ITPR2;FADD;CAPN2;NAE1;HSD17B10;CAPN1;IDE;NCSTN;MAPK1;APOE;CHP1;PPP3CA;BID,144 (144),0.954,1,0,,7 (7),1,1,0.999,1
Transcription of the HIV genome,Reactome,9,ELOC;ELOB;SUPT5H;NCBP1;TAF3;POLR2A;TAF15;SSRP1;SUPT16H,74 (74),0.955,1,0,,7 (10),1,1,0.999,1
Role of Osx and miRNAs in tooth development,Wikipathways,1,CTNNB1,33 (33),0.999,1,0,,0 (1),1,1,0.999,1
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,Reactome,1,BUB3,33 (33),0.999,1,0,,0 (0),1,1,0.999,1
White fat cell differentiation,Wikipathways,3,STAT5B;NR3C1;CTNNA1,32 (32),0.956,1,0,,1 (2),1,1,0.999,1
PD-1 signaling,Reactome,3,PTPN6;CSK;PTPN11,32 (32),0.956,1,0,,3 (4),1,1,0.999,1
Codeine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,32 (32),0.956,1,0,,21 (21),1,1,0.999,1
estrogen responsive protein efp controls cell cycle and breast tumors growth,BioCarta,1,TRIM25,15 (15),0.957,1,0,,1 (1),1,1,0.999,1
Axon guidance - Homo sapiens (human),KEGG,26,MYL12A;DPYSL2;RHOA;PTPN11;PPP3CA;ILK;MYL9;RHOD;CAMK2A;CAMK2D;PIK3R1;CFL1;CFL2;HRAS;ARHGEF12;PAK2;PRKCA;ROCK1;NCK1;GNAI2;GNAI3;MAPK1;CDC42;PLXNB2;ITGB1;RAC1,182 (182),0.958,1,0,,1 (1),1,1,0.999,1
Gene Silencing by RNA,Reactome,19,RAE1;NUP98;NUP133;AGO2;H2AX;TPR;RAN;TSN;ELAC2;NUP160;POLR2A;NUP35;NUP93;NUP210;NUP58;RANBP2;SEC13;NUP205;NUP155,139 (140),0.958,1,0,,5 (8),1,1,0.999,1
RNA Polymerase II Transcription,Reactome,162,TRIM28;SRRM1;SUPT5H;MTA2;MAGOH;CAV1;AGO2;GLS2;NPM1;GAMT;NR3C1;USP9X;ZKSCAN8;BAX;CBX3;U2AF2;PF4;NCBP1;CHD4;GCK;ACTL6A;SKP1;ITGA2B;SSRP1;ITGA5;HNF4A;PRKAB1;RXRA;PRKACA;COX4I1;RRAGC;RPRD1B;BID;TXNRD1;U2AF1;PARP1;PRKAG1;PTPN11;MYL9;PIP4K2C;COX5A;LAMTOR2;YAP1;SRSF4;PIN1;GLS;PIP4P1;ATXN3;RBM14;USP7;LGALS3;CPSF1;PRMT1;TJP1;RBM8A;TP53RK;YWHAQ;LAMTOR1;PRDX5;DNA2;DEK;DDX39B;FKBP5;RABGGTA;RABGGTB;RBX1;PML;COL1A1;HSPD1;GPI;CUL1;ELOC;ELOB;THOC7;ITCH;SRSF1;SRSF2;SRSF3;HDAC6;SRSF5;SRSF6;SRSF7;CALM1;NDUFA4;COX5B;RBBP4;RNPS1;NUDT21;CAMK2A;CAMK2D;RRM2B;POLR2A;COX6A1;COX6C;TP53I3;COX7C;CASP6;GPAM;CAT;RELA;PRDX2;APOE;SARNP;YES1;YWHAB;YWHAE;YWHAG;YWHAH;YWHAZ;SIRT3;THOC5;PPM1A;GSR;RHEB;SNRPD3;RAD50;PPP2CB;PPP2R1A;AIFM2;TAF3;MAPK14;SNW1;MT-CO1;MT-CO2;MT-CO3;ABCA6;LAMTOR4;EIF4A3;PABPN1;MTOR;CSNK2A1;CSNK2A2;CSNK2B;PRKAA1;PRKAA2;PRDX1;SUPT16H;SMARCA2;H2AX;UBE2I;STEAP3;SMARCC2;ALYREF;COX7A2L;TNKS1BP1;TAF15;ATM;EGFR;MAPK1;CTNNB1;WDR61;SNRPB;CTSL;CNOT1;SNRPF;SNRPG;PCK1;PCNA;SOD2;HDAC2;DDX39A;CPSF7,1306 (1307),1,1,2,HMDB0000234;HMDB0001547,44 (62),0.959,1,0.999,1
Leishmania infection,Reactome,45,DPEP1;WASL;MYH9;ABI1;CYFIP1;MAPK14;ARPC1B;BAIAP2;SUGT1;GRB2;CALM1;GNG12;NCKAP1;BRK1;NT5E;IGHG1;ARPC1A;ACTB;ENTPD5;PRKACA;PRKACB;PRKAR1A;ACTG1;PRKAR2A;CYFIP2;C3;NCK1;MAPK1;GNB1;GNB2;LYN;YES1;CDC42;GNAS;ARPC5;ARPC4;ARPC3;ITPR2;ACTR3;ACTR2;CD163;CRK;RAC1;ARPC2;HSP90AB1,323 (323),0.993,1,2,HMDB0007100#HMDB0007101#HMDB0007248#HMDB0007156#HMDB0007112;HMDB0000123,46 (53),0.966,1,0.999,1
Wnt signaling,Wikipathways,15,MAPK9;RHOA;CSNK2A1;PRKCA;CSNK1A1;CSNK2A2;CAMK2A;CAMK2D;PLCB3;CSNK2B;CTBP1;RAC1;SERPINF1;PPP3CA;CTNNB1,114 (114),0.959,1,0,,1 (1),1,1,0.999,1
Inflammatory bowel disease - Homo sapiens (human),KEGG,4,RELA;STAT6;STAT3;STAT4,65 (65),0.999,1,0,,0 (0),1,1,0.999,1
Human T-cell leukemia virus 1 infection - Homo sapiens (human),KEGG,32,B2M;RAN;RANBP1;MAP2K4;VAC14;PPP3CA;MAPK1;SLC25A4;SLC25A5;CALR;PIK3R1;CANX;TLN1;ICAM1;PRKACA;PRKACB;HRAS;BAX;DLG1;TLN2;RELA;VDAC2;ATM;XPO1;BUB3;MAPK9;MAP2K1;MAP2K2;ITGB2;VDAC1;STAT5B;VDAC3,219 (219),0.96,1,0,,5 (5),1,1,0.999,1
Resolution of D-loop Structures through Holliday Junction Intermediates,Reactome,3,ATM;DNA2;RAD50,33 (33),0.963,1,0,,4 (7),1,1,0.999,1
Formation of the HIV-1 Early Elongation Complex,Reactome,3,NCBP1;POLR2A;SUPT5H,33 (33),0.963,1,0,,4 (5),1,1,0.999,1
Formation of the Early Elongation Complex,Reactome,3,NCBP1;POLR2A;SUPT5H,33 (33),0.963,1,0,,4 (5),1,1,0.999,1
Purinergic signaling,Wikipathways,3,GNAS;GNAI2;GNAI3,33 (33),0.963,1,0,,15 (55),1,1,0.999,1
NOTCH3 Activation and Transmission of Signal to the Nucleus,Reactome,2,NCSTN;EGFR,25 (25),0.964,1,0,,3 (3),1,1,0.999,1
G0 and Early G1,Reactome,2,RBBP4;PCNA,25 (25),0.964,1,0,,2 (2),1,1,0.999,1
Mesodermal commitment pathway,Wikipathways,15,HNF4A;CUL4B;TRIM28;C1QBP;PRKAR1A;MACF1;YAP1;HPRT1;DDAH1;RPL38;TRIM5;ACACA;ASCC3;PRKACA;EPB41L5,153 (153),0.999,1,0,,0 (0),1,1,0.999,1
Polo-like kinase mediated events,Reactome,1,RBBP4,16 (16),0.965,1,0,,2 (2),1,1,0.999,1
CRMPs in Sema3A signaling,Reactome,1,DPYSL2,16 (16),0.965,1,0,,2 (2),1,1,0.999,1
Translesion synthesis by REV1,Reactome,1,PCNA,16 (16),0.965,1,0,,2 (4),1,1,0.999,1
Breast cancer pathway,Wikipathways,21,SHC1;HRAS;EGFR;MAP2K2;CSNK2A1;SKP1;MTOR;CSNK1A1;BAX;PIK3R1;ARAF;CSNK2A2;CSNK2B;PARP1;GRB2;IGF1;ATM;MAP2K1;MAPK1;CTNNB1;RAD50,154 (154),0.966,1,0,,4 (4),1,1,0.999,1
Hedgehog signaling pathway - Homo sapiens (human),KEGG,6,CUL3;CUL1;CSNK1A1;CSNK1D;PRKACA;PRKACB,56 (56),0.966,1,0,,1 (1),1,1,0.999,1
TNF signaling,Reactome,3,OTULIN;FADD;RACK1,34 (34),0.968,1,0,,3 (4),1,1,0.999,1
Fluoxetine Action Pathway,SMPDB,3,ATP1B1;ATP1B3;ATP1A1,34 (34),0.968,1,0,,15 (16),1,1,0.999,1
Alcoholism - Homo sapiens (human),KEGG,26,HDAC6;MAOA;MAOB;GNG12;PRKACA;PRKACB;SHC1;HRAS;GRB2;H2AX;CALM1;MACROH2A1;GNAI3;GNAS;MAPK1;GNB1;GNB2;MAP2K1;DDC;SLC29A1;ARAF;GNAI2;HDAC2;PPP1CA;PPP1CB;PPP1CC,186 (187),0.969,1,0,,10 (10),1,1,1,1
A tetrasaccharide linker sequence is required for GAG synthesis,Reactome,2,BGN;DCN,26 (26),0.969,1,0,,5 (6),1,1,1,1
DNA Damage/Telomere Stress Induced Senescence,Reactome,2,ATM;RAD50,26 (26),0.969,1,0,,4 (6),1,1,1,1
Termination of O-glycan biosynthesis,Reactome,2,ST6GAL1;ST3GAL4,26 (26),0.969,1,0,,2 (2),1,1,1,1
Interleukin-7 signaling,Reactome,2,STAT5B;PIK3R1,26 (26),0.969,1,0,,2 (2),1,1,1,1
Complement cascade,Reactome,18,CFI;CFH;CFHR1;CD59;CLU;IGHG1;C3;CD81;C4A;SERPING1;C4BPA;F2;CFB;C5;VTN;C8A;C8B;C9,137 (137),0.971,1,0,,4 (12),1,1,1,1
Malaria - Homo sapiens (human),KEGG,5,CR1L;LRP1;ITGB2;CD81;ICAM1,50 (50),0.971,1,0,,3 (5),1,1,1,1
Leptin Insulin Overlap,Wikipathways,1,STAT3,17 (17),0.971,1,0,,1 (2),1,1,1,1
Serotonin and anxiety,Wikipathways,1,PPP3CA,17 (17),0.971,1,0,,2 (4),1,1,1,1
Translesion synthesis by POLK,Reactome,1,PCNA,17 (17),0.971,1,0,,3 (6),1,1,1,1
Translesion synthesis by POLI,Reactome,1,PCNA,17 (17),0.971,1,0,,2 (4),1,1,1,1
Circadian rhythm pathway,PID,1,PER2,17 (17),0.971,1,0,,3 (4),1,1,1,1
RNA Polymerase II Pre-transcription Events,Reactome,10,ELOC;ELOB;SUPT5H;NCBP1;SSRP1;TAF3;POLR2A;TAF15;WDR61;SUPT16H,85 (85),0.972,1,0,,4 (6),1,1,1,1
JAK-STAT-Core,Signalink,8,EGFR;STAT4;STAT2;STAT3;RAC1;MAPK14;STAT5B;STAT6,104 (104),1,1,0,,0 (0),1,1,1,1
Resolution of D-Loop Structures,Reactome,3,ATM;DNA2;RAD50,35 (35),0.973,1,0,,4 (7),1,1,1,1
Inwardly rectifying K+ channels,Reactome,3,GNG12;GNB1;GNB2,35 (35),0.973,1,0,,2 (2),1,1,1,1
Interactions between immune cells and microRNAs in tumor microenvironment,Wikipathways,2,STAT6;STAT3,50 (50),1,1,0,,0 (1),1,1,1,1
G2/M Checkpoints,Reactome,15,DNA2;UBE2N;H2AX;UBE2V2;BABAM2;YWHAE;YWHAG;YWHAH;YWHAZ;BRCC3;YWHAB;ATM;YWHAQ;BABAM1;RAD50,119 (120),0.974,1,0,,3 (5),1,1,1,1
Constitutive Signaling by AKT1 E17K in Cancer,Reactome,2,MTOR;AKT1S1,27 (27),0.974,1,0,,2 (6),1,1,1,1
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,Reactome,2,SUPT5H;POLR2A,27 (27),0.974,1,0,,2 (4),1,1,1,1
RNA Pol II CTD phosphorylation and interaction with CE,Reactome,2,SUPT5H;POLR2A,27 (27),0.974,1,0,,2 (3),1,1,1,1
Gene expression (Transcription),Reactome,185,MTA2;TPR;COX5A;SRRM1;YAP1;MAGOH;SRSF3;CAV1;AGO2;ITGA2B;NPM1;MYO1C;RAD50;CUL1;NR3C1;USP9X;SRSF4;ACTB;ZKSCAN8;BAX;CBX3;U2AF2;PF4;NCBP1;TSN;CHD4;GCK;ACTL6A;PIP4P1;SKP1;NUP58;SSRP1;ITGA5;HNF4A;PRDX1;ELAC2;PRKACA;COX4I1;RRAGC;RPRD1B;BID;TXNRD1;YWHAE;NUP93;U2AF1;PRDX2;PARP1;PRKAG1;PTPN11;MYL9;RXRA;RNPS1;SUPT5H;UBTF;PIN1;GLS;NUP210;FKBP5;GLS2;ATXN3;RBM14;RAE1;USP7;LGALS3;CPSF1;GAMT;PRMT1;RBM8A;RHEB;TP53RK;YWHAQ;LAMTOR1;PRDX5;DNA2;DEK;NUP160;WDR61;RABGGTA;RABGGTB;RBX1;PML;SEC13;COL1A1;HSPD1;GPI;NDUFA4;ELOC;ELOB;RAN;RANBP2;THOC7;MYBBP1A;ITCH;SRSF1;SRSF2;LAMTOR2;HDAC6;SRSF5;SRSF6;SRSF7;CALM1;COX5B;RBBP4;NUDT21;CAMK2A;CAMK2D;RRM2B;POLR2A;COX6A1;NUP98;COX6C;TP53I3;COX7C;CASP6;TRIM28;GPAM;CAT;RELA;DDX21;APOE;SARNP;YES1;YWHAB;TFAM;YWHAG;YWHAH;YWHAZ;SIRT3;THOC5;PPM1A;GSR;NUP35;SNRPD3;NUP205;PPP2CB;PPP2R1A;AIFM2;TAF3;MAPK14;SNW1;DDX39B;NUP155;MT-CO1;MT-CO2;MT-CO3;SF3B1;ABCA6;LAMTOR4;EIF4A3;TJP1;MTOR;CSNK2A1;CSNK2A2;CSNK2B;PRKAA1;PRKAA2;PRKAB1;SUPT16H;NUP133;SMARCA2;H2AX;UBE2I;STEAP3;SMARCC2;ALYREF;COX7A2L;TNKS1BP1;TAF15;ATM;EGFR;MAPK1;CTNNB1;PIP4K2C;SNRPB;CTSL;CNOT1;SNRPF;SNRPG;CPSF7;PCK1;PCNA;SOD2;HDAC2;DDX39A;PABPN1,1438 (1439),1,1,2,HMDB0000234;HMDB0001547,49 (74),0.974,1,1,1
Signaling by the B Cell Receptor (BCR),Reactome,16,HRAS;STIM1;LYN;PIK3AP1;GRB2;CUL1;CALM1;FKBP1A;RELA;PIK3R1;PTPN6;NCK1;IGHM;SKP1;PPP3CA;ITPR2,126 (126),0.975,1,0,,10 (14),1,1,1,1
Cytosolic DNA-sensing pathway,Wikipathways,8,ATG5;FADD;MAVS;DDX58;RELA;NLRX1;ISG15;TRIM25,73 (73),0.977,1,0,,1 (2),1,1,1,1
TP53 Regulates Transcription of DNA Repair Genes,Reactome,7,ELOC;ELOB;SUPT5H;POLR2A;ATM;SSRP1;SUPT16H,66 (66),0.977,1,0,,2 (2),1,1,1,1
Proteoglycan biosynthesis,Wikipathways,1,PAPSS2,18 (18),0.977,1,0,,13 (17),1,1,1,1
Acyl chain remodelling of PG,Reactome,1,LPGAT1,18 (18),0.977,1,0,,3 (8),1,1,1,1
Phototransduction - Homo sapiens (human),KEGG,2,CALM1;GNB1,28 (29),0.979,1,0,,8 (8),1,1,1,1
Wnt signaling pathway - Homo sapiens (human),KEGG,22,RHOA;CUL1;PPP3CA;RUVBL1;CAMK2D;CSNK1A1;CAMK2A;CSNK2A1;CSNK2A2;CSNK2B;SERPINF1;PRKACA;PRKACB;PRKCA;CTBP1;PLCB3;CTNNB1;CACYBP;MAPK9;SKP1;RAC1;RBX1,166 (166),0.979,1,0,,1 (1),1,1,1,1
Cytosolic DNA-sensing pathway - Homo sapiens (human),KEGG,3,DDX58;RELA;MAVS,63 (63),1,1,0,,0 (1),1,1,1,1
GABA receptor activation,Reactome,6,GNG12;NPTN;GNAI2;GNAI3;GNB1;GNB2,60 (60),0.98,1,0,,7 (7),1,1,1,1
Wnt signaling in kidney disease,Wikipathways,3,MAPK9;RHOA;CTNNB1,37 (37),0.98,1,0,,1 (1),1,1,1,1
Regulation of APC/C activators between G1/S and early anaphase,Reactome,3,BUB3;SKP1;CUL1,37 (37),0.98,1,0,,2 (2),1,1,1,1
HDR through Single Strand Annealing (SSA),Reactome,3,ATM;DNA2;RAD50,37 (37),0.98,1,0,,2 (3),1,1,1,1
G1 to S cell cycle control,Wikipathways,3,ATM;POLE;PCNA,64 (64),1,1,0,,0 (0),1,1,1,1
p53-Dependent G1 DNA Damage Response,Reactome,1,ATM,19 (19),0.981,1,0,,2 (2),1,1,1,1
p53-Dependent G1/S DNA damage checkpoint,Reactome,1,ATM,19 (19),0.981,1,0,,2 (2),1,1,1,1
Neural Crest Differentiation,Wikipathways,7,CDH1;CDH2;ITGB1;GJB1;HDAC2;CTNNB1;HDAC6,101 (101),1,1,0,,0 (0),1,1,1,1
Cyclin A:Cdk2-associated events at S phase entry,Reactome,2,SKP1;CUL1,29 (29),0.982,1,0,,4 (4),1,1,1,1
Cyclin E associated events during G1/S transition ,Reactome,2,SKP1;CUL1,29 (29),0.982,1,0,,4 (4),1,1,1,1
Gastric cancer - Homo sapiens (human),KEGG,19,SHC1;JUP;MTOR;EGFR;BAX;HRAS;CDH1;CSNK1A1;PIK3R1;RXRA;ARAF;CDH17;CTNNA1;CTNNA2;MAP2K1;MAPK1;CTNNB1;MAP2K2;GRB2,149 (149),0.982,1,0,,3 (4),1,1,1,1
Ectoderm Differentiation,Wikipathways,12,GLB1;UBTF;JUP;PI4KA;RAB8B;PGM1;CTBP1;CTNNA2;KIFC3;CTNNB1;HDAC6;RRBP1,142 (142),1,1,0,,0 (0),1,1,1,1
FOXM1 transcription factor network,PID,1,MAP2K1,42 (42),1,1,0,,0 (0),1,1,1,1
Nuclear receptors,Wikipathways,3,RXRA;HNF4A;NR3C1,38 (38),0.983,1,0,,1 (5),1,1,1,1
Cell death signalling via NRAGE_ NRIF and NADE,Reactome,8,CASP3;ARHGEF12;YWHAE;SQSTM1;GNA13;RAC1;ARHGEF10L;NCSTN,76 (76),0.984,1,0,,4 (4),1,1,1,1
Regulation of TP53 Activity through Methylation,Reactome,1,ATM,20 (20),0.985,1,0,,4 (4),1,1,1,1
Transcriptional regulation of white adipocyte differentiation,Reactome,4,RXRA;HELZ2;FABP4;THRAP3,47 (47),0.985,1,0,,4 (4),1,1,1,1
Processing of DNA double-strand break ends,Reactome,11,UBE2I;DNA2;UBE2N;H2AX;UBE2V2;BABAM2;BRCC3;ATM;PPP4C;BABAM1;RAD50,98 (99),0.986,1,0,,7 (10),1,1,1,1
Presynaptic phase of homologous DNA pairing and strand exchange,Reactome,3,ATM;DNA2;RAD50,39 (39),0.986,1,0,,2 (3),1,1,1,1
JAK-STAT signaling pathway - Homo sapiens (human),KEGG,14,HRAS;EGFR;GRB2;MTOR;STAM2;PIK3R1;PTPN6;STAT2;STAT3;STAT4;STAT5B;STAT6;AOX1;PTPN11,162 (162),1,1,0,,0 (0),1,1,1,1
G1/S DNA Damage Checkpoints,Reactome,1,ATM,21 (21),0.988,1,0,,2 (3),1,1,1,1
BMP Signalling Pathway,HumanCyc,1,UBE2D3,21 (21),0.988,1,0,,2 (2),1,1,1,1
Regulation of FZD by ubiquitination,Reactome,1,USP8,21 (21),0.988,1,0,,1 (1),1,1,1,1
NGF-stimulated transcription,Reactome,3,DNM2;CHD4;FUS,40 (40),0.988,1,0,,2 (2),1,1,1,1
JAK STAT MolecularVariation 1,INOH,6,STAT2;STAT3;STAT4;STAT5B;STAT6;KITLG,98 (98),1,1,0,,0 (0),1,1,1,1
DNA strand elongation,Reactome,2,DNA2;PCNA,32 (32),0.99,1,0,,6 (8),1,1,1,1
Positive epigenetic regulation of rRNA expression,Reactome,12,MYO1C;MTA2;DDX21;H2AX;CBX3;RBBP4;DEK;MYBBP1A;CHD4;HDAC2;SF3B1;ACTB,108 (109),0.99,1,0,,4 (6),1,1,1,1
NOTCH2 Activation and Transmission of Signal to the Nucleus,Reactome,1,NCSTN,22 (22),0.99,1,0,,1 (1),1,1,1,1
ESC Pluripotency Pathways,Wikipathways,13,HRAS;MAP2K1;MAP2K2;MAP2K3;ACTR2;MTOR;ARAF;PTPN11;STAT3;EGFR;MAPK1;CTNNB1;GRB2,116 (116),0.991,1,0,,4 (5),1,1,1,1
Homologous DNA Pairing and Strand Exchange,Reactome,3,ATM;DNA2;RAD50,42 (42),0.991,1,0,,2 (4),1,1,1,1
Chemokine receptors bind chemokines,Reactome,2,PXMP2;PF4,62 (62),1,1,0,,0 (0),1,1,1,1
Cell Differentiation - Index,Wikipathways,1,STAT3,49 (49),1,1,0,,0 (0),1,1,1,1
FGF23 signaling in hypophosphatemic rickets and related disorders,Wikipathways,1,ENPP1,23 (23),0.992,1,0,,3 (4),1,1,1,1
Cell adhesion molecules - Homo sapiens (human),KEGG,11,ITGA9;F11R;CDH1;ITGB1;ITGB2;GLG1;CDH2;CLDN3;ALCAM;ICAM1;NECTIN2,148 (149),1,1,0,,0 (0),1,1,1,1
Miscellaneous transport and binding events,Reactome,1,AZGP1,24 (24),0.993,1,0,,9 (11),1,1,1,1
G1/S Transition,Reactome,7,SKP1;CUL1;DHFR;PPP2CB;PPP2R1A;POLE;PCNA,76 (76),0.994,1,0,,4 (7),1,1,1,1
Morphine addiction - Homo sapiens (human),KEGG,9,GNG12;PRKCA;GNAI2;GNAI3;PRKACA;GNAS;PRKACB;GNB1;GNB2,91 (91),0.994,1,0,,9 (12),1,1,1,1
Signaling by NOTCH3,Reactome,3,NCSTN;SNW1;EGFR,44 (44),0.994,1,0,,3 (3),1,1,1,1
APC/C-mediated degradation of cell cycle proteins,Reactome,3,BUB3;SKP1;CUL1,44 (44),0.994,1,0,,4 (4),1,1,1,1
Regulation of mitotic cell cycle,Reactome,3,BUB3;SKP1;CUL1,44 (44),0.994,1,0,,4 (4),1,1,1,1
Transcriptional Regulation by E2F6,Reactome,2,RBBP4;CBX3,35 (35),0.994,1,0,,2 (2),1,1,1,1
Cardiac Progenitor Differentiation,Wikipathways,4,MAPK14;ANPEP;ACTC1;IGF1,53 (53),0.994,1,0,,1 (1),1,1,1,1
Osteoclast differentiation - Homo sapiens (human),KEGG,14,MAPK9;MAP2K1;GRB2;ITGB3;SQSTM1;PIK3R1;RELA;STAT2;ACP5;RAC1;MAPK14;PPP3CA;MAPK1;FCGR2B,127 (128),0.994,1,0,,3 (3),1,1,1,1
DNA Double-Strand Break Repair,Reactome,20,PPP5C;UBE2I;PPP4C;H2AX;UBE2N;UBE2V2;BABAM2;PCNA;LIG3;PARP1;BRCC3;XRCC5;POLE;XRCC6;BABAM1;DNA2;ATM;UBXN1;KPNA2;RAD50,168 (169),0.995,1,0,,12 (17),1,1,1,1
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,Reactome,1,SNW1,25 (25),0.995,1,0,,2 (2),1,1,1,1
Transcriptional misregulation in cancer - Homo sapiens (human),KEGG,16,PER2;MPO;BAX;CD14;RXRA;IGF1;ASPSCR1;JUP;EWSR1;TAF15;DDX5;ATM;FUS;HDAC2;PML;RELA,191 (192),1,1,0,,0 (0),1,1,1,1
Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human),KEGG,10,HRAS;MAP2K1;GRB2;PIK3R1;STAT3;IGF1;MAPK14;MAPK1;CTNNB1;MAP2K2,143 (143),1,1,0,,0 (0),1,1,1,1
miRNAs involved in DNA damage response,Wikipathways,2,ATM;H2AX,67 (67),1,1,0,,0 (0),1,1,1,1
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,Reactome,4,HDAC2;NCSTN;SNW1;HDAC6,54 (54),0.995,1,0,,3 (3),1,1,1,1
Signaling by NOTCH1 in Cancer,Reactome,4,HDAC2;NCSTN;SNW1;HDAC6,54 (54),0.995,1,0,,3 (3),1,1,1,1
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,Reactome,4,HDAC2;NCSTN;SNW1;HDAC6,54 (54),0.995,1,0,,3 (3),1,1,1,1
Constitutive Signaling by NOTCH1 PEST Domain Mutants,Reactome,4,HDAC2;NCSTN;SNW1;HDAC6,54 (54),0.995,1,0,,3 (3),1,1,1,1
Signaling by NOTCH1 PEST Domain Mutants in Cancer,Reactome,4,HDAC2;NCSTN;SNW1;HDAC6,54 (54),0.995,1,0,,3 (3),1,1,1,1
Osteoblast differentiation,Wikipathways,7,MAPK9;PIK3R4;PRKCA;PIK3R1;MAPK14;MAPK1;CTNNB1,118 (118),1,1,0,,0 (0),1,1,1,1
RNA Polymerase II Promoter Escape,Reactome,3,TAF3;TAF15;POLR2A,46 (46),0.996,1,0,,5 (6),1,1,1,1
Packaging Of Telomere Ends,Reactome,1,H2AX,55 (56),1,1,0,,0 (2),1,1,1,1
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,Reactome,9,CALM1;STIM1;LYN;PIK3AP1;GRB2;PIK3R1;NCK1;IGHM;ITPR2,94 (94),0.996,1,0,,5 (8),1,1,1,1
BMP2 signaling TGF-beta MV,INOH,1,STAT3,56 (56),1,1,0,,0 (0),1,1,1,1
Regulation of retinoblastoma protein,PID,5,RBBP4;MAPK9;MAPK14;CKM;CTBP1,64 (64),0.996,1,0,,1 (1),1,1,1,1
HIV Transcription Initiation,Reactome,3,TAF3;TAF15;POLR2A,47 (47),0.996,1,0,,5 (6),1,1,1,1
RNA Polymerase II Transcription Initiation,Reactome,3,TAF3;TAF15;POLR2A,47 (47),0.996,1,0,,5 (6),1,1,1,1
RNA Polymerase II Transcription Initiation And Promoter Clearance,Reactome,3,TAF3;TAF15;POLR2A,47 (47),0.996,1,0,,7 (8),1,1,1,1
RNA Polymerase II HIV Promoter Escape,Reactome,3,TAF3;TAF15;POLR2A,47 (47),0.996,1,0,,5 (6),1,1,1,1
Switching of origins to a post-replicative state,Reactome,3,RBX1;SKP1;CUL1,47 (47),0.996,1,0,,2 (3),1,1,1,1
Polymerase switching on the C-strand of the telomere,Reactome,1,PCNA,27 (27),0.996,1,0,,4 (7),1,1,1,1
Homology Directed Repair,Reactome,15,UBE2I;DNA2;UBE2N;H2AX;UBE2V2;BABAM2;LIG3;PARP1;BRCC3;POLE;PCNA;ATM;PPP4C;BABAM1;RAD50,139 (140),0.997,1,0,,8 (13),1,1,1,1
Cell Differentiation - Index expanded,Wikipathways,1,STAT3,58 (58),1,1,0,,0 (0),1,1,1,1
MicroRNAs in cancer - Homo sapiens (human),KEGG,31,TPM1;RHOA;CRK;VIM;GLS2;GRB2;UBE2I;EGFR;MTOR;MARCKS;PIK3R1;GLS;RDX;SHC1;HRAS;CASP3;HNRNPK;PRKCA;ROCK1;ATM;MAPK1;ITGA5;FSCN1;MAP2K1;MAP2K2;ITGB3;PDCD4;HMOX1;STAT3;CRKL;HDAC2,310 (310),1,1,0,,0 (0),1,1,1,1
Mitotic G1 phase and G1/S transition,Reactome,10,LYN;SKP1;CUL1;RBBP4;DHFR;PPP2CB;PPP2R1A;PPP2R2A;POLE;PCNA,104 (104),0.997,1,0,,4 (7),1,1,1,1
Inhibition of DNA recombination at telomere,Reactome,1,H2AX,59 (60),1,1,0,,0 (2),1,1,1,1
Recognition and association of DNA glycosylase with site containing an affected purine,Reactome,1,H2AX,59 (60),1,1,0,,0 (2),1,1,1,1
Translocation of ZAP-70 to Immunological synapse,Reactome,1,PTPN22,28 (28),0.997,1,0,,4 (5),1,1,1,1
Cardiac conduction,Reactome,10,ATP1B1;STIM1;ATP1B3;FXYD1;ATP2A2;ATP2B1;AHCYL1;ATP1A1;ITPR2;PRKACA,105 (105),0.997,1,0,,10 (11),1,1,1,1
Calcineurin-regulated NFAT-dependent transcription in lymphocytes,PID,3,CALM1;CASP3;ITCH,49 (49),0.997,1,0,,1 (1),1,1,1,1
Transcriptional regulation by RUNX3,Reactome,3,SNW1;CTNNB1;YAP1,49 (49),0.997,1,0,,6 (6),1,1,1,1
Systemic lupus erythematosus - Homo sapiens (human),KEGG,14,SNRPB;H2AX;SNRPD1;SNRPD3;ACTN1;C3;C4A;ACTN4;MACROH2A1;SSB;C5;C8A;C8B;C9,134 (136),0.997,1,0,,2 (3),1,1,1,1
miRNA regulation of DNA damage response,Wikipathways,9,CASP3;BAX;H2AX;SMC1A;RRM2B;ATM;PML;BID;RAD50,98 (98),0.997,1,0,,1 (2),1,1,1,1
NRAGE signals death through JNK,Reactome,4,ARHGEF10L;GNA13;ARHGEF12;RAC1,59 (59),0.998,1,0,,4 (4),1,1,1,1
HDR through Homologous Recombination (HRR),Reactome,5,ATM;RAD50;POLE;DNA2;PCNA,68 (68),0.998,1,0,,5 (9),1,1,1,1
RNA Polymerase I Promoter Escape,Reactome,1,UBTF,30 (30),0.998,1,0,,4 (6),1,1,1,1
Recognition and association of DNA glycosylase with site containing an affected pyrimidine,Reactome,1,H2AX,64 (65),1,1,0,,0 (2),1,1,1,1
DNA Replication,Wikipathways,2,POLE;PCNA,42 (42),0.998,1,0,,7 (7),1,1,1,1
Phosphodiesterases in neuronal function,Wikipathways,3,PDE12;GUCY1A1;GUCY1B1,52 (52),0.998,1,0,,11 (12),1,1,1,1
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,Reactome,6,MTA2;H2AX;CBX3;RBBP4;CHD4;HDAC2,79 (80),0.999,1,0,,2 (3),1,1,1,1
Meiosis,Reactome,6,H2AX;SMC3;STAG2;SMC1A;SYCP2;RAD21,79 (80),0.999,1,0,,4 (6),1,1,1,1
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),Reactome,13,UBE2I;DNA2;UBE2N;H2AX;UBE2V2;BABAM2;BRCC3;POLE;PCNA;ATM;PPP4C;BABAM1;RAD50,133 (134),0.999,1,0,,8 (13),1,1,1,1
15q13.3 copy number variation syndrome,Wikipathways,1,SERPINH1,32 (32),0.999,1,0,,1 (3),1,1,1,1
Oncogene Induced Senescence,Reactome,1,MAPK1,32 (32),0.999,1,0,,2 (2),1,1,1,1
RNA Polymerase I Transcription Initiation,Reactome,1,UBTF,32 (32),0.999,1,0,,2 (3),1,1,1,1
RNA Polymerase I Promoter Clearance,Reactome,1,UBTF,33 (33),0.999,1,0,,7 (9),1,1,1,1
Signaling by NOTCH2,Reactome,1,NCSTN,33 (33),0.999,1,0,,1 (1),1,1,1,1
Activation of the pre-replicative complex,Reactome,1,POLE,33 (33),0.999,1,0,,3 (5),1,1,1,1
FCERI mediated MAPK activation,Reactome,9,SHC1;HRAS;LYN;GRB2;PAK2;MAPK9;MAP2K4;RAC1;MAPK1,108 (108),0.999,1,0,,5 (7),1,1,1,1
RNA Polymerase I Transcription,Reactome,1,UBTF,35 (35),0.999,1,0,,7 (9),1,1,1,1
B-WICH complex positively regulates rRNA expression,Reactome,7,MYO1C;DDX21;H2AX;DEK;MYBBP1A;SF3B1;ACTB,93 (94),0.999,1,0,,2 (3),1,1,1,1
Amyloid fiber formation,Reactome,7,NAT8;APCS;H2AX;GGA1;USP9X;NCSTN;APOE,93 (94),0.999,1,0,,4 (7),1,1,1,1
Breast cancer - Homo sapiens (human),KEGG,14,SHC1;HRAS;EGFR;BAX;MTOR;CSNK1A1;PIK3R1;ARAF;IGF1;MAP2K1;MAPK1;CTNNB1;MAP2K2;GRB2,147 (147),0.999,1,0,,3 (3),1,1,1,1
Genes related to primary cilium development (based on CRISPR),Wikipathways,3,TXNDC15;ARL3;CEP192,103 (103),1,1,0,,0 (0),1,1,1,1
DNA Replication Pre-Initiation,Reactome,1,POLE,37 (37),1,1,0,,3 (5),1,1,1,1
TNFR2 non-canonical NF-kB pathway,Reactome,2,SKP1;CUL1,50 (50),1,1,0,,2 (2),1,1,1,1
Transcriptional regulation by RUNX1,Reactome,20,SMARCA2;LGALS3;H2AX;SMARCC2;CTSL;PRMT1;YAP1;GPAM;PF4;CSNK2A1;CSNK2A2;CSNK2B;PTPN11;ACTL6A;AGO2;ITCH;ITGA2B;PML;TJP1;MYL9,195 (196),1,1,0,,6 (7),1,1,1,1
Epigenetic regulation of gene expression,Reactome,12,MYO1C;MTA2;DDX21;H2AX;CBX3;RBBP4;DEK;MYBBP1A;CHD4;HDAC2;SF3B1;ACTB,139 (140),1,1,0,,13 (22),1,1,1,1
miRNAs involvement in the immune response in sepsis,Wikipathways,3,MAPK14;RELA;ICAM1,64 (64),1,1,0,,1 (1),1,1,1,1
RMTs methylate histone arginines,Reactome,4,SMARCC2;SMARCA2;PRMT1;ACTL6A,74 (74),1,1,0,,4 (4),1,1,1,1
Classical antibody-mediated complement activation,Reactome,1,IGHG1,87 (87),1,1,0,,0 (1),1,1,1,1
Type I diabetes mellitus - Homo sapiens (human),KEGG,1,HSPD1,43 (43),1,1,0,,3 (3),1,1,1,1
CD22 mediated BCR regulation,Reactome,3,PTPN6;LYN;IGHM,70 (70),1,1,0,,2 (3),1,1,1,1
Intestinal immune network for IgA production - Homo sapiens (human),KEGG,1,PIGR,47 (49),1,1,0,,2 (2),1,1,1,1
TCF dependent signaling in response to WNT,Reactome,17,CUL3;H2AX;PPP2CB;CSNK1A1;USP8;PPP2R1A;CSNK2A1;CSNK2A2;CSNK2B;PPP2R5A;YWHAZ;PPP2R5D;PPP2R5E;XPO1;CTNNB1;RBX1;RUVBL1,190 (191),1,1,0,,9 (11),1,1,1,1
Viral protein interaction with cytokine and cytokine receptor - Homo sapiens (human),KEGG,1,PF4,100 (100),1,1,0,,0 (0),1,1,1,1
GPCRs_ Other,Wikipathways,1,ADGRL2,101 (101),1,1,0,,0 (0),1,1,1,1
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,Reactome,5,PF4;ITGA2B;PRMT1;H2AX;MYL9,94 (95),1,1,0,,2 (2),1,1,1,1
Reproduction,Reactome,6,H2AX;SMC3;STAG2;SMC1A;SYCP2;RAD21,105 (106),1,1,0,,9 (11),1,1,1,1
RNA polymerase II transcribes snRNA genes,Reactome,3,RPRD1B;NCBP1;POLR2A,77 (77),1,1,0,,3 (4),1,1,1,1
Class B/2 (Secretin family receptors),Reactome,4,GNG12;GNAS;GNB1;GNB2,91 (91),1,1,0,,2 (2),1,1,1,1
Role of LAT2/NTAL/LAB on calcium mobilization,Reactome,4,SHC1;LYN;GRB2;PIK3R1,92 (92),1,1,0,,3 (7),1,1,1,1
HDACs deacetylate histones,Reactome,4,RBBP4;HDAC2;MTA2;CHD4,94 (94),1,1,0,,2 (3),1,1,1,1
ADORA2B mediated anti-inflammatory cytokines production,Reactome,8,GNG12;PRKAR1A;PRKAR2A;PRKACA;GNAS;GNB2;GNB1;PRKACB,132 (132),1,1,0,,22 (22),1,1,1,1
Oxidative Stress Induced Senescence,Reactome,7,MAPK9;MAP2K3;H2AX;RBBP4;MAP2K4;MAPK14;MAPK1,124 (125),1,1,0,,7 (9),1,1,1,1
PKMTs methylate histone lysines,Reactome,2,RBBP4;RELA,73 (73),1,1,0,,2 (2),1,1,1,1
RUNX1 regulates transcription of genes involved in differentiation of HSCs,Reactome,3,ITCH;YAP1;H2AX,85 (86),1,1,0,,4 (4),1,1,1,1
Taste transduction - Homo sapiens (human),KEGG,3,PLCB3;PRKACA;PRKACB,86 (86),1,1,0,,27 (33),1,1,1,1
Antimicrobial peptides,Reactome,4,S100A9;S100A8;ATOX1;CLU,98 (98),1,1,0,,14 (27),1,1,1,1
Ciliopathies,Wikipathways,5,PIK3R4;TAPT1;ARL3;ATXN10;USP9X,183 (183),1,1,0,,0 (0),1,1,1,1
PRC2 methylates histones and DNA,Reactome,2,RBBP4;H2AX,76 (77),1,1,0,,2 (3),1,1,1,1
Depyrimidination,Reactome,1,H2AX,64 (65),1,1,0,,5 (11),1,1,1,1
Cleavage of the damaged pyrimidine ,Reactome,1,H2AX,64 (65),1,1,0,,5 (11),1,1,1,1
Initial triggering of complement,Reactome,4,C4A;IGHG1;CFB;C3,102 (102),1,1,0,,4 (11),1,1,1,1
HATs acetylate histones,Reactome,8,ELP3;ELP1;RUVBL2;ELP2;KAT8;ACTL6A;ACTB;RUVBL1,142 (142),1,1,0,,2 (2),1,1,1,1
NoRC negatively regulates rRNA expression,Reactome,2,HDAC2;H2AX,80 (81),1,1,0,,2 (5),1,1,1,1
Meiotic recombination,Reactome,1,H2AX,66 (67),1,1,0,,2 (4),1,1,1,1
Formation of the beta-catenin:TCF transactivating complex,Reactome,3,CTNNB1;H2AX;RUVBL1,94 (95),1,1,0,,4 (4),1,1,1,1
Stimuli-sensing channels,Reactome,3,STOM;ANO10;UNC79,94 (94),1,1,0,,9 (11),1,1,1,1
DNA methylation,Reactome,1,H2AX,68 (69),1,1,0,,3 (5),1,1,1,1
Pre-NOTCH Transcription and Translation,Reactome,3,AGO2;SNW1;H2AX,95 (96),1,1,0,,3 (4),1,1,1,1
SIRT1 negatively regulates rRNA expression,Reactome,1,H2AX,71 (72),1,1,0,,4 (6),1,1,1,1
Negative epigenetic regulation of rRNA expression,Reactome,2,HDAC2;H2AX,88 (89),1,1,0,,4 (8),1,1,1,1
Senescence-Associated Secretory Phenotype (SASP),Reactome,4,MAPK1;RPS6KA1;RELA;H2AX,112 (113),1,1,0,,4 (4),1,1,1,1
Potassium Channels,Reactome,3,GNG12;GNB1;GNB2,103 (103),1,1,0,,3 (3),1,1,1,1
Condensation of Prophase Chromosomes,Reactome,1,H2AX,78 (79),1,1,0,,10 (11),1,1,1,1
Cellular Senescence,Reactome,11,MAPK9;MAP2K3;H2AX;RBBP4;MAP2K4;MAPK14;RELA;RPS6KA1;ATM;MAPK1;RAD50,186 (187),1,1,0,,9 (13),1,1,1,1
FCGR activation,Reactome,1,IGHG1,88 (88),1,1,0,,2 (3),1,1,1,1
Creation of C4 and C2 activators,Reactome,1,IGHG1,95 (95),1,1,0,,3 (10),1,1,1,1
Olfactory transduction - Homo sapiens (human),KEGG,7,CALM1;CNGA3;CAMK2A;CAMK2D;PRKACA;GNB1;PRKACB,440 (443),1,1,0,,8 (8),1,1,1,1
GPCR signaling-G alpha s Epac and ERK,INOH,13,MAP2K1;MAP2K2;AGT;GNAI2;RAP1A;KNG1;RAP1B;DBI;IGF1;GNAQ;MAPK1;GNAS;KITLG,272 (272),1,1,0,,4 (4),1,1,1,1
G alpha (s) signalling events,Reactome,4,GNG12;GNAS;GNB1;GNB2,143 (143),1,1,0,,25 (25),1,1,1,1
GPCR signaling-G alpha i,INOH,7,IGF1;GNAI2;DBI;KNG1;GNAS;AGT;KITLG,262 (262),1,1,0,,2 (2),1,1,1,1
Cytokine-cytokine receptor interaction - Homo sapiens (human),KEGG,1,PF4,295 (295),1,1,0,,0 (0),1,1,1,1
GPCR signaling-cholera toxin,INOH,12,PRKAR1A;PRKAR2A;AGT;GNAI2;KNG1;KITLG;DBI;IGF1;GNAQ;GNAS;PRKACA;PRKACB,270 (270),1,1,0,,4 (4),1,1,1,1
Olfactory Signaling Pathway,Reactome,1,GNB1,425 (425),1,1,0,,0 (0),1,1,1,1
Herpes simplex virus 1 infection - Homo sapiens (human),KEGG,42,MTOR;PDIA3;PTPN11;CASP3;SRSF1;SRSF2;SRSF3;SRSF4;SRSF5;SRSF6;SRSF7;MAVS;NECTIN2;CALR;EIF2S1;PIK3R1;B2M;EIF2B4;EIF2B3;EIF2B2;EIF2B5;FADD;BAX;CD74;DDX58;C3;ALYREF;RELA;C5;EIF2B1;ITGA5;PPP1CA;ITGB3;EIF2AK2;TAP2;TAPBP;PPP1CC;STAT2;RHEB;PML;PPP1CB;BID,498 (498),1,1,0,,1 (3),1,1,1,1
GPCR signaling-pertussis toxin,INOH,7,IGF1;GNAI2;DBI;KNG1;GNAS;AGT;KITLG,262 (262),1,1,0,,2 (2),1,1,1,1
Peptide ligand-binding receptors,Reactome,11,F2;AGT;PF4;ANXA1;C3;HEBP1;KNG1;NLN;PXMP2;C5;PSAP,207 (207),1,1,0,,9 (13),1,1,1,1
GPCR signaling-G alpha s PKA and ERK,INOH,18,MAP2K1;PRKAR1A;PRKAR2A;AGT;CRKL;GNAI2;RAP1A;KNG1;RAP1B;PRKACA;DBI;IGF1;GNAQ;MAPK1;PRKACB;GNAS;KITLG;MAP2K2,285 (285),1,1,0,,4 (4),1,1,1,1